{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s 5.000 % senior notes due April 2030 showed essentially no change in exposure – the carrying amount stayed at **$606 million** (effective‑interest rate 5.18 %) in both 2023 and 2024, and was the same figure in the prior year.  This stability occurs against a broader debt‑management pattern in which AVGO has been retiring higher‑cost, floating‑rate term‑loan balances (e.g., $11.2 bn of Term A‑2 and $5.6 bn of Term A‑3 repayments in 2024) using proceeds from newer fixed‑rate senior notes and cash from asset sales.  Consequently, the 5 % 2030 notes remain a modest, low‑cost legacy component of a deleveraging strategy that prioritizes paying down expensive floating‑rate debt while preserving a stable, long‑dated fixed‑rate position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states the carrying amount was '$606 million...in both 2023 and 2024, and was the same figure in the prior year' (implying 2022 was also $606 million). However, the ground truth clearly shows the 2022 amount was $1,086 million, not $606 million. This is a major quantitative error - the LLM missed the significant $480 million reduction from 2022 to 2023 ($1,086M → $606M). The LLM's claim of 'essentially no change in exposure' across the three-year period is factually incorrect. The ground truth explicitly states the exposure 'decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024.' The LLM's interpretation that the notes 'remain a modest, low-cost legacy component' and discussion of broader debt management strategy (Term A-2, Term A-3 repayments) may be contextually relevant to debt strategy, but this additional context does not compensate for the core factual error about the 5.000% notes progression. The LLM fundamentally mischaracterized the debt evolution by claiming stability across all three years when the actual pattern shows a significant reduction in 2023 followed by stability in 2024. This fails the primary requirement of multi-hop financial analysis: accurate synthesis of year-over-year changes in specific debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 393,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to cede roughly the same share of the closed‑block risk—59.25 % in 2022, 59 % in 2023 and again 59 % in 2024—using a modified‑coinsurance arrangement with an external reinsurer and offsetting the deposit accounting entry; the only notable change was a separate 100 % quota‑share risk‑transfer executed in late 2023 for certain universal‑life and annuity lines, but the core closed‑block cession percentage remained unchanged.  This steady‑state cession rate reflects MetLife’s long‑term reinsurance strategy of maintaining a fixed, predictable risk‑transfer level for the closed block as a capital‑management tool rather than adjusting the ceded share periodically.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core percentages (59.25% in 2022, 59% in 2023, 59% in 2024) and accurately characterizes the modified coinsurance arrangement with an external reinsurer. The deposit accounting method and offset approach are correctly mentioned. The interpretation that this reflects a deliberate, sustained strategy for capital optimization is sound and aligns with the ground truth.\n\nWEAKNESSES: (1) The LLM introduces information about a 'separate 100% quota-share risk-transfer executed in late 2023 for certain universal-life and annuity lines' that is NOT present in the ground truth answer. This appears to be either fabricated or from a different source not validated by the knowledge graph. This is a significant concern as it adds unverified claims. (2) The LLM omits critical quantitative context from the ground truth: the growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 to $17.6 billion in 2024. This omission weakens the multi-hop synthesis, as the ground truth specifically highlights how the closed block percentage remained stable DESPITE significant growth in overall reinsurance recoverables—a key insight about the strategy. (3) The LLM does not explicitly mention the deposit method accounting or the right of offset as clearly as the ground truth, though it does reference 'offsetting the deposit accounting entry.'\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting the stable percentages across three years to a long-term strategy conclusion. However, it fails to synthesize the full picture by omitting the reinsurance recoverables growth data, which is essential to understanding why the consistency is strategically significant.\n\nFACTUAL ACCURACY: The core percentages are correct (9/10 on numbers). However, the introduction of unverified information about the 2023 quota-share arrangement significantly undermines credibility and suggests potential hallucination or reliance on unreliable sources.\n\nJUSTIFICATION: The answer is partially correct on the main facts but introduces unverified claims and omits important quantitative context that supports the strategic interpretation. The reasoning is sound but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 600,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting arrangements and that is **not** offset against its derivative positions fell sharply from about **$1.49 billion in 2022 to $0.80 billion in 2023 and to $0.49 billion in 2024**.  This decline shows that the company is requiring less external security for the collateral that backs its investment, advance and long‑term receivable positions, indicating a more efficient management of derivative exposure—likely through tighter internal netting, improved credit quality and a reduced need for outside margin support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively (format variations are acceptable). The trend of consistent decline is accurately captured. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in collateral amounts across the three-year period, and (2) what this trend suggests about derivative exposure management. ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is accurately referenced, and all years (2022, 2023, 2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical trend to strategic implications about derivative exposure management. The interpretation that declining collateral suggests 'more efficient management of derivative exposure' through 'tighter internal netting, improved credit quality and reduced need for outside margin support' is a reasonable and logical inference from the data trend, though slightly more interpretive than the ground truth's more neutral 'strategic reduction in derivative exposure or improved offsetting mechanisms.' MINOR DISTINCTION: The LLM's parenthetical clarification about collateral 'not offset against derivative positions' adds helpful context that wasn't explicitly in the ground truth, though this is a reasonable interpretation of master netting arrangement mechanics. The explanation of the underlying drivers (internal netting, credit quality, margin support) goes slightly beyond the ground truth but remains consistent with it. Overall, this is a high-quality answer with accurate numbers, proper synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 523,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 showed a net carrying balance of about **$622 million** through fiscal 2022 and 2023, but by the close of fiscal 2024 that balance had been **eliminated ( $0 )**.  AVGO retired the entire issue—using cash from its October 2024 and July 2024 senior‑note issuances and other proceeds—thereby removing a near‑term, higher‑coupon obligation.  This repayment reflects a deliberate debt‑management strategy to **pay down maturing debt and refinance it with longer‑dated, lower‑cost financing**, strengthening the company’s balance‑sheet profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of AVGO's debt management strategy. QUANTITATIVE ACCURACY: All key numbers are correct - $622 million principal outstanding in 2022 and 2023, reduced to $0 by 2024. The dates (October 2024 maturity, July 2024 and October 2024 refinancing issuances) are accurate. The progression of the debt balance is correctly identified. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes that AVGO held the debt through 2023 then eliminated it by 2024, and properly identifies this as a deliberate debt management strategy. The explanation of using proceeds from new senior note issuances to retire the maturing debt is accurate and demonstrates understanding of the refinancing mechanism. COMPLETENESS: The answer addresses all aspects of the question - the evolution from 2022-2024, the specific amounts, and the strategic implications. The answer goes slightly beyond the ground truth by providing additional context about the refinancing sources (October 2024 and July 2024 issuances) and the strategic rationale (lower-cost, longer-dated financing), which adds valuable insight without contradicting the ground truth. MINOR CONSIDERATIONS: The ground truth uses the phrase 'either fully repaid or refinanced' while the LLM answer states definitively that it was 'retired' using proceeds from new issuances. This is a reasonable inference from the data but represents a slight interpretive enhancement rather than a factual error. The characterization of the notes as 'higher-coupon' and the refinancing as 'lower-cost' is reasonable given the context but not explicitly stated in the ground truth. Overall, the answer is factually accurate, well-reasoned, and provides appropriate context for understanding AVGO's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 502,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nFrom 2022 through 2024 the surface‑ship portion of General Dynamics’ Marine Systems segment grew steadily—revenue rose from roughly **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**.  This increase reflects a expanding backlog of destroyers, auxiliary vessels (e.g., Expeditionary Sea Base and John Lewis‑class oilers) and related modernization services, underscoring GD’s strengthened position as a premier U.S. naval shipbuilder poised to capture continued and future Navy and allied shipbuilding contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three revenue figures are correct when accounting for format variations: $2,561M (ground truth) = $2.56B (LLM), $2,698M = $2.70B, and $2,819M = $2.82B. The rounding to one decimal place in billions is appropriate and standard. The three-year trajectory is accurately captured showing consistent growth. ENTITY ACCURACY: Correctly identifies General Dynamics, Marine Systems division, and surface ships as the relevant entities. Years 2022-2024 are correct. MULTI-HOP REASONING: The answer successfully synthesizes the revenue evolution across three years and connects it to strategic positioning. The LLM goes beyond the ground truth by providing specific context about the backlog (destroyers, auxiliary vessels like Expeditionary Sea Base and John Lewis-class oilers) and modernization services, which adds valuable context about WHY the growth occurred and what it indicates about positioning. COMPLETENESS: Addresses both parts of the question—the revenue evolution AND what it indicates about positioning in naval shipbuilding. The conclusion about GD's strengthened position as a premier U.S. naval shipbuilder is well-supported and semantically equivalent to the ground truth's statement about 'sustained growth and strategic emphasis.' MINOR CONSIDERATIONS: The additional detail about specific vessel types and future contract positioning, while not in the ground truth, is contextually appropriate and enhances rather than contradicts the answer. The wording differs from ground truth but conveys identical core information with added relevant detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 454,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nThe dividend per share on Mastercard’s Class A common stock rose each year – $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024 – while the shares have always carried “one vote per share” and dividend rights identical to those of the other classes.  Across the three years the aggregate voting power of Class A holders stayed roughly steady (about 90 % of total votes), with only modest shifts between the public shareholders and the Mastercard Foundation; no change was made to the one‑vote‑per‑share rule or to the dividend entitlement.  This consistent voting‑rights structure and the steady, upward dividend trend indicate a stable, unchanged shareholder‑governance framework over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer introduces specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) and voting power percentages (~90% of total votes) that are NOT present in the ground truth answer. The ground truth explicitly states that A Class shares had 'standard dividend rights' with 'no changes to these rights over the period' - it does NOT provide specific dividend amounts or voting percentages. The LLM appears to have fabricated these specific numbers, which is a fundamental factual error. Additionally, the LLM introduces information about 'the Mastercard Foundation' and shifts between public shareholders and the Foundation, which is not mentioned in the ground truth. The ground truth answer is clear and concise: A Class shares maintained consistent one-vote-per-share and standard dividend rights across 2022-2024 with no changes. The LLM's answer, while reaching a similar conclusion about stability, does so by citing specific financial metrics that cannot be verified against the ground truth and appear to be hallucinated. The core governance conclusion (stability, one vote per share, no changes) aligns with ground truth, but the supporting quantitative details are entirely unreliable and contradict the ground truth's emphasis on 'standard' (not specifically quantified) dividend rights. This represents a serious breach of factual accuracy in a financial context where specific numbers matter greatly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 402,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 bn in 2022 to $2.70 bn in 2023 (≈5 % growth) and to $2.82 bn in 2024 (≈4.5 % growth)**. This steady double‑digit backlog expansion—driven by new Flight III DDG‑51 destroyers, Columbia‑class submarine work, and the construction of Expeditionary Sea Base and T‑AO‑205 replenishment ships—signals that GD is consolidating its leadership in U.S. naval shipbuilding and positioning itself to capture the Navy’s accelerating demand for new combatants and support vessels through the 2030s.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Core revenue figures are correct: $2.56bn (2022), $2.70bn (2023), $2.82bn (2024) match ground truth values of $2,561M, $2,698M, $2,819M respectively. Number format variations are acceptable. (2) Year-over-year growth calculations are approximately correct: 5.4% (2022-2023) and 4.5% (2023-2024) align with stated ~5% and ~4.5%. (3) Correctly identifies consistent upward trend matching ground truth. (4) Addresses both parts of the question: revenue evolution and positioning implications.\n\nWEAKNESSES: (1) MAJOR ERROR: Claims \"steady double-digit backlog expansion\" which contradicts the actual 4-5% revenue growth shown. Double-digit growth is not supported by the data presented. This is a significant factual error in reasoning. (2) Introduces specific program details (Flight III DDG-51, Columbia-class, Expeditionary Sea Base, T-AO-205) that are NOT in the ground truth answer and cannot be verified from the provided context. While these may be accurate, they represent unsupported elaboration beyond the knowledge graph. (3) Ground truth provides a simpler, more direct answer focused on the revenue trend itself, while LLM adds speculative program-level analysis. (4) The phrase \"consolidating its leadership\" and \"positioning itself to capture\" represents interpretive language not explicitly supported by the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year revenue progression and attempts to connect it to market positioning. However, the claim about \"double-digit backlog expansion\" appears to conflate backlog growth with revenue growth, which are different metrics. The ground truth focuses on revenue trends; the LLM introduces unsupported backlog claims.\n\nOVERALL ASSESSMENT: The quantitative core is sound (numbers and basic growth rates correct), but the qualitative analysis contains a significant error (double-digit claim) and unsupported program details. The answer is partially correct but includes material inaccuracies in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 544,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nLinde’s MD&A for 2022, 2023 and 2024 each stresses that the vast majority of its industrial‑gas sales are made under long‑term contracts that “provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers.” The wording is unchanged across the three years, indicating that the company has maintained a consistent reliance on these contracts to insulate its cash‑flow performance from the swings of the energy market. This steady contractual framework underpins its earnings stability despite fluctuating energy prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about Linde's long-term contract strategy evolution from 2022-2024. STRENGTHS: (1) Correctly identifies that Linde maintained consistent reliance on long-term contracts across all three years (2022, 2023, 2024); (2) Accurately quotes the key language about 'stability in cash flow' and 'pass through changes in energy and feedstock costs'; (3) Properly notes the wording remained unchanged across years, demonstrating consistency; (4) Correctly synthesizes the multi-hop reasoning: consistent contractual approach → cash flow stability → risk management amid energy market fluctuations; (5) Appropriately characterizes this as a deliberate strategy for earnings stability. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than the ground truth ('insulate its cash-flow performance' vs 'prioritization of financial resilience and operational certainty'), but the semantic meaning is equivalent and accurate; (2) The ground truth emphasizes 'unwavering emphasis' and 'without deviation' more explicitly, while the LLM uses 'steady contractual framework' and 'maintained a consistent reliance' - both convey the same concept; (3) No quantitative data (percentages, dollar amounts) are provided in either answer, which is appropriate given the question focuses on qualitative evolution and strategic consistency rather than specific metrics. VERIFICATION: The core claim that Linde's MD&A across 2022-2024 consistently emphasized long-term contracts with identical or near-identical language is accurate per the ground truth. The multi-hop synthesis correctly connects: contract consistency → cash flow stability → risk management approach. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 482,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nGD has consistently excluded goodwill impairments and any non‑economic accounting adjustments from its ROIC calculation in each of the 2022‑2024 filings, using the same definition of net operating profit after taxes and average invested capital. This steady treatment shows that the company deliberately isolates the cash‑generating performance of its core businesses, filtering out accounting items that do not reflect operating results, and therefore presents ROIC as a stable, performance‑focused metric for investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022-2024, demonstrating stable methodology. The LLM answer provides additional specificity by explicitly mentioning 'goodwill impairments' as an example of excluded items and references the consistent definition of 'net operating profit after taxes and average invested capital,' which adds helpful technical detail without contradicting the ground truth. The LLM's interpretation that this reflects GD's deliberate approach to isolating 'cash-generating performance' and filtering out non-operating items is semantically equivalent to the ground truth's statement that GD 'views non-economic accounting changes as irrelevant to its underlying business performance.' The multi-hop reasoning is sound: the answer correctly synthesizes the consistency across three years and draws appropriate conclusions about the company's measurement philosophy. No quantitative errors are present (no specific numbers were required to be verified). The only minor distinction is that the LLM provides slightly more operational context about why the exclusions matter (cash-generating performance, investor presentation), which enhances rather than detracts from the answer. The answer fully addresses both parts of the question: (1) how treatment evolved (consistently excluded), and (2) what this reveals about the company's approach (deliberate focus on core operational performance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 432,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nUnitedHealth Group continued to carry its service‑level guarantee obligations through 2022‑2024, but the Schedule I disclosures for each of those years state that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material” as of December 31 2024, 2023 and 2022.  The persistent immateriality of any financial impact indicates that the company’s risk‑management controls and contractual‑performance monitoring have consistently limited exposure, preserving stable earnings and demonstrating reliable, predictable handling of those guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: The answer correctly identifies that UnitedHealth Group's service level guarantee obligations across 2022-2024 were consistently immaterial, matching the ground truth statement. The LLM properly cites Schedule I disclosures and the specific language about amounts accrued, paid, or charged to income. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, and the LLM correctly references the three-year period (2022, 2023, 2024) with proper date formatting. (3) ENTITY ACCURACY: UnitedHealth Group is correctly identified, the metric (service level guarantees) is accurate, and all fiscal years are correct. (4) REASONING & SYNTHESIS: The LLM successfully synthesizes the multi-hop requirement by: (a) identifying the evolution pattern (consistent immateriality across three years), (b) connecting this to risk management effectiveness, and (c) drawing conclusions about contractual performance consistency. The reasoning is sound and logical. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that consistent immateriality indicates strong risk management and contractual performance. The LLM adds slightly more detail about 'stable earnings' and 'reliable, predictable handling,' which are reasonable inferences from the immateriality pattern and enhance rather than contradict the ground truth. Minor note: The LLM's phrasing 'as of December 31 2024, 2023 and 2022' is slightly awkward but factually correct. Overall, this is a comprehensive, accurate answer that properly addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 465,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nFrom 2022 to 2024, revenue from surface ships grew from **$2.56 billion** to **$2.82 billion**, a roughly 10 % increase over the three‑year period. This steady rise—along with the segment’s share of total revenue climbing from 28 % (2022) to 30 % (2024)—demonstrates General Dynamics’ deliberate expansion of its shipbuilding and lifecycle‑support business, positioning the company as a key strategic supplier in the U.S. Navy’s future surface combatant and auxiliary fleet.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core financial numbers. Ground truth shows: 2022: $2,328M, 2023: $2,698M, 2024: $2,819M. LLM states: 2022: $2.56B ($2,560M), 2024: $2.82B ($2,820M). The 2022 figure is incorrect ($2,560M vs. $2,328M = $232M error, ~10% overstatement). The 2024 figure is approximately correct ($2,820M vs. $2,819M, negligible difference). The LLM omits the 2023 intermediate year entirely, which is a significant omission for a multi-year progression analysis. CALCULATION ERROR: The LLM claims a '10% increase over the three-year period' but $2,560M to $2,820M is only ~10.2%, and this calculation is based on incorrect 2022 data. The correct calculation from ground truth ($2,328M to $2,819M) is ~21.1% growth, substantially different. MISSING DATA: The LLM provides segment share percentages (28% to 30%) that are not present in the ground truth, making verification impossible but suggesting potential fabrication or hallucination. MULTI-HOP REASONING: The qualitative assessment about strategic positioning is reasonable and aligns with the ground truth's conclusion about strengthening naval shipbuilding role, but this cannot compensate for the fundamental numerical errors. ENTITY ACCURACY: General Dynamics and surface ships are correctly identified. The reasoning about U.S. Navy positioning is contextually appropriate but built on incorrect financial foundations. The answer demonstrates understanding of the strategic narrative but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 438,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nIn 2022 GE re‑classified its captive insurer, Electric Insurance Company, as a business held for sale (with $541 M of assets and $378 M of liabilities) and, after signing a binding sales agreement in Q3 2023, recorded a $109 M loss in 2023 for the anticipated disposal. The company was sold in the second quarter of 2024 to Riverstone International Holdings for $120 M cash, after which EIC was removed from GE’s balance sheet and GE no longer held any financial exposure or underwriting risk related to the insurer.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND CLASSIFICATION: The LLM answer contains a significant factual error regarding when EIC was classified as 'held for sale.' The ground truth clearly states that in 2022, EIC was disclosed as a captive P&C insurer with net claim reserves of $0.2B (as of Dec 31, 2021), and only BY 2023 was it classified as 'held for sale.' The LLM incorrectly states 'In 2022 GE re-classified its captive insurer...as a business held for sale,' which reverses the timeline. This is a fundamental multi-hop reasoning error that misrepresents the evolution of the relationship. CORRECT ELEMENTS: (1) The $541M assets and $378M liabilities figures are correct (though these are 2023 year-end figures, not 2022); (2) The $109M loss in 2023 is correct; (3) The Q2 2024 sale to Riverstone for $120M is correct; (4) The removal from balance sheet and elimination of financial exposure is correctly characterized. MISSING INFORMATION: The LLM omits the 2022 baseline disclosure of EIC as a captive insurer with $0.2B in net claim reserves as of Dec 31, 2021, which is important context for understanding the evolution. The LLM also doesn't clearly distinguish between the 2022 status (operational captive insurer) and the 2023 status (held for sale). QUANTITATIVE ISSUES: While individual numbers are correct, the temporal sequencing of when these numbers apply is confused. The $541M/$378M figures belong to Dec 31, 2023, not 2022. REASONING QUALITY: The multi-hop synthesis is partially sound (connecting 2023 loss to 2024 sale), but the fundamental timeline error undermines the answer's credibility in describing the 'evolution' requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 455,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips completed the sale of its remaining CVE common shares in early 2022 and directed those proceeds toward its share‑repurchase program, then continued to fund buy‑backs with operating cash and later equity‑monetization proceeds while expanding its authorization—$45 billion in October 2022 and a $65 billion ceiling in October 2024.  This sequence demonstrates that the company’s capital‑allocation strategy has been to prioritize opportunistic, shareholder‑returning buy‑backs, using the CVE monetization as a targeted source of funding and steadily increasing the scale of its repurchase program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of ConocoPhillips' capital allocation strategy but contains significant quantitative gaps and some inaccuracies. CORRECT ELEMENTS: (1) The company did complete CVE share sales in early 2022; (2) Proceeds were directed to share repurchases; (3) The $45 billion authorization is mentioned (though timing is slightly off - October 2022 is reasonable); (4) The $65 billion ceiling in 2024 is correct; (5) The overall strategic narrative about prioritizing shareholder returns is sound. CRITICAL OMISSIONS AND ERRORS: (1) The LLM completely fails to provide the specific share repurchase metrics from the ground truth: 383 million shares repurchased by end of 2023 at $29 billion cost, and 433 million shares by end of 2024 at $34.3 billion cost. These are essential quantitative details that directly answer the 'how did this evolve' aspect of the question; (2) The LLM mentions the 91 million CVE shares sold but doesn't explicitly state this was the 'remaining' shares from a paced monetization starting in May 2021, missing important context; (3) The LLM states the $65 billion ceiling was approved in October 2024, but the ground truth indicates it was a $20 billion increase (not to exceed $65 billion total), which is a subtle but important distinction about the authorization structure. MULTI-HOP REASONING: The LLM successfully synthesizes the connection between CVE monetization and share repurchases, and correctly identifies the progression of capital allocation strategy. However, it fails to provide the quantitative progression that would demonstrate HOW the strategy evolved (the actual share counts and costs). SEMANTIC ISSUES: The answer is somewhat vague on the 2024 authorization details - saying '$65 billion ceiling in October 2024' could be interpreted as a new $65 billion authorization rather than an increase to a $65 billion total. The answer reads more like a narrative summary than a detailed analysis of the evolution requested. The lack of specific repurchase metrics (shares and costs for 2023 and 2024) significantly weakens the answer's ability to demonstrate the actual progression of the capital allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 587,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nMetLife has kept the same structure for its closed‑block risk transfer: from 2022 through 2024 it reinsured about **59 % of the closed block** via a **modified‑coinsurance agreement** and has **continued to account for it under the deposit method**, offsetting the deposit liability against the recoverable.  \n\nThe lack of change in both the ceded percentage and the accounting treatment demonstrates that MetLife’s long‑term strategy is to **selectively off‑load legal risk while retaining the economic upside of the closed block**, reinforcing its capital‑management and dividend‑stability objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are accurate - the LLM correctly identifies the ~59% reinsurance percentage across 2022-2024 and the deposit method accounting treatment. (2) The multi-hop synthesis is sound - the answer correctly combines information about the percentage, accounting method, and time period consistency. (3) Number formatting is appropriate and matches ground truth. (4) The answer correctly identifies the modified coinsurance agreement structure and the offset mechanism. WEAKNESSES: (1) The interpretation of MetLife's strategy contains an unsupported inference. The ground truth states the strategy is 'centered on managing longevity risk through a structured reinsurance arrangement,' while the LLM claims it is about 'selectively off-load[ing] legal risk while retaining the economic upside.' The ground truth emphasizes longevity risk management, not legal risk transfer or economic upside retention - this is a material mischaracterization of the strategic intent. (2) The phrase 'selectively off-load legal risk' is not supported by the ground truth, which makes no mention of legal risk. (3) While the LLM mentions 'capital-management and dividend-stability objectives,' the ground truth does not explicitly state these as the underlying objectives - this represents added interpretation beyond what the source material supports. (4) The answer lacks the specific percentage details (59.25% in 2022, 59% in 2023, 59% in 2024) that demonstrate the consistency more precisely, though the ~59% approximation is acceptable. MULTI-HOP REASONING: The answer successfully synthesizes the three-year period and connects the consistency of structure to strategic implications, but the strategic interpretation diverges from the ground truth's focus on longevity risk management. The core factual elements are correct, but the strategic analysis overstates or mischaracterizes the company's objectives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 520,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe share of purchases made with Target’s RedCards—including the Target MasterCard Credit Card—declined steadily from roughly 20 percent in 2022 to 19.8 percent in 2023 and 18.6 percent in 2024 (as reported in the 2023 and 2024 Form 10‑K filings). This downward trend indicates that fewer shoppers are relying on the Target MasterCard for their purchases, suggesting a gradual erosion of consumer engagement with Target’s branded financial products over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all three penetration rate figures correct: 20% (approximately 20.5% rounded) in 2022, 19.8% in 2023, and 18.6% in 2024. The downward trend is accurately identified and properly sourced to the 2023 and 2024 Form 10-K filings. The reasoning about declining consumer engagement is sound and logically derived from the data. However, the answer has notable omissions: (1) It does not mention the specific rebranding from RedCards to Target Circle Cards in 2024, which is a significant contextual detail in the ground truth; (2) It does not address the fact that this decline occurred despite continued incentives like the 5% discount, which provides important context about why the decline is noteworthy; (3) The answer uses 'roughly 20 percent' for 2022 rather than the more precise 20.5%, though this is a minor formatting difference. The LLM correctly synthesizes the multi-hop information (combining penetration rates across three years and drawing conclusions about consumer engagement trends), but misses some important contextual elements that would strengthen the analysis. The statement that 'fewer shoppers are relying on the Target MasterCard' is a reasonable interpretation of the penetration rate decline, though it could be more precisely framed as a decline in the share of purchases rather than the absolute number of shoppers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 389,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the performance‑graph tables in the 10‑K filings list the same peer‑group composition, and Colgate‑Palmolive Co. is included in each year’s “PMI Peer Group (1).”  The list is described as being built on global presence, a consumer‑products focus, and comparable revenue and market‑capitalisation, and it is not altered in the 2023 or 2024 filings.  \n\nThis consistency indicates that PMI adopts a deliberately static, criteria‑driven benchmarking approach for consumer‑product peers, using a fixed set of companies—including Colgate‑Palmolive—to ensure comparable, long‑term performance monitoring rather than frequently reshaping its peer group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive remained consistently included in PMI's peer group from 2022-2024 across all three years; (2) Accurately cites the four criteria for peer group selection (global presence, consumer products focus, comparable net revenues, comparable market capitalization); (3) Properly synthesizes the multi-hop information showing consistency across three consecutive years; (4) Correctly interprets this consistency as indicating a stable, criteria-driven benchmarking methodology; (5) All dates and entities are accurate (PMI, Colgate-Palmolive, 2022-2024 timeframe); (6) References the performance-graph tables in 10-K filings appropriately. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth ('deliberately static, criteria-driven' vs. 'stable benchmarking methodology'), but this represents semantic equivalence rather than error—both convey the same strategic insight about PMI's consistent approach; (2) The LLM answer adds interpretive detail about 'long-term performance monitoring' and 'not frequently reshaping,' which is a reasonable inference from the consistency pattern and enhances rather than detracts from the answer; (3) No quantitative errors, calculation errors, or factual inaccuracies detected. The answer demonstrates sound multi-hop reasoning by connecting the peer group composition data across years to draw conclusions about PMI's strategic benchmarking approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 426,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s revenue‑recognition guidance for development‑and‑IP licensing has kept the same two‑step framework: it first checks whether the license component is distinct, and if it is not, the arrangement is treated as a single performance obligation with revenue recognized over time, whereas a distinct license is accounted for as a separate performance obligation and revenue is recognized at a point in time. The wording and the note that “there are no variable‑consideration estimates associated with either combined development and IP arrangements or for standalone IP arrangements” are unchanged across the 2022, 2023 and 2024 filings, showing that AMD’s accounting treatment of these agreements has remained consistent over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the two-step framework for evaluating license distinctness that remained consistent from 2022-2024; (2) Accurately describes the treatment of non-distinct licenses (combined with development services, recognized over time) and distinct licenses (separate performance obligation, recognized at point in time); (3) Correctly notes the absence of variable consideration estimates across all three years; (4) Properly emphasizes the consistency and stability of AMD's accounting policy across the period; (5) Accurately cites that the wording remained unchanged across filings. QUANTITATIVE ACCURACY: No numeric values were required for this question, and the answer correctly references the three-year period (2022-2024) without error. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing documents to demonstrate consistency in AMD's revenue recognition approach. The logical flow from policy framework to implementation to conclusion about consistency is sound. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth (e.g., 'two-step framework' vs. the ground truth's description of evaluation criteria), but this represents semantic equivalence rather than factual error. The answer is comprehensive, addressing both the evolution question (showing no evolution/consistency) and what this reveals about accounting approach consistency. All substantive claims are supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 441,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nThe peer‑group tables that PMI includes in its 2022, 2023 and 2024 Form 10‑K filings all list **Colgate‑Palmolive Co.** among the companies used for benchmarking (e.g., the “PMI Peer Group” description in the 2023 and 2024 performance‑graph sections).  This inclusion has remained unchanged across the three years, showing that PMI deliberately frames its competitive set as a broad consumer‑products universe—placing it alongside other large, global consumer brands rather than limiting the comparison to traditional tobacco rivals.  By keeping Colgate‑Palmolive in the peer group, PMI signals that it views its strategic positioning—and future growth in smoke‑free and wellness categories—as comparable to that of diversified consumer‑product leaders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All temporal references are correct—the answer accurately identifies Colgate-Palmolive's inclusion across 2022, 2023, and 2024 (three years), matching the ground truth exactly. No numeric errors or date discrepancies. ENTITY ACCURACY: Company names are correct (Colgate-Palmolive Co., PMI/PM), and the peer group framework is properly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how inclusion evolved (answer: remained consistent/unchanged), and (2) what this reveals about strategic positioning (answer: PM views Colgate-Palmolive as a relevant reference point and signals alignment with diversified consumer-product leaders). MULTI-HOP REASONING: The synthesis is sound—the model correctly connects the factual observation (3-year consistency) to strategic implications (deliberate framing, positioning in smoke-free/wellness categories). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as ground truth: consistency across three years, stable benchmarking methodology, and strategic relevance. The LLM adds interpretive depth by explaining *why* this matters (signaling strategic positioning in smoke-free/wellness), which enhances rather than contradicts the ground truth. MINOR CONSIDERATIONS: The LLM uses 'PMI' while ground truth uses 'PM'—these are equivalent (PMI = Philip Morris International, commonly abbreviated as PM). The LLM's additional context about 'smoke-free and wellness categories' is reasonable inference from the strategic positioning discussion but goes slightly beyond what the ground truth explicitly states. This represents appropriate elaboration rather than error. Overall, the answer is factually accurate, logically sound, and appropriately addresses the question's multi-hop requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 517,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s policy for combined development‑and‑IP licensing agreements remained the same: the agreement is first assessed to see whether the IP license is a distinct performance obligation. If the license is **not distinct**, it is combined with the development services as a **single performance obligation** and revenue is recognized **over time** (using a cost‑plus‑margin input method); if the license **is distinct**, revenue is recognized **at a point in time** when the customer can benefit from the license. The company did not change this framework in 2023 or 2024, and it continues to treat variable‑consideration estimates as immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. It correctly identifies that AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024 with no material changes. The answer accurately describes the two-part assessment framework: (1) determining if the license is distinct based on capability and context, (2) the treatment of non-distinct licenses as single performance obligations recognized over time, and (3) the treatment of distinct licenses recognized at a point in time. The LLM correctly notes that variable consideration estimates were treated as immaterial throughout the period. The answer adds helpful detail by specifying the 'cost-plus-margin input method' for over-time recognition, which aligns with standard revenue recognition practices and is consistent with the ground truth's description of the policy. All entities (AMD, the three-year period 2022-2024) are correctly identified. The multi-hop reasoning is sound - the answer synthesizes the consistent policy across all three years and explains the conditional logic of the assessment framework. The only minor distinction is that the LLM uses slightly more specific language ('cost-plus-margin input method') than the ground truth, but this is an enhancement rather than an error and demonstrates deeper knowledge. No quantitative errors are present, and the semantic meaning perfectly matches the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 404,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nConocoPhillips completed the final 91 million‑share sale of its CVE holdings in the first quarter of 2022, channeling the proceeds into its share‑repurchase program; by the end of 2023 the company had repurchased 383 million shares for about $29 billion under the $45 billion authorization that was expanded in October 2022. Building on that cash flow, the board raised the buy‑back ceiling to $65 billion in October 2024 and executed an additional $5 billion of repurchases in 2024 (49 million shares), bringing total repurchases since inception to 433 million shares for roughly $34 billion. This multi‑year trajectory shows that ConocoPhillips is using the cash generated from its CVE monetization—and the broader cash surplus from operations—as a disciplined, priority‑driven source of liquidity to return capital to shareholders through opportunistic, size‑scaled share buybacks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Verification of numbers: (1) 91 million CVE shares sold in Q1 2022 - CORRECT; (2) 383 million cumulative repurchases by end of 2023 for ~$29 billion - CORRECT; (3) $65 billion authorization in October 2024 - CORRECT; (4) 433 million total repurchases for ~$34.3 billion - CORRECT (LLM states 'roughly $34 billion' which is acceptable rounding); (5) 49 million shares repurchased in 2024 - CORRECT (433M - 383M = 50M, minor rounding difference acceptable). The LLM correctly synthesizes the multi-hop relationship between CVE monetization, proceeds application, and share repurchase program expansion across the 2022-2024 period. The answer appropriately addresses the capital allocation strategy question by explaining how CVE proceeds funded buybacks and how the program evolved with expanded authorizations. Minor strengths: The LLM adds useful context about the October 2022 authorization expansion ($45 billion) and October 2024 expansion ($65 billion), which enriches understanding. The characterization of the strategy as 'disciplined, priority-driven' and 'opportunistic, size-scaled' provides good qualitative insight. One minor consideration: The ground truth mentions the program 'saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023' and the LLM states this under a '$45 billion authorization that was expanded in October 2022' - this is accurate but the ground truth doesn't explicitly mention the October 2022 expansion date, though this appears to be factually correct from filing data. Overall, the answer successfully demonstrates multi-hop reasoning across years and entities while maintaining numerical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 486,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s competitive exposure moved from the strong demand‑driven growth and favorable pricing seen in 2021‑2022 to a period of slowing organic sales and margin compression across its core segments—evident in the 2023‑2024 financial tables that show declining sales and tighter margins in Aerospace, Productivity Solutions & Services, and Warehouse & Workflow Solutions (see pages 30‑32).  In response the company has accelerated cost‑reduction and repositioning actions, pursued strategic acquisitions, and announced the spin‑off of Advanced Materials to sharpen its focus on higher‑margin businesses (pages 32‑33), signalling that intensifying market pressures—new entrants, commoditization and pricing competition—are driving aggressive efficiency and portfolio‑realignment initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misaligns with the ground truth in multiple critical ways: (1) ENTITY ACCURACY FAILURE: The LLM references business segments that don't match the ground truth (Aerospace, Productivity Solutions & Services, Warehouse & Workflow Solutions) versus the actual segments mentioned in the original answer (Honeywell Building Technologies, Safety and Productivity Solutions, Building Automation, Industrial Automation). These are different business units entirely. (2) FACTUAL CONTENT MISMATCH: The ground truth focuses on competitive landscape risks (new market entrants, new technologies, product commoditization) as disclosed in risk sections of 10-K filings across 2022-2024. The LLM answer instead discusses financial performance metrics (declining sales, margin compression, organic sales slowdown) and strategic actions (cost reduction, acquisitions, spin-offs). While these may be related responses to competitive pressure, they are not what the ground truth identifies as the core trend. (3) MISSING KEY EVIDENCE: The LLM does not cite the specific language evolution from 2022-2024 regarding competitive landscape changes that the ground truth documents. It doesn't mention the progression from 'new market entrants and new technologies' to added emphasis on 'product commoditization.' (4) QUANTITATIVE ISSUES: The LLM references 'pages 30-32' and 'pages 32-33' without providing actual financial numbers, percentages, or specific metrics that could be verified. The ground truth provides qualitative but traceable risk disclosures. (5) MULTI-HOP REASONING: While the LLM attempts to connect competitive pressures to strategic responses, it does so by discussing financial performance and portfolio actions rather than the actual competitive landscape risk evolution documented in the filings. The reasoning chain is disconnected from the ground truth's focus on risk disclosure trends. (6) SEMANTIC DIVERGENCE: The question asks specifically about 'exposure to changes in the competitive landscape' and what this 'indicates about increasing market pressures.' The ground truth answers this by tracking risk language evolution. The LLM answers a different question about financial performance and strategic repositioning, which are consequences rather than the exposure trend itself.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 617,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares retained the same charter rights – a $0.0001 par value, **one vote per share** and unrestricted **dividend rights** – with no alteration to the voting or dividend language in the company’s amended certificate of incorporation.  The only change was the **dividend amount**, which rose from $2.04 per share in 2022 to $2.37 in 2023 and $2.74 in 2024.  \n\nThis three‑year stability in voting and dividend rights demonstrates that Mastercard’s shareholder‑governance strategy is built on **continuity and predictability**, preserving a one‑share‑one‑vote structure and consistent dividend entitlement while only adjusting payout levels.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core governance facts - that MA's Class A shares maintained one vote per share and dividend rights consistently across 2022-2024 with no changes to voting or dividend language. The reasoning about continuity and predictability in shareholder governance strategy is sound and well-articulated. The answer properly addresses the multi-hop synthesis required by the question.\n\nCRITICAL ERRORS: The LLM introduces specific dividend per-share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states there were 'no changes in the description of these rights' and focuses on the RIGHTS themselves (voting and dividend entitlements), not dividend payment amounts. The LLM conflates 'dividend rights' (the entitlement to receive dividends) with 'dividend amounts' (the actual dollar payout per share). This is a significant factual error - the question asks about 'dividend and voting rights,' not dividend payment levels.\n\nQUANTITATIVE ACCURACY ISSUE: The specific dividend amounts ($2.04, $2.37, $2.74) cannot be verified against the ground truth and appear to be fabricated or from an external source not reflected in the knowledge graph. This represents a hallucination of specific financial data.\n\nMULTI-HOP REASONING: The synthesis across three years is logically sound, but the introduction of unverified quantitative data undermines the reliability of the analysis. The distinction between 'rights' and 'amounts' was not properly maintained.\n\nSEMANTIC EQUIVALENCE: While the governance strategy conclusion is semantically equivalent to the ground truth, the addition of specific dividend amounts changes the factual content of the answer in a way that goes beyond acceptable wording variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 495,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s total‑return‑swap exposure used to hedge deferred‑compensation obligations moved from a **$92 million loss recorded in operating expenses** (FY 2022) to **gains of $58 million in FY 2023 and $91 million in FY 2024**.  This swing from a negative to a positive impact—and the growing magnitude of the gain—shows that Cisco’s financial exposure through these swaps improved markedly over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million. The multi-hop synthesis is sound—the answer correctly traces the evolution across three fiscal years and properly identifies the instrument (Total Return Swaps-Deferred Compensation) and its impact on operating expenses. The reasoning is logical and well-articulated: the answer correctly characterizes the trajectory as a reversal from loss to gains and notes the growing magnitude of gains. The wording differs slightly from the ground truth (e.g., 'swing from negative to positive impact' vs. 'reversal in financial impact') but conveys identical semantic meaning. The answer appropriately addresses all parts of the question: the evolution over the three-year period, the specific gains/losses reported, and the overall trend. No calculation errors are present. The only minor distinction is that the LLM uses slightly more descriptive language ('swing from negative to positive impact' and 'improved markedly') compared to the ground truth's more direct statement, but this represents enhanced clarity rather than any factual deviation. The answer fully satisfies the requirements for a multi-hop financial question requiring synthesis across multiple years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 377,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved the talc liability from its former consumer unit into LTL Management LLC, first filing a Chapter 11 case in late 2021 that was dismissed by the Third Circuit in January 2023; the company then repeatedly refiled (the “LTL 2” filing in 2023 and, after a restructuring, a Texas‑based “Red River” Chapter 11 petition in September 2024) while steadily expanding its reserve‑funding—starting with a $2 bn trust reserve in 2021 and building to a cumulative $5 bn charge and a $11.6 bn present‑value reserve by the end of 2024 to meet the anticipated settlement payments.  At the same time, J&J negotiated a multi‑state settlement with a coalition of 42 attorneys general that was finalized in June 2024, and it is now pursuing a “pre‑packaged” Chapter 11 plan that would pay roughly $6.5 bn (nominal $8 bn) over 25 years to resolve the vast majority of pending talc claims.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed and comprehensive narrative than the ground truth, but contains several significant factual discrepancies that reduce overall correctness:\n\nCRITICAL ERRORS:\n1. TIMELINE MISMATCH: LLM states the first Chapter 11 filing was in \"late 2021\" and dismissed in \"January 2023,\" but ground truth indicates the 2022 reserve establishment and bankruptcy filing occurred in 2022, not 2021. This is a fundamental chronological error.\n2. RESERVE AMOUNTS: LLM claims a \"$2 bn trust reserve in 2021\" but ground truth specifies the $2 billion reserve was established in 2022. The LLM also introduces new figures ($5 bn cumulative charge, $11.6 bn present-value reserve) not mentioned in ground truth, making verification impossible and suggesting potential hallucination.\n3. RED RIVER FILING: LLM mentions a \"Texas-based 'Red River' Chapter 11 petition in September 2024\" which is not mentioned in the ground truth at all. This appears to be additional information not in the knowledge graph.\n4. SETTLEMENT AMOUNT: LLM specifies \"roughly $6.5 bn (nominal $8 bn) over 25 years\" which is not in the ground truth, and the \"June 2024\" finalization date differs from the ground truth's general \"2024\" timeframe.\n\nPARTIAL ACCURACY:\n- Correctly identifies LTL Management LLC as the vehicle for liability management\n- Correctly mentions the Third Circuit reversal and LTL 2 refiling\n- Correctly identifies the 42 states + DC multi-state settlement\n- Correctly characterizes the shift from bankruptcy-focused to dual strategy approach\n- Correctly identifies the pre-packaged Chapter 11 plan concept\n\nMULTI-HOP REASONING:\nThe LLM demonstrates sound multi-hop synthesis by connecting reserve funding evolution, bankruptcy filings, and settlement negotiations across the 2022-2024 period. However, the temporal accuracy issues undermine the reliability of this synthesis.\n\nSEMANTIC EQUIVALENCE:\nWhile the LLM answer is more detailed and provides additional context, the introduction of unverified figures and dates creates factual discrepancies rather than semantic equivalence. The core narrative structure is sound, but the specific numbers and dates are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 592,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.125 % senior notes that mature in January 2025 had an outstanding principal of **$495 million** at the end of fiscal 2022 and that figure remained unchanged through fiscal 2023 and fiscal 2024 (the balance was $495 million as of 3 Nov 2024 and $495 million as of 29 Oct 2023). This stability shows that Broadcom is treating this tranche as a long‑term, low‑cost funding pillar—​it is not being actively issued, retired or refinanced, but is simply held to its maturity while the company focuses debt‑paydown on other, higher‑rate or more flexible obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: All numbers are correct - the $495 million principal balance is accurate for fiscal years 2022, 2023, and 2024. The specific dates provided (3 Nov 2024 and 29 Oct 2023) are appropriate fiscal year-end dates and the consistency of the $495 million figure across all periods matches the ground truth exactly. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the principal balance across the three-year period, (2) the specific instrument identification (3.125% notes due January 2025), and (3) what this indicates about debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, the debt instrument is correctly specified with its coupon rate and maturity date, and all fiscal years are correctly referenced. REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting the stable principal balance across three years to a coherent debt management interpretation. The reasoning that stability indicates the notes are 'not being actively issued, retired or refinanced' is logically sound and goes slightly beyond the ground truth by adding context about the company's broader debt management priorities (focusing paydown on higher-rate obligations). This additional context is reasonable inference from the data and enhances rather than contradicts the ground truth. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while using slightly different wording ('long-term, low-cost funding pillar' vs. 'consistent approach to managing this portion of its capital structure'). Both convey the same essential meaning. Minor note: The LLM provides more specific date references than the ground truth, which adds helpful precision without introducing errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 501,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the effective interest rate on Cisco’s $500 million, 3.50 % June 15 2025 senior note climbed from about **3.2 % (2022)** to **≈6.4 % (2023)** and then to **≈6.7 % (2024)**.  This steady rise in the note’s effective rate—driven by higher market rates and the accretion of discount and issuance costs—shows that Cisco’s borrowing costs have increased materially over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: The effective interest rates are correctly stated as 3.2% (2022), 6.4% (2023), and 6.7% (2024), matching the ground truth values of 3.20%, 6.38%, and 6.66% respectively. The use of approximation symbols (≈) is appropriate given minor rounding differences. The $500 million principal amount is correctly identified. The fiscal year progression (2022-2024) is accurate. Multi-hop reasoning is sound: the answer correctly synthesizes the three-year trend and identifies the underlying drivers (market rates, discount and issuance cost accretion). The interpretation that this represents deteriorating financing terms and materially increased borrowing costs aligns with the ground truth assessment. The answer addresses all parts of the question: (1) the evolution of interest rates across the three-year period, (2) the progression pattern (steady upward trend), and (3) what this indicates about borrowing costs. Minor strengths: The LLM provides additional context by explicitly mentioning the drivers of the rate increase (discount and issuance costs), which adds value beyond the ground truth. The only negligible difference is the use of approximation notation rather than exact percentages, but this is semantically equivalent and actually more precise given rounding conventions. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 401,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior and subordinated notes totaled **$27.38 billion at the end of 2022**, slipped slightly to **$27.22 billion in 2023**, and then **jumped to $30.70 billion by the end of 2024**. This progression reveals a deliberate shift in Capital One’s capital‑structure strategy: after a modest pull‑back in 2023, the firm increased long‑dated debt issuance in 2024, extending maturities and locking in higher‑rate funding to support asset growth and to position its interest‑rate exposure for a higher‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022: LLM states $27.38B, Ground Truth is $27.219B (error of ~$161M, ~0.6% off but directionally wrong)\n   - 2023: LLM states $27.22B, Ground Truth is $31.248B (MAJOR ERROR - off by $4.028B or 12.9%, completely wrong direction)\n   - 2024: LLM states $30.70B, Ground Truth is $30.696B (approximately correct, minor rounding)\n   - The LLM describes 2023 as a \"modest pull-back\" when it was actually a SIGNIFICANT INCREASE of $4.029B\n   - The LLM describes 2024 as a \"jump\" when it was actually a SLIGHT DECLINE of $0.552B\n\n2. MISSING CRITICAL INFORMATION:\n   - LLM completely omits the weighted average interest rate data (2.76% in 2022, 4.48% in 2023, 4.84% in 2024)\n   - This is a core component of the question asking about \"interest rate positioning\"\n   - The interest rate progression is essential to understanding the capital structure strategy\n\n3. FLAWED MULTI-HOP REASONING:\n   - The narrative is inverted: LLM claims a pull-back in 2023 followed by a jump in 2024\n   - Ground truth shows a significant increase in 2023 followed by a modest decline in 2024\n   - This fundamental reversal of the progression undermines the entire analysis\n   - The reasoning about \"locking in higher-rate funding\" is mentioned but not supported by the actual interest rate data provided in ground truth\n\n4. INCOMPLETE ANALYSIS:\n   - The question specifically asks about \"interest rate positioning\" - the LLM provides no interest rate data\n   - The question asks what the progression \"reveals\" about strategy - the LLM's interpretation is contradicted by the actual numbers\n   - Missing the key insight about shift from floating-rate to fixed-rate instruments\n\n5. ENTITY AND METRIC ACCURACY:\n   - Company (Capital One/COF) correctly identified\n   - Years correctly identified (2022-2024)\n   - Metric (senior and subordinated notes) correctly identified\n   - However, the VALUES for these metrics are largely incorrect\n\nThe LLM answer fails on the primary metric of correctness due to inverted year-over-year progression and missing critical interest rate data that directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 607,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nBetween 2022 and 2024 the share of U.S. pension‑plan fixed‑income assets held in Treasury and agency securities fell from **about 40 % (reported for 2022)** to **roughly 30 % (reported for 2024)**.  This deliberate reduction in low‑yielding Treasury/agency exposure signals that Colgate‑Palmolive is re‑balancing its pension fund toward a more diversified fixed‑income mix—emphasizing higher‑yielding corporate bonds and other government securities—to manage interest‑rate risk and seek better returns while still maintaining an overall stable funding posture.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative data. The key percentages are correct: 40% in 2022 declining to 30% in 2024. However, there is a notable omission: the ground truth explicitly states that the allocation was 30% in both 2023 and 2024, indicating the decline occurred between 2022-2023 with stability in 2024. The LLM answer does not mention the 2023 intermediate data point, which is a material omission for a question specifically asking about evolution 'from 2022 to 2024.' The LLM correctly identifies this as a 10 percentage point reduction and accurately characterizes it as a strategic reallocation. The reasoning about yield-seeking behavior and diversification toward corporate bonds is sound and aligns with the ground truth's interpretation. The LLM's explanation of the strategic shift is slightly more detailed than the ground truth (mentioning interest-rate risk management and funding posture), which adds value but doesn't contradict the original answer. The multi-hop synthesis is adequate—the answer correctly connects the numerical trend to strategic implications. The main weakness is the incomplete temporal breakdown (missing 2023 data), which prevents full characterization of how the allocation 'evolved' across the three-year period. This is a 7/10 because while the core facts and main conclusions are correct, the omission of the 2023 data point represents incomplete analysis of the evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 411,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE re‑classified its captive industrial insurer, Electric Insurance Company, as a business held‑for‑sale, recorded a $109 million loss (and a $124 million valuation allowance) in 2023, and completed its sale in the second quarter of 2024 for $120 million in cash, thereby removing its $541 million of assets and $378 million of liabilities from the balance sheet.  This disposal is part of GE’s broader shift away from non‑core insurance activities, simplifying its balance sheet and freeing capital to concentrate on its core industrial and energy businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the key progression: EIC classification as held-for-sale in 2023, the $109 million loss recorded, completion of sale in Q2 2024 for $120 million, and the strategic rationale. STRENGTHS: (1) All core financial figures are accurate ($109M loss, $120M sale price, Q2 2024 timing); (2) Correctly identifies EIC as a captive insurance subsidiary; (3) Properly synthesizes the multi-hop progression across 2022-2024; (4) Accurately captures the strategic intent (divesting non-core insurance to focus on core industrial/energy); (5) Adds relevant balance sheet impact details ($541M assets, $378M liabilities removed). MINOR ISSUES: (1) The LLM mentions a '$124 million valuation allowance' which is not present in the ground truth answer - this appears to be additional detail from the filing that is factually accurate but not mentioned in the original answer, so it represents supplementary information rather than an error; (2) The ground truth mentions 'net claim reserves of $0.2 billion as of December 31, 2021' from 2022 disclosures, which the LLM does not include, though this is a minor historical detail; (3) The ground truth specifies the buyer as 'Riverstone International Holdings Inc.' while the LLM does not name the buyer, which is a minor omission. MULTI-HOP REASONING: The answer correctly synthesizes information across three years showing the evolution from subsidiary status to held-for-sale classification to completed divestiture. The connection between the loss recognition and the sale price is logically presented. QUANTITATIVE VERIFICATION: $109M loss (correct), $120M sale price (correct), Q2 2024 timing (correct), balance sheet figures appear reasonable and are presented as supporting detail. The answer is comprehensive and addresses all aspects of the question with strong factual accuracy, though it omits the buyer's name and the specific reserve figures from 2021.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 533,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nAcross the three filings the 4.45 % Notes due 2044 are repeatedly disclosed in Item 4.1/Exhibit 4.4 as part of the same 2014 indenture—each 10‑K simply restates the original terms and confirms that the securities remain outstanding with no amendment or retirement. This consistent, unchanged reference shows that Apple is deliberately maintaining a low‑coupon, long‑dated debt instrument as a stable component of its capital structure, using it to fund future growth and shareholder‑return initiatives without frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) Correctly identifies the 4.45% Notes due 2044 across all three years (2022, 2023, 2024); (2) Accurately references the May 6, 2014 Officer's Certificate date; (3) Correctly notes the consistent disclosure pattern with no amendments or retirements; (4) Properly identifies the exhibit location (Item 4.1/Exhibit 4.4). All numeric values (4.45%, 2044, 2014) are correct. The multi-hop synthesis across three filing years is sound. However, there are minor qualitative differences: The LLM answer adds interpretive language about Apple 'deliberately maintaining' the instrument and using it to 'fund future growth and shareholder-return initiatives' which goes slightly beyond what the ground truth explicitly states. The ground truth is more conservative, stating only that the pattern 'suggests a stable long-term capital structure' without speculating on strategic intent regarding specific uses of proceeds. The LLM's characterization of it as 'low-coupon' is reasonable given 4.45% context, but this descriptor isn't explicitly in the ground truth. The answer correctly addresses the multi-year pattern question and provides appropriate context about capital structure stability. The reasoning is sound and the synthesis across years is accurate, though the LLM adds some interpretive layers beyond the factual disclosures. Overall, this is a strong answer with minor over-interpretation of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 411,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nCapital One’s senior and subordinated notes grew from roughly $27.4 billion at the end of 2022 to about $30.7 billion by the end of 2023, and remained essentially flat at that level through 2024. This reflects a deliberate increase in long‑term debt to support balance‑sheet expansion, while the weighted‑average interest rate stayed relatively low (≈2.8 % in 2022‑23), indicating the firm is exploiting favorable borrowing conditions and maintaining a cautious stance on interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Critical number errors: LLM states 2022 value as '$27.4 billion' when ground truth is $27,219 million ($27.219 billion) - minor rounding acceptable. However, LLM states 2023 value as '$30.7 billion' when ground truth is $31,248 million ($31.248 billion) - this is a $548 million error (1.75% understatement). LLM then claims 2024 'remained essentially flat' at $30.7 billion, but ground truth shows $30,696 million, which is actually a DECREASE from 2023's $31,248 million (a $552 million decline). The LLM completely mischaracterized the 2023-2024 trend. (2) INTEREST RATE ANALYSIS - CRITICAL ERROR: LLM states weighted-average interest rate 'stayed relatively low (≈2.8% in 2022-23)' but ground truth shows it rose from 2.76% (2022) to 4.84% (2024). The LLM failed to capture the dramatic 208 basis point increase in rates, which is the most important indicator of the company's interest rate positioning strategy. (3) STRATEGIC INTERPRETATION - INCORRECT: LLM claims the company is 'maintaining a cautious stance on interest-rate risk' and 'exploiting favorable borrowing conditions,' but the ground truth indicates the opposite - the company strategically moved toward FIXED-RATE financing and LOCKED IN higher rates amid a rising rate environment. This is a fundamental misunderstanding of the capital structure strategy. (4) MULTI-HOP SYNTHESIS: LLM failed to properly synthesize the relationship between debt levels and interest rate changes, missing the key insight that the company was proactively shifting from floating to fixed-rate debt. (5) COMPLETENESS: LLM addressed the debt values but completely failed on the interest rate positioning analysis, which is central to understanding the company's capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 486,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nIn 2022 Adobe acquired Frame.io and introduced it as a cloud‑native collaboration layer for video and design assets, initially linking it to Premiere Pro and After Effects. By 2023 the platform was expanded into the broader Creative Cloud suite—adding Camera‑to‑Cloud upload, frame‑accurate commenting, and availability through Adobe GenStudio—while in 2024 Frame.io became a central hub of the Creative Cloud ecosystem, tightly integrated with Firefly AI and offered across Adobe Express and other Creative Cloud apps to enable end‑to‑end content creation, review and publishing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERROR - LLM states 'In 2022 Adobe acquired Frame.io' but the ground truth indicates Frame.io was listed as a registered trademark in 2022, with no mention of an acquisition in that year. This is a significant factual error about a key event. (2) MISSING INFORMATION - Ground truth specifies Frame.io was positioned as a 'cloud-native creative collaboration platform' in 2023 with specific features (real-time upload, review, approval, frame-accurate commenting). LLM mentions some features but misses the explicit 2023 positioning language and omits key details about the 2023 feature set. (3) INCORRECT INTEGRATION TIMELINE - LLM claims Frame.io was 'initially linking it to Premiere Pro and After Effects' in 2022, but ground truth shows these integrations were highlighted in 2023. (4) INCOMPLETE 2024 DETAILS - Ground truth specifically mentions integration with Photoshop, Lightroom, and Workfront in 2024, plus inclusion in Adobe GenStudio. LLM mentions GenStudio but omits the specific app integrations (Photoshop, Lightroom, Workfront) and instead adds unsupported claims about 'Firefly AI' integration and 'Adobe Express' that are not in the ground truth. (5) UNSUPPORTED CLAIMS - LLM introduces 'Camera-to-Cloud upload' and 'Firefly AI' integration without ground truth support. (6) MULTI-HOP SYNTHESIS - While the LLM attempts to trace evolution across years, it does so with factual errors and unsupported additions. The core trajectory of increasing integration is captured but with significant inaccuracies in the details and timeline. The answer demonstrates partial understanding but contains multiple factual errors that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 463,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nLowe’s repeatedly cites the 4.550 % Notes due April 5, 2049 in its 2022‑2024 filings because that tranche is a cornerstone of the company’s long‑term financing strategy—locking in low‑cost, fixed‑rate capital that extends the debt maturity ladder well into the 2040s.  By consistently disclosing the 2049 notes, Lowe’s signals a deliberate focus on maintaining a stable, long‑dated funding source to manage cash‑flow risk, preserve leverage discipline, and ensure sufficient liquidity for future growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of Lowe's debt management strategy. STRENGTHS: (1) All quantitative details are correct—the 4.550% interest rate and April 5, 2049 maturity date are accurately cited; (2) The multi-hop reasoning is sound, correctly synthesizing that consistent inclusion across 2022-2024 filings indicates strategic maintenance without early redemption; (3) The answer appropriately characterizes this as a 'cornerstone' of long-term financing and correctly identifies the strategic intent around fixed-rate capital, debt maturity ladder extension, and liquidity management; (4) The semantic meaning aligns well with the ground truth—both answers convey that Lowe's deliberately maintained these notes without modification to ensure stability in long-term debt profile. MINOR DIFFERENCES: (1) The LLM answer adds interpretive language about 'low-cost' capital and 'cash-flow risk' management that, while reasonable inferences, go slightly beyond what the ground truth explicitly states; (2) The ground truth emphasizes 'absence of disclosures suggesting modifications' as evidence, while the LLM focuses more on the strategic intent behind the consistent inclusion; (3) The LLM mentions 'leverage discipline' which is a reasonable inference but not explicitly stated in the ground truth. These are minor elaborations rather than errors—they represent reasonable extensions of the core finding. The answer correctly identifies all entities (Lowe's, the specific notes, the time period), accurately cites the financial terms, and demonstrates proper multi-hop synthesis across the three-year filing period. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 465,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nThe carrying amount of Broadcom’s 3.125% notes due January 2025 was $495 million at the end of fiscal 2022 and remained $495 million through fiscal 2023 and fiscal 2024. This flat trajectory shows that the company is managing this low‑cost, long‑dated tranche passively—holding it to maturity rather than actively repurchasing or refinancing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct—$495 million principal balance is accurately stated for fiscal 2022, 2023, and 2024. The dates (January 2025 maturity, 3.125% coupon) are correct. No calculation errors present. COMPLETENESS: The answer addresses the core question about how the balance evolved (remained flat at $495M) and provides interpretation of the debt management strategy. ENTITY ACCURACY: Broadcom (AVGO) correctly identified, fiscal years 2022-2024 correctly referenced, the specific debt instrument (3.125% notes due January 2025) correctly identified. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly identified that the flat balance across three years indicates no repayments or refinancing activity, and appropriately characterized this as a passive holding strategy to maturity. The characterization as 'low-cost, long-dated tranche' is reasonable inference from the 3.125% coupon rate. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth: (1) $495M balance maintained across all three years, (2) no repayments or issuances, (3) deliberate strategy to hold to maturity. The LLM's phrasing 'holding it to maturity rather than actively repurchasing or refinancing' is semantically equivalent to the ground truth's 'preserved this liability on its balance sheet' and 'no repayments or additional issuances.' MINOR DIFFERENCES: The LLM uses 'carrying amount' terminology (which is technically precise for balance sheet presentation) versus the ground truth's 'outstanding principal balance' (also correct). The LLM adds the characterization 'low-cost' which is a reasonable inference but not explicitly stated in ground truth. Overall, this is a strong answer with accurate numbers, correct multi-hop synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 507,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s disclosure of the 0.950 % Notes due 2025 shifted from a generic exhibit citation—simply noting that the instrument was originally filed in a 2017 Form 8‑K and incorporated by reference (2022 filing)—to a more explicit, stand‑alone reference in the 2024 filing, where the notes appear as a separate class of security (ticker IBM25B) in the “Securities Registered Pursuant to Section 12(b)” table and are backed by a newly filed Indenture dated February 2 2024 (Exhibit 4.1 to a Form 8‑K). The 2023 filing retained the earlier, undifferentiated wording, showing continuity but no new detail. This progression reveals IBM’s intent to treat the 0.950 % Notes as a distinct, manageable component of its capital structure—updating the financing documents and making the debt explicitly visible to investors—thereby signaling a strategy of low‑cost, long‑dated borrowing while enhancing transparency and regulatory compliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 0.950% Notes due 2025, the ticker IBM25B, the 2024 listing on NYSE, and the general progression from 2022-2024. The dates (2022, 2023, 2024) and the May 2017 Form 8-K reference are accurate. The answer appropriately captures the shift toward greater transparency and market visibility. The mention of the February 2, 2024 Indenture and Exhibit 4.1 Form 8-K filing adds specificity that aligns with the ground truth's emphasis on evolving disclosure practices.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces a claim about a 'newly filed Indenture dated February 2, 2024' that is not explicitly confirmed in the ground truth. While this may be factually accurate from the filings, it represents an inference beyond what the ground truth explicitly states, creating potential factual risk. (2) The LLM characterizes the 2022 disclosure as 'generic exhibit citation' and 'undifferentiated,' which is somewhat interpretive language not directly supported by the ground truth's more neutral description. (3) The LLM's statement about 'low-cost, long-dated borrowing' is an inference about IBM's strategy that, while reasonable, goes beyond what the ground truth explicitly supports. The ground truth focuses on the shift from 'less prominent' to 'publicly traded security' without making specific claims about cost optimization. (4) The answer lacks explicit mention that the 2023 filing 'reaffirmed the rights of holders,' which the ground truth specifically notes as evidence of 'ongoing recognition.'\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression pattern. However, the reasoning about what this progression 'indicates' relies on some inferences not fully grounded in the source material. The core multi-hop synthesis (2022 disclosure → 2023 continuation → 2024 NYSE listing) is sound.\n\nNUMERIC/DATE ACCURACY: All dates and percentages are correct (0.950%, 2022, 2023, 2024, May 2017, February 2, 2024). The ticker IBM25B is correct. No calculation errors present.\n\nSEMANTIC EQUIVALENCE: The LLM's conclusion about 'transparency and regulatory compliance' aligns with the ground truth's emphasis on 'transparency,' though the ground truth frames it as a shift to 'active market visibility and tradability' rather than regulatory compliance per se.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 631,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each disclose that KPMG LLP’s PCAOB firm identification number is **185**—the number appears in the “Principal Accountant Fees and Services” section (Item 14) on the respective page 14 of each filing. Consequently, the PCAOB identifier has remained the same across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: The core factual claim is correct—KPMG LLP's PCAOB firm identification number is 185 across all three years (2022, 2023, 2024), matching the ground truth exactly. The answer correctly identifies the consistency of this identifier across the three-year period. (2) QUANTITATIVE ACCURACY: The numeric value (185) is precisely correct with no calculation errors or discrepancies. (3) QUALITATIVE ACCURACY: The LLM demonstrates sound multi-hop reasoning by synthesizing information across three separate filings and correctly identifying the pattern of consistency. The answer appropriately identifies the relevant section (Item 14, 'Principal Accountant Fees and Services') where this information appears, adding helpful contextual detail. Entity identification is accurate (KPMG LLP, PCAOB, Form 10-K filings). (4) CONTEXTUAL RELEVANCE: The answer directly addresses all parts of the multi-part question: it identifies the PCAOB number for each year (2022, 2023, 2024) and explains how it remained consistent. The additional detail about the location in Item 14 enhances relevance without introducing errors. Minor note: The LLM provides slightly more specific locational information (Item 14, page 14) than the ground truth, which is a value-add rather than an error. The answer is semantically equivalent to and factually aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 395,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom 2022 to 2024, Capital One’s Fixed Unsecured Senior Debt carried a weighted‑average interest rate of roughly 4.84 % in 2022, fell to about 4.45 % in 2023, and rose back to near 4.84 % in 2024, with the outstanding carrying balance expanding to $27.2 bn in 2023 before slipping modestly to $26.9 bn in 2024. This pattern reflects a strategy of issuing longer‑dated fixed‑rate notes to lock in funding as market rates climbed, while keeping the overall proportion of senior debt relatively stable to manage interest‑rate risk in a rising‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth. (1) INTEREST RATE TRAJECTORY - Ground truth shows rates rose from 2.91% (2022) to 4.84% (2024), a clear upward trend. The LLM claims rates were 'roughly 4.84% in 2022' (WRONG - should be 2.91%), fell to 4.45% in 2023, then rose to 4.84% in 2024. This inverts the actual 2022-2023 relationship and misrepresents the starting point by ~2 percentage points. (2) DEBT BALANCE PROGRESSION - Ground truth shows $19,975M (2022) to $26,930M (2024). The LLM states $27.2bn in 2023 and $26.9bn in 2024, but provides NO 2022 figure, making it impossible to assess the full multi-year evolution. The 2024 figure of $26.9bn is approximately correct ($26,930M), but the missing 2022 baseline ($19,975M) is a critical omission for a multi-year trend analysis. (3) REASONING QUALITY - While the LLM's narrative about 'locking in funding as market rates climbed' aligns with the correct interpretation, this reasoning is built on incorrect interest rate data. The claim that rates 'fell' in 2023 contradicts the actual upward trend from 2022-2024. (4) MULTI-HOP SYNTHESIS - The answer fails to properly synthesize the relationship between rising rates and increasing debt issuance across the three-year period. The ground truth shows a clear strategic response to rising rates (2.91% → 4.84%), but the LLM's inverted rate trajectory undermines this synthesis. The answer demonstrates partial understanding of capital structure strategy but is undermined by significant quantitative errors that are fundamental to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 446,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s policy for development‑and‑IP‑licensing arrangements has remained essentially unchanged: revenue is recognized when control of the promised goods or services transfers—either over time for combined development‑service and license arrangements or at a point in time when a distinct license is transferred—while no material variable‑consideration estimates are recorded. This consistent treatment signals that AMD is deliberately pursuing a stable, partnership‑driven model of IP monetization, relying on recurring licensing and development‑service fees rather than one‑off sales to smooth and extend the value of its intellectual‑property portfolio over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and confirms consistency in AMD's revenue recognition methodology; (2) Accurately captures the core technical accounting treatment: evaluation of distinctness, combined vs. standalone recognition (over time vs. point in time), and the absence of variable consideration estimates; (3) Properly synthesizes the multi-hop reasoning by connecting consistent methodology to strategic implications about IP monetization; (4) Uses semantically equivalent language ('essentially unchanged' = 'maintained consistent'), 'partnership-driven model' captures the strategic intent; (5) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language about 'recurring licensing and development-service fees' and 'smooth and extend the value' which, while logically sound and consistent with the ground truth's characterization of a 'mature and well-defined policy framework,' represents slight elaboration beyond what was explicitly stated in the ground truth; (2) The phrase 'partnership-driven model' is an inference about strategic approach rather than a direct statement from the filings, though it aligns with the ground truth's conclusion about 'stable and deliberate strategic approach.' These are minor enhancements rather than errors. The answer correctly addresses all parts of the multi-part question: (a) how methodology evolved (answer: it didn't—remained consistent), (b) what this implies strategically (answer: deliberate, stable, mature approach to IP monetization). The reasoning is sound and the synthesis across the three-year period is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 480,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s senior and subordinated notes rose from about $27.4 billion at the end of 2022 to $31.2 billion in 2023, then slipped slightly to $30.7 billion by the end of 2024. The 2023 increase reflects a deliberate expansion of long‑term funding to support balance‑sheet growth, while the modest 2024 pull‑back shows a strategic shift toward optimizing the debt mix and managing interest‑rate exposure as market rates rose.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the three-year progression of total senior and subordinated notes ($27.4B → $31.2B → $30.7B), with appropriate rounding of the 2022 figure ($27,219M ≈ $27.4B). The directional narrative about 2023 expansion and 2024 pullback is accurate. CRITICAL GAPS: The LLM answer is significantly incomplete and fails to address major components of the original question. Most notably: (1) The weighted-average interest rate progression (2.91% → 4.45% → 4.84%) is completely omitted, which is a core metric for understanding interest rate positioning. (2) The strategic shift away from floating-rate debt is entirely missing—the reduction from $1,709M (2022) to $349M (2023) to $0 (2024) is a crucial insight about capital structure strategy that the LLM failed to capture. (3) The LLM provides generic commentary about 'optimizing the debt mix and managing interest-rate exposure' without the specific evidence of the floating-to-fixed conversion strategy. QUANTITATIVE ISSUES: While the dollar amounts are approximately correct (minor rounding acceptable), the answer lacks the interest rate data entirely, which represents a 50% loss of quantitative information required to answer the question. REASONING QUALITY: The LLM's reasoning is superficial—it describes what happened (expansion then pullback) but doesn't explain the strategic 'why' with supporting metrics. The ground truth reveals a deliberate strategy to lock in fixed rates amid rising rates and eliminate floating-rate exposure; the LLM answer hints at this but provides no evidence. MULTI-HOP SYNTHESIS: The answer fails to synthesize the relationship between rising interest rates, the shift in debt composition, and the weighted-average rate increases—all of which are necessary to fully answer the question about capital structure strategy and interest rate positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 506,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior debt rose from about **$24.1 bn** (2022) to **$27.2 bn** (2023) and then slipped slightly to **$26.9 bn** (2024).  The weighted‑average interest rate moved from roughly **4.5 %** in 2022, dipped to **4.4 %** in 2023, and then climbed to **≈4.8 %** in 2024.  The increase in issuance followed by a modest reduction and a higher‑cost stance indicates that Capital One expanded long‑term funding while market rates were low, and is now maintaining a larger debt base at higher rates to manage interest‑rate risk and support its growth strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in all key numeric values. (1) CARRYING VALUE ERRORS: LLM states 2022 value as ~$24.1bn, but ground truth is $19,975 million ($19.975bn) - an error of ~$4.1bn or 20%. The 2023 and 2024 values are approximately correct ($27.2bn and $26.9bn match ground truth of $27,168M and $26,930M). (2) WEIGHTED-AVERAGE INTEREST RATE ERRORS: LLM states 2022 rate as ~4.5%, but ground truth is 2.91% - a massive error of 1.59 percentage points or 54% higher than actual. LLM states 2023 rate as ~4.4%, but ground truth is 4.45% (minor rounding acceptable). LLM states 2024 rate as ~4.8%, which matches ground truth of 4.84% (acceptable). (3) DIRECTIONAL ERRORS: The LLM incorrectly characterizes the interest rate trend, stating it 'dipped to 4.4% in 2023' when the actual trend was a sharp RISE from 2.91% (2022) to 4.45% (2023). This is a fundamental misrepresentation of the data. (4) REASONING FLAWS: The LLM's interpretation that Capital One 'expanded long-term funding while market rates were low' contradicts the actual data showing rates were rising significantly from 2022 to 2023. The ground truth correctly identifies this as a response to rising market rates. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the carrying value and interest rate trends, the incorrect baseline numbers and mischaracterized rate direction undermine the entire analysis. The conclusion about managing interest-rate risk is somewhat reasonable but is built on incorrect premises. The answer fails on the most critical dimension - factual accuracy of the financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 451,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s revenue‑recognition policy for development‑plus‑IP and for standalone IP licensing was applied consistently from 2022 through 2024.  The Company first determines whether the IP license in a combined arrangement is distinct; if it is **not** distinct, the license is combined with the development service and revenue is recognized over time, whereas a **stand‑alone** license (i.e., a sale or license of patents or other IP with no other obligations) is treated as a separate performance obligation and revenue is recognized at a point in time when the customer can benefit from the IP.  The 2022, 2023 and 2024 Form 10‑K filings contain essentially the same language, indicating no substantive change to this methodology—only minor wording updates across the years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core policy framework: non-distinct licenses combined with development services recognized over time, while standalone licenses recognized at point in time. (2) Accurately captures the consistency across 2022-2024 with no material changes to the accounting policy. (3) Properly synthesizes the multi-hop requirement by comparing policy treatment across three fiscal years. (4) Correctly notes that variable consideration estimates were absent in both combined and standalone arrangements (implicit in the answer's focus on the recognition timing distinction). (5) Appropriately emphasizes the stable application of revenue recognition standards. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'sale or license of patents' vs. the ground truth's more general 'distinct licenses'), but this represents semantic equivalence rather than factual error. (2) The LLM explicitly notes 'only minor wording updates across the years' which adds helpful context about the consistency claim, enhancing rather than detracting from accuracy. (3) No quantitative data (dollar amounts, percentages) were required for this policy-focused question, so quantitative accuracy is perfect by default. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022, 2023, 2024) and correctly identifies the distinction between combined vs. standalone arrangements as the key policy differentiator. The reasoning is logically sound and directly addresses the question's focus on policy evolution (or lack thereof). ENTITY ACCURACY: AMD correctly identified, fiscal years correct (2022-2024), and revenue recognition policy terms accurately applied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 501,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nBetween 2022 and 2024 short‑term borrowings fell sharply from **$883 million (2022)** to **$538 million (2023)** and then edged up to **$562 million (2024)**, while total long‑term debt rose from **$48.7 billion (2022)** to **$49.9 billion (2023)** before pulling back to **$45.6 billion (2024)** (see Table 8.1 and Table 9.1).  \n\nThis three‑year pattern shows Capital One has been **reducing reliance on near‑term wholesale funding and extending the maturity of its debt**, financing growth primarily through longer‑dated senior and subordinated notes and securitized obligations (average rates of 4.84 % on 2024 senior debt vs. 3.01 % on 2023 securitized debt).  The shift, together with active use of interest‑rate swaps to hedge fixed‑rate liabilities, reflects a strategy to **lock in funding costs and limit exposure to rising interest rates while maintaining a more stable, longer‑term debt profile**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES:\n\n1. QUANTITATIVE ACCURACY - SEVERE ERRORS:\n   - SHORT-TERM BORROWINGS: LLM states $883M (2022), $538M (2023), $562M (2024). Ground truth does not provide these specific short-term borrowing figures separately, but the total debt figures are clearly stated.\n   - LONG-TERM DEBT: LLM claims $48.7B (2022), $49.9B (2023), $45.6B (2024). Ground truth states: $43.086B (2022), $48.715B (2023), $45.551B (2024). The 2022 figure is WRONG by ~$5.6B (off by 13%), and 2023 is off by ~$1.2B.\n   - TOTAL DEBT CALCULATION: Ground truth total is $43.086B + short-term (2022), $48.715B (2023), $45.551B (2024). LLM's figures don't align with ground truth totals.\n\n2. INTEREST RATE ACCURACY:\n   - Ground truth: weighted-average rates were 2.76% (2022), 4.48% (2023), 4.84% (2024)\n   - LLM mentions 4.84% for 2024 senior debt (correct) but cites 3.01% for 2023 securitized debt (not mentioned in ground truth and appears to be a different metric/subset)\n   - LLM does NOT provide the weighted-average rates that are central to the ground truth answer\n\n3. MULTI-HOP REASONING:\n   - Ground truth clearly states: debt INCREASED from 2022 to 2023, then DECLINED in 2024\n   - LLM's narrative about \"reducing reliance on near-term wholesale funding\" is partially correct directionally but built on incorrect numbers\n   - The synthesis of interest rate exposure is incomplete - missing the key weighted-average rate progression\n\n4. MISSING KEY INSIGHTS:\n   - Ground truth emphasizes the shift toward \"higher-cost fixed-rate debt\" with specific rate progression (2.76% → 4.48% → 4.84%)\n   - LLM mentions interest-rate swaps but doesn't clearly articulate the weighted-average rate increase that is central to understanding COF's debt management strategy\n   - Ground truth's insight about \"initially expanded debt footprint amid rising rates, then began reducing leverage\" is partially captured but undermined by incorrect numbers\n\n5. ENTITY/METRIC ACCURACY:\n   - Company correctly identified as Capital One (COF)\n   - Years correct (2022-2024)\n   - But the specific debt components and their values are materially incorrect\n\nCONCLUSION: While the LLM's qualitative narrative about debt maturity extension and interest rate hedging shows some understanding, the quantitative foundation is severely flawed. The 2022 long-term debt figure is off by ~13%, and the critical weighted-average interest rate progression is not properly presented. This is a multi-hop question requiring precise synthesis of debt levels AND interest rates across three years, and the LLM failed on the quantitative accuracy that is essential to answering this question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 716,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s revenue‑recognition guidance for development‑and‑IP licensing arrangements remained essentially the same: it evaluates whether the IP licence is **distinct** (i.e., both capable of being distinct and distinct in the context of the contract). If the licence is **not distinct**, it is **combined with the development service** and revenue is recognized **over time**; if the licence **is distinct**, revenue is recognized **at a point in time** when the customer can benefit from it. Stand‑alone sale or licensing of patents/IP is also recognized **at a point in time**, and in all cases AMD notes that variable‑consideration estimates are not material. Thus, the distinction between combined arrangements (recognized over time) and standalone licences (recognized at a point in time) was consistently applied across the three years, with only incremental clarification of the distinct‑licence assessment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core policy framework: distinct vs. non-distinct licenses, with combined arrangements recognized over time and standalone licenses at a point in time. (2) Accurately captures the consistency of AMD's policy across 2022-2024 with no material changes. (3) Properly addresses the variable consideration aspect, noting it was not material across all three years. (4) Correctly synthesizes the multi-hop requirement by comparing policy evolution across three fiscal years and distinguishing between combined vs. standalone arrangements. (5) Uses appropriate financial/accounting terminology (performance obligations, distinct, point in time, over time). MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more technical/condensed language than the ground truth (e.g., 'both capable of being distinct and distinct in the context of the contract' vs. ground truth's 'both in capability and context'), but this is semantically equivalent and arguably more precise. (2) The LLM answer mentions 'incremental clarification of the distinct-licence assessment' which is a reasonable inference about the nature of consistency, though the ground truth doesn't explicitly state this. This is a minor enhancement rather than an error. (3) The ground truth mentions 'increased emphasis on the Gaming segment in 2023 and 2024' as contextual information, which the LLM answer omits. However, this contextual detail is not central to the core accounting policy question and its omission does not materially affect the answer's correctness. QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are involved in this question, so this dimension receives full marks for not introducing any errors. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis (comparing policy across three years while distinguishing arrangement types) is correctly executed. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses the specific question about revenue recognition policy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 572,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe fact that Exhibit 4.5 – the **Certificate of Designations of Series B Convertible Participating Preferred Stock** – is listed in the 2022, 2023 and 2024 10‑K/10‑Q filings (and appears unchanged across the three years) shows that the rights, preferences and privileges of this series have not been retired, amended or superseded.  Its persistent appearance signals that the instrument remains a legally‑effective, material component of Visa’s capital structure, underscoring its ongoing relevance for financing, governance and investor considerations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures the core insight about the Certificate of Designations remaining unchanged and integral to Visa's capital structure, but contains a critical factual error regarding exhibit numbering. QUANTITATIVE ACCURACY ISSUES: The ground truth specifies that the exhibit number CHANGED across years (Exhibit 4.5 in 2022, but Exhibit 4.4 in both 2023 and 2024), which is a material detail indicating a reorganization of exhibits while the underlying instrument remained the same. The LLM incorrectly states 'Exhibit 4.5' appears in all three years and uses inconsistent language ('2022, 2023 and 2024 10‑K/10‑Q filings') without clarifying which specific filing types. The ground truth explicitly identifies the exhibit numbers for each year. QUALITATIVE ACCURACY: The LLM correctly identifies the key insight that the instrument remained unchanged, unretired, and unamended across the three-year period. The reasoning about legal effectiveness and ongoing relevance is sound. However, the LLM misses the specific detail about the consistent June 21, 2016 filing date reference, which is mentioned in the ground truth as supporting evidence of stability. COMPLETENESS: The LLM addresses the main question about stability and ongoing relevance but fails to capture the nuanced detail about exhibit number changes while the underlying instrument remained static. This is a meaningful omission because it suggests the company reorganized its exhibit structure while maintaining the same preferred stock terms. SEMANTIC EQUIVALENCE: The LLM's conclusion about 'long-term strategic stability in capital governance' aligns with the ground truth's assessment, but the factual foundation is weakened by the exhibit number error. The LLM appropriately emphasizes that the instrument signals ongoing relevance for financing and governance considerations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 502,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nAcross 2022‑2024 RTX maintained the same controlling interests in the IAE collaboration – a 61 % program‑share interest (and 49.5 % equity stake) in IAE and a 59 % share/ownership in IAE LLC – but the economic exposure tied to the V2500 program expanded markedly: commercial‑aerospace commitments rose from about $735 million in 2022 to roughly $1.05 billion in 2023 and remained sizable in 2024, while the Rolls‑Royce flight‑hour payments that are capitalized as collaboration intangibles increased each year. This growing financial footprint, together with the continued consolidation of IAE and IAE LLC as variable‑interest entities, signals that Pratt & Whitney is deepening its strategic control and long‑term value creation role in the V2500 engine program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces specific dollar amounts ($735M in 2022, $1.05B in 2023) and references to 'Rolls-Royce flight-hour payments' and 'IAE LLC' with a '59% share/ownership' that are NOT present in the ground truth and appear to be fabricated. The ground truth makes no mention of these financial figures or the IAE LLC entity. (2) CONTRADICTORY CLAIMS: The ground truth explicitly states RTX 'did not alter its strategic positioning or risk profile' and emphasizes CONSISTENCY across the three years. The LLM claims economic exposure 'expanded markedly' and that P&W is 'deepening its strategic control,' which directly contradicts the ground truth's finding of stability. (3) MISSING KEY INFORMATION: The LLM fails to mention the critical 57% net program share interest after sub-collaborator participation, which is explicitly stated in the ground truth as remaining 'stable throughout the period.' (4) UNSUPPORTED SYNTHESIS: The LLM's multi-hop reasoning appears to synthesize information that doesn't exist in the source documents, creating a false narrative of expanding economic exposure and deepening control. (5) CORRECT ELEMENTS: The LLM does correctly identify the 61% program-share interest and 49.5% ownership interest, and correctly names the entities (RTX, Pratt & Whitney, IAE, V2500). However, these correct elements are embedded within a fundamentally flawed narrative. The answer demonstrates poor adherence to factual accuracy and introduces material misrepresentations that would mislead readers about RTX's actual strategic positioning in the V2500 program.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 472,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nMedtronic has continued to disclose the same “Non‑Employee Director Deferred Unit Award Agreement” in its 2022, 2023 and 2024 Form 10‑K filings, referencing it as part of the (amended) 2008 Stock Award and Incentive Plan and later under the 2021 Long‑Term Incentive Plan.  The company has not replaced or substantially revised the agreement across these years, indicating a deliberate, long‑term approach that uses deferred equity units to align directors’ interests with shareholders and encourage sustained board participation.  This consistency signals that deferred‑unit compensation is a core, stable element of Medtronic’s director‑pay strategy rather than a periodic or experimental arrangement.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer introduces a factual error regarding plan attribution. The ground truth states the agreement was consistently tied to the '2008 Stock Award and Incentive Plan' across all three years (2022, 2023, 2024). However, the LLM answer claims the agreement was 'later under the 2021 Long-Term Incentive Plan,' which contradicts the ground truth's explicit statement that the deferred unit award 'remained unchanged in structure and plan origin' and was NOT transitioned to newer plan versions. This is a material factual error that misrepresents Medtronic's compensation strategy. The LLM correctly identifies: (1) the consistent use of the Non-Employee Director Deferred Unit Award Agreement across 2022-2024, (2) the lack of substantial revision, and (3) the strategic implication of stability and alignment with shareholder interests. However, the introduction of the '2021 Long-Term Incentive Plan' as a reference point is unsupported by the ground truth and suggests the model either hallucinated this detail or misread the source material. The exhibit numbers are also not verified in the LLM answer (ground truth cites Exhibit 10.41 for 2022 and 10.52 for 2023/2024), and the LLM provides no specific exhibit citations. The reasoning about deferred equity units aligning director interests is sound and relevant, but the factual error regarding plan attribution significantly undermines the answer's reliability. The answer demonstrates partial understanding of the multi-hop synthesis required (tracking evolution across three years) but fails on core factual accuracy regarding which plan governed the agreement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 451,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nFrom the 2022 filing the company disclosed an aggregate notional of **$1.3 billion** of outstanding interest‑rate swaps, and that same $1.3 billion figure is reiterated for 2023 (page 52 of the 2024 10‑K) and again for 2024 (page 52 of the 2025 10‑K).  This follows an earlier increase from roughly **$0.5 billion** disclosed in the 2021 filing (page 66 of the 2021 10‑K).  The steady $1.3 billion level from 2022 through 2024 shows that LMT settled on a consistent hedge size—using variable‑rate swaps to convert a portion of its fixed‑rate debt to variable‑rate exposure—rather than continually expanding or shrinking the hedge, indicating a mature, risk‑balanced approach to managing interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM states that the 2022 filing disclosed $1.3 billion in notional interest rate swaps, but the ground truth clearly establishes that 2022 had $500 million, not $1.3 billion. The LLM then claims this $1.3 billion figure remained steady from 2022-2024, which is incorrect. According to the ground truth: 2022 = $500M, 2023 = $1.3B, 2024 = $1.3B. The LLM has misaligned the years with the amounts, placing the $1.3B figure one year too early. The LLM does correctly identify the progression from $0.5B (2021) to $1.3B, but then incorrectly assigns the $1.3B to 2022 instead of 2023. This is a significant multi-hop synthesis error that undermines the entire answer. QUALITATIVE ASSESSMENT: While the LLM's interpretation about a 'mature, risk-balanced approach' and 'consistent hedge size' is reasonable and aligns with the ground truth's characterization, this reasoning is built on incorrect year-to-year assignments. The LLM correctly identifies the strategic shift toward active interest rate risk management and the stabilization after the initial increase, but these insights are compromised by the factual errors. COMPLETENESS: The answer does address the evolution question and attempts to explain what the progression reveals about strategy, but the incorrect timeline makes the analysis fundamentally flawed. The reference to specific page numbers (52 of 2024 10-K, 52 of 2025 10-K, 66 of 2021 10-K) cannot be verified but the data itself is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 435,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nAbbVie’s charter and by‑laws have kept the same “stockholders may remove directors only for cause” requirement—and the accompanying 80 % super‑majority amendment threshold—through the 2022, 2023 and 2024 Form 10‑K filings, with no substantive amendment or relaxation of that language. This three‑year consistency shows that AbbVie is deliberately maintaining a stable, defensive governance framework, reinforcing its anti‑takeover posture by preserving board‑level control and making it harder for a hostile acquirer to replace or remove incumbent directors.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core governance provision (stockholders may remove directors only for cause), accurately notes the three-year consistency across 2022-2024 filings, and properly characterizes this as a deliberate anti-takeover defense strategy. The semantic understanding of the question and governance implications is sound. The answer appropriately synthesizes the multi-hop requirement (tracking evolution across three years and interpreting strategic implications). CRITICAL WEAKNESS: The LLM introduces a specific quantitative claim—'80% super-majority amendment threshold'—that is NOT present in the ground truth answer. This is a significant factual error. The ground truth mentions 'supermajority voting requirements' generically but does NOT specify an 80% threshold. The LLM appears to have fabricated or misremembered this specific percentage, which violates the strict standard for numeric accuracy in financial/governance disclosures. This is particularly problematic because governance thresholds are precise legal requirements that must be accurate. ASSESSMENT: While the LLM demonstrates good qualitative reasoning about governance strategy and correctly identifies the consistency of the removal-for-cause provision, the introduction of an unverified 80% figure represents a material factual error that undermines confidence in the answer's reliability. The answer would be stronger if it stuck to what was actually disclosed rather than adding specific percentages not confirmed in the source material. The core insight about strategic posture is correct, but the unsupported quantitative claim prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 455,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation in money‑market funds and time deposits dropped from **$21 million at the end of 2022** to **$10 million at the end of 2023** and stayed at roughly **$10 million through 2024** (see the fair‑value tables for 2022, 2023 and 2024 in the 10‑K filings).  This reduction shows that the company is scaling back its low‑yielding money‑market/time‑deposit holdings and instead leans on its larger cash‑and‑cash‑equivalents balance and other investments to fund operations, debt repayment and shareholder returns, maintaining only a modest, stable reserve for immediate liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the core numbers that are essential to answering this question. (1) WRONG STARTING VALUE: LLM states '$21 million at the end of 2022' but ground truth shows $12 million in 2022. This is a 75% overstatement of the 2022 figure. (2) WRONG 2023 VALUE: LLM states '$10 million at the end of 2023' but ground truth shows $21 million in 2023. This is a 52% understatement. (3) CORRECT 2024 VALUE: LLM correctly identifies $10 million for 2024. (4) INVERTED TREND NARRATIVE: Because of the wrong numbers, the LLM describes the trend as a continuous decline ('dropped from $21M to $10M to $10M'), when the actual trend is an increase from 2022 to 2023 ($12M to $21M), followed by a decrease to 2024 ($21M to $10M). This is a fundamental mischaracterization of the evolution pattern. (5) MISSING CONTEXT: The LLM answer fails to mention the overall cash and equivalents balances ($8,449M in 2022, $9,201M in 2023, $5,524M in 2024) which are critical to understanding the liquidity strategy context provided in the ground truth. (6) REASONING QUALITY: While the LLM's interpretation about scaling back low-yielding instruments is reasonable, it is based on incorrect data and therefore reaches conclusions that don't align with the actual trend. The ground truth indicates an initial increase in money market/time deposit allocation before retreating, suggesting a more nuanced strategy than simple continuous reduction. The answer demonstrates poor multi-hop synthesis by failing to connect the money market fund changes to the broader cash balance fluctuations that contextualize the liquidity strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 460,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nFrom 2022 through the 2024 Form 10‑K filings AbbVie’s charter language has remained unchanged: directors may be removed only “for cause,” and any amendment to the director‑related provisions (including the removal rule) requires the affirmative vote of shareholders holding at least 80 % of the voting stock. The same “removal‑for‑cause” and 80 % super‑majority amendment thresholds appear verbatim in the 2022, 2023 and 2024 documents.  \n\nThis steady retention of “removal‑for‑cause” and the other anti‑takeover charter provisions signals that AbbVie is deliberately maintaining a stable, defensive board structure to deter hostile takeovers and protect its long‑term strategic autonomy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies the core governance provision: directors may be removed only 'for cause' across all three years (2022, 2023, 2024). (2) Accurately cites the 80% super-majority voting threshold for amending director-related provisions - this specific quantitative detail is correct and adds precision. (3) Properly synthesizes the multi-hop requirement by confirming consistency across three separate 10-K filings. (4) Correctly interprets the strategic implication: this consistency demonstrates deliberate maintenance of anti-takeover defenses and board stability. (5) Uses appropriate terminology ('removal-for-cause,' 'charter language,' 'super-majority amendment thresholds'). MINOR CONSIDERATIONS: The LLM answer adds the 80% amendment threshold detail, which is not explicitly mentioned in the ground truth but is factually accurate and enhances the answer's completeness by showing the full scope of anti-takeover mechanisms. The ground truth focuses on the removal-for-cause provision itself, while the LLM expands to include the amendment protection mechanism - both are correct and complementary. The reasoning about 'deliberate maintenance' and 'defensive board structure' aligns perfectly with the ground truth's characterization of 'deliberate and sustained effort' and 'core component of anti-takeover defense.' No factual errors detected. The answer demonstrates sound multi-hop reasoning by confirming consistency across three years and connecting this to strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 430,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nIntel first introduced PowerVia in 2022 as the industry‑first backside‑power delivery scheme tied to the planned Intel 20A node, promising up to 15 % performance‑per‑watt gains. By 2023‑24 the company shifted PowerVia to the Intel 18A node (with high‑volume manufacturing targeted for 2025) and later to the Intel 14A roadmap, embedding backside power as a core differentiator for its IDM 2.0 strategy and for leadership products such as Panther Lake. This progression shows Intel’s strategy of using PowerVia to boost performance, density and foundry competitiveness in its most advanced process technologies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM introduces a '15% performance-per-watt gains' metric that is NOT present in the ground truth. This is a factual addition not supported by the source material. (2) ROADMAP DISCREPANCY: The LLM claims PowerVia was 'later' moved to Intel 14A, which contradicts the ground truth. The ground truth explicitly states the progression was 20A (2023) → 18A (2024), with no mention of 14A integration. This is a significant factual error in the multi-hop synthesis. (3) PARTIAL CORRECTNESS: The LLM correctly identifies: (a) 2022 introduction of PowerVia, (b) 2023 positioning with Intel 20A, (c) 2024 shift to Intel 18A, (d) 2025 high-volume manufacturing target. (4) STRATEGIC CONTEXT: The LLM adds contextual details about 'IDM 2.0 strategy' and 'Panther Lake' that are not in the ground truth, making claims beyond what can be verified. (5) CORE REASONING: The LLM correctly identifies the evolution as a strategic pivot and understands backside power delivery as a key differentiator, which aligns with ground truth intent. However, the introduction of unsupported metrics (15% performance gains) and the false claim about 14A integration represent material factual errors that undermine the answer's reliability. The answer demonstrates partial understanding of the multi-hop progression but fails on strict factual accuracy by adding unverified claims and misrepresenting the roadmap evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 401,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 the company’s expected‑volatility assumption in the Black‑Scholes model rose steadily—from about **23 %** in 2022, to **≈24.1 %** in 2023, and to **≈24.3 %** in 2024.  This upward progression shows that Medtronic is increasingly factoring higher market price volatility into the fair‑value calculation of its non‑qualified stock options, reflecting a more conservative valuation approach and resulting in progressively higher option‑based compensation expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and misses the core of the ground truth. Critical issues: (1) QUANTITATIVE FAILURE: The LLM provides specific volatility percentages (23%, 24.1%, 24.3%) that are not mentioned in the ground truth answer. These numbers appear to be fabricated or misattributed, as the original answer makes no reference to specific volatility percentages. (2) METHODOLOGICAL MISUNDERSTANDING: The ground truth focuses on the METHODOLOGY EVOLUTION - from purely historical volatility (2022) to a blended approach using both historical and implied volatility (2023-2024). The LLM completely misses this critical distinction and instead focuses on numerical volatility values increasing over time. (3) MISSING KEY INSIGHT: The LLM fails to identify the fundamental shift in approach - the incorporation of market-traded options data and implied volatility starting in 2023. This is the core answer to what the 'multi-year progression suggests about the company's approach.' (4) INCORRECT INTERPRETATION: The LLM interprets the progression as 'increasingly factoring higher market price volatility' and 'more conservative valuation approach,' but the ground truth indicates the progression reflects a shift toward being MORE MARKET-SENSITIVE and aligned with real-time market expectations, not simply more conservative. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop information about how the company's methodology changed across the three-year period. The answer addresses only numerical changes, not the methodological evolution that is central to the question. The LLM answer appears to confuse or conflate volatility percentage values with the methodology for calculating them.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 469,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from a planned feature of the (now‑canceled) Intel 20A node to the centerpiece of its next‑generation Intel 18A process.  The company refined the backside‑power‑delivery architecture, integrated it with the RibbonFET transistor, and prepared high‑volume manufacturing for Panther Lake on Intel 18A in 2025, positioning PowerVia as a key enabler of higher performance‑per‑watt and density that underpins Intel’s IDM 2.0 and foundry strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of PowerVia technology across 2022-2024. STRENGTHS: (1) Correctly identifies PowerVia's progression from Intel 20A (canceled) to Intel 18A, (2) Accurately notes the integration with RibbonFET transistor, (3) Correctly states Panther Lake as the first processor on Intel 18A with 2025 HVM timeline, (4) Properly contextualizes PowerVia's role in performance-per-watt improvements and density gains, (5) Appropriately connects to Intel's IDM 2.0 and foundry strategy. MINOR OMISSIONS: (1) The ground truth specifies a quantified '15% performance-per-watt improvement over Intel 3' metric that the LLM answer does not include - this is a specific, verifiable number from the original answer that adds precision, (2) The LLM answer does not explicitly mention that PowerVia was 'industry-first backside power delivery solution' positioning, though it does reference 'backside-power-delivery architecture'. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024, 2025) and node names (Intel 20A, Intel 18A, Panther Lake) are correct. The omission of the '15% performance-per-watt improvement' metric prevents a perfect 10, but no incorrect numbers are stated. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about how PowerVia evolved across three years while remaining central to Intel's strategy despite the node name change. The connection to broader strategic initiatives (IDM 2.0, foundry) demonstrates good contextual understanding. SEMANTIC EQUIVALENCE: The core message matches the ground truth - PowerVia remained central despite the 20A cancellation and 18A adoption. The wording differs but conveys equivalent meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 483,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom 2022 to 2024 the Black‑Scholes inputs for MDT’s non‑qualified options shifted from volatility 23.04 % / risk‑free 0.90 % / expected life 6.0 yr / dividend yield 1.95 % (2022) to volatility 24.29 % / risk‑free 4.16 % / expected life 6.1 yr / dividend yield 3.18 % (2024), with the weighted‑average option value falling from $22.83 to $18.49.  The rise in implied volatility and the higher risk‑free rate reflect a more market‑driven calibration, while the steady ~6‑year expected life shows the company continues to view employee exercise behavior as relatively stable over a multi‑year horizon.  Overall, MDT is updating its volatility and interest‑rate assumptions to current conditions but keeps the exercise‑behavior parameter constant, indicating a cautious, data‑based approach to option valuation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical values (volatility 23.04%/24.29%, risk-free rates 0.90%/4.16%, expected life 6.0yr/6.1yr, dividend yields 1.95%/3.18%, option values $22.83/$18.49) that cannot be verified against the ground truth provided. The ground truth does not contain these specific quantitative details - it only describes a qualitative evolution from historical volatility alone (2022) to a combination of implied and historical volatility (2023-2024). The LLM appears to have fabricated precise numerical data that was not in the source material. PARTIAL CREDIT FOR: (1) Correct identification of MDT as the company; (2) Correct time period (2022-2024); (3) Correct identification of Black-Scholes model usage; (4) Reasonable qualitative interpretation that volatility assumptions became more market-driven. MAJOR DEFICIENCIES: (1) The specific percentages and dollar amounts are unverifiable and likely incorrect - they do not appear in the ground truth; (2) The answer claims 'implied volatility' increased from 23.04% to 24.29%, but the ground truth states implied volatility was ADDED to the methodology in 2023, not that it was the sole volatility measure in 2022; (3) The answer misrepresents the evolution - it suggests a simple numerical progression rather than a methodological shift from historical-only to historical+implied; (4) The claim about 'weighted-average option value falling from $22.83 to $18.49' is unsupported by ground truth. REASONING QUALITY: While the LLM's interpretation about market-driven calibration and stable exercise behavior is reasonable and somewhat aligned with the ground truth's conclusion, it is built on a foundation of unverified (and likely fabricated) numerical data. This represents a fundamental failure in financial analysis where precision and verifiability are paramount. The answer reads plausibly but violates the core requirement of factual accuracy in quantitative financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 533,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements—recorded in “Other assets, including intangibles – net”—fell sharply from **$1.49 billion at the end of 2022 to $0.80 billion in 2023 and to $0.49 billion by the end of 2024**.  \n\nThis decline shows that the company is **reducing its external collateral requirements**, likely because it is trimming derivative notional exposure, improving counter‑party credit quality, or relying more on internal margining. In short, the downward trend signals a more streamlined and risk‑averse approach to managing its derivative positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.49 billion (2022) matches $1,494 million, $0.80 billion (2023) matches $800 million, and $0.49 billion (2024) matches $491 million. The format conversion from millions to billions is appropriate and accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the change from 2022 to 2024 is clearly stated with intermediate 2023 data, (2) the trend is identified as declining, and (3) implications for derivative exposure management are discussed. ENTITY ACCURACY: ExxonMobil is correctly identified, the specific balance sheet line item 'Other assets, including intangibles - net' is correctly referenced, and all years (2022, 2023, 2024) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes the collateral data across three years and draws logical conclusions about what the declining trend suggests. The interpretation that the reduction indicates 'reducing external collateral requirements' and 'more streamlined and risk-averse approach' aligns well with the ground truth's assessment of 'strategic reduction in derivative-related exposure' and 'active management of margin requirements.' SEMANTIC EQUIVALENCE: The LLM's explanation of potential causes (trimming derivative notional exposure, improving counterparty credit quality, relying more on internal margining) provides slightly more specific detail than the ground truth's mention of 'lower volatility in commodity markets or shift in hedging strategies,' but both interpretations are reasonable and complementary. The only minor distinction is that the LLM provides more granular mechanistic explanations while the ground truth offers broader market-based explanations - both are valid interpretations of the same data trend. No calculation errors detected. All information is factually accurate and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 532,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of NextEra’s gas‑linked options remained roughly $100 million (net), with implied volatilities used in their valuation staying near 50 % (ranging from about 15 % to 150 %). This stability coincides with a shift in the company’s broader gas‑derivative position—from a $854 million liability in 2022 to a $951 million asset in 2023 and a $387 million asset in 2024—indicating that NextEra has been actively reducing its net gas‑price exposure and using options as a modest, volatility‑neutral hedge.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. FAIR VALUE NUMBERS - MAJOR ERRORS:\n   - Ground Truth: Assets decreased from $356M (2022) → $100M (2023) → $100M (2024); Liabilities from $347M (2022) → $97M (2023) → $102M (2024)\n   - LLM Answer: Claims \"roughly $100 million (net)\" throughout, which is incorrect for 2022 (should be ~$9M net, not $100M)\n   - The LLM completely misses the significant 2022 values ($356M assets, $347M liabilities)\n   - The characterization of \"stability\" is false - there was a major decline from 2022 to 2023\n\n2. IMPLIED VOLATILITY - MAJOR ERRORS:\n   - Ground Truth: Weighted average volatility was 36% (2022), 50% (2023), 52% (2024) - showing an INCREASE\n   - LLM Answer: Claims volatility \"staying near 50%\" with a range of \"15% to 150%\"\n   - The LLM reverses the trend: ground truth shows volatility INCREASED from 36% to 50-52%, not decreased\n   - The range cited (15%-150%) is not mentioned in ground truth and appears fabricated\n\n3. BROADER GAS DERIVATIVE POSITION - UNVERIFIED:\n   - LLM introduces numbers about broader gas-derivative positions ($854M liability in 2022, $951M asset in 2023, $387M asset in 2024)\n   - These figures are NOT in the ground truth and cannot be verified\n   - This appears to be hallucinated data not supported by the source material\n\n4. INTERPRETATION ERRORS:\n   - Ground Truth: Volatility declined from 36% to 50-52% (INCREASE, not decrease as stated)\n   - LLM mischaracterizes the volatility trend entirely\n   - The claim about \"volatility-neutral hedge\" is not supported by the data\n\n5. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the three-year evolution\n   - It missed the critical 2022 baseline values\n   - It inverted the volatility trend direction\n   - It introduced unsupported external data\n\nThe answer demonstrates fundamental misunderstanding of the data and contains multiple fabricated or incorrect numbers that directly contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 552,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 35A remained unchanged in size – a $750 million face amount – and the annual debt‑service charge stayed at about $19.9 million (≈ 2.65 % coupon), with a maturity in 2030.  This consistency shows that SPG is deliberately using a large, low‑cost, long‑dated unsecured note as a stable pillar of its capital structure, preserving predictable financing costs and extending its debt maturities rather than repeatedly refinancing short‑term obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental and severe quantitative error that undermines the entire response. (1) MAJOR FACTUAL ERROR - Face Amount: The ground truth states the face amount is $750,000 (seven hundred fifty thousand dollars), but the LLM claims it is $750 million. This is a 1,000x magnitude error. The LLM misread or misinterpreted the data by three orders of magnitude. (2) MAJOR FACTUAL ERROR - Annual Debt Service: The ground truth states annual debt service is $19,875, but the LLM claims it is approximately $19.9 million. Again, this is roughly a 1,000x error. (3) CALCULATION ERROR - Coupon Rate: The LLM calculates a coupon of approximately 2.65% based on their incorrect $750 million figure ($19.9M / $750M ≈ 2.65%). However, using the correct figures from ground truth: $19,875 / $750,000 = 2.65%, which would be correct IF the base numbers were right. But since the base numbers are wrong by three orders of magnitude, this calculation is meaningless. (4) UNSUPPORTED CLAIM - Maturity Date: The LLM introduces a maturity date of 2030 that is not mentioned in the ground truth answer. This appears to be fabricated or from an unreliable source. (5) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the three-year period (2022-2024) and notes consistency, the entire analysis is built on incorrect numbers, making the strategic conclusions unreliable. (6) SEMANTIC ISSUES: The LLM's characterization of this as a 'large, low-cost, long-dated unsecured note' is contradicted by the actual small face amount of $750,000. The ground truth correctly identifies this as a stable, consistent obligation without overstating its size. The LLM answer demonstrates a critical failure in data accuracy that would mislead any financial analyst or investor relying on this information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 495,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 to 2024 the Embedded‑Processing business moved from a relatively healthy contributor—$3.26 B of revenue with a 38 % operating margin in 2022—to only modest top‑line growth in 2023 ($3.37 B, still 38 % margin) before a sharp 25 % revenue drop in 2024 that cut the margin to just 14 %.  The decline reflects weaker demand, higher fixed‑cost absorption from capacity expansions, and rising manufacturing costs, even though the company continues to list embedded processing as a core strategic pillar.  Consequently, the three‑year trend signals that TI is now tempering its aggressive push into embedded processing and is instead focusing on protecting profitability and leveraging its analog strengths to sustain long‑term free‑cash‑flow growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($3.26B in 2022, $3.37B in 2023, with a 25% drop in 2024) and operating margins (38% in 2022-2023, 14% in 2024) that are not verified in the ground truth and appear to be fabricated or incorrectly sourced. The ground truth makes no mention of these specific financial metrics for the embedded processing segment. (2) CONTRADICTORY NARRATIVE: The ground truth explicitly states that TI's emphasis on embedded processing remained CONSISTENT and UNCHANGED across 2022-2024, with the same language used each year describing it as a core competitive advantage. The LLM claims the opposite—that TI is 'tempering its aggressive push into embedded processing'—which directly contradicts the ground truth's finding of stable, long-term strategic consistency. (3) UNSUPPORTED CLAIMS: The LLM attributes the alleged revenue decline to 'weaker demand, higher fixed-cost absorption from capacity expansions, and rising manufacturing costs,' but the ground truth provides no such operational analysis or explanation. These appear to be speculative interpretations not grounded in the actual filings. (4) MULTI-HOP REASONING FAILURE: The question asks about strategic emphasis evolution and long-term positioning. The ground truth correctly synthesizes that the strategic emphasis remained stable across three years, indicating a foundational, consistent approach. The LLM misinterprets this as a shift away from embedded processing, failing to properly synthesize the multi-year filing data. (5) SEMANTIC MISALIGNMENT: While the LLM addresses the right company (TI/TXN) and timeframe (2022-2024), it fundamentally mischaracterizes the strategic direction and provides unverified financial data that contradicts the ground truth's core finding of consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 522,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast moved shared‑data wireless plans from a peripheral add‑on to a central element of its bundled offering, explicitly marketing “shared‑data” as one of three payment choices (unlimited, shared‑data, or per‑GB) that are packaged together with broadband, video and Wi‑Fi‑hotspot access; by 2024 the company broadened the menu further, introducing prepaid unlimited‑data plans under the NOW brand and promoting shared‑data plans as a distinct, discounted bundle within its overall service packages.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three plan options (unlimited, shared-data, per-GB) available across 2022-2024; (2) Accurately captures the 2024 expansion with prepaid unlimited plans under NOW brand; (3) Properly synthesizes the multi-hop information showing evolution from 2022 to 2024; (4) Correctly identifies CMCSA/Comcast as the subject company; (5) Accurately characterizes shared data plans as maintained throughout the period while new options were added. MINOR WEAKNESSES: (1) The LLM characterizes shared-data plans as moving 'from a peripheral add-on to a central element,' which is a stronger characterization than the ground truth supports - the ground truth indicates they were 'consistently offered' but doesn't explicitly state they were peripheral before becoming central; (2) The phrase 'discounted bundle' in the final clause is not explicitly mentioned in the ground truth, which simply states shared data plans were 'continued' and 'maintained'; (3) The LLM doesn't explicitly mention device financing options (24 months) that were part of the 2022-2023 offerings, though this is a minor omission. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no specific dollar amounts or percentages were required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple service offerings, showing proper understanding of how the strategy evolved. The logical flow from 2022 baseline through 2023 maintenance to 2024 expansion is sound. SEMANTIC EQUIVALENCE: The core message matches - shared data plans remained consistent while new prepaid options were added in 2024, representing strategic expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 481,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the end‑of‑year balances, Mastercard’s Class A Treasury Stock grew from **$(51.4 bn) in 2022** to **$(60.4 bn) in 2023** and then to **$(71.4 bn) in 2024**, with corresponding treasury‑stock purchases of **$8.8 bn, $9.1 bn and $11.0 bn** in those years.  \nThe steady rise shows the company is increasingly deploying excess cash to repurchase its own shares—reducing the float, boosting earnings‑per‑share and signaling confidence in its cash‑flow generation and limited growth‑investment opportunities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that fundamentally undermine the response. (1) WRONG NUMBERS: The LLM states 2022 balance as $(51.4 bn), but the ground truth shows $(36,658) million or $(36.658 bn). This is a $14.7 billion discrepancy - a 40% overstatement. The 2023 and 2024 figures are closer but still problematic when examining precision. (2) CALCULATION ERRORS: The LLM claims year-over-year purchases of $8.8 bn, $9.1 bn, and $11.0 bn. However, these don't align with the stated balances: if 2022 was $(36.658) bn and 2023 was $(60.429) bn, the increase would be approximately $23.8 bn, not $8.8 bn as implied. The LLM appears to have confused or misrepresented the underlying data. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the general trend (increasing treasury stock over time) and provides reasonable strategic interpretation (confidence in cash flow, shareholder returns, EPS accretion), the foundational numbers are wrong, making the analysis unreliable. (4) ENTITY AND METRIC ACCURACY: The company (Mastercard) and metric (Class A Treasury Stock) are correctly identified, and the time period (2022-2024) is correct. (5) REASONING QUALITY: The qualitative analysis about capital allocation strategy is sound and semantically equivalent to the ground truth, but it's built on incorrect quantitative foundations. The explanation of buyback rationale (reducing float, boosting EPS, signaling confidence) is appropriate and well-reasoned, but cannot compensate for the numerical errors. The 2022 figure error is particularly egregious as it's the baseline for the entire trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 458,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRevenue from Repair and other services was **$1.169 billion in 2022**, fell slightly to **$1.132 billion in 2023**, and remained flat at **$1.132 billion in 2024**. This modest decline followed by a plateau indicates that the company’s service business has largely stabilized after a period of growth, with emphasis now shifting toward higher‑value submarine and shipbuilding contracts rather than expanding repair revenues.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All financial numbers are factually correct: $1.169 billion (2022), $1.132 billion (2023), $1.132 billion (2024). The LLM correctly converted the ground truth figures from millions to billions format ($1,169M = $1.169B), which is an acceptable format variation. (2) The decline calculation is accurate: approximately 3.2% decline from 2022 to 2024 is correctly reflected in the narrative. (3) All entities and years are correctly identified. (4) The multi-hop synthesis is sound - the LLM successfully combined revenue data across three years and identified the pattern (decline then plateau). WEAKNESSES: (1) The LLM added interpretive commentary about 'emphasis now shifting toward higher-value submarine and shipbuilding contracts' which is not present in the ground truth answer. While this may be contextually reasonable, it goes beyond what can be verified from the provided data and represents speculation rather than fact-based analysis. (2) The characterization of 'stabilized after a period of growth' is somewhat speculative - the ground truth simply notes 'stagnation or potential contraction,' which is more cautious and accurate given the declining trend. (3) Minor semantic difference: ground truth emphasizes 'stagnation or potential contraction,' while LLM emphasizes 'stabilized' - these convey different implications about the trajectory. CALCULATION VERIFICATION: 2022 to 2024 change = ($1,132M - $1,169M) / $1,169M = -$37M / $1,169M = -3.16%, which rounds to approximately 3.2% decline as stated. This is correct. The answer addresses all parts of the question and provides accurate quantitative data, but the added interpretive elements that exceed the ground truth reduce the qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 474,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nCVS’s residential‑mortgage‑backed‑securities (RMBS) holdings fell from about **$721 million in 2022** (with unrealized losses of roughly **$89 million**) to **$614 million in 2023** (unrealized losses of about **$60 million**) – a reduction documented in the 2023 10‑K (page 149) that compares 2022 and 2023 loss‑position tables.  The 2024 filing shows only a modest increase in the separate‑account RMBS balance to **$71 million** (up from $51 million in 2023) (page 158/160 of the 2024 10‑K), indicating that the company’s overall RMBS exposure remained small and continued to shrink.  This multi‑year trajectory reflects a deliberate de‑risking of the RMBS portfolio, as higher interest rates pressured valuations and the firm chose to limit its exposure to this interest‑rate‑sensitive asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) 2022 RMBS Fair Value: LLM states $721 million, but ground truth shows $629 million - a $92 million discrepancy (13.8% overstatement). (2) 2022 Unrealized Losses: LLM claims $89 million, but ground truth shows $10 million - a massive $79 million error (790% overstatement). This is the most egregious error. (3) 2023 Fair Value: LLM correctly states $614 million (matches ground truth). (4) 2023 Unrealized Losses: LLM correctly states $60 million (matches ground truth). (5) 2024 RMBS Holdings: LLM states $71 million, which matches ground truth, but then confusingly references a 'separate-account RMBS balance' of $51 million in 2023 that is not mentioned in the ground truth, creating confusion about which figure is the primary holding. The LLM appears to be conflating or misinterpreting different RMBS categories. MULTI-HOP REASONING: While the LLM correctly identifies the overall de-risking trajectory and appropriately synthesizes the three-year trend, the foundational numbers are wrong, making the analysis unreliable. The reasoning about interest rate pressures and deliberate de-risking is sound and matches the ground truth conclusion, but it's built on incorrect data. COMPLETENESS: The answer addresses all three years and discusses both fair value and unrealized losses, but the accuracy of the underlying data is severely compromised. The qualitative conclusion about de-risking strategy is correct, but the quantitative foundation is fatally flawed. The 2022 data errors are particularly problematic as they represent the baseline for understanding the trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 471,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s on‑site gas supply contracts remained long‑term (typically 10‑20 year) total‑requirement agreements that include minimum purchase volumes and built‑in price‑escalation provisions tied to published price indices, with any variable price adjustments treated as constrained and recognized only when realizable; revenue is still recognized over time as the product is delivered and the company gains the right to invoice.  The 2024 disclosures highlight roughly $58 billion of future consideration linked to these minimum‑purchase obligations, showing an evolution toward more index‑linked, inflation‑adjusted pricing while preserving the same over‑time revenue recognition model for on‑site customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core contractual structure (10-20 year on-site contracts with minimum purchase requirements and price escalation provisions), accurately describes the variable pricing treatment as constrained, and properly explains the over-time revenue recognition model. The answer demonstrates good understanding of the multi-hop synthesis required across 2022-2024 periods and correctly references ASC 606 principles implicitly through the invoicing rights discussion. The semantic equivalence to the ground truth regarding pricing mechanisms and contract evolution is generally sound.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a specific figure of \"roughly $58 billion of future consideration linked to these minimum-purchase obligations\" which does not appear in the ground truth answer. This is a significant factual claim that cannot be verified against the provided ground truth and represents an unsupported quantitative assertion. (2) MISSING KEY DETAIL - The ground truth explicitly notes that the 2023 disclosure was the first to detail variable pricing components and that this clarification \"was not detailed in 2022.\" The LLM answer does not capture this important temporal distinction about when transparency around variable pricing was introduced. (3) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes a \"growing emphasis on transparency in pricing mechanisms\" as a key evolution from 2022-2024, and specifically highlights the 2023 clarification as a turning point. The LLM answer treats the evolution more as a continuous refinement rather than capturing this specific 2023 disclosure shift. (4) ASC 606 REFERENCE - While the LLM mentions the practical expedient and invoicing rights (which aligns with ground truth), it doesn't explicitly connect this to the 2024 reinforcement of documentation practices noted in the ground truth.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the relationship between contract structure, pricing mechanisms, and revenue recognition. However, the introduction of the $58 billion figure without ground truth support undermines the reliability of the synthesis.\n\nJUSTIFICATION: The answer is partially correct on core concepts but contains a significant unsupported quantitative claim and misses the important 2023 disclosure milestone regarding variable pricing transparency. These issues prevent a higher score despite generally sound reasoning on the contractual and revenue recognition aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 688,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nFrom 2022 through 2024 the disclosed net notional volumes of NEE’s forward‑gas contracts fell from a short position of roughly **1.3 trillion MMBtu** in 2022 to a larger short of **≈1.45 trillion MMBtu** in 2023, and then were trimmed back to about **1.13 trillion MMBtu** by the end of 2024.  This three‑year trend shows that the company first expanded its short exposure—likely to profit from higher gas prices—before reducing that short position in 2024, indicating a more risk‑averse stance and a deliberate de‑risking of its natural‑gas market exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different metric than the ground truth. CRITICAL ERRORS: (1) WRONG METRIC: The LLM discusses 'notional volumes' measured in MMBtu (trillion MMBtu), while the ground truth provides net exposure in dollar amounts ($160M, $300M, $250M). These are entirely different financial measures. (2) WRONG DIRECTION: The LLM describes 'short positions' in MMBtu volumes, but the ground truth shows net asset positions (assets minus liabilities) in dollars. A short position in derivatives is not the same as net exposure calculated from asset/liability values. (3) WRONG NUMBERS: The LLM's figures (1.3 trillion MMBtu, 1.45 trillion MMBtu, 1.13 trillion MMBtu) do not correspond to any values in the ground truth ($160M, $300M, $250M). (4) FAILED MULTI-HOP SYNTHESIS: The question asks about 'net exposure' which the ground truth correctly interprets as the difference between forward gas contract assets and liabilities. The LLM instead provides notional volume data, which is a different disclosure entirely. (5) INCORRECT INTERPRETATION: While the LLM's narrative about 'expanding then contracting' positions has some semantic similarity to the ground truth's pattern, it is based on completely wrong underlying data. The ground truth shows: 2022: $160M (191-31), 2023: $300M (377-77), 2024: $250M (296-46). The LLM provides no dollar values and instead discusses MMBtu volumes that don't match the filing data. This represents a fundamental failure to identify and extract the correct financial metrics from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 436,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nBroadcom has consistently placed industrial‑fiber‑optic components inside its “Industrial” end‑market bucket, but the way it is framed has become progressively more integrated and growth‑focused.  In the 2022 filing the fiber‑optic products were simply listed with optocouplers and motion encoders as part of a generic industrial suite; by 2023‑2024 the language highlighted their use in factory‑automation, renewable‑energy and automotive electronics and paired them with complementary offerings such as industrial sensors, motion‑control encoders and Ethernet ICs, underscoring a broader, higher‑value industrial portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues in accuracy and framing. CORRECT ELEMENTS: (1) Industrial Fiber Optics was consistently positioned within the Industrial end-market across 2022-2023-2024; (2) The products were grouped with optocouplers, sensors, and motion control offerings; (3) Applications like factory automation, renewable energy, and automotive were mentioned; (4) The general trajectory of integration is noted. SIGNIFICANT ERRORS AND ISSUES: (1) The LLM claims the 2022 positioning was 'simply listed with optocouplers and motion encoders as part of a generic industrial suite' - but the ground truth indicates 2022 described Industrial Fiber Optics as part of 'a broad variety of industrial products' across multiple application domains (industrial automation, power generation, medical systems, defense, aerospace, automotive). The LLM oversimplifies 2022 as 'generic' when it was actually quite comprehensive. (2) The LLM characterizes the evolution as 'progressively more integrated and growth-focused' with language becoming 'higher-value' - but the ground truth explicitly states 'The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role...with no significant expansion or contraction.' This is a fundamental mischaracterization of the trajectory. (3) The LLM suggests increased emphasis and integration over time, but ground truth indicates stability, not evolution toward higher-value positioning. (4) The LLM omits key 2022 application areas (power generation, medical systems, defense, aerospace) that were explicitly mentioned in the ground truth. MULTI-HOP REASONING: The LLM attempted to synthesize across three years but drew incorrect conclusions about the nature of change (growth-focused vs. stable). The reasoning is partially sound in structure but reaches wrong conclusions about strategic positioning evolution. QUANTITATIVE ACCURACY: No specific numbers were required, so this scores well (8/10) - dates and years are correct. QUALITATIVE ACCURACY: Moderate issues due to mischaracterization of strategic evolution and oversimplification of 2022 positioning (5/10). CONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about evolution across years but provides misleading conclusions about the nature of that evolution (7/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 631,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Unsecured Notes ‑ 31B showed no change in either size or cost: the notes remained a **$750 million (face) tranche at a fixed 3.25 % coupon**, producing a steady **annual debt‑service amount of roughly $24.375 million**.  \n\nThis consistency indicates that SPG is deliberately **maintaining a stable, low‑cost, long‑dated unsecured debt position**, using the 31B notes as a fixed‑rate pillar of its capital structure rather than expanding or refinancing it, thereby preserving cash flow and limiting refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - face amount of $750 million (properly formatted as $750M), interest rate of 3.25%, and annual debt service of $24.375 million are all accurate and match the ground truth exactly. The format variation ($750 million vs $750M) is acceptable and demonstrates flexibility. COMPLETENESS: The answer addresses all three years (2022-2023-2024) and correctly identifies the consistency across the period. The multi-hop synthesis is sound - the model correctly tracked the same instrument across three fiscal years and identified the lack of change. ENTITY ACCURACY: SPG is correctly identified, the specific instrument (Unsecured Notes - 31B) is properly named, and all financial metrics are correctly attributed. REASONING QUALITY: The LLM goes beyond mere fact-reporting to provide strategic interpretation - characterizing the stable debt position as a deliberate strategy to maintain low-cost, long-dated unsecured debt while preserving cash flow and limiting refinancing risk. This interpretation is logical and well-supported by the data presented. The conclusion that there was 'no refinancing or restructuring observed' is correctly inferred from the unchanged parameters. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('roughly $24.375 million' vs the ground truth's more precise '$24,375,000') but this is semantically equivalent and actually more natural. The strategic interpretation about 'deliberately maintaining' and using the notes as a 'fixed-rate pillar' represents reasonable inference from the stable data, though the ground truth is more conservative in its language. Overall, this is a high-quality answer that correctly synthesizes multi-year data and provides appropriate context about debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 504,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ U.S. defined‑contribution plan expense grew modestly over the period – $70 million in 2022, $75 million in 2023 and $76 million in 2024 (as disclosed on pages 43 and 45 of the 2022‑2024 10‑K filings). This upward trend indicates the company is steadily increasing its financial investment in employee retirement benefits through these plans.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all three years' expense figures ($70M in 2022, $75M in 2023, $76M in 2024) and accurately characterizes the trend as modest/steady growth. The numbers match the ground truth exactly. The answer appropriately synthesizes the multi-hop information by comparing across the three-year period and drawing a reasonable conclusion about the company's commitment to employee retirement benefits. However, the LLM answer has two minor gaps: (1) It does not explicitly calculate or mention the 8.6% total increase from 2022 to 2024 that the ground truth provides, which was part of the original question asking what the trend 'indicates.' (2) The citation to 'pages 43 and 45' adds specificity but cannot be verified against the ground truth and may be a hallucination. The characterization of the trend as 'upward' and 'steadily increasing' is semantically equivalent to the ground truth's 'steady and slightly growing commitment,' though the ground truth notes the increase was 'slight' while the LLM uses 'modest' (both appropriate descriptors). The answer demonstrates sound multi-hop reasoning by synthesizing data across three fiscal years and drawing a logical conclusion about investment trends. The omission of the specific percentage calculation prevents a perfect score, but the core factual content and reasoning are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 379,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes—such as goodwill impairments—from both the numerator (net operating profit after tax) and the denominator (average invested capital) of its ROIC calculation through 2022, 2023 and 2024. By applying the same exclusion each year, the company signals that its performance‑evaluation metric is intended to isolate the recurring, cash‑generating returns of its operations, deliberately filtering out one‑time accounting adjustments that do not reflect underlying operational performance. This steady treatment underscores a methodology that focuses on sustainable earnings and capital efficiency rather than short‑term accounting effects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: The core factual claim matches the ground truth perfectly—GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024. The LLM correctly identifies this consistency and its implications. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension is not applicable. The years cited (2022, 2023, 2024) are correct. (3) QUALITATIVE ACCURACY: The LLM provides enhanced reasoning beyond the ground truth by specifically mentioning goodwill impairments as an example and explaining the dual application to both numerator (NOPAT) and denominator (average invested capital). This demonstrates deeper understanding of ROIC mechanics. The LLM correctly synthesizes that consistent exclusion reveals a disciplined, stable methodology focused on operational performance. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the treatment pattern to broader performance evaluation philosophy. The logic is sound: consistent treatment → stable methodology → focus on sustainable earnings. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth ('consistent exclusion' and 'stable methodology') while adding valuable context about the specific components affected and the strategic intent. The phrase 'deliberately filtering out one-time accounting adjustments' is semantically equivalent to 'removing items not directly reflective of operational results.' Minor deduction (1 point) only because the LLM adds interpretive detail (goodwill impairments, NOPAT/invested capital mechanics) that, while accurate and insightful, goes slightly beyond what can be verified as explicitly stated in the ground truth, though this represents enhancement rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 516,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nCVS’s Separate Accounts assets were $3.31 billion at the end of 2022, fell to $3.20 billion in 2023, and rose again to $3.31 billion by the end of 2024 (see 10‑K 2022 p. 115, 2023 p. 155, and 2024 p. 106). The modest dip followed by a rebound indicates that the company’s exposure to long‑term insurance products remains essentially stable, with only minor portfolio re‑balancing driven by market valuations rather than a strategic shift away from or toward these assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth shows: 2022=$5,087M, 2023=$3,250M, 2024=$3,311M. LLM states: 2022=$3.31B, 2023=$3.20B, 2024=$3.31B. The 2022 figure is completely wrong ($3.31B vs $5.087B - a 35% understatement). The 2023 figure is also incorrect ($3.20B vs $3.250B - minor but still wrong). The 2024 figure happens to be correct ($3.31B). The LLM's narrative interpretation is also fundamentally flawed: it describes the trend as 'modest dip followed by rebound' and 'essentially stable,' when the ground truth shows a SIGNIFICANT 36% decline from 2022 to 2023 (from $5,087M to $3,250M), followed by marginal recovery. This is a material mischaracterization of the trend. The LLM failed to capture the dramatic 2022-2023 decline, which is the most important feature of the 3-year trend. The reasoning about 'minor portfolio re-balancing' is inconsistent with a $1.8 billion reduction in assets. The page citations provided cannot be verified but appear to be fabricated or incorrect given the data discrepancies. Multi-hop synthesis failed: the model did not correctly extract and compare the three years of data from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 343,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nFrom 2022 through 2024 the Target‑TD Bank credit‑card program was updated twice. The **Third Amendment** to the Credit Card Program Agreement was executed on **November 1, 2022** (filed as Exhibit 10.21.3+ to the 2022 Form 10‑Q) and later a **Letter Agreement** dated **March 8, 2023** (Exhibit 10.21.4+ to the 2023 Form 10‑Q) introduced additional modifications. No further amendments were disclosed in the 2024 filing, so the 2022 amendment and the 2023 letter agreement represent the most recent contractual milestones.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims a 'Third Amendment' dated November 1, 2022, but the ground truth indicates the second amendment was dated November 19, 2019 (not 2022). The LLM also introduces a 'Letter Agreement' dated March 8, 2023, which is not mentioned in the ground truth at all. (2) QUANTITATIVE ACCURACY: The dates provided (November 1, 2022 and March 8, 2023) do not match the ground truth dates (October 22, 2012 for original agreement, February 24, 2015 for first amendment, November 19, 2019 for second amendment). The LLM incorrectly identifies which amendment is 'most recent' - claiming the 2022 amendment is the third when the ground truth shows only two amendments through 2024. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution of the agreement across the three-year period. It misidentified amendment numbers and dates, and introduced contractual elements (the March 8, 2023 letter agreement) that are not supported by the ground truth. (4) ENTITY ACCURACY: While the companies (Target Corporation and TD Bank USA, N.A.) are correctly identified, the specific contractual milestones and their dates are fundamentally wrong. The ground truth clearly states the second amendment was from 2019, not 2022. The LLM's claim about 'no further amendments in 2024' cannot be verified against the ground truth which only mentions amendments through 2024 but doesn't explicitly state whether additional amendments exist. The answer demonstrates a fundamental misunderstanding of the actual contractual evolution and provides incorrect dates and amendment numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 460,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022 through 2024 Linde deepened its technological edge in rare‑gas production by scaling both cryogenic and non‑cryogenic air‑separation (VPSA and membrane) processes that co‑produce krypton, neon and xenon, and by embedding those gases in its on‑site plant contracts and global engineering services.  At the same time the company tied rare‑gas supply to its broader clean‑energy and engineering portfolio—using the same separation platforms to deliver low‑carbon hydrogen, carbon‑capture‑ready units and specialty gases—so that rare‑gas sales are now integrated with long‑term on‑site supply agreements, engineering‑driven plant sales and the company’s hydrogen‑and‑carbon‑management strategies, creating a differentiated, cross‑selling offering across its industrial‑gases, engineering and clean‑energy product lines.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of Linde's rare gases strategy from 2022-2024. STRENGTHS: (1) Correctly identifies the specific rare gases (krypton, neon, xenon) mentioned in ground truth; (2) Accurately references both cryogenic and non-cryogenic technologies (VPSA and membrane separation) as stated in original answer; (3) Properly captures the 2024 positioning shift toward technological differentiation and integration; (4) Correctly emphasizes the progression from product-centric to technology/integration-driven approach; (5) No quantitative errors or date inaccuracies; (6) Multi-hop synthesis is sound—connects rare gas production evolution across three years with strategic positioning changes. MINOR GAPS: (1) The LLM answer goes beyond the ground truth by introducing elements not explicitly mentioned in the original (clean-energy portfolio, carbon-capture-ready units, hydrogen-and-carbon-management strategies, engineering services integration). While these represent reasonable inferences about Linde's broader strategy, they are not directly supported by the ground truth provided; (2) The ground truth explicitly mentions 2023's emphasis on 'long-term contracts with price escalation clauses and variable pricing'—the LLM answer mentions long-term contracts but omits the specific pricing mechanism details; (3) The ground truth notes the 2022 baseline of 'three core methods—on-site, merchant, and packaged'—the LLM answer focuses primarily on on-site without explicitly acknowledging the distribution method evolution. SEMANTIC EQUIVALENCE: The core narrative is semantically equivalent—both convey a shift from basic product offering to integrated technology-driven positioning. The LLM's framing of 'cross-selling offering' and 'differentiated' positioning aligns well with the ground truth's 'technology- and integration-driven approach.' The answer demonstrates solid understanding of the multi-hop question structure and synthesizes information appropriately, though it adds interpretive layers beyond the strict ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 570,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nFrom 2022 to 2024 the collateral that ExxonMobil pledged under master‑netting arrangements tied to its advances/receivables from equity companies fell sharply—from about **$1.5 billion in 2022 to $0.8 billion in 2023 and $0.49 billion in 2024**.  The declining pledged amount reflects that the company has been **reducing or settling the derivative‑related positions linked to those equity‑company relationships**, thereby lowering its potential liability exposure from such derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.5 billion (2022), $0.8 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively. The format variation ($1.5B vs $1,494M) is acceptable and demonstrates appropriate rounding. The directional trend (consistent decline) is accurately captured. ENTITY ACCURACY: ExxonMobil correctly identified, master netting arrangements properly referenced, equity company relationships correctly contextualized, and the 2022-2024 timeframe accurately covered. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and connects it to the underlying business implication (derivative liability exposure reduction). The logic is sound - declining collateral pledged under master netting arrangements does indicate reduced derivative exposure. SEMANTIC EQUIVALENCE: The LLM's interpretation that this reflects 'reducing or settling derivative-related positions' and 'lowering potential liability exposure' aligns well with the ground truth's characterization of 'strategic reduction in exposure' and 'de-risking or portfolio optimization efforts.' The wording differs slightly but conveys equivalent meaning. MINOR CONSIDERATIONS: The LLM uses slightly more colloquial phrasing ('fell sharply') compared to the ground truth's more formal 'declined,' but this is a stylistic choice that doesn't affect accuracy. The answer could have explicitly mentioned 'portfolio optimization' as suggested in the ground truth, but the core insight about de-risking is clearly communicated. Overall, this is a high-quality response that accurately addresses all components of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 483,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 NEER’s long‑term bilateral‑contract coverage stayed very high – about 94 % of its net generating capacity was under such contracts by the end of 2023 and again in 2024 (up modestly from roughly 92 % of capacity noted for 2021).  This near‑universal contracting locks in power prices for the bulk of its output, thereby insulating earnings from spot‑market volatility and reinforcing NEER’s strategy of mitigating financial risk in increasingly competitive wholesale markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN BASELINE YEAR: The LLM answer references 2021 data (92% for 2021) when the ground truth specifies 2022 as the starting point (92% in 2022). This is a significant factual error that undermines the temporal analysis of the trend. The LLM states '92% of capacity noted for 2021' but the original answer clearly establishes the trend as 2022→2023→2024. CORRECT ELEMENTS: The percentages for 2023 and 2024 (94% both years) are accurate. The characterization of the strategy (revenue stability, risk mitigation, spot-market insulation) is semantically equivalent and well-reasoned. The qualitative assessment of competitive market dynamics is appropriate. INCOMPLETE ANALYSIS: The LLM answer fails to explicitly identify the 'steady increase' or 'consistent rise' from 92% to 94% as a key trend indicator. While it notes the increase is 'modest,' it doesn't emphasize the directional consistency across the three-year period that the ground truth highlights. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects contract coverage percentages to risk mitigation strategy and market competitiveness. However, the baseline year error (2021 vs 2022) represents a fundamental factual mistake that affects the credibility of the trend analysis. The answer would have scored 8-9 if the temporal framework were correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 377,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe 3.125 % notes maturing in January 2025 carried an outstanding principal of **$495 million** in fiscal 2022 and this balance remained **unchanged at $495 million** through fiscal 2023 and fiscal 2024. This flat trajectory indicates that the company is deliberately maintaining a modest, fixed‑rate tranche and intends to retire the notes at maturity rather than expand or refinance the exposure, reflecting a disciplined, maturity‑focused debt‑management strategy for this instrument.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024), and the fact that it remained unchanged is correctly identified. (2) The note maturity date (January 2025) and coupon rate (3.125%) are correctly cited. (3) Number formatting is appropriate and consistent. (4) The multi-hop synthesis correctly identifies the evolution (or lack thereof) across the three-year period.\n\nWEAKNESSES: (1) The LLM's interpretation of debt management strategy differs from the ground truth. The ground truth suggests AVGO 'may be planning to refinance or use cash reserves to settle the obligation,' which is more cautious and acknowledges uncertainty. The LLM states the company 'intends to retire the notes at maturity rather than expand or refinance the exposure,' which is a more definitive claim not explicitly supported by the data. (2) The LLM characterizes the strategy as 'deliberately maintaining a modest, fixed-rate tranche' and 'disciplined, maturity-focused debt-management,' which adds interpretive language beyond what the facts alone support. The ground truth is more measured in its inference. (3) The phrase 'retire the notes at maturity rather than expand or refinance' presents a false dichotomy - the ground truth acknowledges refinancing as a possibility, not rules it out.\n\nMULTI-HOP REASONING: The model correctly synthesized information across three fiscal years and identified the unchanged balance as the key finding. However, the interpretive leap regarding management intent is somewhat overconfident compared to the ground truth's more cautious framing.\n\nOVERALL: The factual foundation is solid and all numbers are correct, but the strategic interpretation is presented with more certainty than warranted by the underlying data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 500,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s 37B unsecured note remained unchanged: each filing lists a **2.25 % coupon**, a **$700 million face amount**, and a **maturity date of 01/15/2032** (see SPG 10‑K 2022 p. 50, SPG 10‑K 2023 p. 51, SPG 10‑K 2024 p. 52).  \nThe steady terms indicate that Simon Property Group is deliberately using low‑cost, long‑dated unsecured debt to lock in financing for the long term, rather than repeatedly refinancing or altering the instrument, reflecting a stable, long‑term debt‑strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700 million face amount, and January 15, 2032 maturity date match the ground truth exactly. The date format (01/15/2032) is a valid variation of the ground truth format. COMPLETENESS: The answer addresses all three components of the multi-part question: interest rate evolution, face amount evolution, and maturity date evolution across the 2022-2024 period. ENTITY ACCURACY: Simon Property Group is correctly identified, the unsecured notes - 37B is correctly referenced, and all three years (2022, 2023, 2024) are properly covered. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings and identifies the key insight that consistency across all three years indicates a deliberate strategy. The reasoning about 'low-cost, long-dated unsecured debt' and 'lock in financing for the long term' aligns with the ground truth's characterization of a 'deliberate long-term debt strategy focused on maintaining predictable financing costs.' SEMANTIC EQUIVALENCE: The LLM's explanation of the strategic implications ('deliberately using low-cost, long-dated unsecured debt to lock in financing for the long term, rather than repeatedly refinancing') conveys the same meaning as the ground truth's assessment about 'maintaining predictable financing costs and extending liability durations.' The citation references to specific page numbers (p. 50, 51, 52) add credibility, though these cannot be independently verified. Minor note: The LLM uses slightly different phrasing ('coupon' instead of 'interest rate') but this is a standard financial terminology variation and does not affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 482,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K property tables list Melaka, Malaysia exclusively under the **Analog** column – the site is never shown with an “Embedded Processing” designation in any of the yearly filings.  The company’s disclosures therefore reveal a steady, analog‑only footprint in Melaka, with no shift toward embedded‑processing activities over the three‑year period, underscoring that TI’s strategic focus in that Malaysian location remains centered on analog semiconductor manufacturing rather than embedded processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies that Melaka, Malaysia maintained an analog-only operational footprint from 2022-2024 with no embedded processing designation. The core claim that the pattern remained 'unchanged' across all three years matches the ground truth exactly. (2) QUANTITATIVE ACCURACY: No numerical calculations are required for this question, but the temporal scope (2022-2024, three-year period) is correctly identified and applied. The answer appropriately references the property table designations ('X' under Analog, absence under Embedded Processing) consistent with ground truth methodology. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three separate annual 10-K filings to establish a consistent pattern. The logical inference that consistency 'underscores' a targeted investment strategy rather than diversification is sound and matches the ground truth's interpretation. (4) ENTITY ACCURACY: Texas Instruments (TXN) is correctly identified, Melaka, Malaysia is properly specified, and the product categories (Analog vs. Embedded Processing) are accurately distinguished. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('steady, analog-only footprint,' 'no shift toward embedded-processing activities,' 'strategic focus...remains centered on analog') conveys identical meaning to the ground truth's language ('consistently focusing solely on analog,' 'stable, analog-only operational strategy,' 'targeted investment in analog capabilities'). Minor stylistic differences (e.g., 'steady' vs. 'stable,' 'underscoring' vs. 'suggests') represent acceptable variation in professional communication. The answer is comprehensive, directly addresses all aspects of the multi-part question, and provides appropriate context about what the three-year consistency reveals about company strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 527,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard layered additional real‑time‑specific controls onto its existing multi‑layered security model as it rolled out real‑time payment infrastructure in ever more markets. In 2022 the focus was on a baseline cyber‑risk program, third‑party assessments and EMV‑based standards; by 2023 the network had added real‑time clearing, tokenization and intelligent fraud‑scoring across 12‑plus top‑market jurisdictions, and in 2024 it expanded that architecture with joint‑venture domestic processing in China, AI‑driven fraud intelligence, Alias‑Based remittance platforms and broader VCN adoption—all reinforced by continuous ecosystem collaboration and data‑centric governance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding market expansion. The ground truth states that in 2022, real-time payments infrastructure was operational in 12 of the top 50 GDP markets, and by 2023 this expanded to 13 markets. However, the LLM answer reverses this sequence, stating '12-plus top-market jurisdictions' were reached by 2023, which is directionally correct but imprecise. More problematically, the LLM introduces unsupported claims not present in the ground truth: (1) 'AI-driven fraud intelligence' is mentioned as a 2024 addition but is not in the original answer; (2) 'Alias-Based remittance platforms' and 'broader VCN adoption' are introduced without ground truth support; (3) 'baseline cyber-risk program' and 'third-party assessments' in 2022 are mentioned but not explicitly confirmed in the ground truth. CORRECT ELEMENTS: The LLM correctly identifies (1) the 2022 baseline with EMV standards, (2) the 2023 expansion with tokenization and intelligent fraud-scoring, (3) the 2024 China joint venture expansion, and (4) the general evolution of the multi-layered approach. MULTI-HOP REASONING: The answer attempts to synthesize information across three years but introduces speculative details not grounded in the knowledge graph. The core narrative of evolution is present but contaminated with unsupported claims. SEMANTIC ISSUES: While the general structure mirrors the ground truth, the specific technical implementations mentioned (AI-driven fraud intelligence, Alias-Based remittance, VCN adoption) appear to be hallucinations or extrapolations beyond the provided knowledge graph. The answer demonstrates partial understanding of the evolution but fails on factual precision regarding what was actually documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 487,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics steadily raised the number of Light Armored Vehicles it builds for the Canadian Army—360 units in 2022, 399 in 2023 and 449 in 2024. This upward trajectory shows the company is deliberately expanding its LAV production capacity and positioning land‑system sales as a core growth pillar of its strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three production volume figures are correct—360 units (2022), 399 units (2023), and 449 units (2024). The progression is accurately captured with no calculation errors. (2) ENTITY ACCURACY: General Dynamics, Light Armored Vehicles (LAVs), and Canadian Army are all correctly identified. The time period (2022-2024) is accurate. (3) MULTI-HOP REASONING: The answer successfully synthesizes the production data across three years and correctly interprets the upward trajectory as indicating strategic emphasis and commitment. The reasoning that increasing production reflects deliberate expansion and positioning as a growth pillar is sound and logically derived from the data. (4) COMPLETENESS: The answer addresses both parts of the question—the evolution of production volume AND what it indicates about strategic focus. The LLM provides slightly more specific strategic interpretation ('positioning land-system sales as a core growth pillar') compared to the ground truth's more general 'deepening commitment to fulfilling international demand.' Both interpretations are valid and complementary. (5) MINOR DIFFERENCES: The LLM uses slightly different phrasing ('deliberately expanding its LAV production capacity' vs. 'consistent and growing strategic emphasis') but conveys semantically equivalent meaning. The ground truth mentions 'expanding defense contracts and international demand' while the LLM emphasizes 'land-system sales as a core growth pillar'—both are reasonable strategic interpretations of the same data. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 452,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 the pension plan’s hedge‑fund limited‑partnership holdings grew from **$225 million** (reported for 2022) to **$290 million** (reported for 2024), an increase of about **$65 million (≈ 29 %)**.  This steady rise indicates that CVS is deliberately expanding its exposure to alternative‑asset strategies, using hedge‑fund partnerships to boost expected returns and diversify the portfolio as part of a broader, more diversified pension‑fund investment approach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. Specific issues: (1) WRONG 2022 FIGURE: LLM states $225 million for 2022, but ground truth shows $214 million. This is a $11 million error on the starting value. (2) WRONG 2024 FIGURE: LLM states $290 million for 2024, but ground truth shows $252 million. This is a $38 million error on the ending value - a massive discrepancy representing 15% overstatement. (3) WRONG CALCULATION: LLM calculates $65 million increase (29%), but correct calculation is $252M - $214M = $38 million increase (17.8%). The LLM's percentage is off by 11.2 percentage points. (4) MISSING 2023 DATA: LLM fails to mention the 2023 figure of $225 million, which is important for understanding the three-year trajectory. (5) INCORRECT CHARACTERIZATION: LLM describes this as a 'steady rise' and 'deliberately expanding exposure,' but the ground truth shows a more modest, gradual upward trend with the 2023 figure actually matching the LLM's incorrect 2022 figure. The actual pattern is: $214M → $225M → $252M (modest growth), not the aggressive expansion the LLM suggests. The reasoning about alternative asset strategies and portfolio diversification is plausible but is built on incorrect numerical foundations. The multi-hop synthesis fails because the underlying data points are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 386,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe Target MasterCard Credit Card’s penetration slipped from about 19.8 % in 2022 to 18.6 % in 2023 and 17.8 % in 2024, a modest but steady decline. This downward trend indicates that consumer adoption and engagement with Target’s co‑branded credit product have been easing over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate figures. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 17.8%. LLM answer states: 2022: 19.8%, 2023: 18.6%, 2024: 17.8%. The 2022 figure is incorrect (off by 0.7 percentage points), and the 2023 figure is incorrect (off by 1.2 percentage points). Only the 2024 figure of 17.8% is correct. These are not minor rounding variations but substantive errors in the core data being evaluated. INCOMPLETE ANALYSIS: The LLM answer fails to address the second part of the question regarding what the trend suggests about consumer adoption and engagement. The ground truth provides detailed analysis including: (1) the distinction between RedCard sales increasing in dollar terms while total sales grew faster, (2) the dilution effect on penetration rates, (3) potential explanations including shifting consumer preferences, increased competition, and reduced sensitivity to the 5% discount incentive. The LLM answer merely states the trend 'indicates that consumer adoption and engagement...have been easing' without the substantive analysis provided in the ground truth. ENTITY ACCURACY: The LLM correctly identifies the Target MasterCard Credit Card and the time period (2022-2024). REASONING QUALITY: While the LLM correctly identifies the direction of the trend (decline), it fails to provide the multi-hop synthesis required to fully answer the question. The ground truth demonstrates understanding of the relationship between absolute sales growth and penetration rate changes, which the LLM does not address. The answer is superficial and lacks the depth of analysis present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 466,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024, the fair‑value exposure tied to FPL Cost Recovery Clauses rose from about $1 million in 2022 to a peak of roughly $38 million in 2023 and then slipped slightly to about $31 million in 2024. Throughout this period the valuation remained heavily weighted toward significant unobservable inputs—growing from roughly 78 % of the total in 2022 to about 87 % in 2024—while the contribution from significant other observable inputs stayed small (around 10‑13 % of the total).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains multiple significant factual errors that fundamentally contradict the ground truth: (1) WRONG 2024 VALUE: LLM states 2024 fair value was '$31 million' when ground truth clearly shows $38 million. This is a major error. (2) WRONG 2023 VALUE: LLM states 2023 was a 'peak of roughly $38 million' when ground truth shows 2023 was $12 million and 2024 reached $38 million. The LLM has reversed the trajectory. (3) INCORRECT TREND NARRATIVE: LLM describes the 2023-2024 movement as 'slipped slightly' when the actual data shows a sharp INCREASE from $12M to $38M. (4) PERCENTAGE CALCULATIONS APPEAR FABRICATED: LLM claims unobservable inputs were '78% in 2022' and '87% in 2024.' Verification: 2022 ground truth shows $6M unobservable / $1M total = 600% (impossible), suggesting the LLM misunderstood the data structure. The ground truth shows contributions that can be negative (e.g., 2023: -$12M observable, +$24M unobservable), which the LLM's percentage approach doesn't properly account for. (5) MISSING KEY DETAILS: The LLM fails to capture the specific contribution values from observable vs. unobservable inputs for each year, instead providing only percentages that appear incorrect. (6) INCOMPLETE SYNTHESIS: While the LLM attempts to address the multi-hop nature of the question (evolution over time, shift between input types), it does so with fundamentally wrong numbers. The core narrative about 'growing reliance on unobservable inputs' is directionally correct but undermined by the wrong absolute values and reversed year-to-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 440,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Nike’s disclosures show a steady sharpening of its product‑innovation pipeline—continuously rolling out new Air, Zoom, React, Flyknit and other performance technologies—while deepening brand‑engagement through expanded athlete‑endorsement networks, digital‑commerce platforms and community‑investment/DEI initiatives.  These moves are framed in the filings as the primary way Nike “maintains its competitive edge” against rivals such as Anta, whose growth has been concentrated in the Chinese market and whose public emphasis on innovation and brand storytelling is less extensive.  Consequently, Nike’s positioning relative to Anta has evolved from a focus on scale and global reach to a more differentiated strategy built on cutting‑edge product development and immersive brand experiences that reinforce its status as the world’s largest athletic‑apparel seller.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies NKE (Nike) as the global leader in athletic footwear/apparel\n2. Correctly names Anta as a competitor across the period\n3. Accurately captures the evolution toward innovation emphasis (Air, Zoom, React, Flyknit technologies mentioned)\n4. Correctly identifies digital engagement and athlete endorsements as key brand strategies\n5. Appropriately notes Anta's concentration in Chinese market\n6. Correctly frames the strategic shift from scale/global reach to differentiated innovation\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. FACTUAL ERROR: The ground truth explicitly states that in 2022, NKE emphasized 'quality, performance, and reliability' alongside innovation. The LLM answer does not mention this 2022 baseline positioning, instead jumping directly to the innovation pipeline without establishing the 2022 starting point.\n2. MISSING CRITICAL DETAIL: The ground truth specifically notes that by 2023, NKE 'elevated the importance of innovation and development AHEAD OF performance and reliability'—this represents a specific strategic shift in prioritization. The LLM answer does not capture this hierarchical change in emphasis.\n3. INCOMPLETE SYNTHESIS: The ground truth emphasizes that Anta's 'localized and digitally native strategies' are gaining traction. The LLM answer mentions Anta's Chinese market focus but doesn't adequately capture the competitive threat from their digital-native approach.\n4. OVERSTATED CLAIMS: The LLM answer states Nike's emphasis on innovation/brand storytelling is 'less extensive' than Anta's—this is not supported by the ground truth, which actually suggests NKE elevated innovation emphasis in response to competitive pressures.\n5. ADDED INTERPRETATION: The LLM introduces DEI initiatives and community investment as brand engagement strategies, which are not mentioned in the ground truth. While potentially accurate from filings, this represents information synthesis beyond what the ground truth validates.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the evolution pattern, but misses the specific 2022-2023 transition point that the ground truth emphasizes as critical to understanding the strategic shift.\n\nNUMERIC/QUANTITATIVE: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is neutral. However, the temporal framing (2022-2024) is correct.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general narrative of innovation-focused differentiation, it fails to accurately represent the specific evolution of NKE's stated competitive priorities across the three-year period as documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 745,
        "total_tokens": 2245
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nThe equity‑compensation table shows that shares left available for future issuance under the 2003 Director Compensation Plan rose from about **57 million shares at the end of 2022** to **≈65.5 million shares by the end of 2024** (an increase of roughly 8½ million shares). This upward trend indicates that Texas Instruments is deliberately maintaining a sizable share reserve for director‑related equity awards, confirming that the 2003 Director Compensation Plan remains an active component of the company’s long‑term incentive strategy for its board.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all major points: (1) DIRECTIONAL ERROR: The LLM claims shares INCREASED from ~57M (2022) to ~65.5M (2024), but the ground truth indicates the plan was PHASED OUT with decreasing availability. The LLM's core claim about an upward trend is factually wrong. (2) QUANTITATIVE INACCURACY: The specific numbers cited (57M in 2022, 65.5M in 2024) cannot be verified against the ground truth and appear to be fabricated or misread from the source documents. The ground truth explicitly states the plan was 'no longer listed among those with remaining shares available for future issuance' by 2023. (3) REASONING FAILURE: The LLM concludes the plan 'remains an active component' and that TI is 'deliberately maintaining a sizable share reserve,' which directly contradicts the ground truth's statement that by 2024 'the 2003 plan was no longer mentioned as part of the active compensation structure.' (4) MULTI-HOP SYNTHESIS ERROR: The LLM failed to synthesize the temporal evolution correctly. The ground truth shows a clear progression: active in 2022 → no longer listed in 2023 → completely phased out by 2024. The LLM inverted this narrative entirely. (5) STRATEGIC INTERPRETATION ERROR: The ground truth indicates a 'strategic shift toward updated incentive structures' (moving to 2024 LTIP and 2018 Director Plan), while the LLM claims ongoing active use. This is a fundamental misunderstanding of TI's compensation strategy. The answer demonstrates either severe misreading of source documents or hallucination of financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 440,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast layered data‑driven services into its advertising business by expanding programmatic, addressable‑ad capabilities across its X1, Sky Q and NOW streaming platforms and by launching a dedicated advertising marketplace that unifies linear‑TV, streaming and digital inventory.  The company paired this with technology upgrades—DOCSIS 4.0 rollout, network‑virtualization and cloud‑based ad‑serving infrastructure—and new tools such as the Xumo Stream Box and Peacock’s ad‑supported tier, which together deliver multigigabit symmetrical speeds and AI‑powered audience analytics for real‑time ad measurement and buying.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) DOCSIS 4.0, network virtualization, and multigigabit symmetrical speeds are network infrastructure elements unrelated to advertising services evolution - the ground truth focuses on advertising technology, tools, and data-driven services, not broadband infrastructure; (2) Xumo Stream Box and Peacock's ad-supported tier are mentioned but lack clear connection to the 2022-2024 advertising evolution narrative and are not mentioned in the ground truth; (3) The answer conflates network/broadband capabilities with advertising marketplace enhancements, which are distinct business areas; (4) The ground truth emphasizes cloud-based platforms, integrated search functionality, and representation agreements for advertiser reach - none of which are adequately addressed in the LLM response; (5) The LLM introduces specific product names (X1, Sky Q, NOW, Xumo Stream Box) that may be accurate but are not validated against the ground truth and appear to be tangential to the core question about advertising services evolution; (6) The ground truth's emphasis on 'integrated search functionality across content sources' and 'strengthening representation agreements with third parties' for improved targeting precision is completely absent from the LLM answer; (7) While the LLM correctly identifies the time period (2022-2024) and company (Comcast/CMCSA), the substantive content diverges significantly from the ground truth's focus on advertising ecosystem integration and data analytics capabilities. The answer demonstrates a fundamental misalignment between network infrastructure improvements and advertising services evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 479,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nFrom 2022 to 2024 CVS markedly trimmed its commercial‑mortgage‑backed‑securities (CMBS) position: the fair‑value of CMBS that was in an unrealized‑loss position fell from about **$992 million (with $155 million of unrealized losses) in 2022** to **$675 million (with $100 million of unrealized losses) in 2023**, and by 2024 the exposure was essentially negligible – only **$3 million** of CMBS was held (as shown in the 2024 separate‑account assets).  This steady decline in both fair value and unrealized losses reflects a deliberate de‑risking of the CMBS portfolio, as the company has moved away from the longer‑duration, interest‑rate‑sensitive asset class toward more stable, lower‑risk investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) 2022 CMBS Fair Value: LLM states $992 million vs. ground truth of $574 million - a 73% overstatement. (2) 2022 Unrealized Losses: LLM states $155 million vs. ground truth of $12 million - a 1,192% overstatement. (3) 2023 Fair Value: LLM correctly states $675 million (matches ground truth). (4) 2023 Unrealized Losses: LLM correctly states $100 million (matches ground truth). (5) 2024 Holdings: LLM states $3 million vs. ground truth of $6 million - a 50% understatement. The LLM appears to have confused or conflated different data points, possibly mixing CMBS data with other securities or misreading source documents. The 2022 figures are dramatically wrong, which is particularly problematic since they establish the baseline for the entire trend analysis. While the LLM correctly identifies the general trend of de-risking and correctly captures the 2023 data, the foundational 2022 and 2024 numbers are materially incorrect. The qualitative reasoning about de-risking is sound, but it is built on a corrupted quantitative foundation. The answer does address the multi-part question (fair value, unrealized losses, trend analysis, risk positioning), but the execution is severely flawed due to numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 381,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nTarget’s 2022‑2024 Form 10‑K filings each state that employee compensation “includes merchandise and other discounts,” and the language and disclosed scope of that discount are essentially unchanged across the three years. What does shift is the surrounding benefits package—higher starting wages, expanded health‑care and mental‑health resources, and tuition‑free education assistance—indicating that Target is broadening its total‑rewards strategy while keeping the employee merchandise discount as a stable, though modest, component. This multi‑year progression suggests the company is using a stable discount perk as part of a wider, increasingly comprehensive employee‑benefit strategy aimed at attracting and retaining talent.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-year progression and correctly identifies the core narrative: merchandise discounts remained stable while surrounding benefits expanded. STRENGTHS: (1) Correctly identifies that merchandise discount language was 'essentially unchanged' across 2022-2024, which aligns with ground truth; (2) Accurately notes the expansion of wage ranges ($15 to $15-$24/hour progression); (3) Properly synthesizes the multi-hop information showing how benefits evolved from basic offerings to more comprehensive packages including mental health, virtual healthcare, and tuition assistance; (4) Correctly characterizes the strategic shift toward holistic employee well-being; (5) Appropriately concludes that the discount serves as a stable component within a broader total-rewards strategy. WEAKNESSES: (1) The LLM answer is somewhat less detailed than the ground truth in describing the specific progression of benefits across years—it mentions the benefits but doesn't organize them as clearly by year (2022 baseline, 2023 expansion with financial wellness, 2024 mental health/virtual care focus); (2) The phrase 'modest component' in the LLM answer introduces a characterization not explicitly present in the ground truth, though it's a reasonable inference; (3) Missing the explicit mention of 401(k) matching and tuition reimbursement as specific 2023 enhancements. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either answer, so this dimension is less critical. The wage range progression ($15 to $15-$24) is correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple benefit categories, correctly identifying the relationship between stable discounts and expanding benefits. The logic is sound and the conclusion appropriately reflects the data. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential meaning of the ground truth despite slightly different organization and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 547,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s risk disclosures shifted from a brief mention of “cultural challenges associated with integrating employees” (2022) to a detailed focus on cross‑cultural integration—highlighting language and cultural differences, the need to align accounting/HR systems, and the importance of retaining key talent (2023‑2024).  This evolution shows that Linde now treats cultural compatibility as a core strategic priority, embedding dedicated due‑diligence, integration playbooks and talent‑retention programs into its cross‑border M&A approach to mitigate integration risks and protect financial performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year timeframe (2022-2024) and recognizes an evolution in Linde's discussion of cultural challenges. (2) The answer appropriately notes a shift from basic mention to more detailed focus. (3) No numerical errors or date inaccuracies present. (4) The company name (Linde) is correct throughout.\n\nWEAKNESSES: (1) SIGNIFICANT DIVERGENCE FROM GROUND TRUTH: The LLM introduces specific details not present in the original answer—'language and cultural differences,' 'accounting/HR systems alignment,' 'dedicated due-diligence,' 'integration playbooks,' and 'talent-retention programs.' The ground truth makes no mention of these specific mechanisms or implementation details. (2) FRAMING MISMATCH: The ground truth emphasizes that cultural challenges were 'listed among several integration risks' in 2022 and evolved to include 'broader context of global regulatory and compliance risks' by 2023. The LLM instead focuses on operational/tactical details (systems alignment, playbooks) not mentioned in the original answer. (3) MISSING KEY INSIGHT: The ground truth specifically notes that by 2024, Linde framed cultural challenges in terms of 'strategic risk management and financial outcomes rather than just operational hurdles.' The LLM mentions 'protect financial performance' but doesn't capture the nuanced evolution from operational to strategic framing. (4) UNSUPPORTED CLAIMS: The LLM's assertion about 'dedicated due-diligence, integration playbooks and talent-retention programs' appears to be inference or fabrication rather than grounded in the actual filing disclosures referenced in the ground truth. (5) INCOMPLETE SYNTHESIS: The LLM fails to capture the 2023 expansion regarding regulatory and compliance risks compounding cultural differences, which is a key part of the evolution narrative.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but does so by introducing details not supported by the ground truth, suggesting either hallucination or reliance on different source material than the knowledge graph. The logical progression is reasonable but factually divergent from the original answer.\n\nCONCLUSION: While the LLM demonstrates understanding of the general concept (cultural challenges evolved in importance), it introduces unsupported specifics and misses key elements of the actual evolution described in the ground truth, particularly the shift toward regulatory/compliance context and strategic risk framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 668,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the collateral that ExxonMobil posts under master‑netting arrangements fell sharply—from roughly **$1.49 billion in 2022 to $0.49 billion in 2024**, a decline of about **$1.0 billion (≈ 67 %)**.  This reduction shows that the company is relying far less on external collateral to support its derivative positions, reflecting tighter counterparty risk management and a greater use of internal netting and stronger credit relationships to manage its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The key figures are correct - $1.49 billion (2022) vs $0.49 billion (2024) matches the ground truth of $1,494 million to $491 million (minor formatting difference acceptable). The calculated decline of approximately $1.0 billion is accurate ($1,494M - $491M = $1,003M). The percentage decline of 67% is correctly calculated (1,003/1,494 = 67.1%). COMPLETENESS: The answer addresses the core question about the change from 2022 to 2024 and provides interpretation of the trend. However, it omits the intermediate 2023 data point ($800 million), which the ground truth explicitly includes. This is a minor omission since the question specifically asks about 2022 to 2024 change. ENTITY ACCURACY: ExxonMobil correctly identified, metric correctly identified as collateral under master netting arrangements related to Notes and accounts receivable - net, years correctly specified. REASONING QUALITY: The LLM provides sound multi-hop synthesis, correctly interpreting the declining trend as evidence of improved derivative exposure management. The interpretation about 'tighter counterparty risk management' and 'greater use of internal netting' is a reasonable inference from the data trend, though slightly more interpretive than the ground truth's more neutral 'strategic reduction in derivative exposure or improved offsetting mechanisms.' MINOR WEAKNESS: The omission of the 2023 intermediate value ($800 million) prevents full documentation of the three-year trend, though this doesn't materially affect the answer to the specific 2022-2024 question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 450,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform moved from a niche mainframe‑posture tool that simply identified risks and produced remediation steps for internal SIEM use, to a central component of Broadcom’s Enterprise‑Security portfolio that is designed to feed that risk data into external security‑orchestration and SIEM platforms.  The platform’s remediation workflow was broadened to support automated, ad‑hoc remediation actions and tighter integration with threat‑intelligence and AI‑driven detection tools, reflecting a strategic alignment with broader, cross‑stack cybersecurity strategies such as zero‑trust and proactive threat response.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) ENTITY ERROR - LLM refers to 'Broadcom's Enterprise-Security portfolio' when the company is AVGO (Broadcom). While technically Broadcom is the parent company, the ground truth consistently uses AVGO, and this inconsistency suggests potential confusion about the source material. (2) UNSUPPORTED CLAIMS - The LLM introduces specific capabilities NOT mentioned in the ground truth: 'automated, ad-hoc remediation actions,' 'threat-intelligence and AI-driven detection tools,' and 'zero-trust' strategies. These are plausible cybersecurity concepts but are NOT verified in the original answer and represent fabrication/hallucination. (3) INCOMPLETE SYNTHESIS - The LLM correctly identifies the evolution from standalone to integrated tool and mentions SIEM integration, but misses the explicit 2023 emphasis on 'proactive risk response' and the 2024 contextualization within the 'expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps.' (4) PARTIAL ACCURACY - The core narrative of evolution from niche tool to integrated component is directionally correct, and the mention of external SIEM platform integration aligns with ground truth. However, the specific details about 'automated remediation' and 'zero-trust alignment' are not supported by the original answer. (5) REASONING QUALITY - While the LLM demonstrates logical thinking about platform evolution, it appears to have inferred details beyond what the ground truth provides, which is problematic for factual accuracy. The multi-hop synthesis is incomplete, missing key 2023-2024 contextual details about the broader software suite integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 451,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 32B remained unchanged – the issue stayed at a $750 million face amount ( $750,000 thousand ) and a fixed 3.38 % interest rate, maturing on 06/15/27.  This consistency shows that SPG is deliberately using a stable, low‑cost, medium‑term fixed‑rate tranche to lock in financing, limit refinancing risk and preserve a predictable debt‑service profile as part of its long‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numerical values are correct - $750 million face amount (properly formatted as $750,000 thousand), 3.38% interest rate, and maturity date of 06/15/27 (June 15, 2027). The consistency across 2022-2024 is accurately captured. COMPLETENESS: The answer addresses the core question about how the debt evolved (remained unchanged) and provides strategic interpretation. ENTITY ACCURACY: SPG correctly identified, Unsecured Notes - 32B properly referenced, years 2022-2024 correctly covered. REASONING QUALITY: The LLM correctly synthesizes that the unchanged terms across three years indicate a stable debt management strategy. The interpretation about 'deliberately using a stable, low-cost, medium-term fixed-rate tranche' and the strategic benefits (limiting refinancing risk, preserving predictable debt-service profile) are sound inferences from the data. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'stable long-term debt strategy' with 'no early redemption or restructuring' aligns well with the ground truth's assessment. Minor differences in wording ('deliberately using' vs 'chosen to maintain') are semantically equivalent. MINOR CONSIDERATIONS: The LLM provides slightly more strategic interpretation than the ground truth (mentioning 'low-cost' and specific strategic benefits), which adds value without contradicting the facts. The answer is concise while maintaining accuracy. No calculation errors or factual discrepancies identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 440,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen’s fiber rollout moved from early‑stage build‑outs to a broader, multi‑gigabit network that now reaches a substantial share of the markets Comcast serves, and it has added bundled packages that combine fiber broadband, video, voice and wireless services—directly mirroring Comcast’s own bundled offerings and intensifying the competitive threat. This evolution has seen Lumen not only expanding its fiber infrastructure faster across Comcast’s footprint but also marketing those higher‑speed services as part of integrated bundles that compete head‑to‑head with Comcast’s broadband‑video‑voice‑wireless bundles.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general trajectory of Lumen's competitive threat to CMCSA from 2022-2024, correctly identifying fiber expansion and bundled service strategies as core competitive elements. However, there are significant issues with specificity and grounding in the actual filing data:\n\n(1) WHAT WAS CORRECT: The LLM correctly identifies the three-year period (2022-2024), recognizes Lumen as a key competitor, and accurately characterizes the competitive strategies (fiber expansion and bundled offerings combining broadband, video, voice, and wireless). The semantic understanding of escalating competitive pressure is sound.\n\n(2) QUANTITATIVE ACCURACY ISSUES: The LLM introduces specific claims not present in the ground truth, such as 'multi-gigabit network' and 'substantial share of markets' without providing actual percentages, speeds, or market share data. The ground truth is more cautious, noting Lumen was 'noted as part of a group' and 'explicitly called out' without making definitive claims about network reach or market penetration. The LLM's language ('now reaches a substantial share') suggests quantitative precision that isn't supported by the filing data.\n\n(3) MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the bundling strategy evolution. However, it goes beyond the ground truth by making comparative claims ('faster across Comcast's footprint,' 'head-to-head') that aren't explicitly stated in the original answer.\n\n(4) ENTITY AND TEMPORAL ACCURACY: Company names are correct (Lumen/Comcast), years are correct (2022-2024), and the competitive metrics are appropriately identified. However, the LLM adds interpretive language ('early-stage build-outs to broader multi-gigabit') that represents inference rather than direct filing statements.\n\n(5) GROUNDING ISSUES: The ground truth emphasizes what was 'noted,' 'called out,' and 'listed' in filings—suggesting cautious language from CMCSA. The LLM's more assertive tone ('now reaches,' 'intensifying') may overstate the certainty of these competitive claims as presented in the actual filings.\n\nThe answer is directionally correct but lacks the measured tone and specific grounding in filing language that characterizes the ground truth. It reads more like an analyst interpretation than a synthesis of actual filing statements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 638,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nTarget’s branded‑payment‑card penetration fell steadily from roughly 20.5 % of purchases in fiscal 2022 to 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024. This downward trend indicates that the loyalty‑driven 5 % discount attached to the Target Circle Card is losing its ability to generate incremental sales, suggesting the strategy’s effectiveness is eroding over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL ERROR: The LLM provides 18.6% for fiscal 2024, but the ground truth states 17.8% for 2024. This is a material discrepancy of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The error in the 2024 figure is a significant factual mistake that undermines the accuracy of the answer. QUALITATIVE ASSESSMENT: The LLM correctly identifies the downward trend and provides sound reasoning about what the trend suggests (weakening effectiveness of the loyalty strategy). The addition of context about the 5% discount and its diminishing ability to generate incremental sales shows good analytical thinking and adds relevant detail beyond the ground truth. The multi-hop reasoning is sound - the model correctly synthesizes the penetration rate data across three years and draws a logical conclusion about strategy effectiveness. ENTITY ACCURACY: All entities are correctly identified (Target, branded payment cards, fiscal years 2022-2024, penetration rates). COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates and what it suggests about strategy effectiveness. However, the factual error in the 2024 figure (18.6% vs. 17.8%) is a critical flaw that prevents a higher score. The reasoning quality is good, but quantitative accuracy is paramount in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 382,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron continued to hold its offshore stakes in the Republic of Congo—principally a 31.5 % non‑operated interest in the Haute Mer permit block and a 15.75 % stake in the Lianzi field—while directing roughly **$0.7 billion of capital** to offshore development and natural‑gas projects in the country (part of the $0.7 bn Africa spend noted in 2023).  This investment was aimed at boosting upstream production and improving reserve intensity, positioning the Congolese assets as a strategic component of Chevron’s African portfolio and its broader lower‑carbon agenda.  In early 2025 the company completed the sale of those Congolese interests, signaling a strategic exit and a reduction of further investment in the Republic of Congo.  (Pages 35, 41, 33 of the 2022‑2024 10‑K filings)",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key asset percentages (31.5% Haute Mer, 15.75% Lianzi), the $0.7 billion investment figure for 2023, and the strategic exit through asset sales. The numeric data is accurate and properly formatted. The answer correctly synthesizes multi-hop information about Chevron's engagement across the 2022-2024 period.\n\nWEAKNESSES: (1) TIMING ERROR - The LLM states the sale was completed in 'early 2025,' but the ground truth indicates the divestiture occurred 'by 2024.' This is a material factual error regarding when the transaction was completed. (2) INCOMPLETE TEMPORAL NARRATIVE - The ground truth explicitly states that in 2022, Congo was listed as a 'key operational country,' and in 2023 there was 'continued capital commitment.' The LLM conflates these into a single narrative without clearly delineating the 2022-2023 active investment phase versus the 2024 exit phase. (3) MISSING CONTEXT - The ground truth emphasizes the 'transition from active investment and development to divestiture' and 'realignment of portfolio toward higher-priority regions.' The LLM mentions strategic exit but doesn't clearly articulate this evolution as a shift in strategic positioning. (4) PARENTHETICAL CITATION - The LLM includes page references that cannot be verified against the ground truth source material.\n\nCALCULATION/NUMBER VERIFICATION: All numeric values are correct ($0.7B, 31.5%, 15.75%). No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects asset ownership, investment levels, and strategic positioning. However, the temporal sequencing is imprecise, particularly regarding when the divestiture occurred.\n\nSCORE JUSTIFICATION: The answer is substantially correct on facts and numbers (7/10 quantitative), but the timing error regarding 2025 vs. 2024 and incomplete articulation of the strategic evolution reduce overall correctness. The core narrative is present but lacks the clear temporal delineation of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 554,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nFrom 2022 to 2023 NEE’s gas‑related derivative notional volume slipped only slightly (≈1.3 bn MMBtu to ≈1.45 bn MMBtu), yet the Level‑3 fair‑value of those gas‑options surged from $170 m to $951 m as market prices rose and implied volatility jumped from roughly 50 % to over 110 %. By the end of 2024 the notional short position was trimmed further to ≈1.13 bn MMBtu and the fair‑value settled at $387 m, while implied volatility fell back to the low‑50 % range, indicating that NEE has reduced its speculative gas‑price exposure and is now holding a smaller, lower‑volatility hedge.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across nearly all quantitative metrics and contains no overlap with the ground truth data. Specific issues: (1) FAIR VALUE NUMBERS - Ground truth reports 2022: $356M assets/$347M liabilities; 2023: $100M assets/$97M liabilities; 2024: $100M assets/$102M liabilities. LLM reports 2022: $170M, 2023: $951M, 2024: $387M. These are completely different values with no correspondence to ground truth. (2) IMPLIED VOLATILITY - Ground truth shows 2022: 36%, 2023: 50%, 2024: 52%. LLM reports 2022: ~50%, 2023: >110%, 2024: low-50%. The 2023 figure of >110% is dramatically incorrect and contradicts ground truth's 50%. (3) NOTIONAL VOLUMES - LLM introduces notional volume data (1.3bn MMBtu, 1.45bn MMBtu, 1.13bn MMBtu) that is not mentioned in the ground truth answer at all, suggesting data from a different source or misidentification of metrics. (4) DIRECTIONAL NARRATIVE - Ground truth shows sharp DROP from 2022 to 2023 (356M→100M), then stabilization. LLM shows SURGE from 2022 to 2023 (170M→951M), then decline. These are opposite trajectories. (5) MULTI-HOP REASONING - The LLM appears to have synthesized data from different derivative positions or time periods, conflating gas options with other derivatives or misreading the filing data. The answer demonstrates fundamental misunderstanding of NextEra's gas options exposure. No calculations are correct, and the overall risk positioning conclusion is inverted from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 408,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike repeatedly placed FlyEase in the same “proliferation of Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, ZoomX, Air Max and React technologies” list (2022 Form 10‑K p. 6; 2024 Form 10‑K p. 6), showing that the company continued to treat FlyEase as a core, strategic innovation pillar.  The 2024 filing expands the narrative around FlyEase—integrating it into the broader technology portfolio and emphasizing its role in product development—while earlier filings merely introduced it alongside other breakthrough platforms.  This steady inclusion signals that FlyEase has evolved from a niche adaptive‑footwear concept into a central element of Nike’s innovation strategy, driving product differentiation and reinforcing the firm’s focus on inclusive, high‑performance design.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about FlyEase's evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the specific 10-K page references (p. 6 for both 2022 and 2024 filings), showing precise document sourcing. (2) Accurately captures the core narrative progression: FlyEase moved from initial introduction to established core technology. (3) Provides specific textual evidence by quoting the 'proliferation' language appearing in both 2022 and 2024 filings, demonstrating multi-hop synthesis across years. (4) Correctly interprets the strategic implication—evolution from 'niche adaptive-footwear concept' to 'central element of Nike's innovation strategy.' (5) Quantitative accuracy is high: all dates (2022, 2024) and document references are correct. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language ('niche adaptive-footwear concept') that, while reasonable, goes slightly beyond what the ground truth explicitly states. The ground truth uses more neutral language ('newly introduced concept' vs. 'niche adaptive-footwear concept'). (2) The ground truth mentions 2023 as an intermediate year showing 'expansion' and 'scaling,' but the LLM answer focuses primarily on 2022 and 2024 endpoints, omitting the 2023 progression detail. This is a notable gap in completeness. (3) The phrase 'driving product differentiation and reinforcing the firm's focus on inclusive, high-performance design' adds context not explicitly stated in the ground truth, though it's a reasonable inference. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and documents, comparing treatment of FlyEase across filings and drawing conclusions about strategic evolution. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—FlyEase evolved from introduction to foundational element—though the LLM uses slightly different framing and adds some interpretive elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 548,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **Unsecured Notes – 35A** remained essentially unchanged: a **$750 million, 2.65 % fixed‑rate tranche** with an annual debt‑service charge of about **$19.9 million** and a maturity in **July 2030**.  The 2022, 2023 and 2024 10‑K filings all list the same face amount, coupon and maturity, indicating that SPG has deliberately kept this long‑dated, low‑cost obligation on the books rather than retiring or refinancing it.  This consistency reflects a broader long‑term debt strategy of **locking in inexpensive, fixed‑rate financing and extending maturities**, thereby preserving liquidity and minimizing refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - MAGNITUDE DISCREPANCY: The LLM states the face amount as '$750 million' when the ground truth clearly specifies '$750,000' (or $750 thousand). This is a 1,000x overstatement of the actual obligation. Consequently, the annual debt service is also incorrectly stated as '$19.9 million' when it should be '$19,875' (approximately $19.9 thousand, not million). These are fundamental quantitative errors that severely undermine the credibility of the answer. The LLM correctly identifies: (1) the 2.65% interest rate, (2) the July 2030 maturity date, (3) the consistency across 2022-2024, and (4) the strategic interpretation about locking in fixed-rate financing. However, the magnitude errors are so significant that they represent a material misrepresentation of SPG's financial obligations. The reasoning about debt strategy is sound and well-articulated, but it is built on incorrect numerical foundations. The answer demonstrates understanding of the question's multi-hop nature and provides reasonable strategic interpretation, but the quantitative inaccuracy is disqualifying for a financial analysis context where precision is paramount. The error appears to stem from confusing the face amount denomination (thousands vs. millions), a critical distinction in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 364,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing at the core of its analog‑embedded portfolio—revenue was about $3.26 bn in 2022, rose modestly to $3.37 bn in 2023 before slipping to $2.53 bn in 2024, while operating margins fell from roughly 38 % to 30 % and then to 14 %.  Despite the revenue volatility and margin compression, the company continued to allocate capital to protect and expand this segment because its strong cash‑flow generation is the engine behind TI’s long‑term objective of growing free‑cash‑flow‑per‑share and delivering sustained shareholder returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM provides specific revenue figures ($3.26bn in 2022, $3.37bn in 2023, $2.53bn in 2024) and operating margins (38%, 30%, 14%) that cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth does not provide these specific numerical values for embedded processing revenue or margins. The LLM presents these numbers with false precision and confidence, which is a critical error in financial analysis. (2) INCOMPLETE SYNTHESIS: While the LLM does attempt to address the multi-hop nature of the question (evolution across three years + connection to free cash flow per share strategy), it does so by inventing data rather than synthesizing actual filing information. The ground truth emphasizes strategic positioning and narrative consistency across years, not specific revenue/margin figures. (3) MISALIGNMENT WITH GROUND TRUTH: The ground truth focuses on how TI consistently framed embedded processing as central to its business model and competitive advantages across the three years, emphasizing strategic emphasis and capital allocation decisions. The LLM shifts focus to revenue volatility and margin compression, which is a different analytical angle and not supported by the provided ground truth. (4) ENTITY AND METRIC CONFUSION: The LLM conflates 'embedded processing' with what appears to be a specific product line with quantifiable revenue, when the ground truth treats it as a strategic emphasis and portfolio component. The ground truth discusses embedded processing as part of a 'broad portfolio' and 'unique business model,' not as a standalone revenue-generating segment with declining performance. (5) REASONING QUALITY: The LLM's logic that 'despite revenue volatility and margin compression, the company continued to allocate capital' contradicts typical business strategy and lacks support in the ground truth. The ground truth presents a consistent, stable strategic narrative, not a story of declining performance requiring defensive capital allocation. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the strategic positioning narrative across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 615,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved Marvel from a background library asset to a **top‑level navigation tile on Disney+**, promoting Marvel titles as a primary draw for U.S. subscribers by 2023 and keeping that prominence in 2024; this is reflected in the company’s intangible‑asset schedule, where Marvel‑related trademarks are classified as **indefinite‑lived intangibles valued at roughly $1.8 bn** and remain a core component of the $10.7 bn net intangible assets reported for 2024. By treating Marvel as a marquee streaming brand, Disney is using the franchise as a **financial lever to acquire and retain Disney+ subscribers**, directing resources toward Marvel‑centric content and marketing to drive subscriber growth and justify the high valuation of its streaming‑related intangibles.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic evolution of Marvel from background asset to top-level tile on Disney+ by 2023, maintains that prominence in 2024, and accurately characterizes Marvel as an indefinite-lived intangible asset. The reasoning about using Marvel as a financial lever for subscriber acquisition and retention is sound and aligns with the ground truth. The answer appropriately addresses the multi-hop nature of the question by synthesizing Marvel's strategic positioning across years with its financial asset classification.\n\nWEAKNESSES - QUANTITATIVE: The LLM introduces specific dollar valuations ($1.8 billion for Marvel-related trademarks and $10.7 billion for net intangible assets in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and represent unsupported quantitative claims. This is a significant issue because the evaluation criteria emphasize strict accuracy on numbers and financial metrics. The ground truth deliberately avoids specific valuations for Marvel itself, only noting it as an indefinite-lived intangible asset.\n\nWEAKNESSES - COMPLETENESS: The LLM omits several key details from the ground truth: (1) the 2023 Disney+ subscriber base of 123 million as of September 28, 2024, (2) the planned ESPN+ tile launch in early fiscal 2025 as part of the broader branded content strategy, (3) the explicit comparison showing Marvel's transition from passive asset recognition to active brand utilization. These omissions represent incomplete synthesis of the multi-hop information.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects strategic positioning to financial strategy. However, it fails to fully integrate all the supporting evidence (subscriber numbers, ESPN+ strategy, broader platform differentiation context) that the ground truth uses to substantiate the financial strategy narrative.\n\nNUMBER VERIFICATION: The $1.8 billion and $10.7 billion figures appear to be fabricated or from sources outside the provided knowledge graph. This violates the strict requirement for quantitative accuracy in financial evaluations. While the reasoning about intangible asset classification is correct, introducing unverified numbers significantly undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 629,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nMetLife continued to reinsure roughly 59 % (originally 59.25 %) of its closed block through a modified‑coinsurance agreement in each year from 2022 through 2024.  The associated reinsurance‑recoverable balances expanded dramatically—from about $1.8 billion of deposit assets (and $1.4 billion of deposit liabilities) reported at the end of 2021/2022 to $10.3 billion of recoverables recorded in 2023 after the Global Atlantic risk‑transfer, and to $4.6 billion of deposit assets (offset by a $1.2 billion deposit liability) reported at year‑end 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ERRORS: (1) Reinsurance recoverable balances are substantially incorrect - Ground truth shows $3.6B (2022), $4.4B (2023), $4.2B (2024), but LLM reports $1.8B deposit assets/$1.4B deposit liabilities (2021/2022), $10.3B (2023), and $4.6B deposit assets/$1.2B deposit liability (2024). The $10.3B figure appears to conflate the Global Atlantic transaction impact with the modified coinsurance agreement balances, which is a fundamental misunderstanding. (2) The 2023 balance should be $4.4B (unsecured reinsurance recoverable), not $10.3B. (3) The 2024 balance should be $4.2B, not $4.6B in deposit assets. (4) The LLM introduces complexity about deposit assets vs. liabilities and references the Global Atlantic risk-transfer, which adds confusion and appears to conflate different accounting treatments. CORRECT ELEMENTS: The percentage reinsured (59%, originally 59.25%) is correctly identified as stable across the three-year period. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution of the modified coinsurance agreement metrics across the three years. The answer conflates different balance sheet line items and introduces extraneous information about Global Atlantic that obscures the core trend. The ground truth shows a clear, stable pattern with minor fluctuations; the LLM answer presents a confusing narrative with a dramatic spike in 2023 that doesn't match the ground truth. The semantic meaning is fundamentally different - ground truth emphasizes stability with minor fluctuations, while LLM emphasizes dramatic expansion followed by decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 459,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nCVS grew its residential mortgage‑backed securities portfolio from roughly $44 million in 2022 to $51 million in 2023 and $71 million in 2024—a near‑60 % increase over the three‑year span. This uptrend signals a deliberate shift toward higher‑yielding, interest‑rate‑sensitive fixed‑income assets, raising the company’s exposure to rate and prepayment risk while positioning the portfolio for modest income growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all quantitative metrics. Ground truth shows: 2022: $629M, 2023: $614M, 2024: $71M. LLM reports: 2022: $44M, 2023: $51M, 2024: $71M. Only the 2024 figure ($71M) is correct; the 2022 and 2023 figures are drastically wrong (off by ~$585M and ~$563M respectively). The LLM's calculation of a 'near-60% increase' is mathematically incorrect for the reported numbers ($44M to $71M = ~61% increase) and contradicts the actual trend. Most critically, the LLM's narrative is inverted: it describes an uptrend and deliberate shift toward RMBS, when the ground truth shows a significant decline from $629M to $71M in 2024—a de-risking strategy, not an increase in exposure. The LLM completely missed the unrealized losses context ($10M in 2022 rising to $60M in 2023), which is crucial to understanding risk exposure. The reasoning about 'higher-yielding, interest-rate-sensitive' positioning contradicts the actual strategic pivot away from RMBS in 2024. The answer fails on quantitative accuracy (wrong baseline numbers), multi-hop synthesis (missed unrealized losses data), and directional logic (uptrend vs. actual downtrend). This represents a fundamental misreading of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 345,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure roughly **59 % of its closed block** (59.25 % in 2022, 59 % in 2023‑2024) via a modified‑coinsurance agreement with an external reinsurer.  The company has consistently applied the **deposit method**, recording a deposit asset and a matching deposit liability and offsetting the liability against the asset; the percentage of the closed block ceded remained essentially unchanged, while the absolute deposit balances and related amortization of DAC/VOBA evolved in line with the transaction activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE ACCURACY: All percentages are correct - 59.25% in 2022, 59% in 2023-2024. The numbers match the ground truth exactly. COMPLETENESS: The answer addresses all key aspects of the question: (1) the percentage of closed block reinsured, (2) the evolution from 2022-2024, (3) the accounting treatment under the deposit method, and (4) the right of offset applied. ENTITY ACCURACY: Correctly identifies MetLife, the modified coinsurance agreement, the external/unaffiliated reinsurer, and the deposit method. REASONING: The multi-hop synthesis is sound - the answer correctly connects the reinsurance percentages across three years with the consistent accounting treatment. The statement that 'the percentage of the closed block ceded remained essentially unchanged' accurately reflects the stability described in the ground truth. SEMANTIC EQUIVALENCE: The LLM's phrasing 'offsetting the liability against the asset' is semantically equivalent to the ground truth's 'offsetting the modified coinsurance deposit liability with the deposit recoverable.' The additional detail about 'absolute deposit balances and related amortization of DAC/VOBA evolved in line with transaction activity' is contextually appropriate and adds useful nuance without contradicting the ground truth. MINOR CONSIDERATION: The LLM answer includes slightly more technical detail about DAC/VOBA amortization evolution, which goes slightly beyond the ground truth but is not contradictory and demonstrates deeper understanding. The core facts, percentages, and accounting treatment are all accurately presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 452,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s net notional exposure to natural‑gas forward contracts shifted from roughly ‑1.3 trillion MMBtu in 2022 to ‑1.45 trillion MMBtu in 2023 (an increase in short exposure) and then to ‑1.13 trillion MMBtu in 2024 (a reduction of that short position). This pattern shows the company expanded its gas‑price hedging during the heightened volatility of 2023 but trimmed the hedge in 2024, indicating a more measured or risk‑balanced positioning in the natural‑gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different metric than the ground truth. Critical issues: (1) WRONG METRIC: The LLM discusses 'notional exposure to natural-gas forward contracts' measured in MMBtu (physical units), while the ground truth addresses 'net exposure to forward contracts for gas' measured in millions of dollars (financial values). These are entirely different metrics. (2) COMPLETELY WRONG NUMBERS: The LLM provides values of -1.3 trillion MMBtu (2022), -1.45 trillion MMBtu (2023), and -1.13 trillion MMBtu (2024). The ground truth provides: $160 million (2022), $300 million (2023), and $250 million (2024). These numbers are incompatible in both magnitude and unit. (3) INVERTED TREND INTERPRETATION: The LLM claims exposure increased from 2022 to 2023 (from -1.3 to -1.45 trillion), but the ground truth shows it increased from $160M to $300M. While both show an increase 2022-2023, the LLM's subsequent analysis of 2024 is correct directionally (decrease), but this is coincidental given the wrong underlying numbers. (4) MISSING COMPONENT BREAKDOWN: The ground truth provides detailed asset/liability breakdowns ($191M/$31M for 2022, $377M/$77M for 2023, $296M/$46M for 2024), which the LLM completely omits. (5) SEMANTIC CONFUSION: The LLM's interpretation of 'short exposure' and 'hedging' language suggests it may be discussing a different section of the filing entirely. The answer demonstrates a fundamental failure to identify and synthesize the correct financial data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 428,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom broadened the positioning of its industrial fiber‑optic products from a niche add‑on to a core element of a diversified industrial portfolio.  The company expanded the technology’s application scope—targeting industrial automation, renewable‑energy systems, medical equipment, defense/aerospace and electric‑vehicle powertrains—and began offering fiber‑optic modules that are tightly co‑integrated with motion‑encoder interfaces and Ethernet ICs, delivering end‑to‑end sensor‑to‑network solutions for smart‑factory and automotive use cases.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AVGO's strategic evolution with Industrial Fiber Optics from 2022-2024, correctly identifying the core narrative: transition from niche component to integrated industrial solution. STRENGTHS: (1) Correctly identifies the time period (2022-2024) and company (Broadcom/AVGO); (2) Accurately captures application diversity mentioned in ground truth (industrial automation, renewable energy, medical, defense/aerospace, electric vehicles); (3) Correctly identifies key adjacent technologies (motion encoders, Ethernet ICs); (4) Accurately conveys the strategic shift toward integrated, networked solutions; (5) Uses appropriate terminology ('sensor-to-network solutions,' 'smart-factory'). WEAKNESSES: (1) The LLM answer lacks the year-by-year granularity present in ground truth - it doesn't distinguish the specific evolution from 2022 (optocouplers, LED devices alongside fiber optics) through 2023 (sensors, microcontrollers) to 2024 (Ethernet PHYs, switch ICs, camera microcontrollers); (2) Missing specific mention of the 2024 integration with Ethernet PHYs, switch ICs, and camera microcontrollers that ground truth emphasizes; (3) Doesn't explicitly note the progression from 'standalone components' to 'interconnected, intelligent systems' as clearly as ground truth; (4) The characterization of fiber optics as 'niche add-on' in 2022 is slightly imprecise - ground truth shows it was already positioned alongside core industrial components. MULTI-HOP REASONING: The answer successfully synthesizes information about product positioning evolution across three years and correctly links fiber optics with adjacent technologies. However, it doesn't fully capture the nuanced progression of which specific technologies were grouped with fiber optics in each year. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - AVGO elevated fiber optics from a component to an integrated solution - but lacks the detailed year-by-year evolution that demonstrates the strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 550,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the redeemable preferred stock that Sojitz America holds has not changed – it remains a $0.3 million, $1‑par share that is redeemable at par and carries a cumulative $0.10 per share dividend payable each May 31. Because that dividend must be paid in full before any common‑stock dividend can be declared, the priority obligation stayed the same, and Nike’s charter prohibits any additional preferred issuance, leaving the stock structure stable with no modifications across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about Nike's Sojitz America relationship. QUANTITATIVE VERIFICATION: All numeric values are correct - $0.3 million par value, $0.10 per share annual dividend, and the $1 par share designation are all accurate and match the ground truth. The dividend payment date (May 31) is correctly specified. ENTITY AND TEMPORAL ACCURACY: The answer correctly identifies all three fiscal years (2022-2024), the correct company relationship (Nike and Sojitz America), and the specific financial instrument (redeemable preferred stock). MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across the three-year period, correctly identifying that the stock structure remained stable with no changes in terms, ownership, or dividend obligations. The answer properly connects the dividend priority requirement to the broader financial relationship. COMPLETENESS: The answer addresses all key aspects of the question: (1) dividend obligations ($0.10/share, consistent), (2) stock structure stability (no changes, $0.3M par value), (3) the priority of dividend payments before common stock dividends, and (4) the long-term nature of the relationship. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer adds the detail about Nike's charter prohibiting additional preferred issuance, which is a relevant contextual detail not explicitly mentioned in the ground truth but enhances understanding. The LLM also specifies the May 31 dividend payment date, which is a helpful detail. The ground truth mentions that Sojitz America has not sought redemption despite having the option - the LLM answer doesn't explicitly state this, but this is a minor omission that doesn't significantly impact the core answer. SEMANTIC EQUIVALENCE: The LLM's phrasing \"priority obligation stayed the same\" effectively conveys the same meaning as the ground truth's emphasis on \"ongoing financial priority.\" The description of the stock as \"redeemable at par\" is accurate and adds clarity. Overall, the answer demonstrates sound reasoning, accurate synthesis of multi-year information, and correct financial data presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 592,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nSimon Property Group’s Unsecured Notes – Series 31B remained unchanged from the 2022 filing through the 2024 filings: the note carries a fixed 3.25 % interest rate, a $750 million face amount (shown as $750,000 thousands), an annual debt‑service charge of roughly $24.4 million (≈ $24,375 thousands), and a maturity date of 11/30/26. No amendments, retirements, or additional issuances of this series are reported in the 2023 or 2024 tables, indicating that SPG is simply holding the instrument to term. This steady‑state treatment reflects a long‑term financing strategy of locking in low‑cost, medium‑term fixed‑rate debt and minimizing refinancing risk within its overall unsecured‑debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of SPG's Unsecured Notes - 31B. STRENGTHS: (1) All numeric values are correct: $750 million principal ($750,000 thousands), 3.25% fixed interest rate, maturity date of 11/30/26, and calculated annual debt service of ~$24.375 million (3.25% × $750M = $24.375M, correctly verified). (2) The answer correctly identifies that the obligation remained unchanged across 2022-2024, matching the ground truth statement of consistency. (3) Multi-hop synthesis is sound: the LLM correctly synthesizes information about the specific note's stability while acknowledging broader portfolio changes (retirement of certain notes, issuance of 41A in 2024), demonstrating understanding of context. (4) The interpretation of SPG's financing strategy is accurate and well-reasoned: the answer correctly characterizes the steady-state approach as reflecting a strategy to lock in low-cost, fixed-rate debt and minimize refinancing risk. (5) Entity identification is precise (SPG, Series 31B, correct years). MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth ('holding the instrument to term' vs 'preserved its structure without refinancing') but conveys semantically equivalent meaning. The answer is more detailed in explaining the calculation methodology ($24.375 thousands annual charge), which adds value without introducing error. The ground truth emphasizes 'no amendments, retirements, or additional issuances' while the LLM states 'no amendments, retirements, or additional issuances of this series are reported,' which is appropriately qualified and accurate. Overall, the answer fully addresses the multi-part question about evolution, consistency, and strategic implications with factually correct information and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 499,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe value of TI common stock held in the U.S. defined‑contribution plans fell from roughly **$940 million (≈6 million shares) at the end of 2022** to **$873 million (≈5 million shares) at the end of 2023**, and then to **$852 million (still ≈5 million shares) at the end of 2024**. This three‑year decline reflects a falling TI share price and the fact that the common‑stock fund has been frozen to new contributions, so employee exposure to the stock is essentially static while market value erodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key dollar amounts are correct - $940 million (2022), $873 million (2023), and $852 million (2024). The LLM also provides share count estimates (≈6 million shares in 2022, ≈5 million shares in 2023-2024), which adds helpful context though these are approximations not explicitly stated in the ground truth. The directional trend (consistent decline) is accurately captured. QUALITATIVE ANALYSIS: The LLM correctly identifies the multi-hop synthesis required: (1) tracking stock values across three years, (2) understanding the frozen contribution policy since 2016, and (3) interpreting what the decline means. The reasoning that 'market value erodes' while 'employee exposure is essentially static' due to the contribution freeze is sound and aligns with the ground truth's mention of 'strategic reduction' and 'freeze on new contributions.' COMPLETENESS: The answer addresses all parts of the original question - the 3-year evolution, the trend pattern, and what it indicates about stock performance and employee behavior. The LLM goes slightly beyond the ground truth by explicitly attributing the decline to 'falling TI share price' rather than leaving it as 'potential market valuation shifts,' which is a reasonable inference. MINOR CONSIDERATIONS: The ground truth mentions 'strategic reduction in stock allocations by employees' as one possible explanation, while the LLM emphasizes the frozen fund and static exposure. Both interpretations are consistent - the frozen fund prevents new contributions, and the decline reflects market value changes rather than active employee reallocation. The LLM's framing is slightly more precise about causation. No calculation errors detected. All entities (TI, defined contribution plans, years) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 506,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Disney’s workforce expanded modestly—total headcount rose from roughly 220,000 (≈ 166,000 U.S. and 54,000 international) to about 233,000 (≈ 171,000 U.S. and 62,000 international), with the U.S. share falling slightly from ~75 % to ~73 % while the international portion grew from ~25 % to ~27 %.  The proportion of seasonal workers also edged up from about 7 % of the global staff in 2022 to roughly 8 % by 2024, reflecting a modestly larger contingent of temporary labor across the parks and resorts.  A growing share of employees—now covering roughly 76 % full‑time, 16 % part‑time and 8 % seasonal—are represented through collective‑bargaining agreements, works councils and employee resource groups, and the company continues to emphasize DEI‑focused programs such as Disney Aspire, the Heroes Work Here veteran initiative and over 100 employee‑led Business Employee Resource Groups.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Disney's workforce evolution from 2022-2024. QUANTITATIVE VERIFICATION: All key numbers are correct: total employees 220,000→233,000; U.S. employees 166,000→171,000; international employees 54,000→62,000; seasonal percentage 7%→8%. The calculated percentages are accurate: U.S. share ~75%→~73% (166/220=75.5%, 171/233=73.4%), international share ~25%→~27% (54/220=24.5%, 62/233=26.6%). The employment composition breakdown (76% full-time, 16% part-time, 8% seasonal) is mathematically consistent and adds to 100%. COMPLETENESS: The answer addresses all sub-questions: (1) total employees trend ✓, (2) U.S. vs. international distribution ✓, (3) seasonal workforce percentages ✓, (4) employee association representation ✓. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple data points and years, showing the relationship between workforce growth and seasonal staffing increases. ENTITY ACCURACY: Correctly identifies Disney, fiscal years 2022-2024, and relevant metrics. MINOR OBSERVATIONS: The LLM answer goes slightly beyond the ground truth by providing additional context about employment type distribution (full-time/part-time/seasonal percentages) and specific DEI programs (Disney Aspire, Heroes Work Here, ERGs), which adds valuable context without contradicting the original answer. The use of approximation symbols (≈, ~) is appropriate given the nature of workforce data. The semantic meaning is fully preserved and enhanced with relevant supporting details about collective bargaining and employee representation programs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 457,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes (e.g., goodwill impairments) from its ROIC calculations across 2022, 2023 and 2024, as expressly noted in the definition on page 45 and reflected in the ROIC tables for each year. This steady exclusion shows that the company deliberately isolates the returns generated by its core operations, ensuring that ROIC reflects underlying performance rather than one‑off accounting adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024. The LLM provides specific supporting details (reference to page 45 definition and ROIC tables for each year) that enhance credibility without contradicting the ground truth. The reasoning is sound: both answers recognize this consistent exclusion as a deliberate methodology choice to isolate core operational performance from accounting volatility. The LLM's mention of 'goodwill impairments' as an example of non-economic accounting changes is appropriate and illustrative. The semantic meaning is equivalent—both convey that GD maintained a stable framework emphasizing economic performance over accounting adjustments. No quantitative errors are present (no specific numbers to verify, only years which are correct). The multi-hop synthesis is correct: the answer properly connects the treatment across three years to draw a conclusion about the company's performance measurement philosophy. Minor distinction: the LLM provides slightly more concrete detail (page reference, specific examples) which adds value without introducing inaccuracy. The answer fully addresses both parts of the question: (1) how treatment evolved (answer: it didn't—remained consistent), and (2) what this reveals about approach (answer: deliberate focus on core operational performance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 411,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde progressively shifted its rare‑gas business from a pure merchant‑bulk model to an integrated on‑site/engineering offering.  In the 2022 filing (pp. 94‑98) the company described rare gases only as co‑products of its atmospheric‑gas plants and noted that they are sold mainly through the three distribution methods (on‑site, merchant and packaged).  By the 2023 and 2024 filings (pp. 2‑6, 98‑102) the segment tables show a growing share of engineering sales and a disclosed estimate of ≈ $48 bn of future minimum purchase obligations tied to long‑term on‑site contracts, while contract‑liability balances fell and revenue‑recognition policies were updated to treat on‑site and engineering projects as performance obligations satisfied over time.  This evolution—leveraging co‑produced rare gases within long‑term supply agreements and engineering contracts—demonstrates that Linde’s competitive advantage rests on its ability to lock in captive demand, monetize rare‑gas co‑production through plant design and long‑term pricing, and protect margins in a fragmented market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$48 bn' figure for future minimum purchase obligations, which appears to be either fabricated or severely misrepresented. The ground truth makes no mention of this specific dollar amount, and such a figure would be extraordinarily large and verifiable in SEC filings. This is a critical factual error. (2) STRATEGIC NARRATIVE MISMATCH: The ground truth indicates Linde's evolution centered on technological differentiation through non-cryogenic air separation technologies (VPSA, membrane separation) and improved production efficiency. The LLM instead claims the evolution was toward 'integrated on-site/engineering offering' and 'locking in captive demand through long-term contracts.' These are fundamentally different strategic narratives. The ground truth emphasizes TECHNOLOGY and EFFICIENCY; the LLM emphasizes CONTRACTING and CUSTOMER LOCK-IN. (3) MISSING KEY INFORMATION: The LLM completely omits the critical technological advancement mentioned in the ground truth—Linde's identification as a market leader in non-cryogenic air separation technologies by 2024, which is the core of the competitive advantage story. (4) UNSUPPORTED CLAIMS: The LLM makes specific claims about 'segment tables showing growing share of engineering sales' and 'contract-liability balances fell' without verification against the ground truth, and these claims appear to be either fabricated or misinterpreted. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by constructing a narrative that diverges significantly from the actual filing data as represented in the ground truth. The reasoning is internally coherent but factually incorrect. (6) CONTEXTUAL RELEVANCE: The answer does address the evolution question and attempts to explain competitive advantage, but the explanation is based on incorrect premises. The ground truth's focus on technological innovation (VPSA, membrane separation) as the source of competitive advantage is more credible and specific than the LLM's vague claims about 'locking in captive demand.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 594,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral PPAs grew modestly—from roughly 92 % of capacity (the level reported for 2021‑22) to about 94 % by the end of 2024—while the remaining capacity was sold into spot markets or hedged with shorter‑term contracts.  This steady increase shows that NEER is deliberately locking in fixed‑price revenue streams for the bulk of its output, thereby insulating its cash flows from the price swings of wholesale electricity markets and reinforcing its overall risk‑management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key trend and percentages. Quantitative verification: The LLM correctly states the progression from ~92% in 2022 to ~94% by end of 2024, matching the ground truth exactly. The characterization of this as a 'modest' increase is appropriate. Entity accuracy is correct (NEER, long-term bilateral contracts/PPAs, net generating capacity). The multi-hop reasoning is sound—the answer correctly synthesizes the evolution of the metric across the three-year period and connects it to risk management strategy. The LLM appropriately explains the strategic rationale (locking in fixed-price revenue streams, insulating from price swings, reinforcing risk management). Minor strengths: The LLM adds useful context about remaining capacity being sold into spot markets or hedged with shorter-term contracts, which provides helpful detail. Minor weakness: The LLM parenthetically references '2021-22' when discussing the 92% figure, which could be slightly confusing since the ground truth specifically states 2022 as the starting point. The ground truth mentions 'non-qualifying hedges to protect expected revenues' as part of the risk management approach, which the LLM doesn't explicitly reference, though it does mention 'hedged with shorter-term contracts.' Overall, the answer captures the essential facts, the trend direction, and the strategic implications with high accuracy. The semantic meaning aligns well with the ground truth despite slightly different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 426,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125 % senior notes maturing in January 2025 show a flat carrying balance of **$495 million** at the end of fiscal 2022, fiscal 2023 and fiscal 2024 (see the “3.125 % notes due January 2025” line in the senior‑notes tables for Nov 3 2024 and Oct 29 2023).  This lack of change indicates that Broadcom is not actively paying down or refinancing this particular tranche; it is being retained as a low‑cost, long‑dated debt position that will be addressed only when the notes come due in January 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All numbers are correct - the $495 million principal balance is accurate for fiscal years 2022, 2023, and 2024. The dates (January 2025 maturity, Nov 3 2024, Oct 29 2023 fiscal year ends) are correct. ENTITY ACCURACY: The company is correctly identified as Broadcom (AVGO), the debt instrument is correctly identified as 3.125% senior notes due January 2025, and all fiscal years are correct. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of the outstanding principal balance across the three-year period, (2) the trend (flat/unchanged), and (3) what this indicates about debt management strategy. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified that the unchanged balance across three years indicates no active paydown or refinancing, and correctly characterized this as a low-cost, long-dated debt position being retained until maturity. The logic is sound and well-reasoned. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth: stability of the balance, no retirement or refinancing activity, and maintenance of a consistent liability profile. The LLM's characterization of it as 'low-cost, long-dated debt' and noting it 'will be addressed only when the notes come due' provides slightly more interpretive detail than the ground truth but remains consistent with the underlying facts. MINOR NOTES: The LLM references specific filing dates (Nov 3 2024, Oct 29 2023) which adds helpful context and demonstrates proper source documentation. The only very minor difference is that the ground truth uses 'AVGO' while the LLM uses 'Broadcom' - both are correct as they refer to the same company, though the question specifically asked about 'AVGO.' This is a negligible difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 508,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nSPG’s Unsecured Notes – 37B kept the same structural terms throughout the 2022‑2024 filings: a $700 million face amount (reported as $700,000 thousand) and a maturity date of **15 January 2032** in each year.  The company did not grow the issuance of this series, but it used the 37B note to replace shorter‑dated unsecured debt (e.g., the 37A tranche that matured in 2023), thereby extending the overall maturity profile and locking in a low‑coupon, fixed‑rate financing for the next decade.  This pattern reveals SPG’s long‑term debt strategy of **extending debt maturities and increasing the share of long‑dated, fixed‑rate unsecured obligations** to reduce rollover risk and support its growth and sustainability initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the maturity date (01/15/32 or January 15, 2032) and confirms the face amount remained consistent at $700,000 across 2022-2024. The semantic equivalence of $700,000 thousand = $700 million is acceptable. The reasoning about debt strategy (extending maturities, reducing rollover risk) is sound and contextually relevant. The multi-hop synthesis across years is logically structured.\n\nCRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY - The LLM states the face amount as '$700 million (reported as $700,000 thousand)' but the ground truth specifies '$700,000' without the 'thousand' qualifier. This creates ambiguity: $700,000 thousand = $700 million, but the ground truth appears to report it as $700,000 (likely in thousands of dollars, making it $700 million total). The LLM's interpretation may be correct in substance but introduces unnecessary confusion about the reporting unit. (2) UNSUPPORTED CLAIMS - The LLM introduces information NOT in the ground truth: references to '37A tranche that matured in 2023' and claims about 'replacing shorter-dated unsecured debt.' The ground truth makes no mention of 37A or debt replacement strategies. This represents speculation beyond the provided data. (3) INFERENCE OVERREACH - Statements about 'low-coupon, fixed-rate financing' and specific strategic motivations ('growth and sustainability initiatives') are not supported by the ground truth, which only confirms the note remained unchanged.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2022-2024 and identifies the consistency pattern. However, it adds interpretive layers (debt replacement, strategic positioning) that go beyond what the ground truth supports.\n\nCOMPLETENESS: The LLM addresses all parts of the question (face amount evolution, maturity date, strategic implications) but conflates confirmed facts with reasonable but unsupported inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 521,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nTexas Instruments’ Melaka, Malaysia site is listed in the property tables for the 2022, 2023 and 2024 Form 10‑K filings under the **Analog** column (with an “X”) and **never** under the Embedded‑Processing column.  The disclosures show the facility as an analog‑only manufacturing location—indicating that its role in the company’s analog product line has remained unchanged across the three years, with no reported shift or expansion into embedded‑processing activities.  The only variations are the footnote symbols and the reported square‑footage/lease details, but the product‑line classification stays consistently analog.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly aligned with the ground truth. Key strengths: (1) Correctly identifies Melaka, Malaysia as consistently present across all three years (2022, 2023, 2024); (2) Accurately states the facility is marked under Analog operations with an 'X' designation; (3) Correctly confirms no involvement in Embedded Processing across all three years; (4) Properly synthesizes the multi-hop information showing stability and specialization over time; (5) Appropriately notes that variations exist only in footnote symbols and square footage/lease details, not in product-line classification. The answer demonstrates sound multi-hop reasoning by comparing the facility's role across three separate fiscal years and correctly identifying the pattern of consistency. The semantic meaning perfectly matches the ground truth - both convey that Melaka maintained an analog-only, specialized role with no expansion into embedded processing. Minor note: The LLM uses 'X' notation while ground truth mentions 'checkmark' - these are semantically equivalent representations of the same data point. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all aspects of the multi-part question regarding evolution, product lines, and temporal consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 369,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nDisney’s post‑production fees paid to Industrial Light & Magic have been captured in the **“Other revenue”** line of the Content Sales/Licensing segment, which aggregates all ancillary earnings such as music licensing, stage‑play fees and post‑production services. Across fiscal 2022, 2023 and 2024 this line item showed no material change, indicating that Disney’s reliance on ILM for post‑production services remained steady and was not reflected as a separate or growing revenue stream within the segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) ENTITY MISIDENTIFICATION: The LLM claims ILM post-production fees were captured in 'Other revenue' line item, but the ground truth explicitly states ILM was 'listed as part of the Content Sales/Licensing segment' with post-production services reported directly within the segment structure, not aggregated into an ancillary 'Other revenue' category. (2) STRUCTURAL MISCHARACTERIZATION: The ground truth describes ILM as explicitly included in the segment structure across all three years (2022-2024), while the LLM incorrectly suggests it was buried in an 'Other revenue' line alongside music licensing and stage-play fees. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a meaningful evolution from fiscal 2022 through 2024, including a shift in emphasis toward TV/VOD and theatrical distribution, and a strategic repositioning within Disney's DTC-first model. The LLM dismisses this as 'no material change' and 'steady reliance,' missing the contextual repositioning described in the ground truth. (4) QUANTITATIVE FAILURE: The LLM provides no specific numbers, percentages, or revenue figures to support its claim of 'no material change,' while the ground truth implies specific reporting structures that changed across the period. (5) MULTI-HOP REASONING: The LLM fails to synthesize the evolution across the three fiscal years, instead collapsing them into a single static characterization. The ground truth clearly indicates a progression in how ILM's role was framed and positioned within the segment. The LLM answer appears to be based on incorrect assumptions about financial reporting structure and misses the core narrative of strategic repositioning that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 497,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method income from operating joint ventures dropped sharply from **$1.30 billion in 2022 to just $0.15 billion in 2023**, then recovered to **$0.99 billion in 2024**. This swing shows a steep earnings decline in 2023 followed by only a partial rebound, indicating that the insurance‑underwriting joint ventures underperformed dramatically in 2023 and, even after the 2024 recovery, remain well below their prior profitability level—suggesting continued weakness or a strategic reduction in those ventures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.30 billion (2022) vs $1,305 million ground truth (equivalent), $0.15 billion (2023) vs $151 million (equivalent), and $0.99 billion (2024) vs $988 million (equivalent). The number format variations ($1.30B vs $1,305M) are acceptable and properly handled. COMPLETENESS: The answer addresses all required elements - the three-year trend (2022-2024), the specific income values, and the interpretation of what the trend suggests about joint venture performance. ENTITY ACCURACY: Correctly identifies MetLife, equity method investment income, operating joint ventures, and insurance underwriting ventures. Years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the 2023 decline as 'dramatic,' notes the 2024 recovery as 'partial,' and appropriately concludes that ventures remain below prior profitability levels. The characterization of 'volatility' and 'weakness' aligns with the data trajectory. SEMANTIC EQUIVALENCE: The LLM's interpretation that 2024 recovery is 'only partial' and ventures 'remain well below their prior profitability level' adds slightly more analytical depth than the ground truth's 'partial recovery' and 'volatility' characterization, but this represents enhanced analysis rather than factual error. Minor consideration: The LLM's additional inference about 'strategic reduction' is speculative beyond what the numbers alone indicate, though it's presented as interpretive rather than factual. Overall, this is a high-quality response with accurate numbers, proper synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 464,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics raised the number of Light‑Armored Vehicles it is building for the Canadian Army – roughly 360 units in 2022, about 399 units in 2023 and ≈ 449 units in 2024.  This upward production trend signals that the LAV platform has become a strategic growth pillar for GD’s Combat Systems segment, highlighting its importance to the company’s land‑vehicle portfolio and its long‑term defense‑sales strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three production figures are correct - 360 units (2022), 399 units (2023), and 449 units (2024). The numbers match the ground truth exactly, with acceptable formatting variations (≈ 449 vs 449). The upward progression is accurately captured. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the evolution of production volume from 2022-2024, and (b) what this indicates about strategic importance. The temporal scope is correct. (3) ENTITY ACCURACY: General Dynamics is correctly identified, the LAV platform is properly named, the Canadian Army customer is specified, and the Combat Systems segment is appropriately referenced. (4) REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects production volume data to strategic implications, identifying the LAV as a 'strategic growth pillar' and linking it to the company's 'land-vehicle portfolio' and 'defense-sales strategy.' This reasoning parallels the ground truth's assessment of the platform becoming 'increasingly central' and having 'strategic role in meeting global demand.' (5) SEMANTIC EQUIVALENCE: The LLM's characterization ('strategic growth pillar,' 'importance to company's land-vehicle portfolio,' 'long-term defense-sales strategy') conveys essentially the same meaning as the ground truth's assessment ('increasingly central,' 'strategic role in meeting global demand'). Minor difference: The LLM specifies 'Combat Systems segment' while ground truth uses broader 'defense offerings' and 'international markets' framing, but this is a reasonable specification rather than an error. Overall, this is a high-quality response with accurate data synthesis and appropriate contextual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 495,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership holdings grew from roughly **$225 million in 2022 to $237 million in 2023 and about $280 million in 2024**, a steady 20‑30 % increase over the three‑year span.  This upward trajectory shows that the pension fund is deliberately expanding its allocation to alternative‑asset strategies—consistent with the plan’s target 3‑4 % weighting in hedge funds—to boost long‑term returns and diversify the otherwise fixed‑income‑heavy portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in all three years of financial data. Ground truth shows: 2022: $214M, 2023: $225M, 2024: $252M. LLM reports: 2022: $225M, 2023: $237M, 2024: $280M. Every single year's figure is incorrect. The 2022 figure is off by $11M (5% error), 2023 is off by $12M (5% error), and 2024 is off by $28M (11% error). The LLM also incorrectly calculates the growth rate as '20-30%' when the actual growth from 2022-2024 is approximately 17.8% ($214M to $252M), and the year-over-year increases are 5.1% (2022-2023) and 12% (2023-2024). MULTI-HOP REASONING: While the LLM correctly identifies the general trend (upward trajectory) and appropriately synthesizes the strategic implication (deliberate allocation to alternative investments), this qualitative reasoning cannot compensate for the fundamental quantitative errors. The LLM adds contextual details about 'target 3-4% weighting' and 'fixed-income-heavy portfolio' that are not present in the ground truth, which may or may not be accurate but cannot be verified. ENTITY ACCURACY: CVS is correctly identified, the metric (HF LP Investments) is correctly understood, and the time period (2022-2024) is correct. SEMANTIC EQUIVALENCE: The conceptual conclusion about pension fund strategy is semantically similar to the ground truth, but the factual foundation is severely compromised. This is a case where the reasoning framework is sound but the underlying data is fundamentally wrong, making the answer unreliable despite its logical structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 432,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nColgate‑Palmolive lists Sorriso among its principal global trademarks under the Oral, Personal and Home Care segment, and the brand’s performance is captured in the Oral‑Care net‑sales figure that accounted for roughly 43 % of worldwide sales in 2022, 42 % in 2023 and 43 % in 2024.  This stability shows that Sorriso has been maintained as a consistent component of the Oral‑Care portfolio, with the company continuing to integrate it into the same global distribution, marketing and pricing framework used for its other flagship oral‑care brands.  No material shift in its contribution or segmentation occurs across the three years, indicating a steady, fully integrated positioning within the company’s global Oral Care business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) Correctly identifies Sorriso as a principal trademark in the Oral, Personal and Home Care segment across all three years; (2) Correctly notes the brand's consistent positioning across 2022-2024; (3) Appropriately emphasizes stability and integration within the global oral care portfolio. PROBLEMATIC ASPECTS: (1) QUANTITATIVE ERROR - The LLM cites Oral-Care net-sales percentages (43% in 2022, 42% in 2023, 43% in 2024) but these figures are NOT specifically attributed to Sorriso in the ground truth. The ground truth does not provide specific sales contribution percentages for Sorriso itself, only that it was listed among principal trademarks. The LLM appears to conflate overall Oral-Care segment performance with Sorriso's specific contribution, which is a significant analytical error. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes Sorriso's role as a 'regional brand asset' and its importance for 'regional market penetration,' but the LLM answer frames it primarily as part of the global Oral Care business without adequately distinguishing its regional strategic importance. (3) UNSUPPORTED CLAIMS - The LLM states Sorriso is integrated into 'the same global distribution, marketing and pricing framework' as flagship brands, but this level of operational detail is not present in the ground truth and appears to be inference beyond what the filings support. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but makes an unjustified leap by attributing specific sales percentages to Sorriso when the ground truth only confirms its presence in the trademark portfolio. The reasoning about 'no material shift' is sound in concept but is based on potentially incorrect numerical attribution. The answer demonstrates partial understanding but contains a critical quantitative accuracy issue that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 527,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife’s equity‑method exposure to operating joint ventures contracted modestly – the carrying value of those investments fell from about **$25 billion to $24.9 billion**, and the related unfunded‑commitment exposure dropped from **≈ $6.7 billion to ≈ $5.8 billion**.  This reduction in both the size of the portfolio and the amount of future capital that must be funded, together with a sharp dip in net investment income from these ventures in 2023 followed by only a partial rebound in 2024, indicates that MetLife is deliberately **scaling back its joint‑venture holdings and re‑allocating capital toward more controlled, higher‑return investments**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and provides completely wrong financial figures. Ground truth shows MetLife's operating joint venture exposure was $77M (2022), $51M (2023), and $38M (2024). The LLM claims figures of approximately $25 billion to $24.9 billion for carrying value and $6.7 billion to $5.8 billion for unfunded commitments - these are off by a factor of roughly 300-600x. The LLM appears to have confused operating joint ventures with a different investment category or misread the data entirely. While the LLM correctly identifies the direction of the trend (downward) and the strategic interpretation (scaling back), the magnitude of the error is catastrophic. The specific numbers cited ($25B, $24.9B, $6.7B, $5.8B) do not match the ground truth figures ($77M, $51M, $38M) in any reasonable way. The LLM also introduces unsupported claims about 'net investment income' trends without ground truth support. The reasoning about capital reallocation is qualitatively reasonable but is built on entirely false quantitative foundations. This represents a critical failure in multi-hop financial data synthesis - the model either hallucinated the numbers or retrieved data from the wrong investment category entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 348,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron retained its 36.4 % equity stake in Angola LNG Limited, but its involvement deepened from a pure investor to an integrated upstream‑to‑LNG supplier. In 2024 the company added frontier deep‑water exploration rights (Blocks 49 and 50) and secured proved reserves in the New G as Consortium Project (the Quiluma‑Maboqueiro fields), whose gas will be routed to the Soyo LNG plant through an on‑shore treatment facility; it also broadened its participation in the Angola‑DRC and Angola‑ROC joint development areas, while continuing to operate the related PSA blocks. This upstream expansion ties new gas discoveries directly to the Angola LNG plant, reinforcing Chevron’s end‑to‑end gas strategy in the country.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM answer introduces significant factual inaccuracies not present in the ground truth. It mentions 'Blocks 49 and 50' frontier deep-water exploration rights and 'Angola-DRC and Angola-ROC joint development areas' which are NOT mentioned in the original answer and appear to be fabricated details. The ground truth makes no reference to these specific blocks or joint development areas. (2) WORKING INTEREST PERCENTAGE MISSING: The ground truth explicitly states Chevron has a '31% nonoperated working interest' in the NGC (New Gas Consortium Project), but the LLM answer completely omits this critical percentage, which is a key metric for understanding Chevron's operational role. (3) OPERATIONAL ROLE CHARACTERIZATION: The ground truth carefully describes the evolution from 'passive equity investor' (2022) to 'more operationally integrated' (2024), with specific mention of the Soyo plant receiving feedstock from Quiluma and Maboqueiro fields. The LLM answer conflates this into a vague 'integrated upstream-to-LNG supplier' without clearly delineating the 2022-2023-2024 progression. (4) CORRECT ELEMENTS: The LLM answer does correctly identify: the 36.4% stake, the NGC/Quiluma-Maboqueiro fields connection, the Soyo LNG plant, and the general concept of upstream-to-downstream integration. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize upstream and downstream elements, it introduces unverified details that suggest hallucination rather than accurate synthesis from the knowledge graph. The mention of 'on-shore treatment facility' and specific block numbers appears to be extrapolation beyond the source material. (6) SEMANTIC ISSUES: The phrase 'end-to-end gas strategy' is reasonable interpretation but the supporting details are problematic. The answer reads as more comprehensive than the ground truth but this comprehensiveness comes from invented details rather than legitimate expansion of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 538,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 were carried at **$622 million** at the end of fiscal 2022 and 2023 (the $622 million balance appears on the October 29 2023 sheet and is unchanged from the prior year).  By the end of fiscal 2024 the carrying amount had fallen to **$0**, reflecting the company’s full repayment of the notes using proceeds from the October 2024 and July 2024 $5 billion senior‑note issuances and other cash inflows.  This deliberate retirement of the near‑term obligation shows that AVGO’s debt‑management approach was to proactively refinance and retire its closest‑maturity debt, thereby extending the overall maturity profile and reducing near‑term cash‑flow pressure as the maturity date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative facts are correct: $622 million balance in fiscal 2022 and 2023, declining to $0 by fiscal 2024. The dates are accurate (October 2024 maturity, October 29, 2023 balance sheet date). The multi-hop synthesis is sound - the answer correctly traces the evolution of the debt across three fiscal years and connects this progression to AVGO's debt management strategy. The LLM provides additional valuable context beyond the ground truth by specifically mentioning the October 2024 and July 2024 $5 billion senior note issuances as the refinancing mechanism, which demonstrates deeper understanding of how the company executed its debt management strategy. The reasoning about proactive refinancing to extend maturity profile and reduce near-term cash flow pressure is logically sound and well-articulated. The answer fully addresses all aspects of the question: the evolution of the exposure (2022→2023→2024), the progression pattern (stable then retired), and what this reveals about debt management strategy (proactive refinancing approach). Minor deduction from perfect score only because the ground truth doesn't explicitly mention the specific refinancing sources, though this additional detail is factually accurate and enhances rather than detracts from the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 376,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nThe interest expense recorded for Unsecured Notes ‑ 35B was $28.5 million in 2022, $28.5 million in 2023 and $28.5 million in 2024.  This flat trajectory shows that SPG’s financing cost for this note has been essentially unchanged over the three‑year period, reflecting stable borrowing terms and a consistent outstanding balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and effectively addresses the question. QUANTITATIVE ACCURACY: The LLM correctly identifies the interest expense amounts as $28.5 million for all three years (2022, 2023, 2024). The ground truth states $28,500 in thousands, which equals $28.5 million - the LLM's format conversion is accurate and appropriate. All numeric values match the ground truth. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) how the interest expense evolved across the three-year period, (2) what the trend suggests about financing costs. ENTITY ACCURACY: SPG is correctly identified, the instrument (Unsecured Notes - 35B) is correctly named, and all three fiscal years (2022, 2023, 2024) are included. REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop information by comparing values across three years and drawing the logical conclusion that the flat trajectory indicates stable, fixed-rate financing with unchanged borrowing terms. The reasoning is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM's statement that costs have been \"essentially unchanged\" and reflect \"stable borrowing terms and a consistent outstanding balance\" conveys the same meaning as the ground truth's \"fixed interest rate structure.\" The interpretation is semantically equivalent and appropriately nuanced. MINOR CONSIDERATION: The ground truth explicitly states \"fixed interest rate structure\" while the LLM infers this from the data pattern. However, this inference is logical and correct, representing sound financial analysis rather than an error. The LLM's additional insight about \"consistent outstanding balance\" is a reasonable inference from the stable interest expense pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 476,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney pivoted from a broadly diversified, linear‑media‑centric model to a strategy that places its direct‑to‑consumer (DTC) streaming services at the core of growth.  The company poured capital into expanding Disney+—including the launch of an ad‑supported tier, price increases and bundling—while simultaneously raising spend on content, sports‑rights and technology to fuel subscriber growth.  However, soaring programming and rights costs, coupled with intensified competition in the streaming arena, forced Disney to rationalize its linear networks, accelerate cost‑saving initiatives and tap additional financing to sustain its streaming expansion and fund the broader Experiences‑and‑cruise‑ship investments that now accompany its DTC push.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general strategic evolution from linear-centric to DTC-focused model and mentions key initiatives (ad-supported tier, price increases, bundling, cost-saving measures). However, there are significant gaps in specificity and quantitative detail compared to the ground truth.\n\nSTRENGTHS:\n- Correctly identifies the core strategic pivot from linear to DTC (2022-2024)\n- Mentions specific initiatives: ad-supported tier, price increases, bundling\n- Acknowledges rising programming/sports costs and intensified competition\n- References cost-saving initiatives and financing needs\n- Captures the broader context of Experiences and cruise investments\n\nWEAKNESSES:\n1. MISSING SPECIFIC FINANCIAL DATA: The ground truth mentions Disney's $12.25 billion in unused bank facilities (2023), which is a concrete quantitative detail absent from the LLM answer. This is a material omission for a financial analysis question.\n\n2. INCOMPLETE TEMPORAL PROGRESSION: The ground truth provides a clear 3-year trajectory showing:\n   - 2022: Cautious stance with uncertain returns and acknowledged rising costs\n   - 2023: Strategic investments with expectation of revenue offset\n   - 2024: Intensified competition and distributor pressure\n   The LLM answer treats the period more holistically without this granular year-by-year evolution.\n\n3. MISSING KEY STRATEGIC DETAILS: The ground truth specifically mentions:\n   - Negative or low returns on some DTC investments (2022)\n   - Programming distributors demanding terms that reduced revenue or slowed growth\n   - Fewer linear networks but DTC inclusion in distribution deals\n   These specific competitive dynamics are absent from the LLM answer.\n\n4. VAGUE ON FINANCIAL COMMITMENT: While the LLM mentions \"poured capital,\" it lacks the specific acknowledgment from 2022 that \"losses might grow or be reduced more slowly than anticipated,\" which is a critical strategic admission.\n\n5. INCOMPLETE SYNTHESIS: The LLM answer doesn't fully synthesize how Disney's position evolved from acknowledging uncertain returns to making aggressive investments despite rising costs—the core narrative arc of the ground truth.\n\nQUANTITATIVE ACCURACY: 7/10 - No incorrect numbers provided, but critical quantitative details ($12.25B facilities) are omitted entirely.\n\nQUALITATIVE ACCURACY: 6/10 - The reasoning is sound but incomplete. The multi-hop synthesis across 2022-2024 lacks the granular detail and specific strategic admissions from the ground truth.\n\nCONTEXTUAL RELEVANCE: 7/10 - Addresses the main question about investment strategy evolution and competitive positioning, but misses important nuances about how Disney's confidence and approach changed year-to-year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 725,
        "total_tokens": 2290
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to record reinsurance treaties that do not expose it to a significant loss using the deposit method, recognizing the present‑value of recoverables as deposit assets and the present‑value of payables as deposit liabilities. The November 2023 risk‑transfer with Global Atlantic created a modified‑coinsurance arrangement that added a $10.3 billion deposit receivable (included in premiums, reinsurance and other receivables) and a $770 million net‑cost liability, pushing deposit assets to $5.1 billion in 2023 and $4.6 billion in 2024, while deposit liabilities rose modestly to $1.3 billion in 2023 and fell to $1.2 billion in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the deposit method accounting evolution and correctly identifies the key 2023 Global Atlantic transaction. However, there are notable quantitative discrepancies that prevent a higher score:\n\nCORRECT ELEMENTS:\n- Accurately identifies the November 2023 Global Atlantic risk-transfer transaction\n- Correctly states the $10.3 billion deposit receivable amount\n- Correctly reports 2024 deposit assets at $4.6 billion and deposit liabilities at $1.2 billion\n- Properly explains the deposit method accounting approach\n- Correctly identifies the modified-coinsurance arrangement structure\n- Good synthesis of multi-hop information across years and entities\n\nQUANTITATIVE DISCREPANCIES:\n1. 2023 deposit assets: LLM states $5.1 billion, but ground truth indicates the transaction added $10.3 billion in deposit receivables, which should be reflected in the deposit assets figure. The ground truth doesn't explicitly state 2023 year-end deposit assets, but the trajectory from $1.8B (2022) to $4.6B (2024) suggests the LLM's $5.1B figure may be overstated or represents a different measurement point.\n2. 2023 deposit liabilities: LLM states $1.3 billion, ground truth states $1.4 billion for 2022 with no explicit 2023 figure provided, making this a potential error.\n3. The $770 million net-cost liability is mentioned by LLM but not in ground truth, suggesting additional detail that may or may not be accurate.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years (2022-2024) and correctly identifies how the Global Atlantic transaction impacted the deposit method accounting. The reasoning about the 'post-transaction rebalancing' aligns with ground truth's characterization of a 'strategic shift' followed by 'recalibration.'\n\nSEMANTIC ISSUES:\nThe LLM's description of the transaction mechanics is more detailed than ground truth but introduces specific figures ($770 million) that cannot be verified against the provided ground truth, creating uncertainty about accuracy.\n\nOVERALL: Core narrative and most key figures are correct, but the 2023 deposit assets figure and some liability figures show discrepancies that suggest incomplete or slightly inaccurate data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 607,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 CVS trimmed its commercial‑mortgage‑backed‑securities (CMBS) position from roughly **$1.0 billion** in fair value (≈$1.018 bn reported in the 2022 debt‑securities table) to about **$0.98 bn** a year later (≈$975 m in the 2023 table), and then to **only $3 million** by the end of 2024 (the CMBS line in the Separate‑Accounts fair‑value table).  This downward trajectory reflects a deliberate de‑risking of the investment portfolio, with the company shifting capital away from illiquid CMBS toward more liquid or higher‑yielding assets to better align with its insurance cash‑flow and liability management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. Ground truth shows: 2022=$574M, 2023=$675M, 2024=$3M. LLM reports: 2022≈$1.018B ($1,018M), 2023≈$975M, 2024=$3M. The 2022 and 2023 figures are dramatically wrong—off by approximately $444M in 2022 and $300M in 2023. Only the 2024 figure ($3M) is correct. The LLM's claim of a 'roughly $1.0 billion' position in 2022 is nearly double the actual $574M. The 2023 figure of $975M is also significantly overstated compared to the actual $675M. MULTI-HOP REASONING: While the LLM correctly identifies the overall trajectory as a de-risking strategy and correctly notes the dramatic drop to $3M in 2024, the reasoning is built on false premises due to incorrect intermediate values. The characterization of the shift as 'deliberate de-risking' and 'shifting capital away from illiquid CMBS' is qualitatively reasonable but is based on wrong numbers. COMPLETENESS: The answer does address the 3-year trajectory and attempts to interpret the investment strategy, but the factual foundation is severely compromised. The semantic interpretation (de-risking, capital reallocation) aligns with ground truth conclusions, but this cannot overcome the massive quantitative errors. ENTITY ACCURACY: CVS is correctly identified, CMBS is correctly identified, and years are correct, but the financial metrics are substantially wrong. This is a case where the LLM appears to have hallucinated or misread source data, resulting in numbers that are internally inconsistent with the ground truth knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 449,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the “hello” brand remained listed among Colgate‑Palmolive’s principal global trademarks in the “Nature of Operations” section, confirming continuous trademark protection.  Because “hello” is part of the Oral Care portfolio, its segment’s share of worldwide net sales stayed steady at roughly 42‑43 % in each of those years, reflecting a consistent strategic emphasis on the brand within the Oral, Personal and Home Care divisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant issues that limit its correctness: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM introduces specific percentage figures (42-43% of worldwide net sales for Oral Care segment) that are not present in the ground truth answer. These numbers appear to be fabricated or unsupported by the question context, as the original answer makes no mention of specific sales percentages. This is a critical error as it presents unverified quantitative claims. (2) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies that 'hello' remained listed as a principal trademark across 2022-2024, it fails to adequately address the evolution aspect of the question. The ground truth emphasizes the 3-year continuity and strategic positioning evolution, noting how the brand's role was reinforced and remained consistent. The LLM's answer is more static and doesn't capture the nuanced evolution across the three years. (3) ENTITY AND CONTEXT ISSUES: The LLM correctly identifies the brand, company, and years, but makes an unsupported leap by attributing specific sales percentages to the Oral Care segment without evidence from the filings. The claim that 'hello' is 'part of the Oral Care portfolio' is reasonable but the quantitative support is missing. (4) MISSING ELEMENTS: The ground truth emphasizes 'diversification and consumer engagement strategies' and the brand's role in 'key product categories' - the LLM answer doesn't address these strategic dimensions. (5) WHAT WAS CORRECT: The LLM correctly identifies that 'hello' remained a principal trademark across all three years and was disclosed in the Nature of Operations section, which aligns with the ground truth's core finding of continuity. The general conclusion about consistent strategic emphasis is directionally correct. However, the introduction of unsupported quantitative data (42-43% sales figures) is a major accuracy problem that significantly undermines the response's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 537,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to record certain reinsurance arrangements that do not expose the reinsurer to a significant loss under the deposit method, most prominently the November 2023 modified‑coinsurance risk‑transfer with Global Atlantic.  Deposit‑related assets grew sharply from roughly $1.8 bn in the 2021‑22 period to $5.1 bn in 2023 and $4.6 bn in 2024, while deposit‑related liabilities rose from about $1.4 bn to $1.3 bn, indicating a strategic shift toward larger‑scale, capital‑efficient risk transfers.  This expansion reflects a deliberate reinsurance strategy to move substantial blocks of business onto a deposit basis—thereby managing capital and regulatory ratios—but also heightens exposure to counterparty credit and market‑risk volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of MetLife's reinsurance strategy and correctly identifies the Global Atlantic transaction as a key driver. However, there are significant quantitative discrepancies that lower the overall score. QUANTITATIVE ISSUES: (1) The LLM states deposit assets were 'roughly $1.8 bn in the 2021-22 period' - the ground truth specifies 2022 specifically at $1.8B, which is correct, but the phrasing '2021-22 period' is imprecise. (2) CRITICAL ERROR: The LLM claims deposit assets reached '$5.1 bn in 2023' but the ground truth does not mention a $5.1B figure for 2023. The ground truth only provides 2022 ($1.8B) and 2024 ($4.6B) figures, with 2023 described qualitatively without specific asset numbers. This $5.1B figure appears to be fabricated or misattributed. (3) The 2024 deposit assets figure of $4.6B is correct. (4) Deposit liabilities: LLM states 'rose from about $1.4 bn to $1.3 bn' - the ground truth shows 2022 at $1.4B and 2024 at $1.2B. The LLM's $1.3B figure for 2023 is not provided in the ground truth and appears to be an interpolation or error. QUALITATIVE STRENGTHS: The LLM correctly identifies the strategic shift toward deposit method accounting, mentions the Global Atlantic transaction (November 2023), and appropriately discusses capital efficiency and counterparty credit risk implications. The reasoning about risk management and balance sheet flexibility is sound. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information about the evolution over time and connects it to strategic implications, though the missing/incorrect 2023 data point weakens the temporal analysis. The answer addresses both the evolution question and the trend analysis question components. SEMANTIC ISSUES: The characterization of the trend is reasonable, but the quantitative foundation is compromised by the $5.1B discrepancy and the unsupported $1.3B liability figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 520,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nNEE’s Special Use Funds grew from about $4.4 bn in fair‑value (2022) to $5.3 bn (2023, which includes a $199 m Level‑3 tranche) and to roughly $9.8 bn carried on the balance sheet in 2024, reflecting added nuclear decommissioning and storm‑fund assets. The fair‑value disclosures now break the holdings into a three‑level hierarchy and detail the portfolio’s composition (equity, municipal bonds, corporate and ABS debt), while collateral requirements tied to credit‑risk‑related contingent features of NEE’s derivatives (cash and letters of credit of ≈$691 m and $1.6 bn posted in 2023) could be used to meet margin calls, even though the funds themselves are not directly pledged, and their regulatory‑asset/liability treatment means any posted collateral can offset related regulatory liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant numerical discrepancies that undermine credibility. (1) INCORRECT 2022-2023 FIGURES: The LLM states Special Use Funds were '$4.4 bn in fair-value (2022) to $5.3 bn (2023)' but the ground truth clearly indicates equity investments without readily determinable fair values grew from $485 million (2022) to $538 million (2023). The LLM appears to have conflated different metrics or misread source data. The ground truth does not support $4.4bn or $5.3bn figures for these years. (2) 2024 FIGURE CORRECT: The LLM correctly identifies $9.8 bn for 2024 balance sheet presentation, matching ground truth's $9,800 million. (3) MISSING KEY GROUND TRUTH DATA: The LLM fails to mention the $8,698 million figure for 2023 balance sheet presentation or the $1,102 million increase from 2023 to 2024, which are central to understanding the evolution. (4) COLLATERAL INFORMATION: The LLM introduces specific collateral figures ($691m cash, $1.6bn letters of credit in 2023) that are NOT mentioned in the ground truth answer. While these may be accurate from source documents, they represent information beyond what the ground truth synthesized, and the ground truth's focus was on fair value disclosures and balance sheet presentation, not derivative collateral specifics. (5) COMPOSITION DETAILS: The LLM mentions 'nuclear decommissioning and storm-fund assets' and 'three-level hierarchy' with specific asset types (municipal bonds, corporate and ABS debt) - these details are not in the ground truth answer, suggesting either over-specification or potential inaccuracy. (6) MULTI-HOP REASONING: The LLM attempts to connect collateral requirements to Special Use Funds, but the ground truth answer does not establish this connection as a primary evolution metric. The reasoning about regulatory-asset/liability treatment is sophisticated but not grounded in the provided ground truth. STRENGTHS: The answer correctly identifies the 2024 figure and attempts to provide comprehensive context about valuation hierarchies and collateral implications. WEAKNESSES: Fundamental numerical errors in 2022-2023 figures, missing critical balance sheet progression data ($8,698M in 2023), and introduction of unverified collateral specifics that diverge from ground truth focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 621,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform moved from a basic main‑frame posture‑assessment tool that simply identified risks and supplied ad‑hoc remediation guidance to a more tightly integrated remediation engine. By 2023 the platform was positioned to feed its findings directly into customers’ own SIEM and ticketing systems, and by 2024 it was described as delivering AI‑driven, automated remediation recommendations that plug into in‑house SOAR/ITSM workflows, enabling continuous, end‑to‑end risk mitigation.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and represents a significant factual error. Ground truth explicitly states that AVGO 'maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period' from 2022-2024. The LLM answer claims the opposite: that the platform evolved from 'basic mainframe posture-assessment' to a 'tightly integrated remediation engine' with 'AI-driven, automated remediation recommendations' and SOAR/ITSM workflow integration by 2024. This is a complete inversion of the actual evolution described in the filings. The ground truth indicates the platform's description remained 'largely unchanged' and 'consistent' across all three years, with only a consistent emphasis on integration with in-house tools for SIEM. The LLM fabricated specific technical capabilities (AI-driven automation, SOAR/ITSM integration, automated remediation) that were not present in the actual filings. While there are no quantitative errors (dates are correct: 2022, 2023, 2024), the qualitative assessment is entirely wrong. The LLM failed to accurately synthesize the multi-hop information across the three-year period and instead created a narrative of significant platform evolution that contradicts the ground truth's finding of stability and consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 376,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nNIKE continued to **own** its Laakdal, Belgium distribution center in each of the fiscal years 2022, 2023 and 2024, and the facility was repeatedly highlighted as one of the company’s “most significant distribution facilities outside the United States.” This consistent ownership and emphasis—documented on page 28 of the 2022 10‑K and again on page 28 of the 2024 10‑K—signals that Laakdal remains a strategic hub for Nike’s European logistics network, with no indication of divestiture or major operational scaling back.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies NIKE's ownership status (company-owned) across all three fiscal years (2022, 2023, 2024) with no changes; (2) Accurately characterizes the facility as 'one of the company's most significant distribution facilities outside the United States' - semantically equivalent to ground truth's 'most significant international distribution centers'; (3) Properly synthesizes the multi-hop information showing consistency across three years; (4) Correctly interprets the strategic significance and stability of the facility within European logistics; (5) Appropriately cites specific page references (page 28 of 2022 and 2024 10-Ks) demonstrating source verification. Minor considerations: (1) The LLM provides specific page citations that add credibility but cannot be independently verified in this evaluation context - however, this does not detract from accuracy; (2) The answer is slightly more detailed than the ground truth (mentioning 'no indication of divestiture or major operational scaling back') but this represents appropriate elaboration rather than error; (3) The phrasing 'Nike' vs 'NIKE' is a minor stylistic variation with no impact on correctness. The answer fully addresses all components of the multi-part question: ownership evolution (consistent), operational footprint (unchanged), consistency across years (confirmed), and strategic importance (clearly established). The reasoning is sound and the synthesis across the three-year period is logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 435,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 SPG’s Unsecured Notes ‑ 32B remained unchanged – the coupon stayed at **3.38 %**, the outstanding **face amount stayed at $750 million**, and the **maturity remained 15 June 2027**.  The static profile shows that SPG is deliberately maintaining a long‑dated, fixed‑rate unsecured position, using it as a stable, low‑cost funding pillar rather than refinancing or altering the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: (1) Interest rate of 3.38% - CORRECT, matches ground truth exactly. (2) Face amount of $750 million - CORRECT, matches ground truth's $750,000 (interpreting as thousands in filing context = $750M). (3) Maturity date of June 15, 2027 (15 June 2027) - CORRECT, matches ground truth's 06/15/27. (4) Consistency across 2022-2024 - CORRECT, all three years show identical terms. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) interest rate evolution - covered, (2) face amount evolution - covered, (3) maturity date evolution - covered, (4) 3-year pattern analysis - covered, (5) debt management strategy implications - covered. MULTI-HOP REASONING: The LLM correctly synthesized information across three fiscal years and drew appropriate conclusions about SPG's deliberate strategy of maintaining a stable, long-dated, fixed-rate position without refinancing. MINOR OBSERVATION: The ground truth notes that the maturity date was \"unspecified in the 2022 report\" but the LLM states it \"remained 15 June 2027\" across all three years. This is a very minor discrepancy - the LLM may have simplified the presentation by stating the consistent maturity date without noting the 2022 disclosure gap. However, this does not materially affect the core answer's accuracy since the actual maturity date was indeed 06/15/27 when specified. SEMANTIC EQUIVALENCE: The LLM's characterization of the debt strategy as \"stable, low-cost funding pillar\" is semantically equivalent to the ground truth's \"consistent long-term debt strategy\" with \"no refinancing or restructuring actions.\" The language is slightly different but conveys the same analytical conclusion. Overall, this is a high-quality answer with accurate numbers, proper multi-hop synthesis, and sound reasoning about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 520,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nFrom 2022 through 2023 the fair value of CVS’s foreign‑denominated debt securities slipped slightly, from **$2.55 billion to $2.51 billion**, while the gross unrealized loss narrowed from **$244 million to $122 million**. In 2024 the company’s foreign‑security position in its Separate Accounts fell sharply to **$51 million** (down from $202 million in 2023), with no detailed loss figure disclosed, indicating a deliberate pull‑back from international holdings. This decline signals that CVS is reducing its exposure to foreign‑market risks such as currency volatility, overseas interest‑rate shifts, and geopolitical developments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that do not match the ground truth data. Specific errors: (1) The LLM states foreign-denominated debt securities were $2.55 billion in 2022 and $2.51 billion in 2023, but the ground truth shows fair value of foreign securities was $838 million in 2022 and $1,650 million in 2023 - these are completely different numbers and the LLM's figures are roughly 1.5-3x larger than actual values. (2) The LLM correctly identifies the 2024 figure of $51 million, which matches ground truth. (3) The LLM mentions unrealized losses of $244 million in 2022 narrowing to $122 million in 2023, but ground truth shows $24 million in 2022 and $122 million in 2023 - the 2022 figure is off by a factor of 10. (4) The LLM references 'Separate Accounts' and 'foreign-denominated debt securities' which appear to be from a different context (possibly insurance/annuity accounts) rather than the general investment portfolio being asked about. (5) While the LLM correctly identifies the sharp decline to $51 million in 2024 and appropriately concludes this represents de-risking, the foundational data supporting the 2022-2023 trend analysis is entirely incorrect. The multi-hop reasoning about strategic de-risking is sound in concept, but it's built on wrong numbers for the first two years. The answer fails on quantitative accuracy due to massive discrepancies in the 2022-2023 figures, and the entity/context confusion suggests the LLM may have pulled data from a different section of the filing or a different company's filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 433,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife applied internally developed designations only to newly acquired non‑agency RMBS and CMBS that had not yet been evaluated by the NAIC, and the proportion of such placeholder designations declined as the NAIC’s annual rating process produced official designations for an expanding share of the portfolio. This multi‑year shift demonstrates that the company is increasingly deferring to the NAIC’s modeling methodology for credit‑quality assessment, using internal designations merely as a temporary stop‑gap until the regulator’s rating becomes available.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general conceptual trend correctly—that MetLife's reliance on internally developed designations decreased over time as NAIC designations became available—but it fails to include critical quantitative evidence that grounds this claim. MAJOR OMISSIONS: (1) The LLM completely omits the specific dollar amounts and percentages provided in the ground truth: the $4.2 billion (14.5%) increase in Level 3 fixed maturity securities AFS in 2023 and the $1.6 billion (4.9%) increase in 2024. These numbers are essential to demonstrating the 'multi-year pattern' requested in the question. (2) The LLM does not reference the NAIC's methodology refinement as of December 31, 2021, which provides important temporal context. (3) The answer lacks the specific year-by-year evolution narrative that the ground truth provides. WHAT WAS CORRECT: The LLM correctly identifies that internally developed designations were used as a temporary measure for newly acquired securities pending NAIC evaluation, and correctly characterizes the overall trend as a shift toward greater reliance on NAIC methodology. The semantic understanding of the relationship between internal designations and NAIC assessments is sound. REASONING QUALITY: The LLM's logic is sound—it correctly infers that declining use of internal designations indicates increasing reliance on NAIC methodology. However, the answer lacks the quantitative support needed to substantiate this claim convincingly. The ground truth's observation that 'growth in Level 3 securities slowed' from 2023 to 2024 provides concrete evidence of the transition, which the LLM answer does not include. QUANTITATIVE ACCURACY: The LLM provides no specific numbers, percentages, or dollar amounts, making it impossible to verify quantitative accuracy. This is a significant weakness for a question explicitly asking about a 'multi-year pattern' that should be demonstrated through data. The answer reads as a general conceptual statement rather than a data-driven analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 545,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron deepened its upstream footprint in the Republic of Congo by acquiring frontier deep‑water exploration licences in the Lower Congo Basin and funding drilling and reserve‑growth activities on the Haute Mer and Lianzi prospects (see the “Key noteworthy developments” list on page 44 and the reserve tables on pages 107‑111).  However, in early 2025 the company completed the sale of its 31.5 % non‑operated interest in the Haute Mer permit and its 15.75 % stake in the Lianzi block, signalling a strategic pull‑back from direct ownership while still retaining a commercial presence through existing production‑sharing contracts.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH TEMPORAL ACCURACY AND NARRATIVE DIRECTION: The LLM answer contains a fundamental factual error regarding the timeline of events. The ground truth clearly states that by 2024, Chevron had sold its interests in Haute Mer and Lianzi. However, the LLM answer claims these sales were completed in 'early 2025,' which is outside the 2022-2024 timeframe specified in the question. This is a critical error that misrepresents when the divestiture occurred. NARRATIVE CONTRADICTION: The LLM answer describes Chevron as 'deepening its upstream footprint' through 2024 by acquiring licenses and funding drilling activities, which contradicts the ground truth's characterization of a 'shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.' The LLM presents an expansion narrative when the ground truth shows a contraction/exit strategy. MISSING FINANCIAL DATA: The LLM answer fails to mention the $0.7 billion allocation to offshore development and natural gas projects in Africa (including Congo) that occurred in 2023, which is a key quantitative element of the ground truth answer. CORRECT ELEMENTS: The LLM correctly identifies the 31.5% nonoperated interest in Haute Mer and 15.75% stake in Lianzi, and correctly notes these were divested. The mention of Haute Mer and Lianzi prospects is accurate. INCOMPLETE TEMPORAL COVERAGE: The answer does not adequately address the 2022-2023 period's investment activities as described in the ground truth, instead jumping to a narrative of deepening involvement. The characterization of retaining 'commercial presence through existing production-sharing contracts' is not supported by the ground truth. QUANTITATIVE ACCURACY: The percentages (31.5% and 15.75%) are correct, but the timing error (2025 vs 2024) and missing $0.7 billion figure significantly impact overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 506,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 the Embedded‑Processing business grew modestly in 2023 (revenue ≈ $3.3 B, operating‑profit margin ≈ 30 %) but slipped sharply in 2024 (revenue ≈ $2.5 B, margin ≈ 14 %) as higher manufacturing costs and capacity‑expansion investments squeezed profitability.  This evolution reflects TI’s continued reliance on Embedded Processing as a core pillar of its four sustainable competitive advantages—especially the manufacturing‑technology advantage (supply‑chain control) and the broad‑portfolio advantage (diversified growth engine)—while the company now emphasizes cost‑efficiency and margin protection within that segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question being asked. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($3.3B for 2023, $2.5B for 2024) and margin percentages (30% and 14%) that are presented as factual but cannot be verified against the ground truth. The ground truth makes no mention of these specific financial metrics for Embedded Processing Products. These numbers appear to be fabricated or hallucinated. (2) QUESTION MISINTERPRETATION: The question asks about the STRATEGIC EMPHASIS and EVOLUTION of narrative/positioning within TI's competitive advantages framework across 2022-2024. The ground truth correctly identifies this as a qualitative question about how TI's strategic messaging evolved. The LLM instead provides a quantitative business performance analysis (revenue trends, margin compression, manufacturing costs) which is not what was asked. (3) MISSING CORE ANSWER: The ground truth emphasizes that TI's strategic narrative remained CONSISTENT across all three years, with only slight language evolution. The LLM completely misses this key insight and instead focuses on business decline. (4) INCOMPLETE SYNTHESIS: While the LLM mentions the four sustainable competitive advantages and attempts to connect Embedded Processing to them, it does so in the context of financial performance rather than strategic positioning/narrative evolution. (5) FACTUAL CONTRADICTION: The LLM's narrative of declining performance contradicts the ground truth's emphasis on consistent strategic importance. The ground truth indicates stable strategic positioning; the LLM suggests deteriorating business conditions. The LLM appears to have confused a business performance analysis with a strategic positioning analysis, and introduced unverified financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 499,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the effective interest rate on Cisco’s $500 million 3.50 % senior note rose from roughly **3.2 % (July 2022)** to **6.38 % (July 2023)** and then to **6.66 % (July 2024)**.  This upward shift shows that the company’s borrowing cost on this debt more than doubled over the three‑year span, reflecting the impact of higher market rates and the net effect of its interest‑rate‑swap hedging strategy on the note’s effective financing cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative data points are correct: the $500 million principal amount, the 3.50% coupon rate, the effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024), and the June 2025 maturity date. The multi-hop synthesis correctly traces the evolution of interest rate exposure across three fiscal years. The reasoning is sound, accurately characterizing the progression as more than doubling and correctly attributing this to market rate increases and hedging strategy effects. The LLM appropriately adds context about interest-rate-swap hedging strategy, which provides additional insight beyond the ground truth answer while remaining consistent with it. The temporal progression is clearly presented with fiscal year references. Minor observation: the LLM uses parenthetical month/year notations (July 2022, July 2023, July 2024) which are reasonable fiscal year approximations, though the ground truth references fiscal years without specific months. This is a semantic variation that does not detract from accuracy. The answer fully addresses the question's request to explain how the exposure evolved and what this indicates about borrowing costs. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 363,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s ability to plan capital and return cash to shareholders is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning,” and that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status … could result in limitations on our activities.”  The language grew more explicit each year, linking any downgrade or shortfall in capital‑adequacy or liquidity ratios to restrictions on dividends and share‑repurchases, and emphasizing the firm’s dependence on subsidiary dividends and internal credit to fund those returns.  Consequently, while the company continues to target capital returns, its strategic flexibility is bounded by the need to maintain regulatory capital buffers and to comply with U.S. banking capital‑planning rules.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and captures the essential evolution of BNY Mellon's regulatory exposure from 2022-2024. STRENGTHS: (1) Correctly identifies the core regulatory constraints across all three years (U.S. banking laws, capital adequacy requirements, 'well-capitalized' and 'well-managed' status); (2) Accurately reflects the progression toward more explicit language linking regulatory compliance to capital return restrictions; (3) Properly synthesizes the multi-hop relationship between regulatory constraints, capital planning, and shareholder returns; (4) Correctly emphasizes the increasing focus on liquidity management and subsidiary dividend dependencies; (5) No quantitative errors in dates or metrics. MINOR GAPS: (1) The LLM answer does not explicitly mention Delaware law as a constraint (mentioned in 2023 ground truth), though this is a relatively minor omission; (2) The ground truth specifically notes the 2023 addition of 'failure to pay full and timely dividends on preferred stock' language, which the LLM answer does not explicitly reference, though it does capture the broader dividend restriction theme; (3) The LLM answer adds interpretive language about 'strategic flexibility' and 'subsidiary dividends' that goes slightly beyond the ground truth's more measured description, though this interpretation is reasonable and not factually incorrect. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression pattern (general oversight in 2022 → specific regulatory language in 2023 → emphasis on liquidity and consequences in 2024). The connection between regulatory constraints and shareholder return limitations is properly established. SEMANTIC EQUIVALENCE: The LLM's phrasing 'subject to the discretion of our Board of Directors and may be limited by U.S. banking laws' aligns well with the ground truth's description of regulatory constraints on capital returns. The emphasis on 'evolving regulatory expectations' in ground truth is captured through the LLM's discussion of increasingly explicit language and regulatory linkages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 578,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nFrom 2022 to 2023 the “Repair and other services” line in the Marine Systems segment fell modestly from **$1.169 billion to $1.132 billion**, and in 2024 it **held steady at $1.132 billion** (the same amount reported for 2023).  This pattern reflects a deliberately stable, recurring revenue base driven by long‑term maintenance contracts for existing naval platforms rather than growth from new construction, indicating that General Dynamics is focusing on sustaining and modernizing its current fleet and associated support services to generate reliable cash flow.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $1.169B (2022), $1.132B (2023), $1.132B (2024). The LLM properly converted the ground truth values ($1,169M, $1,132M, $1,132M) to billions with correct formatting. (2) The LLM accurately identified the revenue decline from 2022-2023 and the flat performance in 2024. (3) The LLM correctly identified this as part of the Marine Systems segment. (4) Multi-hop synthesis is sound - the LLM connected the revenue pattern to business strategy. WEAKNESSES: (1) The LLM's interpretation diverges from the ground truth's analytical framing. The ground truth emphasizes 'limited growth or strategic prioritization' and suggests possible 'market saturation, resource reallocation to higher-priority programs, or operational constraints.' The LLM instead frames this as 'deliberately stable, recurring revenue base' and 'reliable cash flow,' which is a more positive/optimistic interpretation. (2) The ground truth explicitly notes that the stagnation 'did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships' - this comparative context is absent from the LLM answer. (3) The LLM's explanation focuses on 'long-term maintenance contracts' and 'sustaining and modernizing current fleet,' which may be reasonable inferences but are not explicitly supported by the ground truth's more cautious interpretation. The ground truth presents multiple possible explanations (market saturation, resource reallocation, operational constraints) rather than settling on one narrative. CALCULATION VERIFICATION: No calculations required; all values match ground truth exactly. MULTI-HOP REASONING: The LLM successfully synthesized the revenue pattern across three years and connected it to business strategy, though with a different interpretive lens than the ground truth. The answer is factually accurate on numbers but provides a different analytical perspective on what the pattern suggests.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 532,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s **venture‑investment portfolio stayed roughly steady at about $4.9 billion** (reported for 2023 and 2024).  In contrast, its **equity‑method holdings in health‑care operating businesses grew sharply** – from approximately **$1.5 billion at the end of 2022**, to **$1.4 billion in 2023**, and then to **$3.8 billion as of December 31 2024**.  This jump signals a **strategic emphasis on deepening partnerships and equity stakes in health‑care companies**, complementing its core insurance and pharmacy operations with more substantive investments in the broader health‑care ecosystem.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) VENTURE INVESTMENTS ERROR: The LLM states venture investments 'stayed roughly steady at about $4.9 billion' for 2023-2024, but the ground truth shows equity securities (which includes venture investments) grew from $3.7B (2022) to $4.9B (2023) to $4.9B (2024). The LLM failed to report the 2022 figure of $3.7B, missing the growth trajectory from 2022-2023. (2) EQUITY METHOD INVESTMENTS - MAJOR ERROR: The LLM states equity method investments were '$1.5 billion at the end of 2022,' but the ground truth clearly indicates they were $1.4 billion in 2022 (flat), then $1.5 billion in 2023, then $3.8 billion in 2024. The LLM has confused the 2022 and 2023 figures, stating 2022 was $1.5B when it was actually $1.4B. This is a direct factual error. (3) INCOMPLETE TIMELINE: The LLM failed to provide the complete 2022-2024 progression for venture/equity securities, omitting the $3.7B 2022 baseline. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identified the strategic shift toward equity method investments and the sharp 2024 increase to $3.8B, the foundational numbers are wrong, undermining the entire analysis. (5) POSITIVE ASPECTS: The qualitative interpretation about strategic emphasis on deeper healthcare partnerships is reasonable and aligns with ground truth intent. The semantic understanding of the strategic shift is sound. However, quantitative accuracy is paramount in financial analysis, and these errors are material. The answer demonstrates partial understanding of the strategic narrative but fails on basic factual accuracy of the financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 465,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nPMI’s peer‑group definition—crafted on the basis of global reach, a consumer‑products focus, and comparable size/revenue—has remained unchanged across 2022, 2023 and 2024, and Colgate‑Palmolive Co. has been listed as a member of that peer group in each year’s performance‑graph disclosures.  This multi‑year consistency shows that PMI employs a stable, deliberately curated benchmarking framework, using the same set of peers to compare total‑shareholder‑return and other metrics, thereby reinforcing a long‑term, strategic view of how its tobacco and smoke‑free businesses stack up against comparable consumer‑product companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): No numeric values, dates, or calculations are present in either answer, and the years cited (2022, 2023, 2024) are correctly identified in both. ENTITY ACCURACY: Both answers correctly identify Philip Morris International (PMI) and Colgate-Palmolive Co., with proper company names and no confusion of entities. COMPLETENESS: The LLM answer addresses all parts of the multi-part question: (1) the evolution of Colgate-Palmolive's classification across the three years, (2) the consistency of that classification, and (3) what this reveals about PMI's strategic benchmarking framework. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects it to PMI's broader strategic positioning. It accurately identifies the four characteristics underlying peer selection (global presence, consumer products focus, comparable net revenues, and market capitalization), though the ground truth explicitly lists all four while the LLM uses slightly more condensed language ('comparable size/revenue'). SEMANTIC EQUIVALENCE: The LLM's phrasing 'global reach, a consumer-products focus, and comparable size/revenue' is semantically equivalent to the ground truth's 'global presence, focus on consumer products, net revenues, and market capitalization similar to PMI.' The LLM adds valuable context by mentioning 'total-shareholder-return and other metrics' and explicitly notes that PMI 'excluded direct tobacco industry peers from the comparison,' which aligns with the ground truth's implication that this framework represents a deliberate strategic choice. MINOR OBSERVATION: The LLM uses 'performance-graph disclosures' which is a reasonable inference about the source document type, though the ground truth doesn't explicitly state this. Overall, the answer is factually accurate, logically sound, and appropriately addresses the strategic benchmarking question with strong multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 550,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures show a clear escalation in exposure to abusive behavior as the company broadened its credit‑product portfolio and deepened its reliance on third‑party lenders, payment processors and BNPL‑receivable purchasers; each successive filing adds more detail on the sophistication of fraud schemes, the limits of existing buyer‑/seller‑protection programs, and the difficulty of detecting “new and continually evolving” fraud in these expanded offerings.  The language shifts from a general warning about fraud (2022) to an explicit statement that detection measures “may not be effective” and that third‑party dependencies “inherently increase…financial, legal, reputational, and operational risk” (2023‑2024).  Consequently, the trend indicates that PayPal’s fraud‑mitigation effectiveness has not kept pace with the growing scale and complexity of its credit and third‑party‑linked services, raising questions about the adequacy of its loss‑prevention controls over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively synthesizes the multi-hop information about PayPal's evolving fraud exposure from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression and escalation pattern; (2) Accurately references the €40 billion BNPL receivables agreement (though not explicitly stated, the answer correctly implies the European credit expansion); (3) Properly captures the shift in language from general fraud warnings to explicit statements about detection limitations; (4) Correctly identifies third-party dependencies as a key risk factor; (5) Sound multi-hop reasoning connecting credit product expansion to increased fraud exposure; (6) Accurately characterizes the trend as showing fraud mitigation effectiveness lagging behind business expansion. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the €40 billion figure or the specific European BNPL loan receivable sale agreement that appears in the ground truth, though it does reference BNPL-receivable purchasers generally; (2) Does not explicitly mention regulatory uncertainty regarding loan receivables post-sale validity, which was noted in the ground truth as a specific 2024 concern; (3) The phrase 'stolen identities, financial instruments, and fraudulent transactions' from 2022 disclosures is not directly referenced, though the general concept of fraud sophistication is captured. QUANTITATIVE ACCURACY: The answer contains no specific numbers or calculations, so this is not a limiting factor. The absence of the €40 billion figure is a minor omission but does not materially affect the correctness of the overall trend analysis. QUALITATIVE ACCURACY: The reasoning is sound and properly synthesizes information across the three-year period. The characterization of the evolution from general warnings to explicit statements about detection limitations is accurate and well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: the evolution of exposure, the relationship to credit products, third-party dependencies, and implications for fraud mitigation effectiveness. The answer is appropriately detailed and relevant throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 593,
        "total_tokens": 2172
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nSouthern Company’s natural‑gas option positions grew modestly in the 2023 reporting year—options held by its gas‑distribution segment rose from 93 mmBtu in 2022 to 102 mmBtu in 2023—but pulled back in 2024 to 83 mmBtu.  At the same time, total hedge volume for the company fell from 448 mmBtu (2023) to 431 mmBtu (2024).  This three‑year trend shows the company briefly expanded option usage to capture heightened price volatility in 2023, then reduced its reliance on options and shifted toward more stable swap‑based hedging and regulatory fuel‑recovery mechanisms as market swings moderated.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. Ground truth shows: 2022: 253 million mmBtu, 2023: 339 million mmBtu, 2024: 176 million mmBtu. LLM reports: 2022: 93 mmBtu, 2023: 102 mmBtu, 2024: 83 mmBtu. These are off by orders of magnitude (the LLM numbers are roughly 1/3 of actual values). The LLM appears to have confused or misidentified the data source, possibly reporting only a segment's options rather than company-wide totals. The directional trend interpretation (increase then decrease) happens to align with ground truth, but the underlying numbers are completely wrong. The LLM also introduces unsupported claims about 'gas-distribution segment' specificity and references total hedge volumes (448/431 mmBtu) that are not addressed in the ground truth. The reasoning about market volatility response and shift to swaps is plausible but cannot be verified against the provided ground truth. The answer fails on quantitative accuracy (the primary metric for financial analysis) and therefore cannot receive a passing score despite some qualitative reasoning that might be sound. This is a case where the model appears to have accessed different or incorrect source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 355,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s U.S. defined‑contribution expense grew modestly—$70 million in 2022, $75 million in 2023 and $76 million in 2024.  This upward trend, together with the fact that its qualified defined‑benefit pension plans have been closed to new participants and the non‑qualified defined‑benefit plans remain unfunded, shows that Texas Instruments is deliberately shifting its long‑term employee‑benefit strategy toward defined‑contribution arrangements and reducing reliance on defined‑benefit liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all financial figures correct: $70M (2022), $75M (2023), and $76M (2024). The quantitative data is precisely stated and matches the ground truth exactly. The multi-hop reasoning is sound, correctly synthesizing information about the defined contribution plan expenses and their relationship to the company's broader retirement benefit strategy. The answer appropriately identifies the strategic shift toward defined contribution plans and away from defined benefit liabilities. However, there are minor qualitative differences: (1) The LLM answer states the defined benefit plans were 'closed to new participants' without specifying the 1997 date mentioned in the ground truth, which provides important historical context about the long-standing nature of this strategy. (2) The ground truth emphasizes that the trend reflects 'growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan,' while the LLM frames it more as a deliberate strategic shift away from defined-benefit liabilities. Both interpretations are valid and complementary, but the ground truth provides more nuanced context about which employee populations benefit from this approach. (3) The LLM correctly notes the non-qualified plans remain unfunded, which is accurate and adds relevant detail. Overall, the answer is factually correct, addresses all parts of the question, and demonstrates proper multi-hop synthesis across the retirement benefit strategy question. The minor omission of the 1997 closure date and slightly different framing of the strategic rationale prevent a perfect score, but the core answer is substantively sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 480,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nFrom 2022 through 2024 GM lifted its long‑term expected return on U.S. pension‑plan assets from about **5.4 % (2022)** to **6.3 % (2023)** and then to **6.5 % (2024)**.  This upward revision—driven by a December‑2023 investment‑policy study that raised the weighted‑average ROA from 6.3 % to 6.5 %—signals a more optimistic outlook on market performance and a deliberate increase in risk tolerance (e.g., higher equity allocation and a shift away from lower‑returning debt) to improve funded positions and expected plan returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IDENTIFIED: The LLM answer contains a significant factual error regarding the 2023 rate. The ground truth states that in 2023, the rate 'remained unchanged at 6.3%' (implying it stayed at the 2022 level of 5.4% before being adjusted to 6.3% at some point). However, the LLM claims the 2023 rate was 6.3%, which appears to conflict with the ground truth's statement that 2022 was 5.4% and 2023 'remained unchanged at 6.3%.' Upon closer reading of the ground truth, there is an internal inconsistency: it states 2022 was 5.4%, then 2023 'remained unchanged at 6.3%' - these statements are contradictory. The LLM's interpretation (5.4% → 6.3% → 6.5%) represents a consistent upward progression. STRENGTHS: (1) The LLM correctly identifies all three years (2022, 2023, 2024) and their associated percentages in a logical progression; (2) The LLM provides additional context about the December 2023 investment-policy study, which adds specificity; (3) The reasoning about increased risk tolerance, equity allocation, and improved funded positions is sound and well-articulated; (4) The multi-hop synthesis connecting rate changes to strategic implications is appropriate. WEAKNESSES: (1) The ground truth contains an apparent internal contradiction (5.4% in 2022 cannot 'remain unchanged' at 6.3% in 2023), making evaluation difficult; (2) If the ground truth's 2023 figure of 6.3% is correct and 2022 was actually 5.4%, then the LLM's answer is factually accurate despite the confusing ground truth wording; (3) The LLM adds interpretive detail (December 2023 study) not explicitly confirmed in the ground truth provided. CALCULATION VERIFICATION: The progression 5.4% → 6.3% → 6.5% is mathematically consistent and represents increases of 0.9 percentage points (2022-2023) and 0.2 percentage points (2023-2024). The LLM's characterization of this as an 'upward trend' is accurate. OVERALL ASSESSMENT: The LLM answer appears factually correct in its numerical progression, though the ground truth's wording creates ambiguity. The qualitative analysis of implications is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 566,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the total‑return swaps that Cisco uses to hedge deferred‑compensation liabilities shifted from a **$92 million loss in 2022** to **gains of $58 million in 2023 and $91 million in 2024**.  This progression—moving from a realized loss to increasingly positive gains—shows that the company’s derivative‑based risk‑management program is becoming more effective at offsetting the earnings volatility associated with deferred compensation, indicating a deliberate strategy to stabilize compensation‑related costs and smooth financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $92 million loss in fiscal 2022, $58 million gain in fiscal 2023, and $91 million gain in fiscal 2024 match the ground truth exactly. The progression and direction of changes are accurately represented. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) the evolution of financial exposure across the three-year period, (2) realized gains/losses for each year, and (3) what this indicates about risk management and compensation strategy. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are accurate, and the financial instruments (total return swaps linked to deferred compensation) are properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern (loss to gains progression). The interpretation that this reflects improved market conditions or strategic adjustments is sound and aligns with the ground truth. SEMANTIC EQUIVALENCE: The LLM's explanation of the progression indicating 'a deliberate strategy to stabilize compensation-related costs and smooth financial performance' is semantically equivalent to the ground truth's statement about 'improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.' The LLM actually provides slightly more specific insight about the effectiveness of the derivative-based risk management program. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('derivative-based risk-management program is becoming more effective') compared to the ground truth, but this represents an enhancement rather than an error, providing additional context about the strategic implications. No calculation errors, no missing data points, and no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 524,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nAcross 2022‑2024 PayPal consistently positioned itself as the principal in every payment transaction, set its fees independently of the costs incurred with third‑party processors, and therefore assumed full margin risk – recording those processor fees as “transaction expense.”  Its volume‑based, tiered pricing is treated only as a discount that does not create a material future right, and any customer incentives are accounted for as reductions of revenue rather than as separate obligations; this accounting treatment remained unchanged through 2023‑2024, although the 2023‑2024 filings added greater segment‑expense disclosures and refined the incentive‑accounting disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's consistent principal role across all three years (2022-2024); (2) Accurately captures the core margin risk exposure - that PayPal sets fees independently and bears full margin risk; (3) Properly synthesizes the transaction expense recognition across all three years; (4) Correctly notes that tiered/volume-based pricing does not create material future rights; (5) Accurately reflects that accounting treatment remained unchanged through the period; (6) Appropriately mentions the addition of segment-expense disclosures and refined incentive-accounting disclosures in 2023-2024. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, and none were provided by either answer - this is appropriate. The temporal references (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (pricing control, third-party processor relationships, transaction expense recognition, segment reporting changes). The logical flow connecting these elements is sound. MINOR CONSIDERATIONS: The LLM answer adds slightly more detail about customer incentives being recorded as revenue reductions rather than separate obligations - this is a reasonable elaboration that doesn't contradict the ground truth and adds helpful context. The phrasing 'no structural changes' in the ground truth is effectively captured by the LLM's statement that 'accounting treatment remained unchanged.' Both answers convey the same essential finding: consistent exposure to margin risk with no material changes in recognition or pricing control across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 492,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s Angola LNG natural‑gas output (reported on an oil‑equivalent basis) was roughly 49 million cubic feet per day in 2022 and held steady at about 48 MMCFD in both 2023 and 2024, showing a flat‑to‑slightly‑declining trend over the three‑year period. This stability demonstrates that the Angola LNG project is a mature, reliably‑producing asset that provides Chevron with a consistent LNG supply to meet its long‑term contracts, reinforcing the company’s strategic positioning as a dependable player in the global liquefied‑natural‑gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. (1) QUANTITATIVE ERRORS - The LLM reports Angola LNG natural gas production at approximately 49 MMCFD (2022), 48 MMCFD (2023), and 48 MMCFD (2024), showing a flat-to-declining trend. The ground truth states 592 MMCFD (2022), 596 MMCFD (2023), and 609 MMCFD (2024), showing a steady increase. The LLM's numbers are off by a factor of approximately 12x - this is a catastrophic numerical error, not a minor discrepancy. (2) TREND ANALYSIS - The LLM incorrectly characterizes the trend as flat-to-declining when the actual data shows consistent growth across all three years (592→596→609 represents increases of 4 MMCFD and 13 MMCFD respectively). (3) METRIC CONFUSION - The LLM mentions reporting on an 'oil-equivalent basis' which is not supported by the ground truth and appears to be an attempt to explain away the massive numerical discrepancy. The ground truth clearly states these are natural gas volumes in cubic feet per day. (4) STRATEGIC INTERPRETATION - While the LLM's reasoning about Angola LNG being a 'mature, reliably-producing asset' is plausible language, it contradicts the actual data trend of increasing production volumes, which suggests growth and expansion rather than mere stability. The ground truth correctly identifies the upward trajectory as indicating 'growing operational emphasis on LNG production.' (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the three-year production data from Chevron's filings and draw the appropriate conclusion about strategic positioning. The answer demonstrates either a fundamental data retrieval error or a complete misunderstanding of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 465,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nThe 2022 filing only gave a brief qualitative note that outdoor‑lighting contracts are operating leases with short initial terms and that their payments are treated as variable lease costs and omitted from the maturity table. By 2023 the Company introduced a concrete year‑by‑year maturity schedule for “operating lease obligations,” showing undiscounted cash‑flows, the present‑value discount and a reconciliation to the lease‑liability on the balance sheet. In 2024 the disclosure was further refined: it provided a detailed, year‑specific cash‑flow breakdown, the present‑value of those cash‑flows, the weighted‑average remaining lease term and discount rate, and explicitly reconciled the amounts to the liability. This progression—from a simple footnote to a fully quantified, disclosed schedule—indicates that scheduled payments under outdoor‑lighting contracts have become increasingly material and structurally important to Southern Power’s lease portfolio and overall financial reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) WRONG FOCUS: The LLM discusses 'operating lease obligations' and lease liability reconciliations, but the ground truth specifically addresses outdoor lighting contracts as OPERATING LEASES AT MISSISSIPPI POWER with cash flows that were initially immaterial. The LLM conflates general lease accounting disclosures with the specific evolution of outdoor lighting contract reporting. (2) FACTUAL INACCURACY: The ground truth states that in 2022, outdoor lighting cash flows were 'immaterial' and omitted from maturity analyses. The LLM claims 2022 showed 'variable lease costs and omitted from the maturity table' - while the omission part aligns, the LLM fails to capture the materiality assessment that is central to the ground truth's narrative. (3) MISSING KEY DETAIL: The ground truth explicitly states that by 2023, Southern Power 'began including scheduled payments...in maturity analyses alongside tolling arrangements and PPAs' - this is a critical turning point showing increased materiality. The LLM does not mention this specific inclusion in maturity analyses or the comparison to other contract types (PPAs, tolling). (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes that 2024 showed 'explicit integration...into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs.' The LLM's 2024 description focuses on technical disclosure details (weighted-average terms, discount rates) rather than the strategic integration with PPAs and other revenue arrangements. (5) CONCEPTUAL MISALIGNMENT: The LLM frames the evolution as a progression from 'simple footnote to fully quantified schedule' - a technical accounting disclosure evolution. The ground truth frames it as growing MATERIALITY and STRUCTURAL IMPORTANCE within Southern Power's portfolio. These are different narratives. (6) NO QUANTITATIVE DATA: Neither answer provides specific dollar amounts, but the ground truth's reference to 'immaterial' in 2022 versus inclusion in maturity analyses by 2023 suggests a materiality threshold was crossed - the LLM doesn't capture this quantitative/materiality dimension. The LLM answer appears to describe a generic lease accounting disclosure evolution rather than the specific evolution of outdoor lighting contracts' treatment and their growing importance within Southern Power's financial structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 662,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nAcross the 2022‑2024 filings, TI’s Melaka, Malaysia site remained in the property tables for each year but was always listed under the **Analog** segment (an “X” under Analog and no entry under Embedded Processing). The site continued to serve Analog‑product manufacturing in 2022, 2023 and 2024, with no reported shift or expansion into Embedded Processing during that period. Thus, the operational footprint in Melaka stayed constant—present in all three years, but exclusively tied to the Analog business line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about TXN's Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) Correctly identifies that Melaka remained exclusively in the Analog segment across all three years (2022, 2023, 2024) with no expansion into Embedded Processing - this matches the ground truth exactly. (2) Accurately references the property tables methodology (marking with 'X' under Analog, no entry under Embedded Processing) showing proper understanding of how the data was sourced. (3) Properly synthesizes the multi-hop information across three fiscal years and two business segments. (4) Uses appropriate terminology ('operational footprint,' 'manufacturing,' 'business line') consistent with SEC filing language. (5) Correctly concludes that the footprint remained 'constant' and 'exclusively tied to the Analog business line.' MINOR CONSIDERATIONS: The LLM answer uses slightly more technical/detailed language about the property tables methodology compared to the ground truth's more straightforward narrative approach, but this represents added clarity rather than any factual error. Both answers convey identical factual content: Melaka = Analog only, all three years, no Embedded Processing involvement. No numeric errors, no date errors, no entity misidentification. The reasoning is sound and the synthesis across the three-year period is complete and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 399,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.600 % senior unsecured notes due 2026 remained outstanding with a fixed $700 million aggregate principal, a semi‑annual interest‑payment schedule (April 15 and October 15) and a par‑call date of March 15 2026 that did not change.  The company recorded only modest adjustments to the reported principal balance (e.g., +1.5 million in 2024, +2.6 million in 2023) reflecting discount amortization, but no redemption or refinancing of the notes occurred.  This steady‑state treatment shows that AMT is deliberately preserving the low‑cost, long‑dated 1.600 % debt as a core pillar of its staggered‑maturity, low‑leverage strategy while using newer issuances and credit‑facility borrowings to retire higher‑coupon obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES (Primary Concern): The LLM answer contains a critical numerical error in the direction and magnitude of adjustments. The ground truth states adjustments DECREASED from (2.6) in 2023 to (1.5) in 2024, meaning the 2023 adjustment was larger in absolute value. However, the LLM presents these as '+1.5 million in 2024, +2.6 million in 2023' with positive signs, which reverses the sign convention shown in the ground truth (parentheses indicate negative adjustments). The LLM also reverses the chronological order of the adjustment amounts in its parenthetical example. This is a material error in representing the progression of adjustments over time. CORRECT ELEMENTS: (1) Principal amount of $700 million is correct; (2) Semi-annual payment dates (April 15 and October 15) are correct; (3) Par call date of March 15, 2026 is correct; (4) No redemption or refinancing occurred is correct; (5) The overall characterization of stability is directionally correct. REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting the stable debt terms to AMT's broader debt management strategy (staggered maturity, low-leverage approach, using newer issuances to retire higher-coupon debt). This strategic interpretation goes beyond the ground truth but is logically coherent and contextually appropriate. COMPLETENESS: The answer addresses all parts of the question (principal amount, interest schedule, par call date, and strategic implications), though the adjustment progression is misrepresented. The LLM correctly identifies that adjustments were 'modest' but fails to accurately represent their declining trend. SEMANTIC EQUIVALENCE: While the LLM's strategic narrative about debt management is reasonable and well-reasoned, the factual foundation regarding the adjustment amounts and their direction is compromised, which undermines confidence in the overall analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 516,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco kept its $2 billion, 5.90 % senior note due 2039 on the books throughout fiscal 2022‑2024; the note’s carrying amount rose slightly as the discount was accreted and hedge‑accounting adjustments were recorded, leaving the effective interest rate near 6.1 % each year.  Although total long‑term debt grew to roughly $20 billion after the February 2024 $13.5 billion senior‑note issuance, the 5.90 % tranche still represented about 10 % of that debt, highlighting Cisco’s strategy of maintaining a stable, long‑dated fixed‑rate pillar while supplementing it with commercial‑paper liquidity and a sizable revolving credit facility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's 5.90% Note strategy but has some notable differences from the ground truth:\n\nCORRECT ELEMENTS:\n- Principal amount of $2 billion (or $2,000 million) is correct\n- Effective interest rate near 6.1% (6.11% in ground truth) is accurate\n- The note remained consistent across 2022-2024 period\n- Long-term debt growth to approximately $20 billion is correct (ground truth: $19,621 million in 2024)\n- The strategic narrative about fixed-rate instruments and long-term financing is sound\n- Mention of February 2024 $13.5 billion senior-note issuance adds relevant context\n\nDISCREPANCIES AND GAPS:\n1. The LLM mentions the note's carrying amount \"rose slightly\" due to discount accretion and hedge-accounting adjustments, but the ground truth states the principal amount remained constant at $2,000 million. This is a subtle but important distinction - the LLM conflates carrying value changes with principal amount changes.\n2. The LLM does not explicitly state the total long-term debt figures for 2022 ($8,416 million) and 2023, only mentioning the 2024 figure of roughly $20 billion.\n3. Short-term debt changes are not mentioned in the LLM answer (decreased from $499M to $488M per ground truth), which was part of the original question's scope.\n4. The LLM provides additional context about commercial-paper liquidity and revolving credit facility, which adds value but wasn't in the ground truth.\n5. The calculation that the 5.90% note represents \"about 10%\" of total debt ($2B/$20B = 10%) is mathematically correct and insightful.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information about the note's characteristics, its role in total debt composition, and the broader financing strategy. However, it doesn't fully address the evolution across all three years (2022-2024) with specific debt composition metrics.\n\nQUANTITATIVE ACCURACY:\nNumbers are generally correct ($2B, 6.1%, $20B, $13.5B, 10%), though the LLM doesn't provide the complete debt composition breakdown across all three years that the ground truth includes.\n\nQUALITATIVE ACCURACY:\nThe reasoning about Cisco's strategy is sound and well-articulated, though the distinction between principal amount stability and carrying value changes could be clearer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 617,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nGeneral Dynamics’ LAV output for Canada grew each year: about 360 units were built in 2022, 449 units in 2023, and in 2024 the company began producing 399 new Canadian LAVs plus an additional 66 LRSS‑equipped vehicles (≈ 465 total), continuing the upward trajectory.  This expansion coincides with the Combat Systems segment’s revenue share rising from 18 % (2022) to 20 % (2024), signalling that GD is deliberately scaling its land‑vehicle business—especially LAV production—as a core strategic growth area.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the production volume progression. Ground truth shows: 2022=360 units, 2023=399 units, 2024=449 units. The LLM answer incorrectly states: 2022=360 units (correct), 2023=449 units (WRONG - should be 399), 2024=399 units (WRONG - should be 449). The LLM has transposed the 2023 and 2024 figures, fundamentally reversing the production trajectory. Additionally, the LLM claims 2024 production was '399 new Canadian LAVs plus 66 LRSS' totaling ~465, but ground truth indicates the 449 units in 2024 already includes the LRSS program (66 specialized LAVs), not that they are additive to 399. The LLM's calculation of 399+66=465 is arithmetically correct but based on a misunderstanding of the data structure. MULTI-HOP REASONING: While the LLM correctly identifies the LRSS program as a 2024 addition and attempts to synthesize Combat Systems segment revenue data (18% to 20%), the foundational production numbers are wrong, undermining the entire analysis. The reasoning about strategic focus is sound in principle but is built on incorrect data. ENTITY ACCURACY: General Dynamics and Canadian Army LAV programs are correctly identified. SEMANTIC ISSUES: The phrase 'continuing the upward trajectory' is contradicted by the LLM's own (incorrect) numbers, which show 360→449→399, not a consistent upward trend. The ground truth shows consistent growth (360→399→449), which the LLM fails to capture accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 413,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payments grew as CMS repeatedly revised the risk‑adjustment formula and froze or cut benchmark rates, triggering retroactive RADV audit adjustments that threatened plan revenues. To counter the sustained funding pressure the company progressively tightened its risk‑adjustment documentation, selectively raised member premiums and trimmed benefit designs, exited unprofitable counties, and intensified medical‑cost and operating‑expense management—while also investing in Optum’s analytics and AI‑driven tools to improve risk‑adjustment accuracy and offset the revenue squeeze.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer introduces specific claims not supported by the ground truth: mentions 'retroactive RADV audit adjustments' as a key threat, which is not mentioned in the original answer. This is a factual addition without verification. (2) UNSUPPORTED CLAIMS - The LLM states exposure 'grew' from 2022-2024, but the ground truth indicates 'consistent' exposure across the period, not growth. This is a material mischaracterization of the trend. (3) OPTUM INVESTMENT CLAIM - The LLM adds detail about 'investing in Optum's analytics and AI-driven tools' which is not present in the ground truth. While this may be true, it represents information synthesis beyond what was provided in the original answer. (4) DOCUMENTATION TIGHTENING - The LLM mentions 'progressively tightened its risk-adjustment documentation' which is not explicitly stated in the ground truth. (5) WHAT WAS CORRECT - The LLM correctly identifies: the 3-year period (2022-2024), CMS formula revisions, benchmark freezes/cuts, premium adjustments, benefit design changes, county exits, and cost management focus. These core elements align with the ground truth. (6) MULTI-HOP REASONING - The answer does synthesize information across the three-year period and identifies strategic responses, which is appropriate for the question. However, the synthesis includes unsupported details that deviate from the knowledge graph. (7) SEMANTIC ISSUES - The characterization of 'exposure grew' vs. 'consistent exposure' is a meaningful difference in how the evolution is described. The ground truth emphasizes sustained/consistent pressure requiring 'operational agility,' while the LLM emphasizes growth and progressive tightening. This represents a different interpretation of the data trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 488,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nPayPal’s 2.850 % fixed‑rate notes (issued in September 2019 and maturing on 10/1/2029) stayed on the books at a constant **$1.5 billion** of principal from the end of 2022 through the end of 2024.  The tables for 2022, 2023 and 2024 all list the same $1.5 bn outstanding (with only minor changes in the unamortized premium/discount), showing that the company has not added to, reduced, or refinanced this tranche during those years.  \n\nThis steady exposure signals that PayPal is deliberately maintaining a sizable, long‑dated fixed‑rate debt pillar as part of its capital‑structure strategy—using it to lock in low‑cost financing, preserve balance‑sheet stability, and complement newer issuances while keeping overall leverage and interest‑rate risk in check.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct—$1.5 billion principal amount, maturity date of 10/1/2029, issuance date of September 2019, and the consistent carrying value across 2022-2024 all match the ground truth. The answer correctly identifies that only minor changes occurred in unamortized premium/discount while principal remained constant. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (constant at $1.5B across all three years), and (2) what this indicates about long-term debt strategy (deliberate maintenance of fixed-rate debt pillar). ENTITY ACCURACY: Company (PayPal/PYPL), metric (fixed-rate 2.850% notes), years (2022-2024), and financial terms are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly synthesized information across three years of filings to establish the constant exposure pattern and drew logical conclusions about strategic intent (locking in low-cost financing, preserving balance-sheet stability, managing leverage and interest-rate risk). SEMANTIC EQUIVALENCE: The LLM's interpretation that PayPal 'deliberately maintained' this debt position and used it as a 'long-dated fixed-rate debt pillar' conveys the same strategic intent as the ground truth's statement about 'strategic intent to preserve this liability structure.' The additional context about complementing newer issuances and managing overall leverage adds valuable detail without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM provides slightly more operational detail (issuance date, specific strategic rationales) than the ground truth, but this represents enhancement rather than error. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 497,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron moved from simply holding a 36.4 % stake in Angola LNG Limited to actively integrating new upstream gas discoveries into that facility.  In 2022 the company noted the New Gas Consortium (NGC) offshore Angola project—where the Quiluma‑Maboqueiro fields would be developed and tied to the Soyo LNG plant with first production slated for 2026— and in 2023 it added frontier exploration acreage (Blocks 49 and 50) in the deep‑water lower‑Congo Basin.  By 2024 Chevron had secured proved reserves for NGC, confirmed that the Q&M fields would feed the existing 1.1 bcf/d LNG plant, and emphasized that the plant’s feedstock comes from multiple offshore fields, underscoring a coordinated, long‑term plan to monetize Angola’s associated‑gas resources through upstream development, dedicated gas‑treatment infrastructure, and the Soyo LNG export hub.  This progression reveals Chevron’s strategy of building a fully integrated gas‑to‑LNG value chain in Angola to expand LNG volumes and create a sustainable, export‑oriented natural‑gas business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACILITY NAME ERROR: LLM states 'Soyo LNG plant' multiple times, but ground truth consistently refers to 'Angola LNG Limited' and 'Angola LNG plant.' This is a significant entity identification error that undermines the answer's accuracy. (2) OWNERSHIP STAKE OMISSION: LLM fails to explicitly state that Chevron maintained a consistent 36.4% ownership stake throughout 2022-2024, which is a core factual element of the ground truth. The LLM says 'moved from simply holding a 36.4%' but doesn't clarify this remained constant. (3) TIMELINE INCONSISTENCY: LLM attributes exploration acreage (Blocks 49 and 50) to 2023, while ground truth indicates this occurred in 2024. The LLM also mentions 'first production slated for 2026' which is not in the ground truth and may be inaccurate. (4) FACILITY CAPACITY: LLM mentions '1.1 bcf/d LNG plant' capacity, which is not mentioned in the ground truth and cannot be verified. (5) CORRECT ELEMENTS: The LLM correctly identifies the Q&M (Quiluma-Maboqueiro) fields, the New Gas Consortium Project, the integration strategy, and the multi-year progression concept. The overall narrative about transitioning from standalone facility to integrated hub is semantically aligned with ground truth. (6) MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across years but makes critical errors in entity identification (facility name) and timeline attribution. The reasoning about integrated value chain is sound but built on partially incorrect facts. QUANTITATIVE ACCURACY PENALTY: The facility name error and timeline misattribution significantly impact factual correctness despite correct percentage figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 460,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the trust’s domestic‑equity exposure grew from roughly **$396 million (2022) → $651 million (2023) → $849 million (2024)**, while private‑equity holdings rose modestly from **$161 million to $181 million**. This steady increase shows Southern Company is deliberately shifting more capital into longer‑duration, higher‑return equity assets—especially expanded domestic equity and a modest boost in private‑equity—to support its long‑term funding needs and overall capital‑allocation strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that do not match the ground truth data. Specific issues: (1) DOMESTIC EQUITY NUMBERS ARE WRONG: LLM states $396M (2022) → $651M (2023) → $849M (2024), but ground truth shows $1,016M (2022) → $829M (2023) → $1,099M (2024). The LLM numbers are approximately 60% lower than actual values across all three years. (2) PRIVATE EQUITY NUMBERS ARE PARTIALLY INCORRECT: LLM states $161M to $181M, but ground truth shows $150M (2022) → $161M (2023) → $181M (2024). The LLM omits the 2022 starting point of $150M and incorrectly implies private equity started at $161M. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression across both asset classes. The magnitude of error (off by ~$200-250M per year for domestic equity) indicates the LLM either hallucinated numbers or drew from incorrect sources. (4) NARRATIVE CONTRADICTION: The LLM's conclusion about 'steady increase' in domestic equity is contradicted by the actual data showing a dip in 2023 before rebounding in 2024. The ground truth correctly identifies this pattern; the LLM's narrative is based on false numbers. (5) MISSING CONTEXT: The LLM fails to capture the actual strategic pattern - the 2023 decrease in domestic equity followed by 2024 rebound - which is a key insight about capital allocation strategy. The answer demonstrates a complete failure in quantitative accuracy with no redeeming qualitative insights that could offset the numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 424,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Eliminations/Reclassifications” line subtracted $107 million, $151 million and $296 million respectively from GM’s consolidated net sales and revenue, a steadily expanding reduction.  This growing elimination signals that GM is increasingly consolidating and re‑classifying inter‑segment transactions—especially those involving GM Financial and the Automotive segments—to prevent double‑counting of revenue, reflecting a more integrated internal reporting structure across its business units.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM answer states: 2022=$107M, 2023=$151M, 2024=$296M. This represents multiple incorrect values: (1) 2022 is wrong by $2M ($107M vs $105M), (2) 2023 is dramatically wrong by $44M ($151M vs $107M). Only the 2024 figure of $296M is correct. The LLM has fundamentally misrepresented the trend data. TREND ANALYSIS ERROR: The ground truth identifies a modest increase from $105M to $107M (2% increase), then a significant jump to $296M. The LLM's incorrect numbers ($107M→$151M→$296M) suggest a different trend pattern than what actually occurred. REASONING QUALITY: While the LLM provides reasonable qualitative interpretation about inter-segment transactions and consolidation adjustments, this reasoning is built on incorrect numerical foundations. The explanation about GM Financial and Automotive segments preventing double-counting is contextually relevant but cannot compensate for the factual errors in the core data. COMPLETENESS: The answer does address the evolution question and attempts to explain what the trend reveals, but the incorrect numbers undermine the entire analysis. The semantic interpretation about increasing complexity is reasonable but is based on wrong data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 389,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s “Amended and Restated Performance Bonus Plan” has remained continuously filed as Exhibit 10.5† in each annual Form 10‑K (first restated in the 2022 filing and carried forward unchanged in the 2023 and 2024 filings), confirming that the plan is fully documented and still in force.  The plan is integrated with the company’s broader executive‑compensation framework—its terms are referenced alongside the 2020 Stock Plan’s performance‑based RSU agreements and the Executive Officer Severance and Retention Incentive Plan—so that bonus payouts, equity awards, and severance incentives are coordinated under a single, disclosed compensation structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL DATE ERROR: The LLM states the plan was 'first restated in the 2022 filing' but the ground truth clearly indicates the Amended and Restated version (Exhibit 10.5†) has a filing date of December 9, 2022, meaning it first appeared in the 2023 filing, not 2022. In 2022, it was listed as a historical exhibit (Exhibit 10.6†) from April 28, 2014 with no updates. (2) EXHIBIT NUMBER INCONSISTENCY: The LLM claims Exhibit 10.5† was filed in 2022, but ground truth shows Exhibit 10.6† in 2022 and Exhibit 10.5† (amended/restated) in 2023-2024. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key distinction that 2023 represented an active amendment and restatement (a significant change), while 2024 merely carried it forward. The ground truth emphasizes this 'strategic update in 2023 followed by stabilization in 2024,' which the LLM misses by claiming continuous filing from 2022. (4) MISSING CONTEXT: While the LLM correctly identifies integration with other compensation frameworks (2020 Stock Plan, severance plans), it fails to properly sequence the evolution and misrepresents when the Amended and Restated version actually became effective. The answer demonstrates partial understanding of the integration aspect but fundamentally mischaracterizes the timeline and documentation status evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 395,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon continues to reference its “Business Relationships and Related Party Transactions Policy” in the same Proxy sections—Item 13 (Certain Relationships and Related Party Transactions) and the corporate‑governance subsection of Item 1—without any substantive textual change. This consistent placement alongside the director‑independence and committee‑charter disclosures shows that the firm’s governance narrative and the structure of its board committees have remained steady, reinforcing the reliability of its related‑party and independence disclosures over the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the company as BNY Mellon (BK ticker), confirming the entity. (2) Correctly identifies all three years (2022, 2023, 2024) in the analysis. (3) Accurately references Item 13 as the location of the policy disclosure. (4) Correctly notes the consistent placement and linkage to director independence and committee structures across all three years. (5) The semantic meaning aligns with the ground truth regarding consistency of governance disclosures. WEAKNESSES: (1) The LLM introduces 'Item 1' as an additional location ('Item 13 and the corporate-governance subsection of Item 1'), which is not mentioned in the ground truth. This is a potential factual error or overstatement. (2) The ground truth specifically names three committees: 'Audit Committee,' 'Corporate Governance, Nominating and Social Responsibility Committee,' and 'Human Resources and Compensation Committee.' The LLM references 'committee-charter disclosures' generically without naming these specific committees, representing incomplete detail. (3) The LLM states 'without any substantive textual change,' which is a stronger claim than the ground truth makes. The ground truth focuses on consistent placement and linkage, not explicitly on textual immutability. (4) The phrase 'reinforcing the reliability of its related-party and independence disclosures' adds interpretive language not present in the ground truth. MULTI-HOP REASONING: The LLM demonstrates adequate multi-hop synthesis by connecting the policy disclosure across three years to committee structures and director independence, matching the ground truth's analytical approach. However, the missing specific committee names and the unexplained reference to Item 1 suggest incomplete source integration. OVERALL: The answer captures the core finding (consistent disclosure across three years in Item 13 linked to governance structures) but introduces potential inaccuracies and omits specific committee details that the ground truth includes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 544,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nBetween 2022 and 2024 the fair value of UnitedHealth’s held‑to‑maturity debt securities fell from **$679 million to $508 million**, and the carrying amount declined from **$696 million to $512 million**. This downward trend reflects the impact of rising market interest rates on the price of its fixed‑income holdings, indicating that the company has been reducing exposure to longer‑dated securities and is valuing them primarily through observable market inputs (Level 2), underscoring a more conservative investment stance that treats the fair‑value declines as temporary, rate‑driven rather than credit‑related.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: (1) QUANTITATIVE FAILURES: The LLM provides completely incorrect starting values. Ground truth shows 2022 fair value of $643M and carrying value of $641M, but LLM states $679M and $696M respectively - errors of $36M and $55M (5-9% overstatement). The 2024 ending values are correct ($508M fair value, $512M carrying value), but the starting point is fundamentally wrong, making the 3-year trend analysis invalid. (2) MISSING DATA: LLM fails to provide 2023 intermediate values ($596M fair value, $603M carrying value), which are critical for understanding the 3-year evolution and trend. Ground truth explicitly states these values as part of the trend analysis. (3) REASONING ERRORS: While the LLM correctly identifies the downward trend and mentions interest rate impacts, it misses the key insight from ground truth about the shift away from Level 3 unobservable inputs by 2023-2024, instead claiming reliance on Level 2 inputs without supporting evidence from the filings. (4) INCOMPLETE SYNTHESIS: The LLM provides a partial narrative about investment strategy but fails to synthesize the complete 3-year progression that ground truth emphasizes. The answer addresses only endpoints rather than the full evolution requested. (5) CALCULATION IMPACT: The incorrect starting values compound the error - the actual decline from 2022-2024 is $135M (21%), but LLM's numbers suggest $171M (25%), overstating the magnitude of reduction. This is a material misrepresentation of the company's portfolio changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 427,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nPayPal’s BNPL portfolio grew rapidly through 2022‑2023, and the company’s 10‑K filings show a rising credit‑loss risk – higher default and charge‑off rates were noted in the 2022 and 2023 risk‑factor sections (pages 24‑28, 25).  To curb that exposure, in June 2023 PayPal struck a multi‑year deal to sell up to €40 bn of U.K. and European BNPL receivables and began a forward‑flow sale of future originations, moving the bulk of those loans off its balance sheet (page 25).  This transaction reveals a deliberate risk‑mitigation strategy: rather than retain and fund the BNPL credit risk, PayPal is off‑loading receivables, diversifying funding sources and tightening underwriting, thereby progressively reducing its exposure to bad BNPL transactions over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key quantitative fact (€40 billion BNPL receivables sale in June 2023) and accurately characterizes PayPal's risk mitigation strategy. The multi-hop synthesis is sound: it connects the 2022 exposure concerns, the 2023 transaction, and the ongoing risk management approach. The answer correctly notes the forward-flow arrangement and the strategic intent to move loans off the balance sheet. The reasoning about diversifying funding sources and tightening underwriting is logically sound and relevant to the question.\n\nWEAKNESSES: (1) The LLM answer lacks explicit discussion of the 2024 evolution mentioned in the ground truth, which noted that BNPL receivable sales were subject to conditions and could delay expected benefits. The ground truth emphasizes a three-year progression (2022→2023→2024), but the LLM answer focuses primarily on 2022-2023 without adequately addressing 2024 developments. (2) The LLM answer includes page references (pages 24-28, 25) that cannot be verified against the ground truth and may be fabricated or inaccurate. (3) The claim about 'higher default and charge-off rates' in 2022-2023 is not explicitly confirmed in the ground truth, which only mentions 'exposure to bad transactions' and 'risk of defaults.' (4) The statement about 'tightening underwriting' is an inference not directly supported by the ground truth.\n\nNUMERIC VERIFICATION: The €40 billion figure is correct and matches the ground truth exactly. The June 2023 date is correct. No calculations are required or presented.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information about PayPal's BNPL strategy across time periods, but incompletely covers the full 2022-2024 arc requested in the question. The connection between the 2023 transaction and risk mitigation is well-established, but the 2024 conditional aspects and ongoing challenges are underexplored.\n\nSEMANTIC EQUIVALENCE: The core message aligns with the ground truth regarding the strategic intent and the €40 billion transaction, but the answer is less comprehensive about the evolving nature of the risk (from exposure acknowledgment to active mitigation to conditional implementation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 595,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s net upstream output from Myanmar slipped from about 15 kboe/d in 2022 to roughly 17 kboe/d in 2023, then dropped sharply to only ≈ 4 kboe/d in 2024.  This decline mirrors the company’s January 2022 decision to pursue an orderly exit from the country, scaling back its non‑operated Yadana‑Badamyar‑Sein gas project and associated pipeline as part of a strategic withdrawal.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally contradict the ground truth. (1) REVERSED NUMBERS: Ground truth shows 17 MBD in 2022 declining to 15 MBD in 2023, but LLM states the opposite (15 kboe/d in 2022 rising to 17 kboe/d in 2023). This is a critical reversal of the actual trend. (2) INCORRECT 2024 FIGURE: LLM claims ~4 kboe/d in 2024, but ground truth indicates complete withdrawal in April 2024 (implying zero production by end of 2024, not 4 kboe/d). The 4 kboe/d figure appears fabricated. (3) WRONG TIMELINE FOR EXIT DECISION: LLM cites 'January 2022 decision to pursue orderly exit,' but ground truth indicates the actual exit occurred in April 2024. The January 2022 date is incorrect and misleading about when the strategic shift occurred. (4) UNIT INCONSISTENCY: LLM uses 'kboe/d' while ground truth uses 'MBD' (thousand barrels per day) - while these could be equivalent, the LLM's numbers don't match the ground truth values regardless of unit. (5) INCOMPLETE STRATEGIC NARRATIVE: While LLM mentions portfolio optimization and risk management concepts, it fails to clearly state the complete withdrawal that occurred in April 2024, which is the most significant strategic shift. The answer demonstrates poor multi-hop synthesis - it failed to correctly extract and combine production volume data across the three-year period and misidentified the timing of the strategic decision. The core narrative of declining production culminating in complete exit is obscured by reversed numbers and incorrect figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 434,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nFrom 2022 to 2024 the share of PC & notebooks within TI’s Personal‑Electronics market fell markedly – the segment was only about 15 % of total revenue in 2022 and, while the overall personal‑electronics slice grew to roughly 20‑24 % of revenue in later years, PC & notebooks were no longer called out as a distinct contributor and are listed among many other sub‑categories.  This decline shows that TI is deliberately scaling back its consumer‑PC exposure and is re‑orienting the Personal‑Electronics segment toward higher‑margin, growth‑driven areas such as wearables, data‑storage and connected peripherals, reinforcing a strategic shift away from traditional consumer computing toward industrial, automotive and analog power markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) REVERSED NUMBERS: The LLM states PC & Notebooks were 'only about 15% of total revenue in 2022' when the ground truth clearly shows Personal Electronics (which includes PC & Notebooks) was 24% in 2022. The LLM has inverted the 2022 and 2023 figures. (2) INCORRECT SEGMENT PERCENTAGES: The LLM claims the Personal Electronics segment 'grew to roughly 20-24% of revenue in later years' when ground truth shows it declined from 24% (2022) to 15% (2023) to 20% (2024). The LLM misrepresents the direction and magnitude of change. (3) MISSING KEY FACT: The ground truth explicitly states that in 2023, Personal Electronics declined to 15%, which the LLM completely misses in its chronological analysis. (4) UNSUPPORTED CLAIMS: The LLM introduces specific product categories (wearables, data-storage, connected peripherals) that are NOT mentioned in the ground truth, representing fabrication rather than synthesis from actual filing data. (5) MULTI-HOP REASONING FAILURE: The LLM fails to correctly synthesize the year-over-year evolution (2022→2023→2024) and instead presents a confused narrative that reverses the actual trend. The ground truth shows a clear V-shaped pattern (24%→15%→20%), which the LLM completely misrepresents. While the LLM correctly identifies the strategic shift away from PC & Notebooks toward Automotive and Industrial markets, this correct conclusion is built on fundamentally incorrect numerical foundations, making the overall answer unreliable and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 444,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis under the 2017 Master Agreement remained limited to losses arising from breaches of representations, warranties, emissions‑related claims, product‑liability and recall matters (including the Takata‑inflator recalls).  The company has not accrued any material amount for these obligations—its only recorded indemnity‑related outlays have been immaterial settlements for certain recalls—and it repeatedly states that it cannot estimate any reasonably possible material loss or range of loss that could result from the pending consumer‑lawsuits in Germany, the UK, Austria and the Netherlands or from future regulatory fines.  Consequently, while the exposure is still theoretically present (e.g., potential fines from the European Commission/CMA investigations or additional Takata‑related indemnities), it is considered remote and has not materially evolved over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 2017 Master Agreement framework, accurately names the types of indemnification obligations (representations, warranties, emissions, product liability, recalls, Takata), correctly identifies the regulatory investigations (European Commission, UK CMA), and appropriately characterizes the financial impact as immaterial/remote. The answer correctly notes that no material accruals were recorded and that GM cannot estimate reasonably possible losses. WEAKNESSES: (1) The LLM answer states obligations 'remained limited' and 'has not materially evolved over the 2022-2024 period,' which contradicts the ground truth's clear narrative of EVOLUTION showing 'increasing specificity and emerging regulatory risk exposure over time.' The ground truth explicitly documents a progression: 2022 (no specific disclosures) → 2023 (first disclosure of indemnification obligations) → 2024 (expanded obligations with specific accruals for EC/CMA investigation). The LLM's characterization of 'remained limited' and 'not materially evolved' misses this critical temporal progression. (2) The LLM answer lacks the year-by-year breakdown that the ground truth provides, which is essential for answering a question specifically about how obligations 'evolved from 2022 through 2024.' (3) The LLM mentions 'immaterial settlements for certain recalls' but the ground truth specifies 'an immaterial indemnification already paid' in 2023 and 'accruals of an immaterial amount' in 2024 related to the EC/CMA investigation—the LLM conflates these. (4) The LLM answer mentions 'pending consumer-lawsuits in Germany, the UK, Austria and the Netherlands' which is not explicitly in the ground truth and may introduce unsupported specificity. QUANTITATIVE ACCURACY: All numbers mentioned (or lack thereof) are correct—immaterial amounts, no material accruals. However, the temporal dimension is missing. QUALITATIVE ACCURACY: The reasoning about remote exposure and inability to estimate losses is sound, but the failure to capture the evolution narrative represents a significant gap in multi-hop synthesis across the three-year period. The question explicitly asks about evolution; the answer should demonstrate how the disclosure and risk profile changed year-to-year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 612,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450 % Senior Notes due 2026 were first created by Supplemental Indenture 10 in September 2021, and thereafter the company filed a series of supplemental indentures—including Nos. 12 (April 2022) and Nos. 1‑6 (2023) as well as Nos. 5‑6 (2024)—that added new low‑coupon senior notes and amended the indenture to roll the 2026 maturity forward. This multi‑year pattern shows that American Tower is deliberately laddering its debt, continuously issuing cheap, long‑dated senior notes to replace maturing obligations and lock in low‑cost financing as market conditions allow.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims supplemental indentures Nos. 12 (April 2022), Nos. 1-6 (2023), and Nos. 5-6 (2024) were filed, but the ground truth explicitly states the 1.450% Senior Notes were consistently referenced under Supplemental Indenture No. 10 across all three years with no material modifications. The LLM fabricated specific supplemental indenture numbers and dates that do not appear in the ground truth. (2) QUANTITATIVE ACCURACY: The LLM provides specific dates (April 2022) and indenture numbers (12, 1-6, 5-6) that are entirely unsupported by the ground truth. The ground truth confirms only Supplemental Indenture No. 10 from September 27, 2021. (3) MULTI-HOP REASONING: The LLM's synthesis is fundamentally flawed. It claims the company 'rolled the 2026 maturity forward' and 'continuously issued cheap, long-dated senior notes to replace maturing obligations,' but the ground truth explicitly states there was 'no refinancing or material modification of the instrument over the three-year period.' The LLM mischaracterizes the debt management strategy as active laddering when the ground truth indicates stability and continuity. (4) ENTITY ACCURACY: While American Tower Corporation is correctly identified, the specific debt instruments, indenture numbers, and filing exhibits are incorrectly stated. The ground truth references Exhibits 4.25 (2022), 4.22 (2023), and 4.21 (2024), but the LLM makes no mention of these exhibit numbers and instead invents supplemental indenture details. (5) SEMANTIC DIVERGENCE: The LLM's characterization of the strategy as 'deliberately laddering debt' and 'continuously issuing' new notes directly contradicts the ground truth's description of a 'deliberate and stable debt management strategy' with 'no refinancing or material modification.' This represents a fundamental misunderstanding of the company's actual debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 535,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company kept using the 2019 Long‑Term Incentive Plan, but the actual award documents changed each year.  In 2023 it introduced a new **2023 Performance Share Unit Agreement** and a new **2023 Restricted Stock Unit Agreement** (Exhibits 10.23 & 10.24), and in 2024 it replaced those with updated **2024 Performance Share Unit Agreement** and **2024 Restricted Stock Unit Agreement** (Exhibits 10.25 & 10.26), while also filing a fresh **2024 Deferred Stock Unit Agreement for directors** (Exhibit 10.29).  Thus the plan’s equity‑based compensation evolved by rolling out year‑specific agreement templates that incorporated updated performance metrics and compensation terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG YEAR CLAIMS: The LLM states that in 2023 the company introduced '2023 Performance Share Unit Agreement' and '2023 Restricted Stock Unit Agreement,' but the ground truth indicates these were 2019 forms introduced in 2022, not 2023 forms. (2) INCORRECT AGREEMENT FORMS: The ground truth explicitly mentions '2019 Form of Performance Share Unit Agreement' and '2019 Form of Restricted Stock Unit Agreement' in 2022, and '2022 Form of Performance Share Unit Agreement' in 2024 - not the year-specific 2023 and 2024 forms the LLM claims. (3) MISSING KEY DETAIL: The ground truth specifically mentions the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' introduced in 2023, which the LLM completely misses in its 2023 discussion, only mentioning a 2024 director agreement. (4) INCORRECT PROGRESSION: The LLM suggests a pattern of annual replacement of agreement forms (2023 versions replaced by 2024 versions), but the ground truth shows a more nuanced evolution: 2019 forms in 2022, director-specific forms in 2023, and 2022 forms appearing in 2024. (5) EXHIBIT REFERENCES: The LLM provides specific exhibit numbers (10.23, 10.24, 10.25, 10.26, 10.29) without verification against ground truth, and these appear to be fabricated details not supported by the source material. The LLM's core narrative about 'year-specific agreement templates' fundamentally misrepresents the actual evolution described in the ground truth, which emphasizes the 2019 plan as the foundational framework with incremental refinements and broader application (particularly to directors in 2023).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 465,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 through 2024 the Combat Systems segment shifted from simply highlighting its “leading position” in supplying aerostructures for missile subsystems to concrete capacity‑building actions: in 2023 OTS won awards to expand metal‑parts and propellant production (e.g., 18 K → 86 K rounds/month by 2025, 4 M → 16 M lb/yr propellant by 2028) and in 2024 it entered a strategic partnership to produce solid‑rocket‑motor components, while also scaling 155 mm ammunition capacity. This three‑year trend shows that GD is deliberately fortifying its aerostructure manufacturing base to become the primary domestic supplier of the critical structures, actuators and warheads needed for next‑generation tactical and strategic missile systems, positioning the company to capture the growth expected from the Army’s Indirect‑Fire Modernization and hypersonic missile programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific production capacity numbers (18K → 86K rounds/month, 4M → 16M lb/yr propellant) that are not mentioned in the ground truth. These appear to be fabricated or sourced from incorrect filings. The ground truth provides only revenue percentages (20% in 2023, 19% in 2024) which the LLM completely omits. (2) ENTITY/CONTEXT ERRORS: The LLM references 'OTS' winning awards and entering strategic partnerships - these entities and events are not mentioned in the ground truth. The ground truth focuses on General Dynamics' Combat Systems segment specifically, not subsidiary operations. (3) PROGRAM REFERENCES: The LLM mentions 'Army's Indirect-Fire Modernization and hypersonic missile programs' - while potentially relevant to GD's business, these specific program references are not in the ground truth and appear to be inferred rather than directly supported. (4) MISSING CORE INFORMATION: The LLM fails to mention the key ground truth data points: Combat Systems as 20% of revenue in 2023 declining to 19% in 2024, the explicit mention of aerostructures for next-generation missiles, and the F-35 application context. (5) REASONING QUALITY: While the LLM's narrative about capacity-building is logically coherent, it is not grounded in the provided ground truth. The multi-hop synthesis required comparing 2022-2024 trends in aerostructures focus and revenue share - the LLM instead pivots to production capacity metrics that don't appear in the source material. The answer reads as plausible strategic analysis but fails the fundamental requirement of factual accuracy against the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 481,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nFrom 2022 through 2024 PMI moved Jackpot from a modest, price‑sensitive local label to a deliberately‑backed pillar of its Philippines portfolio—devoting increased marketing spend, refreshed packaging and tighter integration into the South‑East Asia distribution network that serves the region’s “at‑least‑15 % share in roughly 100 markets” (including the Philippines).  This multi‑year push shows that the brand is being used as a cash‑generating anchor to protect PMI’s market position in a key emerging market, while simultaneously providing the earnings base that funds the company’s broader regional growth and its transition toward reduced‑risk products.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites '15% share in roughly 100 markets' - this specific metric does not appear in the ground truth and appears to be fabricated or misattributed. The ground truth mentions PMI's smoke-free products in 95 markets, not a 15% share metric. (2) UNSUPPORTED CLAIMS: The LLM makes detailed assertions about 'increased marketing spend, refreshed packaging, and tighter integration into South-East Asia distribution network' that are not present in the ground truth. These appear to be invented details. (3) CHARACTERIZATION ERRORS: The LLM describes Jackpot as being 'moved from a modest, price-sensitive local label to a deliberately-backed pillar' - the ground truth simply identifies it as a 'key local cigarette brand' consistently mentioned across three years, without describing any evolution in positioning or increased backing. (4) MISSING CORE FACTS: The LLM fails to mention Fortune, which the ground truth identifies as another key local brand alongside Jackpot in 2022. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by inventing details rather than accurately synthesizing what the ground truth provides. The ground truth's key insight - that Jackpot remained 'strategically relevant' despite PMI's smoke-free future vision - is not clearly conveyed. (6) SEMANTIC MISMATCH: The ground truth emphasizes consistency and maintenance of strategic focus; the LLM emphasizes escalation and increased investment, which is not supported by the source material. The answer reads as speculative business analysis rather than evidence-based synthesis of filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 480,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron’s focus in the Republic of Congo remained on sustaining its upstream production, directing capital mainly toward maintaining and modestly extending existing offshore fields rather than launching new large‑scale projects.  At the same time the company continued to evaluate non‑core holdings, a process that culminated in the 2025 agreement to sell its 31.5 % non‑operated interest in the Haute Mer permit, signalling a strategic shift toward asset disposition rather than further capital investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 31.5% nonoperated interest in Haute Mer and the 2025 sale timing. (2) The characterization of a strategic shift toward asset disposition is accurate. (3) The general narrative of moving from operational continuity to divestiture is directionally correct. (4) The mention of offshore fields and capital deployment is appropriate.\n\nWEAKNESSES: (1) INCOMPLETE INFORMATION: The LLM omits the 15.75% interest in the Republic of Congo portion of Lianzi that was also sold, which is a material asset disposition mentioned in the ground truth. This is a significant omission for a question specifically about asset disposition. (2) MISSING QUANTITATIVE DATA: The ground truth specifies approximately $0.7 billion invested in 2023 across offshore development and natural gas projects in Africa including Congo. The LLM provides no specific capital deployment figures, only vague language about 'modestly extending existing offshore fields.' (3) CHARACTERIZATION ISSUE: The LLM describes the 2022-2024 period as focused on 'sustaining production' and 'modest extension,' but the ground truth indicates active capital deployment of $0.7 billion in 2023, suggesting more than just sustenance. (4) TEMPORAL PRECISION: While the LLM correctly notes the 2025 sale, it doesn't clearly establish the 2023 investment activity as part of the 3-year evolution narrative.\n\nMULTI-HOP REASONING: The LLM partially synthesizes the evolution but misses key data points. It correctly connects the dots between operational presence and eventual divestiture, but fails to fully capture the intermediate investment phase in 2023 that is central to understanding the complete trajectory.\n\nNUMERIC VERIFICATION: The 31.5% figure is correct. However, the absence of the $0.7 billion investment figure and the 15.75% Lianzi interest represents incomplete quantitative coverage of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 517,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nSouthern Company continued to classify its outdoor‑lighting contracts as operating leases with initial terms of up to 10 years and month‑to‑month renewals through 2022‑2024, and the related cash‑flow streams were deemed immaterial (particularly for Georgia Power and Mississippi Power) and disclosed in the lease‑maturity tables.  Revenue from these contracts is reported in the “operating‑lease income” line (and, for Georgia Power, as part of variable lease income) and is allocated among the subsidiaries, but the underlying payment structure—scheduled payments that may become variable based on energy production—has not changed; only the relative share of total lease income from these contracts has shifted as other lease categories grew.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT TIMELINE: The LLM claims outdoor lighting contracts were classified as operating leases 'through 2022-2024' with 'initial terms of up to 10 years,' but the ground truth indicates these contracts were considered IMMATERIAL in 2022 with NO SIGNIFICANT VALUE DISCLOSED. The LLM conflates different time periods and misrepresents the evolution of disclosure. (2) MISSING CRITICAL EVOLUTION: The ground truth shows a clear progression - 2022 (immaterial, no disclosure) → 2023 (scheduled lease payments disclosed in maturity analyses) → 2024 (expanded disclosure with initial terms and revenue allocation clarification). The LLM fails to capture this important evolution and instead presents a static picture. (3) REVENUE ALLOCATION MISCHARACTERIZATION: The ground truth states that by 2024, lease income from PPAs was included in WHOLESALE REVENUES for Alabama Power, Georgia Power, and Southern Power. The LLM incorrectly claims revenue is reported in 'operating-lease income' line and mentions 'variable lease income' for Georgia Power without proper context. This is a fundamental misunderstanding of how the revenue is actually classified. (4) MATERIALITY TREATMENT: The ground truth emphasizes the shift from 'immaterial' (2022) to more structured disclosure (2023-2024). The LLM acknowledges immateriality but fails to explain the significance of the change in treatment and transparency. (5) SUBSIDIARY SPECIFICITY: The ground truth specifically identifies Alabama Power, Georgia Power, and Southern Power as having lease income from PPAs included in wholesale revenues. The LLM mentions Georgia Power and Mississippi Power but doesn't properly synthesize the multi-subsidiary analysis. (6) STRUCTURAL CHANGES: The LLM claims 'the underlying payment structure...has not changed' and only 'relative share of total lease income...has shifted,' which contradicts the ground truth's emphasis on expanded disclosure and clarification of lease valuation across subsidiaries. The answer demonstrates poor multi-hop synthesis across the 2022-2024 period and misses the core narrative of increasing transparency and standardization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 603,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due 2025 was carried at a constant $500 million principal in FY 2022, FY 2023 and FY 2024, yet its effective interest rate climbed from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024. This upward shift—driven by rising market rates and the accretion of discount/hedge adjustments—shows that the note’s market value fell relative to its book carrying amount, signalling higher borrowing costs and a tightening interest‑rate environment for Cisco.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - $500 million carrying amount across all three years (FY 2022, 2023, 2024), effective interest rates of 3.20% (FY 2022), 6.38% (FY 2023), and 6.66% (FY 2024) match the ground truth exactly. The note is correctly identified as the 3.50% senior note due 2025. COMPLETENESS: The answer addresses all key aspects of the question - the evolution of carrying amount, the progression of effective interest rates, and the implications for debt valuation and market conditions. MULTI-HOP REASONING: The synthesis is sound, correctly connecting the constant principal amount with the rising effective rates to draw conclusions about market value deterioration relative to book value. ENTITY ACCURACY: Cisco is correctly identified, fiscal years are accurate, and the financial metrics are properly labeled. SEMANTIC EQUIVALENCE: The LLM's explanation that 'the note's market value fell relative to its book carrying amount' and 'signalling higher borrowing costs and a tightening interest-rate environment' conveys the same analytical insight as the ground truth's statement about 'shift in market conditions or internal risk assessments.' The LLM provides slightly more detailed context by mentioning 'accretion of discount/hedge adjustments' which adds reasonable financial interpretation without contradicting the ground truth. Minor: The LLM's phrasing is slightly more elaborate than the original answer, but this represents enhanced clarity rather than inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 436,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nSimon Property Group’s Unsecured Notes – 35A stayed unchanged in size and terms across the three years: the face amount remained $750 million, the coupon stayed at 2.65 % and the maturity stayed at 07/15/30 (see page 50 (2022) and page 51 (2024)).  However, the overall pool of unsecured indebtedness contracted – total consolidated unsecured debt fell from about $21.0 billion at the end of 2022 (page 50) to roughly $19.4 billion by the end of 2024 (page 51).  Consequently, the share of the 35A tranche within the unsecured portfolio edged up only modestly (from ~3.6 % to ~3.9 %).  \n\nThis multi‑year pattern shows that SPG is deliberately **de‑leveraging its unsecured balance sheet while preserving a stable, low‑cost core issuance**.  Rather than growing the 35A issuance, the company is extending maturities and reducing total outstanding unsecured debt, reflecting a long‑term strategy of tightening leverage, extending debt profiles and managing interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sophisticated multi-hop reasoning. STRENGTHS: (1) All core numbers are correct: $750 million face value for Notes-35A, 2.65% coupon, 07/15/30 maturity date across all three years (2022-2024). (2) Quantitative analysis is sound: total unsecured debt figures ($21.0B in 2022 to $19.4B in 2024) are accurate, and the calculated percentages (3.6% to 3.9%) are mathematically correct. (3) Multi-hop synthesis is excellent: the answer correctly connects the stable 35A position with broader portfolio changes (de-leveraging trend), demonstrating understanding of how this specific instrument fits within SPG's overall debt strategy. (4) The reasoning about deliberate de-leveraging while preserving low-cost core issuances aligns with the ground truth's characterization of 'deliberate strategy to maintain stable long-term financing commitments while selectively refinancing.' (5) Page citations (page 50 for 2022, page 51 for 2024) add credibility. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by explicitly calculating the percentage shift and emphasizing de-leveraging metrics, but this represents valuable added analysis rather than error. The ground truth mentions 'new issuances like the 2024 $1 billion Unsecured Notes - 41A' which the LLM doesn't explicitly reference, but this omission is minor since the question focuses on the 35A evolution specifically. The semantic meaning of both answers is equivalent: stable 35A instrument within a contracting unsecured debt portfolio reflects deliberate long-term debt management. No calculation errors detected. All entities correctly identified (Simon Property Group, specific debt instruments, years, metrics).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 475,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 the Embedded‑Processing business moved from a modest growth engine to a shrinking, lower‑margin contributor: revenue rose only 3 % in 2023 but fell 25 % in 2024, and its operating‑profit margin dropped from 38.5 % (2022) to 29.9 % (2023) to 13.9 % (2024).  Consequently, TI now leans on its **manufacturing‑technology advantage** and **capital‑allocation discipline** to sustain cash flow from the segment, while still using its **broad product portfolio and market‑reach advantage** to keep embedded processors in the mix of its four sustainable competitive advantages, but with a reduced emphasis on growth and a greater focus on margin protection.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL CONTRADICTION: The ground truth explicitly states that TI's strategic emphasis on Embedded Processing Products remained CONSISTENT and STABLE from 2022-2024, with identical phrasing used each year. The LLM answer claims the opposite—that the business 'moved from a modest growth engine to a shrinking, lower-margin contributor,' fundamentally misrepresenting the strategic narrative. (2) UNVERIFIED QUANTITATIVE CLAIMS: The LLM provides specific revenue and margin figures (3% growth in 2023, 25% decline in 2024, margin percentages of 38.5%, 29.9%, 13.9%) that are NOT present in the ground truth and cannot be verified. These numbers appear fabricated or sourced from unreliable data. The ground truth makes no such specific financial claims about Embedded Processing Products' performance. (3) MISCHARACTERIZATION OF STRATEGIC ROLE: The ground truth emphasizes that Embedded Processing remained 'the second of four sustainable competitive advantages' with consistent strategic framing focused on 'more opportunity per customer and more value for our investments.' The LLM incorrectly suggests a 'reduced emphasis on growth' and shift toward 'margin protection,' which directly contradicts the ground truth's assertion of stable, consistent strategic positioning. (4) FAILED MULTI-HOP SYNTHESIS: The question asks about evolution within the context of four sustainable competitive advantages. The ground truth correctly identifies this framework and shows consistency. The LLM mentions manufacturing-technology advantage and capital-allocation discipline, which may or may not be part of TI's stated four advantages, but does so in a way that misrepresents the actual strategic narrative. (5) SEMANTIC MISALIGNMENT: The ground truth's core message is strategic STABILITY and CONSISTENCY; the LLM's core message is strategic DECLINE and SHIFT. These are fundamentally incompatible interpretations of the same question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 548,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast broadened the flexibility of its wireless shared‑data offering by adding prepaid “NOW” unlimited‑data plans and tiered per‑gigabyte options, while also extending the service beyond the United States to the United Kingdom and Italy through MVNO agreements (using Virgin Media O2’s network and its own core).  The company further enhanced plan choice by allowing customers to bring their own device or finance purchases interest‑free for up to 48 months abroad, and by offering distinct gigabyte‑based or unlimited plans for international users, markedly expanding both the adaptability of domestic plans and the reach of its wireless service into new markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM introduces specific geographic claims (UK, Italy, Virgin Media O2 network) and financing details (48-month interest-free financing) that are NOT present in the ground truth. These appear to be hallucinated details not supported by the original answer. (2) INCOMPLETE ALIGNMENT - While the LLM correctly identifies the NOW brand prepaid unlimited plans and per-gigabyte options, it adds unverified specifics about international expansion locations and partnership details. (3) MULTI-HOP REASONING - The LLM does attempt to synthesize evolution across 2022-2024, but does so by introducing information not in the ground truth rather than accurately reflecting what was documented. (4) MISSING ELEMENTS - The LLM fails to clearly articulate the 2022 baseline (bundled residential offerings only) and the 2023 emphasis on plan flexibility/choice between unlimited/shared/per-gigabyte options. (5) VERIFICATION ISSUES - The ground truth states international expansion occurred in 2024 but does NOT specify UK/Italy or Virgin Media O2 partnerships. The financing claim (48 months interest-free) is entirely absent from ground truth. These additions suggest the model fabricated details to enhance the answer rather than sticking to documented facts. The answer shows reasonable structure and addresses the question's themes, but the introduction of unverified specific claims significantly undermines credibility and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 407,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures shifted from a broad warning about “increased cybersecurity and payment‑fraud risk” and the general exposure of its credit products to a series of more specific concerns: the 2023 filing detailed the cost of buyer‑ and seller‑protection losses, the underwriting and default risk of its BNPL and merchant‑financing receivables, and the impact of new fraud schemes and regulatory changes on interchange fees; by 2024 the focus had expanded to the accelerating sophistication of third‑party fraud (synthetic identities, account takeovers, illicit use of credit), the complexity of managing multiple funding sources and strategic partnerships, and the need for continual model updates and compliance oversight. This progression shows that managing risk in PayPal’s digital‑payments ecosystem now demands an integrated, multilayered approach that blends fraud detection, credit‑risk modeling, third‑party relationship governance, and regulatory compliance to address an increasingly complex threat landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 3-year progression (2022-2024) and captures the general evolution from broad fraud warnings to more specific, sophisticated threats. It accurately mentions synthetic identity fraud, account takeovers, and the increasing complexity of risk management. The semantic understanding of PayPal's shifting risk landscape is sound, and the answer appropriately emphasizes the multilayered approach needed for modern risk management.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM answer fails to include the specific €40 billion figure mentioned in the ground truth regarding PayPal's multi-year agreement to sell U.K. and European BNPL loan receivables. This is a concrete, verifiable number that should have been included. (2) MISSING KEY DETAIL - The ground truth specifically mentions the 2023 agreement to sell \"up to €40 billion of U.K. and European BNPL loan receivables,\" which is a critical milestone in PayPal's evolution. The LLM mentions BNPL and merchant-financing receivables generally but omits this specific transaction detail. (3) FDIC-INSURED BANKS REFERENCE - The ground truth mentions \"legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks\" in 2024, which the LLM does not address. (4) ACCOUNT CREATION FRAUD - The ground truth specifically mentions \"fraud through fictitious account creation\" in 2022, which the LLM does not explicitly reference.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop reasoning by synthesizing information across three years and connecting fraud evolution to risk management complexity. However, it misses the specific connection between the 2023 BNPL receivables agreement and the introduction of third-party fraud exposure in large-scale loan portfolios.\n\nSEMANTIC EQUIVALENCE: While the LLM's description of the progression is conceptually similar to the ground truth, the omission of specific quantitative details (€40 billion) and regulatory context (FDIC-insured banks) represents a meaningful gap in factual completeness. The answer is directionally correct but incomplete in supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 578,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GILD’s El Segundo, California site progressed from a mainly clinical‑trial cell‑therapy manufacturing location to a fully integrated clinical‑and‑commercial production hub.  The 2023 and 2024 10‑K filings (pages 9‑11) note that the facility is now used for both clinical and commercial manufacturing of cell‑therapy products and that GILD has made strategic capital investments to expand and modernize the site, boosting capacity for Kite’s CAR‑T therapies and supporting the company’s broader cell‑therapy pipeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies El Segundo as a key GILD facility for cell therapy manufacturing and accurately notes the progression from clinical to clinical-and-commercial manufacturing across the 2022-2024 period. The mention of strategic capital investments and Kite's CAR-T therapies is relevant and appropriate. The timeframe (2022-2024) and facility location are correct.\n\nWEAKNESSES: (1) The LLM introduces a characterization not explicitly supported by the ground truth: describing 2022 as 'mainly clinical-trial' manufacturing. The original answer states El Segundo was identified for 'clinical and commercial manufacturing' in 2022, not primarily clinical-trial focused. This is a subtle but meaningful mischaracterization of the facility's initial role. (2) The LLM claims 'strategic capital investments to expand and modernize the site' but provides no specific dollar amounts, dates, or details of these investments. The ground truth mentions 'strategic facility investments' but the LLM adds specificity about expansion and modernization without citing evidence. (3) The LLM references specific 10-K pages (9-11) but these cannot be verified against the ground truth provided. (4) The answer lacks mention of other facilities (Santa Monica, Frederick) that the ground truth identifies as part of the broader context. (5) The ground truth emphasizes 'continuity' and 'no indication of reduced emphasis or facility changes,' which the LLM's framing of 'progression from mainly clinical-trial to fully integrated' somewhat contradicts.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but does so with some interpretive leaps not fully supported by the ground truth. The characterization of evolution is reasonable but overstates the degree of change.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers are provided by either answer, so quantitative accuracy is limited to date/year verification, which is correct (2022-2024). The lack of specific investment amounts in the LLM answer is a limitation but not necessarily an error if such data wasn't available in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 575,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nCostco’s 2.750 % Senior Notes—originally issued in 2017 with a May 18 2024 maturity—were still listed as an outstanding series in the 2022 filing (Exhibit 4.6 on page 66 of the 2022 10‑K).  In the 2023 and 2024 filings the same 2.750 % series no longer appears as a current obligation; instead the company’s Exhibit list (pages 66‑67 of the 2023 10‑K and pages 66‑68 of the 2024 10‑K) shows new senior‑note formats maturing in 2027, 2030 and 2032 (e.g., 1.375 % due 2027, 1.600 % due 2030, 1.750 % due 2032).  This indicates that the 2.750 % notes were retired and replaced with longer‑dated, lower‑coupon debt, revealing Costco’s strategy of extending its debt maturities and locking in cheaper long‑term financing while reducing near‑term refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth. The original answer explicitly states that the maturity structure of Costco's 2.750% Senior Notes 'remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024' and that 'the notes were not refinanced or extended during this period.' The LLM answer claims the opposite: that the 2.750% notes 'were retired and replaced with longer-dated, lower-coupon debt' in the 2023 and 2024 filings. This is a direct factual contradiction. The LLM provides specific exhibit page numbers and references to new debt instruments (1.375% due 2027, 1.600% due 2030, 1.750% due 2032), but these claims are not supported by the ground truth, which indicates the 2.750% notes remained outstanding and unchanged across all three years. The LLM's interpretation of the debt management strategy (extending maturities, locking in cheaper financing) is plausible as a general corporate finance strategy, but it is applied to an incorrect factual premise. The LLM misidentified what actually happened with the 2.750% notes. The answer demonstrates a fundamental failure in multi-hop reasoning by incorrectly synthesizing information about the debt's evolution. While the answer is contextually relevant to the question asked, it provides incorrect information about the core facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 386,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s Angola LNG natural‑gas output was roughly 48 million cubic feet per day in 2022, 2023 and 2024, showing a flat‑to‑stable trend across the three years. This plateau indicates the company is focusing on sustaining and optimizing its existing African gas assets and meeting long‑term delivery contracts rather than expanding production in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical dimensions. QUANTITATIVE ERRORS: The LLM states Angola LNG production was 'roughly 48 million cubic feet per day' across 2022-2024, which is off by a factor of approximately 150x. The ground truth shows: 2022: 7,107 mmcf/d, 2023: 7,148 mmcf/d, 2024: 7,569 mmcf/d. The LLM's numbers are not just wrong—they are drastically understated and bear no resemblance to the actual production volumes. TREND ANALYSIS ERROR: The LLM characterizes the trend as 'flat-to-stable,' when the ground truth shows a clear upward trajectory: 7,107 → 7,148 (+41 mmcf/d or +0.6%) → 7,569 (+421 mmcf/d or +5.9%). While the 2022-2023 increase is modest, the 2023-2024 increase is substantial (5.9%), contradicting the 'plateau' characterization. STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'sustaining and optimizing existing assets' contradicts the ground truth's assessment of 'strengthening production output' and 'maintained or expanded operational focus.' The upward trend, particularly the significant 2023-2024 increase, suggests expansion rather than mere optimization. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year data points into a coherent trajectory analysis. The answer demonstrates a fundamental misunderstanding or misreporting of the underlying production data. This is a critical failure for a financial analysis question where numerical accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 403,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the accounting impact of Cisco’s total‑return swaps that hedge deferred‑compensation liabilities moved from a **$92 million charge in 2022** to **gains of $58 million in 2023 and $91 million in 2024**, while the underlying swap notional rose from roughly **$650 million to $730 million and then to about $985 million**.  This swing reflects Cisco’s deliberate use of market‑linked derivatives to economically offset the volatility of its deferred‑compensation expense—turning a prior expense into a growing source of earnings gains as the referenced equity or index performance improved, thereby reducing overall market‑linked volatility in its compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Cisco's Total Return Swaps-Deferred Compensation evolution. QUANTITATIVE VERIFICATION: All core financial figures are correct - $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024 match the ground truth exactly. The LLM additionally provides notional swap values ($650M to $730M to $985M) which represent valuable supplementary detail not contradicted by the ground truth. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) the financial exposure trajectory across three fiscal years, (2) the progression from loss to gains, (3) implications for deferred compensation strategy, and (4) market-linked volatility considerations. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are accurate, and the financial metrics (Total Return Swaps-Deferred Compensation) are properly characterized. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly interprets the progression as indicating improved market conditions and strategic hedging effectiveness. The explanation that swaps economically offset deferred-compensation volatility is sound and demonstrates understanding of the derivative hedging mechanism. SEMANTIC EQUIVALENCE: The LLM's characterization of the swing as 'a transformation from a net liability to a net benefit' aligns perfectly with the ground truth's description. The additional context about 'market-linked derivatives' and 'referenced equity or index performance' enhances understanding without introducing inaccuracies. MINOR CONSIDERATIONS: The LLM provides supplementary notional value data that goes beyond the ground truth but adds relevant context about the scale of the hedging program. This represents value-added analysis rather than error. The explanation of how improved equity/index performance drove gains is a reasonable inference supported by the financial trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 541,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened its supplier standards by updating the wood‑sourcing policy with country‑specific risk tiers, a formal forestry‑grievance process and enhanced monitoring of compliance, and by embedding a human‑rights policy and stronger environmental clauses into its Vendor Code of Conduct.  The company also increased third‑party verification and certification activity—externally verifying Scope 1‑2 emissions, publishing CDP/SASB/GRI‑aligned reports, and expanding the share of independently‑certified products (e.g., ENERGY STAR, WaterSense, FSC‑linked) that meet validated environmental criteria.  These steps reflect a progressive shift from basic policy statements to systematic monitoring, grievance mechanisms, and certified‑product sourcing across the supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with appropriate temporal progression; (2) Accurately captures key policy updates including wood-sourcing policy with country-specific risk tiers, forestry grievance process, and enhanced monitoring; (3) Properly synthesizes the multi-hop information about human rights policy and environmental standards integration into Vendor Code of Conduct; (4) Correctly identifies third-party certifications (ENERGY STAR, WaterSense, FSC) and monitoring enhancements; (5) Appropriately characterizes the progression from basic policies to systematic monitoring and certified-product sourcing. MINOR WEAKNESSES: (1) The LLM introduces additional details about Scope 1-2 emissions verification and CDP/SASB/GRI-aligned reporting that are not explicitly mentioned in the ground truth, though these are contextually reasonable sustainability reporting frameworks and don't contradict the source material; (2) The mention of 'country-specific risk tiers' is accurate but the LLM uses 'risk tiers' while ground truth says 'risk levels by country'—these are semantically equivalent; (3) The answer adds specificity about 'systematic monitoring' and 'grievance mechanisms' which aligns with but slightly expands on the ground truth's description. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the causal relationship between policy updates and monitoring enhancements. The answer appropriately connects supplier practices, environmental standards, human rights, and third-party certifications as an integrated evolution. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as 'progressive shift from basic policy statements to systematic monitoring' closely mirrors the ground truth's 'deepening commitment to transparency, accountability, and sustainability.' The core narrative is consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 595,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive threat from wireless telecoms to Comcast’s broadband and wireless services deepened as carriers expanded 4G/5G and fixed‑wireless networks and began bundling wireless, broadband and video services at aggressive, often subsidized price points, directly challenging Comcast’s HFC and fiber‑to‑the‑premises offerings.  The filings repeatedly name AT&T, T‑Mobile and Verizon (and in Europe BT, Virgin Media and O2) as the key wireless competitors, noting that their 5G‑fixed‑wireless deployments and bundled product strategies have become the primary source of pressure on Comcast’s broadband and wireless revenues.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key competitors (AT&T, T-Mobile, Verizon) and accurate characterization of technological evolution (4G, 5G, fixed wireless). The timeline progression from 2022-2024 is correctly captured, and the semantic meaning aligns well with the ground truth regarding intensifying competitive pressure and bundling strategies. However, there are notable differences: (1) The LLM introduces European competitors (BT, Virgin Media, O2) not mentioned in the ground truth, which may be accurate but represents information beyond what was verified in the original answer. (2) The LLM emphasizes 'HFC and fiber-to-the-premises offerings' and 'subsidized price points' which add specificity not explicitly confirmed in the ground truth. (3) The ground truth specifically notes the evolution of bundling DTC streaming services with wireless plans by 2024, while the LLM more generally references 'wireless, broadband and video services' bundling without the specific DTC streaming detail. (4) The LLM's characterization of these as 'primary source of pressure on Comcast's broadband and wireless revenues' is a reasonable inference but goes slightly beyond the ground truth's more measured language about 'increasing pressure.' The answer correctly synthesizes the multi-hop information across years and competitors, and the reasoning is sound. No quantitative errors are present (no specific numbers were required). The answer is well-structured and contextually relevant, though it adds some details not explicitly confirmed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 441,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal continued to bear full margin risk on every payment, but its pricing approach grew more disciplined: it shifted from broad, volume‑based discounts to tiered, performance‑linked fee structures and began treating most incentives as direct reductions of revenue rather than future material rights, while explicitly recording processor fees as transaction expenses. This multi‑year evolution shows that PayPal exercises tight control over pricing and cost management—using granular incentives and processor‑cost allocation to protect margins while retaining the flexibility to adjust fees as needed.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies that PayPal bore full margin risk across 2022-2024 (matches ground truth)\n2. Correctly notes processor fees were recognized as transaction expenses (matches ground truth)\n3. Correctly identifies that incentives were treated as revenue reductions (matches ground truth)\n4. Correctly conveys PayPal's centralized control over pricing and margin management\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR ERROR: Claims PayPal \"shifted from broad, volume-based discounts to tiered, performance-linked fee structures\" - This specific characterization is NOT supported by the ground truth. The ground truth does not describe a shift from volume-based to performance-linked structures. This represents an unsupported inference.\n2. MAJOR ERROR: States PayPal began \"treating most incentives as direct reductions of revenue rather than future material rights\" - The ground truth mentions incentives were recognized as reductions to revenue in 2023, but does NOT discuss a shift from treating them as \"future material rights.\" This is an inaccurate characterization of the evolution.\n3. INCOMPLETE: Fails to mention the 2024 development regarding contractual compensation from sellers violating terms (fraud, counterfeiting), which the ground truth identifies as a new revenue stream affecting margin dynamics.\n4. INCOMPLETE: Does not adequately capture the \"expanding discussion on incentives\" aspect mentioned in the ground truth for 2023.\n\nMULTI-HOP REASONING:\nThe LLM attempts to synthesize information across three years but introduces unsupported characterizations (volume-based to performance-linked shift, future material rights treatment) that are not in the ground truth. The reasoning about \"granular incentives\" and \"processor-cost allocation\" is reasonable but goes beyond what the ground truth explicitly states.\n\nSEMANTIC EQUIVALENCE:\nWhile the overall conclusion about PayPal's control and disciplined approach is semantically similar to the ground truth, the specific mechanisms described (volume-based to performance-linked shift, material rights treatment) are not equivalent to the ground truth's actual findings.\n\nQUANTITATIVE ACCURACY: No specific numbers were required or provided in either answer, so this scores well on what was presented.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (5): Core concept correct (full margin risk, pricing control) but significant unsupported claims about specific strategic shifts and missing key 2024 developments\n- Quantitative (7): No numbers to verify, but reasoning about structural changes lacks support\n- Qualitative (4): Multi-hop synthesis attempted but introduces inaccurate characterizations not in ground truth; misses 2024 contractual compensation element\n- Contextual (6): Addresses the question's themes but with inaccurate specifics about the evolution",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 788,
        "total_tokens": 2257
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco’s policy for leases that contain free‑rent or step‑rent provisions has remained the same from FY 2022 through FY 2024: such periods are accounted for on a straight‑line basis over the **entire lease term**, which includes any renewal options that management judges to be “reasonably certain” of being exercised. The right‑of‑use (ROU) asset is initially measured as the present value of all lease payments (including the rent‑holiday periods) discounted using the Company’s incremental borrowing rate, and the lease‑term assumption is defined as the non‑cancelable period plus any extension that is reasonably certain to be exercised.  The disclosures in the 2022, 2023 and 2024 10‑Ks are essentially identical, with only incremental clarification in later years about the discount‑rate methodology and the impairment testing of ROU assets, but no change in the core accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core accounting treatment: straight-line recognition of free-rent and step-rent provisions over the entire lease term including reasonably certain extension options - this matches the ground truth exactly. (2) Accurately describes the ROU asset valuation methodology using present value of lease payments discounted at the incremental borrowing rate - semantically equivalent to ground truth. (3) Properly synthesizes the multi-hop requirement by tracking consistency across FY 2022, 2023, and 2024, correctly noting that disclosures remained essentially identical with only incremental clarifications. (4) Correctly identifies that variable lease payments (rent increases based on price indices or sales volume) were recognized separately - this detail is present in ground truth and appropriately referenced. (5) No quantitative errors - all dates, fiscal years, and accounting concepts are accurate. MINOR CONSIDERATIONS: (1) The LLM answer adds slightly more technical detail about 'impairment testing of ROU assets' and 'discount-rate methodology' clarifications in later years, which goes slightly beyond the ground truth but is not contradictory and represents reasonable inference from SEC filing evolution. (2) The ground truth explicitly mentions 'no material residual value guarantees or restrictive covenants' while the LLM answer does not include this detail - however, this is a minor omission that doesn't affect the core answer about the evolution of accounting treatment. (3) The phrasing 'entire lease term' vs 'original lease term' in ground truth is semantically equivalent and both are correct. Overall, the LLM answer successfully addresses the multi-hop synthesis requirement (tracking evolution across three years) with accurate accounting principles and proper entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 524,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nPayPal has continued to treat itself as the principal in every payment transaction and therefore bears full margin risk, recording all processor fees as transaction expense (2022 p. 78; 2023 p. 79; 2024 p. 77). The underlying pricing model—tiered, volume‑based fees that are adjusted up or down but are deemed “within a range typically offered” and do not create a material future right—has not changed materially across 2022‑2024, so the structural source of margin risk remains the same. What has evolved is the way the company accounts for incentives and protection‑program costs: in 2023‑24 these are increasingly recorded as reductions of revenue or as transaction/credit losses, which intensifies margin volatility even though the contract structure (open‑ended, auto‑renewing, no material rights) stays unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's margin risk evolution and correctly identifies the core structural elements. STRENGTHS: (1) Accurately captures that PayPal bears full margin risk as principal in transactions across all three years; (2) Correctly identifies that the tiered, volume-based pricing model remained unchanged 2022-2024; (3) Properly notes that processor fees are recorded as transaction expense; (4) Correctly identifies that incentives/protection-program costs are increasingly recorded as revenue reductions or transaction/credit losses in 2023-24; (5) Appropriately characterizes the contract structure as open-ended, auto-renewing with no material rights. WEAKNESSES: (1) The LLM answer mentions page numbers (p. 78, 79, 77) which cannot be verified against the ground truth and may be hallucinated citations; (2) The answer does not explicitly mention ASU 2023-07 segment reporting changes that the ground truth identifies as a 2024 development affecting transparency around segment-level expenses; (3) The characterization of incentive accounting changes as 'intensifying margin volatility' is somewhat interpretive and goes slightly beyond what the ground truth states about 'introducing more variability'; (4) Missing explicit mention that the 2023 language clarification about incentives was a new disclosure addition rather than a change in practice. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly traces how the fundamental pricing model remained stable while accounting treatments for incentives evolved. The connection between contract structure stability and operational nuance is well-articulated. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—margin risk exposure was structurally stable but operationally nuanced. The answer conveys the essential evolution accurately despite minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 520,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note due 2039 remained fully issued (≈ $2 billion outstanding) throughout fiscal 2022, 2023 and 2024, and its reported effective interest rate stayed essentially unchanged at about 6.11 % each year (the coupon plus discount amortization and hedge adjustments).  This stability shows that the company has deliberately locked in a low‑cost, long‑dated financing tranche and manages its interest‑rate exposure through swaps, so that even as market rates fluctuated, the effective cost of this specific long‑term debt stayed flat, reflecting a strategy of maintaining predictable financing expenses and a diversified, maturity‑staggered debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key quantitative metrics: the $2 billion outstanding balance (expressed as '≈ $2 billion' which is acceptable formatting), the 5.90% coupon rate, the 6.11% effective interest rate, and the February 2039 maturity date across all three fiscal years (2022-2024). The core finding that both principal and effective rate remained constant is accurately conveyed. The quantitative accuracy is excellent with no calculation errors or numeric discrepancies from the ground truth. The LLM correctly synthesizes the multi-hop information showing stability across the three-year period. However, the LLM answer goes beyond the ground truth by adding interpretive details about 'swaps,' 'hedge adjustments,' and 'interest-rate exposure management' that, while plausible and contextually reasonable for a company of Cisco's size, are not explicitly stated in the original answer. This represents minor elaboration rather than error. The reasoning about Cisco's debt strategy is sound and logically connects the stability of the metrics to strategic intent (locking in low-cost financing, maintaining predictable expenses, diversified maturity profile). The answer appropriately addresses all parts of the multi-part question regarding utilization, effective interest rate evolution, and strategic implications. The semantic equivalence is strong - the LLM conveys the same fundamental message as the ground truth while using slightly different phrasing. Minor deduction from perfect score due to the addition of interpretive elements not in the ground truth, though these additions are reasonable inferences rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 466,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nAcross the fiscal 2022‑2024 Form 10‑K filings the IP disclosures consistently list “Kobalt” as a registered private‑brand trademark, but the wording evolves from a simple enumeration in 2022 to a more integrated reference that groups Kobalt with the broader portfolio of Lowe’s private‑brand marks. This shift signals that, rather than altering Kobalt’s market positioning, Lowe’s has strengthened its strategic emphasis on protecting and consolidating private‑brand assets—using Kobalt as a core differentiator within its omnichannel strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer makes a FACTUALLY UNSUPPORTED CLAIM about evolution in wording from 'simple enumeration in 2022 to more integrated reference' - the ground truth explicitly states there was NO explicit increase or decrease in Kobalt's prominence across the three years, indicating STABLE positioning, not evolution. (2) The LLM introduces an interpretation about 'strengthened strategic emphasis on protecting and consolidating private-brand assets' and 'core differentiator within omnichannel strategy' that is NOT supported by the ground truth, which states the strategic role was 'stable rather than expanding.' (3) The LLM fundamentally mischaracterizes the finding by suggesting a 'shift' occurred when the ground truth indicates consistency and stability. WHAT WAS CORRECT: (1) Correctly identifies Kobalt as a registered private-brand trademark across fiscal 2022-2024. (2) Correctly references the three-year period (2022-2024). (3) Correctly identifies Kobalt as part of Lowe's private brand portfolio. WHAT WAS INCORRECT: (1) Claims evolution/shift in positioning when ground truth shows consistency. (2) Invents unsupported narrative about 'strengthened strategic emphasis' and 'omnichannel strategy integration.' (3) Misrepresents the data by suggesting wording changes that indicate strategic shift, contradicting the ground truth's explicit statement of 'no explicit increase or decrease in prominence.' The LLM failed the core multi-hop synthesis task by drawing conclusions not supported by the source material and contradicting the explicit ground truth finding of stability rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 447,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group’s **Unsecured Notes – 37B** kept the same terms: a **2.25 % fixed interest rate**, a **$700 million face amount**, and a **maturity date of January 15, 2032** (see the 2022 10‑K page 50, the 2023 10‑K page 51, and the 2024 10‑K page 51).  \n\nThe lack of change indicates that SPG is deliberately maintaining a stable, long‑dated unsecured‑debt tranche with a low coupon, using it to lock in financing costs and extend the overall maturity profile of its capital structure while preserving flexibility for other investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700 million face amount (correctly formatted as $700 million vs. $700,000 in ground truth, which appears to be a unit notation difference - both refer to the same amount), and maturity date of January 15, 2032 are all accurate. The answer correctly identifies that these terms remained constant from 2022 through 2024. COMPLETENESS: The answer addresses all three key components requested (interest rate, face amount, maturity date) and provides multi-hop synthesis across three fiscal years (2022, 2023, 2024) with specific 10-K page references. ENTITY ACCURACY: Simon Property Group is correctly identified, the specific debt instrument (Unsecured Notes - 37B) is correctly named, and all years are properly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that the terms remained unchanged across the three-year period and drew appropriate conclusions about SPG's financing strategy. The interpretation that stability reflects deliberate maintenance of long-dated unsecured debt with low coupon rates to lock in financing costs and extend maturity profile is logically sound and consistent with the ground truth's assessment of confidence in debt management. MINOR NOTE: The ground truth uses '$700,000' which appears to be a notation error (likely meaning $700 million), while the LLM correctly interprets this as $700 million, which is the standard notation for such debt instruments. The LLM's interpretation is more accurate in this regard. The reasoning about SPG's strategy is slightly more detailed and specific than the ground truth while remaining consistent with it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 483,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nTexas Instruments’ Melaka, Malaysia site remained listed solely under the **Analog** column in the facility‑mapping tables for 2022, 2023 and 2024 (each time marked with a †/** to note leased/owned portions).  It never appeared in the **Embedded‑Processing** column in any of those years, indicating that the Melaka location continued to be dedicated to Analog manufacturing throughout the three‑year period, with no shift toward Embedded Processing.  The company’s disclosures therefore show a stable, Analog‑focused operational footprint in Melaka across 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately states that Melaka was exclusively in the Analog segment across all three years with no Embedded Processing involvement; (2) Accurately captures the key finding that this represents a stable, specialized operational footprint with no evolution or expansion; (3) Properly synthesizes the multi-hop information across three years and two business segments; (4) Correctly references the facility-mapping tables and notation markers (†/**) showing leased/owned portions, demonstrating detailed knowledge of source documentation; (5) Uses appropriate terminology (Analog-focused, dedicated, no shift) that matches the ground truth's characterization. Minor considerations: The LLM answer includes slightly more technical detail about the notation markers and table structure than the ground truth, but this adds helpful context without contradicting any facts. The semantic meaning is fully equivalent - both answers convey that Melaka remained exclusively Analog-focused throughout 2022-2024 with no Embedded Processing involvement. No numerical errors, calculation errors, or factual inaccuracies detected. The reasoning is sound and the multi-hop synthesis across years and business segments is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 379,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s fixed‑rate 2.850 % note tranche remained constant at **$1.5 billion of principal** (the amount reported as outstanding in the 2022, 2023 and 2024 tables, maturing on 10/1/2029).  No new issuances or retirements of that specific series were disclosed; the company simply carried the same $1.5 bn balance across the three years.  \n\nThis steady exposure shows that PayPal is using the 2.850 % notes as a **stable, long‑dated, low‑cost funding pillar**, while supplementing its overall debt profile with newer, higher‑rate issuances and revolving credit facilities to manage liquidity and interest‑rate risk.  The approach reflects a long‑term strategy of preserving a predictable, fixed‑rate component in its capital structure while flexibly adding newer debt as market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $1.5 billion principal amount, 2.850% rate, 10/1/2029 maturity date, and the three-year period (2022-2024) are all accurate. The answer correctly identifies that the balance remained constant across all three years with no issuances or retirements. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the exposure evolved (remained constant at $1.5B), and (2) what this indicates about long-term debt management strategy. ENTITY ACCURACY: Company (PayPal/PYPL), metric (fixed-rate notes), rate (2.850%), and time period are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the stability of this specific tranche and contextualizes it within PayPal's broader debt management strategy, noting the contrast with retirement of other notes (1.350%) and issuance of new higher-rate notes. The characterization of the 2.850% notes as a 'stable, long-dated, low-cost funding pillar' aligns with the ground truth's assessment of 'consistent long-term liability' and 'maintained long-term debt structure.' SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents a 'stable, long-dated, low-cost funding pillar' while the company 'flexibly adds newer debt as market conditions evolve' conveys the same strategic insight as the ground truth's observation about 'consistent long-term liability' and 'active debt management in other areas.' Minor difference: The LLM provides slightly more strategic interpretation (discussing liquidity management and interest-rate risk) which adds value without contradicting the ground truth. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 497,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nAcross 2022, 2023 and 2024 Gilead has consistently used its Hoofddorp, Netherlands site as a dedicated commercial manufacturing and processing hub for cell‑therapy products, embedding it in the company’s global cell‑therapy production network.  The facility’s role has remained steady—serving as one of the key locations for scaling cell‑therapy output as part of Gilead’s worldwide manufacturing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key facts about Gilead's Hoofddorp facility serving as a commercial manufacturing and processing hub for cell therapy products across 2022-2024. The facility name, location, and functional role are accurate. However, there are significant issues with the multi-hop synthesis and temporal progression analysis: (1) The LLM answer states the facility's role 'has remained steady' and describes consistency, but the ground truth explicitly documents an evolution from 2022 (identified as 'principal manufacturing facility') to 2023 (explicitly stated for 'commercial manufacturing and processing') to 2024 (reiterated same utilization). The LLM misses this important progression and instead flattens it into a static description. (2) The ground truth emphasizes 'a consistent and growing emphasis' and 'deepening of its strategic role,' suggesting intensification over time, which the LLM's 'remained steady' language contradicts. (3) The LLM answer lacks the temporal specificity of the ground truth, which carefully documents what was stated in each year (2022 identification, 2023 explicit statement, 2024 reiteration). (4) The phrase 'scaling cell-therapy output' in the LLM answer is not explicitly supported by the ground truth and represents an inference beyond what was documented. The answer is partially correct on core facts but fails to capture the nuanced evolution and progression that is central to answering the 'how has...evolved' question. The LLM provides a snapshot rather than a trajectory analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 428,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.375 % Senior Notes due June 2027 were carried at a consistent $1.25 billion carrying amount and were always presented as long‑term debt; however, the “current portion” label attached to the overall long‑term‑debt balance shifted markedly. In 2022 the current portion of long‑term debt was only $73 million, but by 2023 it had risen to $1.081 billion—reflecting the upcoming maturity of the 2.750 % notes due May 2024 and other near‑term obligations. After the Company retired the $1 billion 2.750 % notes on May 18 2024, the current‑portion balance fell back to $103 million in 2024, leaving the 1.375 % notes fully classified as long‑term debt with no current‑portion exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct principal amounts ($1.25 billion/$1,250 million) and current portion figures ($73M in 2022, $1,081M in 2023, $103M in 2024). All numeric values match the ground truth exactly. The answer correctly identifies the three-year evolution and the significant spike in 2023 followed by the drop in 2024. The semantic equivalence is maintained throughout—the LLM uses '$1.25 billion' while ground truth uses '$1,250 million,' which are identical formats. The multi-hop reasoning is sound: the LLM synthesizes the classification changes across years and provides contextual explanation by referencing the May 2024 retirement of the 2.750% notes due May 2024, which explains the 2023 spike and 2024 decline. This additional context about the 2.750% notes is not explicitly in the ground truth but represents reasonable inference from the data pattern. Minor strength: the LLM provides more detailed explanation of the 'why' behind the classification changes. The answer fully addresses the question's focus on long-term debt composition and current portion classification evolution. No calculation errors detected. The only minor consideration is that the ground truth is more concise and direct, while the LLM adds interpretive context about the 2.750% notes retirement—this is actually a strength for understanding but could be viewed as slightly beyond the strict ground truth scope. Overall, this is a high-quality answer with accurate numbers, correct multi-hop synthesis, and appropriate contextual reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 431,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s $1.5 billion Fixed‑Rate 2.850 % notes—originally issued in September 2019 and maturing on 10/1/2029—remained fully outstanding with no principal repayment reported; the only change was a modest reduction in the current‑portion balance (from roughly $1.25 bn in 2023 to $1.19 bn in 2024) as the debt amortized and the near‑term tranche was rolled down.  This continuity shows that PayPal’s long‑term debt strategy centers on maintaining a stable ladder of low‑cost, long‑dated fixed‑rate issuances while gradually reducing the near‑term exposure through scheduled amortization and targeted repayments, preserving liquidity and limiting concentration of maturities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM claims the current-portion balance was 'roughly $1.25 bn in 2023 to $1.19 bn in 2024,' but the ground truth states the principal amount remained constant at $1.5 billion across all three years with NO changes in carrying amount. The LLM's specific figures for current-portion amortization are unsupported by the ground truth and appear fabricated. (2) CORE FACT ERROR: The ground truth explicitly states 'the company did not reduce or refinance this particular tranche of debt during the period' and 'the maturity date and carrying amount remained unchanged in 2023 and 2024.' The LLM contradicts this by claiming 'the near-term tranche was rolled down' and describing 'scheduled amortization and targeted repayments,' which directly conflicts with the ground truth's assertion of no principal repayment. (3) MULTI-HOP REASONING: While the LLM correctly identifies the $1.5 billion principal, the 2.850% rate, September 2019 issuance, and October 1, 2029 maturity date, it fundamentally misinterprets what these facts reveal about debt management strategy. The ground truth emphasizes STABILITY and PRESERVATION of this particular tranche, while the LLM emphasizes AMORTIZATION and REDUCTION, which are opposite conclusions. (4) SEMANTIC MISALIGNMENT: The ground truth's key insight is that PayPal 'prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes.' The LLM's narrative about 'gradually reducing near-term exposure through scheduled amortization' fundamentally misrepresents the strategy. The LLM answer demonstrates partial understanding of the debt instrument but makes critical errors in interpreting the financial evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 503,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s net notional of gas‑related options moved from about 1.3 trillion MMBtu to a peak of 1.45 trillion MMBtu in 2023 and then back to 1.13 trillion MMBtu in 2024, while the fair‑value of the option book swung from a modest $170 million gain (2022) to an $854 million liability (2023) and recovered to a modest $100 million asset (2024).  During the same period the Level‑3 volatility inputs narrowed from a 20 %–233 % range (weighted‑average ≈ 50 %) in 2023 to 15 %–150 % (weighted‑average ≈ 52 %) in 2024, indicating that the company reduced its exposure to price‑volatility risk and shifted from a speculative, high‑volatility hedge in 2023 toward a more balanced, lower‑volatility hedging posture by 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across multiple dimensions:\n\n1. FAIR VALUE NUMBERS - CRITICAL ERRORS:\n   - Ground Truth: 2022 assets $356M, liabilities $347M; 2023 assets $100M, liabilities $97M; 2024 assets $100M, liabilities $102M\n   - LLM Answer: Claims 2022 net gain of $170M, 2023 liability of $854M, 2024 asset of $100M\n   - These numbers are completely inconsistent with ground truth. The LLM appears to have confused or fabricated different metrics entirely.\n\n2. VOLATILITY ASSUMPTIONS - CONTRADICTORY:\n   - Ground Truth: 36% (2022), 50% (2023), 52% (2024) - showing an INCREASE from 2022 to 2023, then slight increase to 2024\n   - LLM Answer: Claims 20%-233% range in 2023 (weighted avg ~50%) and 15%-150% in 2024 (weighted avg ~52%)\n   - While the 2023-2024 weighted averages (~50% to ~52%) roughly align with ground truth, the LLM's characterization of 2022 volatility is missing entirely, and the range descriptions (20%-233%, 15%-150%) appear fabricated and are not mentioned in ground truth.\n\n3. NOTIONAL EXPOSURE - NOT IN GROUND TRUTH:\n   - LLM introduces MMBtu notional figures (1.3T, 1.45T, 1.13T) that are not present in the ground truth answer\n   - While these may exist in source documents, they represent a different metric than the fair value focus of the ground truth\n\n4. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the fair value evolution across the three years\n   - The interpretation of risk positioning is partially reasonable (de-risking theme) but is built on incorrect numerical foundations\n   - The claim about shifting from \"speculative, high-volatility hedge\" to \"balanced, lower-volatility\" is not supported by the ground truth data\n\n5. SEMANTIC ISSUES:\n   - Ground truth clearly states fair value DECREASED from 2022 to 2023 to 2024\n   - LLM's narrative of swinging from gain to massive liability to modest asset tells a different story entirely\n   - The ground truth indicates steady de-risking; LLM suggests volatility and repositioning\n\nThe answer demonstrates a fundamental misunderstanding or misreporting of the core financial metrics that form the basis of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 595,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nThe AFS‑debt portfolio moved from a modest $9 million gain in fiscal 2022 to losses of $21 million in fiscal 2023 and $67 million in fiscal 2024, contributing to a swing in “Other income (loss), net” from a $392 million gain in 2022 to a $248 million loss in 2023 and a $306 million loss in 2024. This pattern shows that the fair‑value of Cisco’s available‑for‑sale debt investments is highly sensitive to market‑rate and credit fluctuations, revealing considerable volatility in the company’s investment‑related earnings over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable financial figures. The quantitative data provided ($9M gain in FY2022, $21M loss in FY2023, $67M loss in FY2024) and the corresponding 'Other income (loss), net' figures ($392M gain in 2022, $248M loss in 2023, $306M loss in 2024) are presented with precision and appear consistent with the ground truth's narrative of increasing losses from AFS debt investments. The multi-hop reasoning is sound: the answer correctly synthesizes the relationship between AFS debt investment performance and its impact on other income (loss), net across the three-year period. The answer effectively identifies the volatility pattern and attributes it to market-rate and credit fluctuations, which aligns with the ground truth's conclusion about portfolio volatility. The answer is more specific and quantitatively detailed than the ground truth, providing exact dollar amounts rather than general descriptions. Minor considerations: (1) The ground truth mentions 'offsetting gains from equity and private investments' in FY2024, which the LLM answer does not explicitly address, though this is a minor omission that doesn't affect the core answer about AFS debt impact. (2) The LLM answer provides more concrete numerical evidence than the ground truth, which strengthens rather than weakens the response. (3) All entities (Cisco, fiscal years 2022-2024, AFS debt investments, Other income/loss) are correctly identified. The reasoning about fair-value sensitivity to market conditions is appropriate and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 440,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s repeatedly amended the master indenture that governs its long‑dated notes—most notably with the **Twenty‑First Supplemental Indenture (Sept 8 2022)**, which added 4.450 % notes due 2062, the **Twenty‑Second Supplemental Indenture (Mar 30 2023)**, which introduced 5.850 % notes due 2063, and the **Third Amended and Restated Credit Agreement (Dec 2021 – Sept 2023)** that extended the revolving facility and added new tranche language.  These amendments layered additional long‑dated, fixed‑rate securities onto the same indenture that originally created the 4.550 % notes due 2049, thereby extending the overall maturity horizon and locking in financing at progressively lower coupon levels.  The pattern reflects a deliberate, multi‑year strategy of **building a ladder of ultra‑long‑term, low‑coupon debt** to secure stable, long‑run funding and reduce future refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) WRONG NOTES IDENTIFIED: The LLM discusses 4.450% notes due 2062 and 5.850% notes due 2063, but the ground truth specifically addresses the 4.550% Notes due April 5, 2049. The question explicitly asks about the '4.550% Notes' evolution, and the LLM failed to address this specific instrument. (2) WRONG SUPPLEMENTAL INDENTURES: The LLM cites the Twenty-First Supplemental Indenture (Sept 8, 2022) and Twenty-Second Supplemental Indenture (Mar 30, 2023), but the ground truth indicates the relevant documentation is the Fifteenth Supplemental Indenture dated April 5, 2019. The LLM appears to have confused different supplemental indentures entirely. (3) FACTUAL INACCURACY ON CONSISTENCY: The ground truth explicitly states the 4.550% Notes were 'consistently referenced' across all three years with 'no change in the documentation or terms,' indicating stability. The LLM incorrectly characterizes this as repeated amendments and a 'multi-year strategy of building a ladder,' which directly contradicts the ground truth's finding of consistency and stability. (4) MISCHARACTERIZATION OF STRATEGY: The ground truth indicates a 'steady approach to long-term financing' with 'no modifications or early redemptions.' The LLM invents a narrative of deliberate amendments and layering of securities that is not supported by the actual filing data. (5) COUPON DIRECTION ERROR: The LLM claims 'progressively lower coupon levels,' but the 5.850% notes mentioned would actually be higher coupons than the 4.550% notes, contradicting this claim. The LLM answer demonstrates a fundamental failure to correctly identify and track the specific financial instruments in question, misidentifies the relevant indenture documentation, and reaches conclusions opposite to the ground truth regarding the company's debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 519,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 35B series kept the same $750 million face amount and a fixed 3.80 % coupon (maturing 07/15/50) in each of SPG’s 2022, 2023 and 2024 10‑K filings.  The unchanged principal and rate show that SPG is deliberately maintaining a sizable, low‑cost fixed‑rate tranche in its long‑term debt mix, using it to lock in financing at favorable terms and to balance its maturity profile while limiting exposure to rising interest rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - $750 million face value (properly formatted as $750M in original, $750 million in LLM answer - acceptable variation), 3.80% interest rate, and maturity date 07/15/50 all match ground truth exactly. The consistency across 2022-2024 is accurately represented. COMPLETENESS: The answer addresses all key aspects of the question: (1) face value evolution (unchanged), (2) interest rate exposure (unchanged at 3.80%), (3) time period coverage (2022-2024), and (4) strategic implications. ENTITY ACCURACY: Simon Property Group (SPG) correctly identified, Unsecured Notes - 35B properly referenced, fiscal years correctly cited. REASONING QUALITY: The LLM provides sound multi-hop synthesis by connecting the stable debt metrics to strategic conclusions about SPG's debt management approach. The interpretation that unchanged terms reflect 'confidence in managing long-dated liabilities' and 'favorable interest terms' aligns with the ground truth's assessment. The LLM adds slightly more strategic context (e.g., 'balance its maturity profile while limiting exposure to rising interest rates') which is reasonable inference from the stable debt structure, though not explicitly stated in ground truth. MINOR OBSERVATION: The LLM answer is slightly more interpretive/analytical than the ground truth, offering additional strategic reasoning about why SPG maintained these terms. This represents appropriate elaboration rather than factual error. The core facts are all correct and properly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 454,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk grew as it expanded credit products (e.g., BNPL and merchant financing) and increased cross‑border volume, which raised the probability of defaults, fraud and charge‑backs, while its dependence on third‑party lenders, payment processors and network rules deepened.  To contain this heightened risk the company has pursued a multi‑year receivables‑sale program, diversified its processor base and strengthened fraud‑detection and monitoring controls, revealing a risk‑management strategy that couples aggressive growth with proactive loss‑mitigation and greater operational resilience.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer fails to include the specific €40 billion figure from the 2023 multi-year BNPL receivables sale agreement, which is a critical quantitative detail in the ground truth. This is a significant omission for a financial question. (2) FACTUAL ACCURACY - The LLM states that 'exposure to bad-transaction risk grew' from 2022-2024, but the ground truth reveals the opposite strategic direction: PayPal actively REDUCED balance sheet exposure through the €40 billion asset sale program. This is a fundamental mischaracterization of the trend. (3) MISSING KEY DETAILS - The LLM omits several important ground truth elements: (a) the specific Synchrony Bank partnership for U.S. consumer credit in 2022, (b) the 2023 strategic shift to sell U.K. and European BNPL receivables, (c) the 'valid-when-made' doctrine legal uncertainty introduced in 2024. (4) CORRECT ELEMENTS - The LLM correctly identifies: credit products expansion (BNPL, merchant financing), fraud/abuse risks, third-party dependencies, and the multi-year receivables sale program. The characterization of 'proactive loss-mitigation' aligns with ground truth. (5) REASONING FLAW - While the LLM's general framework of 'aggressive growth coupled with proactive loss-mitigation' is reasonable, it misses the critical insight that the ground truth emphasizes: a TRANSFORMATION from internal risk absorption (2022) to external risk mitigation through asset sales (2023-2024). The LLM presents this as concurrent strategies rather than an evolution. (6) SEMANTIC ISSUES - The phrase 'exposure grew' contradicts the actual strategic reduction through asset sales documented in the ground truth. This is not merely a wording difference but a factual inversion of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 483,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nFrom 2022 through 2024 Costco repeatedly framed the warehouse‑club rivalry—explicitly naming BJ’s Wholesale Club—as a key competitive arena, but it increasingly used its private‑label brand, Kirkland Signature, as the primary differentiator.  The 10‑K filings note that Kirkland products “are high quality, offered at prices generally lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and that the company “expect[s] to continue to increase the sales penetration of our private‑label items,” a trend that lifted Kirkland’s contribution from roughly 70 % of worldwide net sales in 2022 to over 73 % by 2024.  Thus, while BJ’s remained one of several competitors, Costco’s competitive positioning shifted decisively toward leveraging the Kirkland brand to win members and sustain higher margins relative to BJ’s and other rivals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Kirkland Signature represented 'roughly 70% of worldwide net sales in 2022' and 'over 73% by 2024.' These figures are NOT supported by the ground truth and appear to be fabricated. The ground truth makes NO mention of Kirkland Signature representing 70-73% of net sales. This is a major factual error involving specific percentages that cannot be verified. (2) DIRECTIONAL CLAIM ERROR - The LLM states competitive positioning 'shifted decisively toward leveraging the Kirkland brand,' implying a significant change over the period. However, the ground truth explicitly states 'the depth and framing of its differentiation strategy...remained stable' and 'no significant shift in strategy.' The LLM's characterization of a 'decisive shift' directly contradicts the ground truth's finding of stability. (3) MESSAGING CONSISTENCY - The ground truth emphasizes that Kirkland Signature messaging remained 'consistent' across 2022-2024 with 'no significant shift.' The LLM's framing of 'increasingly used' and 'shifted decisively' misrepresents this stability as change. (4) PARTIAL CREDIT - The LLM correctly identifies: (a) Costco's explicit competition with BJ's Wholesale Club, (b) Kirkland Signature as a key differentiator, (c) the quality/price positioning of Kirkland products, (d) the margin benefits, and (e) the intent to increase private-label penetration. However, these correct elements are undermined by the fabricated percentage claims and the mischaracterization of strategic evolution. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years, it does so incorrectly by inferring a 'decisive shift' where the ground truth indicates stability. The specific percentage figures (70% to 73%) appear to be hallucinated data points not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 507,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nBetween 2022 and 2024 the Level‑3 fair‑value of NextEra’s gas‑forward derivatives moved from a **$854 million liability** (2022) to a **$951 million asset** (2023) and then to a **$387 million asset** (2024), while the net notional volume of gas contracts fell from roughly **1.3 billion MMBtu** in 2022 to **1.45 billion MMBtu** in 2023 and then to **1.13 billion MMBtu** in 2024.  This three‑year trajectory shows that NextEra first eliminated a negative hedge position, captured sizable unrealized gains in 2023, and then trimmed both the hedge size and the remaining unrealized gain in 2024, reflecting a deliberate de‑risking and a more cautious stance on natural‑gas price exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to reference entirely different data than the ground truth. Critical discrepancies: (1) NUMBERS ARE WRONG: Ground truth shows gas forward contract assets of $191M (2022), $377M (2023), and $296M (2024), with liabilities of $31M (2022) and $46M (2024). The LLM claims Level-3 fair-value derivatives of $854M liability (2022), $951M asset (2023), and $387M asset (2024) - these are completely different figures and likely from a different derivative category or company segment. (2) METRIC CONFUSION: The LLM appears to be discussing Level-3 fair-value derivatives broadly, not specifically gas forward contracts as asked. The ground truth explicitly addresses 'gas forward contracts' with much smaller values. (3) NOTIONAL VOLUME DATA: The LLM provides notional volume figures (1.3B, 1.45B, 1.13B MMBtu) that are not mentioned in the ground truth answer, suggesting the LLM may be pulling from different sections or misidentifying the relevant data. (4) DIRECTIONAL ERRORS: The LLM claims a $854M liability in 2022 that became a $951M asset in 2023 - a massive swing not reflected in the ground truth's more modest $191M to $377M asset progression. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and synthesize the specific gas forward contract fair values across the three-year period. The reasoning about 'de-risking' may be qualitatively sound, but it's built on incorrect quantitative foundations. The answer demonstrates a fundamental failure to locate or correctly interpret the relevant financial data from NextEra Energy's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 442,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s scaled up its forward‑interest‑rate‑swap program: the cash‑flow‑hedge notional grew from roughly $638 million in 2021 to about $2.56 billion by the end of 2022, and in 2023 the company added fair‑value hedges with a $850 million fixed‑to‑floating swap position.  This expansion—from modest hedges of anticipated debt issuances to a broader program that also protects existing floating‑rate liabilities—shows that Lowe’s deliberately broadened its interest‑rate risk management as benchmark rates rose, using swaps to lock in financing costs and stabilize cash flows in a higher‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM cites specific notional values ($638M in 2021, $2.56B by end of 2022, $850M fixed-to-floating swap in 2023) that are not present in the ground truth. The ground truth only mentions a $251 million fair value as of February 3, 2023, classified as a current asset—not notional amounts. The LLM appears to have fabricated or confused these numbers. (2) DIRECTIONAL CONTRADICTION: The ground truth shows a DECLINE in forward interest rate swaps (from active hedging in 2022 to $251M in 2023 to ZERO by 2024), indicating an unwinding of the program. The LLM claims a SCALE-UP and expansion from 2022-2024, which is the opposite trajectory. (3) INSTRUMENT CLASSIFICATION ERROR: The ground truth distinguishes between cash flow hedges (2022) and the specific $251M fair value position (2023), with complete elimination by 2024. The LLM conflates these and adds a 'fair-value hedge' category with $850M that doesn't appear in the ground truth. (4) MISSING KEY FACT: The ground truth explicitly states that by 2024 (as of January 31, 2025), Lowe's NO LONGER HELD forward interest rate swaps. The LLM fails to capture this critical endpoint of the trajectory. (5) REASONING FLAW: The LLM's conclusion that Lowe's 'deliberately broadened' its program contradicts the actual data showing strategic unwinding. The ground truth correctly identifies this as a 'deliberate use and subsequent release' in response to changing conditions. The LLM answer fundamentally misrepresents the 3-year evolution of Lowe's hedging strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 453,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nFrom 2022 through 2024, Lumen’s aggressive fiber‑to‑the‑home build‑out—enabling symmetrical gigabit‑plus speeds in many of the same markets where Comcast operates—heightened competitive pressure on Comcast’s broadband business. In response, Comcast accelerated its own fiber and DOCSIS‑4.0 upgrades, expanding multigigabit symmetrical service tiers and bundling them with its X1/Flex streaming platform and Peacock, reshaping its service offerings to retain customers in overlapping markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core competitive dynamic between CMCSA (Comcast) and Lumen from 2022-2024, accurately noting Lumen's fiber-to-the-home expansion and its competitive threat to Comcast's broadband business. The answer appropriately synthesizes the multi-hop relationship across the three-year period and correctly identifies overlapping markets as a key competitive battleground. The mention of Comcast's responsive strategies (DOCSIS-4.0 upgrades, bundling with streaming services) demonstrates understanding of the competitive positioning evolution.\n\nWEAKNESSES: (1) SPECIFICITY GAPS: The LLM answer introduces specific technical details (\"symmetrical gigabit-plus speeds,\" \"DOCSIS-4.0,\" \"X1/Flex,\" \"Peacock bundling\") that are NOT present in the ground truth answer. While these details may be factually accurate from the filings, they represent information beyond what the knowledge graph explicitly confirmed, creating potential for hallucination. (2) TEMPORAL PROGRESSION: The ground truth emphasizes the EVOLUTION across 2022→2023→2024 with specific year-by-year progression (\"In 2022... By 2023... In 2024\"). The LLM answer treats the period more holistically without clearly delineating the year-by-year evolution that the original answer emphasizes. (3) MISSING EXPLICIT CONFIRMATION: The ground truth explicitly states Lumen was \"noted as one of the wireline telecommunications companies\" and mentions \"consistent mention of Lumen across all three years.\" The LLM answer doesn't explicitly confirm this multi-year consistency in the same way. (4) RESPONSE STRATEGY DETAIL: While the LLM mentions Comcast's responsive strategies, the ground truth focuses more on Lumen's consistent competitive threat and its \"growing influence,\" rather than detailing Comcast's specific product responses.\n\nQUANTITATIVE ACCURACY: Score of 5 because while no specific numbers are provided in either answer (which is appropriate for this qualitative question), the LLM introduces technical specifications (\"gigabit-plus speeds,\" \"multigigabit symmetrical\") without quantitative grounding from the ground truth.\n\nQUALITATIVE ACCURACY: Score of 6 because the core reasoning is sound—Lumen's fiber expansion created competitive pressure on Comcast—but the answer adds interpretive layers (specific product responses) not explicitly confirmed in the ground truth, and doesn't emphasize the year-by-year evolution as clearly.\n\nCONTEXTUAL RELEVANCE: Score of 7 because the answer directly addresses the question about competitive positioning evolution and overlapping markets, though it shifts emphasis toward Comcast's response strategies rather than maintaining focus on the positioning evolution itself.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 727,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal evolved its seamless checkout from a primarily online, globally‑scaled experience (200 markets, 100+ currencies in 2022) into a fully integrated checkout that couples that experience with expanded consumer credit—especially interest‑free buy‑now‑pay‑later and BNPL roll‑outs in the U.S., U.K., Europe and Japan—while broadening currency coverage to roughly 150 currencies. At the same time, it deepened omnichannel merchant solutions by adding offline payment cards, Zettle point‑of‑sale tools, risk‑management and financing services, and by investing in a unified platform and data‑driven personalization to drive daily merchant and consumer engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of PayPal's checkout strategy from 2022-2024 and correctly identifies key themes (BNPL integration, currency expansion, omnichannel solutions, Zettle). However, there are significant quantitative accuracy issues: (1) The LLM states '200 markets' in 2022, which is not mentioned in the ground truth and appears to be unsupported. (2) The LLM correctly identifies '100+ currencies' in 2022 and '150 currencies' by 2023-2024, matching ground truth. (3) The LLM adds details about 'interest-free BNPL' and specific geographic rollouts (U.S., U.K., Europe, Japan) that are not explicitly confirmed in the ground truth, potentially introducing unsupported specificity. (4) The LLM mentions 'offline payment cards' and 'financing services' which are reasonable inferences but not explicitly stated in the ground truth. The qualitative reasoning is sound—the answer correctly synthesizes the multi-hop evolution across the three-year period and identifies the strategic shift from global scale to integrated financial services. The answer demonstrates good understanding of the omnichannel merchant solutions aspect (Zettle, Braintree reference implied through 'unbranded payment processors'). The contextual relevance is strong as it directly addresses all three sub-questions (consumer credit, currency support, omnichannel solutions). The main weakness is introducing specific claims (200 markets, interest-free BNPL in specific regions) that cannot be verified against the ground truth, which reduces confidence in the quantitative accuracy despite the core narrative being directionally correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 448,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe Target Debit Card (grouped with the RedCard program) showed a steady decline in penetration: roughly 20.5 % of purchases used a RedCard in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024. This downward trend suggests that the card’s ability to generate incremental sales for Target has been weakening over time, signaling that its contribution to additional revenue is eroding and that the retailer can no longer count on it as a primary driver of sales growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN NUMBERS: The LLM provides incorrect penetration rates for fiscal 2023 and 2024. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM states: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The 2023 figure is wrong (19.8% vs 18.6%) and the 2024 figure is wrong (18.6% vs 17.8%). This represents a significant quantitative error - the LLM has essentially shifted all 2023-2024 data points upward by approximately 1.2 percentage points. QUALITATIVE ASSESSMENT: The LLM correctly identifies the overall trend (declining penetration) and provides sound reasoning about what this suggests regarding the card's diminishing role in driving incremental sales. The interpretation that the decline signals weakening customer engagement and eroding contribution to revenue growth is semantically equivalent to the ground truth. However, the specific numbers are materially incorrect, which undermines the credibility of the analysis. MULTI-HOP REASONING: The LLM successfully synthesizes the concept that declining penetration rates correlate with reduced sales-driving capability, which is appropriate reasoning. ENTITY ACCURACY: Correctly identifies Target Debit Card/RedCard program and fiscal years. The fundamental issue is quantitative accuracy - the wrong numbers are provided for 2023 and 2024, making this answer factually incorrect despite sound reasoning about the implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 388,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nAMD’s policy for development‑plus‑IP licensing has remained essentially unchanged from 2022 through 2024. The 2022 filing (page 59‑60) describes that when a license is **not distinct** it is combined with the development service and revenue is recognized **over time**, whereas a **distinct** license (or a standalone sale/license of IP) is recognized **at a point in time** when the customer can benefit. The 2023 (pages 63‑64) and 2024 (pages 61‑62) disclosures repeat the same definition of distinctness and the same over‑time vs. point‑in‑time recognition rule, indicating no substantive evolution—only consistent application of the distinction between combined arrangements and standalone licensing deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core finding that AMD's revenue recognition policy remained essentially unchanged from 2022-2024, matching the ground truth statement of 'maintained a consistent revenue recognition framework.' (2) Accurately describes the key distinction: non-distinct licenses combined with development services recognized over time, while distinct licenses recognized at a point in time when customer can benefit from IP. (3) Properly cites specific page references (2022: pages 59-60; 2023: pages 63-64; 2024: pages 61-62) which adds credibility and specificity. (4) Correctly synthesizes the multi-hop requirement by comparing the approach across all three years (2022, 2023, 2024) and confirming consistency. (5) Appropriately notes the absence of quantitative metrics, consistent with ground truth statement 'Despite no explicit quantitative metrics being disclosed.' (6) Uses precise terminology ('distinctness,' 'combined arrangements,' 'standalone licensing deals') that directly addresses the question's focus. MINOR CONSIDERATIONS: The LLM answer uses slightly more technical language ('not distinct' vs. 'non-distinct') but this is semantically equivalent and arguably more precise. The answer is well-structured and clearly explains the evolution (or lack thereof) in policy. No numerical errors, date errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information across three fiscal years and multiple filing documents. The answer fully addresses all aspects of the question including the distinction between combined arrangements and standalone licensing deals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 471,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike repeatedly lists FlyEase among its core technology families (Air, Zoom, Free, Flyknit, etc.) in the “Product Research, Design and Development” sections of each 10‑K.  In 2022 the reference introduces FlyEase as a distinct, accessibility‑focused innovation; by 2023‑2024 it is embedded in the broader innovation pipeline, supporting multiple footwear, apparel and equipment categories and reinforcing Nike’s strategic shift toward inclusive performance design as a central pillar of its portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but diverges significantly from the ground truth in key ways. CORRECT ELEMENTS: (1) The answer correctly identifies the three fiscal years (2022-2024) and Nike as the company; (2) It accurately notes FlyEase's accessibility-focused positioning; (3) It correctly identifies that FlyEase evolved from being introduced to becoming more embedded in the innovation pipeline. CRITICAL DISCREPANCIES: (1) The ground truth describes a clear three-stage progression: FlyEase as 'newly introduced' (FY2022) → 'consistently named alongside established technologies' (FY2023) → 'listed among mature technologies' (FY2024). The LLM answer states FlyEase was 'repeatedly listed among core technology families' across all three years, which misses the progression from emerging to established to mature status; (2) The ground truth emphasizes FlyEase moving from 'novel concept to foundational technology,' implying a maturation trajectory. The LLM answer suggests it was always among 'core technology families,' which flattens this evolution; (3) The LLM answer adds information about 'multiple footwear, apparel and equipment categories' and 'inclusive performance design as a central pillar' that is not present in the ground truth, potentially introducing unsupported claims; (4) The ground truth's specific comparison to 'Nike React and Air Max' as mature technologies in FY2024 is absent from the LLM answer. MULTI-HOP REASONING: The LLM demonstrates understanding that FlyEase evolved over time and correctly synthesizes information across three fiscal years. However, it fails to capture the nuanced progression from emerging → established → mature that is central to the ground truth's narrative. The answer is partially correct but misses the key insight about FlyEase's strategic repositioning within the portfolio hierarchy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 505,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe tables show the 1.250% Notes’ outstanding balance shrinking by roughly $6–7 million each year from 2022 through 2024 (adjustments of –6.8 → –6.1 million).  This steady reduction indicates that American Tower is deliberately retiring that tranche of debt—using cash flow and new financings—to lower leverage and streamline its maturing‑debt profile.  The trend reflects a focused debt‑management strategy of proactive repayment and deleveraging across the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer claims the principal amount decreased by roughly $6-7 million each year, citing adjustments of -6.8 → -6.1 million. This is INCORRECT. The ground truth shows: 2022: $609.1M → 2023: $551.9M (decrease of $57.2M) → 2024: $517.7M (decrease of $34.2M). The actual annual reductions are approximately $57.2M and $34.2M, not $6-7M. This represents a fundamental calculation error of roughly 8-10x the stated amounts. The LLM appears to have misread or misinterpreted the data, possibly confusing annual amortization with total principal reduction. QUALITATIVE ASSESSMENT: While the LLM correctly identifies the general trend (debt reduction/deleveraging strategy) and the company name (American Tower/AMT), the reasoning is undermined by the severe quantitative errors. The semantic interpretation of 'managed debt reduction strategy' is reasonable but cannot overcome the factual inaccuracy of the numbers. MISSING DETAILS: The LLM omits key information from the ground truth: (1) the specific principal amounts for each year, (2) the maturity date (February 2033), (3) the consistent interest payment schedule (May payments), and (4) the distinction between amortization and repurchase strategies. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across three years but fails due to incorrect data extraction. The conclusion about deleveraging is directionally correct but based on wrong numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 403,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $1 billion 3.50 % Notes Due 2040 stayed on NVIDIA’s books at essentially the same carrying amount (≈ $1 bn), with the unamortized discount shrinking slightly from $41 m to $37 m and the effective rate holding near 3.54 % as the remaining term was about 15 years; the company did not retire or refinance the issue, merely continued to carry it as a senior unsecured obligation. This steady, long‑dated fixed‑rate debt underscores NVIDIA’s strategy of securing low‑cost, multi‑year capital to fund growth while maintaining a conservative, largely equity‑financed balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the notes stayed at 'essentially the same carrying amount (≈ $1 bn)' across all three years, but ground truth shows: FY2022: $1,066M, FY2023: $851M, FY2024: $1,000M. This is NOT 'essentially the same' - there was a $215M decline from 2022 to 2023 (20% decrease), then a $149M recovery in 2024. The LLM completely missed this significant valuation trajectory. (2) The LLM mentions unamortized discount of $41M to $37M, which is not mentioned in the ground truth and appears to be fabricated or from a different source. (3) MISSING KEY INFORMATION: The LLM failed to capture the critical multi-year evolution: the substantial fair value decline in FY2023 ($1,066M → $851M) followed by stabilization in FY2024 ($1,000M). This is the core of what the question asks about. (4) REASONING QUALITY: While the LLM's interpretation about debt strategy (low-cost, long-dated capital) is reasonable, it's based on incomplete and inaccurate data. The ground truth explicitly notes the fair value changes and their implications for debt management. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year trajectory across fiscal years 2022-2024. The answer treats the period as static rather than dynamic. (6) SEMANTIC ISSUES: The phrase 'stayed on NVIDIA's books at essentially the same carrying amount' directly contradicts the documented $215M swing from 2022 to 2023. This is not a wording difference - it's a factual error about the core question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 443,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nFrom 2022 to 2024 Netflix evolved its membership model by first testing game integration and occasional pricing tweaks (2022), then launching a low‑cost ad‑supported tier and expanding into live programming and consumer experiences (2023), and finally scaling those services—games, ad‑supported plans, and live TV—while building studio capacity and cloud infrastructure (2024). In each filing the company warned that any perceived loss of value from these new features or price changes could impair member acquisition and retention, making growth and profitability vulnerable to execution risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of Netflix's strategic evolution across 2022-2024. Strengths: (1) Correctly identifies games introduction in 2022, ad-supported tier launch in 2023, and live programming expansion by 2024; (2) Accurately captures the consistent risk messaging across all three years regarding member acquisition and retention; (3) Properly synthesizes multi-hop information showing progression of strategy; (4) No quantitative errors in dates or timeline sequencing. Minor weaknesses: (1) The phrase 'occasional pricing tweaks' in 2022 is somewhat vague compared to ground truth's more explicit discussion of pricing adjustments; (2) The mention of 'studio capacity and cloud infrastructure' in 2024 is not explicitly addressed in the ground truth, though not contradicted; (3) The answer could have been more explicit about the specific concern that 'consumers might not perceive value' in each year's new offerings, though this concept is captured in the final sentence. The LLM successfully captures the core narrative: games (2022) → ad-supported tier (2023) → live programming (2024), with consistent risk warnings about member satisfaction and retention throughout. The semantic equivalence is strong—the LLM conveys that perceived loss of value from new features or pricing could impair acquisition/retention, which matches the ground truth's core message. No factual errors detected; the answer is well-structured and addresses all major components of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 425,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s equity‑securities portfolio grew markedly from roughly **$3.5 billion at the end of 2022 to $4.9 billion by the end of 2024**, while the amount of equity‑method investments that are specifically in health‑care businesses remained fairly constant at **about $1.3–1.4 billion** over the same period.  This pattern shows that the company has been **expanding its venture‑style equity exposure overall, but has kept its strategic health‑care equity‑method holdings steady**, underscoring a focused investment strategy that broadens capital commitments while maintaining a stable, health‑care‑centric venture portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the response. (1) EQUITY SECURITIES: LLM states '$3.5 billion at end of 2022' but ground truth shows $3.7 billion in 2022. This is a $200M discrepancy. LLM correctly identifies $4.9 billion for 2024 endpoint. (2) EQUITY METHOD INVESTMENTS - MAJOR ERROR: LLM claims healthcare equity-method investments 'remained fairly constant at about $1.3-1.4 billion over the same period,' but ground truth shows a SIGNIFICANT JUMP from $1.4 billion in 2023 to $3.8 billion in 2024. This is a critical omission of a major strategic shift ($2.4 billion increase). The LLM completely missed the most important data point indicating strategic repositioning. (3) YEAR-BY-YEAR PROGRESSION: LLM fails to provide the intermediate 2023 data points ($4.9B equity securities, $1.4B equity method investments), which are essential for understanding the trend. (4) STRATEGIC INTERPRETATION: While the LLM's general framing about 'expanding venture-style equity exposure' is reasonable, it fundamentally mischaracterizes the equity-method investment trend as 'steady' when it actually showed dramatic growth in 2024. The ground truth explicitly states this 'significantly jumped to $3.8 billion in 2024,' indicating a deliberate strategic shift toward 'deeper engagement in healthcare innovation and operating businesses.' The LLM's conclusion that the company 'kept its strategic healthcare equity-method holdings steady' directly contradicts the actual data. MULTI-HOP REASONING: The LLM failed to synthesize the complete three-year progression and missed the critical inflection point in 2024 for equity-method investments. This represents a fundamental failure in multi-hop analysis across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 488,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike’s preferred‑stock relationship with Sojitz America stayed essentially unchanged.  Sojitz America remained the sole owner of the $0.3 million par‑value redeemable preferred stock, which carries a $0.10 per‑share cumulative dividend paid each May 31 and can only be satisfied before any common‑stock dividend is declared – a condition that was still in effect for 2024, 2023 and 2022 【NOTE 8 – REDEEMABLE PREFERRED STOCK (page 79)】.  Sojitz America’s voting rights remain limited to a separate class vote on fundamental transactions such as asset sales, mergers or trademark transfers, and Nike’s charter does not permit any additional preferred‑stock issuance 【NOTE 8】.  Consequently, the entity continues to function as Nike’s Japanese‑trading‑company partner that provides import‑export financing and other support for Nike’s international operations, but its equity stake, dividend obligations and governance role have shown no material evolution over the three fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all quantitative facts - the $0.3 million par value, $0.10 per-share cumulative dividend, May 31 payment date, and Sojitz America's sole ownership status are accurate. The governance details about voting rights limited to fundamental transactions and the charter restriction on additional preferred stock issuance are also correct. Numbers and dates are precisely accurate.\n\nWEAKNESSES: The LLM answer fundamentally misses the key evolution highlighted in the ground truth. The ground truth explicitly states there WAS an evolution from fiscal 2022-2023 (purely financial engagement) to fiscal 2024 (operationally strategic role), with Nike highlighting Sojitz America's import-export financing services since 1972 in fiscal 2024 specifically. The LLM concludes 'no material evolution over the three fiscal years,' which directly contradicts the ground truth's assertion of a shift in how Nike characterized the relationship. The ground truth emphasizes this shift occurred 'amid rising global trade risks' and 'supply chain volatility' - contextual factors the LLM completely omits.\n\nMULTI-HOP REASONING: The LLM fails to synthesize the temporal evolution across the three fiscal years. It treats the relationship as static rather than recognizing the strategic repositioning that occurred in fiscal 2024. The ground truth requires understanding not just the financial mechanics (which the LLM captures) but also the strategic narrative evolution (which the LLM misses entirely).\n\nSEMANTIC ACCURACY: While the LLM's statement about 'no material evolution' is internally consistent with its own analysis, it contradicts the ground truth's explicit finding of evolution in Nike's characterization of Sojitz America's role. This is a fundamental disagreement on the core question, not merely a wording difference.\n\nCONCLUSION: The LLM provides accurate financial and governance details but fails to identify and articulate the key strategic evolution that defines the answer to this multi-hop question. It answers a narrower question about financial stability rather than the broader question about relationship evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 582,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 have been carried at roughly $2 billion throughout the last three fiscal years – $2.0 billion was reported at the end of fiscal 2022, remained $2.0 billion at the end of fiscal 2023, and was still $2.0 billion as of the fiscal 2024 balance‑sheet date (January 28 2024).  This unchanged amount shows that NVIDIA is maintaining a stable, sizable fixed‑rate long‑term debt position rather than increasing or retiring this portion of its capital structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the carrying value was $2.0 billion in fiscal 2022, but ground truth shows $2,147 million. The LLM claims $2.0 billion in fiscal 2023, but ground truth shows $1,604 million - a massive $396 million discrepancy. The LLM claims $2.0 billion in fiscal 2024, which matches ground truth ($2,000 million), but this is only 1 of 3 data points correct. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to capture the actual trend - a significant decline from 2022 to 2023 ($543 million decrease), followed by a substantial recovery in 2024 ($396 million increase). This is not a 'stable' position as claimed. (3) REASONING ERROR: The LLM's conclusion that NVIDIA maintained 'unchanged amount' and 'stable' debt is factually wrong. The actual data shows material fluctuations indicating strategic debt management decisions, not stability. (4) ENTITY ACCURACY: While the note description (3.50% Notes Due 2050) is correct, the financial metrics are severely misrepresented. (5) The LLM appears to have rounded or averaged the values rather than reporting actual carrying values from the filings. This is a fundamental failure in financial data accuracy - the core requirement for evaluating SEC filing questions. The answer would mislead investors about NVIDIA's actual debt positioning and trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 408,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife sustained a diversified set of global funding sources, relying on commercial paper as a short‑term instrument while also tapping long‑term notes, FHLB funding agreements, special‑purpose entity funding, and collateral‑financing arrangements. The commercial‑paper balance fell to about $119 million in 2023 but rose sharply to roughly $465 million in 2024, illustrating a strategic shift toward a broader funding mix that spreads risk and helps lower the overall cost of capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about MetLife's diversified funding sources and mentions commercial paper as a key short-term debt instrument, which aligns with the ground truth. However, there are significant issues with quantitative accuracy that lower the overall score. The LLM introduces specific dollar amounts ($119 million in 2023 and $465 million in 2024 for commercial paper balances) that are not present in the ground truth answer. While these numbers may or may not be accurate to the actual filings, they represent a factual claim that cannot be verified against the provided ground truth, which makes no mention of specific commercial paper balance figures. The ground truth emphasizes consistency and stability in MetLife's funding approach across 2022-2024, with no major structural changes, whereas the LLM characterizes the shift from $119M to $465M as a 'strategic shift toward a broader funding mix.' This interpretation contradicts the ground truth's emphasis on stable, consistent reliance on the same core funding structure. The LLM does correctly identify multiple funding sources (commercial paper, long-term notes, FHLB funding, SPE funding, collateral-financing arrangements) and properly addresses the multi-part question about evolution, diversification, and cost reduction. The reasoning about spreading risk and lowering capital costs is sound and relevant. However, the introduction of unverified specific numbers and the characterization of a 'sharp rise' as a strategic shift when the ground truth emphasizes stability represents a material factual discrepancy. The answer is partially correct in structure and approach but fails on quantitative precision and potentially mischaracterizes the nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 479,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s inter‑company financing to its subsidiaries shifted markedly: the short‑term “notes payable to subsidiaries” fell from $4.9 bn in 2022 to $8.1 bn in 2023 and then to $2.0 bn in 2024, while a new $14.4 bn of long‑term notes payable appeared in 2024.  The accompanying service‑level performance guarantees have remained immaterial throughout the period, indicating that the firm’s liquidity commitments are now concentrated in longer‑dated debt and that its contractual risk exposure, although present, has not grown materially.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the core numbers that are central to answering the question. (1) NOTES PAYABLE FIGURES - MAJOR DISCREPANCY: Ground truth states notes payable to subsidiaries were $8.1B (2022), $9.9B (2023), $2.0B (2024). LLM states $4.9B (2022), $8.1B (2023), $2.0B (2024). The 2022 figure is wrong ($4.9B vs $8.1B) and the 2023 figure is wrong ($8.1B vs $9.9B). These are not minor rounding differences but represent 40% and 18% discrepancies respectively. (2) INTRODUCTION OF NEW LONG-TERM DEBT: The LLM introduces a $14.4B long-term notes payable in 2024 that does not appear in the ground truth answer. This is a significant addition that fundamentally changes the narrative about the company's debt structure and was not mentioned in the original answer. This suggests either fabrication or confusion with different financial metrics. (3) MULTI-HOP REASONING: While the LLM correctly identifies that service level guarantees remained immaterial throughout the period (matching ground truth), the reasoning about liquidity commitments shifting to longer-dated debt is not supported by the ground truth, which does not mention this long-term debt component. (4) DIRECTIONAL ACCURACY: The LLM correctly captures the general trend of volatility in notes payable and the immateriality of service level guarantees, but the specific numbers undermine the credibility of the analysis. The ground truth emphasizes the sharp drop in 2024 and the significance of the 2022-2023 increase, which the LLM's incorrect numbers fail to properly convey. (5) SEMANTIC ISSUES: The characterization of the 2022-2023 movement as a 'fall' is incorrect given the LLM's own numbers would show an increase, creating internal inconsistency. The introduction of unverified long-term debt information represents a significant factual error that cannot be reconciled with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 523,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nAmerican Express remains the world’s fourth‑largest general‑purpose card network, but its competitive edge now hinges less on sheer volume and more on premium‑customer differentiation, expanded travel and digital‑wallet benefits, and deep merchant‑partner ecosystems that compete directly with Visa, Mastercard, UnionPay and fast‑growing fintech platforms.  At the same time, regulatory pressure has intensified: U.S. banking agencies have labeled Amex a Category III firm (with Category II prospects), interchange‑fee caps and merchant‑surcharge rules are under active debate, and heightened scrutiny of data‑privacy, AI, third‑party oversight and AML has forced the company to overhaul its compliance, risk‑management and governance structures, exit certain network‑licensing arrangements in the EU and Australia, and proactively engage regulators while managing ongoing litigation and third‑party risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's competitive positioning and regulatory evolution from 2022-2024, with mostly accurate factual content and appropriate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies Amex as fourth-largest general-purpose card network; (2) Accurately references Category III firm designation under U.S. federal banking framework; (3) Properly identifies key competitive threats (Visa, Mastercard, UnionPay, fintech platforms); (4) Correctly notes regulatory pressures on interchange fees, merchant surcharges, and data privacy; (5) Accurately mentions EU and Australia network licensing exits; (6) Appropriately emphasizes shift from market-driven competition to regulatory navigation. WEAKNESSES: (1) Omits specific mention of alternative payment platforms like Alipay, PayPal, Venmo, and National Payments Corporation of India that were highlighted in ground truth as part of intensified competitive landscape; (2) Does not explicitly reference the temporal evolution across 2022-2023-2024 as clearly as ground truth (which shows progression from strong differentiation in 2022 to intensified competition in 2023 to regulatory constraints in 2024); (3) Mentions 'Category II prospects' which is not clearly supported in ground truth and may introduce ambiguity; (4) Less explicit about the strategic trajectory from independence/competitive edge to regulatory constraint. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The categorical designations (fourth-largest, Category III) are accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects competitive dynamics with regulatory responses, though the temporal progression could be more explicit. The answer correctly links regulatory actions (Category III designation, interchange scrutiny) to strategic responses (EU/Australia exits, compliance overhauls). SEMANTIC EQUIVALENCE: The core message aligns with ground truth—Amex's competitive position has shifted from market-driven differentiation to regulatory-constrained navigation—but the LLM answer emphasizes premium differentiation and merchant ecosystems more than the ground truth's focus on regulatory dependency as the primary driver of change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 637,
        "total_tokens": 2286
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips continued the cash‑settled PSU framework it introduced in 2018: for any performance period that began in 2018 or later the award accrues a reinvested dividend equivalent during the performance cycle, charges that accrual to compensation expense, and pays it only at settlement.  By keeping the dividend‑equivalent accrual in the compensation calculation and tying the payout to the three‑year performance outcome, the company shifts a portion of executive pay from a pure price‑target to a total‑shareholder‑return metric that reflects both stock‑price appreciation and dividend participation, thereby reinforcing a long‑term incentive focus aligned with sustained corporate performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key evolution in ConocoPhillips' PSU dividend equivalent structure for performance periods beginning in 2018 or later, accurately noting that accrued reinvested dividends are paid at settlement. The answer correctly captures the 2022-2024 timeframe and properly identifies the shift toward long-term alignment. The explanation of how dividend equivalents are accrued during the performance cycle and paid at settlement is accurate.\n\nWEAKNESSES: (1) The LLM answer contains a significant factual error by stating the framework was 'introduced in 2018,' when the ground truth indicates the framework was established after the 2012 downstream separation (much earlier). This misrepresents the historical timeline. (2) The answer fails to address the important contrast between pre-2018 and post-2018 performance periods regarding dividend equivalent treatment—specifically that pre-2018 periods had no payments during the performance period but began after conclusion, while 2018+ periods have accrued reinvestment. This is a material omission that weakens the completeness of the answer. (3) The answer does not mention the consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years, which the ground truth identifies as underscoring commitment to cash-based incentive structures. (4) The LLM's interpretation shifts focus to 'total shareholder return metric' language that, while conceptually related, is not explicitly stated in the ground truth and may overstate the characterization.\n\nMULTI-HOP REASONING: The answer demonstrates partial multi-hop synthesis by connecting the dividend accrual mechanism to long-term alignment, but fails to fully synthesize the comparative evolution (pre-2018 vs. 2018+) that is central to understanding how the strategy evolved. The reasoning about alignment is sound but incomplete.\n\nNUMERIC/DATE ACCURACY: The dates mentioned (2022-2024, 2018) are correct. No calculations are required for this question, so quantitative accuracy is adequate where applicable.\n\nSEMANTIC ISSUES: The phrase 'shifts a portion of executive pay from a pure price-target to a total-shareholder-return metric' is an interpretation not explicitly supported by the ground truth, which focuses on the timing and structure of dividend equivalent payments rather than characterizing them as TSR metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 642,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nThe Special‑Use‑Fund balance grew sharply—from roughly **$4.4 bn in 2022 to $5.3 bn in 2023 and $9.8 bn by the end of 2024**—providing a substantially larger, readily marketable collateral pool.  This expansion gives NEE a stronger liquidity buffer to meet the collateral that could be required under its derivative‑related credit‑rating triggers and margin‑call provisions (e.g., up to ≈ $510 m for a one‑notch downgrade and ≈ $2.4 bn for a multi‑notch downgrade).  Consequently, the company’s liquidity positioning has been deliberately reinforced to satisfy derivative‑related collateral obligations throughout the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine the entire response. (1) SPECIAL USE FUNDS - The LLM claims 2022 balance was ~$4.4bn, but ground truth shows no 2022 figure provided in original answer. More critically, the LLM states 2023 was $5.3bn, but ground truth explicitly states $8,698 million ($8.7bn) in 2023. This is a massive discrepancy of ~$3.4bn or 64% error. The 2024 figure of $9.8bn is correct. (2) COLLATERAL REQUIREMENTS - The LLM cites '$510m for one-notch downgrade' which does not appear in the ground truth. Ground truth mentions $2.7bn potential requirement and $2.4bn in 2023, but no $510m figure. The $2.4bn figure is correct but incomplete context. (3) ACTUAL COLLATERAL POSTED - The LLM completely omits the critical detail that actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022, which is a key indicator of liquidity positioning. (4) MULTI-HOP SYNTHESIS - While the LLM attempts to connect Special Use Funds growth to derivative collateral obligations, it fails to properly synthesize the complete picture: the reduction in collateral posting requirements from $5.2bn (2022) to $2.4bn (2023) alongside the increase in actual cash collateral posted. (5) REASONING QUALITY - The conclusion about 'deliberately reinforced' liquidity is reasonable but based on incorrect foundational numbers. The ground truth emphasizes BOTH the growth in Special Use Funds AND the REDUCTION in potential collateral exposure, which the LLM misses. The LLM's answer is internally coherent but factually flawed on critical numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 446,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe 1.600 % senior notes issued on March 29 2021 carried a fixed $700 million principal that stayed on the books through 2022‑2024; the only change in the reported carrying amount was a modest, cumulative discount‑amortization (e.g., a $3.7 million reduction in 2022 and a $2.6 million reduction in 2023). Because no principal was repaid before the notes’ April 15 2026 maturity, the company has treated the issue as a long‑term, low‑cost funding pillar, using cash from its revolving credit facilities to retire higher‑cost maturing debt rather than to amortize or retire the 1.600 % notes early. This multi‑year pattern signals a deliberate debt‑management strategy that preserves the cheap 1.600 % financing until maturity while aggressively refinancing more expensive obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $700 million principal amount as constant across 2022-2024, correctly notes the April 15, 2026 maturity date, and provides sound strategic reasoning about debt management (preserving low-cost financing while refinancing higher-cost debt). The semantic interpretation of the adjustments as discount amortization is reasonable and the overall narrative about deliberate debt strategy is well-reasoned. CRITICAL ERRORS: (1) The LLM states the amortization reduction was '$3.7 million reduction in 2022 and a $2.6 million reduction in 2023,' but the ground truth shows the adjustments were (3.7) million in 2022 and (2.6) million in 2024 - the LLM incorrectly places the 2.6 figure in 2023 instead of 2024. This is a significant year-mismatch error that affects the multi-year trajectory analysis. (2) The LLM does not explicitly mention the 2023 adjustment figure, creating an incomplete picture of the three-year pattern. QUANTITATIVE ACCURACY ISSUES: The year attribution error (2023 vs 2024) is a material factual mistake that undermines the credibility of the multi-year pattern analysis, even though the underlying numbers themselves are correct. The ground truth emphasizes the trajectory from 2022 through 2024, and the LLM's misplacement of the 2024 figure disrupts this analysis. QUALITATIVE ASSESSMENT: The reasoning about debt management strategy is sound and well-articulated, showing good synthesis of financial concepts. However, the factual error in year attribution weakens the foundation of this reasoning. The answer demonstrates understanding of the question's intent but fails on precise execution of the multi-hop temporal synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 465,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s Medicare Advantage risk‑adjustment payments became increasingly volatile as CMS intensified RADV audits and revised the risk‑adjustment model, producing retroactive payment reductions and tighter benchmarks. In response, the company progressively trimmed under‑performing product lines—adjusting member benefits and premiums, exiting certain counties, and sharpening its risk‑adjustment data collection and overall medical‑cost and operating‑expense management—to offset the pressure on capitation revenues.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial understanding of UnitedHealth's Medicare Advantage risk adjustment challenges but introduces significant factual inaccuracies that diverge from the ground truth. CRITICAL ISSUES: (1) The LLM introduces 'RADV audits' as a primary mechanism, which is not mentioned in the ground truth and appears to be an unsupported claim about the specific regulatory driver. (2) The LLM characterizes payments as 'increasingly volatile' with 'retroactive payment reductions,' which is not substantiated in the original answer and may misrepresent the nature of CMS's changes. (3) The ground truth emphasizes CMS 'altering calculation methodologies each year' and 'recalibrations of risk adjustment payments,' while the LLM shifts focus to audit intensity and retroactive adjustments—a material difference in regulatory mechanism. CORRECT ELEMENTS: (1) The three-year timeframe (2022-2024) is accurate. (2) The strategic responses are largely aligned: adjusting benefits/premiums, exiting counties, and intensifying cost management are all mentioned in both answers. (3) The characterization of ongoing pressure and need for continuous adaptation is correct. (4) The focus on maintaining profitability through operational efficiency is appropriate. SYNTHESIS ISSUES: The LLM answer fails to properly synthesize the multi-hop information about how the company's response evolved year-by-year. The ground truth shows a progression (2022: initial adjustments → 2023: continued adaptation with county exits → 2024: further refinement), while the LLM presents a more generic, undifferentiated response across the period. NO QUANTITATIVE DATA: Neither answer contains specific dollar amounts or percentages, so quantitative accuracy cannot be fully assessed, but the LLM's unsupported claims about 'retroactive payment reductions' and 'tighter benchmarks' without evidence lower confidence in numerical precision. The answer is contextually relevant to the question but introduces regulatory mechanisms not supported by the ground truth, which is a significant accuracy concern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 562,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nThe 2022‑2024 Form 10‑K filings consistently list “merchandise and other discounts” as part of the compensation package (2022 p. 7; 2023 p. 7; 2024 p. 7).  However, by 2023 and 2024 the discount is framed alongside a broader set of financial‑well‑being benefits—such as 401(k) matching, tuition‑free education assistance, and free mental‑health services—indicating that Target is embedding the discount within a more comprehensive, financially‑focused benefits strategy rather than treating it as a stand‑alone perk.  This evolution reflects Target’s intent to support employee financial stability through an integrated suite of compensation elements that together enhance overall economic security.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core question and correctly identifies the key evolution of Target's merchandise discount strategy from 2022-2024. STRENGTHS: (1) Correctly identifies that merchandise discounts were consistently offered across all three years (2022, 2023, 2024); (2) Accurately notes the shift from standalone benefit to integrated within broader financial wellness strategy; (3) Correctly identifies supporting benefits like 401(k) matching, tuition-free education assistance, and mental health services; (4) Properly synthesizes the multi-hop reasoning that discounts became embedded in a holistic compensation approach; (5) Page citations (p. 7 for each year) are appropriately specific. WEAKNESSES: (1) The LLM answer omits specific wage progression details mentioned in ground truth (starting wage of at least $15/hour in 2022, expanding to $15-$24/hour by 2023), which was explicitly noted as part of the broader financial well-being strategy evolution; (2) Does not mention sick pay as a new addition in 2023, which the ground truth identifies as signaling expanded support; (3) The framing around 'equitable pay and belonging' narrative in 2024 is absent from the LLM response; (4) Less explicit about the 'holistic financial and well-being strategy aimed at attracting and retaining talent' as the strategic intent. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression from standalone benefit to integrated strategy, which is the core multi-hop requirement. However, it misses some of the supporting details that reinforce this narrative. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is semantically aligned with the ground truth's core finding, though less comprehensive in supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 494,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nBetween 2022 and 2024 the foreign‑government‑bond portfolio expanded modestly—average balances rose from about $650 million to $800 million—while the weighted‑average yield jumped from roughly 3.5 % to just above 6 %, tracking the steep rise in market rates.  Across the three years the securities were overwhelmingly short‑dated, with more than 95 % maturing within one year, indicating that American Express maintains a highly liquid, low‑duration exposure to sovereign debt as a low‑credit‑risk cash‑management asset, reflecting a cautious risk appetite and an asset‑allocation strategy that prioritizes capital preservation and liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) PORTFOLIO SIZE: LLM claims balances rose from ~$650M to ~$800M, but ground truth shows $630M in 2022 with no indication of growth to $800M by 2024. This is a significant quantitative error. (2) YIELD ACCURACY: LLM states yields jumped from 'roughly 3.5%' to 'just above 6%', but ground truth shows: 2022 yields were 1.74% (1-year) and 2.42% (1-5 year), NOT 3.5%; 2023 yields were 6.45% (1-year) and 4.48% (1-5 year); 2024 yields were 5.86% (1-year) and 2.03% (1-5 year). The LLM's 3.5% starting yield is completely inaccurate. (3) MATURITY DISTRIBUTION: LLM claims 'more than 95% maturing within one year' but provides no year-by-year breakdown. Ground truth distinguishes between 1-year and 1-5 year buckets across all three years, showing a more nuanced maturity profile than LLM suggests. (4) STRATEGIC INTERPRETATION: While LLM correctly identifies a cautious risk appetite and liquidity focus, it misses the critical 2023-2024 pattern: the ground truth shows aggressive short-term positioning in 2023 (6.45% yield) followed by a 'partial retreat' in 2024 with 'reduced long-term exposure' (2.03% yield drop). LLM's narrative of 'steady' short-dated positioning misses this dynamic shift. (5) MULTI-HOP SYNTHESIS: LLM fails to properly synthesize the year-by-year yield evolution and maturity distribution changes that are central to answering the question. The answer reads as generic commentary rather than specific analysis of the 3-year pattern. Major calculation and factual errors make this response substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 449,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nThe collateral recorded under master‑netting arrangements—shown in the “Other assets, including intangibles – net” line—fell from roughly **$1.5 billion at the end of 2022 to $0.8 billion in 2023 and to about $0.5 billion by the end of 2024**. This steady decline indicates that ExxonMobil is posting less external collateral, reflecting a lower net derivative notional and more effective offsetting of derivative positions, i.e., the company is managing its derivative exposure with reduced reliance on collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.5 billion (2022), $0.8 billion (2023), and $0.5 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively. The format variation ($1.5B vs $1,494M) is acceptable and represents proper rounding. COMPLETENESS: The answer addresses all required components - the three-year trend, the specific line item ('Other assets, including intangibles - net'), and interpretation of what the trend suggests about derivative exposure management. ENTITY ACCURACY: Correctly identifies ExxonMobil (XOM), the correct financial metric (collateral under master netting arrangements), and all three fiscal years (2022, 2023, 2024). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to derivative exposure management practices. The interpretation that 'lower net derivative notional and more effective offsetting of derivative positions' explains the trend is logically sound and represents a reasonable inference from the data. SEMANTIC EQUIVALENCE: The LLM's explanation of 'reduced reliance on collateral' and 'more effective offsetting of derivative positions' conveys essentially the same insight as the ground truth's 'strategic reduction in derivative-related exposure or shift in risk management practices.' The LLM provides slightly more specific mechanistic detail about how the reduction occurred (offsetting positions vs. just noting the reduction). MINOR CONSIDERATIONS: The LLM uses 'roughly' and 'about' appropriately given the rounding, and the characterization of the trend as 'steady decline' is accurate. No calculation errors detected. The answer fully synthesizes information across the three-year period as required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 506,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe 2.700 % senior unsecured notes were issued on March 29 2021 at a 2.700 % fixed coupon with semi‑annual interest payments on April 15 and October 15 and a final maturity of April 15 2031 (par‑call date January 15 2031).  From 2022 through 2024 the company did **not** issue any new 2.700 % notes; the original tranche remained outstanding, with its principal balance only adjusted for discount amortization (as shown in the 2022‑2024 tables), while the firm increasingly tapped the market with higher‑coupon issuances (e.g., 5‑6 % notes in 2023‑24) to refinance maturing debt and fund acquisitions.  This pattern reveals AMT’s strategy of locking in low‑cost, long‑dated financing early and then using newer, higher‑rate debt to manage liquidity and leverage as market rates rose, preserving the legacy 2.700 % notes as a stable, low‑yield component of its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the issuance date (March 29, 2021), coupon rate (2.700%), semi-annual payment dates (April 15 and October 15), and maturity date (April 15, 2031). The par call date of January 15, 2031 is also correct. The LLM appropriately notes that no new 2.700% notes were issued 2022-2024, and correctly characterizes the strategic shift toward higher-coupon debt issuances. The reasoning about locking in low-cost financing early is sound. CRITICAL ERRORS: (1) The LLM states the maturity date as 'April 15, 2031' but the ground truth clearly states 'April 15, 2031' in one place and 'January 15, 2031' in another - the ground truth shows inconsistency itself, but the LLM should have noted this discrepancy. More importantly, the ground truth indicates the maturity was 'April 15, 2031' in 2022 but changed to 'January 15, 2031' by 2023-2024, which the LLM fails to capture. (2) The LLM completely omits the principal amount ($700.0 million), which is a key quantitative fact mentioned in the ground truth across all three years. (3) The LLM mentions 'discount amortization' affecting principal balance but provides no specific numbers or evidence from the filings. (4) The ground truth mentions an interest rate spread change from (5.0) to (4.4) by 2024, which the LLM entirely omits - this is a specific quantitative detail about financing costs that directly addresses the question about 'interest rate terms.' (5) The LLM's statement about 'par-call date January 15 2031' conflicts with the maturity date evolution described in ground truth. MULTI-HOP REASONING: The LLM provides broader strategic context about debt issuance patterns, which goes beyond the ground truth but is somewhat speculative without specific filing citations. The ground truth focuses on the specific evolution of the 2.700% Notes themselves across years, while the LLM pivots to comparative analysis with other debt issuances. COMPLETENESS: The answer addresses the financing strategy question but incompletely addresses the specific evolution of the 2.700% Notes' terms from 2022-2024. The ground truth shows year-by-year changes in how the notes were disclosed/characterized, while the LLM treats them as static.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 594,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nThe 2.00% Notes Due 2031 kept a $1.25 billion face amount on NVIDIA’s balance sheet from the end of fiscal 2022 through fiscal 2024, with only a small decline in the unamortized discount (see the debt schedule in the 2025 and 2024 Form 10‑K filings, page 72); there were no principal repayments or new issuances during that period. This steady, long‑dated, low‑coupon senior note reflects NVIDIA’s strategy of locking in inexpensive, fixed‑rate financing for an extended horizon to fund its growth initiatives while preserving a stable, long‑term capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable interpretation of NVIDIA's debt strategy but contains significant quantitative discrepancies with the ground truth. Key issues: (1) QUANTITATIVE ACCURACY: The LLM states the face amount was $1.25 billion from end of fiscal 2022 through 2024, but the ground truth shows the fair value was $1.2 billion in 2022, $1.044 billion at beginning of 2023, and $1.057 billion at end of 2023, with $1.25 billion in 2024. The LLM conflates the 2024 carrying value with the entire 2022-2024 period, which is factually incorrect. The progression from $1.2B→$1.044B→$1.057B→$1.25B is materially different from a flat $1.25B across the period. (2) COMPLETENESS: The LLM answer addresses the evolution question but misrepresents the actual trajectory. It correctly identifies no principal repayments or new issuances, but this is only partially supported by the ground truth data provided. (3) ENTITY ACCURACY: Correctly identifies NVIDIA, the 2.00% Notes Due 2031, and the fiscal years. (4) REASONING: The qualitative interpretation about locking in fixed-rate financing and preserving stable capital structure is reasonable and aligns with the ground truth's conclusion about 'strategic consistency,' but the factual foundation is weakened by the quantitative errors. (5) SEMANTIC EQUIVALENCE: While the strategic interpretation is sound, the numerical progression is fundamentally misrepresented. The ground truth shows fluctuation (decline then slight recovery) rather than stability, which contradicts the LLM's 'steady' characterization. The answer demonstrates good understanding of debt strategy concepts but fails on precise financial data synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 466,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑accounted reinsurance assets expanded dramatically—from about **$1.8 billion** (the level reported for 2021/2020) to **$4.6 billion** at the end of 2024 (and $5.1 billion in 2023), while the associated deposit liabilities slipped only modestly from roughly **$1.4 billion** to **$1.2 billion**.  This growth reflects the Company’s increasing use of modified‑coinsurance and other reinsurance structures that are recorded under the deposit method, notably the November 2023 bulk risk‑transfer transaction that generated $10.3 billion of deposit receivables.  The trend shows MetLife is deliberately shifting toward larger, capital‑efficient reinsurance arrangements—especially to manage the closed block and align accounting with the LDTI framework—thereby enhancing its ability to transfer risk while optimizing regulatory capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a significant factual error regarding the 2024 deposit assets figure. The ground truth states deposit assets reached $5.1 billion by end of 2024, but the LLM claims $4.6 billion for 2024 and $5.1 billion for 2023. This is a reversal of the correct figures. The LLM correctly identifies 2022 deposit assets at $1.8 billion and correctly states the liability decline from $1.4 billion to $1.2 billion. However, the core quantitative error (confusing 2023 and 2024 asset values) is material and undermines the accuracy of the trend analysis. QUALITATIVE ACCURACY: The LLM correctly identifies the Global Atlantic transaction with $10.3 billion in reinsurance recoverables and appropriately contextualizes the deposit method accounting. The reasoning about modified-coinsurance structures, capital efficiency, and LDTI framework alignment is sound and adds relevant context. The multi-hop synthesis connecting the transaction to the deposit asset growth is logical. COMPLETENESS: The answer addresses the evolution of both deposit assets and liabilities, discusses the strategic implications, and references the key transaction. However, the quantitative error regarding which year had $5.1 billion vs $4.6 billion is a critical flaw that affects the credibility of the trend analysis. SEMANTIC EQUIVALENCE: While the wording differs from the ground truth, the conceptual understanding is mostly correct except for the year-to-year asset values. The conclusion about strategic shift toward reinsurance structures is appropriate and well-reasoned. The error appears to be a transposition of 2023 and 2024 figures rather than a fundamental misunderstanding of the trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 471,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nUnitedHealth Group’s held‑to‑maturity debt‑security portfolio contracted over the three‑year span: the disclosed fair value fell from **$679 million (2022) → $596 million (2023) → $508 million (2024)**, and the carrying (amortized‑cost) value declined from **$696 million → $603 million → $512 million** during the same periods.  \n\nThis reduction reflects a deliberate downsizing of the held‑to‑maturity book—likely through scheduled maturities and intentional re‑allocation toward more liquid or higher‑yielding assets—while the simultaneous drop in fair value mirrors the impact of rising interest rates on the market price of existing securities. Consequently, the progression signals a strategic shift to manage interest‑rate exposure and preserve capital, with the company accepting modest unrealized losses as it maintains the remaining securities to maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are precisely correct - fair values ($679M→$596M→$508M) and carrying values ($696M→$603M→$512M) match the ground truth exactly across all three years (2022-2024). The directional trends (consistent decline) are accurately captured. COMPLETENESS: The answer addresses all components of the multi-part question: (1) fair value evolution, (2) carrying value evolution, (3) 3-year progression analysis, and (4) strategic implications. ENTITY ACCURACY: UnitedHealth Group (UNH) correctly identified, debt securities held-to-maturity properly specified, and all fiscal years correctly referenced. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (a) presenting parallel data streams (fair vs. carrying value), (b) explaining the divergence between the two metrics through interest rate impacts, (c) connecting the portfolio contraction to strategic decision-making (scheduled maturities, capital reallocation), and (d) interpreting the unrealized losses in context of the held-to-maturity classification. The explanation about rising interest rates depressing fair value while carrying value follows amortized cost is particularly insightful and demonstrates understanding of accounting mechanics. SEMANTIC EQUIVALENCE: The LLM's interpretation of 'strategic reduction or repositioning' aligns with the ground truth's characterization, with added depth regarding interest rate exposure management and capital preservation. Minor enhancement: The LLM provides more detailed strategic context (scheduled maturities, liquidity considerations, interest-rate exposure management) compared to the ground truth, which strengthens rather than detracts from the answer. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 504,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe Target Credit Card (RedCard/Targe​t Circle Card) penetration has been falling: it was about **20.5 % of purchases in fiscal 2022**, slipped to **19.8 % in fiscal 2023**, and fell further to **18.6 % in fiscal 2024**. This steady decline signals that the credit‑card program is becoming less successful at generating incremental sales, suggesting diminishing returns from the current card‑based strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - 20.5% (2022), 19.8% (2023), 18.6% (2024) match ground truth exactly. (2) Fiscal year identification is accurate. (3) The downward trend is correctly identified and characterized. (4) Number formatting is appropriate and clear. WEAKNESSES: (1) The LLM answer interprets the trend more negatively than the ground truth warrants. The ground truth states the decline 'may indicate weakening engagement' but also notes that 'Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.' The LLM concludes the program is 'becoming less successful' and shows 'diminishing returns,' which overstates the negative interpretation. (2) The LLM answer lacks the nuance present in the ground truth - it doesn't acknowledge that despite the decline, there is still 'ongoing strategic value' to the card program. (3) The phrase 'less successful at generating incremental sales' is a stronger negative characterization than the ground truth supports. The ground truth suggests the trend is concerning but doesn't definitively conclude the program is failing. MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend and attempts to draw conclusions about strategy effectiveness, but the conclusion is somewhat one-sided. The ground truth presents a more balanced view acknowledging both the concerning trend and the continued strategic value. OVERALL: The factual data is perfect, but the interpretation and contextual framing could be more balanced and nuanced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 447,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike continued to **own** its major European distribution hub in **Laakdal, Belgium**, listing it alongside other owned sites in China, Japan and Korea as one of the “most significant distribution facilities outside the United States.”  The company’s disclosures show no divestiture or relocation of the Laakdal site—its presence is repeated in both the 2022 and 2024 Form 10‑K property summaries—indicating that Nike has maintained, and implicitly reinforced, this owned logistics node as a core component of its European supply‑chain network.  This persistence signals a strategic focus on **securing and expanding controlled, high‑capacity distribution infrastructure in Europe**, underscoring the region’s importance to Nike’s global logistics and fulfillment strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies Nike's ownership of Laakdal, Belgium facility across fiscal years 2022-2024; (2) Accurately characterizes it as one of the 'most significant distribution facilities outside the United States' - matching the ground truth's description of 'most significant international distribution centers'; (3) Properly notes consistency across multiple 10-K filings with no divestiture or relocation; (4) Correctly synthesizes that this consistency indicates strategic focus on European logistics infrastructure; (5) Appropriately contextualizes Laakdal alongside other owned facilities in China, Japan, and Korea. MINOR CONSIDERATIONS: (1) The LLM adds interpretive language about 'securing and expanding controlled, high-capacity distribution infrastructure' which goes slightly beyond the ground truth's more conservative statement of 'stable strategic focus on maintaining direct control.' The ground truth emphasizes consistency and stability, while the LLM emphasizes expansion - this is a minor interpretive difference rather than factual error; (2) The phrase 'implicitly reinforced' is reasonable inference but adds slight interpretation beyond explicit ground truth statements. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so quantitative scoring reflects the absence of calculation errors and correct handling of temporal references (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple fiscal years and correctly identifies the relationship between ownership consistency and strategic implications. The logic connecting facility persistence to strategic importance is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 498,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lumentum Holdings stayed on NVIDIA’s list of networking‑product competitors (e.g., switches, optical modules) in the 10‑K filings, but its relative standing weakened as NVIDIA broadened its own supply‑chain resilience and intensified IP and export‑control safeguards.  The expansion of NVIDIA’s internal networking silicon, a larger patent portfolio and the tightening of licensing rules for high‑performance products limited Lumentum’s access to restricted markets such as China, curbing its growth prospects compared with the earlier years.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL CONTRADICTION - The LLM answer claims Lumentum's 'relative standing weakened' and that it experienced 'curbed growth prospects,' but the ground truth explicitly states Lumentum 'remained consistently positioned' and 'maintained its relevance' across all three years. This is a fundamental mischaracterization of the competitive positioning evolution. (2) UNSUPPORTED CLAIMS - The LLM introduces claims not present in the ground truth: that NVIDIA's 'expansion of internal networking silicon' limited Lumentum's access to China markets, and that export controls specifically curbed Lumentum's growth. The ground truth does not support these causal claims about market access restrictions or growth impact. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) Lumentum remained on NVIDIA's competitor list across 2022-2024, (b) the domain was networking products (switches, optical modules), (c) NVIDIA expanded supply chain resilience and IP protection during this period. (4) REASONING FLAW - While the LLM attempts multi-hop synthesis connecting NVIDIA's strategic moves to Lumentum's positioning, it draws an incorrect conclusion. The ground truth indicates persistence despite NVIDIA's advances, not weakening due to them. The LLM conflates NVIDIA's strategic strengthening with Lumentum's competitive decline, which is not supported by the filing data. (5) QUANTITATIVE ACCURACY - No specific numbers, dates, or metrics are provided by either answer, so quantitative comparison is limited. Both correctly reference the 2022-2024 timeframe. The LLM's claim about patent expiration dates (2022 to 2045) is mentioned in ground truth but not in LLM answer, which is acceptable as it's supplementary detail. OVERALL: The LLM answer contains a core factual error about the direction of competitive positioning change, introduces unsupported causal mechanisms, and misinterprets the ground truth's conclusion about persistence versus decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 532,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix’s filings make clear that its streaming library remains dependent on licensing agreements with studios, content providers and music‑rights collectives, but the way it manages that dependence has changed.  In the 2022 10‑K the company warned that “if studios or rights‑holders refuse to license content on acceptable terms, our business could be adversely affected,” underscoring the risk of costly withdrawals and rising fees.  By 2023 the narrative shifted toward securing longer‑term, exclusive deals and expanding original‑production budgets to lessen reliance on third‑party libraries, while the 2024 filing adds that emerging regulatory pressures—such as EU cultural‑support quotas, levies and restrictions on ownership rights—are forcing Netflix to negotiate tighter licensing terms, increase co‑production and invest in locally‑produced titles to satisfy both regulators and a more competitive market.  This evolution reveals a strategy that blends continued negotiation with rights‑holders with a growing emphasis on owned content and regulatory‑aware licensing to sustain growth amid intensifying competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the three-year progression (2022-2024) and accurately characterizes Netflix's evolving content strategy. The 2022 framing around rights-holder risks and licensing costs is correct. The 2023 shift toward exclusive deals and original content expansion is accurately captured. The 2024 addition of regulatory pressures (EU cultural quotas, levies, ownership restrictions) is factually sound and matches the ground truth narrative. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, which is appropriate given the qualitative nature of the question. The temporal references (2022, 2023, 2024) are all correct. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings, correctly identifying the progression from risk-focused language (2022) to strategic repositioning (2023) to regulatory-aware adaptation (2024). The synthesis demonstrates understanding of how Netflix's strategy evolved in response to competitive and regulatory pressures. (4) ENTITY ACCURACY: Netflix is correctly identified throughout. The answer properly references relevant entities (studios, rights-holders, music-rights collectives, EU regulators) and correctly identifies key strategic elements (exclusive deals, original production, co-production, locally-produced titles). (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core insights as the ground truth: Netflix's continued dependence on licensing while shifting toward owned content and regulatory compliance. The phrasing differs slightly but captures the essential strategic evolution. Minor differences: The LLM provides slightly more specific examples (EU cultural-support quotas, levies) than the ground truth's more general 'content quotas and investment obligations,' but this represents appropriate elaboration rather than inaccuracy. The answer is comprehensive, well-structured, and demonstrates sound multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 581,
        "total_tokens": 2126
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company continued to disclose scheduled payments under outdoor‑lighting contracts within the “operating leases” portion of its maturity schedules, but the presentation grew more detailed and quantitative—amounts are now shown net of discount, broken out by year for each utility, and labeled as “operating‑lease obligations” rather than being lumped into variable‑lease costs.  The revenue from these contracts is classified as “lease income – operating leases” (or, for PPAs, as wholesale revenue) and is presented separately from variable‑lease income, with the notes explicitly stating that the outdoor‑lighting cash flows are immaterial to the consolidated results.  Consequently, the disclosures evolved from a generic maturity table to a more granular, discounted schedule that isolates and quantifies the scheduled lease payments while maintaining the same operating‑lease revenue classification.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) MATERIALITY CLAIM: The LLM states outdoor lighting cash flows are 'immaterial to consolidated results,' but the ground truth indicates they were considered 'immaterial' only in 2022 at Mississippi Power specifically—not consistently across all years. The LLM incorrectly generalizes this to all periods. (2) REVENUE CLASSIFICATION ERROR: The LLM claims revenue is classified as 'lease income – operating leases' or 'wholesale revenue,' but the ground truth makes no mention of revenue classification changes or these specific revenue line items. This appears to be fabricated detail. (3) PRESENTATION EVOLUTION MISCHARACTERIZED: The LLM describes the evolution as moving from 'generic maturity table to more granular, discounted schedule,' but the ground truth describes a different progression: from immaterial disclosure (2022) → inclusion in maturity analyses alongside tolling/PPAs (2023) → explicit statement of inclusion in maturity analyses (2024). The LLM's characterization of 'net of discount' and 'broken out by year for each utility' is not supported by the ground truth. (4) MISSING KEY PROGRESSION: The LLM fails to capture the critical shift from 2022 (immaterial, not in maturity analyses) to 2023-2024 (included in maturity analyses with increasing transparency). (5) UNSUPPORTED DETAILS: References to 'variable-lease costs,' 'variable-lease income,' and specific labeling conventions are not mentioned in the ground truth and appear to be hallucinated. The answer demonstrates poor multi-hop synthesis and introduces factual claims not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 465,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000 % senior notes maturing in April 2030 continued to show a carrying (and effectively outstanding) principal balance of roughly **$606 million** at the end of fiscal 2022, fiscal 2023 and fiscal 2024 – the amount was unchanged across the three years.  This flat trajectory indicates that AVGO is treating the April 2030 note as a long‑term, low‑cost funding pillar that it intends to retain rather than retire, using other debt‑instrument cash flows (e.g., the 2024 senior‑note proceeds) to repay near‑term term loans while preserving the 2030 tranche for future liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims the outstanding principal balance was 'roughly $606 million' and 'unchanged across the three years' (FY2022, FY2023, FY2024). However, the ground truth clearly states: FY2022: $1,086 million, FY2023: $606 million, FY2024: $606 million. This is a major quantitative error - the LLM missed the significant $480 million reduction that occurred between FY2022 and FY2023 ($1,086M - $606M = $480M decrease). The LLM's claim of a 'flat trajectory' across all three years is factually incorrect. The ground truth explicitly identifies a 'deliberate debt reduction strategy in 2023' with a substantial principal repayment, which the LLM completely failed to capture. While the LLM correctly identifies the note characteristics (5.000%, April 2030 maturity) and correctly states the FY2023-FY2024 balance ($606M), it fundamentally misrepresents the multi-year evolution by claiming no change from FY2022 to FY2023. The LLM's interpretation about debt management strategy (treating it as a 'long-term, low-cost funding pillar' to retain) is contradicted by the actual data showing a major repayment in 2023. The reasoning provided is internally consistent but based on incorrect premises about the data. This is a multi-hop synthesis failure where the model failed to properly track the principal balance across three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 401,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nGM’s U.S. pension long‑term return assumption was 6.3 % in both 2022 and 2023 and was modestly raised to 6.5 % in 2024.  This upward revision aligns with a strategic re‑weighting of the asset mix—U.S. equity exposure grew from 8 % (2022) to 11 % (2023) and “other” (private‑equity, real‑estate, hedge‑fund) assets increased from 23 % to 29 % of the portfolio, while fixed‑income fell from 69 % to 60 %—reflecting the company’s effort to capture higher expected returns and reduce funded‑status volatility as market conditions evolved.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 long-term rate of return assumption. According to the ground truth, GM's weighted-average long-term rate of return on U.S. pension plan assets was 5.4% in 2022, NOT 6.3% as stated in the LLM answer. The LLM incorrectly claims the rate was 6.3% in both 2022 and 2023, when in fact it was 5.4% in 2022 and 6.3% in 2023. This represents a 0.9 percentage point increase from 2022 to 2023, not a flat rate. The 2024 figure of 6.5% is correct. The LLM's statement that the rate 'remained unchanged at 6.3% in 2023' is incorrect—it increased FROM 5.4% TO 6.3%. Additionally, while the LLM provides detailed asset mix allocation percentages (equity 8% to 11%, other assets 23% to 29%, fixed-income 69% to 60%), these specific allocation figures are NOT present in the ground truth answer and cannot be verified. The ground truth only mentions a 'potential shift toward higher-risk, higher-return investment strategies' without providing specific allocation percentages. The LLM appears to have fabricated or hallucinated these specific allocation numbers. The core 3-year trend analysis is also incomplete—the LLM fails to properly characterize the full 2022-2024 trajectory (5.4% → 6.3% → 6.5%), instead presenting an incorrect 2022 baseline. The reasoning about strategic asset mix adjustments is sound in principle but is built on incorrect foundational data and unsupported allocation figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 411,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe company has repeatedly amended the indenture governing its 2.700 % Senior Notes due 2031—first creating the series in a March 2021 supplemental indenture and then updating that indenture in subsequent 2023‑2024 filings.  This pattern shows that American Tower is deliberately extending the maturity of a low‑cost, long‑dated debt instrument and integrating it into a staggered, multi‑year financing schedule, underscoring a long‑term strategy of using stable, long‑maturity senior notes to fund its tower portfolio while preserving liquidity and flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer makes a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the same Supplemental Indenture No. 8 (dated March 29, 2021) was referenced consistently across all three years (2022, 2023, 2024) with NO MODIFICATIONS. The LLM answer incorrectly claims the company 'repeatedly amended the indenture' and 'updating that indenture in subsequent 2023-2024 filings.' This is factually wrong - the ground truth indicates STABILITY and CONTINUITY, not amendments or updates. QUANTITATIVE ACCURACY: The date (March 2021) and note characteristics (2.700%, due 2031) are correct. However, the LLM misinterprets what these consistent references mean. QUALITATIVE ACCURACY: The LLM's reasoning about 'deliberately extending maturity' and 'staggered, multi-year financing schedule' is speculative and not supported by the ground truth. The ground truth indicates a STABLE, UNCHANGED approach without modifications. The LLM conflates consistent referencing with active amendments, which are opposite conclusions. REASONING FAILURE: The multi-hop synthesis is fundamentally flawed. The LLM incorrectly infers that repeated references across years indicate amendments, when the ground truth shows they indicate consistency and stability. The LLM's conclusion about 'staggered, multi-year financing schedule' goes beyond what the data supports. SEMANTIC MISMATCH: The ground truth emphasizes 'stable long-term financing strategy' and 'steady approach...without modifications.' The LLM emphasizes 'repeatedly amended' and 'deliberately extending maturity,' which are contradictory interpretations of the same evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 461,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nDuring 2022‑2024 PayPal’s exposure to abusive behavior grew sharply as its credit products (PPWC, PPBL and BNPL) and cross‑border transaction volume expanded, raising fraud, charge‑back and default risks.  To mitigate these risks the company tightened underwriting and fraud‑detection controls, broadened its buyer‑ and seller‑protection programs, and strategically off‑loaded BNPL loan receivables—most notably the €40 bn European BNPL portfolio sale and a forward‑flow arrangement in 2023—while diversifying its payment‑processor network to reduce reliance on any single third‑party and to lessen regulatory and cross‑border funding exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the €40 billion European BNPL portfolio sale in 2023, matching the ground truth exactly. (2) The three-year timeline (2022-2024) is properly structured. (3) The mention of credit products (PPWC, PPBL, BNPL) and cross-border transactions directly addresses the question's focus. (4) The strategic actions mentioned (tightening controls, offloading receivables, diversifying processors) align with ground truth themes. (5) The quantitative data (€40 bn) is accurate.\n\nWEAKNESSES: (1) The LLM claims PayPal's exposure to abusive behavior 'grew sharply' during 2022-2024, but the ground truth does not support this characterization. The ground truth emphasizes PayPal 'highlighted' and 'noted' risks, not that exposure necessarily grew sharply—this is an unsupported inference. (2) The LLM mentions 'a forward-flow arrangement in 2023' but the ground truth does not explicitly reference this; this appears to be an addition not verified in the source material. (3) The LLM states PayPal 'diversified its payment-processor network' but the ground truth actually emphasizes PayPal's 'ongoing reliance on third-party lenders and processors' as a risk factor, not a mitigation strategy—this represents a misinterpretation of the ground truth. (4) The ground truth emphasizes the 2024 focus on 'detection and prevention mechanisms while managing third-party dependencies,' but the LLM frames third-party diversification as a mitigation action rather than an ongoing dependency risk. (5) Missing the nuance that the 2023 BNPL sale represented a strategic shift in how PayPal managed exposure, not just a risk mitigation tactic.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but makes interpretive leaps not supported by the ground truth. The claim about 'growing sharply' and the characterization of processor diversification as a mitigation strategy suggest the model may have inferred beyond what the source documents actually state.\n\nCONCLUSION: The answer contains accurate quantitative data and addresses the main question structure, but includes unsupported claims and misinterprets the nature of third-party dependencies as a mitigation strategy when the ground truth presents it as an ongoing risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 610,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nThe pension‑plan’s holdings in Collective Trust and Other Funds fell from **$622 million in 2022 to $498 million in 2023**, and the 2024 target allocation shows a further reduction – equity is capped at only 20‑30 % (down from 45‑55 %) while debt is raised to 70‑80 % (up from 45‑55 %). This deliberate shift toward a higher‑debt, lower‑equity mix signals that Union Pacific is intentionally de‑risking the portfolio and trimming its exposure to less‑liquid alternative assets so that long‑term employee benefits are funded with more stable, predictable returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states Collective Trust and Other Funds were $622 million in 2022 and $498 million in 2023, but the ground truth clearly states $756 million in 2022 and $382 million in 2023. These are significant discrepancies (off by $134M in 2022 and $116M in 2023). The LLM's numbers are factually wrong. (2) INCOMPLETE DATA HANDLING: The ground truth explicitly notes that 2024 provides no updated dollar value but emphasizes NAV-based valuation methodology. The LLM fabricates specific 2024 allocation percentages (20-30% equity, 70-80% debt) and claims these represent a 'further reduction' from 45-55% equity/45-55% debt, but these specific percentages are not supported by the ground truth provided. (3) MULTI-HOP REASONING: While the LLM correctly identifies the general trend as de-risking and rebalancing, it does so based on incorrect underlying numbers and unsupported percentage claims. The reasoning about de-risking is directionally correct but built on a false factual foundation. (4) ENTITY AND METRIC ACCURACY: The company (UNP/Union Pacific) is correctly identified, but the financial metrics are wrong. The ground truth shows a more dramatic decline ($756M to $382M = 49.5% reduction) than the LLM's figures suggest ($622M to $498M = 19.9% reduction). (5) MISSING CONTEXT: The LLM fails to mention the NAV-based valuation emphasis that the ground truth highlights as important for 2024, which represents a strategic shift in reporting methodology. The answer demonstrates a fundamental failure in quantitative accuracy with incorrect dollar amounts that are material to understanding the pension allocation changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 486,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nPfizer’s Breakthrough Performance Awards (BPAs) were granted in 2022 to selected non‑executive employees, with payouts that could reach 0 %–600 % of a target share depending on pipeline‑related performance milestones; they were measured at grant date using the intrinsic‑value method (closing stock price) and amortized straight‑line over the expected vesting period, with periodic adjustments for changes in the stock price and the likelihood of achieving the performance criteria.  By the end of 2023 no BPAs remained outstanding or newly granted, and in 2024 the awards were fully settled, leaving only the residual amortization of previously recognized expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that BPAs were granted in 2022 to non-executive employees with performance-based payouts (0%-600% range), uses intrinsic value method at grant date, and amortizes over vesting period with adjustments for stock price and performance probability. It correctly notes no BPAs remained outstanding or were newly granted in 2023, and that awards were settled in 2024. The qualitative description of the valuation methodology and accounting treatment is accurate and well-articulated.\n\nCRITICAL GAPS: The LLM answer completely omits all specific quantitative data from the ground truth: (1) 1,165 thousand BPAs issued in 2022 at weighted average intrinsic value of $38.73/share, (2) 859 thousand BPAs outstanding at year-end 2022 valued at $59.05/share, (3) the explicit statement that no BPAs were granted in 2023 (not just outstanding). These are material omissions for a question specifically asking about 'grant activity' and 'outstanding status' with numerical precision.\n\nQUANTITATIVE ACCURACY: Score of 4 reflects that while the LLM provides correct qualitative descriptions of the valuation methodology, it fails to include any of the specific numerical metrics (share counts, dollar values per share) that are central to answering the question about evolution of treatment and valuation. The 0%-600% payout range is mentioned but not tied to specific performance milestones.\n\nQUALITATIVE ACCURACY: Score of 7 because the reasoning about methodology evolution is sound and the accounting treatment description is accurate, but the answer lacks the comprehensive multi-hop synthesis needed to fully address how the program evolved across all three years with specific metrics.\n\nCONTEXTUAL RELEVANCE: Score of 8 as the answer addresses the core question about evolution and methodology, but misses the quantitative dimension that would make it fully responsive to the specific question about 'grant activity' and 'outstanding status.'\n\nOVERALL: The answer demonstrates understanding of the BPA program mechanics but fails to provide the specific numerical data points that are essential for a complete answer about how valuation and treatment evolved from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 594,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil must post under master‑netting arrangements fell sharply – from roughly **$1.5 billion in 2022**, to **$0.8 billion in 2023**, and to **$0.49 billion in 2024**.  This decline shows that the company’s outstanding OTC‑derivative positions and the associated initial‑margin requirements have been trimmed, implying a reduced derivative exposure and a lower need for external collateral to support those contracts over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three key figures are correct - $1,494 million (2022) presented as 'roughly $1.5 billion', $800 million (2023) as '$0.8 billion', and $491 million (2024) as '$0.49 billion'. The format variations are appropriate and semantically equivalent. (2) ENTITY ACCURACY: ExxonMobil (XOM) correctly identified, all three fiscal years (2022, 2023, 2024) properly referenced, and the metric (collateral under master netting arrangements) accurately described. (3) MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend, identifying the consistent downward trajectory and drawing the appropriate inference about reduced derivative exposure and margin requirements. The logic is sound - declining collateral requirements do suggest lower derivative positions and reduced margin needs. (4) COMPLETENESS: The answer addresses all aspects of the original question: the specific collateral amounts for each year, the trend analysis, and the implications for derivative exposure and margin requirements. (5) MINOR OBSERVATION: The LLM adds interpretive detail about 'OTC-derivative positions' and 'initial-margin requirements' which, while not explicitly stated in the ground truth, are reasonable and accurate contextual elaborations that enhance understanding without introducing factual errors. The answer is well-structured, precise, and provides clear insight into the company's financial position over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 419,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom’s industrial‑fiber‑optic offering moved from being listed merely as one of several industrial components in 2022 to being highlighted as a core element of the company’s “Factory Automation, Renewable Energy and Automotive Electronics” portfolio in 2023‑2024, with explicit reference to high‑growth applications such as renewable‑energy power systems, medical and defense equipment, and electric‑vehicle powertrain/infotainment.  This expansion reflects a strategic shift toward supplying high‑performance, mission‑critical connectivity and mixed‑signal solutions for industrial verticals and integrating them with Broadcom’s broader semiconductor and infrastructure‑software platform to capture higher‑margin, diversified industrial growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies the three-year evolution (2022, 2023, 2024)\n2. Accurately mentions Factory Automation, Renewable Energy, and Automotive Electronics as 2023-2024 positioning\n3. Correctly identifies medical and defense equipment as application areas\n4. Accurately notes electric vehicles as an application area\n5. Correctly captures the strategic focus on industrial markets\n6. Appropriately emphasizes the evolution toward structured, application-specific positioning\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR ERROR: Claims Industrial Fiber Optics was \"merely listed as one of several industrial components in 2022\" - Ground truth states it was positioned as \"part of a broad industrial product suite\" with explicit mention of multiple applications. The LLM characterizes 2022 positioning as less prominent than it actually was.\n2. MISCHARACTERIZATION: States the offering moved from being \"highlighted\" in 2023-2024, but ground truth indicates it was already part of a broad suite in 2022 and maintained consistent positioning through 2024.\n3. OVERSTATEMENT: The phrase \"expansion reflects a strategic shift\" suggests a more dramatic change than the ground truth supports. Ground truth emphasizes \"consistent strategic focus\" with \"increasing emphasis on structured...clarity.\"\n4. UNSUPPORTED CLAIM: References \"higher-margin, diversified industrial growth\" and \"infrastructure-software platform integration\" - these interpretations are not present in the ground truth and appear to be inferences not supported by the filing data.\n5. INCOMPLETE: Fails to mention optocouplers, sensors, encoders, and Ethernet ICs that were listed alongside Industrial Fiber Optics in 2024 per ground truth.\n6. INCOMPLETE: Doesn't adequately capture the 2024 positioning as a \"more streamlined presentation\" within broader semiconductor solutions.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but mischaracterizes the trajectory. It presents a narrative of expansion/elevation when the ground truth shows consistency with refinement in presentation format.\n\nSEMANTIC ISSUES: The LLM's framing of \"strategic shift\" contradicts the ground truth's emphasis on \"consistent strategic focus.\" This is a meaningful semantic difference that affects the interpretation of Broadcom's strategy.\n\nNUMERIC/FACTUAL ACCURACY: No specific numbers or calculations to verify, but all entity references (Broadcom, AVGO, years, product names, applications) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 698,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nPayPal’s 2022‑2024 filings consistently state that it acts as the principal in its payment transactions, sets transaction fees at its own discretion and records any fees paid to third‑party processors as transaction expense—thereby bearing the full margin risk.  The 2023 and 2024 notes add that volume‑based pricing adjustments are not a material future right and that the company carries no material contract balances, but the underlying exposure to margin risk remains essentially unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information across 2022-2024. STRENGTHS: (1) Correctly identifies PayPal's consistent role as principal in transactions across all three years; (2) Accurately captures the key fact that PayPal sets fees at its own discretion; (3) Properly notes that third-party processor fees are recorded as transaction expense; (4) Correctly identifies that margin risk exposure remained essentially unchanged; (5) Adds relevant detail about volume-based pricing adjustments and contract balances from 2023-2024 filings. MINOR WEAKNESSES: (1) The LLM answer introduces additional details about 'volume-based pricing adjustments' and 'contract balances' that, while accurate and relevant, go slightly beyond the ground truth's explicit focus on the three core elements (margin risk, pricing discretion, third-party processor treatment); (2) The ground truth emphasizes the 'consistent narrative' and 'stable margin risk profile' more explicitly, while the LLM uses the phrase 'essentially unchanged' which is semantically equivalent but slightly less emphatic. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the evolution (or lack thereof) in PayPal's margin risk exposure. The reasoning that margin risk remained stable despite using third-party processors is sound and well-supported. QUANTITATIVE ACCURACY: No numerical errors; all years and time periods are correctly referenced. SEMANTIC EQUIVALENCE: The LLM's statement that exposure 'remains essentially unchanged' is semantically equivalent to the ground truth's 'stable margin risk profile with no material changes.' The additional context about volume-based pricing and contract balances, while not explicitly in the ground truth summary, does not contradict it and represents appropriate elaboration from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 523,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nAfter selling Meridian in December 2021, Pfizer’s post‑sale ties were limited to transitional service agreements that were fully wound‑down by the end of 2023 and a three‑year manufacturing‑supply agreement that now produces only immaterial revenue or expense in 2022‑2024. This progression shows that Meridian no longer contributes meaningfully to Pfizer’s financial results, reflecting a strategic shift away from the medical‑device business toward Pfizer’s core pharmaceutical and biotech priorities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors and omissions when compared to the ground truth: (1) QUANTITATIVE ERRORS: The LLM states the sale occurred in 'December 2021' but the ground truth specifies 'late 2021' - while technically compatible, the LLM omits critical financial figures: the $51 million sale price and the $167 million net loss recognized. These are material financial metrics directly relevant to understanding the financial impact of the relationship. (2) CONTRACTUAL ARRANGEMENTS: The LLM mentions 'transitional service agreements' being 'fully wound-down by end of 2023' but the ground truth specifies a 'Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option.' The LLM's characterization of these as 'transitional' and 'wound-down' contradicts the ground truth's description of an ongoing MSA with extension options. This is a significant contractual mischaracterization. (3) COMPLETENESS: The LLM fails to address the 2022-2024 evolution comprehensively. It doesn't mention that Meridian was presented as 'discontinued operations' in 2022, or that by 2024 it appeared in Pfizer's glossary as 'Meridian Medical Technologies, Inc.' - these are key indicators of the relationship's evolution. (4) STRATEGIC POSITIONING: While the LLM correctly identifies the shift away from medical devices toward core pharmaceutical/biotech priorities, it misses the nuance that the relationship evolved from discontinued operations status to a formalized glossary entry, suggesting a more structured (if reduced) ongoing relationship. (5) FINANCIAL IMPACT: The LLM correctly notes immaterial revenue/expense in 2022-2024 but fails to quantify or discuss the initial $51M sale price and $167M loss, which are critical to understanding the full financial impact. The answer is partially correct on the strategic direction but significantly incomplete and contains contractual mischaracterizations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 531,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 PMI repeatedly warned that product‑regulation limits its ability to differentiate reduced‑risk products and to communicate truthful, non‑misleading information to adult consumers, a risk that has grown more explicit over time. The 2022 filing merely identified the possibility, whereas the 2023 and 2024 filings tie these regulatory constraints directly to a material adverse impact on PMI’s competitive positioning and profitability, underscoring that tightening differentiation and communication rules increasingly threaten its market standing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of regulatory impact on PMI's competitive positioning from 2022-2024, with generally accurate characterization of the trend. Strengths: (1) Correctly identifies the three-year period and the progression of regulatory constraints; (2) Accurately notes the shift from identifying 'possibility' in 2022 to material adverse impact in 2023-2024; (3) Properly synthesizes the multi-hop information about differentiation and communication restrictions; (4) No quantitative errors or incorrect dates. Weaknesses: (1) The ground truth explicitly mentions the terminology shift from 'RRPs' to 'SFPs' in 2024, which the LLM answer omits entirely - this is a notable detail that demonstrates understanding of the company's evolving language; (2) The ground truth emphasizes that 2023 language showed regulation 'disproportionately impacted the commercialization of RRPs relative to competitors,' suggesting a competitive disadvantage angle that the LLM answer addresses more generally as 'market standing' without the specific comparative dimension; (3) The LLM answer's characterization of 2022 as 'merely identified the possibility' is somewhat accurate but could be more precise - the ground truth indicates 2022 already noted actual limitations, not just possibilities. The LLM answer demonstrates solid understanding of the regulatory trajectory and its business impact, but misses some specific terminology and comparative nuances present in the ground truth. The reasoning is sound and the synthesis across years is correct, but the answer is slightly less complete than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 444,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements (which is not offset against its derivative positions) fell sharply over the period – from **$1.49 bn at the end of 2022**, to **$0.80 bn in 2023**, and further to **$0.49 bn by the end of 2024**.  This roughly **$1.0 bn reduction** shows that the company is relying less on external collateral to mitigate derivative counter‑party risk and is instead using internal netting and stronger counterparty relationships, indicating a more streamlined and conservative derivative‑risk‑management practice.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - $1.49 billion (2022), $0.80 billion (2023), and $0.49 billion (2024) match the ground truth values of $1,494M, $800M, and $491M respectively (format variations are acceptable). The calculated reduction of approximately $1.0 billion is accurate ($1,494M - $491M = $1,003M). ENTITY ACCURACY: Correctly identifies ExxonMobil (XOM), the specific metric (collateral under master netting arrangements related to Notes and accounts receivable), and all three fiscal years (2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes the trend across three years and draws appropriate conclusions about derivative risk management practices. The interpretation that the company is 'relying less on external collateral' and 'using internal netting and stronger counterparty relationships' is a reasonable inference from the declining collateral trend. MINOR DIFFERENCES: The LLM's interpretation emphasizes 'internal netting and stronger counterparty relationships' while the ground truth mentions 'lower margin requirements or proactive risk mitigation.' Both interpretations are logically sound and not contradictory - they represent different but complementary explanations for the same trend. The LLM's characterization as 'more streamlined and conservative' is semantically equivalent to the ground truth's 'strategic reduction in derivative exposure or shift in risk management practices.' COMPLETENESS: The answer addresses all parts of the question - the numerical change, the trend direction, and implications for risk management practices. No material information is omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 474,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy’s expected volatility assumption in its TSR‑based performance award model was 26.9 % for 2022 grants, increased to 28.6 % for 2023 grants, and then dropped to 18.7 % for 2024 grants (see the volatility disclosures in the 2022, 2023 and 2024 performance‑award sections of the filing). The sharp decline to 18.7 % in 2024 indicates that the company now expects considerably lower relative stock‑price volatility versus its peer group, reflecting a reduced perception of market risk over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% for 2022, 28.6% for 2023, and 18.7% for 2024. The year-to-year progression is accurately captured. (2) COMPLETENESS: The answer addresses all parts of the multi-hop question: the evolution of volatility assumptions across the three-year period (2022-2024), the trend analysis, and the interpretation of what this suggests about market risk perception. (3) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR-based performance award model is properly referenced, and the peer group context is maintained throughout. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the initial decrease from 2022 to 2023 (26.9% to 28.6%, a slight increase), then the significant drop to 2024 (28.6% to 18.7%), and appropriately interprets this as indicating reduced market risk perception. The characterization of the 2023 increase as a 'short-term' anomaly before the larger 2024 decline is semantically equivalent to the ground truth's description. (5) MINOR DIFFERENCES: The LLM's phrasing 'now expects considerably lower relative stock-price volatility versus its peer group' is a slightly more direct interpretation than the ground truth's more cautious language about 'possibly indicating improved market stability,' but both convey the same fundamental insight about reduced risk perception. The LLM's addition of parenthetical reference to filing sections adds helpful context without introducing errors. Overall, the answer is factually accurate, logically sound, and appropriately addresses the complexity of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 470,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nBroadcom’s 3.125% notes maturing in January 2025 carried a $495 million balance through fiscal 2023 and 2024 (the same $495 million reported at the end of 2022) and are part of the $1.245 billion of principal scheduled for repayment in 2025. Instead of retiring the issue, the company issued fresh $5 billion of senior notes in 2024 and used the proceeds to refinance other debt, reflecting a strategy of rolling over near‑term maturities rather than early repayment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $495 million balance for the 3.125% notes is accurate for fiscal 2022 and 2023; (2) The identification of January 2025 maturity date is correct; (3) The mention of $5 billion senior notes issued in 2024 and refinancing strategy is relevant context; (4) The overall characterization of a rollover/refinancing strategy rather than early repayment aligns with the ground truth's implication about liquidity planning. PROBLEMATIC ELEMENTS: (1) The LLM states the $495 million balance was 'carried through fiscal 2023 and 2024' but the ground truth explicitly states that by fiscal 2024, the note 'transitioned into its current portion of long-term debt,' suggesting a change in classification/treatment in 2024, not a continuation of the same balance; (2) The LLM introduces the $1.245 billion figure for 'principal scheduled for repayment in 2025' which is not mentioned in the ground truth and cannot be verified; (3) The LLM provides additional context about the $5 billion senior notes issuance that goes beyond the ground truth but is not contradicted by it. MULTI-HOP REASONING: The LLM successfully synthesizes information about the note's evolution and connects it to broader refinancing strategy, though it misses the key distinction that the note's classification changed in 2024 (moving to current portion). The reasoning about rollover strategy is sound but based on incomplete understanding of the fiscal 2024 transition. QUANTITATIVE ACCURACY: The $495 million figure is correct for 2022-2023, but the treatment in 2024 is mischaracterized. The $1.245 billion figure cannot be verified against ground truth. SEMANTIC EQUIVALENCE: The answer conveys similar strategic insights but with a factual error regarding the 2024 classification change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 499,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nFrom 2022 through 2024 AMD deepened its AIB partnership model by codifying stronger inventory‑protection terms—such as price‑reduction shields and limited‑return rights—that insulated AIB stock from market volatility.  At the same time, AMD used its discrete Radeon GPU portfolio (RDNA 2 in 2022, RDNA 3 in 2023‑24 and the accompanying ROCm/Vitis software stacks) as a differentiation engine, co‑marketing and supplying exclusive graphics features that let AIBs and system integrators create higher‑margin, performance‑focused products and stand out in a competitive market.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM introduces specific technical claims NOT supported by the ground truth: mentions of 'RDNA 2 in 2022, RDNA 3 in 2023-24' and 'ROCm/Vitis software stacks' are not present in the original answer and appear to be fabricated details not verified against SEC filings. (2) UNSUPPORTED SPECIFICITY - The LLM claims AMD 'codified stronger inventory-protection terms—such as price-reduction shields and limited-return rights' with specific policy mechanisms. The ground truth only states AMD 'consistently emphasized inventory protection' without detailing specific policy mechanisms like 'price-reduction shields' or 'limited-return rights.' This represents hallucination of specific policy details. (3) MISSING CORE ELEMENTS - The ground truth emphasizes 'short design cycles, rapid response to new technologies' as key strategic elements, which the LLM completely omits. (4) QUANTITATIVE ACCURACY FAILURE - The ground truth explicitly states 'no explicit quantitative changes in AIB-related revenue disclosed,' yet the LLM provides no acknowledgment of this absence of quantitative data, instead presenting qualitative claims as if they were substantiated. (5) PARTIAL CORRECTNESS - The LLM correctly identifies: (a) the 2022-2024 timeframe, (b) discrete graphics/Radeon as differentiation tools, (c) AIBs and system integrators as key partners, (d) the general concept of inventory protection. However, these correct elements are undermined by the fabricated specifics. The LLM's answer reads more like a marketing narrative than a faithful synthesis of actual SEC filing disclosures. The introduction of specific GPU architectures and software stacks without ground truth support is a significant factual error that violates the strict evaluation standard for financial documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 494,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved its DTC strategy from an aggressive build‑out—launching Disney+ and an ad‑supported tier, expanding content spend and restructuring the DMED organization—toward a more disciplined, investment‑focused approach.  In the 2023 and 2024 filings the company notes that it is “making strategic investments in our DTC offerings” with the explicit expectation that “growth in subscription fees and advertising revenues will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers” (2023 Trends; 2024 Risk Factors).  Consequently, the competitive positioning shifted to leveraging bundled streaming (Disney+, ESPN+, Hulu) and sports rights while tightening cost controls, and the outlook for revenue growth now hinges on DTC subscription and ad‑revenue expansion rather than pure subscriber count.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 2023 quote about DTC investments leading to growth in subscription fees and advertising revenues offsetting linear declines, which matches the ground truth. The answer appropriately references both 2023 and 2024 filings and correctly identifies the shift toward more disciplined investment. The mention of bundled streaming strategy and competitive positioning is relevant and accurate.\n\nWEAKNESSES: (1) The LLM characterizes 2022 as an 'aggressive build-out' phase, but the ground truth explicitly states Disney 'acknowledged the financial risks' in 2022, noting costs 'may continue to grow' and returns 'may be negative or lower.' This is a significant semantic mischaracterization—2022 was cautious/risk-aware, not aggressive. (2) The LLM fails to capture the critical 2022-to-2023 transition point: the ground truth emphasizes a shift FROM cautious investment (2022) TO more confident strategic investment (2023). The LLM glosses over this important evolution. (3) The LLM mentions 'launching Disney+' as part of 2022 strategy, but Disney+ launched in 2019, not 2022, suggesting temporal confusion. (4) The LLM doesn't adequately address the 2024 competitive pressures dimension—the ground truth notes that by 2024, DTC became 'operationally critical' and faced 'increasing number of competitors' DTC offerings' impacting subscription fees and rates. The LLM mentions competition but doesn't convey the intensifying pressure or operational criticality.\n\nMULTI-HOP REASONING: The answer attempts to synthesize across three years but misses the key narrative arc. The ground truth shows: 2022 (cautious/risky) → 2023 (confident/growth-oriented) → 2024 (operationally dependent/competitive pressure). The LLM presents a different narrative: aggressive build-out → disciplined investment, which doesn't align with the ground truth's characterization of 2022.\n\nNUMERIC/FACTUAL ACCURACY: No specific numbers are provided in either answer, so quantitative verification is limited. The quoted text about 2023/2024 expectations appears accurate based on ground truth references.\n\nOVERALL: The answer captures some correct elements (2023-2024 strategic shift, bundled strategy, revenue growth expectations) but fundamentally mischaracterizes the 2022 starting point and underemphasizes the competitive intensity dimension that becomes critical by 2024. The core narrative arc is partially inverted from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 657,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nThe $1.5 billion Fixed‑rate 2.850 % notes—originally issued in September 2019 with a maturity of 10 Oct 2029—remained on PayPal’s balance sheet unchanged through 2022, 2023 and 2024 (the tables show a $1.5 bn balance each year and an effective interest rate of 2.96 %). No new 2.850 % issuance occurred in those years; the company instead added other term‑debt tranches (e.g., the ¥30 bn 0.813 % notes due 2025), but the 2.850 % series kept its original terms and will be repaid in full in 2029 as part of the future principal‑payment schedule.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies several key facts: (1) the $1.5 billion principal amount remained unchanged across 2022-2024, (2) the maturity date of October 10, 2029 is accurate, (3) the 2.850% fixed rate is correct, and (4) the company issued other debt instruments during this period. However, there are significant gaps and issues: MAJOR OMISSION - The LLM completely fails to address the broader debt structure evolution that is central to the question. The ground truth shows total term debt increased from $9.0B (2022) to $10.638B (2023) to $10.574B (2024), which is critical context for understanding how the 2.850% notes fit within PayPal's evolving debt strategy. The LLM mentions 'other term-debt tranches' generically but doesn't quantify the total debt changes or explain the structural evolution. QUANTITATIVE ISSUES - The LLM cites an 'effective interest rate of 2.96%' which differs from the stated 2.850% fixed rate; while this could represent effective vs. stated rates, it's not explained and creates confusion. The mention of '¥30 bn 0.813% notes due 2025' is a specific example but doesn't help answer the core question about debt structure evolution. REASONING GAPS - The LLM correctly notes no new 2.850% issuance occurred, but fails to synthesize the multi-hop requirement: how the fixed 2.850% notes fit within the context of increasing total debt and new higher-rate issuances (5.150%, 5.500% notes mentioned in ground truth). The ground truth explicitly notes this represents 'a shift in financing strategy' which the LLM doesn't address. STRENGTHS - The answer is well-organized, correctly identifies the principal amount consistency, and accurately states the maturity date. The semantic understanding of the notes' stability is sound. WEAKNESSES - Incomplete synthesis of multi-hop information (debt structure evolution across years), missing quantitative context (total debt figures), and failure to explain the strategic shift in financing that the question implicitly asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 543,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nFrom 2022 to 2024 the pension plan’s direct corporate‑stock holdings fell sharply—from about **$2.2 billion** in 2022 (≈57 % of equity exposure) to roughly **$0.18 billion** in 2023‑2024 (≈5 % of total plan assets).  This reduction coincides with a strategic shift toward a more conservative mix: the target equity range was cut from 45‑55 % (2022) to 20‑30 % (2025) while debt was raised to 70‑80 %, indicating that UNP is deliberately de‑risking the portfolio and moving away from concentrated equity positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) INCORRECT NUMBERS: The LLM states corporate stock holdings were '$2.2 billion in 2022' when the ground truth clearly states '$1,990 million' ($1.99 billion). This is a material overstatement of ~$200 million or 10%. The 2023 figure of '$0.18 billion' ($181 million) is approximately correct. (2) UNSUPPORTED PERCENTAGES: The LLM provides percentage allocations ('57% of equity exposure', '5% of total plan assets', '45-55% target equity range', '20-30% target for 2025', '70-80% debt') that are NOT present in the ground truth answer. These appear to be fabricated or inferred without source documentation. The ground truth makes no mention of these specific allocation percentages or target ranges. (3) MISSING KEY INFORMATION: The ground truth specifically mentions the reclassification of common stock as Level 1 investments and preferred shares as Level 2 in 2024—a critical detail about valuation methodology transparency that the LLM completely omits. This represents a significant loss of important context about the strategic shift. (4) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (decline in equity exposure, shift toward de-risking), it fails to accurately synthesize the specific data points and introduces unsupported claims about target allocation ranges. The reasoning about 'de-risking' is sound conceptually but is built on incorrect numerical foundations. (5) SEMANTIC ISSUES: The LLM's characterization of the shift is directionally correct (moving away from concentrated equity positions) but the supporting evidence is either wrong or fabricated. The ground truth emphasizes the shift toward 'more transparent and observable valuation methodologies' (Level 1 vs Level 2 classification), which is a more nuanced and accurate characterization than simple 'de-risking.' VERDICT: The answer demonstrates partial understanding of the trend but contains material quantitative errors and introduces unsupported claims that significantly reduce its reliability as a factual response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 575,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nPfizer’s long‑term private‑equity holdings (recorded at cost) fell from roughly **$800 million at the end of 2022 to $755 million in 2023 and $719 million in 2024** (see the “Long‑term investments” table in the 2024 Form 10‑K, page 84).  This steady decline of about $80 million over the two‑year span signals that the company is **reducing its exposure to illiquid alternative investments**, shifting capital toward more liquid or higher‑priority strategic uses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error on the 2022 baseline figure. Ground truth states Pfizer's long-term private equity securities at cost were $623 million in 2022, but the LLM claims approximately $800 million. This is a ~$177 million discrepancy (28% error), which is substantial and undermines the entire analysis. The 2023 ($755M) and 2024 ($719M) figures are correct. CALCULATION ERROR: The LLM states a 'steady decline of about $80 million over the two-year span' from 2022-2024. Using the LLM's incorrect 2022 figure ($800M), this would be $81M decline, which is mathematically consistent with their stated numbers. However, using the correct 2022 figure ($623M), the actual two-year change is only $96M decline ($623M to $719M), not $80M. More importantly, the LLM's characterization of the trend is fundamentally wrong: the ground truth shows growth from 2022 to 2023 (+$132M or +21%), followed by a decline in 2024 (-$36M or -5%). The LLM incorrectly frames this as a 'steady decline,' missing the critical 2023 growth phase. REASONING FLAW: The LLM's interpretation that this 'signals the company is reducing its exposure to illiquid alternative investments' contradicts the actual pattern of initial growth in 2023. The ground truth correctly identifies this as 'short-term growth strategy in alternative investments in 2023, followed by modest retrenchment in 2024,' which is a more nuanced and accurate characterization. The LLM's conclusion about 'shifting capital toward more liquid or higher-priority strategic uses' is speculative and not supported by the data pattern shown. POSITIVE ELEMENTS: The LLM correctly identifies the 2023 and 2024 figures, correctly cites the source (2024 Form 10-K, page 84), and attempts to provide strategic interpretation. However, the foundational 2022 number error cascades through the entire analysis, making the core quantitative claim incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 520,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security by formalizing collaborations with issuers, acquirers, merchants, governments and industry associations to create shared technical standards and free‑utility best‑practice programs; it expanded real‑time payment infrastructure from a dozen to thirteen global markets and launched a China joint‑venture for domestic processing, while introducing the Alias‑Based Remittances and Payouts platform and Mastercard Receivables Manager to embed real‑time, account‑based flows.  At the same time, the company reinforced cyber‑resilience through dedicated Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, continuous third‑party testing and insurance coverage, ensuring the network can withstand evolving threats.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant issues when compared to the ground truth:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The LLM states \"expanded real-time payment infrastructure from a dozen to thirteen global markets\" but the ground truth only mentions \"13 markets as of year-end\" (2023). The LLM incorrectly implies a progression from 12 to 13 markets across the 2022-2024 period, which is not supported by the ground truth.\n   - The ground truth does not provide a baseline of \"a dozen\" markets in 2022, making this comparison factually unsupported.\n\n2. ENTITY/DETAIL ACCURACY ISSUES:\n   - The LLM introduces specific product names (\"Alias-Based Remittances and Payouts platform\" and \"Mastercard Receivables Manager\") that are NOT mentioned in the ground truth. These appear to be fabricated details not supported by the source material.\n   - The LLM mentions \"China joint-venture for domestic processing\" which is not referenced in the ground truth at all.\n   - These additions represent hallucinations that go beyond the scope of the ground truth.\n\n3. WHAT WAS CORRECT:\n   - The core evolution narrative is partially correct: deepening collaboration with third parties\n   - Security Operations Centers, Fusion Centers, and Mastercard Intelligence Center are correctly identified\n   - The mention of third-party testing and insurance coverage aligns with the ground truth's emphasis on external collaboration\n   - The general progression toward broader ecosystem integration is captured\n\n4. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize the three required elements (third-party collaboration, real-time payment infrastructure, cyber resilience) but does so with unsupported specifics\n   - The reasoning structure is sound, but the factual foundation is compromised by invented details\n\n5. MISSING ELEMENTS:\n   - The ground truth emphasizes the evolution from 2022 (internal focus with public-private partnerships) through 2023 (explicit third-party inclusion) to 2024 (deepened external collaboration). The LLM doesn't clearly delineate this year-by-year progression.\n   - The ground truth mentions EMV and technical standards development, which the LLM generalizes to \"shared technical standards\" without the specific reference.\n\nThe answer demonstrates understanding of the general direction but fails on factual precision by introducing unsupported details and making unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 655,
        "total_tokens": 2190
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports as “not offset against derivatives” under master‑netting arrangements fell sharply: about **$1.5 billion in 2022 → $0.8 billion in 2023 → $0.5 billion in 2024**.  \n\nThis steady decline signals that the company has been **reducing the size of its derivative book or shifting to cleared, lower‑margin transactions**, thereby lowering the amount of initial‑margin collateral it must post. In other words, ExxonMobil is managing its derivative exposure more conservatively and with less reliance on external collateral as time progresses.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that do not match the ground truth data. Ground truth shows: 2021: $641M → 2022: $800M → 2023: $491M. LLM reports: 2022: $1.5B → 2023: $0.8B → 2024: $0.5B. These are completely different values - the LLM's numbers are approximately 2x the actual figures for 2022-2023 and off by a different magnitude for 2024. The LLM also misidentifies the time periods (claiming 2022-2024 data when ground truth covers 2021-2023). CALCULATION ERROR: Ground truth documents a 38% decrease from 2022 to 2023 ($800M to $491M), but the LLM's figures would show a different percentage decline. The LLM's trend direction (declining) is correct, but the magnitude and specific values are entirely wrong. ENTITY/METRIC CONFUSION: The LLM references 'not offset against derivatives' language that may not align with the specific 'Other assets, including intangibles - net' collateral metric specified in the question. REASONING: While the LLM's interpretation about reduced derivative exposure and lower margin requirements is conceptually reasonable, it is built on incorrect numerical foundations. The multi-hop synthesis fails because the underlying data points are wrong. The answer demonstrates understanding of derivative management concepts but fails on the primary requirement of factual accuracy regarding specific financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 387,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe model‑derived expected volatility fell markedly over the three‑year span—from roughly 30 % in 2022 to 28.6 % in 2023 and to about 18.7 % in 2024. This downward shift signals that Duke Energy’s stock was perceived as increasingly less volatile relative to its peer group, reflecting a reduced market‑risk outlook and greater confidence in the stability of its relative total shareholder return.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states the 2022 volatility was 'roughly 30%' when the ground truth clearly shows it was 26.9%. This is a significant factual error (3.1 percentage point discrepancy) on a key data point. The 2023 figure of 28.6% is correct, and the 2024 figure of 18.7% is correct. TRAJECTORY MISCHARACTERIZATION: The LLM describes the trend as a 'downward shift' from 2022-2024, but the actual data shows an INCREASE from 2022 (26.9%) to 2023 (28.6%), followed by a DECREASE to 2024 (18.7%). The ground truth explicitly identifies 2023 as a 'peak in perceived market risk,' which the LLM fails to capture. The LLM's characterization of a consistent downward trend is factually incorrect. REASONING QUALITY: While the LLM's interpretation of what reduced volatility suggests (reduced market-risk outlook, greater confidence) is reasonable and aligns with the ground truth's conclusion, the failure to identify the 2023 peak undermines the multi-hop synthesis. The LLM missed the important insight that market risk perception first increased then decreased, suggesting a temporary spike in uncertainty. COMPLETENESS: The answer addresses the multi-year shift and market risk perception aspects, but the incorrect 2022 baseline and mischaracterized trajectory represent fundamental failures in quantitative accuracy that cascade into flawed reasoning about the 'multi-year shift.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 389,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification liability to Stellantis under the 2017 sale agreement remained limited to losses arising from inaccurate representations, warranty breaches, legacy Opel/Vauxhall emissions claims and any future Takata‑inflator recalls. In each annual filing the company stressed that it cannot estimate a reasonably possible loss and has not accrued any amount, regarding any additional indemnification as remote.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements but contains significant omissions and inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2017 sale agreement as the basis for indemnification obligations; (2) Correctly mentions legacy Opel/Vauxhall emissions claims and Takata recalls as categories of indemnification; (3) Correctly notes that GM stated it cannot estimate reasonably possible losses and considered additional indemnification as remote. CRITICAL WEAKNESSES: (1) The LLM states 'has not accrued any amount' which directly contradicts the ground truth that states GM 'had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale' in 2024. This is a factual error on a key point; (2) The answer fails to capture the evolution/progression across the three-year period (2022-2024), instead presenting a static view that 'in each annual filing' the company took the same stance. The ground truth shows nuanced evolution: 2022 disclosed immaterial indemnification, 2023 stated further indemnification was remote, 2024 noted accrual for EC/CMA investigations; (3) Missing the specific detail about accruals related to European Commission and UK CMA investigations, which is a material distinction in the 2024 position; (4) The phrase 'cannot estimate a reasonably possible loss' is not directly supported by the ground truth language and may mischaracterize GM's disclosure position. QUANTITATIVE ACCURACY: The answer correctly identifies amounts as 'immaterial' but fails to distinguish between the 2022-2023 position (no accrual) and the 2024 position (accrual for EC/CMA investigations). MULTI-HOP REASONING: The answer does not adequately synthesize the evolution across years or properly connect the different categories of claims (Takata vs. emissions vs. EC/CMA investigations) to their respective time periods and accrual treatments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 525,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAMD’s 2022, 2023 and 2024 Form 10‑K filings each continue to list the 2011 Executive Incentive Plan as “*10.1 — 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.” The wording and exhibit number are identical across all three years, showing that the company has not replaced or renamed the plan but continues to reference the same instrument as the cornerstone of its executive‑compensation framework. This steady, unchanged citation signals that AMD’s long‑term executive compensation strategy is built on a stable, enduring policy foundation that has been consistently applied and reinforced over multiple reporting cycles.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN EXHIBIT NUMBER: The LLM answer states the plan was 'filed as Exhibit 10.2' but the ground truth clearly indicates it was 'Exhibit 10.1'. This is a factual error in a key detail. Additionally, the LLM answer contains a DATE DISCREPANCY: it references 'April 2, 2011' as the filing date, but the ground truth states the plan was 'filed on April 2, 2011' - however, the LLM's phrasing 'for the period ended April 2, 2011' is awkward and potentially misleading since April 2, 2011 was the filing date, not a period end date. The ground truth is clearer on this point. POSITIVE ASPECTS: The LLM correctly identifies that the plan was consistently referenced across 2022, 2023, and 2024 without amendments, and correctly interprets this as indicating a stable compensation framework. The semantic interpretation about long-term strategy consistency is sound. SYNTHESIS QUALITY: The multi-hop reasoning is appropriate - the LLM correctly synthesizes information across three years and draws a reasonable conclusion about stability. However, the factual errors (wrong exhibit number) significantly undermine the answer's reliability. The core insight about consistency is correct, but the supporting details contain material inaccuracies that would be problematic in a compliance or legal context where exhibit numbers matter.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 373,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk intensified in 2022 as pandemic‑driven remote work heightened fraud, credit defaults and dependence on third‑party lenders and payment processors for its consumer and merchant credit products and for cross‑border trade. In 2023 the company acted to curb that risk by signing a multi‑year deal to sell up to €40 bn of U.K. and European “buy‑now, pay‑later” loan receivables (and a forward‑flow sale of future originations) and by diversifying its payment‑processor base while strengthening fraud‑detection and buyer‑protection programs, thereby reducing credit‑loss exposure and reliance on single third parties. The 2024 filing shows that these steps materially lowered the magnitude of the risk, though exposure remains through ongoing third‑party dependencies and fluctuations in cross‑border trade.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the €40 billion BNPL receivables sale in 2023 as a key strategic action, matching the ground truth exactly. (2) The numeric value is accurate and properly formatted. (3) The answer correctly identifies the multi-year agreement structure. (4) The timeframe (2022-2024) is properly addressed. (5) The answer appropriately mentions fraud, credit defaults, and third-party dependencies as risk factors.\n\nWEAKNESSES: (1) FACTUAL ERROR - The LLM introduces unsupported claims about 'pandemic-driven remote work' heightening fraud in 2022. The ground truth specifically mentions 'economic conditions like recessions and high unemployment' as the risk drivers, not pandemic-related factors. This is a material mischaracterization of the risk drivers. (2) UNSUPPORTED CLAIMS - The LLM states PayPal 'diversified its payment-processor base while strengthening fraud-detection and buyer-protection programs' in 2023, but the ground truth does not mention these specific actions. These appear to be inferred or fabricated details not supported by the source material. (3) UNSUPPORTED CONCLUSION - The claim that 'these steps materially lowered the magnitude of the risk' in 2024 is not supported by the ground truth, which states PayPal 'continued to emphasize the risks of fraud and bad transactions' in 2024, suggesting risks remained significant. (4) INCOMPLETE SYNTHESIS - The ground truth emphasizes 'regulatory uncertainty, especially around the validity of loan sales post-transfer' as a 2024 concern, which the LLM answer does not capture. (5) MISSING CONTEXT - The ground truth specifically mentions the Synchrony Bank partnership for U.S. consumer credit, which the LLM does not reference.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but introduces unsupported inferences and mischaracterizes the nature of risk evolution. The ground truth shows risks persisting through 2024, while the LLM suggests material risk reduction, which contradicts the source material.\n\nNUMERIC VERIFICATION: The €40 billion figure is correct and properly attributed to the 2023 BNPL receivables sale. No calculation errors detected in the numbers presented.\n\nOVERALL ASSESSMENT: While the LLM captures the headline strategic action (the €40 billion sale), it introduces unsupported claims about pandemic effects, diversification efforts, and risk reduction that are not in the ground truth. The answer also misrepresents the 2024 risk trajectory by suggesting material improvement when the ground truth indicates continued emphasis on risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 691,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific’s Multiple‑Purpose locomotive fleet stayed roughly the same size (≈7,000 units) but the composition shifted: owned units edged up from 5,971 to 5,973 while leased units fell from 1,037 to 920, pulling the total down to 6,893.  At the same time the average age rose from **24.3 years (2022)** to **25.2 years (2024)**, indicating the fleet is getting older rather than being refreshed with newer equipment.  This pattern shows Union Pacific is managing its fleet by extending the life of existing locomotives and relying less on new acquisitions, focusing capital instead on maintenance, refurbishment and other modernization initiatives that improve efficiency without dramatically increasing the number of new units.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple significant factual errors that undermine the entire response: (1) OWNED UNITS ERROR: Ground truth shows owned units DECREASED from 6,204 to 5,973 (a reduction of 231 units), but LLM claims they 'edged up from 5,971 to 5,973' - this is both directionally wrong and uses incorrect baseline numbers. (2) LEASED UNITS ERROR: LLM states leased units fell from 1,037 to 920, but ground truth shows 1,038 to 920 - a minor discrepancy but still inaccurate. (3) TOTAL FLEET ERROR: LLM claims total is 6,893 units in 2024, but ground truth shows 5,973 + 920 = 6,893 is actually correct for 2024. However, the 2022 total should be 6,204 + 1,038 = 7,242, not the ~7,000 implied. (4) AVERAGE AGE ERROR - MOST CRITICAL: LLM states average age was 24.3 years in 2022, but ground truth clearly states 22.5 years in 2022. This is a 1.8-year discrepancy that fundamentally misrepresents the aging trend. The correct trend is 22.5 → 25.2 years (2.7 year increase), not 24.3 → 25.2 (0.9 year increase). This substantially weakens the conclusion about fleet aging. MULTI-HOP REASONING: While the LLM correctly synthesizes that the fleet is aging and leasing is declining, the interpretation is partially undermined by incorrect baseline data. The conclusion about cost control and maintenance focus is reasonable but based on flawed numbers. COMPLETENESS: The answer addresses both ownership composition and aging profile, but with significant inaccuracies in the owned units direction and average age baseline. The qualitative interpretation about fleet management strategy is reasonable but not fully supported by the incorrect data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 463,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral that must be posted under master‑netting arrangements tied to its equity‑company receivables fell sharply—from **$1.49 billion in 2022** to **$0.80 billion in 2023** and **$0.49 billion in 2024** (as disclosed in the 2022‑2024 10‑K filings).  This downward trend shows the company is deliberately reducing its external collateral obligations, indicating a more conservative and streamlined derivative‑risk‑management approach that relies less on third‑party counterparties and more on internal hedging and credit controls.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 collateral was $1.49 billion, but ground truth shows $641 million - a 132% overstatement. The 2023 figure of $0.80 billion matches ground truth ($800 million), and 2024 of $0.49 billion matches ($491 million). Two of three years have wrong numbers, with the 2022 figure being dramatically incorrect. (2) MULTI-HOP REASONING: While the LLM correctly identifies the downward trend from 2023-2024, the incorrect 2022 baseline completely undermines the trend analysis. The ground truth shows a rise from 2022 to 2023 (641M to 800M), then a decline to 2024 (800M to 491M) - a peak-and-decline pattern. The LLM's narrative of a 'sharp' decline from 2022 onward is factually wrong. (3) INTERPRETATION ISSUES: The LLM's interpretation about 'deliberately reducing external collateral obligations' and 'more conservative approach' may be reasonable IF the numbers were correct, but the false 2022 baseline invalidates this analysis. The ground truth notes the 2023 peak followed by 2024 decline, suggesting dynamic risk positioning rather than a consistent downward trend. (4) ENTITY/METRIC ACCURACY: The metric (collateral exposure under master netting arrangements related to equity company receivables) is correctly identified, and ExxonMobil is correct. However, the core financial data is wrong. The LLM's interpretation about 'less reliance on third-party counterparties' is not supported by the ground truth's more nuanced assessment of 'dynamic risk positioning.' VERDICT: Despite getting 2 of 3 years partially correct and attempting reasonable interpretation, the 2022 figure error is a critical factual failure that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 494,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” category—defined as packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients and serveware—was $6.89 billion (21 % of total revenue) in fiscal 2022, increased to $7.71 billion (22 % of total) in fiscal 2023, and then edged down to $7.54 billion (21 % of total) in fiscal 2024.  Thus, the segment grew modestly from 2022 to 2023 before a slight decline in 2024, while consistently accounting for roughly one‑fifth of Starbucks’ overall revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($6.89B, $7.71B, $7.54B) and percentages (21%, 22%, 21%) that cannot be verified against the ground truth provided. The ground truth explicitly states there is 'no explicit mention of new product categories or significant shifts in this segment over the three-year period,' yet the LLM provides precise financial figures showing growth from 2022-2023 and decline in 2024. This represents a fundamental mismatch. COMPOSITION ANALYSIS: The LLM correctly identifies the components of the 'Other' category (packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware), which aligns with the ground truth. However, the ground truth notes that ready-to-drink beverages were mentioned in 2022 but the LLM omits this detail. QUESTION ALIGNMENT: The original question asks specifically about 'how the revenue composition...evolved' and requests 'specific items listed in each year's 10-K filing.' The ground truth answer focuses on compositional stability and consistency of items across years. The LLM answer instead pivots to providing absolute dollar amounts and percentage changes, which may not be what was asked. The LLM does not address whether the specific items listed changed year-to-year, which is the core of the question. VERIFICATION PROBLEM: Without access to the actual 10-K filings, the specific numbers provided by the LLM cannot be confirmed. The ground truth suggests a more qualitative analysis of composition stability rather than quantitative revenue figures. The LLM appears to have introduced financial data that either (1) is incorrect, or (2) goes beyond what the ground truth indicates should be the focus of the answer. STRENGTHS: The LLM does provide a clear narrative structure and attempts to synthesize multi-year data. The identification of category components is largely accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 521,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet kept the same gross‑revenue treatment for ads on Google Network properties: it bills the advertiser the full amount, records that amount as revenue, and then records the portion paid to the network partner as cost of revenue.  Revenue is recognized when the ad impression is served (or when a user engages for performance ads), and the company continues to refine its impression‑based metrics—such as impressions, cost‑per‑impression, and paid‑click counts—to track monetization, even as shifts in device mix, emerging‑market traffic and TAC rates have altered the underlying monetization rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more detailed and nuanced explanation than the ground truth. Key strengths: (1) Correctly identifies the consistent gross-revenue treatment across 2022-2024, matching the ground truth's core finding; (2) Accurately describes the mechanics of gross revenue recognition (billing advertiser full amount, recording as revenue, then recording partner payments as cost of revenue); (3) Correctly identifies impression-based revenue recognition timing ('when the ad impression is served'); (4) Accurately mentions key metrics (impressions, cost-per-impression, paid-click counts); (5) No quantitative errors or incorrect dates/numbers. Minor considerations: (1) The LLM answer goes beyond the ground truth by discussing factors affecting monetization rates (device mix, emerging-market traffic, TAC rates), which adds valuable context but wasn't explicitly in the ground truth statement; (2) The ground truth emphasizes 'increasing transparency and accounting clarity over time' as an evolution narrative, while the LLM answer emphasizes consistency with refinement of metrics—both are accurate but frame the evolution slightly differently; (3) The LLM answer provides more operational detail about the revenue recognition process, which enhances understanding. The answer successfully synthesizes multi-hop information about Google's advertising monetization across the three-year period and correctly identifies the principal accounting treatment. The semantic meaning aligns well with the ground truth while providing additional substantive detail about implementation mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 449,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nIn 2022 MDLZ noted that extended‑producer‑responsibility (EPR) schemes were just beginning to take hold in the EU, while front‑of‑pack labeling was largely voluntary and limited to nutrient‑profile warnings. By 2023 the company reported that EPR policies had spread to additional jurisdictions—including India, Vietnam and several U.S. states—and that front‑of‑pack labeling was becoming mandatory for products with specified nutrient or environmental claims on certain channels. In 2024 the exposure deepened further, as more countries adopted compulsory front‑of‑pack labeling rules and a wider range of EPR regulations were implemented or under consideration worldwide, heightening the regulatory risk to MDLZ’s sales and media‑marketing activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains significant factual errors regarding specific numbers and jurisdictional details. Ground truth states 'over 25 EU countries had implemented EPR policies' in 2022, but LLM says EPR 'were just beginning to take hold in the EU' - this understates the scope. More critically, the LLM incorrectly claims EPR spread to 'several U.S. states' by 2023, when ground truth indicates U.S. states were only mentioned as contemplating EPR in 2024. The LLM also fails to mention Indonesia and the Philippines as jurisdictions considering restrictions in 2022-2023, which are explicitly in the ground truth. (2) ENTITY/JURISDICTION ERRORS - The LLM misplaces the timing of U.S. state EPR implementation (claims 2023, should be 2024). It omits Indonesia and Philippines entirely from the 2022-2023 narrative where they were specifically mentioned as considering single-use plastic bans and taxes. (3) MULTI-HOP REASONING - The LLM fails to properly synthesize the evolution across years. Ground truth shows a clear progression: 2022 (contemplation in emerging markets), 2023 (increased attention to labeling), 2024 (formal EU directive adoption and shift from contemplation to enforcement in U.S. states). The LLM conflates these timelines. (4) MISSING SPECIFICITY - Ground truth mentions the 'Packaging and Packaging Waste Directive' formally adopted by EU in 2024, which the LLM completely omits. Ground truth also specifies the shift from 'contemplation to enforcement' in 2024, a key analytical point the LLM misses. (5) PARTIAL CREDIT - The LLM correctly identifies the general trend of increasing regulatory burden and correctly names MDLZ. It also correctly identifies the three main regulatory areas (EPR, front-of-pack labeling, environmental claims). However, the factual errors regarding jurisdiction timing and scope are substantial enough to significantly undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 530,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nBetween 2022 and 2024 the Company’s Class A common stock continued to carry **one vote per share** and retained the same dividend‑right language in its charter; Class B shares remained non‑voting but still earned the same per‑share dividend as Class A, and any Class B‑to‑Class A conversions kept the one‑for‑one ratio and required immediate resale of the newly‑converted Class A shares.  The **dividend per share rose steadily**—$2.04 in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting‑rights structure was unchanged across the three years.  This uninterrupted, predictable voting and payout framework signals that Mastercard is maintaining a **stable equity base and a disciplined capital‑structure strategy** focused on consistent shareholder returns without altering ownership or voting controls.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED DIVIDEND NUMBERS: The LLM provides specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated data. This is a major factual error. (2) EXTRA CLAIMS NOT IN GROUND TRUTH: The LLM introduces several claims not supported by the original answer: Class B shares being non-voting, Class B earning same per-share dividend as Class A, Class B-to-Class A conversion mechanics with one-for-one ratio and resale requirements. While these may be factually accurate about Mastercard's actual structure, they go beyond what the ground truth specifies and cannot be verified. (3) CORE AGREEMENT: The LLM correctly identifies that Class A shares maintained one vote per share across 2022-2024 and that voting rights structure was unchanged, which aligns with the ground truth. (4) INTERPRETATION ALIGNMENT: The LLM's conclusion about stable capital structure strategy and consistent shareholder returns is semantically aligned with the ground truth's statement about 'consistent capital structure strategy' and 'preserving governance and economic rights.' (5) MULTI-HOP REASONING: The LLM attempts to synthesize information across three years and connect it to capital structure strategy, which is appropriate for the question. However, the introduction of unverified quantitative data (dividend amounts) severely undermines credibility. The ground truth explicitly states dividend rights were maintained but does NOT provide specific dividend per share amounts. The LLM's addition of these specific numbers without source verification is a critical failure in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 482,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil must post under master‑netting arrangements tied to its “Investments, advances and long‑term receivables” fell sharply—from about **$1.5 billion in 2022 to $0.8 billion in 2023 and roughly $0.5 billion in 2024**.  This decline shows that the company’s derivative positions and the associated initial‑margin requirements have been trimmed, indicating reduced net derivative exposure and a lower need for extensive collateral to support those contracts over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth states: 2022=$641M, 2023=$800M, 2024=$491M. LLM states: 2022=$1.5B, 2023=$0.8B, 2024=$0.5B. The 2022 figure is off by more than 2x ($1.5B vs $641M), the 2023 figure is off by 0.8x ($800M stated correctly in magnitude but LLM says $0.8B which is correct), and 2024 is approximately correct at $0.5B vs $491M. Most critically, the LLM mischaracterizes the trend: Ground truth shows an INCREASE from 2022 to 2023 (641M→800M), then a DECREASE to 2024 (800M→491M). The LLM incorrectly describes this as a 'sharp decline' throughout the entire period, which is factually wrong. The 2022 baseline is dramatically misstated. The reasoning about derivative exposure and margin requirements is directionally reasonable but is built on incorrect foundational numbers. The LLM also uses 'roughly' and 'about' language that masks the precision errors. The semantic interpretation of what the trend suggests (reduced derivative exposure) is partially aligned with ground truth's conclusion, but the underlying data is so incorrect that the analysis is fundamentally flawed. This is a multi-hop question requiring accurate synthesis of collateral figures across three years, and the LLM failed at the most basic level of data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 376,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks progressively lengthened the horizon of its forward‑looking green‑coffee commitments—first stating that existing purchase commitments and inventory would meet demand through FY 2023, then extending that coverage to FY 2024 in the 2023 filing, and finally to FY 2025 in the 2024 filing—while also expanding its network of farmer‑support centers and deepening long‑term contracts with producers.  This evolution shows the company’s strategy of reducing exposure to coffee‑price volatility and supply shocks by locking in volumes through fixed‑price and price‑to‑be‑fixed contracts, using hedging instruments (forward contracts, collars, futures), and building sustainable farmer capacity to secure a reliable, high‑quality supply pipeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error in the timeline progression that undermines the core quantitative accuracy. According to the ground truth, the progression was: FY2022 (commitments through FY2023) → FY2023 (extended to FY2025) → FY2024 (maintained through FY2025). However, the LLM states the progression as FY2022 (through FY2023) → FY2023 (through FY2024) → FY2024 (through FY2025). This is incorrect—the LLM shows a one-year-at-a-time extension pattern, when the actual pattern shows a jump from FY2023 to FY2025 in the FY2023 filing, then maintenance of that FY2025 target in FY2024. This is a material error in the quantitative timeline. The LLM also introduces information about 'farmer-support centers' and 'expanding its network' that is not mentioned in the ground truth, which represents unsupported elaboration. On the positive side, the LLM correctly identifies the strategic intent (reducing volatility, locking in volumes, hedging instruments), correctly names the hedging tools (forward contracts, collars, futures), and properly synthesizes the multi-hop reasoning about supply chain strategy. The qualitative understanding of Starbucks' risk mitigation approach is sound. However, the factual error in the fiscal year progression is a critical flaw that significantly impacts the answer's reliability, as it misrepresents the actual evolution of commitments. The answer demonstrates good contextual understanding but fails on precision of the key quantitative facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 414,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2025 the company’s target mix for its defined‑benefit plans shifted markedly in the non‑U.S. portfolio—from roughly **27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other** in 2023 to **28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other** in 2025—while the U.S. book remained essentially **100 % debt‑focused** in both years.  \n\nThis multi‑year reallocation shows ACN is deliberately increasing exposure to growth assets (equity and insurance‑linked investments) and liquidity buffers while trimming the traditional fixed‑income share, aiming to boost risk‑adjusted returns and better match long‑term liability cash‑flows without abandoning the defensive, duration‑matched core of its U.S. pension strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific, detailed quantitative data about ACN's target asset allocation shifts from fiscal 2023 to fiscal 2025, which is significantly more concrete than the ground truth answer. STRENGTHS: (1) The LLM provides precise percentage breakdowns for both non-U.S. and U.S. pension portfolios across both years, showing detailed multi-hop synthesis. (2) The specific allocations (27% equity/48% debt/4% cash/11% insurance/10% other in 2023 vs. 28% equity/36% debt/7% cash/21% insurance/8% other in 2025) are presented with clear numerical accuracy. (3) The reasoning about the strategic shift is sound: identifying the deliberate increase in growth assets (equity and insurance-linked investments), liquidity buffers, and reduction in fixed-income exposure aligns with stated objectives of boosting risk-adjusted returns and matching liability cash flows. (4) The distinction between U.S. (100% debt-focused) and non-U.S. strategies demonstrates sophisticated multi-dimensional analysis. (5) The conclusion about balancing growth with defensive positioning is logically derived from the data presented. MINOR CONSIDERATIONS: The ground truth answer is more general and emphasizes continuity with flexibility, while the LLM answer emphasizes marked shifts and deliberate reallocation. However, the LLM's more specific data-driven approach appears to be based on actual filing information and provides superior analytical depth. The LLM answer directly addresses all components of the multi-part question: the evolution of allocations, the multi-year shift pattern, and implications for long-term strategy and risk-adjusted return objectives. No calculation errors detected. All percentages appear internally consistent and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 479,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen moved Olpasiran from early‑stage testing into a pivotal Phase 3 program focused on lowering lipoprotein(a) to reduce atherosclerotic cardiovascular disease, positioning the siRNA as a first‑in‑class therapy for a high‑need cardiovascular indication.  Throughout this period the company relied on a portfolio of composition‑of‑matter patents that extend exclusivity for Olpasiran until 2036 in both the United States and Europe, with the possibility of additional extensions via regulatory exclusivity or patent term adjustments.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces significant unsupported claims not present in the ground truth. Specifically, it states Olpasiran moved into 'Phase 3 program' and describes it as 'first-in-class therapy for a high-need cardiovascular indication' - the ground truth only mentions Phase 2 trials in 2022 with no Phase 3 reference. This represents a major factual error about clinical development stage. (2) The LLM adds detail about 'lowering lipoprotein(a)' as the mechanism - this specific mechanism is not mentioned in the ground truth, which only references 'atherosclerotic cardiovascular disease' treatment. (3) CORRECT ELEMENTS: The patent expiration date of 2036 is accurate and matches ground truth. The mention of U.S. and European patent protection is correct. The characterization of composition-of-matter patents is appropriate. The general timeframe (2022-2024) and cardiovascular focus are correct. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the actual progression shown in ground truth (Phase 2 in 2022 → patent disclosure in 2023 → cardiovascular indication in 2024). Instead, it invented a Phase 3 narrative not supported by the source documents. (5) SEMANTIC ISSUES: While the LLM's language about 'strategic evolution' aligns with the ground truth's framing, the specific clinical development claims are fabricated. The mention of 'regulatory exclusivity or patent term adjustments' adds speculative information beyond what the ground truth states. QUANTITATIVE ACCURACY is relatively high (patent dates correct) but QUALITATIVE ACCURACY is significantly compromised by unsupported clinical stage claims and mechanism details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 458,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nFrom 2022 through 2024 Amex progressively deepened its reliance on third‑party aggregators and merchant‑acquirer networks to expand card acceptance, moving from a general acknowledgement of limited alternatives in 2022 to an explicit note that the “increasing number of third parties” creates greater governance complexity by 2023‑2024. Each year’s filing stressed that this expanded reliance reduces Amex’s control, subjects it to heightened U.S. and global regulatory scrutiny of outsourcing, and makes the business vulnerable to service disruptions at shared providers—risks that could trigger fines, litigation or reputational damage if oversight fails.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of American Express's reliance on aggregators from 2022-2024 and correctly identifies key risk themes. STRENGTHS: (1) Correctly identifies the progression from 2022 to 2024 with appropriate temporal framing; (2) Accurately captures the core risks mentioned: merchant steering, surcharging, regulatory scrutiny, service disruptions, litigation exposure, and reputational damage; (3) Properly synthesizes the multi-hop information showing how emphasis shifted over time; (4) Uses appropriate company identifier (Amex/AXP); (5) Correctly notes the increasing complexity and governance challenges. WEAKNESSES: (1) The LLM answer emphasizes 'governance complexity' and 'limited alternatives' as 2022 themes, but the ground truth specifically highlights concerns about aggregators acting against AXP's interests and impacting card usage/merchant acceptance - these are subtly different framings; (2) The LLM answer mentions 'U.S. and global regulatory scrutiny of outsourcing' which is accurate but somewhat generic compared to the ground truth's more specific focus on merchant behavior impacts in 2022-2023; (3) The ground truth explicitly notes a shift from 'merchant behavior focus to broader systemic and legal concerns' by 2024, which the LLM captures but less explicitly; (4) No quantitative data is provided in either answer (no percentages, dollar amounts, or specific metrics), so quantitative accuracy cannot be fully assessed, though this may reflect the nature of the source material. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the evolution pattern, though with slightly less precision than the ground truth regarding the specific nature of risks emphasized in each year. The answer is semantically equivalent to the ground truth in most respects but lacks some of the nuanced distinctions about how risk characterization evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 528,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks moved its green‑coffee hedging from a short‑term focus—using fixed‑price and price‑to‑be‑fixed contracts together with forward, futures and collar instruments to protect against “C”‑price swings and commodity‑index‑fund activity, with purchase commitments sufficient only through fiscal 2023—to a longer‑term strategy that extends the coverage of those forward supply commitments out to fiscal 2025.  This shift reflects a broader set of purchase commitments and longer‑dated forward contracts that reduce reliance on spot‑market price volatility and the influence of hedge funds and commodity‑index funds, thereby smoothing exposure to green‑coffee price swings over an expanded horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and fiscal year references are correct—fiscal 2022, 2023, and 2024 are properly identified, and the extension of supply commitments through fiscal 2025 is accurately stated. No numerical errors or calculation issues detected. ENTITY ACCURACY: Starbucks is correctly identified, and all relevant financial instruments (fixed-price contracts, price-to-be-fixed contracts, forward contracts, futures, collar instruments) are properly named. The reference to commodity index funds and their influence on arabica coffee futures is accurate. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across three fiscal years, correctly identifying the progression from short-term focus (through fiscal 2023) to longer-term strategy (through fiscal 2025). The causal connection between commodity index fund activity and hedging strategy adjustments is properly established. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth—that Starbucks shifted from short-term to longer-term supply commitments in response to market volatility. The phrase 'smoothing exposure to green-coffee price swings over an expanded horizon' effectively captures the strategic intent described in the ground truth. MINOR CONSIDERATIONS: The LLM answer provides slightly more technical detail about specific hedging instruments (collar instruments, price-to-be-fixed contracts) compared to the ground truth, which is additive rather than contradictory. The answer maintains focus on the key finding that supply commitments extended from fiscal 2023 to fiscal 2025, matching the ground truth exactly. The explanation of why this shift occurred (reducing reliance on spot-market volatility and financial participants) aligns with the ground truth's characterization of 'strategic shift toward longer-term risk mitigation.' No factual errors, omissions of critical information, or logical inconsistencies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 556,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture grew both the size of its open‑market share‑repurchase program and the amount it actually spent: the Board’s authorized capacity rose from roughly **$3 billion in 2022** to **$6.7 billion after the September 2024 increase**, while cash used for repurchases increased from **about $4.1 billion in FY 2022** to **$4.5 billion in FY 2024** (including 2.07 million shares bought in Q4 2024). This multi‑year expansion shows that Accenture is deliberately scaling its share‑buyback capability as part of a broader capital‑return strategy that combines regular dividends with opportunistic equity repurchases to return cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility:\n\n(1) MAJOR QUANTITATIVE ERRORS:\n- FY 2022 repurchase amount: LLM claims \"about $4.1 billion\" but ground truth shows NO FY 2022 repurchase amount is provided in the original answer. The ground truth only mentions FY 2023 repurchases of $605 million.\n- FY 2024 repurchase amount: LLM claims \"$4.5 billion\" with \"2.07 million shares bought in Q4 2024\" - these figures are NOT in the ground truth and appear to be fabricated.\n- The LLM conflates authorization amounts with actual repurchase spending, which are different metrics.\n\n(2) AUTHORIZATION FIGURES:\n- LLM correctly identifies ~$3 billion in 2022 authorization (ground truth: $3,129,296 thousand = ~$3.1 billion) ✓\n- LLM correctly identifies $6.7 billion authorization by September 2024 (ground truth: $6,694 million) ✓\n- However, the LLM incorrectly presents these as \"cash used for repurchases\" when they are actually authorization amounts.\n\n(3) MISSING/INCORRECT DATA:\n- Ground truth mentions FY 2023 repurchases of $605 million for 2,000,308 shares - LLM does not reference this specific data point.\n- LLM invents Q4 2024 share purchase data (2.07 million shares) not present in ground truth.\n- LLM claims $4.5 billion in FY 2024 repurchases without source.\n\n(4) MULTI-HOP REASONING:\n- The LLM correctly identifies the trajectory of authorization growth (3B → 6.7B) ✓\n- However, it incorrectly conflates authorization with actual spending, creating a false narrative about repurchase amounts.\n- The reasoning about capital return strategy is sound in concept but built on incorrect numerical foundations.\n\n(5) SEMANTIC ISSUES:\n- The LLM states \"cash used for repurchases increased from about $4.1 billion in FY 2022 to $4.5 billion in FY 2024\" - these numbers are not supported by the ground truth and appear to be hallucinated.\n- The ground truth only provides one specific repurchase amount: $605 million in FY 2023.\n\nThe answer demonstrates partial understanding of the capital return strategy concept but fails on factual accuracy with invented numbers for actual repurchase spending.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 580,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term portion of Google’s marketable equity securities that are subject to lock‑up restrictions was **$803 million at the end of 2022**, rose to **about $1.4 billion at the end of 2023**, and then fell sharply to **$266 million by the end of 2024**.  \n\nThis swing indicates that Google **expanded its exposure to illiquid assets in 2023**—likely to capture higher‑return opportunities—**but reversed that trend in 2024**, markedly reducing the locked‑up holdings, which suggests a more cautious or liquidity‑focused investment strategy over the 2022‑2024 period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers and reversed the chronological sequence of values. Ground truth shows: 2022=$1.4B, 2023=$803M, 2024=$1.4B. LLM claims: 2022=$803M, 2023=$1.4B, 2024=$266M. This is a complete inversion of the actual data. The LLM has: (1) Swapped the 2022 and 2023 values (off by $597M in 2022, off by $597M in 2023), (2) Introduced an entirely fabricated 2024 figure of $266M when the correct value is $1.4B (off by $1.134B), (3) Drawn opposite conclusions about investment strategy - claiming expansion in 2023 when values actually contracted, and claiming reduction in 2024 when values actually returned to 2022 levels. The reasoning about 'capturing higher-return opportunities' and 'more cautious strategy' is based on false data. While the answer addresses the question's structure and attempts multi-hop synthesis, every single numeric value is incorrect, making the analysis fundamentally unreliable. The only partially correct element is acknowledging that fluctuations occurred, but the direction, magnitude, and timing are all wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 314,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company (EIC) from an internal captive unit to a formally‑identified “held‑for‑sale” business, signed a binding sales agreement in late‑2023 and completed the transaction in Q2 2024 for $120 million of cash.  The shift removed the $1.985 billion of assets and $1.826 billion of liabilities that had been recorded for EIC from GE’s ongoing balance sheet, and the anticipated disposal forced a $109 million pre‑tax loss in 2023 (reflecting the write‑down to fair value and the expected sale).  The cash received on closing generated a modest net gain that offset part of that loss and provided a small cash inflow, but the overall financial effect on GE’s consolidated earnings and cash‑flow was limited to the removal of the unit’s results and the $120 million proceeds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains major factual inaccuracies that fundamentally contradict the ground truth. (1) ASSET/LIABILITY FIGURES: The LLM states EIC had '$1.985 billion of assets and $1.826 billion of liabilities' but the ground truth clearly indicates assets of $541 million and liabilities of $378 million as of December 31, 2023. This is a massive discrepancy (nearly 4x overstatement of assets, nearly 5x overstatement of liabilities). These numbers appear to be completely fabricated or sourced from an incorrect entity. (2) LOSS RECOGNITION: The LLM correctly identifies the $109 million loss in 2023, which matches ground truth. (3) SALE PRICE: The LLM correctly states the sale price was $120 million in cash, matching ground truth. (4) TIMING: The LLM correctly identifies the progression from 2022 through 2024 and mentions Q2 2024 completion, which aligns with ground truth. (5) STRATEGIC POSITIONING: The LLM correctly characterizes this as a strategic exit from a non-core business, matching the ground truth narrative. MULTI-HOP REASONING: While the LLM demonstrates understanding of the three-year progression and the strategic intent, the quantitative foundation is severely compromised by the incorrect balance sheet figures. The reasoning about removal of assets/liabilities and the $120 million proceeds is logically sound, but built on false premises. SEMANTIC ISSUES: The LLM's statement about 'modest net gain' and 'small cash inflow' is vague and potentially misleading given the $109 million loss recognized. The ground truth presents this more clearly as a loss-generating transaction. The core narrative structure is present but the numerical accuracy is unacceptable for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 484,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nAmgen’s Phase 3 pipeline expanded sharply from 13 programs in early 2022 to 24 programs by the end of 2024 (and to 25 by early 2025).  The growth was driven by the initiation of five new Phase 3 studies—including Tarlatamab (SCLC), Rocatinlimab (atopic dermatitis), TEPEZZA (sub‑cutaneous TED), Olpasiran (ASCVD) and Dazodalibep (Sjögren’s)—plus three FDA approvals of existing Phase 3 assets and the acquisition of Horizon‑derived candidates.  This progression shows Amgen’s deliberate R&D‑pipeline expansion into oncology, cardiovascular, rare‑disease and inflammatory‑disease areas, a greater reliance on novel modalities (BiTEs, siRNA, antibody‑drug conjugates) and collaborations, and a corresponding increase in R&D spending (from $4.4 B in 2021 to $6.0 B in 2024) to move more candidates toward commercialization.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the overall trajectory of Amgen's Phase 3 pipeline expansion and provides relevant context about strategic focus areas (oncology, cardiovascular, rare disease, inflammatory disease), novel modalities (BiTEs, siRNA, ADCs), and R&D spending increases. The answer demonstrates good understanding of the multi-hop synthesis required and addresses the question's core inquiry about pipeline evolution and strategic implications.\n\nCRITICAL ERRORS: (1) The LLM states the portfolio grew to '24 programs by the end of 2024 (and to 25 by early 2025)' but the ground truth clearly states 24 programs in 2024 and 25 programs in 2024 (not 2025). This is a significant dating error that contradicts the ground truth timeline. (2) The LLM claims the growth was driven by 'initiation of five new Phase 3 studies' with specific named programs, but the ground truth attributes the growth to 'acquisition of five programs from Horizon in 2023' - these are different mechanisms (internal initiation vs. acquisition). The LLM conflates or misidentifies the source of pipeline expansion.\n\nNUMBER VERIFICATION: The starting point (13 in 2022) and intermediate point (18 in 2023, implied in ground truth) are not explicitly mentioned in LLM answer. The LLM correctly identifies 24 and 25 as endpoints but places them in wrong years. The R&D spending figures ($4.4B in 2021 to $6.0B in 2024) are provided by LLM but cannot be verified against the ground truth provided, which doesn't include these specific numbers.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of pipeline evolution with strategic context, but the factual errors about timing and acquisition vs. initiation undermine the accuracy of the multi-hop analysis. The connection between pipeline expansion and R&D spending increase is logical but not verified in ground truth.\n\nSEMANTIC ISSUES: The ground truth mentions 'regulatory approvals in both the U.S. and Japan' as part of the 2024 trajectory, which the LLM mentions as 'three FDA approvals of existing Phase 3 assets' - this is a partial match but the geographic scope differs.\n\nOVERALL: While the LLM demonstrates understanding of the question's complexity and provides contextually relevant information about Amgen's R&D strategy, the factual errors regarding timeline (2024 vs 2025 for the 25-program milestone) and the mechanism of growth (acquisition vs. initiation) are significant enough to warrant a below-average correctness score. The answer is partially correct but contains material inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 684,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nFrom 2022 through 2024 American Express’s ties to global card networks have become more constrained and strategically focused.  Heightened regulatory scrutiny—especially U.S. and EU actions targeting interchange‑fee caps, merchant‑surcharge rules and non‑discrimination provisions—has forced the company to curb its network‑licensing business (e.g., exits from EU and Australia and the 2024 Visa/Mastercard settlement that would cap interchange fees, see 2024 pp. 32‑36) and to adjust pricing and acceptance terms.  In response, Amex has leaned on its premium‑card franchise, investing in differentiated products, data‑driven services and enterprise‑service partnerships to maintain a competitive edge amid growing pressure from rival networks and alternative payment platforms (see competition discussion in 2022‑2023 pp. 12‑14 and the 2024 risk‑overview on page 36).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of AXP's relationship with global card networks from 2022-2024, correctly identifying the shift from competitive positioning to regulatory constraint. Key strengths: (1) Accurately identifies regulatory pressures in EU and Australia leading to network licensing exits; (2) Correctly notes the shift toward premium-card franchise and differentiated products; (3) Properly synthesizes multi-hop information about competitive dynamics and alternative payment platforms; (4) Appropriately contextualizes the 2024 Visa/Mastercard settlement impact. However, there are notable weaknesses: (1) The LLM cites specific page numbers (pp. 32-36, pp. 12-14, page 36) that cannot be verified against the ground truth knowledge graph and may be fabricated or inaccurate; (2) References to '2024 Visa/Mastercard settlement that would cap interchange fees' lack specific quantitative details that could be verified; (3) The answer provides more specific regulatory detail than the ground truth (interchange-fee caps, merchant-surcharge rules, non-discrimination provisions) which, while plausible, goes beyond what can be confirmed in the ground truth; (4) Missing explicit mention of uncertainty regarding cobrand arrangements in the EU, which was highlighted in the original answer. The semantic meaning aligns well with the ground truth trajectory (competition → regulatory constraint), and the reasoning about strategic response (premium products, data services, partnerships) is sound. The quantitative accuracy score is lower due to unverifiable page citations and lack of specific financial metrics, though no actual numbers are contradicted. Overall, the answer demonstrates good understanding of the multi-hop relationship evolution but includes details that cannot be confirmed against the knowledge graph baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 502,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nConocoPhillips completed the sale of the remaining 91 million CVE shares in the first quarter of 2022 and used the proceeds to fund its share‑repurchase program. In 2022 it repurchased 87.7 million shares, in 2023 it repurchased 48.6 million shares, and in 2024 it repurchased 49.1 million shares, with the 2024 repurchases adding $5.3 billion (bringing total repurchase spending since inception to $34.3 billion for 433 million shares, including the $29 billion spent through the end of 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more granular detail than the ground truth. Verification of key claims: (1) CVE share sale: LLM correctly states 91 million shares sold in Q1 2022, matching ground truth. (2) Share repurchase breakdown: LLM provides year-by-year detail (87.7M in 2022, 48.6M in 2023, 49.1M in 2024) totaling 185.4M shares across these three years. Ground truth states 383M shares repurchased in 2022 alone - this is a significant discrepancy. However, the LLM's cumulative total of 433 million shares at $34.3 billion matches ground truth exactly. (3) 2024 repurchase amount: LLM states $5.3 billion in 2024, with cumulative $34.3 billion through 2024, implying $29 billion through 2023 - this is mathematically consistent and matches ground truth. (4) Authorization increase: LLM correctly notes the $65 billion authorization increase in October 2024. The primary issue is the apparent discrepancy in the 2022 repurchase volume (87.7M per LLM vs 383M per ground truth). This could reflect different measurement methodologies or data sources, but the LLM's year-by-year breakdown and cumulative totals are internally consistent and match the ground truth endpoints. The LLM provides superior detail by breaking down repurchases by year, directly addressing the 'evolve from 2022 through 2024' aspect of the question more thoroughly than the ground truth. The answer correctly synthesizes the multi-hop relationship between CVE monetization and share repurchase proceeds. Minor deduction due to the apparent volume discrepancy in 2022, though cumulative figures align perfectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 445,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nFrom the filings, the Omnibus Plan’s share reserve fell steadily: after the May 2022 amendment the plan began with roughly **117 million shares** available for future grants, that number had shrunk to **≈77 million shares** by the end of fiscal 2024 (January 28 2024) and to **≈70 million shares** by early 2025 (February 2 2025).  This decline reflects growing use of the plan for stock‑option, restricted‑stock, RSU and performance‑share awards—and for the shares repurchased under the company’s $15 billion buy‑back program—showing that Home Depot’s equity‑compensation capacity is being increasingly tapped and that future equity grants will be constrained by the dwindling reserve unless the share pool is expanded.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) MAJOR FACTUAL ERROR - The LLM conflates two distinct time periods and introduces incorrect numbers. The ground truth clearly states: 117M shares in 2022, 77M in 2023, and 70M in 2024. The LLM incorrectly states '77 million shares by end of fiscal 2024 (January 28 2024)' and then '70 million shares by early 2025 (February 2 2025)' - this shifts the timeline by one year and misaligns the fiscal year dates. (2) UNSUPPORTED CLAIM - The LLM introduces information about a '$15 billion buy-back program' that is NOT mentioned in the ground truth answer and appears to conflate stock buybacks with the Omnibus Plan share utilization. This is a significant factual error that conflates two separate corporate actions. (3) CORRECT ELEMENTS - The LLM correctly identifies the three share amounts (117M, 77M, 70M) and correctly characterizes the trend as a 'steady decline' reflecting increased equity compensation utilization. The reasoning about constrained future capacity is sound. (4) TIMELINE CONFUSION - The LLM's reference to 'May 2022 amendment' and the fiscal year dates (January 28 2024, February 2 2025) introduces unnecessary complexity and appears to misalign with the ground truth's simpler 2022-2023-2024 progression. (5) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize information about share utilization and its implications, the introduction of the buyback program represents either hallucination or confusion with separate corporate actions. The core multi-hop reasoning (shares declining = increased utilization) is correct, but the supporting details are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 442,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares in fiscal 2022** to **141 million shares in fiscal 2024** (an ≈11 % increase).  Although the pool of shares available for future grants slipped only modestly—from **27.38 million (2022) to 27.27 million (2024)**—the larger authorization signals that Accenture is deliberately expanding its equity‑compensation capacity to sustain a vigorous share‑based incentive program as it scales its workforce and growth initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core authorized share numbers (127 million in 2022 and 141 million in 2024) and accurately calculates the approximate 11% increase. The answer properly addresses the multi-hop question by synthesizing information about the authorization evolution and providing strategic interpretation. However, there are some issues: (1) The LLM introduces additional data points about 'available shares for future grants' (27.38 million in 2022 and 27.27 million in 2024) that are not present in the ground truth answer. While these numbers may be factually correct from the filings, they represent information beyond what was verified in the original answer and add complexity that wasn't requested. (2) The ground truth explicitly states the increase occurred 'by 2023 and 2024' (implying both years had 141 million), while the LLM only compares 2022 to 2024, potentially missing the 2023 data point. (3) The LLM's strategic interpretation ('deliberately expanding its equity-compensation capacity to sustain a vigorous share-based incentive program') is reasonable and aligns with the ground truth's characterization of 'growing emphasis on equity-based incentives,' though the wording differs. The quantitative accuracy is strong on the main numbers but the introduction of unverified supplementary data and the potential omission of 2023 specifics slightly reduces confidence. The qualitative reasoning about strategic intent is sound and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 417,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on foreign government bonds and obligations rose from about **3.1 % in 2022** (as shown in the 2022 filing’s maturity‑yield table) to roughly **6.1 % in 2024** (the non‑U.S. portion of taxable investment securities in the 2024 “Distribution of Assets, Liabilities & Shareholders’ Equity” table). This near‑doubling indicates that American Express has shifted a larger share of its interest‑earning assets into foreign‑government debt, making its earnings increasingly sensitive to movements in international interest‑rate environments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM states the weighted average yield was 3.1% in 2022 and 6.1% in 2024, but the ground truth clearly shows 5.86% in 2022 and 5.86% in 2024 (with a peak of 6.45% in 2023). The LLM's numbers are completely wrong - off by 2.76 percentage points in 2022 and 0.25 percentage points in 2024. The claim of a 'near-doubling' from 3.1% to 6.1% is factually incorrect. (2) MISSING KEY DATA: The LLM completely omits the 2023 data point (6.45%), which is crucial to understanding the trend. The ground truth explicitly states there was a peak in 2023 followed by a return to 2022 levels in 2024. The LLM's narrative of continuous rise is contradicted by the actual data showing a reversal. (3) INCORRECT SYNTHESIS: The LLM misidentifies the source data, referencing 'maturity-yield table' and 'Distribution of Assets, Liabilities & Shareholders' Equity' table without proper verification. The ground truth references specific instruments 'due within one year' with precise yields. (4) FLAWED REASONING: The conclusion that AXP 'shifted a larger share of its interest-earning assets into foreign-government debt' is not supported by the data. The actual trend shows volatility with a return to baseline, not a sustained increase. (5) MISSING CONTEXT: The LLM fails to capture the key insight from the ground truth - that the 2024 yield returned to 2022 levels (5.86%), suggesting stabilization or strategic adjustments, not continued exposure increase. The answer fundamentally misrepresents the three-year trajectory and provides incorrect numerical values for all years mentioned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 462,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign‑government‑bond holdings rose to 6.45 % in 2023 and slipped to 5.85 % in 2024, after a 2022 portfolio that was overwhelmingly short‑dated—about $628 million of the $630 million fair‑value was due within one year with only modest exposure beyond that. This progression shows the company deliberately extended duration and chased higher yields during the 2023 rate‑hike cycle, then began to de‑risk or rebalance as market rates plateaued in 2024, reflecting both its strategic response and the broader shift in interest‑rate conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $630M total, $628M maturing within one year in 2022, 6.45% yield in 2023, 5.85% yield in 2024. (2) Quantitative accuracy is excellent - numbers match ground truth precisely with acceptable formatting variations. (3) Multi-hop synthesis is sound: correctly connects 2022 portfolio composition (short-duration focus) to 2023 yield peak (6.45%) to 2024 decline (5.85%). (4) Contextual relevance is strong - addresses the evolution question and provides reasonable interpretation of strategic implications. (5) The interpretation about 'deliberately extended duration and chased higher yields during 2023 rate-hike cycle' is a reasonable inference from the data pattern.\n\nWEAKNESSES: (1) The LLM answer makes a specific claim that the company 'deliberately extended duration and chased higher yields during the 2023 rate-hike cycle' - while this is a plausible interpretation, the ground truth is more cautious, stating it 'suggests a potential shift' and 'possibly reducing exposure' rather than asserting deliberate strategy. The LLM presents inference as fact. (2) The ground truth explicitly mentions 'a response to falling interest rates or a deliberate risk management move' as alternative explanations, showing appropriate uncertainty. The LLM is more definitive in its causal attribution. (3) Minor: The LLM says rates 'plateaued in 2024' which is an interpretation not explicitly stated in ground truth.\n\nCORRECTION VERIFICATION: All numbers verified correct. The yield progression (6.45% → 5.85%) and portfolio composition ($630M, $628M short-duration) match exactly. The reasoning about duration extension and rebalancing is logically sound but slightly overstates certainty compared to ground truth's more measured language about 'potential shifts' and 'possible' strategic adjustments.\n\nSCORE JUSTIFICATION: 7/10 because while quantitative accuracy is excellent (9/10) and the multi-hop synthesis is present, the qualitative reasoning slightly overstates certainty about strategic intent compared to the ground truth's more measured interpretation. The answer is substantially correct but presents inference as established fact rather than acknowledging alternative explanations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 599,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nIn each of the 2022, 2023 and 2024 Form 10‑K filings the 7% Debentures due 2029 appear only in the “Securities registered pursuant to Section 12(b)” table, listed identically as “7% Debentures due 2029” with CUSIP‑718507BK1 and shown as traded on the NYSE. The wording, formatting and any accompanying quantitative detail are unchanged across the three years, indicating that ConocoPhillips treats the debenture as a routine, fully registered security and relies solely on the standard registration table for its public disclosure. This consistent, unchanged presentation reflects a stable, compliance‑driven approach to reporting the instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE NARRATIVE: The LLM answer fundamentally contradicts the ground truth on the key finding of this multi-hop question. Ground truth explicitly states that the presentation EVOLVED across the three years: (1) 2022 showed debentures listed alongside Common Stock without separate row distinction, (2) 2023 showed separation into its own row with clearer distinction, (3) 2024 maintained the structured disclosure. The LLM answer claims the presentation was 'unchanged across the three years' and 'identical' - this is factually incorrect and represents a failure to identify the multi-year progression that is the core of the question. QUANTITATIVE ACCURACY: The CUSIP number (718507BK1) and security name (7% Debentures due 2029) are correct, and the NYSE listing is accurate. These numeric/identifier elements score well. QUALITATIVE ACCURACY: The LLM fundamentally misunderstood the multi-hop synthesis required. The question explicitly asks about 'evolution' and 'multi-year progression,' and the ground truth demonstrates clear changes in presentation structure (from combined listing to separate row). The LLM's conclusion that this reflects a 'stable, compliance-driven approach' directly contradicts the ground truth's finding of 'growing emphasis on clarity and specificity.' This represents a major reasoning failure. CONTEXTUAL RELEVANCE: While the answer addresses the right security and years, it fails to capture the essential narrative arc of the question - the evolution of disclosure practices. The answer treats the disclosure as static when the question and ground truth both emphasize dynamic change. The semantic meaning is fundamentally different from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 465,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 2.00% Notes Due 2031 retained a constant $1.25 billion carrying amount from fiscal 2022 through 2024, with the effective interest rate of 2.09 % and the weighted‑average remaining term shrinking from roughly 7 years to 6.4 years as the maturity approached. This unchanged, low‑coupon, long‑dated exposure demonstrates that the company is managing its long‑term debt by holding the senior unsecured notes to maturity rather than refinancing or retiring them, preserving cash and maintaining a stable, low‑cost financing base.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM claims the carrying amount was 'constant $1.25 billion from fiscal 2022 through 2024,' but the ground truth shows: 2022: $1.2 billion, 2023: $1.057 billion, 2024: $1.25 billion. This is demonstrably incorrect - the values were NOT constant and varied significantly (especially the 2023 dip to $1.057B). The LLM's claim of constancy is factually wrong. (2) MISSING/INCORRECT DATA: The LLM provides an effective interest rate of 2.09% and weighted-average remaining term information (7 years to 6.4 years) that is not mentioned in the ground truth and cannot be verified. While these details might be accurate from the filings, they don't address the core question about how exposure 'evolved' - which requires showing the progression across years. (3) MULTI-HOP REASONING FAILURE: The question explicitly asks about evolution 'from fiscal year 2022 through 2024' - requiring a year-by-year comparison. The LLM failed to capture the actual progression: increase from 2022 to 2023 (actually a decrease to $1.057B), then increase to 2024. The ground truth correctly identifies this non-linear pattern. (4) SEMANTIC CONTRADICTION: The LLM's conclusion that the company is 'holding the senior unsecured notes to maturity' and maintaining 'unchanged' exposure directly contradicts the ground truth's observation of 'increased' exposure and 'consistent long-term debt position with this instrument.' The ground truth acknowledges variation; the LLM incorrectly claims constancy. (5) ANSWER QUALITY: While the LLM provides additional context about interest rates and maturity terms, these additions don't compensate for the fundamental error of claiming constant values when the data shows clear variation. The core factual claim is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 506,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Disney shifted Marvel from a primarily theatrical/linear‑network brand to a core driver of its direct‑to‑consumer offering—Marvel series and films now headline Disney+ (and, via the Star tier, international Disney+), while the Marvel trademark remains listed as an **indefinite‑lived intangible asset** (e.g., $1.79 bn of indefinite‑lived intangibles on page 114).  Consequently, Marvel’s IP is treated as a perpetual asset on the balance sheet, underscoring its strategic role in Disney’s streaming portfolio without being amortized.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and one unverified quantitative claim. STRENGTHS: (1) Correctly identifies Marvel as an indefinite-lived intangible asset across the period; (2) Accurately describes the strategic shift toward DTC/streaming emphasis; (3) Correctly notes Marvel's role in Disney+ branding; (4) Properly explains the accounting treatment (no amortization for indefinite-lived assets). WEAKNESSES: (1) The specific dollar amount of $1.79 billion for indefinite-lived intangibles cannot be verified against the ground truth provided and appears to be a specific page reference that may or may not be accurate—this is a quantitative claim that requires verification; (2) The answer fails to explicitly address the 2023 specific finding about Marvel as a 'top-level branded tile within the Disney+ interface,' which was highlighted in the ground truth as a key strategic positioning element; (3) The answer doesn't clearly articulate the three-year evolution as distinctly as the ground truth does (2022 listing, 2023 streaming prominence, 2024 reaffirmation); (4) The answer conflates the indefinite-lived asset listing across years without clearly distinguishing what changed or remained consistent year-to-year. MULTI-HOP REASONING: The answer attempts to synthesize financial accounting treatment with strategic positioning but doesn't fully integrate the temporal dimension across all three fiscal years. The ground truth emphasizes the parallel evolution on both dimensions (financial recognition AND streaming prominence), while the LLM answer focuses more heavily on the accounting/balance sheet aspect. CALCULATION/VERIFICATION: The $1.79 billion figure is presented without context and cannot be verified against the ground truth. This is problematic for a quantitative claim. The answer would be stronger if it either omitted this specific number or provided clearer sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 522,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nFrom 2022 through 2024 American Express continued to recognize discount revenue at the moment a Card‑Member transaction is settled, recording the network‑rate fee paid by third‑party merchant acquirers (e.g., under the OptBlue program) as part of that revenue; contracts with large merchants were typically multi‑year (three‑to‑seven‑year) with auto‑renewal clauses, whereas small‑merchant agreements remained open‑ended, giving the company flexibility to renegotiate fees and terms.  At the same time, the firm accelerated global merchant‑coverage expansion—using targeted marketing, digital onboarding and partnerships with acquirers to add merchants in high‑growth verticals and key international cities—while closely monitoring how competitive pressure and regulatory changes affect merchant‑discount rates and overall acceptance.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual issues and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM introduces specific contract terms (three-to-seven-year multi-year contracts with auto-renewal clauses for large merchants, open-ended agreements for small merchants) that are NOT mentioned in the ground truth answer. This appears to be fabricated detail. (2) The LLM fails to mention the 2023 introduction of 'processed revenue' from network partnership agreements and royalties/fees for facilitating transactions on partner-issued cards—a key evolution point explicitly stated in the ground truth. (3) The LLM does not adequately capture the strategic shift toward 'deeper collaboration with third-party acquirers' or the emphasis on 'enhancing value propositions' mentioned in the ground truth. PARTIAL CREDIT: (1) Correctly identifies OptBlue program and third-party acquirers. (2) Correctly notes discount revenue recognition at transaction settlement. (3) Correctly mentions global merchant coverage expansion and digital integration. (4) Appropriately references competitive pressure and regulatory considerations. MISSING ELEMENTS: (1) No mention of the 2023 clarification about network rate fees and processed revenue. (2) No discussion of royalties and fees from network partnerships. (3) Lacks the year-by-year progression framework that the ground truth provides. The answer demonstrates partial understanding but introduces unsupported details while omitting critical evolution points, particularly the 2023 processed revenue development. The multi-hop synthesis is incomplete, failing to capture the full strategic evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 466,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nAmgen’s 10‑K disclosures moved from a broad warning that its drug‑delivery devices are subject to FDA oversight and could trigger labeling changes or loss of approval (2022) to a more specific focus on concrete post‑marketing obligations—such as required feasibility studies, mandatory companion‑diagnostic clearances, and the risk that device‑related safety signals could delay or block product approvals (2023). By 2024 the language emphasized the direct dependence of clinical‑trial execution and commercial sales on the timely supply and regulatory clearance of these devices, warning that any device‑related safety finding or regulatory action could result in revised labeling, recalls or revocation of approval, thereby materially affecting the company’s financial results.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Amgen's regulatory risk disclosures across 2022-2024, with accurate temporal progression and appropriate emphasis on the shift from general to specific concerns. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with appropriate characterization of each phase; (2) Accurately captures the shift from broad warnings to specific post-marketing obligations; (3) Properly synthesizes multi-hop information about drug delivery devices, clinical trials, and regulatory oversight; (4) Correctly references concrete examples like feasibility studies and companion-diagnostic clearances; (5) Appropriately emphasizes the financial materiality angle. WEAKNESSES: (1) The LLM answer does not explicitly mention LUMAKRAS or the Complete Response Letter from FDA, which are specific factual details in the ground truth that demonstrate concrete examples of the regulatory challenges described; (2) The ground truth specifically mentions 'surrogate endpoints in clinical trials' and 'confirmatory studies' as 2023 developments, which the LLM answer does not explicitly address; (3) The ground truth mentions 'pharmacovigilance or quality assessment requirements' as specific compliance areas, while the LLM uses more general language about 'device-related safety signals'; (4) The ground truth's framing of the transformation as moving from 'general dependencies to specific post-marketing and safety compliance challenges' is captured in spirit but lacks some of the specific regulatory terminology. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple regulatory concepts (device oversight, clinical trials, post-marketing requirements, safety reviews), demonstrating sound logical progression. The connection between device regulatory status and commercial viability is properly established. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—Amgen's disclosures evolved from general to specific, with increasing emphasis on post-marketing obligations and safety compliance. The omission of LUMAKRAS and specific regulatory mechanisms (surrogate endpoints, confirmatory studies) represents a moderate gap in completeness rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 614,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nFrom 2022 to 2024 ConocoPhillips broadened the HSE audit scope from a purely operational safety focus to a company‑wide review that also covers emerging climate‑related and low‑carbon performance criteria.  The program now uses a formal improvement‑tracking system that assigns each audit finding to an owner, sets closure deadlines and records progress in a centralized register.  Governance reporting was strengthened by requiring regular audit‑result updates to the Executive Leadership Team and the Board of Directors, with the Board receiving a dedicated HSE performance dashboard as part of its risk‑oversight structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is substantially incorrect and diverges significantly from the ground truth. Key issues: (1) FACTUAL ERRORS - The LLM introduces climate-related and low-carbon performance criteria as part of HSE audit evolution, which is not mentioned in the ground truth. This is a major factual error that misrepresents the actual scope of ConocoPhillips' HSE audit program. (2) MISSING CORE ELEMENTS - The ground truth emphasizes specific evolution markers: 2022 focused on conformance with company policies and HSE excellence framework; 2023 introduced Life Saving Rules, Process Safety Fundamentals, and stop work policy; 2024 introduced 'Corporate HSE audits' terminology suggesting centralization. The LLM answer completely omits these specific, documented elements. (3) INCORRECT SCOPE CHARACTERIZATION - The ground truth describes evolution from 'localized conformance checks' to 'integrated safety systems' to 'corporate-level standardization.' The LLM incorrectly frames this as expansion to climate/low-carbon criteria, which is not supported by the source material. (4) IMPROVEMENT TRACKING - While the LLM mentions formal tracking with owners and deadlines, the ground truth simply states 'tracking to completion' without these specific procedural details. The LLM adds specificity not present in ground truth. (5) GOVERNANCE REPORTING - The LLM mentions a 'dedicated HSE performance dashboard' which is not mentioned in the ground truth. The ground truth only references reporting to ELT and Board, with consistent governance structure across all three years. (6) MULTI-HOP SYNTHESIS - The LLM fails to properly synthesize the three-year evolution narrative that the ground truth clearly establishes. Instead, it creates an alternative narrative around climate/low-carbon integration that appears to be hallucinated. The answer demonstrates poor understanding of the actual HSE audit program evolution and introduces material that contradicts the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 533,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nFrom 2022 through 2024 Accenture shifted from largely time‑and‑material or fixed‑price contracts toward value‑based, consumption‑oriented and outcome‑linked pricing for its AI‑enabled and cloud‑centric offerings, attempting to align fees with the business impact of those technologies.  Across the three years the company repeatedly warned that a core risk is its inability to create pricing models that properly capture the value of rapidly evolving AI and cloud solutions—leading to delayed client spending, margin pressure, competitive pricing attacks, and potential regulatory or reputational costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in addressing the ground truth. STRENGTHS: (1) Correctly identifies the evolution of pricing models from 2022-2024, (2) Accurately notes the shift toward value-based and consumption-oriented pricing, (3) Correctly identifies AI and cloud as key technological drivers, (4) Properly identifies the core risk of inability to create pricing models that capture value of new technologies. WEAKNESSES: (1) The LLM answer introduces specific contract types (time-and-material, fixed-price, outcome-linked) that are NOT mentioned in the ground truth, potentially adding unsupported detail. (2) Missing the year-by-year progression detail that the ground truth emphasizes: 2022 (general acknowledgment of need for change), 2023 (focus on innovation and strategic investments with delays in client spending), 2024 (dependence on successful deployment with significant AI investments already made). (3) The LLM answer mentions 'regulatory or reputational costs' which are NOT in the ground truth's list of risks. (4) The ground truth emphasizes 'client adoption rates' as a specific risk factor, which the LLM answer does not explicitly mention. (5) The LLM answer lacks the specific framing that the ground truth provides about how the company's approach became 'more strategic and investment-driven' over time. MULTI-HOP REASONING: The LLM answer demonstrates understanding of the evolution across years but fails to capture the nuanced progression and specific risks highlighted in each year. The synthesis is somewhat generic rather than grounded in the specific evolution described in the ground truth. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). SEMANTIC EQUIVALENCE: While the LLM captures the general concept of pricing model evolution, it diverges from the ground truth by adding unsupported details and omitting key year-specific developments and risk factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 549,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nGE’s exposure to AerCap moved from a sizable equity position to a lone debt holding.  In 2022 the company still owned a material equity stake in AerCap (the $944 million AerCap note and related equity gains/losses are reported in Note 19 and Note 21), and it recorded unrealized gains and losses on that investment.  By the end of 2023 GE had sold essentially all of those shares, receiving ≈ $6.6 billion in proceeds and leaving only the AerCap senior note (≈ $982 million) on its balance sheet – a figure that appears again in the 2024 fair‑value tables (Note 21, page 71).  The 2024 filings show the note still outstanding (≈ $982 million), with no remaining equity interest.  \n\nThis trajectory indicates that GE deliberately liquidated its equity investment in AerCap, converting the stake into cash and retaining only the senior note as a passive, interest‑bearing asset.  The move reflects a strategy of monetizing the AerCap position while limiting ongoing exposure, allowing GE to focus on its core aerospace, healthcare and energy businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) NUMBERS INCORRECT: The ground truth states GE's AerCap note holdings were $993 million at end of 2021 (reported in 2022) declining to $944 million at end of 2023 (reported in 2024). The LLM claims the note was '≈ $982 million' in 2023 and 2024, which does not match the ground truth figure of $944 million. The LLM also references a $6.6 billion equity sale proceeds figure that is not mentioned in the ground truth. (2) TIMELINE CONFUSION: The LLM conflates different time periods. It states 'In 2022 the company still owned...the $944 million AerCap note' but the ground truth indicates $944 million was the 2023 year-end figure, not 2022. The $993 million figure (2021 year-end) is completely absent from the LLM answer. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from 2022 through 2024,' requiring tracking the progression across three years. The LLM fails to establish the proper chronological sequence of holdings. The ground truth shows a clear two-year decline ($993M → $944M), but the LLM presents inconsistent figures ($944M in 2022, then $982M in 2023-2024) that don't form a coherent progression. (4) NARRATIVE DIVERGENCE: While the LLM's interpretation about strategic liquidation of equity and retention of debt is plausible and well-reasoned, it is built on incorrect numerical foundations. The specific claim about $6.6 billion in proceeds cannot be verified against the ground truth provided. (5) ENTITY/METRIC ACCURACY: The LLM correctly identifies GE and AerCap, and correctly distinguishes between equity and debt holdings, but misidentifies the actual dollar amounts at key dates. The core issue is that the LLM answer presents a different numerical narrative than the ground truth, making it factually incorrect despite reasonable strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 521,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen moved bemarituzumab from the start of its first Phase 3 study (identified in the February 2022 “Phase 3 Program Changes” table) into a fully enrolled Phase 3 program that continued through 2023‑2024, with additional data read‑outs and regulatory interactions (e.g., the 2021 Breakthrough‑Therapy designation and ongoing FDA interactions).  Throughout this period the company’s composition‑of‑matter patent filings for bemarituzumab in the United States and Europe remained unchanged, both showing an estimated expiration in 2029 (U.S. 2029, Europe 2029), with the caveat that term adjustments or supplemental protection certificates could extend exclusivity.  Thus, while the clinical‑development timeline advanced from Phase 3 initiation to later‑stage Phase 3 activity, the IP protection for the molecule stayed anchored to the 2029 expiration estimate.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key points but includes some speculative elements not present in the ground truth. CORRECT ELEMENTS: (1) Patent expiration dates of 2029 for both U.S. and European patents are accurate and match ground truth exactly. (2) The identification of Phase 3 clinical trials is correct. (3) The mention of 2021 Breakthrough Therapy designation is accurate. (4) The overall narrative of clinical progression from Phase 3 initiation through 2023-2024 is sound. ISSUES: (1) The LLM references a 'February 2022 Phase 3 Program Changes table' which is not mentioned in the ground truth, suggesting potential over-specification or hallucination of source details. (2) The LLM emphasizes 'fully enrolled Phase 3 program' and 'data read-outs' which are not explicitly confirmed in the ground truth. (3) The ground truth mentions expansion to 'gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC' by 2024, which the LLM answer does not capture. (4) The LLM's discussion of 'term adjustments or supplemental protection certificates' adds nuance not present in ground truth but is contextually reasonable. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes the relationship between clinical progression and IP strategy across the 2022-2024 period, though it misses the therapeutic scope expansion mentioned in ground truth. QUANTITATIVE ACCURACY: The 2029 patent expiration dates are precisely correct. The temporal progression (2022 Phase 3 initiation through 2023-2024) aligns with ground truth. SEMANTIC EQUIVALENCE: The core message about clinical advancement paired with stable IP protection is conveyed, though the LLM's answer is more detailed on clinical mechanics and less detailed on therapeutic indication expansion than ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 492,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosures shift from warning‑only language about “intense competition” and “alternative payment mechanisms” toward a concrete strategy of sustained technology spending and partnership‑driven innovation.  Across the 2022‑2024 10‑K filings American Express repeatedly cites the need to invest in AI, cybersecurity, real‑time settlement, open‑banking and digital‑wallet integrations, while also expanding joint‑venture and minority‑investment initiatives to stay embedded in emerging fintech ecosystems.  This evolution reveals a long‑term response that preserves its premium, data‑rich brand but increasingly relies on heavy‑weight technological investment and strategic alliances to offset fintech disruption and maintain competitive relevance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the temporal evolution from 2022-2024 and captures the shift from defensive to proactive positioning. (2) Specific technologies mentioned (AI, cybersecurity, real-time settlement, open banking, digital wallets, tokenization) align with ground truth. (3) The characterization of the strategic shift from 'warning-only language' to 'concrete strategy' is semantically consistent with the ground truth's 'defensive acknowledgment to proactive investment' framing. (4) The mention of joint ventures and minority investments as part of the response strategy is a reasonable inference consistent with the ground truth's emphasis on integration and investment. (5) No quantitative errors detected—no specific numbers, dates, or percentages were claimed that could be verified as incorrect.\n\nWEAKNESSES: (1) The LLM answer lacks the specific, granular detail present in the ground truth regarding the evolution of threat categories. Ground truth explicitly identifies: 2022 (digital wallets, BNPL, blockchain), 2023 (expanded to open banking and payment facilitators), 2024 (shift to dependency/integration posture). The LLM conflates these into a more general narrative without clearly delineating the year-by-year progression of threat identification. (2) The ground truth emphasizes a critical conceptual shift in 2024 from 'alternative payment mechanisms as competitive threat' to 'necessity of investing in and integrating these technologies'—a dependency posture. The LLM captures the investment aspect but doesn't clearly articulate this fundamental reframing of the relationship to alternative payment mechanisms. (3) The phrase 'preserves its premium, data-rich brand' is an inference not explicitly grounded in the provided ground truth, though not contradictory. (4) The LLM's framing of 'heavy-weight technological investment and strategic alliances' is somewhat generic and doesn't capture the specificity of the ground truth's emphasis on integration of specific technologies (tokenization, real-time settlement, open banking) as foundational to future competitiveness.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop reasoning by synthesizing information across three years of filings and identifying a coherent strategic evolution. However, the reasoning lacks the precision of the ground truth in distinguishing between different phases of the evolution and the qualitative shift in how American Express frames its relationship to alternative payment mechanisms.\n\nSEMANTIC EQUIVALENCE: While the LLM answer conveys the general direction of strategic evolution correctly, it loses important nuance about the specific nature of the shift (from threat to dependency/necessity) and the granular progression of threat identification across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 741,
        "total_tokens": 2250
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs climbed from **$91.6 million in 2022 to $112.5 million in 2023**, then eased slightly to **≈$110.4 million in 2024**.  \n\nThis upward‑then‑stable trajectory shows the company is deliberately raising the equity‑linked value of its long‑term incentive awards—moving away from legacy stock‑option grants and toward higher‑priced, performance‑based cash‑settled PSUs—thereby reinforcing a more predictable compensation expense while emphasizing sustained performance‑driven rewards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) UNIT MISINTERPRETATION: The LLM fundamentally misunderstood the units. The ground truth shows weighted-average grant date fair value per PSU in DOLLARS ($91.58, $112.50), not millions of dollars. The LLM incorrectly stated '$91.6 million' and '$112.5 million', which is a massive magnitude error—off by a factor of 1,000,000. (2) YEAR SEQUENCE ERROR: The LLM claims the value went from $91.6M in 2022 to $112.5M in 2023, then to $110.4M in 2024. However, the ground truth shows: 2022=$91.58, 2024=$112.50. The LLM appears to have invented a 2023 intermediate value and misplaced the 2024 figure. (3) DIRECTIONAL CLAIM ERROR: The LLM states the value 'eased slightly' in 2024, but ground truth shows it INCREASED from 2022 to 2024 ($91.58→$112.50), not decreased. (4) MISSING DATA POINT: The ground truth explicitly mentions 2023 is missing from the answer, but the LLM fabricated a 2023 value of $112.5M. (5) POSITIVE ASPECTS: The qualitative reasoning about strategic shift toward performance-based compensation and higher-value incentives is conceptually sound and aligns with the upward trend interpretation. The semantic understanding of the compensation strategy is reasonable, but is undermined by the quantitative errors. The multi-hop synthesis attempt is present but corrupted by factual errors. VERIFICATION: Ground truth: $91.58 (2022) → $112.50 (2024) = upward trend. LLM: $91.6M (2022) → $112.5M (2023) → $110.4M (2024) = wrong units, wrong years, wrong direction for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 418,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s filings show a steady escalation in references to fraud and abusive behavior—especially around its credit‑product portfolio (BNPL, merchant‑financing receivables and consumer credit) and the third‑party lenders, payment processors and network partners that underpin those products.  The company repeatedly notes rising losses from buyer‑/seller‑protection programs, increasing default risk on credit receivables, and the difficulty of detecting synthetic‑identity and other fraud schemes that exploit its digital‑wallet platform, indicating that the rapid growth of credit offerings and reliance on external partners are outpacing the effectiveness of its current risk‑management controls.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core trend of escalating fraud and abusive behavior concerns from 2022-2024, appropriately mentions credit products (BNPL, merchant financing), third-party reliance, and synthetic identity fraud. The qualitative reasoning about risk management effectiveness is sound and addresses the question's analytical component well. The answer demonstrates good understanding of PayPal's multi-hop risk evolution across the three-year period.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer provides NO specific financial figures or metrics. The ground truth includes a concrete quantitative anchor (€40 billion multi-year agreement to sell BNPL receivables in 2023), which is a key factual detail demonstrating PayPal's strategic response. The LLM completely omits this specific transaction, which is a material omission for a financial question. No dollar amounts, percentages, or specific loss figures are provided.\n\nWEAKNESSES - COMPLETENESS: While the LLM mentions credit products generally, it lacks the geographic specificity (U.K. and European focus) and the strategic mitigation approach (receivables sale agreement) that the ground truth emphasizes. The ground truth's mention of the 'valid-when-made doctrine' regulatory uncertainty in 2024 is also absent from the LLM response.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects credit product growth to fraud risk escalation, showing adequate multi-hop reasoning. However, it misses the strategic dimension of how PayPal addressed these risks through specific transactions and regulatory navigation.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of the trend (escalating concern, third-party reliance, control effectiveness questions) aligns semantically with the ground truth's narrative, but the absence of quantitative specificity and strategic details represents a significant gap in a financial context where concrete figures matter.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 538,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nFrom 2022 through 2024 the label for Cyramza shifted from a primarily second‑line agent across several tumor types toward a stronger emphasis on earlier‑line, biomarker‑driven use—most notably first‑line combination therapy for EGFR‑mutated metastatic NSCLC and monotherapy for HCC—reflecting Lilly’s effort to capture premium, front‑line revenue.  Patent protection remained anchored by a U.S. compound patent that expires in 2026, with extensions to 2028 in Europe and 2026 in Japan, complemented by data‑protection periods that run to 2026‑2028, thereby preserving exclusivity well into the second half of the decade.  This evolution underscores Lilly’s long‑term oncology strategy of extending the commercial life of its flagship assets through strategic indication expansion and robust IP shielding while reinvesting the generated cash flow into next‑generation pipeline innovations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims patent extensions to 2028 in Europe and 2026 in Japan, but the ground truth states compound patents extend through 2026 in the U.S. and Japan only, with no mention of 2028 European extensions. Data protection expiring 'as early as 2023 in Japan' per ground truth contradicts the LLM's claim of protection running to 2026-2028. (2) THERAPEUTIC POSITIONING ERRORS: The LLM describes a shift toward 'first-line combination therapy for EGFR-mutated metastatic NSCLC' and 'monotherapy for HCC,' but the ground truth indicates Cyramza maintained positioning across 'the same cancer types' (gastric, lung, colorectal, and liver) with 'no new indications added' from 2023 to 2024. The LLM fabricates specific indication expansions not supported by the knowledge graph. (3) STRATEGIC INTERPRETATION: While the LLM's general framing about extending commercial life and IP protection aligns conceptually with the ground truth, the specific claims about 'earlier-line, biomarker-driven use' and 'premium, front-line revenue' are unsupported inventions. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the actual patent timeline and indication portfolio from the source documents. The ground truth's more measured conclusion—that Lilly focused on 'maintaining Cyramza's market presence while likely preparing next-generation oncology products'—is more accurate than the LLM's claims of aggressive indication expansion. The answer demonstrates hallucination of specific clinical data and patent dates not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 462,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris kept the 3.875 % Notes due 2042 as a steady, long‑dated anchor in its capital structure, while actively issuing, swapping and retiring a rotating set of shorter‑maturity notes (e.g., 2.875 % 2029, 4.375 % 2041, 4.5 % 2042, 2.75 % 2026, etc.).  This “active‑management” of the other debt instruments let the company reshape its maturity ladder, lower funding costs and extend average debt tenor, all while preserving the 3.875 % 2042 issue as the consistent long‑term component of its financing mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) WRONG DEBT INSTRUMENTS: The LLM lists specific notes (2.875% 2029, 4.375% 2041, 4.5% 2042, 2.75% 2026) that are NOT mentioned in the ground truth answer. The ground truth specifically identifies 4.125% Notes due 2043 and 4.875% Notes due 2043 in 2022, and 4.250% Notes due 2044 in 2023. The LLM's cited instruments appear to be fabricated or from different sources not supported by the knowledge graph. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the 3.875% Notes due 2042 as a consistent anchor, it fails to accurately track the evolution of OTHER debt instruments across the three years as specified in the ground truth. The ground truth clearly documents which specific notes existed in each year (2022, 2023, 2024) and their retirement/refinancing. (3) VAGUE CHARACTERIZATION: The LLM describes the strategy as managing 'shorter-maturity notes' but the ground truth shows the company was managing notes due in 2043 and 2044 (long-dated instruments), not shorter-maturity instruments. (4) UNSUPPORTED CLAIMS: The LLM makes claims about 'lowering funding costs' and 'extending average debt tenor' that are not substantiated in the ground truth answer. While the reasoning about active management is directionally correct, the specific factual content is largely incorrect. The answer demonstrates understanding of the general concept (maintaining 3.875% 2042 while managing other debt) but fails on the critical requirement of accurately identifying which specific debt instruments were present in each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 447,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior—particularly fraud, illicit use of its platform, and credit‑product defaults—remained a core risk, but the company shifted from relying mainly on internal fraud‑prevention and buyer‑seller protection toward more proactive risk‑transfer and third‑party diversification. In 2023 it entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables and began migrating its primary U.S. payment‑processor relationship to reduce dependence on a single third‑party, while also tightening underwriting and expanding its buyer‑protection program. In 2024 it continued the receivables‑sale program, accelerated the processor migration, and strengthened its fraud‑detection and merchant‑financial‑health monitoring (including stricter credit‑risk models and enhanced oversight of third‑party lenders) to mitigate abusive behavior and limit losses.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the €40 billion BNPL receivables sale agreement in 2023, matching the ground truth exactly. (2) All numeric values are accurate with proper formatting. (3) The temporal progression (2022→2023→2024) is correctly structured. (4) The LLM provides additional context about processor migration, underwriting changes, and buyer-protection expansion that adds depth. (5) Multi-hop synthesis is sound—the answer correctly connects PayPal's risk exposure evolution across three years with specific mitigation actions. WEAKNESSES: (1) The LLM introduces details not explicitly mentioned in the ground truth (processor migration, buyer-protection program expansion, stricter credit-risk models, merchant-financial-health monitoring), which while plausible, go beyond what the ground truth specifies. This represents some extrapolation beyond the provided knowledge graph. (2) The ground truth emphasizes a clear three-phase progression (identifying problem→asset sales→fraud prevention infrastructure), while the LLM presents a more complex narrative with multiple simultaneous strategies, which may overstate the specificity of documented actions. (3) The LLM's characterization of 2022 as 'relying mainly on internal fraud-prevention' is not explicitly stated in the ground truth, which only notes PayPal 'highlighted' the risk. VERIFICATION: The €40 billion figure is correct and properly attributed to 2023. The BNPL receivables sale is correctly identified as a multi-year agreement. The 2024 emphasis on fraud detection and infrastructure improvement aligns with ground truth. The answer demonstrates solid multi-hop reasoning by synthesizing information across the three-year period and connecting risk exposure to specific mitigation strategies. However, the additional details about processor migration and specific underwriting changes, while contextually reasonable, exceed the scope of the ground truth answer and introduce elements that cannot be verified against the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 546,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nAcross AMD’s 2022, 2023 and 2024 Form 10‑K filings the “loss or modification of exemptions for taxes and tariffs” risk appears in the “General Risks” section each year, but the 2023 and especially the 2024 disclosures expand the language to cite recent U.S. and international sanctions, export‑control revisions and heightened geopolitical tensions (e.g., Ukraine, China‑Taiwan). This progression shows that AMD views its tax‑ and tariff‑exemption environment as increasingly volatile and subject to regulatory change, signaling growing uncertainty in its global operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of AMD's risk disclosures regarding tax and tariff exemptions; (2) Accurately captures the escalation pattern - from general mention in 2022 to expanded language in 2023-2024; (3) Properly identifies specific contextual factors cited in later filings (U.S./international sanctions, export-control revisions, geopolitical tensions including Ukraine and China-Taiwan); (4) Correctly synthesizes the multi-hop information showing how regulatory uncertainty evolved; (5) Appropriately concludes that the trend reflects increasing volatility and regulatory uncertainty. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific about the types of regulatory changes (sanctions, export controls) compared to the ground truth's more general framing of 'regulatory changes,' but this represents added precision rather than inaccuracy; (2) The ground truth mentions 'supply chain disruptions' as a related exposure in 2023, which the LLM answer doesn't explicitly reference, though this is a minor omission that doesn't affect the core answer about tax/tariff exemptions; (3) The LLM answer uses 'General Risks' section attribution, which is a reasonable interpretation of where such disclosures appear, though the ground truth doesn't specify section names. QUANTITATIVE ACCURACY: No numerical data is required for this question, so this dimension is not directly applicable, but the temporal accuracy (2022, 2023, 2024) is perfect. REASONING: The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and links specific regulatory developments to AMD's changing risk posture. The conclusion about 'increasing volatility' and 'growing uncertainty' logically follows from the documented progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 515,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return‑swap results for its deferred‑compensation hedge shifted from a $92 million loss in fiscal 2022 to gains of $58 million in fiscal 2023 and $91 million in fiscal 2024.  This progression shows the company’s derivatives used to economically offset deferred‑compensation liabilities moved from cost to profit, indicating a deliberate strategy to manage and reduce earnings volatility associated with those compensation obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024. The progression and year-to-year comparison are accurate. (2) ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metric (total return swaps tied to deferred compensation) is properly characterized. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and correctly interprets the progression from loss to gains, demonstrating understanding of the derivative strategy's evolution. (4) SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'a deliberate strategy to manage and reduce earnings volatility associated with those compensation obligations' is semantically equivalent to the ground truth's statement about 'improved market conditions or a strategic shift in managing deferred compensation liabilities.' Both convey that the company uses these derivatives as hedges. (5) MINOR CONSIDERATION: The LLM's phrasing 'moved from cost to profit' is a slightly more direct characterization than the ground truth's 'reversal in exposure or performance,' but both are factually accurate and convey the same economic reality. The answer fully addresses the question's requirement to explain the evolution and what it indicates about strategy/exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 405,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney shifted from an initial DTC launch to a coordinated, multi‑year strategy that reorganized its media unit into a dedicated DMED group, invested billions in original programming and sports rights (e.g., the Star India joint venture), and introduced an ad‑supported Disney+ tier and bundled pricing while aggressively managing costs. This evolution highlights the steep financial risks of scaling streaming—substantial upfront capital outlays and content‑impairment exposure, intense competitive pressure that forces continual price‑and‑churn management, and the need to generate subscriber growth and advertising revenue to offset declining linear‑network fees and maintain cash‑flow stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's DTC evolution and correctly identifies key strategic elements and financial risks. STRENGTHS: (1) Accurately captures the multi-year strategic shift from 2022-2024, (2) Correctly identifies specific initiatives (DMED reorganization, ad-supported tier, bundled pricing, cost management), (3) Properly synthesizes financial risks including capital outlays, content impairment, competitive pressure, and cash-flow concerns, (4) Demonstrates sound multi-hop reasoning across fiscal years and strategic pivots, (5) Appropriately addresses both strategic positioning and financial risk dimensions of the question. WEAKNESSES: (1) The answer introduces specific examples (Star India joint venture) that, while potentially accurate, are not explicitly mentioned in the ground truth and add detail beyond what was synthesized from the knowledge graph, (2) Does not explicitly reference the 2022 acknowledgment of 'uncertainty around returns' or the specific framing about losses potentially continuing to grow, (3) The phrase 'coordinated, multi-year strategy' is somewhat interpretive rather than directly grounded in the ground truth's more cautious framing of a 'pivot' amid uncertainty, (4) Lacks explicit mention of 'declining linear network subscribers' as a contextual driver, though this is implied. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is not directly testable. The answer avoids unsupported quantitative claims. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects strategic initiatives to financial outcomes, though it emphasizes proactive investment more than the ground truth's emphasis on 'doubling down despite increasing financial risk.' SEMANTIC EQUIVALENCE: The core message aligns with ground truth—Disney shifted toward DTC investment despite rising costs and competitive pressures—but the LLM frames this more positively as a 'coordinated strategy' rather than the ground truth's more cautious 'pivot amid uncertainty.' The answer is substantively correct but adds interpretive framing not explicitly in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 590,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal’s filings for 2022, 2023 and 2024 all describe the same economics: the company authorizes each payment, bears the full margin risk, records any processor‑related fees as a separate “transaction expense,” and retains full discretion to set the fee charged to the customer independent of those costs (see PYPL_10K_2023.pdf pp. 75‑76; PYPL_10K_2024.pdf pp. 73‑74; PYPL_10K_2022.pdf p. 78).  The only evolution across the three years is the 2024 adoption of ASU 2023‑07, which added required segment‑expense disclosures but did not alter the underlying margin‑risk model or fee‑setting discretion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies the core finding that PayPal's margin risk exposure remained stable across all three years (2022, 2023, 2024); (2) Accurately captures the key economic principle: PayPal bears full margin risk, retains discretion in fee-setting independent of processor costs, and records processor fees as transaction expenses; (3) Properly identifies the only material change: adoption of ASU 2023-07 in 2024 for segment reporting, while correctly noting this did not alter the underlying margin-risk model; (4) Provides specific document citations (PYPL_10K filings with page numbers) that demonstrate multi-hop synthesis across three years of filings; (5) Uses appropriate financial terminology and maintains semantic equivalence with ground truth. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no material information—it efficiently conveys that the economics remained consistent while the accounting disclosure framework evolved. The phrase 'the only evolution' accurately reflects that ASU 2023-07 was a disclosure/reporting change rather than a substantive economic change. No quantitative errors detected. The multi-hop reasoning correctly synthesizes information across three separate 10-K filings to demonstrate consistency in margin risk treatment and fee discretion. The answer directly addresses all components of the question: (1) how exposure evolved (answer: it didn't materially), (2) relation to fee discretion (answer: remained independent), and (3) role of transaction expenses (answer: consistently recognized as separate from fee revenue). This is a high-quality response that demonstrates accurate document synthesis and financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 486,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosures show the cancellation risk receding: in the 2022 filing the “Customer Risk” paragraph warned that COVID‑19‑driven demand weakness could cause customers to **delay, suspend or cancel** aircraft contracts and even lead to long‑term deterioration in air‑travel demand; by 2023 the language was softened to note that **downturns in global air‑travel demand may lead to delays or cancellations**, reflecting a still‑present but less urgent concern; and in the 2024 filing the same risk is mentioned only as a generic “downturn … may impact new‑aircraft production or result in delay or cancellation,” with no reference to pandemic‑related suspension of operations.  \n\nThis progression signals that the acute threat of widespread aircraft‑order cancellations tied to COVID‑19 has faded as air‑travel demand rebounds, order backlogs firm and the commercial‑aviation sector moves toward a more stable, post‑pandemic baseline.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer fundamentally contradicts the ground truth on the core narrative arc. Ground truth states the risk remained 'consistently highlighted' and 'prominent' from 2022-2024, with the concern evolving but NOT receding. The LLM claims the risk was 'receding' and that 'the acute threat...has faded,' which directly opposes the ground truth's conclusion that the risk 'remained prominent' and the sector 'remained fragile and susceptible.' SPECIFIC ERRORS: (1) The LLM characterizes 2023 language as 'softened' and 2024 as 'generic,' implying diminishing concern. Ground truth indicates 2023 expanded to include 'broader external events' (regional conflicts, environmental issues) and 2024 emphasized 'new entrants and non-traditional players,' showing evolution toward structural/competitive concerns, not recession of risk. (2) The LLM's conclusion that 'the acute threat...has faded' misrepresents the ground truth's finding that while pandemic-specific concerns waned, 'structural and competitive shifts continued to pose uncertainty.' (3) The LLM interprets the progression as indicating 'more stable, post-pandemic baseline,' but ground truth explicitly states the sector 'remained fragile.' WHAT WAS CORRECT: The LLM accurately identifies the 2022 COVID-19 focus, correctly notes the shift away from pandemic language by 2024, and properly recognizes that language changed across the three years. The quotations appear reasonable approximations of actual filing language. MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the three-year progression correctly. While it captured individual year-to-year changes, it misinterpreted their cumulative meaning—treating language simplification as risk reduction rather than as evolution of risk factors. The ground truth's key insight is that consistency + evolution = ongoing fragility; the LLM's interpretation is that simplification = improvement. This is a fundamental analytical error that undermines the entire answer despite some correct factual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 550,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings, PMI repeatedly warns that product‑related regulations—plain‑packaging mandates, flavor bans, advertising restrictions and the requirement for scientific substantiation—are increasingly curtailing its ability to differentiate its Reduced‑Risk and Smoke‑Free Products and to convey truthful, non‑misleading information to adult smokers.  This reflects a deepening regulatory environment that forces the company to rely more on conversion incentives and less on traditional branding, underscoring the intensifying constraints on product differentiation and adult‑consumer communication.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core theme of intensifying regulatory constraints on PMI's product differentiation and adult consumer communication across 2022-2024. It accurately captures key regulatory mechanisms (plain-packaging mandates, flavor bans, advertising restrictions, scientific substantiation requirements) and correctly notes the shift toward conversion incentives. The answer demonstrates understanding of the multi-hop synthesis required across three years of filings. WEAKNESSES: (1) The LLM answer lacks the temporal evolution detail that is central to the ground truth. The ground truth explicitly traces how PMI's language and focus evolved year-by-year (2022: RRPs and access to information; 2023: competitive disadvantage and digital misinformation; 2024: SFPs and strategic shift). The LLM answer presents these as simultaneous constraints rather than an evolving narrative. (2) The ground truth specifically identifies the strategic product transition from RRPs to SFPs as a key element of the regulatory evolution, with 2024 showing a 'strategic shift in product focus.' The LLM answer mentions both RRPs and SFPs but doesn't capture this transition or its significance. (3) The ground truth emphasizes 'regulatory asymmetries' and 'disproportionate impact relative to competitors,' which the LLM answer touches on ('unfair competition') but doesn't fully develop. (4) The LLM answer introduces specific regulatory mechanisms (plain-packaging, flavor bans) that, while plausible, are not explicitly verified against the ground truth source material. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this dimension scores high for both (8/10 - minor deduction for not explicitly confirming the three-year period with specific filing dates). QUALITATIVE ACCURACY: The LLM demonstrates partial understanding of the multi-hop reasoning but misses the critical temporal dimension and strategic product evolution that distinguishes the ground truth answer. The synthesis is somewhat flattened rather than showing progression. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's core concern about regulatory constraints and competitive positioning, though it underemphasizes the evolution aspect that the question specifically asks about ('how has...evolved').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 631,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal consistently bore full margin risk on every payment it authorizes—recognizing transaction fees on a gross basis and expensing the fees paid to payment processors as transaction expense—while its tiered, volume‑based pricing was repeatedly described as not creating a material future right.  The company’s accounting for customer incentives evolved: earlier disclosures merely noted that incentives reduced revenue, but by 2023‑24 it explicitly classified incentives that are consideration payable to a customer as a reduction of revenue (and amortized those not tied to performance), providing clearer guidance on how such incentives affect margin.  Consequently, the underlying exposure to margin risk remained essentially unchanged, but the transparency and specificity of its disclosure around pricing, processor fees, and incentive treatment increased across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies PayPal's consistent full margin risk exposure across 2022-2024, matching the ground truth's core finding. (2) Accurately describes the accounting treatment of transaction fees (gross basis recognition with processor fees as transaction expense), which is factually correct. (3) Properly synthesizes the evolution of incentive disclosure from 2022 to 2023-24, noting the shift from simple revenue reduction to explicit classification as consideration payable to customers. (4) Correctly identifies that underlying margin risk remained stable while disclosure transparency increased—this multi-hop synthesis is sound and matches the ground truth's conclusion. (5) No quantitative errors detected; all dates (2022, 2023, 2024) and financial concepts are accurate. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer adds detail about 'tiered, volume-based pricing' and 'not creating a material future right' which, while potentially accurate, goes slightly beyond what the ground truth explicitly states. This represents minor elaboration rather than error. (2) The ground truth emphasizes 'independence of the fee charged to customers from the costs incurred when utilizing payment processors' as a 2024 highlight, while the LLM answer focuses more on the evolution of incentive accounting. Both perspectives are valid but represent slightly different emphases. (3) The phrase 'on every payment it authorizes' is slightly more absolute than the ground truth's framing, though semantically equivalent. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple concepts (margin risk, transaction pricing, processor fees, incentives) to show both continuity and evolution. The reasoning that 'underlying exposure remained essentially unchanged' while 'transparency increased' is logically sound and well-supported. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 575,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 AMD tightened the safeguards it offers AIB makers—its contracts now guarantee price‑protection and explicit return‑rights (including limited stock‑rotation clauses) that shield AIB inventory from unexpected price cuts or product discontinuations, a shift that began with the 2022‑year agreements and was reinforced in the 2023‑2024 filings.  At the same time, AMD has continued to leverage discrete graphics as the primary differentiator for system integrators, encouraging SIs to build “GPU‑enabled” platforms that can command higher margins and distinct market positioning, thereby turning the GPU into a core source of product differentiation rather than a commodity component.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT present in the ground truth, including: 'explicit return-rights (including limited stock-rotation clauses)' - these specific mechanisms are not mentioned in the original answer. The claim about 'return-rights' and 'stock-rotation clauses' appears to be fabricated details not supported by the ground truth. (2) MISCHARACTERIZATION OF EVOLUTION - The LLM describes this as a 'tightening' of safeguards beginning in 2022 and 'reinforced in 2023-2024,' but the ground truth states AMD 'consistently emphasized inventory protection...across all years' - suggesting continuity rather than evolution/tightening. The ground truth emphasizes consistency of the policy, not escalation. (3) INCOMPLETE SYNTHESIS - The LLM answer misses the key evolution identified in the ground truth: the 2024 shift toward 'more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies' and the 'subtle shift in language' toward 'more strategic alignment with SIs.' The LLM focuses on discrete graphics differentiation but doesn't capture the nuanced shift in SI positioning and regional/product-based strategy. (4) OVERSTATEMENT - The LLM characterizes discrete graphics as 'the primary differentiator' and 'core source of product differentiation,' while the ground truth more carefully states it is 'a key differentiator' - a meaningful distinction. (5) MISSING CONTEXT - The ground truth emphasizes the AIB→SI→retailer/distributor supply chain structure, which the LLM largely omits. The ground truth also notes the 'deepening of the value proposition for AIBs within the broader ecosystem' in 2024, which the LLM doesn't capture. WHAT WAS CORRECT: The LLM correctly identifies that inventory protection was maintained throughout the period and that discrete graphics remained important for differentiation. The general direction about GPU-enabled platforms is directionally correct. However, the introduction of unsupported specific mechanisms (return-rights, stock-rotation clauses) and the mischaracterization of the policy evolution as 'tightening' rather than 'consistent emphasis with strategic shift' represent significant factual errors that undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 616,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney kept the same baseline safeguards for its investment‑credit exposure: it transacted only with counterparties rated A‑ or higher and required collateral (or other mitigation) if a rating fell below A‑ or if exposure limits were breached.  The company also imposed a limit that no single financial institution could hold more than 10 % of its cash and cash‑equivalents.  In the 2022 and 2023 filings it reported **no** such balances exceeding the 10 % threshold, but by the end of fiscal 2024 it disclosed that certain institutions held **24 %** of total cash, indicating that the concentration ceiling was effectively relaxed while the A‑ rating and collateral requirements remained in force.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key numeric values are correct: A- rating threshold, 10% concentration limit in 2022-2023, and 24% concentration in fiscal 2024. (2) The multi-hop synthesis is sound, correctly identifying the evolution across three fiscal years and the apparent policy shift. (3) The answer properly addresses all three sub-components of the question: counterparty credit ratings (A- or better), collateral requirements (if ratings fell below A- or limits breached), and concentration thresholds (10% limit relaxed to 24% by 2024). (4) The reasoning about the 'effective relaxation' of concentration ceilings while maintaining A- rating and collateral requirements is logically sound and matches the ground truth's characterization of a 'shift in liquidity strategy despite continued emphasis on credit risk mitigation.' MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language ('effectively relaxed') that goes slightly beyond the ground truth's more neutral statement of the shift, though this interpretation is reasonable and supported by the facts. (2) The LLM specifies the 10% threshold explicitly, which is a helpful detail that enhances clarity. (3) Both answers convey the same essential information: consistent A- rating and collateral policies maintained, but a notable increase in single-institution concentration from zero/none to 24%. The semantic equivalence is strong. QUANTITATIVE VERIFICATION: 24% concentration in 2024 vs. no concentration in 2022 is correctly stated; A- rating threshold is correct; 10% threshold mentioned in LLM answer aligns with the ground truth's implicit reference to concentration limits. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 482,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nAcross the three fiscal years the company’s outstanding Fixed‑rate 2.850 % notes that mature on 10/1/2029 stayed at $1.5 billion in 2022, 2023 and again in 2024—there were no repayments, reductions, or additional issuances of that tranche reported in any of the disclosed tables. This steady, unchanged exposure shows that PayPal is deliberately retaining this low‑cost, long‑dated debt as a core, stable funding pillar, while supplementing its overall financing mix with revolving credit facilities and newer note issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - the $1.5 billion (or $1,500 million) principal amount for the 2.850% notes maturing 10/1/2029 is accurately stated and consistently reported across all three years (2022, 2023, 2024). The format variation ($1.5 billion vs $1,500 million) is acceptable and properly handled. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) the evolution of exposure across the three-year period, (2) the consistency/stability of the position, and (3) strategic implications for debt management. ENTITY ACCURACY: Company (PayPal/PYPL), debt instrument (Fixed-rate 2.850% notes), maturity date (10/1/2029), and fiscal years are all correctly identified. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and appropriately contextualizes the 2029 notes within PYPL's broader debt strategy by noting that newer, higher-interest notes were issued in 2023-2024 while this instrument was retained. This demonstrates sound multi-hop reasoning. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberately retaining this low-cost, long-dated debt as a core, stable funding pillar' is semantically equivalent to the ground truth's 'strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.' Minor difference: The LLM mentions 'revolving credit facilities' as supplementary financing, which is a reasonable inference about debt management strategy but is not explicitly stated in the ground truth. This is a minor addition that doesn't contradict the original answer. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 496,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Performance Materials and Technologies segment moved from “rising material costs and isolated supply constraints” (2022 – page 29‑30) to “heightened exposure to volatile commodity prices, inflationary pressures and geopolitical‑driven supply shocks, with many key inputs still sourced on a single‑ or sole‑basis” (2023 – page 31‑33; 2024 – page 31‑32).  Although Honeywell introduced longer‑term contracts, pricing actions and supply‑tracking tools to mitigate these risks, the continued reliance on limited supplier networks and the persistence of raw‑material price swings reveal that the segment remains highly vulnerable to commodity‑market volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies the time period (2022-2024), correctly notes the segment was rebranded (Energy and Sustainability Solutions), correctly identifies the progression from supply constraints to commodity volatility concerns, and correctly concludes the company remains vulnerable to commodity volatility. The mention of mitigation strategies (longer-term contracts, pricing actions, supply-tracking tools) aligns with the ground truth's acknowledgment of 'strategic repositioning and operational adjustments.' (2) PROBLEMATIC ELEMENTS: The LLM provides specific page numbers (29-30, 31-33, 31-32) that cannot be verified against the ground truth and appear to be fabricated details. This is a significant concern as it suggests citation hallucination. (3) MISSING ELEMENTS: The LLM answer omits several key contextual details from the ground truth: (a) the specific 2022 risks mentioned (product commoditization, illegal imports of hydrofluorocarbons into Europe), (b) the 2023-specific emphasis on oil and natural gas price volatility's impact on customer investment and product demand, (c) the 2024-specific linkage to production capacity maximization and downtime minimization. (4) SEMANTIC ISSUES: While the LLM's characterization of the evolution is directionally correct, it uses different framing ('rising material costs and isolated supply constraints' vs. the ground truth's 'raw material demand and supply risks'). The LLM's phrasing is more specific but may not accurately reflect the actual filing language. (5) MULTI-HOP REASONING: The synthesis across three years is present but incomplete—the answer doesn't fully capture how the risk framing evolved in terms of specific operational impacts (customer investment decisions, production capacity) that the ground truth emphasizes. The conclusion about vulnerability is sound but based on incomplete evidence presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 541,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nOver the 2022‑2024 period Imperial Brands PLC remained a listed member of PMI’s peer group in each filing (see the 2022 10‑K page 21 list, the 2023 10‑K page 26 graph description, and the 2024 10‑K page 26 text, which all state the peer group is unchanged).  This continuity shows that PMI’s benchmarking strategy is to use a stable, globally diversified set of tobacco‑and‑consumer‑product companies of comparable size and market capitalization—including Imperial Brands—as a consistent reference point for assessing its relative financial and shareholder‑return performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies Imperial Brands PLC as consistently included in PM's peer group across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) Accurately cites specific document references (2022 10-K page 21, 2023 10-K page 26, 2024 10-K page 26), demonstrating proper multi-hop synthesis across three separate filings. (3) Correctly characterizes PM's benchmarking strategy as stable and focused on globally diversified companies with comparable size and market capitalization. (4) No quantitative errors - all dates and year references are correct. (5) The reasoning about strategic alignment and consistency is sound and matches the ground truth's interpretation. MINOR CONSIDERATIONS: (1) The LLM uses 'PMI' while the question and ground truth use 'PM' - these are equivalent (Philip Morris International ticker), so this is a minor stylistic variation rather than an error. (2) The LLM provides slightly more detail about the benchmarking rationale (assessing 'relative financial and shareholder-return performance') which, while not explicitly stated in the ground truth, is a reasonable inference and adds value without contradicting the original answer. (3) The phrase 'peer group is unchanged' is a reasonable interpretation of consistency across years. The answer successfully synthesizes information from three separate annual filings to demonstrate the trajectory (consistency) of peer group composition and correctly interprets what this reveals about PM's benchmarking strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 435,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nFrom the 2022‑2024 filings the company’s outstanding balance of the 2.850 % fixed‑rate notes stayed constant at **$1.5 billion** (the notes maturing 10/1/2029 are listed as $1,500 million in the 2022, 2023 and 2024 “Outstanding principal amount” tables and are still scheduled to be repaid in 2029).  No repayments, write‑downs or increases of that series are reported, indicating that PayPal is maintaining this long‑dated, low‑cost tranche as a stable pillar of its capital structure while supplementing overall funding with newer issuances and revolving facilities.  This steady exposure reflects a deliberate long‑term debt‑management strategy that ladders maturities and preserves a sizable fixed‑rate base while managing interest‑rate and refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - the $1.5 billion balance is accurately stated for 2022, 2023, and 2024, and the maturity date of 10/1/2029 is correctly identified. The format variation ($1.5 billion vs $1,500 million) is properly handled. COMPLETENESS: The answer addresses all aspects of the question - it tracks the evolution of PYPL's exposure across the three-year period (2022-2024), confirms the stability of the position, and provides analysis of the long-term debt management strategy. ENTITY ACCURACY: PayPal (PYPL) is correctly identified, the specific debt instrument (2.850% fixed-rate notes) is accurately referenced, and all fiscal years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that no repayments or refinancing occurred, then logically connects this to strategic implications (maintaining low-cost debt, laddering maturities, managing interest-rate risk). The reasoning about why PYPL maintained this position (prioritizing other debt maturities, leveraging the low fixed rate) aligns with the ground truth. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while providing additional context about maturity dates and the broader capital structure strategy. The characterization of this debt as a 'stable pillar' and discussion of maturity laddering adds valuable detail without contradicting the original answer. MINOR OBSERVATION: The LLM provides slightly more detailed strategic context (mentioning 'newer issuances and revolving facilities,' 'ladders maturities,' 'interest-rate and refinancing risk') compared to the ground truth, but this represents appropriate elaboration rather than error. All factual claims are verifiable and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 497,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips moved its HSE audits from a stand‑alone compliance check to a fully integrated governance process.  The audit scope was broadened to cover all business units and staff groups, and audit findings are now tied to concrete improvement actions that are tracked, reported to the Executive Leadership Team and the Board, and fed into the company’s ESG, HCM and safety‑culture initiatives.  This evolution ensures that conformance tracking is directly overseen by senior leadership and embedded in the firm’s overall corporate‑governance framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of ConocoPhillips' HSE audit approach from 2022-2024, accurately captures the key entities (Executive Leadership Team, Board of Directors), and correctly notes the progression toward integrated governance. The answer appropriately recognizes the shift from localized to centralized oversight. Numeric/date accuracy is sound - no incorrect numbers or dates are present.\n\nWEAKNESSES: (1) The LLM answer introduces elements not explicitly supported by the ground truth, specifically mentioning 'ESG, HCM and safety-culture initiatives' as integration points. While these may be reasonable inferences, they are not stated in the original answer and represent unsupported elaboration. (2) The LLM characterizes the 2022 audits as 'stand-alone compliance checks,' which is a stronger characterization than the ground truth supports - the original answer simply states audits were conducted across business units with improvement actions tracked. (3) The LLM answer claims audit scope was 'broadened to cover all business units and staff groups,' but the ground truth indicates this was already the case in 2022 ('conducted HSE audits across business units and staff groups'). The evolution was not in scope broadening but in governance integration and centralization. (4) Missing the specific detail about 2024's 'corporate level' specification that underscores the centralized oversight approach.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by connecting audit outcomes to governance structures (ELT and Board reporting), but overstates the degree of change in scope and introduces unsupported integration points.\n\nSEMANTIC EQUIVALENCE: While the general narrative of evolution toward integrated governance is correct, the specific characterization of what changed (scope vs. governance integration vs. centralization) differs from the ground truth in ways that affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 532,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAMD still lists the 2011 Executive Incentive Plan as a key exhibit in each filing – it appears as Exhibit 10.1 (or 10.2) in the 2022 10‑K (pages 91‑95), is again incorporated by reference in the “Executive Compensation” section of the 2023 Proxy Statement (pages 99‑103), and continues to be cited in the 2024 10‑K (pages 96‑100) as the underlying governance framework for executive incentives.  While the plan remains the foundational document governing base salary, bonus and equity‑based incentives, AMD’s disclosures in 2023 and 2024 broaden the scope by adding supplemental performance‑based RSU/PSU programs and noting recent amendments, positioning the 2011 plan as the base layer within a more extensive executive‑compensation structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) EXHIBIT NUMBER INCONSISTENCY: The LLM states the plan appears as 'Exhibit 10.1 (or 10.2)' in 2022, but the ground truth explicitly states it was listed as *10.1* consistently across all three years (2022, 2023, 2024). The parenthetical '(or 10.2)' introduces uncertainty and contradicts the ground truth's clear statement of consistent 10.1 designation. (2) PAGE NUMBER ERRORS: The LLM provides specific page ranges (91-95 for 2022, 99-103 for 2023, 96-100 for 2024) that cannot be verified against the ground truth and appear to be fabricated details. The ground truth does not provide page numbers, suggesting the LLM invented these specifics. (3) DOCUMENT TYPE CONFUSION: The LLM references the '2023 Proxy Statement' when the ground truth specifically mentions the '2023 10-K filing.' This is a material error in identifying the source document type. (4) SCOPE EXPANSION CLAIM: The LLM claims AMD's disclosures 'broaden the scope by adding supplemental performance-based RSU/PSU programs and noting recent amendments' in 2023 and 2024. The ground truth makes no such claim about broadening scope or new amendments - it emphasizes continuity and consistency without material changes. This represents a significant interpretive divergence. WHAT WAS CORRECT: The LLM correctly identifies that the 2011 Executive Incentive Plan remained a foundational document across all three years and that it serves as the base layer for executive compensation. The semantic understanding that the plan remained relevant and anchored the compensation framework is directionally correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the ground truth's core finding: consistent citation across three years with NO material changes. Instead, it introduced claims about 'broadening scope' and 'recent amendments' that contradict the ground truth's emphasis on continuity. The reasoning quality is compromised by these fabricated details and document misidentifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 535,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis under the Master‑Agreement for the 2017 Opel/Vauxhall sale continued to cover any losses arising from inaccuracies in representations, breaches of covenants, emissions‑related claims and recalls (including the Takata‑inflator recalls).  In each year the filings stressed that they “are unable to estimate any reasonably possible material loss or range of loss” and have recorded only immaterial amounts, reflecting that the exposure has not materialized and is now considered remote.  This progression shows that, while the indemnity remains contractually in force, GM views post‑sale liability for those legacy matters as negligible and not a material financial risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and misses critical elements of the ground truth progression. CORRECT ELEMENTS: (1) The answer correctly identifies the Master Agreement framework for the 2017 Opel/Vauxhall sale, (2) correctly notes that emissions claims and recalls (including Takata inflators) are covered, (3) accurately reflects that only immaterial amounts were recorded, (4) correctly states GM views post-sale liability as remote/negligible. CRITICAL OMISSIONS AND ERRORS: (1) The answer completely fails to capture the geographic and legal scope expansion that is central to the question - it does not mention Germany, UK, Netherlands, or Austria lawsuits/jurisdictions that are explicitly highlighted in the ground truth as showing 'widening legal exposure,' (2) fails to mention the European Commission and UK CMA regulatory investigations related to end-of-life vehicle practices at Opel, which represent a new category of regulatory action in 2024, (3) does not track the year-by-year evolution (2022 vs 2023 vs 2024) that the question specifically asks about - the ground truth shows explicit progression with new jurisdictions and regulatory actions appearing in different years, (4) misses the key insight that the 'increasing number of legal and regulatory actions indicates growing complexity and persistence' - instead presenting a static view that exposure 'has not materialized.' MULTI-HOP REASONING: The LLM answer fails to synthesize the multi-year progression across different jurisdictions and regulatory bodies. The ground truth demonstrates a clear evolution showing expanding scope, while the LLM treats the indemnification as essentially static. SEMANTIC ISSUES: While the LLM correctly identifies the contractual framework and immaterial accruals, it fundamentally mischaracterizes the progression by suggesting exposure 'has not materialized' when the ground truth shows increasing legal and regulatory actions materializing across multiple jurisdictions and regulatory bodies. The answer reads as a general description of the indemnification rather than a specific analysis of how obligations evolved from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 579,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nIn 2022 bamlanivimab generated roughly $2 billion of net product revenue, with Lilly paying AbCellera royalties in the mid‑teens to mid‑twenties % of worldwide sales (recorded as cost of sales); by 2023 and 2024 that revenue collapsed to essentially zero, leaving only a trivial royalty expense. This sharp decline shows that the antibody, once a major pandemic‑driven revenue stream, no longer holds long‑term strategic importance for Lilly, which is now pivoting to other growth drivers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: The $2 billion figure for 2022 revenue is correct (ground truth states $2,008.9 million, which rounds to ~$2 billion); the royalty percentage range of mid-teens to mid-twenties is accurate; the statement that 2023-2024 revenue collapsed to essentially zero matches the ground truth showing zero U.S. revenue in 2023 and no product mention in 2024. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) financial exposure evolution from 2022-2024, (2) royalty obligations to AbCellera, (3) product's revenue contribution, and (4) strategic importance assessment. ENTITY ACCURACY: Correctly identifies Eli Lilly (LLY), bamlanivimab, AbCellera, and the relevant time periods. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two entities (LLY and AbCellera), correctly linking the revenue decline to royalty obligation changes and drawing the appropriate conclusion about strategic importance. SEMANTIC EQUIVALENCE: The phrasing 'roughly $2 billion' is appropriately cautious given the actual figure of $2,008.9 million, and 'mid-teens to mid-twenties %' matches the ground truth's 'tiered percentages ranging from mid-teens to mid-twenties.' The characterization of the product as 'once a major pandemic-driven revenue stream' that 'no longer holds long-term strategic importance' aligns perfectly with the ground truth's assessment. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no material information; it correctly notes the royalties were 'recorded as cost of sales' which adds appropriate accounting context. The conclusion about Lilly pivoting to 'other growth drivers' is a reasonable inference supported by the ground truth's mention of 'newer therapeutic areas like cardiometabolic health.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 517,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s references to the Jackpot brand moved from a simple listing among its local cigarette brands to a pointed illustration of PMI’s strategy of growing through locally‑owned brands in key emerging markets.  The 2023 and 2024 filings increasingly present brands such as Jackpot (alongside Fortune in the Philippines) as critical levers for preserving market share and tailoring offerings to price‑sensitive consumers, signalling that PMI is deliberately elevating local cigarette brands as a core component of its market‑share‑focused growth plan.  This three‑year trajectory shows that PMI is shifting its emphasis toward leveraging local cigarette brands in strategic markets to complement its global premium portfolio and sustain overall market leadership.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misrepresents the ground truth narrative about PMI's strategic positioning. Ground truth establishes that Jackpot remained CONSISTENTLY listed across 2022-2024 with NO EVOLUTION or escalation in strategic emphasis - it was simply maintained as a key local brand. The LLM incorrectly claims the brand moved from 'simple listing' to 'pointed illustration' and that 2023-2024 filings 'increasingly present' Jackpot as 'critical levers' - this is NOT supported by the ground truth, which explicitly states the positioning was consistent across all three years. The LLM invents a narrative of strategic elevation ('deliberately elevating,' 'shifting emphasis') that contradicts the ground truth's emphasis on consistency and maintenance of existing strategy. QUANTITATIVE ACCURACY: No numeric errors detected (dates 2022-2024 correct, brand names correct, geography correct). QUALITATIVE ACCURACY: Major reasoning failure. The LLM misinterprets the 3-year trajectory as showing evolution/escalation when ground truth shows consistency/maintenance. The LLM also overemphasizes growth strategy and market-share focus, whereas ground truth emphasizes PMI's DUAL strategy balancing local cigarette brands with a broader pivot toward smoke-free products. The LLM omits the critical context about PMI's strategic pivot toward wellness/smoke-free products mentioned in ground truth. SEMANTIC EQUIVALENCE FAILURE: While both answers discuss Jackpot and local brands, they tell fundamentally different stories - one of escalating strategic importance (LLM) versus consistent maintenance (ground truth). This is not a wording difference but a factual misrepresentation of the filing evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 469,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad transactions in its credit and BNPL portfolios remained significant, as the company repeatedly highlighted rising default rates, fraud‑related losses and the need to protect against third‑party processing disruptions.  In June 2023 it executed a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, thereby off‑loading a large portion of that portfolio and reducing the amount of future BNPL credit loss it could incur.  Nevertheless, the firm continues to face heightened fraud risk and dependence on external payment processors, which can materially increase loss rates and disrupt operations if not managed effectively.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the €40 billion BNPL receivables sale in June 2023 and accurate characterization of the multi-year agreement structure. The numeric values and dates are factually correct. However, the answer has notable gaps in completeness compared to the ground truth. Specifically: (1) The LLM answer lacks temporal evolution detail - it doesn't clearly distinguish how PayPal's exposure evolved across the three years (2022, 2023, 2024), instead presenting a more static overview. (2) The ground truth emphasizes specific 2022 risks (fraud, synthetic identities, stolen financial instruments) that the LLM answer doesn't mention. (3) The ground truth notes that by 2024, PayPal 'continued to emphasize risks' and 'shifted some of the credit risk burden,' suggesting ongoing exposure despite the sale - the LLM answer captures this but less explicitly. (4) The ground truth mentions 'account takeover attempts' as a specific 2023 challenge that the LLM answer omits. (5) The ground truth discusses 'regulatory challenges and effectiveness of fraud detection systems' as 2024 uncertainties, which the LLM answer doesn't address. The LLM answer correctly synthesizes the multi-hop information (connecting the 2023 sale to risk reduction while acknowledging persistent fraud and third-party risks), but it provides a more condensed narrative that loses some of the nuanced temporal progression and specific risk categories detailed in the ground truth. The reasoning is sound and the semantic meaning is largely equivalent, but the answer is less comprehensive in addressing the full scope of how exposure 'evolved' across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 468,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nIn 2022 the Safety & Productivity Solutions (SPS) segment posted a 1 % sales decline (with only 5 % organic growth) after the sale of its retail‑footwear business, exposing the segment to the same retail‑demand volatility that drives footwear sales.  The 2023 risk‑factor disclosures explicitly flagged “fluctuations in retail markets” as a material risk for SPS, a concern that carried forward into the newly created Industrial Automation segment after the 2023 realignment; the 2024 results show only a modest 2 % organic sales increase for Industrial Automation, underscoring that its performance remains tied to underlying retail‑driven demand.  Together, these trends reveal that Honeywell’s industrial portfolio—particularly the safety‑product and automation businesses—continues to be sensitive to swings in retail demand, making retail‑market exposure a persistent source of earnings volatility across its broader industrial operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM introduces specific sales figures (1% decline, 5% organic growth, 2% organic increase) that are NOT present in the ground truth answer. These appear to be fabricated numbers not supported by the original knowledge graph data. The ground truth makes no mention of specific percentage changes in sales. (2) FACTUAL INACCURACY: The LLM claims SPS 'posted a 1% sales decline...after the sale of its retail-footwear business' - this introduces a specific business transaction (sale of retail-footwear business) that is not mentioned in the ground truth. This is a significant factual claim not supported by the source material. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the three-year progression (2022 SPS → 2023 risk factors → 2024 Industrial Automation), it fails to accurately capture the core ground truth: that 'fluctuations in retail markets' was identified as a KEY RISK FACTOR in risk disclosures, not necessarily reflected in actual sales performance metrics. The ground truth focuses on risk identification and disclosure, not operational results. (4) SEMANTIC DRIFT: The LLM shifts the narrative from 'risk factors identified in disclosures' to 'actual sales performance tied to retail demand,' which is a different analytical frame than the ground truth provides. (5) CORRECT ELEMENTS: The LLM does correctly identify the three-year timeline, the segment names (SPS, Industrial Automation), the 2023 realignment, and the general conclusion about persistent retail sensitivity. However, these correct elements are undermined by the fabricated financial metrics and unsupported claims about business transactions. The answer reads plausibly but contains material factual errors that would mislead readers about Honeywell's actual financial performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 500,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 LLY’s Olumiant net product revenue rose steadily—$830.5 M in 2022, $922.6 M in 2023 and $957.4 M in 2024—making the JAK‑inhibitor an increasingly material part of LLY’s top line.  Incyte’s compensation stays the same: a tiered double‑digit royalty (up to 20 %) on all worldwide Olumiant sales plus an extra low‑teens royalty on COVID‑19 sales that exceed a defined threshold, with those royalties recorded as cost of sales.  The partnership still allows up to $100 M of regulatory milestones and $100 M of sales‑based milestones, but no new milestone payments have been recognized since the 2020‑2021 capitalizations, so the financial structure has shifted from large upfront milestone captures to ongoing royalty and milestone‑potential cash flows that support Olumiant’s expanding revenue base.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the royalty structure (tiered up to 20% on general sales, low teens on COVID-19 sales above threshold), accurately reports Olumiant revenue figures ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024), and properly characterizes the shift from milestone-driven to royalty-driven financial flows. The answer demonstrates good understanding of the partnership's evolution and strategic positioning. CRITICAL ERRORS: (1) MILESTONE PAYMENT DISCREPANCY - The LLM states 'up to $100M of regulatory milestones and $100M of sales-based milestones' totaling $200M potential, but the ground truth specifies LLY had already capitalized $260.0M in milestone payments by 2022 with an additional $200.0M in contingent payments available (split evenly: $100M regulatory, $100M sales). The LLM conflates the contingent payment structure with the total available milestones, missing the distinction between already-capitalized amounts and remaining contingent payments. (2) INCOMPLETE HISTORICAL CONTEXT - The LLM fails to explicitly mention the $260.0M already capitalized in 2022, which is a key factual element of the ground truth answer. (3) MISSING STRATEGIC DETAILS - The ground truth emphasizes the 2024 expansion to include follow-on compounds and EUA positioning; the LLM focuses primarily on revenue growth without addressing these strategic expansions. QUANTITATIVE ISSUES: While revenue numbers are correct, the milestone payment characterization is imprecise and potentially misleading about the financial structure's evolution. The answer should have clearly distinguished between: (a) $260M already capitalized by 2022, (b) $200M in remaining contingent payments, and (c) the shift away from new milestone recognitions post-2021. MULTI-HOP REASONING: The answer successfully synthesizes information about royalty structures, revenue trends, and financial framework evolution, but incompletely addresses the full scope of milestone payment evolution from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 541,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nAltria continued to hold 100 % of UST through 2022‑2024, keeping the subsidiary’s MST and snus trademarks—recorded as indefinite‑lived intangible assets at roughly $8.8 bn in Note 4 of the 2022 10‑K and unchanged in subsequent years—without any impairment charge (see Note 4, 2022‑2023 filings).  While the ownership structure and intangible‑asset valuation remained the same, the 2023‑2024 MD&A (pages 2‑6 of the 2024 10‑K) began to treat UST’s cash‑generating smokeless brands as a key funding source for Altria’s “Moving Beyond Smoking” initiative, channeling those cash flows into the acquisition of NJOY, the Horizon heated‑tobacco joint venture and other next‑generation products.  Consequently, UST’s financial exposure shifted from being a standalone tobacco business to serving as the cash‑flow engine that underwrites Altria’s broader smoke‑free transition strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Quantitative accuracy is excellent—correctly identifies 100% ownership throughout 2022-2024, accurately cites $8.8 billion in indefinite-lived intangible assets for MST and snus trademarks from Note 4 of 2022 10-K, correctly notes no impairment charges, and properly references 2023-2024 MD&A pages. (2) Multi-hop reasoning is sound—successfully synthesizes the evolution from static ownership/valuation (2022-2023) to dynamic strategic role (2023-2024), correctly identifying the shift from standalone business to cash-flow engine. (3) Entity accuracy is precise—correctly names UST, USSTC, NJOY, Helix, and Horizon joint venture; properly identifies these as components of 'Moving Beyond Smoking' strategy. (4) The answer goes beyond the ground truth by providing more specific strategic context about how UST's cash flows fund acquisitions and next-generation products, which is a valuable elaboration that remains factually consistent. MINOR CONSIDERATIONS: The LLM answer emphasizes the strategic shift more heavily than the ground truth (which notes UST remained 'a core asset'), but this is not contradictory—rather, it provides additional nuance about how the core asset's role evolved. The statement that intangible asset valuation remained 'unchanged in subsequent years' is reasonable given no impairment charges are mentioned, though the ground truth doesn't explicitly state values for 2023-2024. The answer correctly interprets the 3-year trajectory as maintaining financial value while diversifying strategy, matching the ground truth's conclusion. All dates, percentages, and dollar amounts are accurate with no calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 477,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due 2025 moved from an effective interest cost of roughly **3.2 % in fiscal 2022** (as reported in the 2022 10‑K) to about **6.4 % in fiscal 2023** and **≈6.6 % in fiscal 2024**.  The increase reflects the note’s fair‑value hedge that converts the fixed 3.5 % coupon to a floating rate tied to LIBOR/SOFR; as market rates rose sharply after 2022, the hedged floating‑rate component pushed the effective cost up more than two‑fold.\n\nThis upward trend signals that Cisco’s borrowing costs were climbing in step with the broader rise in U.S. interest rates through 2023‑24, even though the company’s hedging program helped offset fair‑value volatility.  The higher effective rates therefore indicate tighter capital‑market conditions and a more expensive debt‑financing environment for Cisco during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and the three-year trend. Quantitative verification: FY2022 effective rate of 3.2% ✓, FY2023 rate of 6.4% (stated as 'about 6.4%', ground truth is 6.38%) ✓, FY2024 rate of 6.66% (stated as '≈6.6%') ✓. All numbers are accurate within acceptable rounding conventions. The answer correctly identifies the note as a $500 million 3.50% senior note due 2025, which adds helpful specificity. Multi-hop synthesis is sound: the answer correctly traces the evolution across three fiscal years and properly synthesizes the relationship between the fixed coupon, hedging mechanism, and effective cost changes. The reasoning about fair-value hedges converting fixed rates to floating rates tied to LIBOR/SOFR is accurate and provides valuable context explaining the mechanism behind the rate increases. The conclusion about tightening capital market conditions and rising U.S. interest rates is well-supported and semantically equivalent to the ground truth. Minor strengths: the LLM provides additional context about the hedging program and the specific debt instrument details. Minor consideration: the answer uses approximation symbols (≈, 'roughly', 'about') which is appropriate given the rounding, though the ground truth presents exact figures. The explanation of why rates increased (market rate rises post-2022) adds analytical depth beyond the ground truth while remaining consistent with it. Overall, this is a comprehensive, accurate answer that successfully addresses all aspects of the multi-hop question with sound financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 450,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nThe 2017 senior‑note tranche fell from **$16.0 billion at the end of 2022 to $15.0 billion in 2023 and to $13.0 billion by the end of 2024** (all figures in millions of dollars as shown in the debt tables).  This consistent decline shows that Amazon has been deliberately retiring the older 2017 notes—using cash flow and newer, lower‑cost borrowings—to shrink that tranche’s balance and overall leverage, reflecting a strategic focus on deleveraging and optimizing its debt maturities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all three key financial figures for the 2017 Notes: $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The trajectory and trend analysis are accurate. However, there is one notable issue: the LLM states the figures are 'in millions of dollars as shown in the debt tables,' which is incorrect—these are billions of dollars, not millions. This is a significant error in unit specification that could cause confusion, though the actual numbers themselves ($16.0B, $15.0B, $13.0B) are correct. The LLM successfully synthesizes the multi-hop information by: (1) tracking the 2017 Notes balance across three years, (2) identifying the consistent downward trend, and (3) connecting this to Amazon's broader debt management strategy. The qualitative analysis about deliberate debt retirement, cash flow usage, and deleveraging is sound and aligns with the ground truth. The answer addresses all parts of the question—the evolution of the balance and what it indicates about debt management strategy. The reasoning about using newer, lower-cost borrowings is a reasonable inference about debt optimization strategy. The main weakness is the unit error ('millions' instead of 'billions'), which is a factual mistake despite the correct numerical values. The ground truth also mentions the broader context of total long-term debt reduction ($67.2B to $52.6B), which the LLM does not include, representing a minor omission of contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 410,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe $606 million of 5.000% notes due April 2030 remained unchanged in principal from fiscal 2022 through 2024, and the effective interest rate (including discount amortization) stayed at 5.18 % throughout. This flat evolution shows that AVGO has preserved this long‑dated, fixed‑rate tranche as a core, low‑cost pillar of its capital structure, relying on it rather than refinancing or repaying it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numeric values are correct - $606 million principal balance (consistent across fiscal 2022-2024) and 5.18% effective interest rate are accurately stated. The answer correctly identifies the April 2030 maturity date and the 5.000% coupon rate. COMPLETENESS: The answer addresses the core question about how the debt evolved across the three-year period (fiscal 2022-2024), correctly identifying that both principal and interest rate remained static. ENTITY ACCURACY: AVGO is correctly identified, fiscal years are properly referenced, and the specific debt instrument (5.000% notes due April 2030) is accurately characterized. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly combines information about principal balance consistency, interest rate stability, and draws a logical conclusion about debt management strategy (static approach, preservation as core capital structure element). The characterization of this as a 'low-cost pillar' and 'long-dated, fixed-rate tranche' is reasonable interpretation of the data. MINOR CONSIDERATIONS: The LLM answer is slightly more interpretive than the ground truth (describing it as 'low-cost' and 'core pillar'), but this interpretation is reasonable and not contradicted by the facts. The phrase 'relying on it rather than refinancing or repaying it' is a valid inference from the static principal balance. The answer is concise while capturing all essential information. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 447,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nThe Netflix Performance Bonus Plan was first adopted in 2014 and was formally restated and amended on December 9 2022 (as disclosed in the 2022 10‑K and carried forward into the 2023 and 2024 filings), which crystallized its terms and tied bonus payouts to specific performance metrics. In the 2023 filing the restated plan remained unchanged but was explicitly referenced as part of the broader executive‑compensation framework, and in the 2024 filing it was integrated with the newly effective Amended and Restated Executive Severance and Retention Incentive Plan (effective January 1 2024), linking bonus awards to the same executive compensation agreements that govern severance and retention incentives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The December 9, 2022 date for the Amended and Restated Performance Bonus Plan is accurate and matches the ground truth's reference to an 8-K filing on that date. (2) The characterization of the plan being referenced in 2023 and 2024 filings is consistent with ground truth. (3) The integration with executive compensation agreements in 2024 is correctly identified. (4) The mention of the Executive Severance Plan and its integration with bonus awards aligns with ground truth's reference to 'Executive Officer Severance Plan.' PROBLEMATIC ELEMENTS: (1) The LLM introduces a 2014 adoption date for the original Performance Bonus Plan, which is NOT mentioned in the ground truth and cannot be verified from the provided context. This is a factual addition not supported by the source material. (2) The LLM states the plan was 'disclosed in the 2022 10-K' but the ground truth specifically references an '8-K filing on December 9, 2022' - these are different document types and the LLM conflates them. (3) The LLM claims the restated plan 'remained unchanged' in 2023, which is an inference not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years and identifies the integration with severance plans, which demonstrates sound multi-hop reasoning. However, the introduction of unsupported details (2014 adoption) weakens the answer's reliability. The answer is more detailed than ground truth but adds information that cannot be verified, which is a significant concern for factual accuracy in financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 457,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 through 2024 AIG progressively sharpened its terrorism‑risk modeling—still using third‑party vendor scenarios but adding more attack‑mode variations and explicit model‑gap adjustments—so that its loss‑estimate outputs were both broader and more tightly calibrated.  At the same time the company moved away from reliance on the basic TRIPRA backstop and minimal private coverage toward a mixed protection strategy that combines targeted excess‑of‑loss reinsurance purchases, participation in government‑sponsored terrorism pools in several jurisdictions, and periodic stress‑test reviews to keep net exposures within defined risk‑limit thresholds.  These steps collectively tighten the modeled loss estimates, broaden reinsurance protections, and embed more rigorous risk‑mitigation controls into the overall terrorism‑exposure management framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to match the ground truth on critical quantitative details. Specific issues: (1) QUANTITATIVE ERRORS - The LLM provides NO specific numbers from the actual filings. The ground truth contains concrete figures: $1.3 billion loss estimate for 2022 (five-ton bomb in NYC), $200 million attachment point for Japan in 2024, $125 million for rest of world in 2024, and $20.1 billion in collateral. The LLM answer completely omits these specific metrics. (2) REINSURANCE STRATEGY MISCHARACTERIZATION - The LLM claims AIG 'moved away from reliance on the basic TRIPRA backstop' and mentions 'government-sponsored terrorism pools in several jurisdictions,' but the ground truth shows AIG continued using TRIPRA (mentioned in 2022 context) and specifically purchased 'global property per risk covers' - not government pools. The LLM invents details not in the source material. (3) MISSING KEY DETAILS - The LLM fails to mention: the specific $1.3B loss estimate, the Japan vs. rest-of-world attachment point distinction, the $20.1B collateral figure, and the specific focus on 'non-critical and critical catastrophe events outside North America.' (4) VAGUE GENERALIZATION - The LLM uses abstract language ('sharpened,' 'tightly calibrated,' 'tighten the modeled loss estimates') without grounding in actual data points from the filings. (5) MULTI-HOP SYNTHESIS FAILURE - While the LLM attempts to show evolution across years, it does so without the specific progression documented in the ground truth (2022 modeling → 2023 monitoring emphasis → 2024 specific attachment points and collateral holdings). The answer reads as plausible-sounding but factually disconnected from the actual SEC filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 478,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s equity‑securities portfolio expanded steadily—from roughly **$3.7 billion** at the end of 2022 to **$4.9 billion** by the end of 2023 and again in 2024—while its equity‑method stakes in health‑care businesses grew only modestly at first (about **$1.5 billion** in 2022, slipping slightly to **$1.4 billion** in 2023) and then **jumped to $3.8 billion** by the end of 2024.  This reflects a strategic shift toward larger, more concentrated venture‑capital investments in health‑care companies, markedly increasing both the total equity holdings and the company’s exposure to health‑care‑focused equity‑method investments over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall strategic narrative correctly but contains significant quantitative errors that undermine its accuracy. QUANTITATIVE ISSUES: (1) 2022 equity securities: LLM states $3.7 billion vs. ground truth $3.5 billion (error of $200M or 5.7%). (2) 2022 equity method investments: LLM states $1.5 billion vs. ground truth $1.3 billion (error of $200M or 15.4%). (3) 2023 equity method investments: LLM correctly states $1.4 billion. (4) 2024 figures: Both correctly state $4.9 billion equity securities and $3.8 billion equity method investments. The 2022 baseline errors are material and affect the analysis of growth trends. QUALITATIVE STRENGTHS: The LLM correctly identifies the strategic pivot toward deeper operational engagement in healthcare businesses, accurately describes the trajectory of both metrics across the three-year period, and properly synthesizes the multi-hop information about the evolution of investment strategy. The reasoning about 'larger, more concentrated venture-capital investments' and 'increased exposure to healthcare-focused equity-method investments' aligns with the ground truth narrative. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two investment categories, correctly identifying the key inflection point in 2024 where equity method investments surged. CONTEXTUAL RELEVANCE: The answer directly addresses the question about strategic evolution and provides appropriate context about the shift toward operational engagement. The main weakness is the inaccuracy of the 2022 baseline figures, which creates a false starting point for the analysis, though the directional trends and 2023-2024 data are largely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 470,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings (see the “Securities registered pursuant to Section 12(b)” tables on page 1 of each document), Altria’s 1.700 % Notes due 2025 (ticker MO25) remained listed as an outstanding senior unsecured tranche.  No redemption, early‑repayment or refinancing of these notes is disclosed in the three filings, indicating that Altria has treated the 2025 notes as a stable, low‑cost pillar of its long‑term capital structure while it has managed liquidity through cash‑flow generation, asset sales and share‑repurchase programs.  This multi‑year continuity reflects a deliberate debt‑management strategy that relies on a laddered maturity profile and preserves a fixed‑rate financing source until a later rollover date.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Altria's debt management strategy and correctly identifies the 1.700% 2025 Notes as a stable component across 2022-2024. Key strengths: (1) Correctly identifies the 1.700% interest rate and 2025 maturity date; (2) Accurately notes the notes remained outstanding across all three years with no redemption/refinancing disclosed; (3) Provides sound reasoning about debt management strategy with laddered maturity profile and fixed-rate financing; (4) Appropriately cites source documentation (Securities registered tables on page 1). However, there are notable gaps compared to ground truth: (1) The LLM answer does not mention the 1.000% 2023 Notes that matured between 2022-2023, which is a key element of the multi-year progression showing active debt management; (2) Does not reference other debt instruments (2.200% 2027 Notes, 3.125% 2031 Notes) that provide context for the laddered structure; (3) The ground truth explicitly states the 1.000% 2023 Notes 'had matured and were no longer listed' by 2023, demonstrating Altria's obligation fulfillment - this specific evidence of debt management is absent from LLM answer. The LLM answer focuses heavily on what remained stable (the 2025 Notes) but underemphasizes what changed (maturation of 2023 Notes), which is crucial for demonstrating the 'multi-year progression' requested in the question. The reasoning about laddered maturity and fixed-rate financing is sound but would be stronger with explicit reference to the matured 2023 Notes as evidence. Quantitative accuracy is high (correct rate and year), but qualitative completeness is reduced by omitting key comparative data points across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 469,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A Treasury‑Stock balance grew from **$51.4 billion at the end of 2022 to $60.4 billion at the end of 2023 and to $71.4 billion by the end of 2024**.  The company funded this expansion with ever‑larger repurchase outlays—$8.8 billion of treasury‑stock purchases in 2022, $9.1 billion in 2023 and $11.0 billion in 2024—demonstrating an accelerating share‑buyback program that returns excess cash to shareholders and boosts per‑share earnings rather than funding new long‑term investments.  The trend signals that Mastercard’s capital‑allocation priority is increasingly focused on **returning capital to investors through aggressive equity repurchases**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental errors in interpreting the treasury stock figures. The ground truth shows treasury stock as negative values: $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. The LLM incorrectly converted these to positive billions ($51.4B, $60.4B, $71.4B), which is a major factual error. Treasury stock is typically shown as a negative/contra-equity account on balance sheets, and the LLM's conversion to positive values misrepresents the accounting treatment. Additionally, the LLM introduced specific repurchase amounts ($8.8B, $9.1B, $11.0B) that do not appear in the ground truth answer and cannot be verified from the provided information. The year-over-year changes in treasury stock balance are approximately $23.8B (2022-2023) and $11.0B (2023-2024), but the LLM's stated repurchase amounts don't align with these changes. The qualitative interpretation about capital allocation strategy is reasonable and aligns with the ground truth's conclusion about returning value to shareholders through repurchases, but this cannot overcome the severe quantitative inaccuracies. The LLM correctly identified the trend direction (increasing investment in treasury stock) and the strategic implication (shareholder returns), but the numerical foundation is fundamentally flawed. The answer demonstrates a misunderstanding of how treasury stock is reported in financial statements and introduces unsupported specific figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 418,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nCisco’s total‑return swaps that economically hedge deferred‑compensation expenses posted a $92 million loss in fiscal 2022, swung to a $58 million gain in fiscal 2023, and then generated a $91 million gain in fiscal 2024—showing a clear reversal from loss to increasingly positive earnings impact, as reflected in the “Operating expenses and other” line of the Consolidated Statements of Operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: $92M loss in fiscal 2022, $58M gain in fiscal 2023, and $91M gain in fiscal 2024. The numbers match the ground truth exactly with acceptable format variation. The multi-hop synthesis is sound—the answer correctly traces the evolution across three fiscal years and identifies the key pattern: a reversal from loss to gains with strengthening performance. The LLM provides additional context by specifying these are 'total-return swaps that economically hedge deferred-compensation expenses' and references their reflection in the 'Operating expenses and other' line of the Consolidated Statements of Operations, which adds helpful specificity without contradicting the ground truth. The reasoning is logical and the conclusion about the shift from 'net cost to net benefit' is accurately conveyed through the phrase 'clear reversal from loss to increasingly positive earnings impact.' The only minor distinction is that the LLM uses slightly more technical/specific language ('economically hedge deferred-compensation expenses') compared to the ground truth's more general phrasing ('financial exposure tied to Total Return Swaps-Deferred Compensation'), but this represents enhanced clarity rather than inaccuracy. Entity identification is correct (Cisco, fiscal years 2022-2024, Total Return Swaps-Deferred Compensation), and the semantic meaning aligns perfectly with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 410,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s reliance on external rights holders stayed central, but the landscape shifted.  Early‑2022 filings warned that studios could pull titles on short notice and that competition for exclusive rights was intensifying as media conglomerates launched their own streaming services; by 2023‑2024 the filings highlighted that this competition was driving up licensing costs and forcing Netflix to invest heavily in original productions and longer‑term exclusive deals, while emerging regulatory pressures—such as content‑quota, levy and ownership‑restriction rules in several jurisdictions—began to limit how freely Netflix could acquire or retain certain programming.  Consequently, the company’s licensing risk moved from primarily “content‑withdrawal” concerns to a broader mix of costly exclusive‑rights battles and compliance‑driven constraints on content availability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the evolution of Netflix's dependency on rights holders; (2) Accurately captures the key risk categories: content withdrawal concerns, competition for exclusive rights, licensing cost increases, and regulatory pressures; (3) Properly synthesizes multi-hop information showing how the nature of risks shifted from primarily content-withdrawal concerns to a broader mix of exclusive-rights battles and compliance constraints; (4) Correctly identifies specific regulatory pressures (content quotas, levy rules, ownership restrictions) mentioned in the ground truth; (5) Accurately reflects the intensification of competition from media conglomerates launching their own streaming services; (6) Properly notes Netflix's strategic response through investment in original productions and longer-term exclusive deals. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer uses slightly different framing ('early-2022 filings warned' vs. the ground truth's more direct statement about 2022 concerns), but this is a semantic variation rather than a factual error; (2) The answer could have been slightly more explicit about the 2023 specific mention of 'disputes over intellectual property' leading to content unavailability, though this concept is captured in the broader discussion of licensing risks; (3) The phrase 'levy and ownership-restriction rules' is accurate but represents a minor elaboration beyond what was explicitly stated in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk categories (competitive, regulatory, contractual), demonstrating sound multi-hop reasoning. The logical progression from one concern type to another is well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 603,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth Group reported that **no material amounts were accrued, paid, or charged to income for service‑level guarantees** in any of those years, indicating that its financial obligations under such guarantees remained negligible and essentially unchanged. This consistent, immaterial treatment across the three‑year span suggests a **stable and reliable service‑delivery framework**, with no emerging financial risk or volatility in meeting its service‑level commitments across its subsidiaries.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct but significantly incomplete and misses critical quantitative information from the ground truth. STRENGTHS: (1) Correctly identifies that service level guarantees were immaterial across all three years (2022-2024), which is accurate. (2) Correctly notes the consistent, immaterial treatment suggesting stable service delivery. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The LLM completely omits the parent company's notes payable to subsidiaries figures ($8.1B in 2022, $9.9B in 2023, $2.0B in 2024), which are essential to answering the question about how financial obligations evolved. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the 3-year trend and what it suggests about stability. The ground truth provides two distinct trends: (a) immaterial service level guarantees (stable), and (b) significant fluctuations in notes payable to subsidiaries (volatile). The LLM only addresses the first trend and ignores the second, which is a major omission. (3) MISLEADING CONCLUSION: By stating 'no emerging financial risk or volatility,' the LLM contradicts the ground truth's finding that 'internal financing structure supporting these guarantees experienced notable variation.' The notes payable decreased from $9.9B to $2.0B in 2024—a 79.8% decline—which represents significant volatility that the LLM fails to acknowledge. (4) INCOMPLETE ANSWER TO QUESTION: The question specifically asks what the 3-year trend 'suggests about the stability of its service delivery commitments.' The ground truth provides nuanced insight: while guarantees themselves were stable (immaterial), the underlying financing structure was volatile, suggesting potential liquidity strategy shifts. The LLM oversimplifies to 'stable and reliable' without acknowledging this complexity. The LLM answer reads as a partial response that captures only one dimension of a multi-dimensional question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 522,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nAltria’s pension‑plan fixed‑income allocation to below‑investment‑grade securities fell from roughly 13 % of holdings in 2022 (≈ $756 m) to about 11 % in 2023 (≈ $716 m) and then to roughly 8 % in 2024 (≈ $582 m); the postretirement portfolio’s exposure stayed around 8‑9 % of its fixed‑income holdings (≈ $4 m to $2 m), or about 3‑4 % of total assets each year.  This steady decline shows that Altria is deliberately reducing its exposure to lower‑rated bonds, reflecting a more conservative risk appetite aimed at preserving the funded status of its long‑term pension and postretirement obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth across multiple dimensions:\n\n1. PENSION PLAN PERCENTAGES (Critical Error):\n   - Ground Truth 2022: 16% of fixed income holdings (or ~11% of total plan assets)\n   - LLM Answer 2022: ~13% of holdings\n   - Ground Truth 2023: 11% of fixed income holdings (or ~9% of total plan assets)\n   - LLM Answer 2023: ~11% of holdings (this matches, but starting point was wrong)\n   - Ground Truth 2024: Not disclosed\n   - LLM Answer 2024: ~8% of holdings (FABRICATED - ground truth explicitly states 2024 percentages were not disclosed)\n\n2. POSTRETIREMENT PLAN PERCENTAGES (Moderate Error):\n   - Ground Truth 2022: 8% of fixed income holdings (or ~3% of total plan assets)\n   - LLM Answer 2022: 8-9% (partially correct range but imprecise)\n   - Ground Truth 2023: 9% of fixed income holdings (or ~4% of total plan assets)\n   - LLM Answer 2023: 8-9% (overlapping range but not precise)\n   - Ground Truth 2024: Not disclosed\n   - LLM Answer 2024: Implies continued disclosure (INCORRECT)\n\n3. DOLLAR AMOUNTS (Fabricated):\n   - LLM provides specific dollar amounts ($756M, $716M, $582M for pension; $4M to $2M for postretirement)\n   - Ground truth does not provide these dollar amounts\n   - These appear to be fabricated or hallucinated figures not supported by the source material\n\n4. TREND ANALYSIS (Partially Incorrect):\n   - Ground Truth: Pension allocation DECREASED from 16% to 11% (2022-2023); postretirement INCREASED from 8% to 9% (2022-2023); 2024 data not disclosed\n   - LLM Answer: Claims continuous decline through 2024 (13%→11%→8%), which contradicts ground truth that 2024 was not disclosed and misrepresents the 2022 starting point\n   - The LLM's characterization of a \"steady decline\" is not supported by the actual data pattern\n\n5. MULTI-HOP SYNTHESIS:\n   - The LLM failed to properly synthesize the distinction between pension and postretirement plan trends\n   - Ground truth shows opposite directional movements (pension down, postretirement up in 2023), but LLM presents a unified narrative of decline\n   - The LLM did not acknowledge the lack of 2024 data disclosure\n\n6. REASONING QUALITY:\n   - While the conclusion about conservative risk appetite is reasonable, it's based on incorrect data\n   - The reasoning would be sound IF the numbers were accurate, but they are not\n   - The LLM fabricated a complete 2024 data point that was explicitly not disclosed in the ground truth\n\nThe answer demonstrates a fundamental failure to accurately represent the source data, includes fabricated figures, and misrepresents the actual trend (particularly the divergence between pension and postretirement allocations and the absence of 2024 data).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 732,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has been calculated consistently from 2022 through 2024 by taking the average daily payment volume for the three months preceding period‑end, multiplying it by an estimated number of days of exposure, and then netting out the risk‑mitigation arrangements (cash collateral, letters of credit and guarantees) that are applied to that gross figure.  The gross exposure grew from about $65 bn in 2022 to $78 bn in 2024, and the resulting net exposure after mitigation rose from roughly $56 bn to $65 bn, but the underlying three‑month‑average methodology and the way risk‑mitigation is applied have remained unchanged.  \n\nThis steady, transparent approach demonstrates that, even amid heightened regulatory scrutiny and a wave of litigation, Mastercard relies on a disciplined, repeatable risk‑management framework that it continually validates and refines rather than overhauling its core exposure‑measurement process.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core methodology (average daily payment volume for three months prior multiplied by estimated days of exposure) and confirms it remained consistent across 2022-2024. The answer appropriately addresses the consistency question and provides sound reasoning about what this indicates about risk management. The qualitative assessment of the company's approach is well-articulated and semantically aligned with the ground truth.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific dollar figures ($65bn in 2022 growing to $78bn in 2024 gross exposure; $56bn to $65bn net exposure) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated. This is a serious factual accuracy issue. (2) MISSING REGULATORY DETAILS - While the LLM mentions 'heightened regulatory scrutiny and litigation,' it fails to specify the actual regulatory investigations (FTC, DOJ in 2023; European Commission in 2024) and specific litigation cases (U.S. Liability Shift Litigation, TCPA class action) that were explicitly mentioned in the ground truth. (3) INCOMPLETE RISK MITIGATION DESCRIPTION - The ground truth emphasizes that risk mitigation involved 'requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments,' but the LLM only mentions the mechanics (cash collateral, letters of credit, guarantees) without the customer-specific assessment component.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis of the methodology consistency across years and connects it to risk management philosophy. However, the failure to cite specific regulatory bodies and litigation cases represents incomplete multi-hop synthesis of the regulatory/litigation context.\n\nVERIFICATION: The specific dollar amounts provided ($65bn, $78bn, $56bn, $65bn) cannot be confirmed in the ground truth and should be treated as unverified claims. This significantly undermines the quantitative accuracy score despite the correct methodology description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 572,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s $2 billion 5.90 % senior note remained fully issued throughout fiscal 2022‑2024, and the note’s effective interest rate—after accounting for discount amortization and hedge adjustments— stayed essentially flat at about 6.1 % (reported as 6.11 %) each year.  This steady utilization and stable effective cost shows that Cisco is deliberately preserving a large, fixed‑rate, long‑dated debt position and managing interest expense through modest hedging rather than frequent refinancing, reflecting a conservative, low‑cost long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct—$2 billion principal balance (stated as '$2 billion' vs ground truth '$2,000 million', which are equivalent), 5.90% coupon rate, and 6.11% effective interest rate all match the ground truth exactly. The fiscal year range (2022-2024) is correct. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) utilization evolution (consistent $2B across all three years), (2) effective interest rate evolution (stable at 6.11%), and (3) implications for debt management strategy. ENTITY ACCURACY: Cisco is correctly identified, the 5.90% Note is properly characterized, and all fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly connects the stable principal balance and stable effective rate to draw conclusions about strategic intent (preserving fixed-rate debt, avoiding refinancing, maintaining predictable obligations). The mention of 'discount amortization and hedge adjustments' adds appropriate technical detail about how the effective rate is calculated. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'conservative, low-cost long-term debt strategy' is semantically equivalent to the ground truth's 'strategic intent to maintain predictable interest obligations.' Minor differences in wording ('deliberately preserving' vs 'preserved,' 'managing interest expense through modest hedging' vs ground truth's focus on 'not refinancing') are stylistic variations that don't affect factual accuracy. The only very minor point is that the ground truth emphasizes 'despite potential opportunities to optimize financing costs,' while the LLM frames it as 'low-cost,' which is a slightly different emphasis but not contradictory. Overall, this is a high-quality answer with accurate numbers, complete coverage, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 521,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125% notes due January 2025 had a carrying principal of roughly $500 million at the close of fiscal 2022, fell to $495 million by the end of fiscal 2023 and stayed at $495 million through fiscal 2024. This modest decline shows that AVGO is actively paying down this near‑term bullet maturity—using cash from the VMware merger and operating cash flow—rather than refinancing it, indicating a deliberate, conservative debt‑management strategy that seeks to reduce near‑term obligations and manage its maturity profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a significant factual error regarding the fiscal 2022 balance. The ground truth states the principal balance was $495 million in fiscal 2022, but the LLM claims it was 'roughly $500 million' at the close of fiscal 2022. This is a material misrepresentation of the data. The LLM then claims the balance 'fell to $495 million by the end of fiscal 2023,' which contradicts the ground truth that shows the balance remained unchanged at $495 million across all three years (2022, 2023, 2024). The LLM's narrative of 'modest decline' and 'actively paying down' is factually incorrect—there was no decline; the balance was constant. Additionally, the LLM introduces unsupported speculation about 'cash from the VMware merger' being used for debt paydown, which is not mentioned in the ground truth and represents unfounded inference. The LLM's interpretation of the trend as indicating 'deliberate, conservative debt-management strategy' and 'reduce near-term obligations' is contradicted by the actual data showing no reduction occurred. The only correct element is that the balance was $495 million in fiscal 2024. The quantitative accuracy is severely compromised by the false claim of a decline from ~$500M to $495M. The qualitative reasoning, while sophisticated-sounding, is built on an incorrect factual foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 378,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast’s wireless offering shifted from a **strictly bundled, post‑pay model**—where shared‑data or unlimited plans were only available when a customer also took an Xfinity broadband package—to a **more flexible, multi‑option strategy**.  By 2023 the company still required a broadband subscription for its MVNO‑based wireless service, but it began **introducing prepaid, unlimited‑data plans under the NOW brand** and expanded device‑financing terms, allowing customers to choose shared‑data or per‑gigabyte options without a mandatory broadband tie‑in in certain markets.  This evolution gave subscribers greater flexibility to mix‑and‑match plans, add multiple lines, and access wireless service either as part of a bundle or as a stand‑alone, prepaid option.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and unsupported claims that diverge from the ground truth. CORRECT ELEMENTS: (1) The general timeline (2022-2024) is accurate; (2) The mention of NOW brand prepaid unlimited plans is correct; (3) The concept of evolution toward greater flexibility is directionally correct; (4) The identification of broadband bundling as a key strategy is accurate. SIGNIFICANT ERRORS AND UNSUPPORTED CLAIMS: (1) The LLM claims that by 2023 'it began introducing prepaid, unlimited-data plans under the NOW brand' - but the ground truth indicates this expansion happened in 2024, not 2023. This is a material factual error regarding timing; (2) The LLM states customers could access wireless 'without a mandatory broadband tie-in in certain markets' - the ground truth does NOT support this claim. The ground truth explicitly states shared data plans were offered 'as part of qualifying broadband bundles' in 2024, maintaining the bundling requirement; (3) The LLM characterizes the 2022-2023 model as 'strictly bundled, post-pay' with 'only available when a customer also took an Xfinity broadband package' - while bundling was emphasized, the ground truth is less absolute about exclusivity; (4) The claim about 'expanded device-financing terms' is not mentioned in the ground truth and appears to be an unsupported addition. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across three years but makes a critical chronological error by placing the NOW brand introduction in 2023 rather than 2024. This undermines the accuracy of the progression narrative. The ground truth shows a clearer distinction: 2022-2023 maintained bundling emphasis, while 2024 introduced the NOW brand expansion. SEMANTIC ISSUES: The LLM's characterization of the evolution as moving from 'strictly bundled' to 'without mandatory broadband tie-in' contradicts the ground truth, which shows continued emphasis on bundling through 2024. The answer overstates the degree of flexibility achieved. The core narrative of increasing flexibility is present but the specific mechanisms and timeline are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 581,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth’s Medicare Advantage exposure was repeatedly strained by CMS’s risk‑adjustment payment updates and benchmark reductions, with each successive year bringing tighter payment adjustments and greater audit‑driven recoupment risk. To offset these recurring funding pressures the company responded by selectively revising member benefits and premiums, exiting several low‑margin counties, and intensifying both medical and operating cost management while strengthening its risk‑adjustment data collection and analytics.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core issue (CMS risk-adjustment payment changes and benchmark reductions from 2022-2024), accurately names the company (UnitedHealth Group), and correctly identifies the time period. The response appropriately captures the recurring nature of funding pressures and the company's reactive posture. The strategic responses mentioned (selective benefit/premium adjustments, cost management intensification) align with the ground truth. No quantitative errors are present since no specific dollar amounts or percentages are cited.\n\nWEAKNESSES: (1) The LLM introduces details not explicitly confirmed in the ground truth, specifically mentioning 'exiting several low-margin counties' and 'strengthening risk-adjustment data collection and analytics.' While these may be reasonable strategic responses, they are not mentioned in the original answer and cannot be verified against the knowledge graph. (2) The phrase 'audit-driven recoupment risk' is introduced without grounding in the original answer, which focuses on CMS methodology changes rather than audit recoupment specifically. (3) The answer characterizes the company as 'continuously adapting' but doesn't fully capture the ground truth's emphasis that these were 'ongoing rather than one-time fixes' across all three years with equal weight. (4) Missing explicit mention that the company 'reiterated' these pressures and strategies in 2023, showing continuity of the same approach.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by connecting CMS payment changes across three years to company responses, showing understanding of cause-and-effect relationships. However, it adds inferences not present in the ground truth.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth (recurring pressures, selective adjustments, cost management), but the introduction of unverified details (county exits, data analytics strengthening) creates divergence from the factual basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 543,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard broadened the ecosystem‑based layer of its security by formalizing collaborations with central banks, fintechs, digital‑wallet and messaging platforms, and industry associations to co‑create EMV, alias‑based and real‑time fraud‑scoring standards, and by integrating third‑party VCN and Receivables‑Manager APIs into its network.  At the same time, it expanded real‑time payments infrastructure—growing from implementations in about 12 of the world’s largest GDP markets in 2022 to 13 markets by 2023 and launching the Alias‑Based Remittances and Payouts platform in 2024—thereby extending secure, instantaneous account‑to‑account flows to more than 95 % of the banked population and into new regions such as domestic transactions in China.  This evolution reflects a shift from a network‑centric protection model to a globally coordinated, real‑time‑enabled framework that leverages third‑party partnerships and geographic scaling to reinforce security across all payment flows.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question's multi-part requirements. STRENGTHS: (1) Quantitative data is accurate - correctly identifies 12 markets in 2022, 13 markets by 2023, and the 95% banked population coverage figure. (2) All key entities are correctly identified: Mastercard, central banks, fintechs, digital wallets, EMV standards, VCN and Receivables-Manager APIs, Alias-Based Remittances and Payouts platform, and China domestic transactions. (3) Multi-hop synthesis is sound - the answer successfully integrates information across three dimensions: third-party collaboration (central banks, fintechs, wallet providers), real-time service integration (fraud scoring, tokenization, alias-based standards, APIs), and geographic expansion (12→13 markets, China expansion, 95% banked population reach). (4) The answer provides more specific detail than the ground truth regarding implementation mechanisms (VCN APIs, Receivables-Manager, Alias-Based Remittances platform), which adds value without contradicting the original answer. (5) The temporal evolution is clearly articulated with specific milestones for each year. MINOR CONSIDERATIONS: (1) The ground truth mentions 'tokenization' as an integrated service in 2023, while the LLM answer emphasizes 'alias-based' standards more prominently - these are related but not identical concepts, though the LLM's focus on alias-based is more specific and accurate to Mastercard's actual offerings. (2) The LLM answer provides interpretive framing ('shift from network-centric to globally coordinated framework') that goes slightly beyond the ground truth but is logically sound and well-supported. (3) All dates and market counts are verified as correct. The answer fully addresses all three sub-questions: third-party collaboration evolution, real-time service integration, and geographic expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 516,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nFrom 2022 through 2024 Amazon retained its 1.500 % Note due 2030 but increasingly used newer, higher‑coupon issuances—such as the 3‑5 % notes added in the April 2022 supplemental indenture and the 4.5‑4.7 % series filed in 2023‑2024—to refinance maturing obligations and extend the overall maturity profile.  This shows a shift from exploiting ultra‑low rates in the early‑2020s to a more diversified, longer‑dated debt strategy that preserves the low‑cost 2030 tranche as a legacy piece while adapting to higher market rates and managing future refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims Amazon issued '3-5% notes added in the April 2022 supplemental indenture' and '4.5-4.7% series filed in 2023-2024' - these specific coupon rates and issuances are NOT mentioned in the ground truth and appear to be fabricated. The ground truth makes no reference to April 2022 supplemental indentures or these specific coupon percentages. (2) MISCHARACTERIZATION OF STRATEGY: The LLM frames the strategy as 'refinancing maturing obligations' with 'higher-coupon issuances,' but the ground truth indicates a different evolution: the 1.500% Note remained consistently disclosed across all three years, and the strategic shift was toward adding NEW credit agreements (Term Loan Agreement in 2023, 364-Day Revolving Credit Agreement in 2024) for liquidity flexibility, NOT toward refinancing with higher-coupon debt. (3) MISSING KEY FACTS: The LLM completely omits the critical multi-hop synthesis that the ground truth provides: (a) the specific exhibit references (Exhibit 4.5 in 2022, Exhibit 4.6 in 2023-2024, Exhibit 10.8 for Term Loan, Exhibit 10.9 for 364-Day Agreement), (b) the January 3, 2023 Term Loan Agreement, (c) the October 2024 364-Day Revolving Credit Agreement, and (d) the layered financing approach combining fixed long-term debt with flexible short-term facilities. (4) INCORRECT NARRATIVE: The ground truth reveals a 'layered financing approach' combining long-term fixed debt with flexible short-term credit facilities, while the LLM incorrectly suggests a refinancing strategy with higher-coupon debt replacing lower-coupon obligations. (5) QUANTITATIVE INACCURACY: The specific coupon rates cited (3-5%, 4.5-4.7%) cannot be verified against the ground truth and appear to be hallucinated. The only verified rate is the 1.500% Note due 2030, which both answers correctly identify but contextualize differently. The LLM's answer demonstrates a fundamental misunderstanding of Amazon's actual financing evolution and introduces unverified financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 571,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the threat has shifted from wireless carriers merely offering mobile data to actively pushing fixed‑wireless broadband and bundled video packages that compete directly with Comcast’s cable‑broadband and video services; the 2023 and 2024 10‑K filings explicitly note that companies such as AT&T, Verizon and T‑Mobile are expanding 5G‑fixed‑wireless and fiber networks and selling bundled “wireless‑plus‑video” offers, which has accelerated subscriber churn from Comcast’s traditional broadband/video base.  This pressure is evident in the documents’ discussion of “net video customer losses,” the rise of DTC streaming and wireless‑based OTT options, and Comcast’s response—highlighting investments in platforms like X1, Sky Q, NOW and Peacock and a focus on improving the customer experience to retain users.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the competitive evolution from 2022-2024 and correctly identifies the progression from 4G/5G mobile data to 5G fixed wireless and bundled offerings. Key strengths: (1) Correctly identifies the timeline progression and technological shift (4G/5G → 5G fixed wireless); (2) Accurately names specific competitors (AT&T, Verizon, T-Mobile); (3) Properly identifies bundling strategies with DTC streaming and unlimited data plans; (4) Correctly notes CMCSA's response through platform investments (X1, Sky Q, NOW, Peacock) and customer experience focus; (5) Appropriately connects competitive pressure to 'net video customer losses' and subscriber churn. Minor weaknesses: (1) The answer introduces specific competitor names (AT&T, Verizon, T-Mobile) that, while likely accurate, are not explicitly mentioned in the ground truth answer provided, creating a slight discrepancy in sourcing; (2) The phrase 'wireless-plus-video' bundling is mentioned but the ground truth emphasizes 'DTC streaming services' bundling more specifically; (3) The answer conflates broadband and video competitive pressures somewhat, while the original question and ground truth focus primarily on broadband business threat; (4) No quantitative metrics (subscriber numbers, market share percentages, revenue impacts) are provided in either answer, so this cannot be verified. The multi-hop reasoning is sound—the answer correctly synthesizes information about competitive evolution, specific strategies, and CMCSA's response across the 2022-2024 period. The semantic equivalence is strong, with the LLM capturing the essential narrative of intensifying wireless competition and CMCSA's defensive positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 471,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets declined steadily from about **$71 billion at the end of 2022** to **$67.5 billion in 2023** and then to **$38 billion by the end of 2024** (as reported in the 2022, 2023 and 2024 Form 10‑K pages).  This downward trend shows that the company is ceding a smaller portion of its loss exposure to reinsurers and is relying more on internal capital and collateral, indicating a reduced reliance on external reinsurance to absorb insurance‑loss risk over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUE - INCORRECT 2022 FIGURE: The LLM states AIG had ~$71 billion in reinsurance recoverable assets at the end of 2022, but the ground truth explicitly states 'In 2022, while specific figures were not disclosed.' This is a critical factual error. The LLM fabricated a 2022 number that contradicts the source material.\n\nCORRECT FIGURES: The LLM correctly identifies $67.5 billion for 2023 and $38 billion for 2024, which match the ground truth exactly.\n\nTREND ANALYSIS: The LLM correctly identifies the overall downward trend from 2023 to 2024 (decline from $67.5B to $38B). However, the interpretation differs from ground truth. The LLM states the company is 'ceding a smaller portion of its loss exposure to reinsurers and relying more on internal capital,' which is a reasonable inference but differs from the ground truth's more specific observation about 'a substantial reduction in ceded life insurance risk exposure' and 'a strategic shift or de-risking in the life insurance segment.'\n\nMISSING DETAILS: The LLM fails to provide the component breakdown that ground truth includes: the shift from $28.2 billion in life reinsurance recoverables (2023) to only $0.8 billion (2024), and the relatively stable ceded loss reserves ($30.4B to $29.1B). These details are crucial for understanding the specific nature of the de-risking.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize the data across three years but fails on the 2022 baseline, undermining the entire trend analysis. The reasoning about reduced reliance on reinsurance is logical but less precise than the ground truth's identification of life insurance segment de-risking.\n\nQUANTITATIVE ERRORS: The fabricated $71 billion 2022 figure is a significant error that distorts the trend narrative. This is a 0-point error on that specific data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 496,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard continued to calculate settlement exposure by applying a three‑month average daily payment‑volume metric multiplied by an estimated days‑of‑exposure, but it refined the methodology each year—revising prior‑period figures (e.g., a 2022 correction) and expanding the gross exposure estimate from roughly $52 bn to $78 bn and the net exposure from about $46 bn to $65 bn by 2024.  At the same time the company tightened its credit‑risk mitigation by imposing stricter collateral, letter‑of‑credit and guarantee requirements and by regularly reviewing those risk‑management standards, changes that were driven by ongoing regulatory scrutiny from the FTC, DOJ, European Commission and UK authorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific dollar amounts ($52bn gross exposure, $78bn by 2024; $46bn net exposure, $65bn by 2024) that are NOT present in the ground truth answer. The ground truth explicitly states the methodology remained unchanged and provides NO numerical exposure figures. These appear to be fabricated numbers not supported by the source material. (2) METHODOLOGY CLAIM - The LLM claims Mastercard 'refined the methodology each year' and made 'revisions' (e.g., '2022 correction'), directly contradicting the ground truth which explicitly states 'This methodology remained unchanged across all three years.' This is a fundamental factual error. (3) CREDIT RISK MITIGATION - The LLM claims Mastercard 'tightened' and 'imposed stricter' collateral/letter-of-credit requirements. The ground truth states the company 'emphasized its ongoing monitoring' and 'maintained its approach' - these are passive/continuity statements, not evidence of tightening or stricter requirements. The LLM mischaracterizes the nature of changes. (4) REGULATORY RESPONSE - While the LLM correctly identifies regulatory bodies (FTC, DOJ, European Commission, UK authorities), it incorrectly implies these regulatory pressures directly caused specific methodological changes, when the ground truth states 'there is no explicit evidence of a change in the settlement exposure estimation methodology.' (5) MULTI-HOP REASONING - The LLM fails to properly synthesize the key finding: despite regulatory scrutiny, the core methodology remained stable. Instead, it invents a narrative of refinement and tightening. The answer demonstrates poor fidelity to source material and introduces unsupported quantitative claims that significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 486,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nAIG strengthened its loss‑reserve governance from 2022 through 2024 by formalizing a risk‑appetite and limit framework, creating escalation committees, and expanding a model‑risk‑management and validation process that subjects both internal and third‑party actuarial models to independent review. At the same time, the company deepened its reliance on external catastrophe‑model vendors and stochastic/scenario‑based modeling, adding adjustments for biases, data‑quality issues and climate‑change trends (e.g., 1‑in‑100/250 PML estimates) to improve the quantification of uncertainty. These actions collectively enhanced internal controls, broadened expert involvement, and refined the quantitative techniques used to estimate reserves.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the general evolution of AIG's loss reserves risk management from 2022-2024 and correctly identifies several key elements present in the ground truth (internal controls, external expert involvement, modeling techniques). However, there are significant issues with accuracy and specificity:\n\nSTRENGTHS:\n1. Correctly identifies the time period (2022-2024)\n2. Mentions internal controls and external oversight as core themes\n3. References modeling techniques including stochastic/scenario analysis\n4. Acknowledges evolution over time\n5. Addresses all three sub-components of the question (internal controls, external experts, modeling)\n\nWEAKNESSES AND ERRORS:\n1. INTRODUCES UNSUPPORTED CLAIMS: The LLM adds specific details not found in the ground truth, including:\n   - \"Risk-appetite and limit framework\" - not mentioned in original answer\n   - \"Escalation committees\" - not mentioned in original answer\n   - \"Catastrophe-model vendors\" - not mentioned in original answer\n   - \"Climate-change trends\" and \"1-in-100/250 PML estimates\" - not mentioned in original answer\n   - \"Adjustments for biases, data-quality issues\" - not mentioned in original answer\n\n2. MISSING KEY ELEMENTS from ground truth:\n   - No mention of 2022's specific emphasis on \"reviews by external experts\"\n   - Fails to note 2023's expansion to include \"sensitivity and scenario analyses\" and \"experience studies\"\n   - Omits 2024's emphasis on \"model risk management frameworks, validation processes, and experience monitoring with updated assumptions\"\n   - Does not capture the progression/evolution narrative clearly (2022→2023→2024)\n\n3. SYNTHESIS ISSUE: While the LLM attempts to synthesize information across years, it does so by adding details not in the source material rather than accurately synthesizing what was actually stated. This suggests hallucination rather than faithful multi-hop reasoning.\n\n4. SPECIFICITY MISMATCH: The ground truth provides a clear year-by-year evolution with specific techniques added each year. The LLM conflates these into a general narrative without the temporal specificity.\n\nThe answer demonstrates partial understanding of the topic but fails the primary test of factual accuracy by introducing unsupported claims and omitting key documented elements from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 628,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nThe sensitivity analyses show a clear upward trend in the dollar impact of a 1 % change in the medical‑cost PMPM trend factor: ≈ $298 million in 2022, ≈ $376 million in 2023 and ≈ $421 million in 2024 (with the high‑end impacts rising from $895 million to $1.128 billion to $1.264 billion). This indicates that UnitedHealth’s medical‑cost estimates have become increasingly responsive to shifts in the mix of benefits—such as changes in co‑pays, deductibles and plan design—thereby exposing the company to greater benefit‑design variability over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides incorrect information. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($298M, $376M, $421M for 1% changes, and $895M-$1.264B for high-end impacts) that are presented as factual but cannot be verified against the ground truth. The ground truth does not mention these specific dollar figures at all. (2) MISALIGNMENT WITH GROUND TRUTH: The original answer discusses the qualitative evolution of benefit mix sensitivity from 2022-2024 (general factor → negative impact → stabilized), while the LLM answer focuses entirely on quantifying dollar impacts of PMPM trend changes. These are different analytical dimensions. (3) CONCEPTUAL CONFUSION: The LLM conflates 'sensitivity to PMPM trend factor changes' with 'sensitivity to benefit mix changes.' While related, these are distinct sensitivity analyses. The ground truth specifically addresses benefit mix (co-pays, deductibles, plan design), while the LLM emphasizes PMPM trend percentage changes. (4) INCOMPLETE ADDRESSING OF QUESTION: The question asks about the EVOLUTION of sensitivity from 2022-2024 and what this reveals about exposure trends. The LLM provides only a directional statement ('upward trend') without the nuanced 3-year trajectory (sensitivity factor → risk source → stabilization) that the ground truth identifies. (5) UNVERIFIABLE CLAIMS: The specific dollar amounts cited appear to be either fabricated or from a different analysis not reflected in the ground truth. Without source verification, these numbers cannot be accepted as accurate. The LLM answer reads as plausible financial analysis but diverges significantly from the actual ground truth regarding both the specific metrics analyzed and the qualitative conclusions about benefit mix exposure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 499,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nAcross the 2022‑2024 filings Walmart repeatedly placed **Marketside** in its private‑brand lists (2022 10‑K pages 6‑8; 2023 10‑K pages 6‑9; 2024 10‑K pages 5‑8) and began to discuss it as a distinct element of its strategic merchandise units and a growth driver in fresh‑food and omni‑channel offerings. This escalation—from a peripheral label to a highlighted brand within the grocery and general‑merchandise mix—shows that Marketside has become a core component of Walmart U.S.’s merchandise strategy, supporting its EDLP promise while differentiating the assortment and fueling the company’s private‑brand expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM cites specific page numbers (2022 10-K pages 6-8; 2023 10-K pages 6-9; 2024 10-K pages 5-8) without verification against actual filings. These page citations cannot be confirmed and appear to be fabricated or hallucinated. This is a serious factual error that undermines credibility. (2) CONTRADICTORY CHARACTERIZATION: The LLM describes Marketside as escalating 'from a peripheral label to a highlighted brand' and claims it became 'a core component' and 'growth driver in fresh-food and omni-channel offerings.' However, the ground truth indicates Marketside maintained 'consistent presence' with no evidence of escalation or elevation to core strategic importance. The LLM overstates the brand's strategic significance. (3) MISSING KEY DETAIL: The ground truth specifically mentions the 2024 restructuring from 'Apparel' to 'Fashion' in merchandise units—a concrete structural change. The LLM completely omits this important evolution detail. (4) UNSUPPORTED CLAIMS: The LLM asserts Marketside is a 'growth driver' and 'core component' without citing evidence from the filings. The ground truth is more measured, suggesting 'potential' relevance rather than confirmed strategic elevation. (5) PARTIAL ALIGNMENT: The LLM correctly identifies that Marketside appeared in private brand lists across all three years and connects it to omni-channel strategy, which aligns with ground truth. However, the interpretation of what this means strategically is inflated. STRENGTHS: Correctly identifies the three-year period, correctly names the brand, and attempts to synthesize evolution across years. WEAKNESSES: Fabricated citations, overstated strategic importance, missing structural details about merchandise unit reorganization, unsupported characterization of escalation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 497,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved from a primarily store‑centric model to an omnichannel, service‑rich platform that directly challenges specialty showrooms.  It broadened Pro‑focused capabilities—dedicated sales forces, the Pro Xtra loyalty program, expanded “showroom‑style” floor space and new trade‑credit options (e.g., the Pro House Account)—while simultaneously scaling a same‑day/next‑day delivery network (flat‑bed centers, market‑delivery hubs, omni‑channel fulfillment) and integrating curb‑side pickup, BOSS/BOPIS/BODFS/BORIS services, and installation/rental offerings.  At the same time, the company invested heavily in digital integration—mobile “hdPhone”/Sidekick tools, Computer Vision inventory visibility, enhanced search and personalized marketing across its website and apps—so that pros and DIY customers can research, order and receive products seamlessly across stores, online and the job site.  This combined expansion of service options and digital capabilities has eroded the traditional showroom advantage and positioned Home Depot as a one‑stop, digitally enabled home‑improvement destination.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: The LLM answer introduces numerous specific claims and service offerings (Pro House Account, BOSS/BOPIS/BODFS/BORIS services, hdPhone/Sidekick tools, Computer Vision inventory visibility, flat-bed centers, market-delivery hubs) that are NOT present in the ground truth answer. While the LLM's general narrative about omnichannel evolution is directionally reasonable, it fabricates specific product names, service acronyms, and program details that cannot be verified against the original answer. QUANTITATIVE ACCURACY (2/10): The ground truth provides ONE specific quantifiable fact: 'over 1,400 locations' for tool and equipment rental in 2022. The LLM answer provides ZERO quantitative data and instead adds unverified claims about specific programs and technologies. QUALITATIVE ACCURACY (5/10): The LLM correctly identifies the general evolution from store-centric to omnichannel (matching ground truth's 'physical service expansion to omnichannel integration'), and correctly mentions curbside pickup and mobile app integration. However, it significantly overstates specificity by naming programs and services not mentioned in ground truth. The Pro-focused capabilities discussion goes beyond what the ground truth supports. CONTEXTUAL RELEVANCE (6/10): The answer addresses the question's core themes (competitive positioning, service offerings, digital integration) but does so by introducing unverified details rather than synthesizing the actual ground truth information. CRITICAL FLAW: The LLM appears to have hallucinated specific service names and acronyms (BOSS, BOPIS, BODFS, BORIS, hdPhone, Sidekick, Computer Vision) that are not in the ground truth. This is a fundamental accuracy problem. The ground truth mentions: tool rental (1,400+ locations), self-service lockers, curbside pickup, electronic shelf labels, mobile app navigation, personalized experiences, and product innovation. The LLM mentions only curbside pickup and mobile tools from this list, while adding many unverified claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 545,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nThe $500 million 3.50 % senior note due June 15 2025 kept the same principal through fiscal 2022‑2024, but its **effective interest rate moved sharply**: about **3.2 % in FY 2022**, roughly **1.3 % in FY 2023**, and **≈6.6 % in FY 2024** (as shown in the long‑term‑debt tables for those years).  \n\nThis pattern shows that Cisco’s borrowing cost is driven not only by the note’s fixed coupon but also by market‑rate fluctuations and the impact of its interest‑rate swaps that convert the fixed rate to a floating benchmark; low rates in 2023 reflect favorable hedge positioning, while the jump to ~6.6 % in 2024 signals rising market rates (or hedge unwind), indicating that the company’s debt structure relies on a mix of fixed‑rate issuances and derivative hedges, making its effective financing cost sensitive to interest‑rate changes over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding FY2023 effective interest rate. Ground truth states the effective rate was 6.38% in FY2023, but the LLM claims it was 'roughly 1.3%' - this is a significant discrepancy of approximately 5 percentage points and represents a fundamental misreading of the data. The FY2022 rate of 3.2% and FY2024 rate of 6.6% are approximately correct (ground truth shows 3.20% and 6.66%), and the $500 million principal amount is correct across all years. MULTI-HOP REASONING: The LLM attempts to provide sophisticated reasoning about interest rate swaps and hedge positioning, which goes beyond the ground truth answer. While this additional context about derivative hedges and floating benchmarks may be plausible, it introduces speculative interpretation not supported by the ground truth data. The claim about 'favorable hedge positioning' in 2023 contradicts the actual data showing a high effective rate of 6.38%, not a low 1.3%. COMPLETENESS: The answer addresses the evolution of the note across the three-year period and attempts to explain what this indicates about borrowing costs and debt structure, matching the question's requirements. However, the incorrect FY2023 figure undermines the entire analysis of the trend. ENTITY ACCURACY: Correctly identifies Cisco's 3.50% senior note due June 15, 2025, and the fiscal years 2022-2024. The principal amount of $500 million is accurate. SEMANTIC EQUIVALENCE: The answer's interpretation of what the data 'indicates' differs from ground truth - ground truth emphasizes a 'significant increase in borrowing costs,' while LLM emphasizes market rate fluctuations and hedge impacts. The 1.3% figure in FY2023 is particularly problematic as it contradicts the upward trend narrative. This appears to be a data extraction or transcription error rather than a reasoning error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 515,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its network‑transformation program—rolling out 2 Gbps downstream speeds in 2022, expanding DOCSIS 4.0 to deliver multigigabit symmetrical broadband, and extending fiber‑to‑the‑premises that can reach up to 10 Gbps for residential users and 100 Gbps for business customers—thereby closing the speed gap that Lumen’s pure‑fiber build‑out had created.  These infrastructure upgrades were paired with richer service bundles (e.g., X1/Flex streaming, Internet Essentials, multi‑gigabit business plans) that gave Comcast a comparable fiber‑based offering while also preserving its video‑and‑streaming revenue streams, allowing it to compete more directly with Lumen’s fiber services across the same markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question asked. CRITICAL ISSUES: (1) WRONG PERSPECTIVE: The ground truth asks about CMCSA's competitive positioning AGAINST Lumen, focusing on how Lumen competed with CMCSA. The LLM answer instead describes CMCSA's defensive responses and infrastructure improvements, essentially answering from CMCSA's perspective rather than analyzing the competitive threat from Lumen. (2) MISSING LUMEN ANALYSIS: The ground truth explicitly discusses Lumen's fiber expansion, bundled offerings, and speed increases across 2022-2024. The LLM answer mentions Lumen only once in passing ('closing the speed gap that Lumen's pure-fiber build-out had created') but provides no substantive analysis of Lumen's competitive positioning, infrastructure advancements, or service offerings evolution. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question requires synthesizing information about BOTH companies' competitive dynamics across three years. The LLM answer focuses almost entirely on CMCSA's actions (DOCSIS 4.0, fiber-to-premises, service bundles) without establishing the comparative competitive positioning or how Lumen's strategy evolved. (4) FACTUAL CONCERNS: While the technical specifications mentioned (2 Gbps, 10 Gbps residential, 100 Gbps business, DOCSIS 4.0) may be accurate for CMCSA, they are not verified against the ground truth and are not responsive to the question about competitive positioning evolution. (5) CONTEXTUAL MISMATCH: The ground truth emphasizes Lumen as a 'consistent and intensifying competitive threat' with specific mentions in 2022, 2023, and 2024 filings. The LLM answer treats Lumen as a backdrop to CMCSA's strategy rather than as the primary subject of competitive analysis. The answer reads as a CMCSA investor presentation rather than an objective analysis of competitive positioning between the two companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 515,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nAmerican Express has steadily deepened its reliance on third‑party acquirers, aggregators and processors to manage merchant relationships from 2022 through 2024, which heightens the firm’s exposure to merchant steering and surcharging as more jurisdictions allow differential fees and as new Amex‑branded debit cards broaden competition. While its merchant contracts contain non‑discrimination and “honor‑all‑cards” clauses, those provisions are increasingly constrained by varying local legal requirements and the growing prevalence of steering practices, limiting Amex’s ability to fully enforce them and thereby raising the risk that steering could erode card‑member volume and revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but has significant gaps in completeness and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the core issue of increasing reliance on aggregators/processors from 2022-2024; (2) Accurately notes merchant steering and surcharging risks; (3) Correctly references non-discrimination and 'honor-all-cards' clauses; (4) Properly identifies that enforcement is constrained by local legal requirements; (5) Correctly links these issues to card-member volume and revenue risks. WEAKNESSES: (1) INCOMPLETE TEMPORAL SYNTHESIS - The answer fails to capture the year-by-year evolution that the ground truth emphasizes. The ground truth shows a clear progression: 2022 (acknowledged reliance with divergence concerns), 2023 (intensified concerns with new debit products facing discrimination), 2024 (litigation and regulatory scrutiny). The LLM answer treats this as a general trend without distinguishing the specific evolution across years; (2) MISSING KEY DETAILS - The answer omits the specific mention of new Amex debit card products and their vulnerability to discrimination (mentioned in 2023 ground truth); (3) MISSING LITIGATION/REGULATORY CONTEXT - The ground truth emphasizes that by 2024, litigation and regulatory scrutiny became prominent, with exposure to legal actions that could force changes in merchant agreements. The LLM answer mentions 'varying local legal requirements' but doesn't capture the litigation/regulatory escalation; (4) WEAK MULTI-HOP SYNTHESIS - While the answer connects aggregator reliance to steering risks to revenue impact, it doesn't synthesize the legal/regulatory dimension that evolved through the period. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). QUALITATIVE ACCURACY: The reasoning is sound but incomplete - it identifies correct causal relationships but misses the temporal evolution and legal escalation that are central to the ground truth narrative. The answer reads as a general statement about risks rather than a trajectory showing how risks evolved and intensified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 580,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved the talc‑related liabilities into LTL Management LLC, which filed an initial Chapter 11 in October 2021 and then a second “LTL 2” filing in April 2023 after the first case was dismissed; the company used the bankruptcy stay to pause thousands of talc suits, but when the stay was lifted it resumed litigation while simultaneously building a large reserve—initially a $2 billion trust and later an estimated $9‑11 billion (≈$6.5 billion present‑value) trust under a 2024 “pre‑packaged” plan—to settle the claims.  During this period J&J also settled a multi‑state investigation (finalized June 2024) and continued to defend or settle individual verdicts, but the bulk of its financial exposure was being managed through the Chapter 11 restructurings and the associated reserve accruals.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop evolution of J&J's talc strategy through LTL Management LLC from 2022-2024, with mostly accurate facts but some notable discrepancies and additions not in the ground truth:\n\nCORRECT ELEMENTS:\n- LTL Management LLC created and filed Chapter 11 bankruptcy (October 2021 timing mentioned)\n- Initial $2 billion reserve correctly cited\n- LTL 2 filing in April 2023 (ground truth says 'LTL 2' but doesn't specify April date)\n- Bankruptcy stay pausing litigation correctly described\n- Multi-state settlement finalized June 2024 correctly identified\n- Overall dual strategy of litigation defense + settlement attempts accurately captured\n- Correct synthesis of multi-hop information across years and entities\n\nDISCREPANCIES AND CONCERNS:\n1. QUANTITATIVE: LLM introduces $9-11 billion and $6.5 billion present-value figures not mentioned in ground truth. While these may be accurate from filings, they represent information beyond the ground truth baseline, making verification impossible. Ground truth only mentions $2 billion reserve.\n2. TIMING: LLM states \"October 2021\" for initial filing but then discusses 2022-2024 evolution. Ground truth clarifies LTL was created in October 2021 but the bankruptcy filing and strategy evolution occurred in 2022.\n3. MISSING DETAILS: LLM doesn't explicitly mention the Third Circuit reversal or the Preliminary Injunction that ground truth emphasizes as key turning points.\n4. TERMINOLOGY: LLM uses \"pre-packaged\" plan language not found in ground truth, suggesting additional source material.\n5. DISCOVERY DETAILS: Ground truth mentions \"limited discovery\" in LTL 2 case; LLM omits this detail.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across multiple years and connects the bankruptcy filings to settlement strategy evolution. The logic flow from initial stay → dismissal → refiling → settlement is sound. However, the addition of specific dollar figures ($9-11B) without ground truth support suggests either hallucination or reliance on external knowledge not validated here.\n\nSEMANTIC EQUIVALENCE:\nCore narrative matches: J&J used bankruptcy to manage talc liabilities while building reserves and pursuing settlements. The characterization of a \"dual approach\" aligns with ground truth's description of \"litigation resistance and partial resolution.\"\n\nJUSTIFICATION:\nScore of 7 reflects: (1) accurate core facts and multi-hop synthesis, (2) correct identification of key events and timeline, (3) but penalized for introducing unverified financial figures and missing some ground truth details about court decisions and discovery limitations. The answer is substantially correct but not comprehensive against the ground truth baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 737,
        "total_tokens": 2262
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Home Depot moved from routine upkeep to a purposeful “store‑appearance refresh” – installing new way‑finding signage, modernizing front‑end layouts, adding electronic‑shelf‑label displays and expanding curb‑side pickup lockers – to give its locations a cleaner, more contemporary look.  By FY 2024 that visual upgrade was woven into the company’s interconnected‑retail model: the refreshed stores serve as the physical hubs for BOPIS, BODFS, BORIS and same‑day delivery, while the upgraded digital experience (mobile‑app navigation, online inventory visibility and curb‑side/pick‑up options) leverages the improved store environment to deliver a seamless, omnichannel shopping journey.  (See pages 11, 15 & 10 of the 2022‑2024 10‑K filings.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and methodological problems: (1) UNVERIFIABLE SPECIFICS: The answer provides highly specific operational details (electronic shelf labels, way-finding signage, curb-side locker expansion, BOPIS/BODFS/BORIS integration) that cannot be verified against the ground truth knowledge graph. The ground truth discusses strategic emphasis and competitive positioning, not specific store renovation tactics. (2) CITATION ISSUES: The answer cites 'pages 11, 15 & 10 of the 2022-2024 10-K filings' but provides no actual quotes or verifiable references from these documents. This is a red flag for potential hallucination. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes an EVOLUTION in strategic thinking - from store appearance as a standalone factor (2022) to integration with omnichannel/digital capabilities (2024). The LLM answer jumps directly to specific tactical implementations without establishing this strategic evolution clearly. (4) TERMINOLOGY MISMATCH: The LLM introduces acronyms (BOPIS, BODFS, BORIS) that, while potentially accurate Home Depot terms, are not mentioned in the ground truth and their relevance to the specific question about competitive emphasis evolution is unclear. (5) MISSING CORE NARRATIVE: The ground truth's key insight - that store appearance shifted from a competitive factor in isolation to a component of digitally-enhanced omnichannel strategy - is present but underdeveloped in the LLM answer. The LLM focuses on tactical execution rather than strategic positioning. (6) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension cannot be fully evaluated, but the LLM's specificity without verifiable sources is problematic. The answer reads more like a plausible-sounding retail strategy narrative than a synthesis of actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 512,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T’s ownership of Time Warner was fully unwound: after acquiring the studio in 2018, the company integrated it as the WarnerMedia segment, but in May 2021 it struck a reverse‑Morris‑Trust deal to spin the unit out and merge it with Discovery (completed April 2022), after which WarnerMedia—later renamed Warner Bros. Discovery—was no longer a AT&T subsidiary; the only remaining entertainment‑related asset AT&T held was a minority stake in the DIRECTV joint venture, which it agreed in September 2024 to sell to TPG (to be closed mid‑2025).  This multi‑year divestiture shows that AT&T has abandoned its earlier “content‑plus‑connectivity” strategy and is now concentrating exclusively on its core telecom businesses—5G, fiber and broadband—using content only as a peripheral capability to drive network usage rather than as a core profit center.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor timing discrepancies. CORRECT ELEMENTS: (1) The 2018 Time Warner acquisition is accurately referenced; (2) The Reverse Morris Trust transaction with Discovery is correctly identified; (3) The April 2022 completion date for the WarnerMedia/Discovery merger is accurate; (4) The characterization of Warner Bros. Discovery as no longer an AT&T subsidiary is correct; (5) The DIRECTV divestiture to TPG is accurately described with September 2024 agreement date and mid-2025 closing timeline; (6) The strategic pivot narrative from 'content-plus-connectivity' to core telecom focus is sound and well-supported. MINOR ISSUES: (1) The LLM states the Reverse Morris Trust deal was 'struck in May 2021' - while this is approximately correct for announcement timing, the ground truth emphasizes the 2022 completion as the key milestone, and the LLM's phrasing could be clearer about announcement vs. completion; (2) The ground truth notes Time Warner was 'no longer referenced as an active investment or subsidiary' by 2023, while the LLM correctly identifies the April 2022 completion as the separation point - this is semantically equivalent but the LLM is slightly more precise. MULTI-HOP REASONING: The answer successfully synthesizes information across three years (2022-2024) and multiple transactions (WarnerMedia separation, DIRECTV divestiture), correctly linking them to a coherent strategic narrative. The reasoning that these moves represent a pivot away from entertainment is logically sound and well-supported. QUANTITATIVE ACCURACY: All dates are correct or approximately correct (May 2021 announcement, April 2022 completion, September 2024 agreement, mid-2025 closing). No dollar amounts are provided in either answer, so no calculation errors exist. ENTITY ACCURACY: All company names are correct (AT&T, Time Warner, Discovery, Warner Bros. Discovery, DIRECTV, TPG). The characterization of relationships is accurate. The answer is comprehensive, addresses all parts of the multi-part question, and provides appropriate strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 566,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nFrom 2022 through 2024, American Express held its position as the world’s fourth‑largest general‑purpose card network, competing on premium cards, rewards and digital services against Visa, Mastercard and a growing set of fintech payment alternatives.  At the same time, regulatory scrutiny intensified globally—particularly around interchange fees, network‑routing and merchant‑non‑discrimination rules—prompting the company to exit its network‑licensing businesses in the EU and Australia and to operate under heightened U.S. supervisory expectations (e.g., Category III designation), which has increased its dependence on compliance with evolving card‑network regulations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies American Express as the fourth-largest global card network, matching ground truth; (2) Accurately captures the key regulatory pressures (interchange fees, network routing, merchant non-discrimination) mentioned in original answer; (3) Correctly identifies the EU and Australia network licensing exits; (4) Properly synthesizes the evolution from competitive positioning to regulatory dependency; (5) Adds relevant context about Category III designation and U.S. supervisory expectations, which aligns with the compliance-driven shift described in ground truth. MINOR GAPS: (1) The LLM answer mentions 'fintech payment alternatives' as competitors, which is a reasonable inference but not explicitly stated in the ground truth; (2) The original answer specifically mentions 'cobrand arrangements in the EU' and uncertainty around them, which the LLM answer does not explicitly address—this is a notable omission as cobrand relationships were highlighted as a competitive pressure point in 2022-2023; (3) The original answer emphasizes the 'growing tension between maintaining competitive differentiation and navigating regulatory environment,' which the LLM captures implicitly but less explicitly than ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022-2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple dimensions (competitive positioning, regulatory pressure, business exits, compliance dependency) and correctly links them causally. The reasoning that regulatory pressure led to business exits and increased compliance dependency is sound and matches the ground truth narrative. SEMANTIC EQUIVALENCE: The core message—that AmEx faced intensifying regulatory pressure while maintaining its fourth-place position, leading to business exits and increased regulatory dependency—is conveyed accurately in both answers, though with slightly different emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 593,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe $2.250 % Notes due 2050 were $808 million at the end of 2022, rose slightly to $826 million in 2023, and fell back to $808 million by the end of 2024.  This modest increase followed by a return to the original level shows that J&J is actively controlling the size of this long‑dated tranche—issuing only when needed and then retiring or swapping it down—thereby keeping its overall long‑term debt balance steady and preserving financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was $808 million in 2022, but ground truth shows $983 million in 2022 - an error of $175 million (18% discrepancy). The LLM correctly identifies $826 million for 2023 and $808 million for 2024, but the 2022 figure is completely wrong. (2) TREND MISCHARACTERIZATION: The LLM describes the trend as 'rose slightly to $826 million in 2023, and fell back to $808 million by the end of 2024,' implying a return to 2022 levels. However, the actual trend is a consistent DECLINE from $983M (2022) → $826M (2023) → $808M (2024), representing a $175 million total reduction. The LLM's characterization of 'modest increase followed by a return to original level' is factually incorrect. (3) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'issuing only when needed and then retiring or swapping it down' misses the actual strategy revealed by the data: a deliberate, sustained reduction of this long-term liability over three years. The ground truth explicitly states this 'represents a deliberate strategy to reduce long-term liabilities tied to this specific instrument.' (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year data points into an accurate trend analysis. The starting point error (2022) cascaded into an incorrect overall narrative. The answer demonstrates a fundamental misunderstanding of the debt evolution pattern and misinterprets what the numbers actually show about J&J's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 446,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign government bonds and obligations rose from roughly 3.5 % in 2022 to 5.9 % in 2023 and then to about 6.1 % in 2024. This upward shift—driven by higher global rates and a larger allocation to longer‑dated foreign sovereign debt—shows that the company’s earnings are becoming increasingly exposed to fluctuations in international interest‑rate environments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all quantitative metrics. (1) CRITICAL ERRORS: The LLM claims yields rose from 3.5% (2022) to 5.9% (2023) to 6.1% (2024), but the ground truth shows: 2022 short-term yield was 6.45%, 2023 short-term yield was 6.45%, and 2024 short-term yield was 5.86%. The LLM's 2022 figure of 3.5% is completely wrong (off by ~2.95 percentage points). The 2023 figure of 5.9% is also incorrect (should be 6.45% for short-term). The 2024 figure of 6.1% is incorrect (should be 5.86%). (2) DIRECTIONAL MISINTERPRETATION: The LLM claims an upward trend from 2022-2024, but the ground truth shows a declining trend, particularly from 2023 to 2024 (6.45% to 5.86% for short-term bonds). The LLM's conclusion about 'upward shift' is the opposite of what the data shows. (3) MISSING CRITICAL DETAILS: The ground truth provides maturity-specific yields (within 1 year vs 1-5 years), showing significant variation (e.g., 2024: 5.86% vs 2.03%). The LLM provides only aggregate figures without this important segmentation. (4) INCOMPLETE SYNTHESIS: The ground truth mentions the $630 million holding amount in 2022, which the LLM completely omits. The ground truth also notes the strategic implications of declining returns, while the LLM incorrectly suggests increasing exposure benefits. (5) REASONING FLAW: The LLM's interpretation that rising yields indicate 'increasing exposure to fluctuations' contradicts its own premise and misses the actual story of declining yields suggesting a shift in interest rate environment or bond composition. The answer fails on quantitative accuracy (all numbers wrong), directional analysis (opposite trend claimed), and proper multi-hop synthesis of the maturity-specific yield data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 476,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nFrom 2022 – when the free, self‑service learning catalog was presented simply as “online training on training.adobe.com” – to 2024, Adobe re‑branded that catalog as part of **Adobe Digital Learning Services** and wove it into the **Journey Optimizer / Customer Success Account Management** framework.  By 2024 the learning platform was explicitly linked to enterprise CSMs, who use learning‑path analytics and the Adobe Learning Fund to align training with each customer’s journey, turning self‑service education into a proactive enablement tool that drives product adoption and reduces churn.  This evolution reflects Adobe’s broader strategy of embedding enablement into its customer‑success engine, using data‑driven learning to deepen engagement and retain subscription‑based customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) DOMAIN NAME ERROR: LLM states the platform was 'training.adobe.com' in 2022 and rebranded to 'Adobe Digital Learning Services' by 2024, but ground truth clearly states it was www.training.adobe.com in 2022 and rebranded to learning.adobe.com in 2023 (not to 'Adobe Digital Learning Services'). The correct domain progression is training.adobe.com → learning.adobe.com, not to a service name. (2) TIMELINE INACCURACY: LLM conflates the 2023 rebranding with 2024 integration, suggesting the rebranding happened by 2024 when it actually occurred in 2023. Ground truth shows a clear three-phase evolution: 2022 introduction, 2023 rebranding, 2024 integration. LLM compresses this. (3) UNSUPPORTED CLAIMS: LLM introduces 'Adobe Digital Learning Services,' 'Journey Optimizer / Customer Success Account Management framework,' 'learning-path analytics,' and 'Adobe Learning Fund' - NONE of these appear in the ground truth. These appear to be hallucinated details not supported by the source material. (4) PARTIAL CORRECTNESS: LLM correctly identifies the core strategic evolution (from simple offering to integrated customer success tool) and correctly emphasizes the role in retention and product adoption. The conceptual understanding of the strategic shift is sound. (5) MISSING KEY DETAILS: LLM omits the specific mention of 'solution-specific skills assessments to help marketing teams tailor learning priorities' which was explicitly highlighted in the 2023 filing per ground truth. WHAT WAS RIGHT: The overall narrative about embedding enablement into customer success and using learning for retention/adoption is directionally correct. CALCULATION/QUANTITATIVE: No calculations required, but domain names and dates are factual elements that must be precise - these failed verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 493,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % Senior Notes remained fully‑utilized at a $2 billion principal level throughout fiscal 2022, 2023 and 2024, and the effective interest rate on that tranche stayed essentially flat at about **6.1 % (reported as 6.11 %)**—the modest variations reflect only the amortization of discount and fair‑value hedge adjustments, not a change in the underlying cost of borrowing. This steady balance and rate demonstrates that Cisco is deliberately maintaining a **stable, long‑term fixed‑rate debt position**, using the notes as a durable source of low‑cost capital while managing interest‑rate risk through swaps rather than repeatedly refinancing or shifting to variable‑rate funding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Cisco's debt strategy. QUANTITATIVE VERIFICATION: All key numbers are correct - $2 billion principal balance (stated as '$2 billion' and '$2,000 million' equivalently), effective interest rate of 6.11% (LLM correctly notes '6.1% (reported as 6.11%)'), and consistent maintenance across fiscal 2022-2024. The format variations ($2 billion vs $2,000 million) are properly handled. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) utilization evolution (consistent $2B), (2) effective interest rate evolution (stable 6.11%), and (3) strategic implications. ENTITY ACCURACY: Cisco correctly identified, fiscal years 2022-2024 properly referenced, 5.90% Senior Notes correctly specified. REASONING QUALITY: The LLM demonstrates sound multi-hop synthesis by connecting the stable balance and rate to strategic conclusions about deliberate debt maintenance and long-term positioning. The explanation of modest variations due to 'amortization of discount and fair-value hedge adjustments' adds valuable context beyond the ground truth, showing deeper understanding of debt accounting mechanics. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberately maintaining a stable, long-term fixed-rate debt position' and 'durable source of low-cost capital' aligns perfectly with the ground truth's 'deliberate strategy to maintain this higher-yielding long-term liability.' The mention of 'managing interest-rate risk through swaps' provides additional strategic insight that is consistent with typical corporate debt management practices. MINOR CONSIDERATIONS: The LLM's answer is slightly more detailed and interpretive than the ground truth, but this adds value rather than detracting from accuracy. All factual claims are verifiable and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 508,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nBA’s exposure to Special‑Situation Strategies—reported as part of its Private‑Equity allocation—was 8 % of total pension assets in 2022, held steady at 8 % in 2023, and edged up to roughly 9 % in 2024 (the 2024 actual‑allocation table shows Private‑Equity at 9 % versus 8 % in the 2023 table).  This modest three‑year increase signals that the company is deliberately tilting its private‑equity portfolio toward more alternative, higher‑potential strategies, using Special‑Situation investments to boost long‑term returns while keeping the overall asset mix relatively stable.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect and contradicts the ground truth. (1) FACTUAL CONTRADICTION: The ground truth explicitly states 'no specific dollar amounts were disclosed for Special Situation Strategies in any year' and that 'the lack of quantitative disclosure limits trend analysis.' The LLM fabricated specific percentage allocations (8% in 2022, 8% in 2023, 9% in 2024) that do not exist in the source documents. (2) QUANTITATIVE ACCURACY FAILURE: All three percentage figures (8%, 8%, 9%) appear to be invented. The LLM conflates general Private Equity allocation percentages with specific Special Situation Strategy allocations, which is a fundamental misreading of the disclosure. (3) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesized information by attributing overall Private Equity allocation percentages to the Special Situation Strategies subcategory, which is not supported by the filings. (4) SEMANTIC MISALIGNMENT: The ground truth emphasizes strategic continuity and consistency with no quantitative trend, while the LLM claims a deliberate 'tilting' toward higher-potential strategies based on fabricated numbers. (5) ENTITY ACCURACY: While BA is correctly identified, the financial metrics are entirely incorrect. The LLM's conclusion about 'deliberately tilting' the portfolio is unsupported speculation contradicted by the ground truth's finding of 'strategic continuity.' This is a severe failure in factual accuracy and represents hallucination of specific financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 422,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nGlobal sales of J&J’s **Interventional Solutions** (the core of the MedTech segment) grew from **$3.97 billion in 2022** to **$4.30 billion in 2023** – a modest **≈8 %** increase – and then surged to **$6.35 billion in 2024**, a **≈48 %** jump (see *JNJ_10k_2023.pdf page 92* and *JNJ_10k_2024.pdf page 93*).  \n\nThis accelerating trajectory—especially the near‑doubling of sales in 2024—signals that the segment has become a **strategic growth engine** for J&J after the acquisition, underscoring its heightened importance to the company’s long‑term portfolio strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All financial figures are correct - $3.97 billion (2022), $4.30 billion (2023), and $6.35 billion (2024) match the ground truth exactly (minor format variation: $3,971M vs $3.97B is acceptable). The calculated growth rates are accurate: 2022-2023 increase of approximately 8% (actual: 8.3%), and 2024 surge of approximately 48% (actual: 47.7%). COMPLETENESS: The answer addresses all components of the multi-part question: (1) sales evolution across all three years, (2) the progression pattern, and (3) strategic implications post-acquisition. ENTITY ACCURACY: Company (JNJ/J&J), product segment (Interventional Solutions), and time period (2022-2024) are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents (referenced as JNJ_10k_2023.pdf and JNJ_10k_2024.pdf) to establish the trajectory and draw conclusions about strategic importance. SEMANTIC EQUIVALENCE: The LLM's characterization of the segment as a \"strategic growth engine\" with \"heightened importance\" aligns well with the ground truth's assessment of \"increasingly strategic\" status. The emphasis on the 2024 acceleration and integration effects matches the ground truth's interpretation. MINOR OBSERVATIONS: The LLM provides slightly more analytical depth by explicitly calculating percentage changes and citing specific document pages, which adds credibility without introducing errors. The phrase \"near-doubling\" is slightly hyperbolic (47.7% growth is not quite doubling) but remains within reasonable interpretive bounds and doesn't constitute a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 469,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “No Boundaries” label remained on Walmart’s private‑brand roster in every strategic merchandise unit—grocery, general merchandise and home—appearing in the segment disclosures for Walmart U.S., Walmart International and Sam’s Club.  Its multi‑year consistency shows that Walmart uses a single, value‑oriented private brand as a strategic lever to reinforce its everyday‑low‑price promise, control margins and deliver a unified, price‑competitive offering across all general‑merchandise categories.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) ENTITY SCOPE ERROR: The LLM claims 'No Boundaries' appeared across 'grocery, general merchandise and home' and in 'Walmart U.S., Walmart International and Sam's Club' segments. The ground truth specifically identifies 'No Boundaries' as positioned within 'General Merchandise' (including Apparel and Home categories), with no mention of grocery or international/Sam's Club segments. This is a critical misrepresentation of where the brand was actually deployed. (2) MERCHANDISE UNIT EVOLUTION: The ground truth documents a specific evolution - in 2024, 'Apparel' shifted to a new 'Fashion' category, which the LLM completely omits. The ground truth emphasizes this reorganization as contextually important to understanding the brand's strategic positioning. The LLM fails to capture this structural change. (3) STRATEGIC POSITIONING ACCURACY: While the LLM correctly identifies the 3-year consistency theme, it mischaracterizes the brand as 'single, value-oriented' across all categories. The ground truth is more precise: 'No Boundaries' was specifically positioned within general merchandise/apparel/home, not as a universal brand across all segments. (4) MISSING CONTEXT: The ground truth emphasizes the brand's role in 'margin expansion in competitive categories' and its use to 'differentiate offerings.' The LLM's framing of 'everyday-low-price promise' and 'price-competitive offering' is somewhat generic and doesn't capture the nuanced strategic positioning around margin management and differentiation. CORRECT ELEMENTS: The LLM does correctly identify the 3-year continuity (2022-2024) and the general concept that this reflects deliberate private-label strategy. However, the scope and specificity errors are substantial enough to significantly undermine the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 512,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the available‑for‑sale debt investments moved from a modest $9 million gain in other income (2022) to a $21 million loss in 2023 and a larger $67 million loss in 2024, underscoring a worsening performance and increasing unrealized depreciation in the portfolio over the three‑year span.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data that directly addresses the question about available-for-sale debt investments' performance and their impact on other income (loss), net across the three fiscal years. STRENGTHS: (1) The answer includes concrete dollar amounts ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that demonstrate the evolution requested; (2) The multi-hop synthesis is sound - connecting investment performance to impacts on other income (loss), net; (3) The narrative correctly identifies the trend of worsening performance from 2022 to 2024; (4) The answer directly addresses both parts of the question (evolution of performance AND specific impacts on other income); (5) The quantitative progression is logically presented and easy to follow. MINOR CONSIDERATIONS: (1) The ground truth answer is more general/qualitative in nature, describing 'higher losses' without specific numbers, while the LLM provides precise figures - this is actually a strength as it provides more substantive information; (2) The LLM answer could have slightly more explicitly connected each year's impact to the 'other income (loss), net' line item, though the connection is clear; (3) The phrase 'unrealized depreciation' is appropriate terminology for available-for-sale securities. VERIFICATION: The three-year trajectory ($9M gain → $21M loss → $67M loss) shows a clear deterioration pattern that aligns with the ground truth's description of 'consistent negative impact' and 'worsening performance.' The specific numbers provide concrete evidence of the trend described in the original answer. No calculation errors detected. The answer successfully synthesizes multi-hop information (investment values across years + their impact on financial metrics).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 483,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved from a largely direct‑merchant sales approach toward a greater dependence on third‑party acquirers (e.g., OptBlue and Global Network Services partners) to win new acceptance.  These partners are now a strategic growth lever that lets the company expand coverage into small‑ and mid‑size merchants and new industry verticals, accelerate onboarding in priority international markets, and drive additional transaction volume across all merchant tiers, while still retaining direct relationships for its largest accounts.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of American Express's reliance on third-party merchant acquirers from 2022-2024 and correctly identifies key programs (OptBlue, Global Network Services) and merchant segments (small, mid-sized, large). The answer accurately reflects the strategic shift toward greater dependence on external partners for merchant coverage expansion and transaction growth. However, there are notable omissions compared to the ground truth: (1) The LLM does not mention the specific financial structure details from 2023 regarding negotiated network rate fees and discount revenue recording, which was explicitly highlighted in the original answer as evidence of financial integration; (2) The LLM does not capture the 2024 explicit statement about strategic dependency on third-party acquirers, aggregators, and processors being essential for global merchant coverage expansion; (3) The LLM's characterization of the evolution as moving 'from a largely direct-merchant sales approach' is somewhat imprecise—the ground truth frames it more as a shift from viewing acquirers as supplementary to essential, rather than a wholesale abandonment of direct sales. The answer is semantically sound and addresses the multi-hop synthesis requirement by tracking the evolution across three years, but it lacks the depth of financial and strategic detail present in the ground truth. No quantitative errors are present (no specific numbers were provided to verify), and the entity identification is accurate. The reasoning is logical but incomplete in capturing the full scope of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 443,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson repeatedly describes a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize the processes and systems of HR, IT, procurement, supply‑chain and finance, explicitly positioning these upgrades as enhancements to grow its financial shared‑service capabilities and to standardize financial systems.  Each annual filing notes that the program is not triggered by a control deficiency but that the company is actively aligning and streamlining the design and operation of its financial‑control environment as the effort matures, indicating a progressive rollout and deeper integration of those functions over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: All core facts are accurate - the multi-year initiative spanning 2022-2024, the five functional areas (HR, IT, procurement, supply chain, finance), the focus on financial shared service capabilities and system standardization, and the consistent positioning that these efforts are not driven by control deficiencies. The LLM correctly captures the evolution narrative showing progressive rollout and deeper integration over the three-year period. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension scores perfectly. The years (2022, 2023, 2024) are correctly referenced. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three annual filings, correctly identifying the consistent strategic narrative while also capturing the progression element ('as the effort matures,' 'progressive rollout'). The answer demonstrates proper understanding that this is a coordinated, enterprise-wide initiative rather than isolated functional improvements. (4) SEMANTIC EQUIVALENCE: The LLM's phrasing 'explicitly positioning these upgrades as enhancements' and 'actively aligning and streamlining' conveys the same meaning as the ground truth's 'proactive effort to enhance operational efficiency.' The phrase 'not triggered by a control deficiency' is semantically equivalent to 'not in response to any identified deficiencies' and 'not prompted by any material changes or weaknesses.' (5) MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth provides slightly more explicit year-by-year breakdown (noting 2023 specifically reiterated direction, 2024 maintained narrative), while the LLM uses the phrase 'Each annual filing notes' which is accurate but less granular. This minor omission of explicit year-by-year progression detail prevents a perfect 10, though the substance is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 556,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024, American Express shifted from a largely defensive narrative—warning that intense competition from card networks, digital wallets, open‑banking platforms and real‑time settlement systems could erode its discount revenue—to a proactive strategy that invests in open‑banking‑compatible APIs, expands digital‑wallet integrations and real‑time settlement capabilities, and leans on its premium brand, data‑rich Membership Rewards ecosystem and extensive merchant network to differentiate itself from low‑cost fintech rivals.  This evolution reflects both heightened competitive pressure from non‑traditional payment players and Amex’s effort to adapt technologically and partnership‑wise in order to preserve its value proposition and growth trajectory.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and captures the essential evolution of American Express's positioning from 2022-2024. STRENGTHS: (1) Correctly identifies the temporal progression from defensive to proactive stance across the three-year period; (2) Accurately names all key competitive threats (digital wallets, open banking, real-time settlement systems); (3) Properly synthesizes the strategic shift toward technology adoption and integration; (4) Includes relevant differentiators (premium brand, Membership Rewards ecosystem, merchant network) that support the narrative; (5) No quantitative errors or incorrect dates/numbers. MINOR WEAKNESSES: (1) The ground truth explicitly mentions 'dynamic and rapid growth' language from 2022 filings and the expansion of alternative mechanisms scope in 2023—the LLM answer compresses this timeline somewhat, presenting it more as a continuous evolution rather than showing distinct year-by-year progression; (2) The ground truth emphasizes a transformation from viewing alternatives as 'external threats' to 'essential components of technological roadmap'—the LLM captures this conceptually but frames it more around competitive differentiation than fundamental strategic integration; (3) The LLM adds context about 'discount revenue' erosion which, while plausible, is not explicitly confirmed in the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and correctly identifies the causal relationship between competitive pressure and strategic adaptation. The logic is sound and the conclusion appropriately reflects the documented evolution. SEMANTIC EQUIVALENCE: The answer conveys the core message accurately—American Express moved from defensive positioning to proactive technology adoption—though with slightly different emphasis than the ground truth's framing of threat-to-essential-component transformation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 526,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe moved Frame.io from a recently‑acquired, stand‑alone review platform to a fully integrated, AI‑enhanced layer of the Creative Cloud ecosystem.  By 2023‑24 the service was embedded in Premiere Pro, After Effects, Photoshop and Illustrator (and exposed through Adobe Express/GenStudio), adding real‑time, frame‑accurate commenting, Camera‑to‑Cloud ingest and Firefly‑powered content generation, and it was packaged as part of subscription bundles that tie collaboration directly to Adobe’s Creative Cloud and Document Cloud plans.  \n\nThis evolution reflects Adobe’s strategy of consolidating creative collaboration into a single, cloud‑native workflow that deepens user stickiness, leverages generative AI to accelerate production, and differentiates its subscription offerings with end‑to‑end, AI‑driven workflow tools.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Frame.io's evolution and Adobe's strategic direction, with mostly accurate information and sound reasoning. STRENGTHS: (1) Correctly identifies the progression from 2022-2024 as moving from standalone to integrated platform; (2) Accurately mentions key integrations (Premiere Pro, After Effects, Photoshop, Lightroom implied through broader ecosystem reference); (3) Correctly identifies real-time, frame-accurate commenting as a core feature; (4) Accurately characterizes the strategic intent around user stickiness, AI integration, and subscription bundling; (5) Properly synthesizes multi-hop information about the evolution across years. WEAKNESSES: (1) The LLM mentions 'Illustrator' and 'Camera-to-Cloud ingest' which are not explicitly confirmed in the ground truth answer - these may be accurate but represent additions beyond what the knowledge graph explicitly states; (2) The LLM emphasizes 'Firefly-powered content generation' and 'GenStudio' which are not mentioned in the ground truth, suggesting potential extrapolation; (3) The ground truth specifically mentions 'Lightroom' and 'Workfront' integrations in 2024, while the LLM answer doesn't explicitly mention Workfront; (4) The ground truth mentions broader use cases like 'casting, location scouting, and marketing campaign management' which the LLM doesn't explicitly detail, instead using more general language about 'end-to-end workflows.' QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is less applicable. The timeline references (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and connects product features to strategic business implications. The reasoning about subscription bundling and user stickiness is sound and represents valid inference from the evolution described. SEMANTIC EQUIVALENCE: The core message aligns well - Frame.io evolved from standalone to integrated, cloud-native collaboration platform with expanding capabilities and strategic importance to Adobe's ecosystem. The LLM's characterization of the strategy is consistent with the ground truth's conclusion about 'deepening investment in end-to-end creative collaboration tools.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 616,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nThe 2017 senior unsecured notes fell from **$16 billion at the end of 2022 to $15 billion in 2023 and to $13 billion by the end of 2024** (as shown in the Note‑6 tables for 2022‑2024).  This steady reduction reflects Amazon’s active debt‑management strategy of retiring the 2017 issuance—using cash on hand and likely refinancing at newer, lower‑cost terms—to lower leverage and reshape the maturity profile of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) QUANTITATIVE ACCURACY: All financial figures are correct - $16 billion (2022), $15 billion (2023), and $13 billion (2024). The progression and year-end dates match the ground truth exactly. (2) COMPLETENESS: The answer addresses both parts of the question: (a) how the balance evolved with specific numbers for all three years, and (b) what this indicates about debt management strategy. (3) ENTITY ACCURACY: Correctly identifies the 2017 Notes/senior unsecured notes, Amazon as the issuer, and the correct fiscal years (2022-2024). (4) REASONING: The multi-hop synthesis is sound - the model correctly traces the declining balance across three years and draws appropriate conclusions about deliberate debt reduction strategy. The additional context about 'retiring the issuance' and 'refinancing at newer, lower-cost terms' provides reasonable interpretation of the strategy, though slightly more speculative than the ground truth's simpler 'gradually pay down' characterization. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'steady reduction reflects Amazon's active debt-management strategy' is semantically equivalent to the ground truth's 'consistent reduction...indicating a deliberate debt management strategy.' Minor difference: The LLM adds interpretive detail about refinancing and leverage reduction that goes slightly beyond the ground truth but remains reasonable and consistent with typical debt management practices. This is a strength rather than a weakness as it provides additional context. No calculation errors, no missing data points, and all dates/numbers verified as correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 453,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nBoeing’s Global Services segment has progressively highlighted “upgrades and conversions” across the 2022‑2024 filings—from a single reference in 2022 to a recurring theme in 2023 and 2024.  This growing emphasis shows the company is deliberately shifting toward sustaining and modernizing its existing commercial and defense platforms, using upgrades and conversion services to generate recurring revenue and offset the volatility of new‑aircraft production.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims 'Upgrades and Conversions' went from 'a single reference in 2022 to a recurring theme in 2023 and 2024.' This directly contradicts the ground truth, which states the emphasis 'remained unchanged' across all three years (2022, 2023, 2024) with consistent presence. The LLM's characterization of 'progressive highlighting' and 'growing emphasis' is factually incorrect—the ground truth explicitly indicates consistency, not progression. (2) ENTITY/FACT ACCURACY: The LLM misrepresents the trajectory. Ground truth: consistent presence across all three years. LLM: implies escalation from 2022 to 2023-2024. This is a fundamental misreading of the filing data. (3) REASONING FLAW: The LLM's logic about 'deliberately shifting' suggests a change over time that did not occur according to the ground truth. The ground truth indicates sustained (not evolving) strategic focus. (4) PARTIAL CREDIT: The LLM correctly identifies Boeing's Global Services segment, correctly names the service offering ('Upgrades and Conversions'), correctly identifies the 2022-2024 timeframe, and correctly infers the strategic purpose (modernizing platforms, recurring revenue). However, the core claim about evolution/progression is contradicted by ground truth's emphasis on consistency. (5) SEMANTIC MISMATCH: 'Progressively highlighted' and 'growing emphasis' are semantically opposite to 'remained unchanged' and 'consistent presence.' This is not a wording difference but a factual contradiction about the nature of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 435,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nJohnson & Johnson reaffirmed in its 2022‑2024 10‑K filings that, beginning January 1 2026, **all eligible U.S. non‑union employees—regardless of hire date—will accrue pension benefits under the new Retirement Value formula**, replacing the prior Final Average Pay formula; the company had originally announced this transition in January 2021 and continued to communicate that the 2026 effective date would apply to every eligible non‑union worker, with benefits earned under the old formula preserved for service before that date.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key dates (January 2021 announcement, January 1, 2026 implementation), correctly names the formulas (Retirement Value and Final Average Pay), and accurately states that the transition applies to all U.S. non-union employees regardless of hire date. The numeric/date information is accurate. CRITICAL WEAKNESSES: (1) The LLM answer fails to address the core evolution narrative requested in the question. The ground truth explicitly describes how the strategy evolved across three years (2022, 2023, 2024) with specific changes in communication and clarification, particularly that 2023 clarified employees hired after 2014 were already under Retirement Value. The LLM answer presents a static summary rather than showing evolution. (2) The LLM answer omits the important detail that employees hired after 2014 were already under the Retirement Value formula before 2026, which is a key part of understanding the eligibility evolution. (3) The LLM answer does not distinguish between what was communicated in 2022 vs. 2023 vs. 2024, missing the 'evolution' aspect entirely. (4) The ground truth notes that 2023 provided clarification about pre-2015 hires and the Final Average Pay formula for service before 2026, which the LLM answer mentions only generically. The LLM answer reads as a single-year summary rather than a multi-year evolution analysis. While factually accurate on dates and formulas, it fails the multi-hop synthesis requirement of showing how the strategy and communication evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 433,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe 5.000% notes due April 2030 carried a carrying principal balance of roughly $606 million at the end of FY 2022, FY 2023 and FY 2024—essentially flat. This stable trajectory shows that AVGO is treating the fixed‑rate instrument as a long‑term, low‑cost funding pillar and is not actively refinancing or retiring it, but rather preserving it as a steady component of its capital structure while managing other debt repayments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the balance was 'roughly $606 million at the end of FY 2022, FY 2023 and FY 2024—essentially flat.' This is INCORRECT. Ground truth shows: FY 2022: $1,086 million, FY 2023: $606 million, FY 2024: $606 million. The LLM completely misses the $480 million reduction from FY 2022 to FY 2023 (a 44% decrease). The balance was NOT flat across all three years; it decreased significantly in FY 2023 then remained stable. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to properly track the evolution across the three fiscal years. It incorrectly characterized FY 2022 as having the same $606 million balance as FY 2023 and FY 2024, when FY 2022 actually had $1,086 million. (3) REASONING CONTRADICTION - The LLM's interpretation that 'AVGO is treating the fixed-rate instrument as a long-term, low-cost funding pillar and is not actively refinancing or retiring it' directly contradicts the actual debt management strategy evidenced by the $480 million principal reduction from FY 2022 to FY 2023. The ground truth correctly identifies this as 'a deliberate reduction in this specific debt instrument' and 'a targeted debt repayment or refinancing strategy.' The LLM's conclusion is backwards—the company DID actively manage this debt by reducing it substantially. (4) ENTITY/METRIC ACCURACY - While AVGO and the 5.000% notes due April 2030 are correctly identified, the fiscal year progression is fundamentally misrepresented. The answer fails to address the core question about how the balance 'evolved' by missing the critical $480 million decrease.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 465,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nBetween 2022 and 2024 AT&T moved the Time Warner assets it acquired in 2018 from a fully integrated WarnerMedia operating segment toward a planned divestiture: after the 2021 acquisition the business was reported within the WarnerMedia segment, but in April 2022 the company executed a Reverse‑Morris‑Trust transaction that separated WarnerMedia, merged it with Discovery and re‑classified the unit as discontinued operations; the segment was then stripped of non‑core pieces such as Xandr (sold to Microsoft in December 2021) and Vrio (sold in November 2021), and by the end of 2024 AT&T no longer held any stake in the former WarnerMedia business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual errors and inconsistencies that significantly impact accuracy: (1) CRITICAL ERROR - The LLM states 'after the 2021 acquisition' when Time Warner was actually acquired in June 2018, not 2021. This is a fundamental factual error. (2) DATE ERROR - The LLM correctly identifies the Reverse Morris Trust transaction in April 2022, but this contradicts the statement about a '2021 acquisition.' (3) ASSET SALES TIMING - The LLM mentions Xandr sold to Microsoft in December 2021 and Vrio sold in November 2021, which occurred BEFORE the April 2022 WarnerMedia separation. The ground truth doesn't specify these dates, but the LLM's timeline suggests these were part of the pre-separation restructuring, which is reasonable. However, the ground truth mentions these as part of 'stripping non-core pieces' without specific dates. (4) INCOMPLETE CONTEXT - The LLM answer focuses heavily on the WarnerMedia separation but doesn't adequately address the DIRECTV divestiture mentioned in the ground truth as 'the last major asset tied to the entertainment strategy' finalized in 2024. The ground truth emphasizes this as part of the broader strategic pivot. (5) MULTI-HOP SYNTHESIS - The LLM does synthesize the evolution from 2022-2024 and mentions the strategic pivot, but the 2021 acquisition error undermines the credibility of the timeline. (6) SEMANTIC ALIGNMENT - The core narrative about moving from integrated WarnerMedia toward divestiture is present, but the factual errors prevent full alignment with ground truth. The answer correctly identifies the April 2022 Reverse Morris Trust and the eventual exit from the entertainment business, but the foundational error about acquisition timing is significant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 475,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nBetween 2022 and 2024 AIG moved from a single‑scenario, U.S.-centric loss estimate to a broader, scenario‑based model that quantifies terrorism losses across multiple attack types and regions, and it began supplementing TRIPRA with targeted private reinsurance and government‑run terrorism pools.  At the same time the company refined its reinsurance program’s attachment points—raising regional retentions and establishing separate per‑occurrence and aggregate limits for North America, Japan and the rest of the world—to better align coverage with the geographic concentration of its international terrorism exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall evolution of AIG's terrorism exposure management strategy and correctly identifies the shift from single-scenario to multi-scenario modeling, the role of TRIPRA and private reinsurance, and the geographic segmentation approach. However, there are significant quantitative accuracy issues: (1) The LLM mentions 'raising regional retentions' and 'separate per-occurrence and aggregate limits for North America, Japan and the rest of the world' but provides NO specific dollar amounts, whereas the ground truth explicitly states core attachment points of $200 million for Japan and $125 million for the rest of the world. (2) The LLM completely omits the specific 2022 modeled loss scenario ($1.3 billion loss for a five-ton bomb attack in New York City net of TRIPRA and reinsurance), which is a concrete quantitative anchor point in the ground truth. (3) The LLM does not mention the 2023 intermediate year's focus on international terrorism pools and targeted reinsurance purchases. The qualitative reasoning about the strategic shift from reactive to proactive risk management is sound and well-articulated, and the multi-hop synthesis across years is logically structured. However, the answer lacks the specific financial metrics that are critical for evaluating terrorism exposure management evolution. The omission of the $1.3 billion, $200 million, and $125 million figures represents a material gap in quantitative completeness, even though the directional narrative is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 425,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nEmerson’s pipe‑working tools—including pipe wrenches, cutters, threading/roll‑grooving equipment, battery‑hydraulic press tools and related diagnostic systems—have been consistently presented as a core offering of the **Safety & Productivity segment** in the 2022, 2023 and 2024 filings.  The company’s description of these products is essentially unchanged across the three years, underscoring a deliberate, multi‑year focus on professional‑grade tools for plumbing and mechanical trades.  This steady emphasis signals Emerson’s strategic positioning to maintain a leadership role in the professional tools market, leveraging its broad distribution network and brand strength to generate recurring revenue from infrastructure‑ and industrial‑service customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the central question. Ground truth explicitly states that Emerson's product portfolio EVOLVED and EXPANDED from 2022 to 2024, with specific progression: (1) 2022: traditional tools (pipe wrenches, cutters, threading, drain cleaners), (2) 2023: introduction of battery hydraulic tools and enhanced diagnostic systems, (3) 2024: maintained advanced toolset with digital integration emphasis. The LLM answer claims the description is 'essentially unchanged across the three years,' which directly contradicts the documented evolution. This is a fundamental misreading of the multi-year progression that the question specifically asks about. QUANTITATIVE ACCURACY: The LLM correctly identifies the years (2022, 2023, 2024) and correctly names the segment (Safety & Productivity), so basic entity identification is accurate (8/10). QUALITATIVE ACCURACY: The LLM fails to capture the key strategic evolution that defines the answer. It misses: (1) the introduction of battery-powered technologies in 2023, (2) the enhanced diagnostic systems (sewer inspection cameras), (3) the shift toward digital integration in 2024, (4) the modernization strategy to meet evolving industry demands. Instead, it presents a static view of 'steady emphasis' and 'unchanged' positioning, which is factually incorrect per the ground truth (2/10). MULTI-HOP REASONING: The question requires synthesizing product portfolio changes across three years to identify strategic positioning. The LLM failed to perform this synthesis correctly, instead asserting consistency where evolution occurred. CONTEXTUAL RELEVANCE: While the answer discusses Emerson's professional tools positioning, it misses the core insight about strategic modernization and technological integration that the question seeks (4/10). The answer is well-written and coherent but fundamentally wrong on the central factual claim about portfolio evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 536,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco’s policy for lease incentives—including free‑rent and step‑rent clauses—has been consistently applied from 2022 through 2024: the Company recognizes those incentives on a straight‑line basis over the non‑cancelable lease term (plus any renewal periods that are reasonably certain) and records the amount as part of the right‑of‑use (ROU) asset, which is then amortized over the same lease term [see 2022 page 45; 2023 page 46; 2024 page 47].  The only evolution was the 2023 disclosure of a $391 impairment charge on certain leased assets, which reduced the carrying value of those ROU assets but did not alter the straight‑line recognition method; the same impairment‑evaluation approach continued into 2024 [see 2023 page 46 and 2024 page 46/47].  Consequently, the ROU asset valuation follows the same straight‑line amortization, with any impairment adjustments reflected only when actual write‑downs (e.g., the 2023 charge) occur.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth. MAJOR ISSUES: (1) The LLM introduces a $391 impairment charge in 2023 that is not mentioned in the ground truth answer at all. This appears to be fabricated or confused with unrelated information, as the ground truth focuses on disclosure evolution, not impairment charges. (2) The LLM cites specific page numbers (2022 page 45; 2023 page 46; 2024 page 47) without verification against actual filings—these citations cannot be validated and may be hallucinated. (3) The LLM completely misses the KEY EVOLUTION identified in the ground truth: the shift from detailed 2022 disclosure about discounted future minimum lease payments, incremental borrowing rates, and ARO treatment to more standardized language in 2023-2024. This is the core of the question about 'evolution.' (4) The LLM fails to address the ground truth's central finding that disclosure depth decreased over time while accounting policy remained stable. (5) The LLM does not mention the incremental borrowing rate methodology or the discounting process that was explicitly disclosed in 2022 but not repeated later. WHAT WAS CORRECT: The LLM correctly identifies that straight-line recognition was consistently applied across all three years and that lease incentives are recorded as part of ROU assets. However, this correct information is overshadowed by the introduction of unsubstantiated impairment charges and the failure to capture the disclosure evolution that is central to answering the question. The answer addresses the 'recognition methodology' part but largely ignores the 'disclosure evolution' and 'impact on ROU asset valuation' aspects of the question. The multi-hop reasoning is weak because it conflates impairment adjustments (which are not the focus of the ground truth) with the actual evolution of accounting treatment and disclosure practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 522,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft’s 2.000 % notes were first created under the Base Indenture (May 18 2009) and were initially supplemented by the Fourth Supplemental Indenture (Nov 7 2012). In the 2022 10‑K the notes were listed as part of the series with a final maturity in 2025 and were governed by the supplemental indenture dated May 2 2013 (the “Sixth Supplemental Indenture”). The 2023 10‑K introduced a new “Fifteenth Supplemental Indenture” (dated Nov 6 2023) that added a fresh tranche of 2.000 % notes and extended the ultimate maturity to 2026/2027, thereby updating the indenture documentation that now governs the issue. The 2024 10‑K continues to reference this same Fifteenth Supplemental Indenture, confirming that the maturity schedule established in 2023 remains in force.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. Specific errors: (1) INDENTURE DATES: LLM claims the notes were governed by the 'Sixth Supplemental Indenture' dated May 2, 2013 in 2022, but ground truth states they were under the 'Eleventh Supplemental Indenture' dated August 8, 2016. (2) MATURITY DATES: LLM claims 2025 maturity in 2022 and 2026/2027 in 2023-2024, but ground truth clearly states the maturity was 2023 across all three years (2022, 2023, 2024). (3) NEW ISSUANCE CLAIM: LLM incorrectly asserts that the 2023 10-K introduced a 'Fifteenth Supplemental Indenture' dated Nov 6, 2023 with a 'fresh tranche' of notes. Ground truth explicitly states there were NO structural changes and the same note was referenced under identical documentation across all three years. (4) EVOLUTION NARRATIVE: LLM fabricates an evolution story (new indenture in 2023, extended maturity to 2026/2027) that directly contradicts the ground truth's core finding that the notes showed 'consistent debt instrument with no modifications across the three years.' (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize information across the three years, instead inventing a false narrative of changes and new issuances. The answer demonstrates fundamental misunderstanding of the actual debt structure and indenture documentation referenced in Microsoft's filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 393,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon records revenue from third‑party seller services when the service is rendered—generally when the seller’s product is shipped to a carrier or delivered to the customer—so the timing of recognition has remained the same from 2022 through 2024.  Over those years the mix of revenue has shifted toward a larger share of fulfillment and shipping fees as Amazon expanded FBA and other logistics services, while the commission component (a percentage of sales) has stayed relatively stable; beginning in 2023 the company started capitalizing and amortizing certain multi‑year referral commissions, further altering the reported composition of commissions versus fulfillment fees.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims 'the mix of revenue has shifted toward a larger share of fulfillment and shipping fees' with no supporting evidence from the ground truth, which makes no such claim about compositional shifts. (2) The LLM introduces a claim about 'beginning in 2023 the company started capitalizing and amortizing certain multi-year referral commissions' - this specific accounting treatment is not mentioned in the ground truth and appears to be fabricated. (3) The LLM states timing 'has remained the same from 2022 through 2024' but the ground truth indicates that in 2023 Amazon 'specified' the timing (suggesting a change in disclosure clarity, not that timing was identical across all years). CORRECT ELEMENTS: The LLM correctly identifies that revenue is recognized when services are rendered (upon delivery/shipment to carrier), which aligns with the 2023 disclosure mentioned in ground truth. The general framework of commission and fulfillment fees is correct. MISSING ELEMENTS: The LLM fails to capture the evolution in disclosure clarity that the ground truth emphasizes - that 2023 brought 'increasing clarity in disclosures over time' with specific mention of when services are rendered. The answer also doesn't acknowledge that 2024 showed 'no specific changes in revenue recognition timing were mentioned,' which is an important distinction. The LLM appears to have invented details about compositional shifts and accounting treatment changes that are not supported by the source material, which is a serious accuracy problem for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 462,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s 2022‑2024 filings repeatedly list a 2011 guaranty that “covers certain obligations of Southwestern Bell Telephone Co.” and remains outstanding (see T‑10K 2022 p. 136; T‑10K 2024 p. 96; T‑10K 2023 p. 100).  By keeping this guarantee in place, AT&T is deliberately retaining a back‑stop for the legacy Bell entity’s commitments rather than shedding them, using the guarantee to preserve the credit standing of the former operating company and to limit its own exposure to unexpected liabilities.  This reflects a long‑term liability‑management strategy that consolidates legacy telecom obligations under AT&T’s umbrella while protecting both the company’s balance sheet and its ability to meet creditor expectations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the 2011 guaranty covering Southwestern Bell Telephone Co.'s obligations; (2) Accurately cites specific page references from 10-K filings (2022 p. 136, 2024 p. 96, 2023 p. 100); (3) Properly identifies the three-year period (2022-2024) and notes the guarantee's persistence across all filings; (4) Provides sound reasoning about AT&T's liability management strategy, including the deliberate retention of the guarantee and its protective function; (5) Correctly synthesizes that the unchanged guarantee reflects a stable, long-term strategy. MINOR WEAKNESSES: (1) The LLM answer adds interpretive details about 'protecting both the company's balance sheet' and 'limiting its own exposure to unexpected liabilities' that go slightly beyond what the ground truth explicitly states—the ground truth focuses on the fact of the guarantee's persistence and what that suggests about strategy, while the LLM adds additional strategic rationales not explicitly confirmed in the ground truth; (2) The phrase 'consolidates legacy telecom obligations under AT&T's umbrella' is a reasonable inference but represents some extrapolation beyond the ground truth's more measured statement about 'maintaining full financial responsibility.' QUANTITATIVE VERIFICATION: All dates (2011, 2022, 2023, 2024) are correct; page numbers are cited appropriately; no calculations are required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings to identify the pattern of guarantee persistence and draws appropriate conclusions about strategy. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the core message of the ground truth—that AT&T's continued guarantee reflects a deliberate, stable strategy for managing legacy telecom liabilities without reduction or restructuring—though with somewhat more interpretive elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 546,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nFrom the end of 2022 through 2024 the carrying amount of J&J’s 2.250% Notes due 2050 moved from roughly **$984 million** (2022) to **$808 million** (2023) and then edged up to **$826 million** (2024).  The 2023 decline reflects a deliberate retirement/re‑purchase of that low‑coupon, long‑dated tranche, while the modest 2024 rebound shows the company is fine‑tuning the balance as market conditions shift.  Together, the pattern signals that J&J is actively managing the size of its longest‑dated, low‑cost debt to reduce leverage and preserve financial flexibility within its broader long‑term financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN NUMERICAL SEQUENCE: The LLM answer contains a fundamental factual error in the year-to-year progression. According to the ground truth, the correct sequence is: 2022: $983M → 2023: $826M → 2024: $808M. However, the LLM states: 2022: $984M → 2023: $808M → 2024: $826M. This reverses the 2023 and 2024 values, which is a major error that contradicts the actual data trend. The LLM claims there was a 'modest 2024 rebound' from $808M to $826M, when in fact the value declined from $826M to $808M. This inverts the entire narrative about the company's debt management strategy. QUANTITATIVE ACCURACY ISSUES: (1) 2022 figure of $984M is marginally off from $983M (acceptable rounding), but (2) the 2023 and 2024 figures are transposed, creating a completely false trend narrative. REASONING FLAWS: The LLM's interpretation that 'the modest 2024 rebound shows the company is fine-tuning the balance as market conditions shift' is factually incorrect—there was no rebound, only a continued decline. The ground truth correctly identifies a 'gradual decline' reflecting a 'cautious approach,' while the LLM incorrectly describes an upward movement in 2024. SEMANTIC ISSUES: While the LLM's general framing about long-term debt strategy and financial flexibility is reasonable, it is built on incorrect numerical data. The fixed effective rate of 2.29% mentioned in the ground truth is not addressed by the LLM. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression across the filing data, which is the core requirement of this multi-hop question. The transposition of 2023 and 2024 values represents a fundamental failure in data accuracy that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 468,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.375 % Senior Notes due June 2027 remained unchanged at a $1.25 billion carrying amount each year and, as shown in the 2024 maturity schedule, it is set to mature in 2027 as part of a $2.25 billion 2027‑maturity bucket that also includes the $1 billion 3 % Senior Notes due May 2027.  In 2024 the company retired its $1 billion 2.75 % Senior Notes due May 2024, reducing near‑term debt and reinforcing a longer‑dated, low‑coupon debt profile.  This pattern reveals Costco’s capital‑management strategy of extending maturities, maintaining a stable, low‑cost long‑term debt base, and using cash flows to retire short‑term obligations while preserving liquidity for dividends, share repurchases and investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct but has some notable differences from the ground truth. STRENGTHS: (1) Correctly identifies the 1.375% Senior Notes at $1.25 billion ($1,250 million) remaining constant across 2022-2024. (2) Accurately notes the June 2027 maturity date. (3) Correctly identifies the retirement of the $1 billion 2.75% Senior Notes due May 2024. (4) Provides sound reasoning about capital management strategy focusing on maturity extension and low-cost debt maintenance. (5) Appropriately contextualizes the strategy within broader capital allocation priorities (dividends, buybacks, investments). WEAKNESSES: (1) The LLM answer does NOT provide the total long-term debt figures from the ground truth ($6,590M in 2022, $6,484M in 2023, $5,919M in 2024), which are key to demonstrating the 'gradual reduction in overall debt burden' mentioned in the original answer. (2) The LLM introduces additional detail about the 2027 maturity bucket ($2.25 billion total including $1B 3% Senior Notes due May 2027) that, while potentially accurate, goes beyond what the ground truth explicitly states and wasn't asked for. (3) The LLM answer emphasizes the 2024 debt retirement more heavily than the ground truth, which focuses on the three-year trend of the specific 1.375% notes. QUANTITATIVE VERIFICATION: The $1.25 billion figure is correct (equivalent to $1,250 million in ground truth). The $1 billion 2.75% Senior Notes retirement is correctly stated. The 2027 maturity date is correct. MULTI-HOP REASONING: The LLM successfully synthesizes information about the specific debt instrument, its stability, and the broader capital management strategy. However, it misses the key multi-hop element of comparing total debt levels across the three years, which is central to understanding the 'selective capital management strategy' described in the ground truth. The answer would be stronger if it included the total debt trajectory alongside the specific notes analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 534,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard layered its security controls—real‑time fraud scoring, tokenization, the Mastercard Intelligence Center and strict settlement‑exposure guarantees—directly onto the expanding real‑time account‑based and ACH infrastructure it rolled out in 12‑13 markets and across its cross‑border network.  This parallel rollout of a more distributed, peer‑to‑peer architecture and new payment‑flow capabilities (e.g., Mastercard Send, VCN, Alias‑Based Remittances) was matched by tighter operational standards, proactive monitoring and ecosystem‑wide governance to keep the surge in global transaction volume and cross‑border risk in check.  The strategy shows that as Mastercard scaled worldwide, it deliberately grew its payments‑processing capacity only after reinforcing a multi‑layered security and stewardship framework to manage the heightened risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims Mastercard expanded real-time payments to '12-13 markets' but the ground truth specifies 12 markets as of Dec 31, 2021, then 13 markets by 2023. The LLM conflates these numbers and doesn't track the temporal progression correctly. More critically, the LLM introduces UNSUPPORTED SPECIFIC CLAIMS: 'real-time fraud scoring, tokenization, the Mastercard Intelligence Center and strict settlement-exposure guarantees' - NONE of these specific security mechanisms are mentioned in the ground truth. The ground truth only references 'multi-layered security approach,' 'robust program to protect network from cyber threats,' 'third-party assessments and partnerships' - NOT the specific tools the LLM lists. (2) FABRICATED DETAILS: The LLM invents specific product names and capabilities ('Mastercard Send, VCN, Alias-Based Remittances') that do not appear in the ground truth. This is a critical failure - the model is hallucinating financial/operational details. (3) REASONING FLAW: The ground truth explicitly states 'the filings do not explicitly state that security measures directly enabled infrastructure expansion,' yet the LLM claims 'it deliberately grew its payments-processing capacity only after reinforcing a multi-layered security framework' - this overstates the causal relationship beyond what the source material supports. (4) CORRECT ELEMENTS: The LLM does correctly identify the parallel evolution of security and real-time payments infrastructure, and the general strategic intent around risk management. However, the numerous fabricated specifics and unsupported claims severely undermine credibility. (5) TEMPORAL TRACKING: The LLM fails to properly track the 2022→2023→2024 progression and the qualitative shift to 'several countries' mentioned in ground truth for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 502,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nMicrosoft first created the 4.000 % Notes due 2021 in 2011 (the Third Supplemental Indenture) and has since expanded that series through a series of supplemental indentures filed in the last three fiscal years – the Twelfth (2022), Fourteenth (2023) and Fifteenth (2024) Supplemental Indentures.  Each amendment added new tranches and increased the aggregate principal of the 4.000 % Notes, while also extending the overall maturity schedule and often lowering the effective financing cost.  This incremental, staged approach shows that Microsoft is deliberately layering additional long‑term fixed‑rate debt to diversify its funding base, smooth out repayment timing and lock in low‑cost capital over the long term.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) CREATION DATE ERROR: The LLM claims the 4.000% Notes were 'first created in 2011' with the Third Supplemental Indenture, but the ground truth clearly states the underlying Indenture is dated May 18, 2009, and the Third Supplemental Indenture was referenced in 2022 filings - this is a major chronological error. (2) SUPPLEMENTAL INDENTURE IDENTIFICATION ERROR: The LLM incorrectly identifies the supplemental indentures as 'Twelfth (2022), Fourteenth (2023) and Fifteenth (2024)' with no evidence in the ground truth supporting these specific numbering claims. The ground truth only references 'Third Supplemental Indenture' consistently across all three years. (3) STRUCTURAL CHANGES CLAIM: The LLM asserts that 'Each amendment added new tranches and increased the aggregate principal' and 'extended the overall maturity schedule' - the ground truth explicitly states 'no structural changes' and that the same instrument was 'again referenced under the same exhibit number and description.' (4) MATURITY HANDLING MISINTERPRETATION: The LLM fails to address the key insight from ground truth that despite the note being past its maturity date (2021), Microsoft continued disclosing it in 2024, suggesting delayed settlement or rollover. Instead, the LLM invents a narrative about expanding tranches and extending maturity. (5) MULTI-HOP REASONING FAILURE: The LLM did not correctly synthesize the actual pattern across fiscal years 2022-2024, which was consistent disclosure with no structural changes, not incremental expansion. The answer demonstrates fundamental misunderstanding of the source material and provides fabricated details about supplemental indenture numbers and debt expansion that contradict the ground truth's emphasis on consistency and transparency in post-maturity disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 515,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon’s frequent reference to the 1.500 % senior unsecured note due 2030 shows that it views this low‑coupon, long‑dated tranche as a cornerstone of its long‑term financing, using it to lock in cheap capital and diversify its maturity ladder. Compared with its higher‑coupon bonds (e.g., 3‑5 % issues maturing in the 2030s‑2060s) and revolving credit facilities, the 2030 note highlights Amazon’s strategy of securing stable, inexpensive funding while preserving cash‑flow flexibility and maintaining an investment‑grade capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 1.500% Note due 2030 as a cornerstone of Amazon's long-term financing strategy and accurately characterizes it as low-coupon, long-dated debt. The numeric value (1.500%) and maturity year (2030) are correct. However, there are significant gaps in completeness and multi-hop synthesis compared to the ground truth:\n\n(1) WHAT WAS CORRECT: The LLM correctly identifies the note as low-coupon, long-dated debt used to lock in cheap capital. The characterization of Amazon's strategy to diversify maturity ladder and maintain investment-grade structure is sound.\n\n(2) QUANTITATIVE ACCURACY: The 1.500% coupon and 2030 maturity are correct. The LLM mentions '3-5% issues' which is vague but directionally accurate compared to ground truth's specific examples (4.700% Note due 2024, 4.700% Note due 2032). The LLM does not provide specific comparative data points from multiple years.\n\n(3) MULTI-HOP REASONING GAPS: The ground truth explicitly traces the note's presence across 2022, 2023, and 2024 filings, showing how Amazon's strategy evolved year-by-year (introducing the note in 2022, managing near-term obligations in 2023, balancing old and new instruments in 2024). The LLM answer lacks this temporal dimension and multi-year synthesis. It does not demonstrate how the note's role changed or remained consistent across the three-year period.\n\n(4) MISSING SPECIFIC COMPARISONS: Ground truth provides concrete examples of comparative instruments (4.700% Note due 2024, 4.700% Note due 2032, instruments maturing to 2060). The LLM's reference to '3-5% issues' and 'revolving credit facilities' is less specific and doesn't demonstrate the same level of detailed synthesis from actual filings.\n\n(5) INCOMPLETE CONTEXT: The ground truth emphasizes how the note was 'introduced' in 2022 as part of a broader issuance, 'reiterated' in 2023 alongside newer instruments, and 'continued' in 2024 amidst newer higher-yielding instruments. This temporal narrative is absent from the LLM answer, which treats the strategy as static rather than evolving.\n\n(6) REASONING QUALITY: While the LLM's reasoning about capital structure strategy is sound, it fails to demonstrate the multi-hop synthesis across multiple years and documents that the question specifically asks for. The answer reads as a general statement about Amazon's debt strategy rather than a specific analysis of how the 1.500% Note's role evolved across 2022-2024 filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 658,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through 2023 AT&T held a 41.3 % equity interest in SKY Mexico and accounted for it under the equity‑method (see the 2023 equity‑affiliate table on page 68 of the 2023 10‑K). In June 2024 the company sold its entire 41.3 % stake, removing the investment from its balance sheet (see the disposition note on page 67 of the 2024 10‑K). This exit reflects AT&T’s broader strategy of divesting non‑core international pay‑TV assets and monetizing equity‑method holdings to refocus capital on its core wireless and broadband businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - 41.3% ownership stake accurately cited, June 2024 sale date correct, equity method accounting properly identified. (2) Multi-hop synthesis is sound - correctly connects ownership stake across 2022-2023, identifies equity method treatment in 2023, and documents complete exit in mid-2024. (3) Strategic interpretation is reasonable - correctly identifies divestiture of non-core international pay-TV assets and refocus on core U.S. operations. (4) Citations to specific 10-K pages (page 68 for 2023 equity-affiliate table, page 67 for 2024 disposition note) demonstrate proper source documentation.\n\nWEAKNESSES: (1) INCOMPLETE TEMPORAL COVERAGE - The LLM answer only explicitly addresses 2022-2023 and 2024, but does not clearly establish the 2022 baseline. The ground truth explicitly states 'In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio,' which provides important context about why AT&T retained this stake. The LLM answer begins with 'From 2022 through 2023' but doesn't establish what happened in 2022 specifically or why the stake was retained. (2) MISSING CONTEXTUAL DETAIL - The ground truth mentions the Vrio sale context and explicitly notes SKY Mexico was 'still part of AT&T's equity method investments alongside DIRECTV and Gigapower' in 2023, providing comparative context. The LLM answer omits these comparative investments and the Vrio sale context. (3) PHASED APPROACH NOT EMPHASIZED - The ground truth explicitly describes this as a 'phased approach to shedding international media assets,' while the LLM answer presents it more as a straightforward divestiture without emphasizing the deliberate, multi-year strategic sequencing.\n\nQUANTITATIVE VERIFICATION: 41.3% stake - CORRECT; June 2024 sale - CORRECT; equity method accounting - CORRECT. No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects ownership structure to accounting treatment to strategic exit. However, it misses the intermediate step of explicitly establishing 2022 as a baseline year with deliberate retention of the stake.\n\nSCORE JUSTIFICATION: The answer is substantially correct on core facts and numbers (9/10 quantitative), but falls short on completeness of the 3-year trajectory narrative and contextual richness (7/10 qualitative). The answer addresses the main question but omits important intermediate details about 2022 positioning and comparative context that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 683,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nAIG’s U.S. pension glide‑path shifted gradually from a 2022 target of roughly 15 % equity, 75 % fixed‑maturity and 10 % other to a 2023 target of 13 % equity, 72 % fixed‑maturity and 15 % other, and then to a 2024 target of 9 % equity, 80 % fixed‑maturity and 11 % other.  This steady reduction in growth‑oriented equity and corresponding increase in liability‑hedging fixed‑maturity securities shows that AIG was deliberately de‑risking the portfolio as the plan’s funded ratio improved, moving assets toward more stable, interest‑rate‑matched holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific percentage allocations (15% equity/75% fixed-maturity/10% other for 2022, 13%/72%/15% for 2023, and 9%/80%/11% for 2024) that cannot be verified against the ground truth provided. The ground truth does not contain these specific numerical allocations, making it impossible to confirm their accuracy. The ground truth emphasizes the conceptual framework of the glide path evolution—that target allocations were based on funded status at specific year-end dates (Dec 31, 2021 for 2022 targets, Dec 31, 2023 for 2024 targets, Dec 31, 2024 for 2025 targets)—but does not provide the actual percentage breakdowns cited by the LLM. The LLM's answer does correctly identify the directional trend (reduction in equity, increase in fixed-maturity/liability-hedging assets) and the de-risking strategy, which aligns with the ground truth's conceptual description. However, the introduction of specific numerical allocations without corroboration from the ground truth represents a significant factual risk. The LLM also fails to address the temporal relationship between funded status measurement dates and target allocation years, which is a key element of the ground truth answer. The reasoning about de-risking and liability-driven investing is sound and matches the ground truth's conclusion, but the unsupported specific percentages undermine the overall credibility of the response. Without access to the actual SEC filings to verify these numbers, the answer cannot be considered reliable despite its logical structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 426,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nMastercard has steadily tightened its credit‑risk framework from 2022 through 2024—updating its risk‑standards, expanding collateral requirements (cash, letters‑of‑credit and guarantees), and recalibrating settlement‑exposure models—so that gross exposure rose from roughly $59 bn to $78 bn while net exposure was trimmed through risk‑mitigation arrangements.  At the same time the company broadened its hedging toolkit (cash‑flow and fair‑value swaps, net‑investment hedges) and recorded larger litigation‑related accruals (e.g., $559 m for U.S. MDL matters, $200 m for the UK settlement, $93 m for ATM class actions) to reflect the growing regulatory and litigation pressure.  This continual refinement of exposure calculations, collateral policies and reserve accounting shows a highly adaptable risk‑management system that evolves in real time to meet emerging legal and regulatory challenges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) UNVERIFIED NUMBERS: The LLM provides specific dollar amounts ($59bn to $78bn gross exposure, $559m for U.S. MDL matters, $200m for UK settlement, $93m for ATM class actions) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated. (2) FACTUAL DISCREPANCIES: The ground truth explicitly states Mastercard 'consistently reported a low level of losses from customer settlement failures' and maintained 'consistent framework' across the three years. The LLM claims the company 'steadily tightened' its framework and 'expanded collateral requirements,' which contradicts the ground truth's emphasis on consistency. (3) MISSING KEY CONTEXT: The LLM fails to mention critical regulatory events from the ground truth: the FTC's finalized consent agreement (2023), DOJ antitrust investigation into U.S. debit program (2023), U.S. Liability Shift Litigation (2024), and European Commission investigation (2024). These are essential to understanding how regulatory scrutiny evolved. (4) HEDGING TOOLKIT CLAIM: The LLM mentions 'broadening hedging toolkit (cash-flow and fair-value swaps, net-investment hedges)' but this is not substantiated in the ground truth, which focuses on credit risk mitigation arrangements (cash collateral, letters of credit, guarantees). (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information across years, it does so by introducing unverified quantitative claims rather than accurately synthesizing the ground truth's narrative about consistent core strategies amid escalating external pressures. The ground truth's key insight—that core credit risk strategies remained effective despite external pressures—is largely absent from the LLM response. (6) TONE MISMATCH: The LLM's conclusion about 'highly adaptable risk-management system that evolves in real time' overstates the evidence; the ground truth emphasizes consistency of core strategies with contextual changes in regulatory environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 554,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the shares reserved for future grants under the Omnibus Plan dropped from roughly **78 million** to **77 million** and then to **about 70 million**.  This decline shows that Home Depot is exhausting its equity reserve for ongoing award commitments and is pulling back on new equity grants, signaling a strategic move to limit dilution and place greater emphasis on share‑repurchases and cash‑based compensation rather than expanding stock‑based incentives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The 2022 baseline is drastically wrong - the LLM states '78 million' when the ground truth clearly shows 117 million shares available in 2022. This is a 39 million share discrepancy (33% error). The 2023 figure of 77 million is correct, and the 2024 figure of 70 million is also correct, but the starting point error is severe. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year trend. The ground truth shows a dramatic decline from 117M → 77M → 70M (a 40 million share reduction in year 1 alone), indicating aggressive equity issuance. The LLM's characterization of 'roughly 78 million to 77 million' completely misses the magnitude of the 2022-2023 decline and misrepresents the trend as minimal. (3) REASONING ERROR: The LLM's interpretation is contradicted by the data. The ground truth correctly identifies that the sharp decline suggests 'actively issuing stock-based compensation' and 'increased reliance on equity incentives.' The LLM incorrectly concludes the company is 'pulling back on new equity grants' and 'limiting dilution' - this is backwards. A 40 million share reduction in one year indicates heavy usage of the reserve, not restraint. The LLM's claim about 'greater emphasis on share-repurchases and cash-based compensation' is unsupported and contradicts what the declining available shares actually suggest. (4) ENTITY/CONTEXT: The LLM correctly identifies the Omnibus Plan and Home Depot, but misinterprets the strategic implications. The consistent decline in available shares indicates the opposite of what the LLM claims - it shows the company IS actively using equity compensation, not pulling back from it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 493,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 had a carrying balance of **$622 million at the end of fiscal 2023** (Oct 29, 2023) but were **completely retired by the end of fiscal 2024**, dropping to **$0** (Nov 3, 2024).  This repayment was funded with the proceeds from Broadcom’s July 2024 and October 2024 senior‑note issuances and the repayment of portions of its 2023 term‑loan facilities, effectively replacing the near‑term, lower‑coupon debt with newer, longer‑dated obligations.  The move signals a strategic shift to extend maturity profiles and optimize the capital structure after the VMware merger.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial progression - $622 million in fiscal 2023 and $0 in fiscal 2024 - and accurately notes the October 2024 maturity date. The identification of the notes as 3.625% senior notes is correct. The LLM also correctly identifies that the notes were fully retired/repaid by fiscal 2024. WEAKNESSES: (1) CRITICAL OMISSION - The LLM fails to address fiscal year 2022 data entirely. The ground truth explicitly states the obligation was $622 million in FY2022 and remained unchanged in FY2023. The LLM only mentions the FY2023 figure, missing the multi-year progression that is central to the question. (2) UNSUPPORTED DETAIL - The LLM provides specific information about funding sources (July 2024 and October 2024 senior-note issuances, 2023 term-loan facilities repayment) and mentions the VMware merger context. While this additional context may be accurate, it goes beyond what can be verified from the ground truth and represents information synthesis not explicitly confirmed in the original answer. (3) INCOMPLETE MULTI-HOP ANALYSIS - The question specifically asks about evolution 'across fiscal years 2022, 2023, and 2024.' The LLM only addresses 2023-2024, missing the 2022 baseline. The ground truth clearly shows: FY2022: $622M → FY2023: $622M (unchanged) → FY2024: $0. This three-year progression is essential to understanding the debt management strategy. QUANTITATIVE ACCURACY: The numbers provided ($622M, $0) are correct, but the temporal scope is incomplete. QUALITATIVE ACCURACY: While the reasoning about debt management strategy is sound, the failure to address the full three-year period and the introduction of unverified details about merger-related financing weakens the analysis. CONTEXTUAL RELEVANCE: The answer addresses the core question but incompletely, missing the critical FY2022 baseline that would show the stability of the obligation before its elimination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 523,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T transformed its relationship with Time Warner from full‑scale integration (the 2018 acquisition of Time Warner) to a deliberate divestiture: after announcing in 2021 a merger of WarnerMedia with Discovery, the combined company was spun out in April 2022 and later became Warner Bros. Discovery; AT&T then sold its remaining stake in DIRECTV—whose assets included the former Turner/WarnerMedia entertainment holdings—to TPG in late 2024, completing its exit from the content business. This sequence reveals that AT&T has abandoned the entertainment‑media strategy it pursued after the Time Warner merger and is now concentrating almost exclusively on its core telecommunications infrastructure—5G, fiber‑to‑the‑home and broadband—while shedding legacy media assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AT&T's strategic evolution regarding Time Warner/WarnerMedia from 2022-2024, with mostly accurate facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the 2018 Time Warner acquisition as the starting point; (2) Accurately dates the WarnerMedia-Discovery merger completion to April 2022 and correctly names the resulting entity (Warner Bros. Discovery); (3) Correctly identifies the DIRECTV sale to TPG in late 2024 as the final exit; (4) Properly synthesizes the multi-year strategic reversal from vertical integration to telecom focus; (5) Accurately characterizes the shift away from entertainment/media back to core telecommunications infrastructure (5G, fiber, broadband). MINOR ISSUES: (1) The statement about DIRECTV assets including 'former Turner/WarnerMedia entertainment holdings' is somewhat imprecise—DIRECTV was primarily a pay-TV distributor, not a content holder. Turner/WarnerMedia content went to Warner Bros. Discovery in the 2022 separation, not to DIRECTV. This is a factual inaccuracy that slightly muddies the narrative; (2) The reference to 'announcing in 2021' the WarnerMedia-Discovery merger is technically correct but the LLM answer emphasizes 2021 while the ground truth focuses on 2023 as the completion year, creating minor temporal emphasis differences. QUANTITATIVE VERIFICATION: All dates are accurate (2018 acquisition, April 2022 spin-off, late 2024 DIRECTV sale). No specific dollar amounts were provided in either answer, so no calculation errors to assess. MULTI-HOP REASONING: The answer correctly synthesizes information across three time periods and multiple entities (AT&T, Time Warner, WarnerMedia, Discovery, Warner Bros. Discovery, DIRECTV, TPG), demonstrating solid multi-hop reasoning. The logical progression from integration to divestiture to exit is clearly articulated. SEMANTIC EQUIVALENCE: The core message matches the ground truth—AT&T moved from entertainment integration to telecom focus—though the LLM provides slightly more operational detail about the specific transactions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 565,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson refocused its Pipe Cutters offering inside the Safety & Productivity segment by moving from a purely mechanical, pneumatic design to a battery‑powered, digitally‑enabled suite.  The line now incorporates battery‑hydraulic drive systems and integrated diagnostic tools—such as closed‑circuit‑TV pipe‑inspection and electronic pipe‑locating equipment—giving users cordless, higher‑productivity solutions that improve jobsite safety and provide real‑time data.  This evolution positions the Pipe Cutters portfolio as a portable, data‑driven alternative that aligns with the segment’s broader push toward battery‑powered technologies and advanced diagnostics.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer demonstrates partial correctness with significant concerns about factual grounding.\n\nSTRENGTHS:\n1. Correctly identifies the time period (2022-2024) and company (Emerson/EMR)\n2. Accurately captures the core evolution narrative: mechanical/pneumatic → battery-powered → integrated diagnostics\n3. Correctly mentions battery-hydraulic systems and diagnostic integration (sewer inspection cameras)\n4. Appropriately contextualizes within Safety & Productivity segment\n5. Semantic alignment with ground truth on the strategic direction\n\nWEAKNESSES & CONCERNS:\n1. FACTUAL ACCURACY ISSUE: The LLM introduces \"pneumatic design\" as the 2022 baseline, but the ground truth states Pipe Cutters were \"standalone tools used by plumbing professionals\" with NO mention of pneumatic technology. This is a potential fabrication or hallucination.\n2. SPECIFICITY MISMATCH: The LLM mentions \"closed-circuit-TV pipe-inspection and electronic pipe-locating equipment\" while ground truth specifically references \"sewer inspection cameras.\" The LLM's description is broader and may overstate the product integration.\n3. MISSING TEMPORAL DETAIL: Ground truth provides specific year-by-year progression (2022 standalone → 2023 battery-hydraulic link → 2024 ecosystem integration). LLM collapses this into a general 2022-2024 narrative without the granular temporal markers.\n4. UNVERIFIED CLAIMS: Phrases like \"data-driven alternative\" and \"real-time data\" are not explicitly supported in the ground truth, suggesting potential inference beyond documented facts.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between battery technology adoption and diagnostic system integration, demonstrating sound logical connection. However, the introduction of unsupported details (pneumatic baseline) undermines confidence in the synthesis.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension is neutral (8/10 for not introducing false metrics).\n\nCONCLUSION: The answer captures the directional evolution correctly but introduces potentially fabricated details (pneumatic baseline) and lacks the precise temporal granularity of the ground truth. The core narrative is sound but execution has credibility issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 618,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson has continued and deepened its multi‑year, enterprise‑wide initiative to integrate, simplify and standardize the processes and systems that support HR, IT, procurement, supply‑chain and finance, expanding the scope of its financial shared‑service platform and repeatedly aligning the design of its financial control environment.  This persistent focus shows that standardizing and centralizing financial processes is a strategic priority for the company, aimed at improving efficiency, scalability and governance across its operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the multi-year enterprise-wide initiative spanning 2022-2024. (2) Accurately captures the core themes of integration, simplification, and standardization. (3) Correctly emphasizes the strategic focus on financial process standardization and efficiency. (4) No numeric errors or date inaccuracies present. (5) Properly synthesizes the consistent messaging across three years.\n\nWEAKNESSES: (1) SIGNIFICANT SCOPE EXPANSION ERROR: The LLM introduces HR, IT, procurement, and supply-chain as part of the initiative, but the ground truth specifically states the initiative focuses on 'key functions including finance' - the ground truth does not mention these other functions. This represents a factual inaccuracy that goes beyond the scope of what was documented. (2) MISSING KEY DETAIL: The ground truth explicitly notes that in 2022, J&J described this as 'not in response to any internal control deficiencies' - this important contextual detail is omitted from the LLM answer. (3) MISSING YEAR-BY-YEAR EVOLUTION: The ground truth provides specific narrative evolution (2022: proactive effort; 2023: reiterated with ongoing enhancements; 2024: maintained narrative), but the LLM provides only a general summary without showing how the messaging evolved across the three years. (4) INCOMPLETE SYNTHESIS: While the LLM captures the overall strategic commitment, it fails to demonstrate the specific year-by-year progression that the question asks about ('how has...evolved'). (5) The phrase 'expanding the scope of its financial shared-service platform' is not explicitly supported by the ground truth, which focuses on standardization rather than scope expansion.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis of the three-year period but fails to properly trace the evolution and specific messaging changes across years. The introduction of unsupported functions (HR, IT, procurement, supply-chain) suggests the model may have conflated information or made inferences beyond the documented facts.\n\nOVERALL ASSESSMENT: The answer captures the general strategic direction but contains a material factual error regarding scope, omits important contextual details, and fails to adequately address the 'evolution' aspect of the question by not showing year-by-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 622,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nCostco has continued to list the “Costco Wholesale Executive Health Plan” as Exhibit 10.1* in its Form 10‑K filings for fiscal 2022, 2023 and 2024, with the same description and original filing date (9/2/2012 – 10/19/2012) appearing each year.  The plan’s inclusion has been steady—no amendments, new filings, or changes in filing status are disclosed—indicating that the company maintains a consistent, long‑term executive health‑benefit offering as part of its overall executive compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about Costco's Executive Health Plan disclosures across fiscal years 2022-2024. STRENGTHS: (1) All dates are correct - the Period Ended date of 9/2/2012 and Filing Date of 10/19/2012 match the ground truth exactly (minor formatting variation: '9/2/2012 – 10/19/2012' vs 'September 2, 2012' and 'October 19, 2012' is acceptable). (2) Correctly identifies the plan as Exhibit 10.1* across all three fiscal years. (3) Accurately synthesizes the multi-hop information: recognizes consistency across 2022, 2023, and 2024; notes absence of amendments or new filings; draws appropriate conclusion about stable executive benefit strategy. (4) The reasoning is sound - the consistency of filing information logically indicates no material updates. (5) Correctly identifies this as part of overall executive compensation strategy. MINOR CONSIDERATIONS: The LLM answer uses slightly different date formatting (9/2/2012 – 10/19/2012) compared to the ground truth's spelled-out format (September 2, 2012 and October 19, 2012), but this is a stylistic variation that does not affect accuracy. The LLM answer is actually more concise while maintaining all essential information. The semantic meaning is identical - both convey that the same plan with the same filing dates appeared consistently across all three years with no changes. The conclusion about long-term strategy stability is appropriately supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 415,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 the cash dividend on Mastercard’s Class A (and Class B) shares rose steadily—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting entitlement of each Class A share remained “one vote per share” and Class B shares stayed non‑voting.  Ownership‑voting alignment was essentially unchanged: public Class A holders held about 90 % of both equity and voting power, the Mastercard Foundation ~10 %, and Class B customers less than 1 %.  This uninterrupted one‑share‑one‑vote framework and the consistent, upward dividend trend reflect Mastercard’s deliberate, shareholder‑friendly governance stance that prioritizes stability, predictability and alignment of shareholder interests.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally misinterprets the question and provides incorrect information. (1) VOTING RIGHTS ACCURACY: The ground truth states that A Class Shares maintained 'one vote per share' consistently across 2022-2024, which the LLM correctly identifies. However, the LLM introduces Class B shares and ownership percentages that are NOT part of the original question about A Class Shares specifically. (2) DIVIDEND RIGHTS MISINTERPRETATION: The ground truth explicitly states A Class Shares had 'standard dividend rights' with NO CHANGE across the three years. The LLM instead provides SPECIFIC CASH DIVIDEND AMOUNTS ($2.04, $2.37, $2.74) that represent ACTUAL DIVIDEND PAYMENTS, not the structural rights themselves. This is a fundamental category error—the question asks about the RIGHTS ASSOCIATED WITH the shares (structural governance features), not the actual dividend payments made. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM conflates dividend payment amounts with dividend rights. While dividend payments did increase, the RIGHTS themselves (the entitlement structure) remained unchanged. The ground truth emphasizes consistency in shareholder RIGHTS, not dividend payment amounts. (4) SCOPE CREEP: The LLM introduces Class B shares, ownership percentages (~90%, ~10%, <1%), and Foundation information that are not mentioned in the ground truth answer and go beyond the specific question about A Class Shares' dividend and voting rights. (5) GOVERNANCE STRATEGY INTERPRETATION: While both answers conclude the company has a stable governance strategy, the LLM's reasoning is based on incorrect premises (conflating payment amounts with rights). The ground truth correctly identifies that the RIGHTS themselves remained constant, which is the actual evidence of governance stability. The LLM answer demonstrates a misunderstanding of the distinction between shareholder rights (structural) versus dividend payments (operational/financial).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 531,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nAcross fiscal 2022 → 2023 → 2024 the Security Insights Platform moved from a standalone mainframe‑risk engine to a core element of Broadcom’s Enterprise‑Security portfolio, with each filing stressing that it “quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps” and that this output is made available for use with customers’ own security‑information‑and‑event‑management and other in‑house security tools.  The 2023 and 2024 disclosures broaden the language to describe “ongoing and ad‑hoc” risk identification and highlight tighter integration with broader security‑orchestration capabilities, indicating a progressively deeper integration and richer risk‑identification functionality over the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer makes a MAJOR FACTUAL ERROR by claiming the platform 'moved from a standalone mainframe-risk engine to a core element of Broadcom's Enterprise-Security portfolio' - this characterization of evolution is NOT supported by the ground truth, which explicitly states the platform maintained 'stable functionality and consistent integration' across the three years with NO such transformation described. (2) The LLM introduces unsupported claims about '2023 and 2024 disclosures broaden the language' and 'tighter integration with broader security-orchestration capabilities' and 'progressively deeper integration and richer risk-identification functionality' - the ground truth explicitly contradicts this by stating the platform 'retained the same description' in 2024 and showed 'stable functionality' over the period. (3) The LLM's characterization of evolution is fundamentally misleading - it suggests significant progression when the ground truth indicates consistency and maturity rather than evolution. WHAT WAS CORRECT: (1) Fiscal years 2022, 2023, 2024 correctly identified. (2) Core functionality description (mainframe security posture assessment, risk identification, remediation) is accurate. (3) Integration with in-house SIEM tools correctly mentioned. (4) The quote about 'quickly interprets and assesses mainframe security posture' appears consistent with ground truth language. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the three-year narrative - it imposed a false narrative of 'progressive' evolution when the ground truth explicitly states the offering remained stable and well-defined. This is a fundamental misreading of the source material. The answer reads as if the LLM inferred evolution where none existed, rather than accurately reporting the stable, mature nature of the platform across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 510,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 to 2024 AIG shifted its loss‑reserve risk management from a largely internal, actuarial‑only approach to a structured model‑risk framework that formally incorporates third‑party catastrophe and stochastic models; by 2024 the company routinely engages independent modeling firms and other external experts to validate those models, adjust for emerging drivers such as climate change, and stress‑test the reserve assumptions. This evolution also added a dedicated model‑risk management and validation process—including challenge reviews by ERM and audit functions—to ensure that reserve adequacy estimates are continuously reviewed, calibrated and aligned with the company’s risk‑appetite limits.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year timeframe (2022-2024) and captures several accurate elements: (1) the evolution toward more structured oversight, (2) the incorporation of external experts and third-party validation, (3) the role of ERM reviews and audit functions, and (4) the shift toward more formalized risk management. The answer demonstrates understanding of the multi-hop synthesis required across three years of filings. WEAKNESSES: (1) The LLM introduces specific methodological details (catastrophe models, climate change adjustments, stochastic models) that are not explicitly confirmed in the ground truth answer, which mentions 'stochastic and deterministic' modeling but doesn't specifically reference catastrophe models or climate change. This represents potential over-specification or hallucination of details. (2) The LLM characterizes the 2022 approach as 'largely internal, actuarial-only' which contradicts the ground truth stating that 2022 already included 'external reviews.' (3) The LLM's framing of the evolution as moving FROM an 'actuarial-only approach' TO a 'model-risk framework' is somewhat misleading—the ground truth shows continuous use of external reviews from 2022 onward, not a transition from internal-only to external. (4) The LLM answer emphasizes 'independent modeling firms' and 'third-party catastrophe models' more prominently than the ground truth, which focuses on 'external experts' more broadly. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores well (8/10) with only minor concerns about the characterization of the 2022 baseline. QUALITATIVE ACCURACY: The reasoning is partially sound but contains logical inconsistencies in characterizing the 2022 starting point. The multi-hop synthesis across years is attempted but the characterization of change is somewhat distorted. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on evolution, methodologies, and external expert roles, though with some embellishment beyond what the ground truth supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 573,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nIn 2022 Electrical Distribution Equipment generated about $2.4 bn of sales within the Industrial Solutions sub‑category of Automation Solutions—up from $2.27 bn in 2021—highlighting its role as a growth driver. By 2023 the offering was folded into the Discrete Automation segment, which grew to $2.63 bn, and in 2024 the segment held $2.51 bn, showing Emerson’s shift to embed Electrical Distribution Equipment in a broader, higher‑margin discrete‑automation portfolio that couples hardware with control‑systems and software. This evolution reveals a strategic emphasis on integrated, value‑added discrete‑automation solutions rather than standalone electrical distribution.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM provides specific dollar amounts ($2.4bn in 2022, $2.27bn in 2021, $2.63bn in 2023, $2.51bn in 2024) that cannot be verified against the ground truth and appear to be fabricated. The ground truth makes no mention of these specific revenue figures for Electrical Distribution Equipment. The LLM also claims these figures represent 'Electrical Distribution Equipment' specifically, but the ground truth does not provide such granular financial data for this product line. (2) STRUCTURAL MISALIGNMENT: The ground truth clearly states that in 2022, Electrical Distribution Equipment was part of the 'Industrial Solutions segment,' not a sub-category within Automation Solutions as the LLM claims. This is a fundamental organizational error. (3) MULTI-HOP REASONING FAILURE: While the LLM correctly identifies the 2023 reorganization into Discrete Automation and the 2024 continuation, it fails to properly synthesize the organizational context. The ground truth emphasizes the strategic positioning and product groupings (solenoid valves, programmable automation systems, electric linear motion solutions, programmable control systems), whereas the LLM focuses entirely on invented financial metrics. (4) MISSING CORE CONTENT: The LLM completely omits the key strategic insight from the ground truth—that Electrical Distribution Equipment was repositioned alongside specific automation products (solenoid valves, programmable systems, linear motion solutions) to signal deeper integration with discrete manufacturing. Instead, the LLM vaguely references 'hardware with control-systems and software' without the specificity present in the ground truth. (5) HALLUCINATION RISK: The specific revenue figures appear to be hallucinated, as they are presented with false confidence but lack any grounding in the provided context. The answer reads plausibly but contains invented data points that would mislead any user relying on these numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 557,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 J&J continued to implement the Retirement Value amendment it announced in January 2021—recording the change as a roughly $1.8 billion reduction to the projected benefit obligation and revising the pension accounting (amortization of prior‑service cost, actuarial gains/losses, funding contributions, and updated discount‑rate assumptions) in its 2022‑2024 financial statements.  By gradually moving all eligible U.S. non‑union employees onto the new Retirement Value formula (to be effective Jan 1 2026), the company is reshaping its defined‑benefit structure to a more uniform, predictable and financially sustainable model, reflecting a long‑term workforce strategy that seeks to align retirement compensation with a stable, cost‑controlled talent pipeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic shift toward the Retirement Value formula for U.S. non-union employees effective January 1, 2026, and accurately characterizes the long-term workforce strategy as seeking cost predictability and standardization. The qualitative reasoning about the shift from Final Average Pay to a more uniform, predictable model is sound and aligns with the ground truth's characterization of the strategy. The answer appropriately addresses the multi-year evolution question and provides relevant context about pension accounting changes.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces a specific dollar figure ($1.8 billion reduction to projected benefit obligation) that is NOT present in the ground truth answer. This is a significant factual claim that cannot be verified against the provided ground truth and represents an unsupported quantitative assertion. (2) MISSING CONSISTENCY ANALYSIS - The ground truth emphasizes that disclosures were \"consistent\" across 2022-2024 with \"no reversal or delay,\" which is a key finding about the multi-year evolution. The LLM answer does not explicitly address this consistency or lack of policy changes across the three-year period. (3) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM mentions pension accounting changes (amortization, actuarial gains/losses, discount rates), it doesn't clearly synthesize how these accounting treatments remained consistent across the 2022-2024 period as the ground truth implies. (4) TEMPORAL FRAMING - The LLM references the January 2021 announcement as context, which is outside the 2022-2024 window specified in the question, though this is a minor issue.\n\nCRITICAL ISSUE: The introduction of the $1.8 billion figure without ground truth support is problematic for a financial question where precision is paramount. This appears to be either a hallucination or information from an external source not reflected in the knowledge graph answer. This significantly impacts the quantitative accuracy score despite the qualitative reasoning being sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 564,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nThe filings do not disclose a detailed brand‑level split, so the exact year‑over‑year change in Downy’s share of the Fabric & Home Care segment cannot be quantified. However, Downy is consistently listed among the segment’s major brands and the segment’s overall performance remained steady, indicating that its contribution has been stable but modest, reflecting a steady rather than growing strategic importance in P&G’s portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the filings do not disclose brand-level splits and that Downy's exact contribution cannot be quantified. However, the ground truth explicitly provides specific percentages: Downy's contribution to the Fabric & Home Care segment was 35% in 2022 and 36% in both 2023 and 2024. These are concrete, verifiable numbers that the LLM failed to identify or report. (2) FACTUAL CONTRADICTION: The LLM characterizes Downy's contribution as 'stable but modest' with 'steady rather than growing strategic importance,' which directly contradicts the ground truth showing growth from 35% to 36% and describing it as 'consistently remained a key brand' with 'sustained strategic importance.' (3) MULTI-HOP REASONING FAILURE: The question requires synthesizing Downy's brand-level contribution data across three fiscal years (2022-2024) within the Fabric & Home Care segment context. The LLM failed to perform this synthesis, instead claiming data unavailability when the data exists in the filings. (4) INCOMPLETE ANSWER: The LLM does not address the specific 3-year trend (35%→36%→36%) or provide the requested analysis of what this trend suggests about strategic importance. The ground truth clearly identifies a positive trend (growth from 35% to 36%) suggesting sustained/growing importance, while the LLM suggests the opposite ('steady rather than growing'). (5) ENTITY AND METRIC ACCURACY: While the LLM correctly identifies P&G, Downy, and the Fabric & Home Care segment, it fails to correctly identify or report the key metric (percentage contribution) across the required time periods. This is a severe failure in a multi-hop financial analysis task where specific quantitative data is available and required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 504,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nCapital One’s senior and subordinated notes grew from about **$27.4 bn at the end of 2022** to **$27.2 bn in 2023** (a slight decline), and then jumped to **≈ $30.7 bn by the end of 2024**.  This pattern shows that after a brief pull‑back in 2023, the company markedly increased its long‑term debt issuance in 2024, underscoring a strategic shift toward expanding and diversifying its senior‑note portfolio to fund loan‑book growth and refinance maturing obligations while capitalizing on favorable market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the core numbers. Ground truth shows: 2022=$27,219M, 2023=$31,248M, 2024=$31,248M. LLM reports: 2022≈$27.4bn (close), 2023=$27.2bn (INCORRECT - should be $31,248M), 2024≈$30.7bn (INCORRECT - should be $31,248M). The LLM fundamentally misrepresents the trend by claiming a decline in 2023 to $27.2bn when the actual data shows a significant INCREASE to $31,248M. This is a critical error that inverts the actual trend. The LLM also incorrectly states 2024 was $30.7bn when it remained flat at $31,248M from 2023. REASONING ISSUES: The LLM's narrative about 'a brief pull-back in 2023' is completely contradicted by the ground truth, which shows 2023 was the peak year with the largest increase from 2022. The characterization of the trend is therefore fundamentally wrong. WHAT WAS CORRECT: The LLM correctly identified Capital One (COF), correctly addressed the three-year period (2022-2024), and correctly identified the metric (senior and subordinated notes carrying value). The general conclusion about strategic debt financing is directionally reasonable, but is based on incorrect intermediate data. MULTI-HOP SYNTHESIS: The model failed to accurately synthesize the year-over-year progression across the three-year period, which is the core requirement of this multi-hop question. The 2023 figure is off by approximately $4,000M (13% error), and the 2024 figure is off by approximately $500M (1.6% error), but the directional error in 2023 completely undermines the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 432,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2023 AT&T maintained a roughly 41.3 % equity stake in SKY Mexico and accounted for it under the equity‑method (see the 2023 10‑K, page 68, which lists SKY Mexico among its equity‑method affiliates, and the 2022 filing, page 93, which notes the 41.3 % interest). In June 2024 the company sold its entire 41.3 % holding, removing the investment from its balance sheet (2024 10‑K, page 69). This exit illustrates AT&T’s broader divestiture strategy of shedding non‑core Latin‑American pay‑TV assets to refocus capital on its core wireless and broadband businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All quantitative data correct - 41.3% ownership stake accurately cited, June 2024 exit date correct, proper filing references provided (2023 10-K page 68, 2022 filing page 93, 2024 10-K page 69). (2) Proper entity identification - correctly identifies AT&T (T), SKY Mexico, and the equity method accounting treatment. (3) Sound multi-hop reasoning - successfully synthesizes the 3-year trajectory (2022 holding → 2023 equity method treatment → 2024 divestiture) and connects it to broader strategic context. (4) Accurate characterization of divestiture strategy - correctly frames exit as part of AT&T's shift away from non-core Latin American pay-TV assets toward core wireless and broadband. (5) Semantic equivalence maintained - conveys same information as ground truth despite different wording. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth, omitting explicit mention of DIRECTV and Gigapower as comparable equity method investments, though this omission does not materially affect the answer's correctness or completeness regarding the specific question asked about SKY Mexico's trajectory. The answer directly addresses all components of the multi-part question: ownership stake evolution, equity method accounting treatment, exit details, and strategic implications. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 404,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nBNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings all warned that returning capital to shareholders is constrained by U.S. banking laws, board discretion and the need to remain “well‑capitalized” and “well‑managed.” The 2022 filing emphasized board authority and the requirement to pay full and timely preferred‑stock dividends, the 2023 filing added explicit references to capital‑adequacy rules and stress‑test results, and the 2024 filing highlighted compliance with Basel‑III standards and Federal Reserve capital‑planning expectations, underscoring that any weakening of capital ratios or dividend coverage could limit future dividends and share repurchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the three-year period (2022-2024) and accurate characterization of BNY Mellon's regulatory constraints. The answer correctly identifies key regulatory frameworks (U.S. banking laws, capital adequacy rules, Basel III, Federal Reserve capital planning) and accurately captures the evolution of disclosures across the three years. The specific details about preferred dividend requirements (2022), capital adequacy rules and stress tests (2023), and Basel III/Federal Reserve expectations (2024) align with the ground truth's description of evolving complexity. No quantitative errors are present - all dates and regulatory references are accurate. The multi-hop synthesis across three years is sound, correctly showing progression from basic regulatory constraints to more complex capital planning considerations. However, the answer has minor gaps: (1) it does not explicitly mention Delaware law constraints noted in the ground truth, (2) it does not address the ESG-related regulatory pressures mentioned for 2023, (3) it does not discuss the Parent company's reliance on subsidiary dividends emphasized in 2024, and (4) it does not mention strategic transformation initiatives' impact on capital planning. These omissions represent contextual details that, while not central to the core answer, were highlighted in the ground truth as part of the evolving disclosure narrative. The answer's characterization of the trend as showing 'stable regulatory framework with increasing contextual complexity' is semantically equivalent to the LLM's framing of evolving constraints. The answer is well-structured, factually sound on major points, and demonstrates correct multi-hop reasoning across the three-year period, but lacks some of the nuanced contextual details that would make it fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 510,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\n3M’s Structural Adhesives have been pulled out of a stand‑alone line and folded into a newly created **Industrial Specialties** unit within the Safety & Industrial segment (effective Q1 2024) – a move that bundles adhesives together with former Closure & Masking and Personal‑Safety products (and related tapes) to sell them as part of an integrated specialty‑product suite【page_110】.  The change is reflected in the segment’s sales profile (Safety & Industrial net sales held steady at ≈ $11 B in 2023‑24) and in the company’s broader segment‑re‑organization that reshaped how it reports operating performance【page_112】.  By packaging adhesives with complementary specialty offerings, 3M is treating adhesives as a strategic core that underpins a broader portfolio of industrial solutions rather than as an isolated commodity, underscoring their pivotal role in delivering end‑to‑end industrial applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer provides specific organizational details (Q1 2024 reorganization into Industrial Specialties unit) and a quantitative anchor (Safety & Industrial segment at ~$11B in 2023-24) that are not present in the ground truth. However, there are significant discrepancies in how the evolution is characterized.\n\nCORRECT ELEMENTS:\n- The core insight that adhesives are positioned as strategic components within broader industrial solutions is correct\n- The general timeframe (2022-2024) and segment identification (Safety and Industrial) are accurate\n- The semantic conclusion about adhesives' strategic role is aligned with ground truth\n- The $11B figure for Safety & Industrial segment appears reasonable for the period\n\nPROBLEMATIC ELEMENTS:\n1. ORGANIZATIONAL STRUCTURE CLAIM: The LLM states Structural Adhesives were \"pulled out of a stand-alone line and folded into a newly created Industrial Specialties unit (effective Q1 2024).\" The ground truth indicates adhesives remained \"a core part of the Safety and Industrial segment\" throughout 2022-2024 with no mention of a Q1 2024 reorganization into a new unit. This is a significant structural claim not supported by the ground truth.\n\n2. PRODUCT BUNDLING SPECIFICITY: The LLM claims bundling with \"former Closure & Masking and Personal-Safety products (and related tapes).\" The ground truth mentions \"packaging and closure systems\" in 2023 and \"industrial specialty products\" in 2024, but does not specify these exact product categories or confirm they were bundled together in a new unit.\n\n3. EVOLUTION NARRATIVE: Ground truth shows evolution from (2022) metalworking/OEM electrical focus → (2023) packaging/closure emphasis → (2024) specialized industrial/construction focus. The LLM presents a different narrative centered on a 2024 reorganization event that isn't clearly documented in the ground truth.\n\n4. PAGE REFERENCES: The LLM cites \"page_110\" and \"page_112\" but these cannot be verified against the ground truth provided.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize organizational structure with strategic positioning, but the specific reorganization claim appears to be either an inference or potentially inaccurate. The connection between the reorganization and strategic role is logical, but the factual basis is questionable.\n\nQUANTITATIVE ACCURACY: The $11B figure is presented without error, and the segment identification is correct. However, the lack of specific product-level financial data in either answer limits verification.\n\nOVERALL: The answer demonstrates good understanding of the strategic positioning question but introduces specific organizational claims (Q1 2024 reorganization, Industrial Specialties unit) that diverge from or are not clearly supported by the ground truth. This creates uncertainty about factual accuracy despite the logical coherence of the narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 768,
        "total_tokens": 2231
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024 Eli Lilly kept Cyramza marketed as a broad‑spectrum oncology agent—initially as a second‑line option for gastric, NSCLC, colorectal and HCC cancers and later emphasized its first‑line use together with EGFR‑mutant NSCLC and combination regimens for gastric and colorectal cancers.  At the same time the company extended its market exclusivity by securing compound‑patent protection that expires in 2026 (U.S.), 2028 (Europe) and 2026 (Japan), backed by data‑protection periods and regulatory term extensions (e.g., Supplementary Protection Certificates), thereby preserving IP coverage through the late‑2020s across its key global markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies in patent/data protection expiration dates that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims patent protection expires in 2028 in Europe and 2026 in Japan, but the ground truth explicitly states data protection in Japan expires in 2023, European countries in 2024, and U.S. biologics data protection in 2026. The LLM's dates (2028 Europe, 2026 Japan) are factually incorrect and represent a fundamental misunderstanding of the IP timeline. (2) THERAPEUTIC INDICATIONS: The LLM correctly identifies the broad oncology indications (gastric, NSCLC, colorectal, HCC) and mentions evolution toward first-line use, which aligns with the ground truth's statement of 'sustained clinical positioning.' However, the ground truth does not specify first-line vs. second-line distinctions or mention EGFR-mutant NSCLC specifically, so this represents added detail not verified against the source. (3) MULTI-HOP REASONING: The LLM attempts to synthesize therapeutic evolution with IP strategy, which is appropriate to the question. However, the core IP timeline synthesis is fundamentally wrong. The ground truth presents a clear expiration sequence (Japan 2023 → Europe 2024 → U.S. 2026), while the LLM inverts and extends these dates significantly. (4) MISSING CONTEXT: The LLM fails to capture the ground truth's key insight about 'managing Cyramza's lifecycle' and 'preparing for eventual market competition' as the strategic narrative. Instead, it frames the strategy as 'preserving IP coverage through the late-2020s,' which contradicts the actual expiration timeline. The claim of extending market exclusivity through 2028 in Europe is particularly problematic as it directly contradicts the 2024 expiration date stated in the ground truth. This is a critical factual error that undermines the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 521,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s fixed unsecured senior debt carried a carrying value of roughly $26.9 billion in 2022, rose to about $27.2 billion in 2023, then slipped back to $26.9 billion in 2024, while the weighted‑average interest rate stayed essentially flat at around 4.8 % each year. This flat‑to‑slightly‑down trajectory shows the company has kept its senior‑debt balance stable but is absorbing a higher, steady financing cost, reflecting a strategy that prioritizes a consistent funding profile amid rising market rates rather than expanding debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth: (1) CARRYING VALUE ERROR: The LLM states 2022 carrying value was 'roughly $26.9 billion' when ground truth shows $19,975 million ($19.975 billion). This is a ~$7 billion error (35% overstatement). The LLM also claims 2024 was $26.9 billion, which matches ground truth, but the 2022 figure is completely wrong. (2) INTEREST RATE ERROR: The LLM claims the weighted-average interest rate 'stayed essentially flat at around 4.8% each year,' but ground truth shows it rose from 2.91% in 2022 to 4.84% in 2024 - a 193 basis point increase. This is a major mischaracterization of the trend. (3) TREND ANALYSIS ERROR: The LLM describes the trajectory as 'flat-to-slightly-down' when the ground truth shows a significant increase from $19.975B to $26.930B (a 34.8% increase in carrying value). The LLM's characterization of 'stable' debt balance is incorrect. (4) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion that the company 'prioritizes a consistent funding profile' contradicts the actual trend of increasing debt issuance at rising rates. The ground truth interpretation of 'strategic shift toward issuing more fixed-rate debt at higher interest rates' is more accurate. The LLM failed to correctly synthesize the multi-year data across 2022-2024, misrepresenting both the magnitude of change and the direction of the trend. This represents a fundamental failure in multi-hop financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 415,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Cisco’s total‑return swaps that economically hedge its deferred‑compensation liability moved from a **$92 million loss in 2022** to **gains of $58 million in 2023 and $91 million in 2024**.  The swing reflects both the larger notional amount of swaps (≈ $651 M → $985 M) and favorable market movements, but the year‑to‑year changes—loss → modest gain → larger gain—show that the instrument’s fair‑value adjustments remain volatile despite the overall upward trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024. The temporal sequence and pattern identification are accurate. The answer correctly identifies the three-year evolution and characterizes the volatility appropriately. The LLM goes beyond the ground truth by providing additional context about notional amounts ($651M → $985M) and explaining the underlying drivers (market movements, larger notional amounts), which adds valuable insight without contradicting the original answer. The multi-hop synthesis is sound—the answer correctly connects the financial results across three fiscal years and draws appropriate conclusions about volatility. The characterization of the pattern as 'loss → modest gain → larger gain' with an 'overall upward trend' is semantically equivalent to the ground truth's description of 'volatile financial impact...swinging from a notable loss to consistent gains.' Minor note: The LLM's additional explanatory details about notional amounts and market movements, while not explicitly in the ground truth, are reasonable inferences that enhance rather than detract from the answer. No calculation errors detected. All entities (Cisco, Total Return Swaps, Deferred Compensation, fiscal years 2022-2024) are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 389,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the company moved from isolated visual upgrades to a systematic, company‑wide store‑appearance overhaul that introduced uniform signage, modernized layout and “self‑service” pickup points (lockers, curb‑side kiosks) and rolled out electronic‑shelf‑label and checkout technology across the U.S. store base.  These investments were paired with the opening of roughly 80 new stores and the expansion of same‑day/next‑day delivery to about 90 % of the population, which lifted the share of online orders fulfilled through stores from ≈55 % (2021) to roughly 50 % (2024) and produced higher customer‑satisfaction and conversion scores.  By coupling a more attractive, easier‑to‑navigate physical footprint with faster, more reliable pickup and delivery options, Home Depot strengthened its omnichannel proposition and narrowed the gap with multichannel and pure‑play online rivals, securing a stronger competitive position in the home‑improvement market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ERRORS: The LLM claims specific metrics (80 new stores opened, 90% same-day/next-day delivery coverage, online orders fulfilled through stores declining from ~55% in 2021 to ~50% in 2024) that are not present in the ground truth answer. These specific numbers appear to be hallucinated rather than derived from actual SEC filings. The ground truth makes no mention of these specific store counts or delivery percentages. (2) DIRECTIONAL CONTRADICTION: The LLM claims online orders fulfilled through stores DECLINED from 55% to 50%, which would represent a negative trend, yet frames this as a positive competitive outcome. This is logically inconsistent with the narrative of strengthening omnichannel capabilities. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the evolution from isolated upgrades to integrated omnichannel strategy, it fails to capture the ground truth's key insight about the strategic pivot from 2022 (store appearance as standalone differentiator) through 2023 (tied to digital capabilities) to 2024 (fully integrated omnichannel with explicit Pro/DIY customer support). (4) MISSING CONTEXT: The ground truth emphasizes the integration with digital capabilities, mobile platforms, and in-store digital tools as part of the evolution. The LLM mentions electronic shelf labels and checkout technology but misses the broader digital integration narrative. (5) SPECIFICITY PROBLEM: The LLM provides very specific operational details (uniform signage, modernized layout, self-service pickup points) that are not mentioned in the ground truth, suggesting these may be fabricated details rather than actual filing information. The ground truth focuses on strategic positioning and competitive implications rather than specific operational implementations. The answer demonstrates a fundamental failure to distinguish between what can be verified from the ground truth versus unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 571,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a carrying value of roughly **$1.637 billion at the end of fiscal 2022**, **$1.604 billion at the close of fiscal 2023**, and then **$2.0 billion (face amount) by the end of fiscal 2024**. This upward trend demonstrates that NVIDIA is deliberately expanding a large, long‑dated, low‑coupon debt tranche, using the 2050 notes as a cornerstone of its long‑term financing strategy to fund future growth while extending its maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it substantially incorrect: (1) FISCAL YEAR 2022 VALUE: Ground truth states $2,147 million; LLM claims $1.637 billion (~$1,637 million). This is a major discrepancy - the LLM appears to have confused the FY2023 value with FY2022. (2) FISCAL YEAR 2023 VALUE: Ground truth states $1,637 million; LLM claims $1.604 billion (~$1,604 million). This is close but still incorrect - off by $33 million. (3) FISCAL YEAR 2024 VALUE: Both agree on approximately $2,000 million/$2.0 billion, which is correct. (4) TREND CHARACTERIZATION: The LLM describes an 'upward trend' which is misleading. The actual progression is: $2,147M (FY2022) → $1,637M (FY2023) → $2,000M (FY2024). This shows a DECLINE followed by a RECOVERY, not a consistent upward trend. The LLM's characterization of 'deliberately expanding' is not supported by the data pattern. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression, misaligning the values with their corresponding fiscal years. (6) REASONING QUALITY: While the LLM's interpretation about long-term financing strategy is plausible, it's based on incorrect data analysis. The ground truth's characterization of 'temporary reduction followed by stabilization' is more accurate to the actual data pattern. The answer demonstrates poor quantitative accuracy with multiple number errors and misalignment of values to years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 404,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nFrom 2022 through 2024 the legal exposure tied to 3M’s Scotchgard‑related PFAS deepened and widened: a wave of state‑attorney‑general actions (Michigan, Illinois, Vermont, New Hampshire, Maine, Maryland, Hawaii, Connecticut, etc.) and U.S.‑territory suits added dozens of new co‑defendants—including DuPont, Chemours, carpet, metal‑plating and other manufacturers—while the MDL docket grew to include thousands of public‑water‑system and personal‑injury bellwether cases across the Midwest, Gulf Coast, Alaska, Guam and the Northern Mariana Islands.  In 2023‑2024 3M entered a tentative $10.5‑12.5 billion settlement of the public‑water‑system MDL (subject to court approval) and resolved several bellwether water‑provider and personal‑injury actions, marking the first large‑scale resolution of its Scotchgard exposure, and the number of defendants in individual suits swelled into the dozens as the geographic footprint of the litigation expanded nationwide.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) SETTLEMENT AMOUNTS: The LLM claims a '$10.5-12.5 billion settlement' of the public-water-system MDL, but the ground truth provides specific documented settlements: $65 million (Baker case, 2022) and a non-material settlement (Michigan case, 2023). The LLM's $10.5-12.5 billion figure is not mentioned in the ground truth and appears to be fabricated or confused with other cases. (2) CASE DETAILS: The ground truth specifically mentions the Baker case (2022, $65 million, involving 3M, Saint-Gobain, and Honeywell in New York) and the Michigan Wolverine World Wide case (2023), but the LLM omits these specific settlements entirely. (3) GEOGRAPHIC EXPANSION: While the LLM correctly identifies geographic expansion and mentions multiple states, it adds unverified locations (Alaska, Guam, Northern Mariana Islands) not mentioned in the ground truth. The ground truth specifically mentions Alabama and Georgia expansion. (4) DEFENDANTS: The LLM correctly identifies DuPont and Chemours as co-defendants, which matches the ground truth. However, the LLM's claim about 'dozens' of defendants in individual suits is vague and unsupported by the ground truth's more measured description. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the documented settlement progression from 2022-2024. It jumps to a massive settlement figure without grounding it in the actual documented cases. (6) MISSING KEY DETAILS: The LLM omits the specific Mohawk Industries lawsuit mentioned in the ground truth and doesn't properly characterize the 2022-2023 settlements as 'immaterial' or 'non-material' as documented. The answer reads as speculative rather than grounded in actual filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 487,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom the 2020 AbCellera collaboration LLY pays tiered royalties in the mid‑teens to mid‑twenties on worldwide net sales of bamlanivimab and bebtelovimab, recording those royalties as cost of sales, and no additional regulatory or sales‑based milestones have been earned since the $195 million milestone that was capitalized in 2021. Net product revenue from the COVID‑19 antibodies dropped from $2.24 billion in 2021 to $2.02 billion in 2022 and to essentially zero in 2023‑2024 as EUAs expired and demand waned, leaving only the ongoing royalty payments to AbCellera.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about the AbCellera collaboration but contains a significant quantitative discrepancy that undermines accuracy. CORRECT ELEMENTS: (1) Royalty structure (mid-teens to mid-twenties) is accurate; (2) Product names (bamlanivimab and bebtelovimab) are correct; (3) The trajectory of declining sales is correct; (4) The 2022 revenue figure of $2.02 billion matches ground truth; (5) The statement that sales dropped to essentially zero in 2023-2024 is accurate; (6) The mention of EUAs expiring is contextually relevant; (7) The royalty payments being recorded as cost of sales is appropriate detail. CRITICAL ERROR: The LLM states 2021 revenue was $2.24 billion, but the ground truth only provides 2022 ($2.02 billion) and 2023 (zero) data. The LLM appears to have introduced a 2021 figure not present in the ground truth, which is problematic for a multi-hop question focused on 2022-2024 evolution. ADDITIONAL ISSUES: (1) The mention of a $195 million milestone capitalized in 2021 is not addressed in the ground truth, suggesting the LLM may be drawing from different source documents; (2) The ground truth emphasizes that 'no new milestone payments were made to AbCellera' in 2024, which the LLM addresses by noting no additional milestones since 2021, but this is slightly different framing. MULTI-HOP REASONING: The LLM successfully synthesizes information about royalty structure, revenue trends, and commercial performance across the time period, though the inclusion of 2021 data when the question specifically asks about 2022-2024 evolution is a scope issue. The reasoning connecting EUA expiration to sales decline is sound and adds helpful context. OVERALL: The answer demonstrates good understanding of the collaboration's trajectory and includes relevant details, but the quantitative discrepancy regarding the 2021 figure and the slight deviation from the specified 2022-2024 timeframe reduce confidence in accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 530,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nFrom the 2022‑2024 10‑K filings, Dawn dish soap consistently appears as a major brand within the Fabric & Home Care segment—accounting for a sizable share of the segment’s 36 % of total net sales and 34 % of its earnings (see page 18 segment table).  However, the narrative shifts in the 2024 “Summary of 2024 Results” (page 20) where the company notes **mid‑single‑digit organic sales growth** for Fabric & Home Care and specifically cites “high‑single‑digit productivity improvements” that are tied to innovation and sustainability initiatives around brands like Dawn.  This evolution shows that P&G has moved Dawn from being merely a core revenue‑generating staple to a **strategic growth and innovation platform**, underscoring its importance to the company’s overall portfolio and its long‑term earnings, cash‑flow and shareholder‑return objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Dawn remained a major brand in Fabric & Home Care across 2022-2024. (2) The segment percentages cited (36% of net sales, 34% of earnings) are accurate for 2024 and align with ground truth. (3) The LLM appropriately references specific page numbers and document sections, suggesting proper source engagement. (4) The mention of 'mid-single-digit organic sales growth' and 'high-single-digit productivity improvements' appears to be accurate contextual detail from 2024 filings.\n\nWEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to provide the full three-year comparison that the ground truth establishes. Ground truth shows: 2022 (35% sales, 31% earnings), 2023 (36% sales, 34% earnings), 2024 (36% sales, 34% earnings). The LLM only cites 2024 figures and does not demonstrate the year-over-year evolution requested in the question. (2) INTERPRETATION DIVERGENCE: The LLM interprets the evolution as a shift from 'core revenue-generating staple' to 'strategic growth and innovation platform,' but the ground truth indicates CONSISTENCY with 'no indication of reduced emphasis or strategic repositioning.' The LLM's narrative suggests a more dramatic strategic pivot than the data supports. (3) MISSING COMPARATIVE ANALYSIS: The question specifically asks 'how did...evolve from 2022 to 2024,' requiring explicit comparison across all three years. The LLM provides only 2024 data and inferred narrative rather than documented year-over-year changes. (4) SPECULATIVE REASONING: The characterization of the shift to an 'innovation platform' appears to be inference from 2024 language rather than demonstrated evolution across the three-year period.\n\nQUANTITATIVE VERIFICATION: The 36% and 34% figures are correct for 2024, but the LLM should have included 2022 (35%, 31%) and 2023 (36%, 34%) to properly address the 'evolution' aspect. The organic growth and productivity improvement figures appear reasonable but cannot be fully verified against ground truth provided.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting segment performance to brand positioning and innovation initiatives, but fails to complete the full temporal synthesis required by the question (2022→2023→2024 trajectory).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 612,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from roughly $880 million to $540 million (with a modest rebound to $560 million in 2024), while its long‑term debt peaked at about $49.3 billion in 2023 and declined to $45.0 billion in 2024. This three‑year trend reflects a deliberate reduction in wholesale funding and a shift toward a larger share of fixed‑rate senior notes, causing the floating‑rate unsecured senior debt component to shrink from around $1.7 billion to essentially zero, thereby lowering the company’s exposure to floating‑rate interest‑rate risk and reinforcing a more stable, fixed‑rate debt structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental quantitative inaccuracies that severely undermine its credibility:\n\n1. TOTAL DEBT FIGURES - MAJOR DISCREPANCY:\n   - Ground Truth: 2022=$43.086B, 2023=$48.715B, 2024=$45.551B\n   - LLM Answer: Claims long-term debt peaked at ~$49.3B in 2023 and declined to ~$45.0B in 2024\n   - The 2023 figure of $49.3B is close to ground truth ($48.715B), but the 2024 figure of $45.0B significantly understates the actual $45.551B\n   - More critically, the LLM completely fails to report the 2022 baseline of $43.086B, making it impossible to assess the full 3-year trend\n\n2. SHORT-TERM BORROWINGS - COMPLETELY WRONG:\n   - Ground Truth: Does not provide specific short-term borrowing figures in the original answer\n   - LLM Answer: Claims short-term borrowings fell from ~$880M to ~$540M (2024: $560M)\n   - These figures appear to be fabricated or sourced from incorrect data, as they don't align with the total debt figures provided\n   - The LLM's breakdown doesn't reconcile: if short-term is ~$560M and long-term is ~$45.0B, total would be ~$45.56B, which happens to match ground truth 2024 total, but the intermediate figures are inconsistent\n\n3. FLOATING UNSECURED SENIOR DEBT - PARTIALLY CORRECT:\n   - Ground Truth: $1.709B (2022) → $349M (2023) → $0 (2024)\n   - LLM Answer: \"shrink from around $1.7 billion to essentially zero\"\n   - The LLM correctly identifies the trend direction and approximate starting point ($1.7B) but fails to mention the intermediate 2023 figure of $349M, which is important for understanding the trajectory\n   - The characterization as \"essentially zero\" is correct for 2024\n\n4. WEIGHTED-AVERAGE INTEREST RATES - COMPLETELY OMITTED:\n   - Ground Truth: Fixed unsecured senior debt rates rose from 2.91% (2022) → 4.45% (2023) → 4.84% (2024)\n   - LLM Answer: Makes no mention of specific interest rate percentages\n   - The question explicitly asks about interest rate exposure, and the LLM fails to provide the quantitative evidence of rising rates\n   - This is a significant omission that weakens the answer's ability to demonstrate the strategic shift\n\n5. MULTI-HOP REASONING:\n   - The LLM correctly identifies the strategic shift toward fixed-rate debt and away from floating-rate exposure\n   - The reasoning about interest rate risk reduction is sound\n   - However, the lack of specific interest rate data undermines the analytical depth\n\n6. SEMANTIC ISSUES:\n   - The LLM's characterization of \"deliberate reduction in wholesale funding\" is reasonable interpretation but not explicitly supported by the ground truth data\n   - The statement about \"larger share of fixed-rate senior notes\" is correct in direction but lacks quantitative support\n\nSUMMARY: While the LLM demonstrates understanding of the general trend (debt increase then decrease, shift to fixed-rate, elimination of floating-rate debt), it fails on critical quantitative accuracy. The missing 2022 baseline, incorrect short-term borrowing figures, omitted interest rate data, and incomplete intermediate figures represent substantial factual errors that would mislead a financial analyst. The answer reads plausibly but contains multiple numerical inaccuracies that violate the strict standard required for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 865,
        "total_tokens": 2224
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Cisco’s 5.90 % senior note (maturing 2039) remained a $2 billion fixed‑rate issuance, but its weight in the capital structure shifted as the company added $13.5 billion of new senior debt in early 2024, expanding total long‑term debt from roughly $9 billion (2022) to about $20.3 billion (2024).  The note’s effective interest rate—reflecting the stated 5.90 % coupon, discount amortization and fair‑value hedge adjustments—has stayed essentially constant at ≈ 6.1 % each year, and it continues to be classified as long‑term debt (with only a minor current‑portion disclosure) because its maturity is well beyond the next fiscal year.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and addresses all major components correctly. STRENGTHS: (1) Correctly identifies the $2 billion principal amount of the 5.90% Note as constant across 2022-2024; (2) Accurately states the effective interest rate at approximately 6.1% throughout the period; (3) Properly synthesizes the multi-hop concept that while the note remained stable, its proportion of total debt shifted due to overall debt expansion; (4) Correctly identifies the long-term debt classification; (5) Provides helpful context about the 2039 maturity date and the 2024 debt issuance. MINOR DISCREPANCIES: (1) LLM states long-term debt was 'roughly $9 billion (2022)' while ground truth specifies $8,416 million ($8.416 billion)—this is a minor rounding difference but represents approximately 7% variance; (2) LLM states total long-term debt reached 'about $20.3 billion (2024)' while ground truth specifies $19,621 million ($19.621 billion)—again a minor overstatement of approximately 3.5%; (3) LLM mentions '$13.5 billion of new senior debt in early 2024' which is not explicitly confirmed in the ground truth but appears to be a reasonable inference from the debt increase ($19.621B - $8.416B = $11.205B, so the $13.5B figure may reflect gross issuances rather than net increase). The reasoning is sound and multi-hop synthesis is correct: the note remained a fixed component while the overall debt portfolio expanded. The answer effectively conveys that the note's relative importance in the capital structure diminished even as its absolute terms remained constant. The slight numerical imprecision (rounding/approximation) does not materially affect the correctness of the core narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 471,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 showed a virtually unchanged carrying (face) amount of roughly **$1.25 billion** in fiscal 2024 and fiscal 2025, and the **effective interest rate** disclosed in the debt‑table remained steady at **about 1.64 %** (the same rate reported for fiscal 2023).  This stability indicates that NVIDIA has deliberately retained this low‑cost, long‑dated fixed‑rate tranche on its balance sheet, using it as a stable source of long‑term financing rather than repeatedly issuing new short‑term debt or refinancing the issue.  The consistent effective rate—only modestly above the nominal coupon—reflects a strategic emphasis on locking in inexpensive capital for an extended horizon (maturity 2028).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains multiple major factual inaccuracies that fundamentally contradict the ground truth: (1) FISCAL YEAR SCOPE ERROR: The LLM discusses fiscal 2024 and fiscal 2025, but the question and ground truth only address fiscal years 2022-2024. The introduction of fiscal 2025 data is outside the requested scope and appears to be fabricated. (2) CARRYING VALUE ERRORS: The LLM claims the carrying value was 'roughly $1.25 billion' in both fiscal 2024 and 2025, but the ground truth shows: FY2022: $1,200M, FY2023: $1,099M, FY2024: $1,250M. The LLM fails to capture the critical 2023 dip to $1,099M and the subsequent recovery to $1,250M in 2024. This is a significant omission that obscures the actual trend. (3) EFFECTIVE INTEREST RATE ERROR: The LLM states the rate 'remained steady at about 1.64% (the same rate reported for fiscal 2023)' but the ground truth indicates the rate increased FROM an implied rate in 2022 TO 1.64% in 2024. The LLM incorrectly suggests the rate was already 1.64% in 2023. (4) TREND ANALYSIS FAILURE: The ground truth explicitly describes a three-year evolution with a temporary decrease in 2023 followed by recovery in 2024, revealing strategic reacquisition. The LLM's claim of 'virtually unchanged' and 'stability' directly contradicts this documented volatility and misses the key insight about the company's strategic debt management. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the multi-year trend across FY2022-2024, instead presenting a static picture that obscures the actual carrying value fluctuations. The reasoning about 'deliberately retained' debt is speculative and not supported by the actual data pattern. The answer demonstrates fundamental misunderstanding of the question's temporal scope and the actual financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 493,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google treated the Pixel line as a distinct “devices” revenue stream inside the broader **Google Subscriptions, Platforms & Devices** category, explicitly noting that device sales carry lower margins and higher inventory/TAC costs than its advertising business (see 2023 pages 31‑35).  The company continued to pour R&D and capital into hardware, launching newer Pixel 6/7 phones and Nest devices while integrating AI offerings such as Gemini/Vertex AI, signaling a sustained strategic emphasis on hardware innovation even as it acknowledged the modest, cost‑intensive contribution of devices to overall revenue (pages 5‑9, 31‑35, 57‑61).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that Pixel devices were categorized under 'Subscriptions, Platforms & Devices' segment, acknowledges the 2022-2024 timeframe, mentions lower margins/higher costs for devices vs. advertising, and notes continued R&D investment and AI integration (Gemini/Vertex AI). The semantic understanding of the strategic evolution is partially sound. (2) QUANTITATIVE ACCURACY ISSUES: The LLM cites specific page numbers (31-35, 5-9, 57-61) without verification against actual filings. While page references may be accurate, they cannot be verified from the ground truth provided. No specific financial figures, revenue amounts, or percentages are provided to verify. (3) FACTUAL CONCERNS: The LLM mentions 'Pixel 6/7 phones' as being launched during 2022-2024, but Pixel 6/7 were released in 2021, not within the evaluation period. This is a factual error regarding product launch timing. The ground truth emphasizes a progression from 'long-term investment focus' (2022) to 'distinct categorization' (2023) to 'mature, strategically embedded' (2024), but the LLM treats this more as a continuous state rather than showing clear evolution across the three years. (4) MULTI-HOP REASONING: The LLM partially synthesizes the evolution but doesn't clearly delineate the year-by-year progression as the ground truth does. It conflates the 2022-2024 period into a single narrative rather than showing transformation over time. (5) MISSING ELEMENTS: The ground truth emphasizes the transformation FROM hardware investment focus TO mature product line integration. The LLM acknowledges sustained emphasis but doesn't clearly articulate this transformation narrative. The mention of Fitbit and Nest products in the ground truth is absent from the LLM answer, though this is a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 515,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings all locate the shareholder “Item 3 – Ratification of KPMG LLP” in the same Proxy‑statement section and simply restate the firm’s PCAOB identification number (185); the language does not add new details or change the wording, only updating the year‑reference to the most recent annual meeting. This consistent presentation shows that BNY Mellon has retained KPMG LLP as its principal auditor without interruption, underscoring a stable, long‑standing audit relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric references are correct - KPMG LLP's PCAOB firm identification number (185) is accurately cited, and the three-year period (2022-2024) is correctly identified. No calculations are required for this question, and all dates/numbers present are accurate. ENTITY ACCURACY: BNY Mellon and KPMG LLP are correctly identified throughout. The reference to 'Item 3 – Ratification of KPMG LLP' in the Proxy statement is accurate. COMPLETENESS: The LLM answer addresses all aspects of the multi-part question: (1) how disclosure evolved (answer: it remained consistent), (2) what this reveals about audit relationship stability (answer: stable, long-standing, uninterrupted relationship). MULTI-HOP REASONING: The answer correctly synthesizes information across three years (2022, 2023, 2024) and draws the appropriate logical conclusion that consistency in disclosure language and structure indicates stability in the audit relationship. SEMANTIC EQUIVALENCE: The LLM's phrasing ('retained KPMG LLP as its principal auditor without interruption,' 'stable, long-standing audit relationship') conveys the same meaning as the ground truth ('stable and ongoing relationship,' 'no disruptions or changes'). MINOR DIFFERENCES: The LLM uses slightly different wording ('10-K filings' vs. 'Proxy' in the ground truth's phrasing, though both are technically correct as the ratification disclosure appears in proxy materials). The LLM's statement about 'only updating the year-reference to the most recent annual meeting' is a reasonable inference about standard proxy statement practices, though not explicitly stated in the ground truth. Overall, the answer is factually accurate, logically sound, and appropriately addresses the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 505,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nLLY’s private‑alternative‑investment holdings in its pension plans rose from roughly **$7.9 bn in 2022 to $8.6 bn in 2023 and to about $8.9 bn in 2024** (including the retiree‑health plan), keeping the share of total plan assets steady at **≈50‑55 %**. This steady growth and consistent weighting indicates a **deliberate, long‑term strategy to maintain a sizable exposure to illiquid assets—such as hedge funds, private‑equity‑like funds and real estate—to diversify returns and capture higher yields over the long run.**",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that do not match the ground truth data. Ground truth shows: 2022: $10,542.5M, 2023: $10,335.2M, 2024: $10,051.0M. LLM reports: 2022: ~$7.9B, 2023: ~$8.6B, 2024: ~$8.9B. These are significantly different values (off by approximately $2.6-2.9 billion across all years). The LLM's numbers are roughly 75-85% of the actual figures, suggesting either a different data source or a fundamental misunderstanding of which allocation metric was being referenced. Additionally, the LLM's characterization of the trend is inverted - it describes an INCREASE from 2022 to 2024 ($7.9B→$8.9B), while the ground truth shows a DECREASE ($10,542.5M→$10,051.0M). The percentage allocation claim (50-55% of total plan assets) cannot be verified against the ground truth provided. While the LLM correctly identifies the qualitative strategy (long-term diversification through illiquid assets like hedge funds, private equity, real estate), the quantitative foundation is entirely wrong. The multi-hop reasoning about strategy is sound in concept but is built on incorrect numerical data, making the overall answer unreliable for financial analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 341,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross 2022, 2023 and 2024 Tampax was never moved out of the **Feminine‑Care sub‑category** of the **Baby / Feminine & Family Care** segment; it was consistently presented as a core **menstrual‑care brand** and highlighted for its > 25 % global market‑share leadership.  The company’s commentary each year emphasized Tampax’s role in driving growth within menstrual care through product‑innovation and marketing, even as the broader Baby‑Feminine‑Family Care segment showed only low‑single‑digit organic sales growth.  In short, the classification stayed the same, but the strategic emphasis on Tampax as a leading menstrual‑care brand was maintained throughout the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) MAJOR ERROR - The LLM claims 'classification stayed the same' across all three years, but the ground truth explicitly states that 'Menstrual Care' replaced 'Feminine Care' as a sub-category between 2022 and 2023. This is a fundamental misunderstanding of the evolution being asked about. (2) QUANTITATIVE ERRORS - The LLM mentions '>25% global market-share leadership' but provides no specific segment sales contribution percentages (25% in 2022, 24% in 2023-2024 per ground truth). The LLM fails to cite the actual segment sales percentages that are central to tracking the evolution. (3) INCOMPLETE SYNTHESIS - The LLM completely misses the critical 2024 change: removal of 'Baby Care' from the segment entirely, which the ground truth identifies as 'signaling a strategic shift toward focusing on feminine and family care products.' This is a major structural change that the LLM failed to capture. (4) CONTRADICTORY CLAIMS - The LLM states classification 'stayed the same' while the ground truth documents a clear progression: Feminine Care (2022) → Menstrual Care (2023-2024), with segment restructuring in 2024. (5) MISSING CONTEXT - The LLM provides generic commentary about 'product-innovation and marketing' without addressing the specific categorical and structural evolution that the question asks about. The answer reads as a general statement about Tampax's market position rather than a detailed analysis of how its positioning evolved across the three-year period. The core premise of the LLM answer—that classification remained constant—is factually incorrect based on the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 465,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nCapital One continues to value its net derivative assets (liabilities) at Level 3 using discounted‑cash‑flow (vendor‑pricing) models.  The key unobservable input—swap rates—was 1‑2 % (weighted‑average ≈ 2 %) in 2021, widened to a 3‑5 % range (weighted‑average ≈ 4 %) by 2022 and stayed around 4 % through 2023‑2024, while default‑rate assumptions remained modest (≈ 2 % weighted‑average) and were applied mainly to retained‑interest valuations rather than directly to derivatives.  Consequently, the Level 3 balance grew from $5 million at the end of 2022 to $58 million at the end of 2023 and held at $58 million in 2024 (see 2022 10‑K pp. 220‑221, 2023 10‑K pp. 207‑209, 2024 10‑K pp. 215‑219).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) SWAP RATES - LLM claims swap rates were 1-2% in 2021 and 3-5% by 2022, but ground truth shows 3-5% range starting in 2023. The LLM incorrectly backdates the 3-5% range to 2022. (2) DEFAULT RATES - Ground truth explicitly states default rates of 53-163% in 2023, but LLM claims default rates were 'modest (≈ 2% weighted-average)' and applied mainly to retained interests, not derivatives. This is a fundamental factual error - the 53-163% range is dramatically different from 2%. (3) FAIR VALUE 2022 - Ground truth states $19 million in 2022, but LLM states $5 million at end of 2022. This is a significant numerical discrepancy. (4) METHODOLOGY DISCLOSURE - Ground truth notes that specific valuation technique was NOT disclosed in 2022, but LLM claims the company 'continues to value' using DCF models, implying consistency back to 2022 when this wasn't explicitly stated. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the evolution of assumptions across years. The key insight from ground truth is the SHIFT toward transparency starting in 2023 with specific default rate ranges (53-163%), which the LLM completely misses. (6) CONTEXTUAL ACCURACY - While the LLM correctly identifies Level 3 classification and DCF methodology for 2023-2024, it misrepresents the historical data and default rate assumptions. The answer provides page references (which is helpful) but the underlying data is incorrect. CORRECT ELEMENTS: Fair value of $58M for 2023-2024 is accurate; swap rate range of 3-5% for 2023-2024 is accurate; DCF methodology for 2023-2024 is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 441,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments generated a modest $9 million gain in fiscal 2022 but recorded losses of $21 million in 2023 and $67 million in 2024, directly pulling “other income (loss), net” from a $392 million gain to a $306 million loss over the same periods. This trend reveals growing unrealized losses and impairments on the AFS portfolio, indicating heightened sensitivity to interest‑rate and credit‑quality risks and a deteriorating financial performance of those investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) and claims about 'other income (loss), net' changing from $392M gain to $306M loss. However, the ground truth explicitly states that fiscal 2022 had 'no specific performance metrics' provided, making the $9M figure fabricated. The ground truth does not provide the specific loss amounts of $21M and $67M for 2023 and 2024, nor does it mention the $392M to $306M swing in 'other income (loss), net.' These appear to be hallucinated numbers. (2) INCOMPLETE SYNTHESIS: The ground truth indicates that in 2023 and 2024, AFS debt investment losses were 'a primary driver' of decline in 'other income (loss), net,' but the LLM's specific quantification of this relationship is not supported by the source material. The ground truth also notes 'partial offsets from gains in equity investments' in 2024, which the LLM fails to mention. (3) REASONING QUALITY: While the LLM correctly identifies the trend of increasing losses and the risk implications (interest-rate and credit-quality sensitivity), it does so by inventing specific numbers rather than acknowledging the lack of detailed metrics in 2022 as the ground truth does. (4) ENTITY AND METRIC ACCURACY: The LLM correctly identifies Cisco, AFS debt investments, and 'other income (loss), net,' but misrepresents the availability and nature of the data. The ground truth's key insight—that 2022 lacked performance data while 2023-2024 showed material negative impacts—is fundamentally altered by the LLM's fabrication of 2022 figures. This represents a major failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 489,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nStarbucks’ green‑coffee outlook lengthened over the three fiscal years: the 2022 filing projected an adequate supply only through fiscal 2023, the 2023 filing pushed that horizon to fiscal 2025, and the 2024 filing continues to assure supply through fiscal 2025 (with a specific reference to “through fiscal 2025” in its purchase‑commitment language). This progression shows that Starbucks has moved from short‑term, commodity‑price exposure to a longer‑term sourcing strategy that relies on fixed‑price and price‑to‑be‑fixed contracts, forward/hedge instruments, diversified global producer relationships, and its farmer‑support centers—an approach designed to lock in quality green coffee, smooth out price volatility, and mitigate supply‑chain risk across multiple years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more comprehensive analysis than the ground truth. QUANTITATIVE ACCURACY: All dates and fiscal year projections are correct - fiscal 2022 filing projected adequacy through fiscal 2023, fiscal 2023 filing extended to fiscal 2025, and fiscal 2024 filing maintains fiscal 2025 projection. These match the ground truth exactly. COMPLETENESS: The LLM answer addresses all parts of the multi-hop question: (1) the evolution of green coffee supply adequacy across three fiscal years, (2) the multi-year progression pattern, and (3) implications for sourcing strategy and risk mitigation. ENTITY ACCURACY: Starbucks is correctly identified, fiscal years are accurate, and green coffee supply metrics are properly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the lengthening supply horizon as evidence of strategic improvement and provides specific mechanisms (fixed-price contracts, price-to-be-fixed contracts, forward/hedge instruments, diversified producer relationships, farmer-support centers) that support the risk mitigation conclusion. This goes beyond the ground truth by providing concrete examples of the sourcing strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of the progression as moving from 'short-term, commodity-price exposure to a longer-term sourcing strategy' is semantically equivalent to and more detailed than the ground truth's description of 'strengthening sourcing strategy by securing longer-term purchase commitments.' The explanation of how this reduces 'delivery risk with coffee producers' aligns with the LLM's broader risk mitigation framing. MINOR CONSIDERATION: The LLM provides additional strategic detail (specific contract types, hedging instruments, farmer-support centers) that, while not contradicting the ground truth, goes beyond what was explicitly stated in the original answer. This represents enhanced context rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 538,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nNVIDIA’s 2.00 % Notes Due 2031 have remained essentially unchanged in size from fiscal 2022 through 2024 – the table in the 2022 filing (p. 78), the 2023 filing (p. 65) and the 2024 filing (p. 72) all list a $1.25 billion face amount outstanding, with only modest changes in the net carrying amount as the discount is amortized.  This stability shows that the company is maintaining a small, low‑cost, long‑dated debt tranche while repaying shorter‑maturity notes and relying chiefly on operating cash flow to fund growth, reflecting a disciplined, conservative long‑term financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the face amount remained at $1.25 billion across all three years (2022-2024), but the ground truth shows: FY2022: $1,200 million, FY2023: $1,044 million, FY2024: $1,250 million. The LLM incorrectly states the 2022 amount was $1.25 billion when it was actually $1.2 billion. (2) TREND ANALYSIS FAILURE: The LLM characterizes the debt as 'essentially unchanged' and 'stable,' which is factually wrong. The ground truth reveals a significant decline from $1,200M to $1,044M (13% decrease) in 2023, followed by a recovery to $1,250M in 2024. This is not 'essentially unchanged' - it represents meaningful fluctuations. (3) MULTI-HOP SYNTHESIS ERROR: The LLM failed to properly synthesize the three-year trend data. It should have identified the 2023 dip as notable and the 2024 recovery as significant, not dismissed all changes as 'modest.' (4) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'maintaining a small, low-cost, long-dated debt tranche' contradicts the actual trend showing the company increased exposure from 2023 to 2024. The characterization of strategy as 'disciplined, conservative' may be reasonable, but it's based on incorrect premise that amounts were stable. (5) CITATION ISSUES: While the LLM provides specific page references, the underlying data cited is inaccurate. The answer demonstrates a fundamental misreading or misinterpretation of the actual filing data across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 437,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 3M re‑organized its Safety & Industrial segment by creating an **Industrial Specialties** division that gathered the former Personal‑Safety products—including fall‑protection solutions—into a distinct sub‑business.  This re‑categorization placed fall‑protection offerings as a dedicated, strategically‑emphasized line within Safety & Industrial, a move that is reflected in the segment’s operating income jumping from **$1.1 bn in 2022 to $2.5 bn in 2024**, underscoring a heightened focus on fall‑protection relative to other industrial‑safety products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Safety & Industrial segment operating income jumped from $1.1 billion in 2022 to $2.5 billion in 2024. These specific numbers cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. The ground truth makes no mention of these operating income figures or their relationship to fall protection positioning. (2) STRUCTURAL CLAIM ERROR: The LLM asserts that 3M created an 'Industrial Specialties' division as a distinct sub-business reorganization. The ground truth indicates no such formal reorganization occurred—rather, it describes a subtle shift in how fall protection was presented/grouped within the existing Safety and Industrial segment structure. (3) EMPHASIS MISCHARACTERIZATION: The LLM claims fall protection became 'a dedicated, strategically-emphasized line' with 'heightened focus.' The ground truth actually states fall protection was presented with 'slightly revised grouping' and 'appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category'—the opposite of the LLM's claim of increased emphasis. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the question asks about product categorization and emphasis evolution, the LLM conflates operating income changes with positioning changes without establishing a causal or evidential link. The ground truth focuses on listing order, grouping presentation, and framing—not financial metrics. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes subtle, incremental changes in presentation and grouping; the LLM describes a major structural reorganization with strategic emphasis—fundamentally different narratives. The answer demonstrates poor adherence to the source material and introduces unsupported financial claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 527,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nEli Lilly’s sales of bamlanivimab (reported as part of its COVID‑19 antibody line) were about **$2.24 billion in 2021**, fell to roughly **$2.0 billion in 2022**, and then dropped to **near‑zero in 2023‑2024** (the tables show “‑” for 2023‑2024 and only a $2.0 bn U.S. figure for 2022).  This sharp decline indicates that the company’s reliance on its COVID‑19 antibody portfolio has largely disappeared, with the revenue contribution becoming immaterial in recent years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CRITICAL ISSUES: (1) The LLM introduces a 2021 figure of $2.24 billion that is not part of the question scope (which asks for 2022-2024) and is not verified in the ground truth. (2) The LLM states 2022 revenue as 'roughly $2.0 billion' when the ground truth clearly specifies $2.01 billion - while close, this is presented with less precision than the source data. (3) Most importantly, the LLM's characterization of the data is confusing and potentially misleading: it says the tables show '‑' for 2023-2024 and 'only a $2.0 bn U.S. figure for 2022,' which creates ambiguity about whether these are complete figures or partial data. The ground truth is unambiguous: $2.01B (2022), $0 (2023), $0 (2024). CORRECT ELEMENTS: The LLM correctly identifies the sharp decline trend and accurately concludes that reliance on the COVID-19 antibody portfolio has largely disappeared. The semantic interpretation of the trend is sound. MULTI-HOP REASONING: The answer does synthesize the revenue evolution across the three-year period and connects it to the company's changing reliance on the product, which is appropriate. However, the introduction of 2021 data outside the question scope and the imprecise/ambiguous presentation of 2022-2024 figures suggests incomplete or confused source material interpretation. The answer would score higher if it stuck to the requested 2022-2024 timeframe with precise figures ($2.01B, $0, $0) rather than introducing extraneous data and hedging language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 431,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks extended its supply‑coverage horizon—from “adequate supply through fiscal 2023” to “adequate supply through fiscal 2025”—while continuing to hedge ‘C’‑price exposure with forward contracts, futures, collars and fixed‑price/price‑to‑be‑fixed purchase commitments that offset the volatility amplified by commodity‑index‑fund trading. This progression reveals a deliberate, long‑term risk‑management strategy that locks in green‑coffee supply and mitigates price swings, ensuring a stable supply pipeline well beyond the near term.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information about Starbucks' commodity exposure and risk management evolution. STRENGTHS: (1) Correctly identifies the key progression from 'adequate supply through fiscal 2023' (2022) to 'adequate supply through fiscal 2025' (2024), which is the core quantitative finding. (2) Accurately names the hedging instruments used (forward contracts, futures, collars, fixed-price/price-to-be-fixed commitments). (3) Properly synthesizes the multi-hop reasoning: acknowledges ongoing commodity index fund impact while demonstrating improved risk management over time. (4) Correctly interprets the strategic implication—that Starbucks deliberately extended supply visibility and locked in commitments. (5) All dates and fiscal years are accurate. MINOR WEAKNESSES: (1) The original answer explicitly mentions 'remote delivery risk assessments' maintained across all three years, which the LLM answer omits. While this is a relatively minor detail, it represents incomplete coverage of the ground truth. (2) The LLM answer could have been slightly more explicit about the 'consistent acknowledgment' of commodity index fund influence across all three years, though it does reference this implicitly. (3) The phrase 'price-to-be-fixed purchase commitments' is accurate but the original answer uses slightly different terminology ('forward contracts, futures contracts, and collars'). The LLM adds 'fixed-price/price-to-be-fixed' which is reasonable expansion but not explicitly stated in the original. QUANTITATIVE VERIFICATION: All fiscal years (2022, 2023, 2024, 2025) are correctly referenced. The supply horizon extension (2023→2025) is accurately stated. No calculations are required or presented, so quantitative accuracy is high. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects commodity index fund exposure to hedging strategy to supply chain resilience. The logical flow is sound and the conclusion about deliberate long-term strategy is well-supported. The answer is semantically equivalent to the ground truth despite slightly different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 588,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nGoogle’s Ad Manager has long been the core platform for selling impression‑based inventory, and the 2022 – 2024 filings show that the company continued to grow that business while its share of total advertising revenues stayed roughly stable (see pages 30‑31, 55‑57).  In 2023 Alphabet changed the estimated useful life of its server hardware from 4 to 6 years, which cut depreciation expense by about $3.9 billion and lifted net income by roughly $3 billion that year (pages 56‑57).  That lower‑cost depreciation gave the company a cash‑flow boost that it could reinvest in Ad Manager and other growth engines, helping to preserve long‑term profitability even as impression‑based revenues face margin pressure from higher TAC and content costs (pages 30‑31, 56‑57).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All key numeric values are correct: $3.9 billion depreciation reduction, $3.0 billion net income increase, server useful life change from 4 to 6 years. (2) The LLM correctly identifies the 2023 depreciation schedule adjustment and its financial impact. (3) Multi-hop synthesis is sound - the answer connects the depreciation change to Ad Manager operations and long-term profitability. (4) The mention of TAC and content cost pressures adds relevant context about margin dynamics. WEAKNESSES: (1) The LLM introduces information about 'TAC and content costs' and 'margin pressure' that is not explicitly present in the ground truth answer, which focuses on the depreciation adjustment and its direct implications. While this may be contextually relevant, it goes beyond what the ground truth establishes. (2) The answer states Ad Manager's 'share of total advertising revenues stayed roughly stable' - this claim is not substantiated in the ground truth, which doesn't discuss market share stability. (3) The ground truth emphasizes that the depreciation change 'directly affected infrastructure-heavy operations like Ad Manager,' while the LLM frames it more as a general cash-flow boost for reinvestment. The ground truth's framing is more specific to the question's focus on Ad Manager's evolution. (4) The LLM references specific page numbers (30-31, 55-57) which cannot be verified against the ground truth. CALCULATION VERIFICATION: All numbers match ground truth exactly ($3.9B depreciation, $3.0B net income, 4-to-6 year change). MULTI-HOP REASONING: The answer correctly synthesizes information across 2022-2024 and connects the depreciation policy change to Ad Manager's role, though with some added interpretation beyond the ground truth. The core logic is sound but slightly diverges from the ground truth's specific framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 501,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nUnder the 2019 Long‑Term Incentive Plan, BNY Mellon has issued a new version of its Performance Share Unit Agreement in each of the last three years— the 2022 PSU agreement (Exhibit 10.21 filed in the 2022 10‑Q), the 2023 PSU agreement (Exhibit 10.23 filed in the 2023 10‑Q), and the 2024 PSU agreement (Exhibit 10.25 filed in the 2023 10‑K and listed as the “2025” form).  This incremental rollout reflects a deliberate, year‑over‑year refinement of the performance‑based equity component, tightening the performance metrics and extending the measurement period.  The progression shows that the firm is sharpening its focus on long‑term shareholder value, using PSUs to tie a growing share of executive compensation to sustained performance rather than short‑term earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its credibility: (1) ENTITY ERROR: The answer refers to 'BNY Mellon' when the question asks about 'BK' (Bank of New York Mellon). While these are the same company, the ticker symbol mismatch suggests potential confusion. (2) EXHIBIT NUMBER ERRORS: The LLM cites specific exhibit numbers (10.21, 10.23, 10.25) that do not match the ground truth exhibits (10.45 in 2022, 10.14 in 2023, 10.18 in 2024). These are precise factual claims about filing references that are demonstrably incorrect. (3) AGREEMENT YEAR ERRORS: The LLM claims new PSU agreements were issued in 2022, 2023, and 2024, but the ground truth shows: 2021 agreement referenced in 2022, 2019 plan re-filed in 2023, and 2022 agreement incorporated in 2024. The LLM's timeline is shifted and inaccurate. (4) FILING DOCUMENT ERRORS: The LLM references '2022 10-Q', '2023 10-Q', and '2023 10-K' but provides no verification these are correct filing types or years. The ground truth references specific 10-K filings. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution pattern. The ground truth shows a pattern of referencing prior-year agreements (2021 in 2022, then 2022 in 2024) with a plan re-filing in 2023. The LLM's claimed 'year-over-year' progression with new agreements each year is factually incorrect. (6) UNSUPPORTED CLAIMS: The LLM makes specific claims about 'tightening performance metrics' and 'extending measurement period' that are not supported by the ground truth and appear to be fabricated details. The answer demonstrates fundamental factual inaccuracy on multiple verifiable points, making it unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 471,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings the Safety & Industrial segment’s electrical offering moved from a broad “electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs)” description to a more granular categorization that isolates those items within the newly created **Industrial Specialties** division, explicitly labeling them as “electrical products and materials for construction and maintenance, power distribution and electrical OEMs.”  This added specificity—reflected in the segment‑level sales, operating‑income and capital‑expenditure tables that now track electrical‑OEM performance separately—signals that 3M is sharpening its strategic focus on the electrical‑OEM market, allocating resources and monitoring profitability toward that sub‑segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims there was a 'newly created Industrial Specialties division' that isolated electrical products. The ground truth makes no mention of any new division or reorganization. This is a fundamental factual error. (2) DESCRIPTION ACCURACY - The LLM states the 2022 description was 'electrical products and materials for construction and maintenance, power distribution and electrical original-equipment manufacturers (OEMs)' but the ground truth shows it was simply 'construction and maintenance, power distribution and electrical OEMs' without the 'products and materials' prefix or the full 'original-equipment manufacturers' spelling in 2022. (3) MISSING EVOLUTION DETAIL - The ground truth clearly documents a three-year progression: 2022 used 'electrical OEMs', 2023 refined to 'electrical original equipment manufacturers (OEMs)' with increased precision, and 2024 added 'power distribution and electrical original equipment manufacturers (OEMs)'. The LLM fails to capture this nuanced year-by-year evolution. (4) UNSUPPORTED CLAIMS - The LLM references 'segment-level sales, operating-income and capital-expenditure tables that now track electrical-OEM performance separately' but provides no evidence or numbers to support this claim. The ground truth focuses on descriptive language evolution, not on new tracking mechanisms. (5) REASONING FLAW - While the LLM correctly identifies that the evolution suggests strategic focus on electrical OEM markets, it does so by inventing structural changes (new division, separate tracking tables) rather than analyzing the actual linguistic and categorical refinements documented in the filings. The answer demonstrates a fundamental misunderstanding of what changed (language precision) versus what didn't (no new divisions mentioned in ground truth).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 528,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt slipped from roughly $27.5 billion in 2022 to $27.2 billion in 2023 and $26.9 billion in 2024, while the weighted‑average interest rate stayed near 4.5‑4.8 % (≈4.45 % in 2022‑23 and 4.84 % in 2024). This modest reduction and flat cost of funding show the firm is gradually trimming higher‑cost long‑term borrowings and relying more on lower‑cost deposits, reflecting a strategy of preserving liquidity and managing interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that contradict the ground truth across all key metrics. (1) CARRYING VALUE ERRORS: The LLM states 2022 value as 'roughly $27.5 billion' when ground truth shows $19,975 million ($19.975 billion) - an error of ~$7.5 billion or 37.5%. The LLM also incorrectly describes the trend as 'slipped from roughly $27.5 billion in 2022 to $27.2 billion in 2023' when the actual progression was $19.975B → $27.168B → $26.930B, showing a significant INCREASE from 2022 to 2023 (not a decrease). (2) INTEREST RATE ERRORS: The LLM claims the weighted-average interest rate was '≈4.45% in 2022-23' when ground truth clearly shows 2.91% in 2022 and 4.45% in 2023. This is a massive error for 2022 (off by 1.54 percentage points). The LLM correctly identifies 4.84% for 2024 but mischaracterizes the overall trend. (3) STRATEGIC INTERPRETATION ERRORS: The LLM's interpretation is fundamentally wrong. Ground truth indicates a strategic shift toward 'securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs.' The LLM incorrectly suggests the company is 'gradually trimming higher-cost long-term borrowings' when the data shows the opposite - debt grew significantly from 2022 to 2023. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression and draw accurate conclusions about debt strategy. The answer demonstrates a fundamental misunderstanding of the data trajectory and strategic implications. The only partially correct element is the 2024 interest rate (4.84%) and the general direction of 2023-2024 carrying value decline, but these cannot offset the pervasive errors in 2022 baseline figures and overall strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 491,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 NVIDIA’s 3.50% Notes Due 2040 remained on the books at roughly $1 billion of carrying value, with only modest declines in market value (from about $870 million in FY 2023 to $851 million in FY 2024) as interest rates rose; the company did not retire or re‑price the issue, merely amortizing a small discount. This steady, long‑dated senior unsecured tranche reflects NVIDIA’s strategy of anchoring its capital structure with low‑coupon, long‑maturity debt to fund sustained growth and acquisitions while limiting refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple significant factual errors that contradict the ground truth: (1) FY2022 value: Ground truth states $1,066 million fair value; LLM omits this entirely and only references 'roughly $1 billion carrying value' without distinguishing fair value from carrying value. (2) FY2023 value: Ground truth clearly states $851 million; LLM incorrectly states 'about $870 million in FY 2023' - this is a $19 million error. (3) FY2024 value: Ground truth indicates the company shifted to reporting $1,000 million carrying amount (not fair value); LLM's statement about 'modest declines...from about $870 million in FY 2023 to $851 million in FY 2024' is internally contradictory and factually wrong - the ground truth shows FY2023 was $851 million, not $870 million, and FY2024 was $1,000 million carrying amount, not a further decline to $851 million. (4) ACCOUNTING TREATMENT MISCHARACTERIZATION: The LLM fundamentally misses the key insight from ground truth - that NVIDIA shifted from reporting fair value (FY2022-2023) to carrying amount (FY2024), which is a significant change in accounting presentation. The LLM conflates fair value and carrying value without acknowledging this shift. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM fails to properly synthesize the three-year progression. The ground truth shows: FY2022 fair value $1,066M → FY2023 fair value $851M (decline) → FY2024 carrying amount $1,000M (shift in reporting). The LLM's narrative of 'modest declines' from $870M to $851M doesn't match this pattern. (6) STRATEGIC INTERPRETATION: While the LLM's qualitative discussion of debt strategy is reasonable, it's built on incorrect numerical foundations. The ground truth's interpretation about 'shift in accounting and management approach' is more accurate than the LLM's 'steady, long-dated' characterization, which misses the reporting change. POSITIVE ELEMENTS: The LLM correctly identifies the 3.50% coupon, the 2040 maturity date, and the general concept of long-term debt strategy, but these correct elements cannot overcome the fundamental numerical and accounting treatment errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 578,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe balance of Amazon’s 2017 senior notes fell steadily — from about **$16 billion** of carrying amount at the end of 2022, to **$15 billion** at the end of 2023, and further to roughly **$13 billion** by the end of 2024 (see Note 6 tables for 2022‑2024).  This consistent reduction shows that Amazon is actively repaying the 2017 issuance, using cash flow and newer debt financings to lower the outstanding principal and manage the overall leverage of that series of notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three key figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The year-over-year progression matches the ground truth exactly. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the outstanding balance across the three-year period, and (2) what this trajectory suggests about debt management strategy. ENTITY ACCURACY: Correctly identifies Amazon's 2017 Notes and the specific time period (2022-2024). REASONING QUALITY: The LLM properly synthesizes the multi-hop information by tracking the balance changes across years and drawing a logical conclusion about deliberate debt management. The statement that Amazon is 'actively repaying the 2017 issuance' and managing leverage is semantically equivalent to the ground truth's 'deliberate debt management strategy to gradually retire this issuance.' MINOR DIFFERENCES: The LLM uses slightly more detailed language ('using cash flow and newer debt financings') and references 'Note 6 tables' for sourcing, which adds helpful context without contradicting the ground truth. The phrase 'carrying amount' is technically precise accounting terminology that aligns with how debt is typically reported. The reduction trajectory ($1B from 2022-2023, $2B from 2023-2024) is correctly implied through the stated figures. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 412,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings continue to list the “Floating Rate Notes due 2019” (and comparable series) among the company’s outstanding debt disclosures (see the officer’s certificates on pages 54‑56 of the 2022, 2023 and 2024 filings).  This repetition shows that Apple still maintains a program of short‑term, floating‑rate borrowing—whose interest resets with market rates—rather than relying solely on fixed‑rate, long‑dated issuance.  Consequently, when market interest rates rise, the coupon on those floating‑rate notes will increase, directly lifting Apple’s interest expense and making earnings more sensitive to rate hikes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Apple's 2022, 2023, and 2024 filings include Floating Rate Notes due 2019, accurately explains the mechanics of floating rate notes (interest resets with market rates), and correctly reasons that rising rates would increase Apple's interest expense and earnings sensitivity. The semantic understanding of the relationship between floating rate debt and interest rate risk is sound. The answer appropriately addresses both parts of the multi-part question: (1) what the inclusion suggests about short-term debt exposure, and (2) how it affects interest expense sensitivity in rising rates.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY: The LLM cites specific page numbers (pages 54-56) without verification against the ground truth, which does not provide these page references. This is a factual claim that cannot be confirmed and represents potential inaccuracy. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes that the notes had a 2019 maturity date but were still appearing in 2022, 2023, and 2024 filings—suggesting rollover obligations or continuing disclosure obligations despite the maturity having passed. The LLM does not adequately address this temporal anomaly or explain why notes that matured in 2019 would still appear in 2022+ filings. This is a critical multi-hop reasoning gap. (3) MISSING CONTEXT: The ground truth references the Officer's Certificate dated May 6, 2014, as the source document being incorporated by reference. The LLM mentions officer's certificates but does not reference the specific date or explain the 'incorporated by reference' mechanism, which is important for understanding the disclosure structure. (4) OVERSIMPLIFICATION: The LLM states Apple 'still maintains a program of short-term, floating-rate borrowing,' but the ground truth is more cautious, noting 'some level of exposure' and suggesting this may reflect 'rollover obligations or continuing commitments' rather than active ongoing issuance. The LLM's interpretation assumes active maintenance rather than legacy obligations.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the connection between floating rate notes and interest rate sensitivity across the three years, but fails to synthesize the temporal puzzle of why 2019-maturity notes appear in 2022+ filings, which is central to understanding Apple's actual debt exposure and obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 640,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved the Pixel line from a series of experimental launches (Pixel 5a/6 and early Nest/Fitbit expansions) to a maturing, AI‑centric hardware platform built around its custom Tensor chips and tighter integration with Google services; the company correspondingly increased R&D and supply‑chain investment while scaling production.  Device‑related revenues—still a modest, lower‑margin slice of the “subscriptions, platforms & devices” segment—have risen steadily each year, indicating growing contribution despite their small overall share.  This progression shows Google is positioning the Pixel family not as a standalone profit center but as a strategic, long‑term ecosystem anchor that locks users into its AI‑driven services and cements a durable, vertically integrated presence in the consumer‑hardware market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core progression from investment phase to revenue-generating category and accurately captures the strategic positioning around AI/Tensor chips and ecosystem integration. The semantic understanding of Google's long-term hardware strategy is sound. The answer appropriately addresses all parts of the multi-part question (investment focus, revenue contribution, product maturity, and market positioning). WEAKNESSES: (1) QUANTITATIVE ISSUES - The LLM introduces specific claims about 'steady yearly revenue increases' and characterizes device revenues as 'modest, lower-margin' without providing actual numbers from the filings. The ground truth does not include specific revenue figures or margin data, so these quantitative claims cannot be verified and may be speculative. (2) UNSUPPORTED DETAILS - The LLM adds details about 'custom Tensor chips,' 'Nest/Fitbit expansions,' and 'supply-chain investment' that are not present in the ground truth answer. While these may be factually accurate from the filings, they go beyond what the ground truth establishes and introduce unverified specificity. (3) CHARACTERIZATION DIFFERENCES - The ground truth emphasizes the transition from 'long-term investment focus' to 'revenue-generating product category' with 'increased confidence.' The LLM reframes this as positioning Pixel 'not as a standalone profit center but as a strategic ecosystem anchor,' which is a different interpretation not explicitly supported by the ground truth. (4) MISSING CORE ELEMENTS - The LLM does not explicitly mention the 2022 reference to Pixel 5a 5G and Pixel 6, or the specific categorization under 'devices' as a distinct revenue stream in 2023, which are key factual anchors in the ground truth. MULTI-HOP REASONING: The LLM demonstrates sound reasoning about the progression across years and correctly synthesizes the strategic implications, but introduces claims not grounded in the provided ground truth. The answer is more speculative and interpretive than the ground truth, which sticks to observable facts from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 566,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s pledging of client securities grew as margin‑loan balances and securities‑lending activity expanded, with the firm routinely pledging client collateral to satisfy regulatory, clearing‑house and short‑term borrowing needs.  At the same time it trimmed internal short‑term credit lines (e.g., terminating the TDAC facility and cutting uncommitted lines from $950 M to $500 M) and shifted toward external repo and FHLB funding, indicating a more disciplined collateral‑management strategy that emphasizes over‑collateralization, daily collateral monitoring and the use of practical‑expedient loss estimates to limit credit‑risk exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) UNSUPPORTED CLAIMS: The answer references specific dollar amounts ($950M to $500M credit line reduction, TDAC facility termination) that are NOT mentioned in the ground truth. These appear to be fabricated or from different sources not validated by the knowledge graph. (2) MISSING CORE INFORMATION: The ground truth explicitly states that in 2022 'no specific dollar value was provided' for pledged securities, in 2023 collateralized securities were 'not reflected in consolidated financial statements,' and in 2024 Schwab was 'pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation.' The LLM answer omits these specific, documented details. (3) UNSUBSTANTIATED DETAILS: The LLM introduces concepts like 'practical-expedient loss estimates,' 'daily collateral monitoring,' and 'over-collateralization' that are not mentioned in the ground truth and cannot be verified. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to show evolution across years, it fails to accurately capture the documented progression: the shift from undisclosed amounts (2022) → formalized collateral management (2023) → active pledging for specific regulatory purposes (2024). (5) QUANTITATIVE ACCURACY FAILURE: The specific numbers cited ($950M, $500M) lack grounding in the provided ground truth and represent a major accuracy concern. The answer appears to conflate or confabulate financial details. The LLM does correctly identify that Schwab's strategy evolved toward broader use of client assets, but this correct inference is undermined by the numerous unsupported claims and missing documented facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 489,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nFrom 2022 to 2024 GE shifted from a passive “track‑and‑monitor” stance on long‑term‑care premium‑rate filings to an active, joint‑filing partnership with the primary insurers that cede its run‑off business.  In 2022 the company simply recorded the historical filing experience; by 2023 it was updating the net‑premium ratio each quarter and incorporating newly approved rate‑increase actions into its premium‑deficiency testing, and in 2024 it was systematically embedding those approved and anticipated increases—and the associated cash‑flow assumptions—into reserve and capital models.  This progression shows that GE’s reinsurance risk‑management strategy relies on close collaboration to lock‑in future premium assumptions, protect statutory capital, and align reinsurance recoveries with emerging claim‑cost trends in its long‑term‑care portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year progression (2022-2023-2024) and captures the evolution from passive to active engagement. (2) No factual errors regarding dates or entities - GE and long-term care premium rate increases are correctly identified. (3) The characterization of increasing collaboration and formalization over time aligns with the ground truth's core narrative. (4) The conclusion about risk management strategy and integration with primary insurers is semantically consistent with the original answer's emphasis on 'proactive risk management and tighter integration.' WEAKNESSES: (1) The LLM introduces specific operational details ('track-and-monitor,' 'quarterly updates to net-premium ratio,' 'premium-deficiency testing,' 'reserve and capital models') that are NOT present in the ground truth answer. While these details may be plausible for insurance operations, they represent embellishment beyond what the knowledge graph confirms. (2) The ground truth emphasizes 'formalized collaboration under reinsurance contractual terms' and 'structured approach' in 2023, but the LLM's characterization of 'joint-filing partnership' and specific quarterly/systematic processes goes beyond the documented evidence. (3) The ground truth notes GE used 'recent experience from ceding companies and regulatory precedents' in 2024, but the LLM's framing of 'locking-in future premium assumptions' and 'protecting statutory capital' adds interpretive layers not explicitly confirmed. (4) The LLM's description of embedding 'approved and anticipated increases' into 'reserve and capital models' is more granular than the ground truth's statement about 'stabilizing future policy benefit reserves.' MULTI-HOP REASONING: The LLM correctly synthesizes the three-year evolution and connects it to risk management strategy, matching the ground truth's multi-hop structure. However, the added operational specificity suggests the model may have inferred details rather than strictly adhering to documented facts. SEMANTIC EQUIVALENCE: The core message about evolution from passive to active collaboration is preserved, but the LLM's answer contains inferential details that, while potentially accurate, exceed the scope of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 606,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nCVS’s residential‑mortgage‑backed‑securities (RMBS) position was relatively stable but modestly expanding from 2022 through 2024.  The fair‑value of its RMBS holdings rose from roughly **$757 million in 2022 to $810 million in 2023**, and the separate‑account balance grew from **$51 million (2023) to $71 million (2024)**, indicating a small upward trend.  This pattern shows the company is maintaining a **conservative, high‑quality exposure to structured‑credit instruments**, limiting RMBS allocations while still holding a modest, low‑risk position in agency‑guaranteed securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states RMBS holdings were '$757 million in 2022 to $810 million in 2023' when the ground truth shows $721 million (2022) to $614 million (2023) - a difference of $36M and $196M respectively. The LLM also claims a separate account balance of '$51 million (2023) to $71 million (2024)' when the ground truth shows the 2024 figure was $71 million total RMBS (not a separate account), and there is no $51M figure mentioned for 2023 in the ground truth. (2) DIRECTIONAL MISINTERPRETATION: The LLM characterizes the trend as 'modestly expanding' and 'upward trend' when the ground truth clearly shows a DECREASE from $721M to $614M in 2023 (a 15% reduction), followed by a further decrease to $71M in 2024 (an 88% reduction from 2023). This is a declining trend, not an expanding one. (3) MISSING KEY INSIGHT: The ground truth emphasizes a 'cautious reduction in RMBS holdings in 2023 amid rising unrealized losses' - a critical risk management narrative that the LLM completely misses. The LLM instead claims 'conservative, high-quality exposure' and 'maintaining' positions, which mischaracterizes the actual strategic reduction. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the 3-year evolution and identify the actual risk positioning shift. The ground truth reveals dynamic risk management with deliberate de-risking in 2023 and selective rebalancing in 2024, while the LLM suggests stable, conservative positioning. (5) SEMANTIC MISALIGNMENT: The characterization of 'modestly expanding' and 'upward trend' is semantically opposite to the actual declining exposure pattern shown in the ground truth. This represents a fundamental misunderstanding of the data trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 503,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nFrom 2022 through 2024 the sum of COF’s short‑term borrowings and long‑term debt rose from roughly **$40.5 bn** to **$43.1 bn** and then to **$45.6 bn** (in millions).  This steady increase indicates that the firm has been deliberately expanding its leverage—issuing more long‑dated debt while keeping short‑term borrowings modest—to fund growth and diversify its funding base.  The progression reflects a capital‑structure strategy that relies on stable, longer‑term financing and active management of interest‑rate risk rather than aggressive short‑term borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES:\n\n1. QUANTITATIVE ACCURACY - SEVERE ERRORS:\n   - LLM states 2022 figure as \"roughly $40.5 bn\" but ground truth is $43.086 billion (off by ~$2.6 billion or 6%)\n   - LLM states 2023 figure as \"$43.1 bn\" but ground truth is $49.856 billion (off by ~$6.8 billion or 14% - MAJOR ERROR)\n   - LLM states 2024 figure as \"$45.6 bn\" which is approximately correct ($45.551 billion), but this is the only accurate number\n   - The LLM fundamentally misrepresents the 2023 peak, which is the most critical data point in the 3-year progression\n\n2. TREND ANALYSIS - COMPLETELY WRONG:\n   - LLM describes a \"steady increase\" from $40.5bn → $43.1bn → $45.6bn\n   - Ground truth shows: $43.086bn → $49.856bn (PEAK) → $45.551bn (DECLINE)\n   - The LLM completely misses the critical 2023 peak and subsequent 2024 deleveraging\n   - This is not a \"steady increase\" - it's an increase followed by a strategic reduction\n\n3. MISSING CRITICAL INFORMATION:\n   - LLM fails to mention weighted-average interest rates (2.76% → 4.48% → 4.84%)\n   - LLM fails to mention the reduction in floating unsecured senior debt ($1,709M → $349M → $0)\n   - LLM fails to capture the \"strategic deleveraging in 2024\" which is a key insight\n   - LLM misses the rising borrowing costs environment\n\n4. REASONING QUALITY:\n   - LLM's interpretation of \"steady increase\" contradicts the actual data pattern\n   - The conclusion about \"deliberately expanding leverage\" is incorrect - the company actually deleveraged in 2024\n   - The narrative about \"stable, longer-term financing\" misses the dynamic nature of the capital structure changes\n   - Multi-hop synthesis failed: did not properly integrate the 3-year progression with interest rate and debt composition changes\n\n5. SEMANTIC ISSUES:\n   - The characterization as \"steady increase\" is fundamentally misleading when the actual pattern is increase-then-decrease\n   - The interpretation of strategy is inverted - the company was NOT \"deliberately expanding leverage\" overall; it expanded in 2023 then strategically reduced in 2024\n\nSUMMARY: The LLM answer contains multiple critical numerical errors (especially the 2023 figure being off by $6.8 billion), completely misses the key 2023 peak and 2024 deleveraging pattern, omits essential supporting metrics (interest rates, debt composition), and draws incorrect strategic conclusions. This is a fundamentally flawed response that fails on both quantitative accuracy and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 674,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a flat‑line long‑term liability of **$2.0 billion** at the close of fiscal 2022, **$2.0 billion** at the end of fiscal 2023, and **$2.0 billion** again at the end of fiscal 2024 (the $2,000 million line item appears in the 2024 and 2023 tables).  \n\nThis consistency indicates that NVIDIA has deliberately maintained a stable, low‑cost senior‑debt tranche as part of its capital structure, relying on operating cash flows and equity rather than expanding or retiring this long‑dated debt. The unchanged exposure reflects a conservative leverage strategy that prioritizes financial flexibility and steady‑state financing while funding growth internally.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key quantitative metrics. Ground truth shows: FY2022: $2,147M, FY2023: $1,637M, FY2024: $1,604M - a clear declining trend. The LLM claims all three years were flat at $2.0 billion ($2,000M), which contradicts the ground truth data entirely. Specific errors: (1) FY2022 should be $2,147M, not $2,000M (off by $147M or 6.8%); (2) FY2023 should be $1,637M, not $2,000M (off by $363M or 22.2%); (3) FY2024 should be $1,604M, not $2,000M (off by $396M or 24.7%). The LLM's core claim of 'flat-line' liability is factually wrong - there was a significant $543M reduction from FY2022 to FY2024 (25.3% decrease). The reasoning about 'deliberately maintained a stable, low-cost senior-debt tranche' directly contradicts the actual trend of deliberate reduction. The LLM failed to identify the multi-hop synthesis requirement (tracking evolution across three fiscal years) and instead provided incorrect static values. The qualitative interpretation about 'conservative leverage strategy' and 'steady-state financing' is incompatible with the actual data showing active debt reduction. This represents a complete failure to accurately extract and synthesize the financial data from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 349,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to list the 0.45 % Notes due 2016 in the same “Officer’s Certificate” (Exhibit 4.3) that originates from the 2013 indenture, with no indication of a new issuance or amendment in those years. This consistent reference shows Apple’s long‑term debt strategy relies on a stable, transparent indenture framework—maintaining and simply re‑disclosing legacy note series rather than repeatedly creating new tranches.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more detailed and nuanced response than the ground truth. Key strengths: (1) All numeric values are correct (0.45%, 2016 maturity date, 2013 issuance year, 2022-2024 filing years). (2) The answer correctly identifies the specific exhibit location (Exhibit 4.3) and references the 2013 indenture framework, adding specificity beyond the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly concludes that Apple maintains legacy debt disclosures without new issuances or amendments. (4) The semantic meaning aligns with ground truth: both convey that Apple continues to reference historical debt instruments for transparency and legal continuity. Minor considerations: (1) The LLM answer goes slightly beyond the ground truth by specifying 'Officer's Certificate' and the indenture framework, which is accurate but represents inference rather than explicit ground truth statement. (2) The phrase 'rather than repeatedly creating new tranches' is a reasonable interpretation of Apple's strategy but adds analytical depth not explicitly stated in ground truth. (3) The answer could have been slightly more explicit about the maturity date (2016) having already passed during the 2022-2024 period, though this is implied. Overall, the LLM provides a more comprehensive and detailed answer that is factually correct and demonstrates superior multi-hop synthesis while maintaining fidelity to the core ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 426,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net derivative position moved from a small net liability of about $5 million (2022) to a net asset of roughly $58 million (2023) and $69 million (2024).  The shift reflects a marked increase in the key unobservable input used for valuation—swap rates—from the low‑single‑digit % range (≈1‑2 % in 2021‑22) to about 4 % in 2023‑24, together with a surge in issuances/settlements (e.g., 36 → 166 → 12 million) and a swing from a $33 million unrealized loss in 2022 to $63 million of unrealized gains in 2023‑24.  This multi‑year progression shows that the firm’s interest‑rate derivative exposure grew substantially and that its fair‑value modeling now relies more heavily on higher‑level, market‑observable‑plus‑adjusted assumptions (notably higher swap rates and related credit‑risk inputs), indicating greater sensitivity to interest‑rate and credit‑spread movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - 2022 valuation: LLM states \"small net liability of about $5 million\" vs. ground truth of $31 million net derivative assets. This is a significant misstatement of the baseline position.\n   - 2024 valuation: LLM claims $69 million vs. ground truth of $58 million. This is a $11 million error (19% overstatement).\n   - Unrealized losses/gains: LLM states \"$33 million unrealized loss in 2022\" and \"$63 million unrealized gains in 2023-24\" - ground truth shows $20 million net unrealized loss in 2022 with no mention of $63 million gains in later years.\n   - Swap rates: LLM claims rates increased from \"1-2% in 2021-22 to 4% in 2023-24\" but ground truth shows 4% in both 2023 and 2024, with no 1-2% baseline mentioned.\n\n2. ENTITY/METRIC CONFUSION:\n   - LLM conflates different metrics (issuances/settlements volumes are not clearly connected to the derivative valuation discussion in ground truth).\n   - The ground truth explicitly states the significant unobservable input was 'default' in 2023 (not swap rates), shifting to 'swap rates' only in 2024. LLM incorrectly emphasizes swap rates throughout.\n\n3. REASONING ERRORS:\n   - LLM's multi-hop synthesis is flawed. It incorrectly traces the evolution of key risk drivers, missing the critical shift from default assumptions (2023) to swap rates (2024).\n   - The conclusion about \"greater sensitivity to interest-rate and credit-spread movements\" is partially supported but built on incorrect intermediate facts.\n\n4. WHAT WAS CORRECT:\n   - General direction of movement from 2022 to 2023-24 (increase in net derivative assets).\n   - Recognition that swap rates are a key input in later years.\n   - General theme of increased interest-rate sensitivity.\n\n5. CRITICAL OMISSIONS:\n   - Failed to identify the shift in significant unobservable input from 'default' (2023) to 'swap rates' (2024), which is a key insight in the ground truth.\n   - Did not accurately capture the stabilization of fair value at $58 million from 2023-2024.\n   - Mischaracterized the realized loss reduction narrative.\n\nThe answer demonstrates partial understanding of the topic but contains too many quantitative errors and misidentifications of key metrics to be considered substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 637,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the 1.55 % Notes Due 2028 showed essentially no change in principal – the gross carrying amount remained $1.25 billion (the same $1.25 billion reported at the end of FY 2023 and FY 2024), with an effective interest rate of about 1.64 % and roughly 3.4 years left to maturity.  This stability indicates that NVIDIA is deliberately using a low‑cost, long‑dated unsecured issuance to lock in cheap financing, maintain a predictable maturity profile and keep overall leverage modest, underscoring a conservative, flexibility‑focused long‑term debt strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims the principal remained at $1.25 billion throughout FY2022-2024, but ground truth shows: FY2022=$1.2B, FY2023=$1.1B, FY2024=$1.25B. The LLM incorrectly states 'the same $1.25 billion reported at the end of FY 2023 and FY 2024' when FY2023 was actually $1.1B - a $150M discrepancy. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to track the evolution across three fiscal years. It missed the 2023 reduction from $1.2B to $1.1B and mischaracterized the progression as 'essentially no change' when there was actually a $100M decrease then $150M increase. (3) INCOMPLETE ANALYSIS - While the LLM correctly identifies the 1.55% interest rate and discusses debt strategy appropriately, the foundational numbers are wrong, undermining the entire analysis. The characterization of 'stability' is factually incorrect given the documented fluctuations. (4) REASONING QUALITY - The strategic interpretation about 'low-cost, long-dated unsecured issuance' and 'conservative, flexibility-focused' approach may be reasonable conclusions, but they're built on incorrect numerical premises. The answer demonstrates good understanding of debt strategy concepts but fails on basic factual accuracy. Ground truth shows a more dynamic pattern (down then up) rather than the claimed stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 397,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nBetween 2022 and 2024 GE’s 10‑K filings repeatedly highlighted the same trailing‑liability portfolio: legacy Alstom litigation over alleged anti‑competitive conduct and corruption that continues to generate potential settlement, judgment and penalty cash‑outflows, and unresolved shareholder suits tied to earlier financial‑reporting and accounting practices.  The company continues to record reserves for these matters but emphasizes that actual losses may exceed those estimates, and each filing stresses that the risks remain “material” and “ongoing.”  This consistent language shows that the contingent liabilities have persisted unchanged in magnitude and financial impact, underscoring their enduring effect on GE’s earnings, cash‑flow and leverage.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core factual elements and reasoning. STRENGTHS: (1) Correctly identifies the two primary liability categories: Alstom-related legacy litigation (anti-competitive conduct, corruption) and shareholder lawsuits tied to historical financial reporting. (2) Accurately captures the 3-year progression (2022-2024) showing persistence of these liabilities. (3) Correctly notes that GE records reserves but acknowledges potential for actual losses to exceed estimates. (4) Properly synthesizes the multi-hop reasoning: connecting Alstom acquisition (2015) to ongoing 2022-2024 exposure, and linking shareholder suits to historical accounting practices. (5) Appropriately characterizes the liabilities as 'material,' 'ongoing,' and having 'enduring effect' on earnings, cash flow, and leverage. (6) No quantitative errors in dates or entity identification. MINOR WEAKNESSES: (1) The LLM states liabilities 'persisted unchanged in magnitude and financial impact' - while the ground truth emphasizes persistence, it doesn't explicitly claim magnitude remained unchanged; the ground truth focuses on persistence and potential for exceeding estimates rather than claiming static magnitude. This is a subtle semantic distinction but represents a slight overstatement. (2) The LLM answer is somewhat more compressed and doesn't explicitly mention 'reputational risks' as emphasized in the ground truth, though it does reference 'material' impact. (3) The phrase 'contingent liabilities from exited businesses' mentioned in the ground truth is not explicitly addressed in the LLM answer, though it's a secondary element. MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and two distinct liability categories, properly connecting historical events (Alstom acquisition, past financial reporting) to current (2024) exposure. The reasoning chain is sound and logically presented. OVERALL: The answer is substantially correct with strong factual accuracy and appropriate synthesis, with only minor omissions and one slight semantic overstatement regarding magnitude constancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 580,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure rose from roughly **$237 million in 2022 to $252 million in 2023 and $280 million in 2024**, reflecting an ~18 % increase over the three‑year span.  This growth coincides with a modest upward shift in the plan’s target allocation—from **3 % hedge‑fund weighting in 2022 to 4 % in 2024 (and the addition of a 2 % private‑credit slice)**—indicating that CVS is deliberately expanding its allocation to alternative assets.  The move is aimed at boosting expected returns and better matching the pension fund’s liability profile, underscoring a strategic pivot toward a more diversified, higher‑return‑oriented investment mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains significant quantitative errors that fundamentally undermine its credibility. (1) NUMBERS ARE WRONG: Ground truth shows $214M (2022), $225M (2023), $252M (2024). LLM claims $237M (2022), $252M (2023), $280M (2024). All three year-end values are incorrect - the 2022 figure is off by $23M, the 2023 figure is off by $27M, and the 2024 figure is off by $28M. (2) CALCULATION ERROR: LLM states an ~18% increase over three years. Actual increase: ($252M - $214M) / $214M = 17.8%, which rounds to 18%. However, this calculation is based on wrong numbers, so while the percentage methodology is sound, it's applied to incorrect data. (3) UNSUPPORTED CLAIMS: The LLM introduces specific allocation percentages (3% in 2022, 4% in 2024) and mentions a 2% private-credit allocation that are NOT present in the ground truth answer. These appear to be fabricated details not supported by the source material. (4) MULTI-HOP REASONING: While the LLM's reasoning about strategic intent and portfolio diversification is logically coherent, it's built on a foundation of incorrect numbers, making the entire analysis unreliable. (5) SEMANTIC ISSUES: The LLM correctly identifies the general trend (upward movement in hedge fund allocations) but gets the magnitude completely wrong. The ground truth shows a more modest increase ($214M to $252M = 17.8%), while the LLM's numbers suggest a steeper trajectory ($237M to $280M = 18.1%), but more importantly, the starting and ending points are factually incorrect. The answer demonstrates reasonable analytical thinking about pension fund strategy but fails the primary requirement of factual accuracy on the specific numbers that form the basis of the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 481,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nFrom 2022 to 2023 operating profit in Africa/Eurasia rose to **$254 million**, then edged down only slightly to **$253 million in 2024**, showing modest growth followed by a flat‑to‑slightly‑lower trend. The 2023 restructuring charges tied to the 2022 Global Productivity Initiative allocated roughly **10 % of the $32 million pre‑tax program cost** to the region (about **$3 million**), reflecting continued efficiency‑focused spending. Depreciation and amortization outlays for Africa/Eurasia remained minimal, totaling **$8 million in 2024**, indicating limited additional capital investment in the area.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that contradict the ground truth across all key metrics:\n\n(1) OPERATING PROFIT - CRITICAL ERROR: The LLM claims operating profit was $254 million in 2023 and $253 million in 2024. The ground truth states operating profit was $203 million in 2022 with no mention of increases to $254M/$253M in subsequent years. The LLM has fabricated significantly higher numbers ($254M vs $203M = 25% overstatement) and introduced data points for years not addressed in the ground truth.\n\n(2) RESTRUCTURING CHARGES - CRITICAL ERROR: The LLM states \"10% of the $32 million pre-tax program cost\" equals \"about $3 million.\" This is mathematically incorrect (10% of $32M = $3.2M, which rounds to $3M, so the math is barely acceptable). However, the ground truth explicitly states the allocation was \"$20 to $24 million,\" not $3 million. This represents a 7-8x understatement of the actual restructuring charges allocated to Africa/Eurasia.\n\n(3) DEPRECIATION AND AMORTIZATION - PARTIALLY CORRECT: The LLM correctly identifies $8 million for 2024. However, it fails to mention the ground truth's important context that this declined from $9 million in both 2022 and 2023, missing the comparative analysis that demonstrates the declining trend.\n\n(4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year trajectory. It introduced operating profit figures for 2023-2024 that don't appear in the ground truth, while omitting the 2022 baseline of $203 million that anchors the analysis.\n\n(5) CONTEXTUAL INTERPRETATION: The LLM's narrative about \"modest growth followed by flat-to-slightly-lower trend\" contradicts the ground truth's characterization of \"consistent but low-level financial presence\" with \"limited growth investment and focus on cost optimization.\"\n\nThe answer demonstrates fundamental misunderstanding of the source data, with invented numbers, calculation errors, and failure to capture the actual financial trajectory described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 553,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nAIG’s international terrorism exposure remains concentrated in high‑value U.S. commercial and personal lines, with modeled net loss estimates for a major attack holding steady at roughly $1.3 billion net of TRIPRA and private reinsurance from 2022 through 2024.  The reinsurance program shifted from a 2022 structure with $150 million (U.S.) and $200 million (Japan) retentions to a 2023‑2024 program that kept the $500 million North‑America commercial retention but reduced the Japan attachment point to $150 million and added higher vertical limits and per‑risk covers.  Accordingly, total reinsurance recoverable assets fell sharply—from about $67 billion in 2023 to $38 billion in 2024—reflecting a smaller ceded portfolio and reduced reliance on collateral.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors and contradictions with the ground truth:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - LLM claims Japan attachment point was $200M in 2022, then reduced to $150M in 2023-2024. Ground truth states Japan retained $200M consistently through the period.\n   - LLM introduces a $500M North America commercial retention not mentioned in ground truth.\n   - LLM claims reinsurance recoverable assets fell from $67B (2023) to $38B (2024). Ground truth only confirms $38.0B in 2024 and does not provide a 2023 figure of $67B for comparison.\n   - LLM states $150M U.S. retention in 2022, but ground truth specifies $125M elsewhere (non-Japan) and $200M Japan, with no mention of $150M U.S. figure.\n\n2. FACTUAL INACCURACIES:\n   - The $1.3 billion net loss estimate is correctly cited, but the context about it being from a \"five-ton bomb attack in New York City\" is omitted.\n   - Ground truth mentions $1.7 billion TRIPRA deductible in 2022, which LLM does not address.\n   - Ground truth specifies $29.1 billion in ceded loss reserves within the $38.0B total, which LLM omits.\n   - LLM incorrectly characterizes the reinsurance program evolution with specific retention changes not supported by ground truth.\n\n3. MULTI-HOP REASONING ISSUES:\n   - LLM failed to properly synthesize the three-year evolution. It invents a 2023 baseline ($67B) not in ground truth.\n   - The claim about \"reduced reliance on collateral\" is not supported by ground truth.\n   - LLM mischaracterizes the nature of the exposure as \"concentrated in high-value U.S. commercial and personal lines\" when ground truth emphasizes international exposure and global management.\n\n4. MISSING KEY INFORMATION:\n   - No mention of third-party vendor models for scenario-based modeling (2023).\n   - No discussion of targeted reinsurance purchases for international exposure.\n   - Omits the specific breakdown of ceded loss reserves ($29.1B of $38.0B).\n\n5. SEMANTIC ISSUES:\n   - The characterization of evolution is backwards—ground truth shows expansion of reinsurance protections, while LLM suggests contraction.\n   - Ground truth emphasizes consistent approach with increased reliance on reinsurance; LLM suggests reduced reliance.\n\nThe answer demonstrates partial understanding of the topic but introduces fabricated numbers and contradicts ground truth on key metrics and trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 644,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe carrying amount of NVIDIA’s 2.00% Notes Due 2031 was about $1.2 billion in 2022, slipped to roughly $1.044 billion in 2023 (reflecting discount amortization and a modest retirement), and then rose back toward $1.25 billion in 2024 as disclosed in Note 12 (page 72) and the liability table (page 65).  This pattern shows that the company is treating the 2031 notes as a stable, low‑cost long‑term financing tool, adjusting the balance only modestly for accounting amortization rather than aggressively reducing or expanding debt, thereby preserving liquidity while funding ongoing operations and strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of NVIDIA's debt management strategy. QUANTITATIVE VERIFICATION: All three carrying amounts are correct - $1.2 billion (2022), $1.044 billion (2023), and $1.25 billion (2024). The numbers match the ground truth exactly. COMPLETENESS: The answer addresses all key aspects of the question: (1) the trend across three fiscal years, (2) the specific carrying amounts, (3) the interpretation of the slight reduction in 2023, and (4) the return to higher levels in 2024. ENTITY ACCURACY: NVIDIA, the 2.00% Notes Due 2031, and the fiscal years 2022-2024 are all correctly identified. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (a) acknowledging the stability of the debt instrument, (b) explaining the 2023 dip as reflecting 'discount amortization and modest retirement' (semantically equivalent to the ground truth's 'debt repayments or reclassifications'), and (c) interpreting the 2024 return as evidence of strategic preservation of capital structure. The conclusion that NVIDIA treats this as a 'stable, low-cost long-term financing tool' aligns well with the ground truth's assessment of 'consistent long-term debt strategy' and 'strategic intent to preserve stable long-term liabilities.' MINOR DIFFERENCES: The LLM provides slightly more specific accounting detail (mentioning 'discount amortization') and references specific page numbers (72, 65), which adds credibility but is not required by the ground truth. The wording differs slightly but conveys equivalent meaning - both answers conclude the company maintained stable long-term debt without material alterations. No calculation errors detected. The answer is well-structured, factually sound, and demonstrates proper multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 498,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 were originally created under Apple’s 2013 indenture and were listed in the 2014 Officer’s Certificate (shown in the 2022 filing as part of the legacy global‑note schedule). By the 2023 and 2024 10‑Ks that series no longer appears—having been retired and supplanted by newer tranches such as the 2023 4.421 % Notes due 2026—yet the underlying indenture and global‑note framework remain in place. This illustrates that Apple’s debt structure has long‑term visibility through its continuous indenture, but individual note series are finite and are systematically rolled forward, preserving the overall framework while the specific 1.05 % 2017 instrument drops out of the public record.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Presence across years: The ground truth explicitly states the 1.05% Notes due 2017 'remained consistent across all three years—2022, 2023, and 2024' as part of Apple's incorporated debt instruments. The LLM claims 'By the 2023 and 2024 10-Ks that series no longer appears,' which is the opposite of what the ground truth indicates. This is a major factual error on the core question. (2) CRITICAL ERROR - Maturity status: The ground truth notes that 'Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation.' The LLM's claim that the notes 'drops out of the public record' by 2023-2024 contradicts the ground truth's assertion of persistent inclusion. (3) ENTITY/REFERENCE ERRORS: The LLM introduces specific references (2013 indenture, 2014 Officer's Certificate, 2023 4.421% Notes due 2026) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated details. (4) REASONING FAILURE: The LLM's multi-hop synthesis is fundamentally flawed. It claims a retirement/replacement narrative ('retired and supplanted by newer tranches') when the ground truth indicates continuity and persistent documentation. (5) SEMANTIC CONTRADICTION: The LLM's conclusion about 'long-term visibility through its continuous indenture' while claiming the specific instrument 'drops out' contradicts the ground truth's emphasis on the instrument's consistent presence across all three years. The answer fails on the primary factual claim about whether the notes appear in 2023-2024 filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 473,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s IDA‑migration rights shifted when the original 2019 IDA agreement was superseded by the 2023 IDA agreement. Under the 2019 arrangement (still in effect in 2022) Schwab could move up to $10 billion of IDA balances each 12‑month window—subject to keeping at least $50 billion of IDA balances on the books through June 2031 and maintaining ≥ 80 % of those balances as fixed‑rate obligations through June 2026. The 2023 agreement kept the $10 billion‑per‑year cap but restricted migrations to **floating‑rate** IDA balances only, eliminated the 80 % fixed‑rate requirement, and introduced new balance‑maintenance thresholds: through September 10 2025 Schwab must keep IDA balances above the total of outstanding unmatured fixed‑rate obligations plus a $30 billion buffer (with a maximum $30 billion above that total), and after that date it must sustain a minimum of $60 billion and a maximum of $90 billion of IDA balances for the remainder of the sweep period (extended to July 1 2034). Consequently, although the migration option remained, Schwab did not execute any balance transfers in 2024, reflecting the tighter floating‑rate‑only limitation and the higher minimum‑balance requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM claims the 2019 agreement required 'at least $50 billion of IDA balances on the books through June 2031' and '≥80% of those balances as fixed-rate obligations through June 2026' - these specific thresholds and dates are not mentioned in the ground truth and appear to be fabricated. The ground truth only mentions that Schwab 'had already moved $10.1 billion by year-end' 2022 under the $10 billion annual migration option. (2) UNSUPPORTED DETAILS: The LLM provides extensive detail about 'floating-rate IDA balances only' restrictions, the specific formula 'total of outstanding unmatured fixed-rate obligations plus a $30 billion buffer,' and the extended sweep period to 'July 1 2034' - none of which appear in the ground truth. (3) MISSING CORE FACTS: The ground truth emphasizes that in 2023 Schwab 'no longer exercised this migration option' and was 'bound by new minimum and maximum balance thresholds,' but the LLM incorrectly states 'the migration option remained' and that Schwab 'did not execute any balance transfers in 2024' due to 'tighter floating-rate-only limitation' rather than the strategic shift away from migration described in the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution across years, it does so by introducing fabricated details rather than accurately synthesizing the actual documented changes. The ground truth shows a clear transition from active migration (2022) to constrained off-balance sheet management (2023-2024), but the LLM mischaracterizes this as a continuation of migration rights with new restrictions. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes a 'strategic shift toward maintaining off-balance sheet deposits' while the LLM frames it as continued migration capability with floating-rate restrictions - fundamentally different interpretations. The answer demonstrates hallucination of specific financial terms and thresholds not present in source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 569,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 the estimated loss‑exposure tied to Bank BPH’s borrower‑litigation grew from **$1.36 bn (2022)** to **$2.67 bn (2023)** and was later revised to roughly **$2.46 bn by the end of 2024**.  To keep regulatory capital adequacy, GE injected **$530 m of cash in 2022**, then executed a **$1.80 bn non‑cash inter‑company loan‑forgiveness in 2023** (no additional cash contribution was required in 2024).  As a result of the settlement program and subsequent valuation allowance, the **mortgage‑portfolio carrying value was written down to zero by year‑end 2023 and remained zero in 2024**.  (Pages 50, 51, 94, 52).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key financial metrics and timeline evolution. CORRECT ELEMENTS: (1) Estimated losses progression: $1.36bn (2022) → $2.67bn (2023) → $2.46bn (2024) - all figures match ground truth exactly; (2) Capital contributions: $530m cash in 2022 and $1.80bn non-cash intercompany loan forgiveness in 2023 are correct; (3) No additional contributions in 2024 is accurate; (4) Mortgage portfolio carrying value written to zero is correct; (5) Multi-hop synthesis across years and metrics is sound. MINOR ISSUES: (1) The LLM states the mortgage portfolio 'was written down to zero by year-end 2023 and remained zero in 2024,' but the ground truth specifies it 'dropped to zero by the end of 2024.' This is a temporal discrepancy - the ground truth indicates the write-down occurred in 2024, not 2023. This is a meaningful error regarding when the valuation write-down occurred; (2) The LLM mentions 'settlement program and subsequent valuation allowance' but doesn't explicitly note the $1,014 million Q2 2023 charge that was part of the settlement program, though this is a minor omission rather than an error; (3) The narrative about 'worsening litigation environment through 2023 followed by stabilization in 2024' and 'GE absorbing significant losses and ultimately exiting active involvement' is implicit but not explicitly stated in the LLM answer. QUANTITATIVE VERIFICATION: All dollar amounts are correctly formatted and match ground truth values. The progression of numbers is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, connecting estimated losses, capital contributions, and portfolio valuation changes. The logical flow showing escalation in 2023 and stabilization in 2024 is sound. The primary weakness is the timing error regarding when the mortgage portfolio reached zero carrying value (2023 vs 2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 524,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nFrom 2022 through 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities slipped modestly—from about **$1.02 bn to $0.98 bn**—while the unrealized loss narrowed from **≈$155 m to $100 m**, showing that the company’s mark‑to‑market losses were reduced even as the portfolio shrank.  The 2024 data (which disclose only **$3 m of CMBS in separate‑account holdings**) indicate that the firm has further trimmed its exposure, reflecting a deliberate risk‑management strategy of de‑risking higher‑volatility tranches and preserving capital.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all major metrics. Specific errors: (1) 2022-2023 fair value figures are completely wrong - LLM states $1.02bn to $0.98bn when ground truth shows $574M to $675M (off by approximately 1.5-1.8x); (2) 2022 unrealized losses are drastically incorrect - LLM claims ~$155M when ground truth shows $12M (off by 12.9x); (3) 2023 unrealized losses are stated correctly at $100M, but this is the only accurate number in the entire response; (4) The 2024 figure of $3M is correct. The LLM appears to have confused CVS's CMBS holdings with a different portfolio or misread the source data entirely. The narrative about de-risking strategy is qualitatively reasonable and the 2024 conclusion is sound, but the massive quantitative errors in 2022-2023 data undermine the entire analysis. The multi-hop synthesis fails because the foundational numbers are wrong, making any trend analysis based on these figures unreliable. The answer demonstrates a critical failure in data accuracy that would mislead any stakeholder relying on this information for financial analysis or decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 333,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Walmart repeatedly listed “Marketside” in its private‑brand rosters (2022 p. 7; 2023 p. 6; 2024 p. 7) and disclosed that the brand was being broadened with additional SKUs and new grocery categories, while the company’s overall private‑label share of grocery sales grew each year.  This three‑year trajectory shows that Walmart is deliberately expanding Marketside as a core grocery‑private‑label platform to capture price‑sensitive shoppers, increase margin, and differentiate its offering in a crowded grocery market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer makes specific claims about page numbers (2022 p. 7; 2023 p. 6; 2024 p. 7) that cannot be verified and appear to be fabricated citations. This is a serious factual error. (2) The LLM claims Marketside was 'being broadened with additional SKUs and new grocery categories' - this specific detail is NOT present in the ground truth answer and appears to be an unsupported assertion. (3) The LLM states 'the company's overall private-label share of grocery sales grew each year' - this is a quantitative claim with NO supporting numbers provided, and this metric is not mentioned in the ground truth. (4) The LLM's interpretation that Walmart is 'deliberately expanding Marketside as a core grocery-private-label platform to capture price-sensitive shoppers, increase margin, and differentiate its offering' goes beyond what the ground truth supports - the ground truth emphasizes 'dual approach of preserving trusted private brands while innovating,' not aggressive expansion of Marketside specifically. WHAT WAS CORRECT: (1) Correctly identified Marketside as appearing across 2022-2024. (2) Correctly noted the introduction of new brands like 'bettergoods' (implied by 'new private brands'). (3) The general strategic direction about balancing legacy and new brands is directionally aligned. MULTI-HOP REASONING: The LLM failed to properly synthesize the ground truth's key insight - that Walmart maintained Marketside WHILE introducing new brands, suggesting a balanced portfolio strategy. Instead, the LLM overemphasized Marketside expansion without evidence. The fabricated page citations and unsupported quantitative claims significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 463,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s moved from a generic supplier code of conduct to a risk‑based approach that includes country‑specific wood‑sourcing risk tiers, a new forestry grievance process, mandatory CDP emissions reporting and 100 % SmartWay certification for transportation providers, thereby tightening environmental and human‑rights enforcement (pages 9, 10).  At the same time the company invested more than $550 million in energy‑efficiency upgrades, on‑site solar at 174 stores, and renewable‑energy PPAs, and it set a net‑zero Scope 1‑3 target for 2050 with interim 2030 cuts of 42 % (Scope 1‑2) and 25 % (Scope 3) (pages 9, 12).  These policy enhancements and capital investments collectively deepened supply‑chain due diligence and sustainability capacity across Lowe’s operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding investments. The ground truth states 'multi-year investments exceeding $550 million by 2022 and over $400 million through 2023' in operational sustainability initiatives. The LLM conflates this with energy-efficiency upgrades and renewable energy investments, stating '$550 million in energy-efficiency upgrades, on-site solar at 174 stores, and renewable-energy PPAs' without clarifying these are different investment categories or time periods. This is a critical misrepresentation of the investment data. PARTIAL CREDIT FOR POLICY ENHANCEMENTS: The LLM correctly identifies several policy improvements (country-specific wood-sourcing risk tiers, forestry grievance process, CDP emissions reporting, SmartWay certification) that align with the ground truth's description of evolution from 2022-2024. However, the answer introduces elements (mandatory CDP emissions reporting, 100% SmartWay certification, net-zero 2050 target with specific interim targets) that are NOT mentioned in the ground truth answer, suggesting potential hallucination or information from different sources not validated against the knowledge graph. INCOMPLETE SYNTHESIS: The ground truth emphasizes the progression across three years (2022 baseline monitoring → 2023 policy updates → 2024 further strengthening), while the LLM collapses this into a general 2022-2024 evolution without clearly delineating year-by-year changes. MISSING ELEMENTS: The LLM omits specific mention of human rights policy, conflict minerals policy, and the requirement for wood from well-managed, non-endangered forests that are highlighted in the ground truth. The answer also doesn't clearly distinguish between monitoring/enforcement enhancements and capital investments as separate but complementary strategies. CONTEXTUAL RELEVANCE: The answer does address the core question about evolution of monitoring/enforcement and investments, but the factual errors and potential hallucinations significantly undermine reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 559,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nThe 2.40 % Notes due 2023 first appeared in Apple’s 2022 Form 10‑K (Exhibit 4.3) as part of the 2013 indenture, and the same series was still listed in the 2023 and 2024 filings; however, by 2024 it was shown only as a legacy tranche with a near‑term maturity while newer, longer‑dated notes (e.g., the 2026‑2053 issuances) were added to the exhibit list. This three‑year evolution demonstrates Apple’s active debt‑management strategy of rolling maturing debt into longer‑dated, low‑coupon securities to extend its maturity profile and preserve financial flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 2.40% Notes due 2023 did appear in Apple's 2022, 2023, and 2024 filings - this is accurate. (2) The note was part of the 2013 indenture - correct. (3) The note had a near-term maturity by 2024 - accurate. (4) Apple did issue longer-dated notes (2026-2053 range) - this is factually supported. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific exhibit references (Exhibit 4.3) that are not verified in the ground truth and may be inaccurate. (2) The LLM characterizes the pattern as demonstrating 'active debt-management strategy of rolling maturing debt into longer-dated securities' - this is an interpretation that goes beyond what the ground truth supports. The ground truth emphasizes 'sustained transparency' and 'stable and transparent debt disclosure strategy,' not an active rolling/refinancing strategy. (3) The LLM's framing suggests the 2.40% Notes were replaced or rolled into newer notes, but the ground truth simply states the notes were consistently disclosed across three years without indicating they were refinanced or replaced. MULTI-HOP REASONING: The LLM attempts to synthesize information about the note's appearance across three years and connect it to debt management strategy, but the interpretation diverges from the ground truth's emphasis on transparency and consistency. The ground truth focuses on disclosure patterns, while the LLM focuses on debt restructuring strategy - these are different analytical angles. QUANTITATIVE ACCURACY: The dates (2022, 2023, 2024) and the coupon rate (2.40%) are correct. The maturity year (2023) is correct. The reference to 2026-2053 issuances is reasonable but not specifically verified against ground truth. SEMANTIC EQUIVALENCE: While both answers discuss the three-year pattern, they reach different conclusions about what it indicates. The ground truth emphasizes transparency and legacy debt management, while the LLM emphasizes active debt rolling and maturity extension. This represents a meaningful divergence in interpretation rather than mere wording differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 572,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 to 2024 the AerCap exposure swung from a **$865 million unrealized loss** (2022) to a **$129 million unrealized gain** (2023) and then to a **modest $38 million gain** (2024).  This shift reflects that GE sold its remaining AerCap equity shares in 2023, retained only a senior note, and is now winding down that position, underscoring a strategic move to shed non‑core financial investments and simplify its portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM provides unrealized gain/loss figures ($865M loss, $129M gain, $38M gain) that are completely different from the ground truth holding values ($976M in 2022, $944M in 2023, $982M in 2024). These appear to be unrealized gains/losses on the note position, not the actual holdings amounts requested. The LLM conflates two different metrics. (2) FACTUAL INACCURACY - The ground truth shows holdings decreased slightly from 2022 to 2023 ($976M to $944M), then increased in 2024 ($944M to $982M). The LLM's narrative about 'selling remaining AerCap equity shares in 2023' and 'winding down that position' contradicts the ground truth showing an increase in holdings in 2024. (3) MULTI-HOP SYNTHESIS FAILURE - The question asks about the evolution of holdings and what it suggests about investment strategy. The ground truth correctly identifies this as showing 'dynamic approach' and 'slight overall stability' with holdings returning near 2022 levels. The LLM incorrectly characterizes this as a wind-down strategy. (4) MISSING CONTEXT - The ground truth appropriately contextualizes the AerCap note holdings within broader portfolio changes (U.S. corporate debt, mortgage-backed securities). The LLM provides no such context. (5) SEMANTIC MISMATCH - The LLM's interpretation of 'winding down' contradicts the actual data showing a rebound in 2024 holdings. The answer demonstrates a fundamental misunderstanding of the data and provides incorrect financial metrics that don't match the question's focus on holdings evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 446,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s U.S. pension glide‑path cut the strategic equity allocation from **15 % (target 2022)** to **9 % (target 2023‑2025)**, while raising the fixed‑maturity share from **75 % to 80 %** and modestly increasing the “other” bucket from **10 % to 11 %**. This systematic move toward higher‑quality, liability‑hedging assets reflects the plan’s improving funded ratio, showing a deliberate de‑risking strategy that reduces exposure to growth‑oriented assets as the sponsor’s solvency strengthens.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical allocations (15% equity target 2022, 9% target 2023-2025, 75% to 80% fixed-maturity, 10% to 11% other) that cannot be verified against the ground truth. The ground truth explicitly states that AIG's glide path approach 'progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets' but does NOT provide specific percentage figures for these allocations. The LLM appears to have fabricated precise numbers without sourcing them from the actual filings. The ground truth emphasizes the METHODOLOGY of the glide path (using funded status at specific dates to determine target allocations for future years) and the PRINCIPLE of de-risking, but does not cite the exact percentages the LLM claims. The LLM correctly identifies the de-risking strategy and liability-driven investing principles, and the directional movement (reducing growth assets, increasing liability-hedging) aligns with the ground truth narrative. However, the critical failure is presenting unverified specific percentages as fact. The LLM also conflates 'target 2023-2025' when the ground truth indicates distinct target allocations for 2022, 2024, and 2025 based on different funded status dates. The answer demonstrates understanding of the conceptual framework but fails on quantitative accuracy by introducing numbers not present in the ground truth, which is a fundamental error in financial analysis where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 413,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept embedded‑processing at the core of its strategy, but the segment’s financial trajectory was uneven: revenue rose only 3 % in 2023 before slipping 25 % in 2024, and operating‑profit margins fell from roughly 38 % (2023) to about 14 % (2024) as mix‑related cost pressures grew. This multi‑year consistency—maintaining the segment as a strategic pillar despite short‑term volatility—highlights that embedded processing remains a reliable, high‑margin source of cash that underpins the company’s long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent Texas Instruments' embedded processing strategy and financial performance. (1) CRITICAL QUANTITATIVE ERRORS: The LLM provides specific revenue and margin figures (3% revenue growth in 2023, 25% decline in 2024, 38% operating margins in 2023, 14% in 2024) that are NOT present in the ground truth and cannot be verified from the provided context. These appear to be fabricated numbers. The ground truth makes no mention of specific revenue percentages or operating margin figures for embedded processing. (2) MISALIGNMENT WITH GROUND TRUTH: The original answer emphasizes that embedded processing is a 'foundational pillar' and 'not a tactical shift,' highlighting strategic consistency and qualitative benefits ('more opportunity per customer,' 'supply chain control,' 'customer reach'). The LLM answer contradicts this by framing the segment as experiencing 'uneven' financial trajectory and 'short-term volatility,' which introduces a negative financial narrative not supported by the ground truth. (3) MULTI-HOP REASONING FAILURE: The question asks about strategic emphasis evolution and what consistency reveals about long-term cash flow growth. The ground truth correctly identifies that consistency across three years indicates embedded processing is foundational to long-term strategy. The LLM attempts to address this but does so by inventing financial metrics and creating a narrative of volatility that contradicts the ground truth's emphasis on strategic consistency. (4) SEMANTIC DIVERGENCE: While the LLM uses similar language ('core of strategy,' 'strategic pillar,' 'long-term free-cash-flow-per-share growth'), it fundamentally reframes the answer around financial volatility rather than strategic consistency, which is the core insight of the ground truth. The LLM's conclusion that embedded processing 'remains a reliable, high-margin source' contradicts its own invented data showing margin compression from 38% to 14%. This internal inconsistency further undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 559,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s IP strategy for its private‑brand suite—led by the Kobalt line—shifted from simply defending existing trademarks and patents to a deliberate portfolio balance that couples value‑oriented private labels with national power brands while deepening localization and rural‑market coverage.  At the same time, the company integrated these brands into its digital‑first omnichannel platform (e‑commerce, virtual design and sales tools, curb‑side and delivery fulfillment), using the same digital channels to promote and protect Kobalt and other private‑brand assets, and reinforced trademark, patent and domain‑name protections to safeguard the brand across all online and on‑site touch‑points.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to match the ground truth on multiple critical dimensions: (1) ENTITY ACCURACY FAILURE: The LLM introduces concepts not supported by the ground truth, including 'value-oriented private labels,' 'national power brands,' 'localization and rural-market coverage,' and 'virtual design and sales tools.' These are fabricated details not present in the original answer. (2) BRAND PORTFOLIO MISREPRESENTATION: The ground truth explicitly documents a specific evolution: fiscal 2022 included Kobalt, STAINMASTER, allen+roth, RONA, and Reno Depot; fiscal 2023 streamlined to only Kobalt, STAINMASTER, and allen+roth (removing RONA and Reno Depot); fiscal 2024 maintained the same three brands. The LLM answer completely fails to capture this documented portfolio evolution and the strategic shift from broader to narrower brand emphasis. (3) DIGITAL TRANSFORMATION CONTEXT: While the LLM correctly identifies digital transformation as part of the strategy, it invents specific digital initiatives (virtual design tools, curbside fulfillment, domain-name protections) that are not mentioned in the ground truth. The ground truth specifically mentions 'remote customer support and mobile checkout' as the digital elements, which the LLM omits. (4) MULTI-HOP REASONING FAILURE: The LLM fails to synthesize the key insight from the ground truth—that the removal of RONA and Reno Depot from IP disclosures represents a strategic refocusing, not an expansion. Instead, the LLM invents a narrative about 'portfolio balance' and 'localization' that contradicts the documented streamlining. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral, but the LLM's invented details represent a form of false specificity. The answer demonstrates hallucination of supporting details rather than accurate synthesis of the documented IP strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 531,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s annual reports moved the notion of client relationships and trust from a peripheral risk factor to a central competitive advantage.  In the 2022 filing trust was cited mainly as a vulnerability (“Damage to IBM’s reputation could impact the business”), whereas the 2023 and 2024 filings explicitly list “client relationships and trust” among the firm’s principal methods of competition and tie that trust directly to its hybrid‑cloud and AI platform, ecosystem of partners, and ability to deliver business value.  This multi‑year progression shows IBM is positioning itself as a trusted partner that can guide clients through complex cloud‑and‑AI transformations, differentiating its offering on the basis of reliability and long‑term relationship depth rather than solely on technology or price.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022-2024 timeframe and the evolution of trust from a peripheral concern to a central competitive advantage. (2) The characterization of 2022 as focusing on trust as a vulnerability/risk factor is a valid interpretation, though the ground truth frames it differently (as part of hybrid cloud/AI platform integration). (3) The LLM correctly notes that 2023-2024 filings explicitly position client relationships and trust as principal competitive methods. (4) The connection to hybrid cloud, AI platforms, and partner ecosystems is accurate. (5) No quantitative errors in dates or numbers (all years cited correctly). WEAKNESSES: (1) The LLM's framing of 2022 trust as primarily a 'vulnerability' or 'risk factor' differs significantly from the ground truth, which emphasizes trust as a positive differentiator tied to industry expertise and secure platforms. This represents a different interpretation of the same data. (2) The LLM does not specifically mention the evolution of strategic partnerships (AWS, Microsoft, SAP in 2023, and Palo Alto Networks in 2024), which the ground truth identifies as a key element of the strategic progression. (3) The LLM misses the specific insight about cybersecurity-focused partners being added to the alliance list in 2024, which the ground truth identifies as indicating growing emphasis on security as a trust component. (4) The LLM's conclusion about 'reliability and long-term relationship depth rather than solely on technology or price' is reasonable but less precise than the ground truth's observation about data governance and digital transformation alignment. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects trust positioning to competitive strategy, but it misses the specific partner ecosystem evolution that the ground truth identifies as central to understanding the strategic progression. The reasoning is sound but incomplete in capturing the full scope of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 545,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s El Segundo, California site was repeatedly described as the company’s “clinical and commercial manufacturing and processing” hub for cell‑therapy products.  Initially the facility was used to produce clinical‑grade material for Kite’s CAR‑T candidates, but by 2023‑2024 it was also supplying commercial batches of approved therapies such as Yescarta and Tecartus and supporting later‑stage pipeline products, indicating a shift from early‑stage clinical production to a full‑scale, multi‑product commercial manufacturing role.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a significant factual error that directly contradicts the ground truth. The original answer clearly states that the El Segundo facility's role 'remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities' and that there was 'continuity in Gilead's strategic use of El Segundo for cell therapy manufacturing.' However, the LLM answer claims there was 'a shift from early-stage clinical production to a full-scale, multi-product commercial manufacturing role' by 2023-2024, suggesting an evolution or expansion of responsibilities. This is a fundamental mischaracterization of the facility's trajectory. The LLM correctly identifies that the facility was used for 'clinical and commercial manufacturing and processing' and correctly names specific products (Yescarta and Tecartus), but it incorrectly interprets this as evidence of a shift or expansion rather than consistency. The LLM also correctly identifies the facility's location (El Segundo, California) and the time period (2022-2024). The core error is in the reasoning and interpretation: the LLM inferred a narrative of change and expansion where the ground truth explicitly documents stability and consistency. This represents a failure in multi-hop reasoning and synthesis, as the LLM appears to have misinterpreted the presence of commercial products as evidence of a transition, when in fact the facility was already serving both clinical and commercial roles from 2022 onward. The answer is partially relevant to the question but fundamentally incorrect in its main conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 448,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s did not issue any new 4.550 % notes; the only 4.550 % tranche remains the series originally sold in the 2019 Fifteenth Supplemental Indenture (maturing April 5 2049).  Instead, the company added three supplemental indentures (the 20th – Sept 2022, 21st – Mar 2023 and 22nd – Mar 2023) that introduced fresh senior unsecured notes with staggered maturities (2025‑2063) and coupons ranging from 3.35 % to 5.85 %.  This multi‑year pattern shows Lowe’s is building a laddered, long‑dated debt profile—extending average maturity and diversifying funding—rather than repeatedly rolling or expanding the original 4.550 % issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially more detailed and accurate information than the ground truth answer. Key strengths: (1) Correctly identifies that the 4.550% Notes due April 5, 2049 were issued under the Fifteenth Supplemental Indenture dated April 5, 2019 and remained unchanged across 2022-2024; (2) Accurately identifies three new supplemental indentures (20th-Sept 2022, 21st-Mar 2023, 22nd-Mar 2023) with correct dates; (3) Correctly specifies the coupon range (3.35%-5.85%) and maturity range (2025-2063) for new notes; (4) Provides sound multi-hop reasoning about Lowe's debt strategy, correctly synthesizing that the company pursued a laddered debt approach rather than expanding the original 4.550% tranche. Quantitative accuracy is high - all dates, percentages, and maturity years are verifiable and correct. The reasoning about capital structure strategy (avoiding refinancing risk, extending maturities, diversifying funding) is logically sound and well-supported by the facts presented. Minor consideration: The ground truth answer is somewhat vague and less informative than the LLM answer, which actually provides superior detail about the company's actual debt issuance pattern. The LLM answer goes beyond the ground truth by explaining what Lowe's actually did (issued new tranches) rather than just noting the consistency of the 4.550% Notes. This represents more complete and useful analysis of the multi-year pattern requested in the question. No factual errors detected in the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 418,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the exposure tied to 3M’s Scotchgard PFAS products moved from a scattered docket of state‑AG and private contamination suits to a single, court‑approved settlement that will cost the company $10.5 billion‑$12.5 billion (a $10.3 bn pre‑tax charge was recorded in Q2 2023).  The settlement, finalized in early 2024 after preliminary approval in 2023, resolves most public‑water claims and many other PFAS actions and commits 3M to multi‑year payments through 2036.  This evolution shows that PFAS‑related litigation has become a multi‑billion‑dollar financial drag on 3M, forcing the company to set aside large reserves and reshaping its earnings outlook.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM introduces a $10.5-12.5 billion settlement figure with a $10.3 billion Q2 2023 charge that does not appear in the ground truth. The ground truth specifically mentions a $65 million settlement in 2022 (with Saint-Gobain and Honeywell), a non-material settlement in Michigan in 2023, and a $65 million settlement in New York finalized in 2024. The LLM's multi-billion dollar figures are not supported by the ground truth data. (2) COMPLETENESS FAILURE: The ground truth describes an evolution across 2022-2024 with specific cases, jurisdictions, and settlement amounts. The LLM collapses this into a single 'court-approved settlement' narrative that doesn't match the ground truth's description of multiple, ongoing litigations across different states (New York, Michigan, Illinois, Canada, Alabama, Georgia). The ground truth explicitly states litigation 'expanded further' and had 'trial dates set for 2026,' indicating ongoing exposure, not resolution. (3) ENTITY/TIMELINE ACCURACY: The LLM claims the settlement was 'finalized in early 2024 after preliminary approval in 2023,' but the ground truth shows the $65 million New York settlement being 'finalized' in 2024 while Alabama litigation remained active with future trial dates. The LLM mischaracterizes the scope and status of litigation. (4) REASONING QUALITY: The LLM's synthesis is fundamentally flawed—it presents a consolidated settlement narrative when the ground truth shows expanding, fragmented litigation across multiple jurisdictions. The LLM's conclusion about 'most public-water claims' being resolved contradicts the ground truth's emphasis on escalating geographic spread and case complexity. (5) SEMANTIC MISMATCH: While the LLM correctly identifies PFAS litigation as a financial burden, it does so with entirely different numbers and a different legal structure than what the ground truth documents. The answer appears to reference a different, larger settlement framework not present in the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 571,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 the Foster City, California campus shifted from a primarily early‑stage chemistry and analytical‑development hub to a central source of API for both clinical and commercial batches of newly approved products (e.g., Livdelzi, Trodelvy, Biktarvy, Vemlidy) and for the company’s expanding cell‑therapy pipeline.  This evolution tied the site into Gilead’s global manufacturing network—linking its proprietary process‑chemistry and formulation expertise with scale‑up and commercial production at other worldwide facilities (Ireland, Canada, the Netherlands, etc.)—so that R&D output at Foster City could be rapidly translated into global supply for Gilead’s worldwide operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF EVOLUTION: The LLM claims Foster City shifted from 'early-stage chemistry and analytical-development hub' to 'a central source of API for both clinical and commercial batches,' but the ground truth indicates the opposite trajectory—Foster City became MORE focused on early-stage development and clinical manufacturing (not commercial-scale production). The ground truth explicitly states other locations like La Verne, Oceanside, and international sites handled commercial-scale manufacturing. (2) PRODUCT EXAMPLES UNSUPPORTED: The LLM lists specific products (Livdelzi, Trodelvy, Biktarvy, Vemlidy) as being manufactured at Foster City for 'clinical and commercial batches,' but the ground truth makes no mention of these specific products or confirms commercial-scale manufacturing at Foster City. This appears to be fabricated detail. (3) MISALIGNMENT WITH GROUND TRUTH SCOPE: The ground truth emphasizes Foster City's role in 'process chemistry research, analytical method development, formulation, device development, and manufacturing of API and drug product for CLINICAL TRIALS' (emphasis on clinical, not commercial). The LLM's claim about 'commercial batches' directly contradicts this. (4) GEOGRAPHIC NETWORK DESCRIPTION: While the LLM correctly identifies international facilities (Ireland, Canada, Netherlands), it misrepresents Foster City's role within that network. The ground truth indicates Foster City is the R&D/clinical hub, while other sites handle commercial production—the LLM reverses this relationship. (5) CELL-THERAPY PIPELINE: The LLM mentions 'expanding cell-therapy pipeline' without ground truth support. (6) TEMPORAL PROGRESSION: The ground truth shows a clear 2022→2023-2024 shift toward more specific definition of Foster City's role; the LLM's characterization of this shift is fundamentally inverted. The answer demonstrates poor multi-hop synthesis and appears to contain speculative or fabricated details not supported by the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 573,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nFrom 2022 through 2024 AIG strengthened its loss‑reserve oversight by instituting a formal three‑tiered limit hierarchy and embedding ERM‑driven risk‑committees, second‑line challenge and internal‑audit reviews into the reserve‑setting process.  Its modeling evolved from deterministic reserve estimates to sophisticated stochastic PML frameworks that incorporate climate‑change adjustments and third‑party catastrophe models, with explicit external validation of those models.  Consequently, AIG began routinely integrating outside expertise—independent catastrophe‑model vendors, external actuaries and reinsurer credit reviews—into both the development and challenge of loss‑reserve assumptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT supported by the ground truth: 'formal three-tiered limit hierarchy,' 'stochastic PML frameworks,' 'climate-change adjustments,' 'third-party catastrophe models,' and 'reinsurer credit reviews.' These details are fabricated and not present in the original answer. (2) QUANTITATIVE ACCURACY FAILURE - No numbers, dates, or metrics are provided in either answer, so quantitative comparison is limited, but the LLM's introduction of unsupported technical terminology (PML, stochastic frameworks, climate adjustments) suggests hallucination rather than faithful synthesis. (3) PARTIAL ALIGNMENT - The LLM correctly identifies: (a) evolution from 2022-2024, (b) integration of external reviews, (c) second-line review/challenge mechanisms, (d) ERM framework integration, and (e) movement toward more sophisticated approaches. However, these correct elements are mixed with fabricated specifics. (4) MULTI-HOP REASONING - The LLM fails to accurately synthesize the ground truth's key progression: from 2022 (uncertainty + internal/external reviews) → 2023 (sensitivity, scenario, stochastic methods, experience studies) → 2024 (ERM integration, second-line review, enhanced reporting). Instead, the LLM conflates these into a single narrative with invented details. (5) SEMANTIC DIVERGENCE - While both answers discuss evolution and sophistication, the LLM's specific claims about 'PML frameworks,' 'climate-change adjustments,' and 'catastrophe models' are not mentioned in the ground truth and represent either hallucination or confusion with other companies' practices. The ground truth emphasizes 'sensitivity and scenario analyses' and 'stochastic methods' more generally, not specific PML or climate frameworks. VERDICT: The answer contains some correct directional elements but is significantly compromised by fabricated technical details that do not appear in the source material, indicating the model generated plausible-sounding but unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 551,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nFrom 2022 through 2024 the property tables in TI’s 10‑K filings consistently placed **Melaka, Malaysia in the “Analog” column only**, never under “Embedded Processing.”  The site’s designation remained unchanged across the three years, and the overall growth in overseas square‑footage (e.g., rising from ~10 M ft² in 2021 to >12 M ft² by 2024) shows that the Melaka facility was being expanded or maintained as part of TI’s analog‑chip manufacturing network.  Consequently, the three‑year progression underscores that TI’s regional footprint in Malaysia is strategically focused on analog semiconductor production rather than embedded‑processing devices.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Melaka, Malaysia remained exclusively in the Analog column from 2022-2024 with no expansion into Embedded Processing, matching the ground truth. The reasoning is sound and well-synthesized across the multi-year period. However, there is a quantitative accuracy issue: the LLM cites specific square footage figures (~10M ft² in 2021 rising to >12M ft² by 2024) that are not present in the ground truth answer and cannot be verified against it. While these numbers may be accurate from the actual 10-K filings, they represent additional claims beyond what the ground truth confirms. The LLM appropriately qualifies the growth claim with 'e.g.' and 'rising from' language, suggesting these are illustrative examples rather than definitive statements. The semantic equivalence is strong - both answers convey that Melaka maintained a stable, specialized Analog-only focus. The multi-hop synthesis is correct: the LLM properly connected the property table designations across three years to the broader strategic implication about TI's regional manufacturing focus. The main weakness is the introduction of unverified quantitative details about overall overseas square footage, which, while potentially accurate, goes beyond the ground truth's scope and introduces minor quantitative uncertainty. The answer would score higher if it stuck to verifiable facts from the ground truth or clearly labeled additional details as supplementary context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 413,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nFrom FY 2022 through FY 2024 Lowe’s forward‑interest‑rate swap exposure contracted sharply: the company carried a $2.56 billion notional cash‑flow hedge at the end of FY 2022, and the fair‑value of those swaps fell from a $251 million asset (recorded as of Feb 3 2023) to essentially $0 by the end of FY 2024.  This reduction shows that the swaps were used to lock in rates for anticipated bond issuances and were unwound or rolled as those debt financings were executed, indicating a deliberate, timing‑matched hedging strategy that eliminates the derivative position once the forecasted debt is issued.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses: STRENGTHS: (1) Correctly identifies the $251 million fair value of forward interest rate swaps as of Feb 3, 2023 (FY 2023), matching the ground truth exactly. (2) Accurately captures the strategic shift from hedging forecasted debt issuances to managing existing debt. (3) Correctly notes that forward swaps were eliminated/unwound by FY 2024. (4) Provides sound reasoning about timing-matched hedging strategy. (5) Appropriately addresses the multi-hop question about evolution across three fiscal years. WEAKNESSES: (1) CRITICAL ERROR - Introduces a $2.56 billion notional cash-flow hedge figure for FY 2022 that is NOT mentioned in the ground truth and cannot be verified. This is a significant quantitative claim without supporting evidence. (2) States fair value 'fell from $251 million...to essentially $0' but the ground truth indicates the $251 million figure is from FY 2023 (Feb 3, 2023), not FY 2022. The LLM conflates the timeline. (3) Missing important context from ground truth: the FY 2022 disclosure referenced 'impact on other comprehensive income and earnings' and historical hedging activity from 2019-2021, which the LLM omits. (4) Does not explicitly mention the shift to 'fixed-to-floating interest rate swaps as fair value hedges' that the ground truth identifies as the replacement strategy. CALCULATION/VERIFICATION: The $2.56 billion notional amount cannot be verified against the ground truth and appears to be either fabricated or from a source not reflected in the knowledge graph. This is a material factual error. The $251 million figure is correct but misplaced temporally in the LLM's narrative. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year progression and identifies the strategic shift, but the introduction of unverified quantitative data undermines the analysis. The reasoning about 'timing-matched hedging' is sound and well-articulated, but built partially on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 547,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings IBM continues to list the 6.50 % Debentures due 2028 as **Exhibit 2 to the Form 8‑K filed on January 8 1998**, incorporating that same exhibit by reference each year without alteration. The unchanged filing date and exhibit number show that the debenture’s governing indenture has remained the same since its original 1998 filing, indicating a stable, long‑term debt structure that IBM simply re‑references in its periodic reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about IBM's 6.50% Debentures due 2028 across three years of filings. QUANTITATIVE ACCURACY: All numeric values are correct—the debenture rate (6.50%), maturity year (2028), and the filing date (January 8, 1998) are all accurately stated. The exhibit reference (Exhibit 2 to Form 8-K) is also correct. COMPLETENESS: The answer addresses all key aspects of the question: (1) the consistency of disclosure across 2022, 2023, and 2024, (2) the specific exhibit and filing date referenced, and (3) what this consistency reveals about the debt instrument's structure. ENTITY ACCURACY: IBM is correctly identified, the debenture specifications are accurate, and the time periods (2022, 2023, 2024) are properly referenced. REASONING: The multi-hop synthesis is sound—the model correctly identified that the same exhibit reference across three years indicates unchanged documentation and stable debt structure. The logical conclusion that this reflects no material amendments or refinancing activity is well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, using slightly different phrasing ('incorporating that same exhibit by reference each year without alteration' vs. 'consistently referenced') but maintaining identical factual content. Minor stylistic differences (spacing in 'January 8 1998' vs. 'January 8, 1998') do not affect accuracy. The answer demonstrates strong understanding of the multi-hop nature of the question and successfully synthesizes information across multiple filing years to reach the correct conclusion about long-term debt structure stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 465,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nReflective signage was first listed as one of the product offerings within 3M’s **Transportation and Electronics** segment in the 2022 and 2023 10‑K filings (e.g., “Reflective signage for highway and vehicle safety” under the segment’s product description).  In the 2024 filing the company reorganized that segment, creating a dedicated **Commercial Branding and Transportation** division that explicitly incorporates the reflective‑signage business, moving it out of the generic Transportation and Electronics group and giving it its own reporting line.  This progression—from a peripheral product line to a stand‑alone division—indicates that 3M now treats reflective signage as a strategically important, high‑growth component of its portfolio, warranting separate management focus and resources.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) POSITIONING DATA: The ground truth provides specific positional rankings (5th in 2022, 4th in 2023, 4th in 2024) showing how Reflective Signage moved within the product list. The LLM answer completely ignores these positional details and instead claims Reflective Signage was moved to a 'dedicated Commercial Branding and Transportation division' in 2024. This is factually wrong—the ground truth explicitly states it remained in the Transportation and Electronics segment in the fourth position in 2024. (2) STRUCTURAL CHANGES: The LLM invents a reorganization that doesn't match the ground truth. The ground truth shows Reflective Signage staying within the same segment across all three years with only positional shifts within that segment's product list. The LLM's claim about creating a 'separate reporting line' and 'stand-alone division' is not supported by the ground truth and appears to be a hallucination. (3) STRATEGIC INTERPRETATION: While both answers attempt to interpret strategic importance, they reach different conclusions based on different (incorrect in LLM's case) factual premises. The ground truth's interpretation of 'consistent placement in top half' and 'slight early boost in prominence' is based on actual positional data. The LLM's interpretation of 'peripheral to stand-alone division' is based on a false structural reorganization. (4) MULTI-HOP SYNTHESIS: The question requires synthesizing positioning data across three years. The LLM failed to identify or synthesize the actual positional progression and instead fabricated a different narrative about organizational restructuring. (5) COMPLETENESS: The ground truth addresses the specific evolution of positioning across all three years with concrete rankings. The LLM provides no positional data whatsoever and instead discusses a non-existent reorganization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 528,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Hoofddorp, Netherlands site from an early‑stage production location to a fully integrated commercial cell‑therapy manufacturing hub.  The 2022 10‑K first listed Hoofddorp as a principal manufacturing facility for cell‑therapy products, and each subsequent filing (2023 and 2024 10‑Ks) reiterated that the plant is used for “commercial manufacturing and processing of our cell‑therapy products,” reflecting a scaling of capacity and a broader product mix (e.g., Yescarta, Tecartus) that now makes the site a strategic cornerstone of Gilead’s European commercial output.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information about Hoofddorp's evolution from 2022-2024. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and the progression of the facility's role; (2) Accurately captures the core narrative that Hoofddorp evolved from a principal manufacturing facility to a dedicated commercial cell therapy hub; (3) Correctly references the facility's use for 'commercial manufacturing and processing of cell-therapy products' across the 2023-2024 period; (4) Appropriately adds specific product examples (Yescarta, Tecartus) that demonstrate understanding of Gilead's cell therapy portfolio; (5) Properly synthesizes the strategic importance across multiple filings. MINOR CONSIDERATIONS: (1) The LLM characterizes 2022 as 'early-stage production' while the ground truth simply states it was identified as a 'principal manufacturing facility' - this is a slight interpretive addition not explicitly stated in the ground truth, though it's a reasonable inference about the progression; (2) The LLM adds contextual detail about 'European commercial output' which, while logical and likely accurate, goes slightly beyond what the ground truth explicitly states; (3) The phrase 'fully integrated commercial cell-therapy manufacturing hub' is the LLM's characterization rather than direct ground truth language, though semantically equivalent to the ground truth's description of 'key facility for commercial cell therapy manufacturing.' QUANTITATIVE ACCURACY: All dates and years are correct (2022, 2023, 2024). No numerical calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings to show progression and strategic importance. The logic flow is sound and demonstrates proper understanding of how the facility's role evolved. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - that Hoofddorp became increasingly important for cell therapy manufacturing - though with slightly more interpretive framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 568,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nThe share reserve under the 2003 Director Compensation Plan slipped from roughly 1.79 million shares at the end of 2022 to about 1.75 million shares by the end of 2023 and remained essentially flat through 2024. This modest decline shows that Texas Instruments continues to award shares to directors under the plan, but the company must periodically amend the plan to restore the reserve, underscoring its ongoing reliance on the plan for director compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant inaccuracies in the specific share numbers. Ground truth shows: 2022: 1,843,134 shares; 2023: 1,786,785 shares; 2024: 1,745,284 shares. The LLM states 'roughly 1.79 million shares at the end of 2022' which is incorrect (should be 1.843 million). The LLM also states shares 'remained essentially flat through 2024,' which directly contradicts the ground truth showing a continued decline from 1,786,785 (2023) to 1,745,284 (2024) - a decrease of 41,501 shares. This is a material error in describing the trend. CALCULATION ERRORS: The LLM failed to accurately track the year-over-year declines: 2022-2023 decline was 56,349 shares; 2023-2024 decline was 41,501 shares. The characterization of 'remained essentially flat' is factually wrong. REASONING ISSUES: While the LLM correctly identifies that the plan is being actively used and mentions the need for periodic amendments, it fundamentally mischaracterizes the 2024 data as flat rather than continuing the downward trend. The multi-hop synthesis is incomplete - the LLM should have tracked all three years' specific numbers and identified the consistent year-over-year decline pattern. POSITIVE ASPECTS: The LLM correctly identifies the company (Texas Instruments), the plan (2003 Director Compensation Plan), and the general concept that shares are being actively used for director compensation. The mention of periodic amendments is a reasonable inference, though not explicitly stated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 420,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nFrom 2022 through 2023 IBM’s 10‑K filings only incorporated by reference the 2017 Form 8‑K that defined the rights of the 0.950% Notes due 2025, offering no separate, detailed disclosure of the issue’s terms or market identifiers. In the 2024 filing the company added the notes to the “Securities Registered Pursuant to Section 12(b)” table, assigning them the ticker IBM25B and listing them on the NYSE, thereby explicitly revealing the instrument, its exchange venue and ticker. This shift—from indirect incorporation to full, market‑visible disclosure—reflects a broader capital‑market strategy of increasing transparency and simplifying investor access to IBM’s debt securities, underscoring a more proactive and investor‑friendly approach to financing communications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates are correct (2022, 2023, 2024; May 22, 2017 Form 8-K reference). The ticker symbol IBM25B is accurately cited. The percentage rate 0.950% and maturity year 2025 are correct. No calculations are required or present, and all numeric references are accurate. QUALITATIVE ACCURACY (9/10): The multi-hop reasoning is sound and well-synthesized. The LLM correctly identifies the three-year progression: (1) 2022-2023: incorporation by reference to 2017 Form 8-K with limited disclosure, (2) 2024: addition to Section 12(b) table with explicit ticker and exchange listing. The characterization of this as a shift from 'indirect incorporation to full, market-visible disclosure' accurately captures the evolution described in the ground truth. The LLM properly synthesizes the strategic implications—increased transparency, investor accessibility, and proactive financing communications. Minor note: The LLM uses slightly different phrasing ('Securities Registered Pursuant to Section 12(b)' table vs. ground truth's 'explicitly listed with a dedicated trading symbol'), but this is semantically equivalent and reflects accurate understanding of the regulatory mechanism. CONTEXTUAL RELEVANCE (9/10): The answer directly addresses all aspects of the multi-part question: (1) treatment evolution across years, (2) market transparency progression, (3) broader capital market strategy implications, and (4) investor engagement approach. The response appropriately contextualizes the findings within IBM's strategic objectives. COMPLETENESS: The answer covers the full 2022-2024 timeline and synthesizes information across multiple filing years as required by the multi-hop nature of the question. The only minor gap is that the ground truth mentions 2023 as a transitional year with 'increased prominence' and 'listing alongside newer instruments,' while the LLM groups 2022-2023 together as a single phase. However, this does not materially affect the accuracy of the core narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 566,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑method balances steadily contracted: the “deposit assets on reinsurance” shown in the 2023‑2024 balance‑sheet tables fell from **$5.1 bn (2023) to $4.6 bn (2024)**, while the related “deposit liabilities on reinsurance” declined from **$1.3 bn to $1.2 bn**, indicating that the company was using the deposit accounting technique less intensively in its traditional reinsurance program.  \n\nThe November 2023 risk‑transfer with Global Atlantic marked a strategic shift—MetLife moved a large block of universal‑life and annuity liabilities into a **modified‑coinsurance arrangement that is accounted for under the deposit method**, recording a **$10.3 bn deposit receivable** and a **$770 m net cost of reinsurance**, and then offsetting the deposit with the recoverable.  This transaction converted a portion of its reinsurance coverage into a capital‑efficient, cash‑generating structure rather than a conventional reinsurance purchase, signalling a deliberate re‑design of its reinsurance strategy to manage risk and capital more directly.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023-2024 trend (deposit assets declining from $5.1bn to $4.6bn, liabilities from $1.3bn to $1.2bn), accurately cites the $10.3bn deposit receivable from the Global Atlantic transaction, and provides sound qualitative reasoning about the strategic shift toward modified-coinsurance arrangements and capital-efficient structures. The multi-hop synthesis connecting the transaction to the broader accounting evolution is logical and well-articulated.\n\nCRITICAL ERRORS: (1) The LLM completely omits 2022 baseline data ($1.8bn deposit assets, $1.4bn liabilities), which is essential for understanding the 'evolution from 2022 through 2024' as explicitly requested. This is a significant omission that undermines the completeness of the answer. (2) The LLM introduces a '$770m net cost of reinsurance' figure that does not appear in the ground truth answer and cannot be verified. This represents an unsourced quantitative claim. (3) The LLM's characterization of the 2023-2024 period as 'steadily contracted' is misleading—the actual evolution shows a dramatic INCREASE from 2022 to 2023 ($1.8bn to $5.1bn), followed by a modest decrease to 2024. The LLM's framing obscures this critical inflection point.\n\nMULTI-HOP REASONING: The LLM demonstrates good synthesis of the Global Atlantic transaction details and its relationship to the deposit method accounting approach. However, the failure to incorporate 2022 data breaks the three-year comparative analysis that the question explicitly requests.\n\nQUANTITATIVE VERIFICATION: Core 2023-2024 numbers are correct ($5.1bn→$4.6bn assets; $1.3bn→$1.2bn liabilities; $10.3bn deposit receivable). The $770m figure is unverified and problematic. The omission of 2022 figures represents incomplete quantitative coverage.\n\nJUSTIFICATION: While the LLM provides accurate data for the 2023-2024 period and sound strategic analysis, the omission of 2022 baseline data is a material gap for a question explicitly asking about evolution 'from 2022 through 2024.' The introduction of an unverified $770m figure adds another accuracy concern. These issues prevent a higher score despite otherwise solid qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 590,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the company kept fall‑protection equipment (harnesses, lanyards, anchor points, etc.) inside its Safety & Industrial segment, but in early 2024 it reshaped that segment by creating an **Industrial Specialties** division that consolidates fall‑protection products with other specialty safety lines such as adhesives and personal‑safety items (see page 108, page 110 and page 131).  This reorganization, together with the segment’s operating‑income growth from $1.1 B (2021) to $2.5 B (2023) and higher asset investment, demonstrates that 3M is deliberately expanding and prioritizing workplace‑safety solutions as a core growth pillar.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) STRUCTURAL CLAIM ERROR: The LLM claims that in 'early 2024' 3M 'reshaped that segment by creating an Industrial Specialties division' that consolidates fall-protection products. The ground truth indicates no such reorganization occurred - fall protection remained consistently listed as part of 'respiratory, hearing, eye and fall protection solutions' across all three years (2022-2024) with only minor phrasing adjustments. (2) QUANTITATIVE ERRORS: The LLM cites operating income growth from '$1.1B (2021) to $2.5B (2023)' but provides no verification these numbers are correct, and more critically, these figures are not mentioned in the ground truth answer at all. The ground truth focuses on product portfolio consistency, not financial metrics. (3) MULTI-HOP REASONING FAILURE: The LLM fundamentally misunderstands the question's focus. The question asks about portfolio evolution and what the 3-year progression indicates. The ground truth correctly identifies that the progression shows CONSISTENCY and STABILITY in fall protection positioning. The LLM invents a narrative about reorganization and divisional restructuring that contradicts the actual finding of consistency. (4) CITATION ISSUES: The LLM references specific pages (108, 110, 131) without verification that these support the claimed reorganization. (5) SEMANTIC MISMATCH: The ground truth emphasizes 'stable strategic focus' and 'consistency,' while the LLM emphasizes 'reshaping' and 'reorganization' - these are contradictory interpretations. The LLM appears to have fabricated details about an Industrial Specialties division and structural changes that are not supported by the ground truth knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 491,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nFrom 2022 through 2024 Altria kept UST as a wholly‑owned subsidiary, but its role evolved: in 2022 it solely marketed moist smokeless tobacco, in 2023 a joint‑venture for heated tobacco was created and oral‑nicotine‑pouch maker Helix was added to the oral‑tobacco segment, and in 2024 Altria sold the U.S. IQOS rights and narrowed its focus to UST’s MST and Helix’s pouches. This shift demonstrates Altria’s strategic pivot toward oral‑nicotine products as the core of its smoke‑free portfolio, using UST as the central platform.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM mentions a 2023 joint venture for heated tobacco and the addition of Helix to the oral-tobacco segment, but the ground truth makes no mention of these developments in 2023. The ground truth only references UST's MST and snus products through 2023, with no mention of Helix acquisition timing. The LLM also claims Altria sold U.S. IQOS rights in 2024, which is not mentioned in the ground truth. (2) MISSING KEY INFORMATION: The ground truth specifically mentions the $8.8 billion valuation of UST trademarks in 2022 and amortization expenses, which the LLM completely omits. The ground truth emphasizes the 'Moving Beyond Smoking' initiative in 2024, which the LLM does not reference. (3) ENTITY ACCURACY ISSUES: While the LLM correctly identifies UST as wholly-owned and mentions MST products, it introduces Helix and IQOS transactions without ground truth support. The timing and nature of these strategic moves appear to be fabricated or misattributed. (4) REASONING QUALITY: The LLM's narrative about a strategic pivot toward oral-nicotine products is partially aligned with the ground truth's 'reduced-risk tobacco offerings' concept, but the specific transactions cited (2023 joint venture, Helix addition, 2024 IQOS sale) are not validated by the ground truth and represent a different strategic narrative. (5) SYNTHESIS FAILURE: The LLM failed to properly synthesize the multi-hop information about how UST's role evolved from a trademark-valued subsidiary (2022) to a core operating company (2024) under the 'Moving Beyond Smoking' initiative. Instead, it created a different evolution narrative centered on product portfolio changes that lack ground truth support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 497,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nThe repeated citation of the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 in Tesla’s 2022‑2024 Form 10‑K filings shows that the company continues to treat this securitized debt as a core element of its solar‑energy financing. By referencing the same indenture across three consecutive years, Tesla signals that it views the bond program as a stable, long‑term source of capital to fund and support its solar projects, and that it plans to rely on similar structured‑financing arrangements for future solar initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key bond details (SolarCity 5.45% Solar Bonds, Series 2015/C92-15) and accurately conveys the core insight that Tesla's repeated references across 2022-2024 filings indicate sustained reliance on securitized solar financing. All numeric values (5.45%, the bond series designation) are correct. The reasoning about long-term financing strategy and structured debt is sound and semantically equivalent to the ground truth. However, the LLM answer omits some specific contextual details present in the original: (1) it does not mention the specific indenture date (August 24, 2015) or the reference to the 'One Hundred-and-Sixteenth Supplemental Indenture,' which adds documentary precision; (2) it does not explicitly note that the bond's continued performance and alignment with Tesla's clean energy business model are factors supporting the strategy. The LLM's characterization of the bonds as 'stable, long-term source of capital' and 'core element of solar-energy financing' captures the essential meaning but lacks the granular detail about the specific legal instruments and performance confidence mentioned in the ground truth. The multi-hop synthesis across three years (2022, 2023, 2024) is correctly executed. Overall, the answer is substantially correct in its core claims but moderately incomplete in supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 381,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings IBM repeatedly warns that “governmental and stock‑exchange regulations” can affect the marketability, pricing and liquidity of both its debt and equity securities, and that any change in listing requirements or trading rules may impair its ability to raise capital. The consistent emphasis over the three years shows that IBM’s capital‑market risk strategy is built on continuous regulatory monitoring, diversification of financing sources and maintaining strong credit ratings to offset the impact of unforeseen exchange‑regulatory shifts.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer fundamentally misrepresents IBM's capital market risk management strategy. The ground truth explicitly states 'no material reduction in dependency or mitigation strategy over the three-year period,' indicating IBM did NOT successfully develop or implement meaningful mitigation strategies. The LLM claims IBM's strategy is 'built on continuous regulatory monitoring, diversification of financing sources and maintaining strong credit ratings' - these are speculative assertions NOT supported by the ground truth, which indicates regulatory exposure remained unmitigated. (2) The LLM answer inverts the key finding: the ground truth shows IBM's exposure remained persistent and systemic with no reduction, while the LLM suggests proactive management strategies that the filings do not support. (3) MULTI-HOP REASONING FAILURE: The question asks what the progression 'reveals about its capital market risk management strategy.' The ground truth reveals a lack of effective strategy (persistent exposure, no mitigation), but the LLM invents a positive strategy narrative. (4) PARTIAL ACCURACY: The LLM correctly identifies that IBM mentioned stock exchange regulations across all three years (2022-2024) and that these affect debt/equity securities, marketability, pricing, and liquidity. The reference to 'governmental and stock-exchange regulations' is accurate. (5) MISSING KEY INSIGHT: The LLM fails to capture the critical evolution described in the ground truth - that by 2024, IBM 'expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view.' The LLM does not distinguish the 2024 expansion or integration of risks. (6) UNSUPPORTED CLAIMS: The specific strategies mentioned (diversification, credit ratings) are not grounded in the filing evidence presented in the ground truth. The answer reads as generic risk management platitudes rather than evidence-based synthesis. QUANTITATIVE: No specific numbers were required or provided in either answer, so this scores high for consistency. QUALITATIVE: Major failure in reasoning - the LLM fundamentally misunderstands what the multi-year progression reveals about IBM's strategy effectiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 603,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nMMM’s electrical‑products‑for‑construction‑and‑maintenance line has been housed in the Safety & Industrial segment for all three years.  Net sales for that segment were roughly $11.6 bn in 2022 and held steady at about $11 bn in 2023‑2024, while operating income jumped from $1.1 bn in 2022 to $2.5 bn in 2024, and in 2024 the company created an “Industrial Specialties” division (within Safety & Industrial) to sharpen its focus on those markets.  This multi‑year progression shows 3M is deliberately consolidating and investing in its industrial‑maintenance portfolio, signaling a strategic shift toward higher‑margin industrial and construction‑related markets and away from slower‑growth health‑care and consumer businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM provides specific financial figures ($11.6bn in 2022, $11bn in 2023-2024, $1.1bn operating income in 2022, $2.5bn in 2024) that are NOT mentioned in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and appear to be fabricated or hallucinated. (2) STRUCTURAL MISREPRESENTATION: The ground truth explicitly states that MMM 'consistently listed' electrical products across all three years with evolving descriptions of complementary product lines. The LLM incorrectly claims MMM 'created an Industrial Specialties division (within Safety & Industrial)' in 2024 - this specific organizational claim is not supported by the ground truth. (3) INCOMPLETE SYNTHESIS: The ground truth details specific product line evolution (closure systems/masking/packaging in 2022; addition of abrasives/autobody repair in 2023; rephrasing in 2024). The LLM completely omits these nuanced changes and instead focuses on financial metrics and a divisional restructuring claim. (4) REASONING FLAW: The LLM's conclusion about 'strategic shift toward higher-margin industrial and construction-related markets and away from slower-growth health-care and consumer businesses' is an inference not supported by the ground truth, which focuses on product portfolio evolution within the Safety and Industrial segment. (5) MISSING CORE CONTENT: The LLM fails to address the actual multi-year progression of product descriptions that the ground truth emphasizes. The question asks about evolution of focus on electrical products - the ground truth answers this by tracking how electrical products remained core while complementary offerings shifted. The LLM instead pivots to financial performance and organizational structure. The answer demonstrates poor multi-hop synthesis and introduces unsupported quantitative claims that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 545,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the Oceanside, California site from a primarily clinical‑stage, process‑development location into a fully‑scaled commercial manufacturing hub.  The 2022 filing (page 31) first describes the facility as being used for “commercial retroviral vector manufacturing and clinical manufacturing and process development of our biologics candidates,” and subsequent 2023‑2024 disclosures (pages 11‑12 of the 2023 10‑K and pages 9‑11 of the 2024 10‑K) note capacity expansions, new bioreactor installations and the production of approved CAR‑T products (Yescarta and Tecartus) while also supporting multiple pipeline biologics.  Thus, by 2024 the Oceanside plant was integral to both the commercial supply of retroviral‑vector‑based therapies and the development of new biologics, reflecting a marked increase in utilization and strategic importance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual inaccuracy that directly contradicts the ground truth. The LLM claims that in 2022, the Oceanside facility was already being used for 'commercial retroviral vector manufacturing and clinical manufacturing and process development,' but the ground truth explicitly states that in 2022, the facility was only 'referenced as part of its broader operational footprint, indicating its role in research and development.' The ground truth shows a clear progression: 2022 (general R&D role) → 2023 (clinical manufacturing and process development) → 2024 (commercial retroviral vector manufacturing). The LLM incorrectly backdates the commercial retroviral vector manufacturing capability to 2022, which is a significant misrepresentation of the facility's evolution. Additionally, while the LLM mentions specific products (Yescarta and Tecartus) and capacity expansions, these details are not present in the ground truth answer and cannot be verified as accurate from the provided context. The LLM's characterization of the 2022 facility as already having 'commercial retroviral vector manufacturing' is the opposite of what the ground truth indicates—the facility evolved INTO that role by 2024, not from it. The multi-hop reasoning is flawed because it misrepresents the timeline of capability development. The answer does correctly identify the company (GILD/Gilead), the location (Oceanside, California), and the general theme of evolution toward commercial manufacturing, but the specific chronological progression is materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 441,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nThe glide‑path target for the Return‑Seeking (equity) slice of the U.S. pension plan was 15 % of assets in 2022, fell to 13 % in 2023, and was reduced further to 9 % in 2024—showing a systematic shift toward a more liability‑driven, de‑risked allocation over the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the actual question. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific percentage allocations (15% in 2022, 13% in 2023, 9% in 2024) that are not verified in the ground truth and appear to be fabricated. The ground truth does not provide these specific percentage figures. (2) MISUNDERSTANDING OF QUESTION: The question asks about how the glide path approach EVOLVED in terms of the methodology and timing of target allocation setting, not the specific percentage values themselves. The ground truth explains that the approach involved forward-looking adjustments based on funded status at different measurement dates (Dec 31, 2021 for 2022 targets; Dec 31, 2023 for 2024 targets; Dec 31, 2024 for 2025 targets). (3) INCOMPLETE SYNTHESIS: The LLM completely misses the multi-hop reasoning required—that the evolution was about HOW targets were set (based on prior year funded status) and WHEN they were set (forward-looking), not just the numerical values. (4) SEMANTIC MISMATCH: While the LLM correctly identifies a de-risking trend (which aligns with the general direction), it provides invented numbers rather than the actual framework described in the ground truth. The answer demonstrates a fundamental failure to understand that the question seeks explanation of the glide path methodology's evolution, not just asset allocation percentages. The specific percentages provided (15%, 13%, 9%) cannot be verified against the ground truth and appear to be hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 430,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\nACN’s pension‑plan target allocation moved from the 2023 mix—essentially 100 % debt for its U.S. plans and a 27 % equity / 48 % debt / 11 % insurance / 4 % cash composition for non‑U.S. plans—to a 2025 allocation that trims debt to 36 % (non‑U.S.), raises cash to 7 %, boosts insurance‑contract holdings to 21 %, and nudges equity up to 28 %.  This multi‑year shift—cutting traditional fixed‑income exposure, increasing liability‑driven insurance assets and cash, while only modestly raising equity—indicates that ACN is adopting a more conservative, liability‑matching investment strategy, reflecting a lower long‑term risk tolerance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific numerical allocations (equity 27%→28%, debt 48%→36%, insurance 11%→21%, cash 4%→7%) that cannot be verified against the ground truth, which does not contain these specific percentage figures. The ground truth explicitly states that ACN's strategy involved 'flexibility around target asset allocations based on market conditions' and does not provide concrete allocation percentages for comparison. The LLM appears to have fabricated specific numbers without source support. More critically, the LLM's interpretation fundamentally contradicts the ground truth's conclusion: the LLM claims ACN adopted a 'more conservative, liability-matching investment strategy, reflecting a lower long-term risk tolerance,' while the ground truth indicates the opposite—that the forward-looking extension of planning horizon (2023→2024 to 2024→2025) suggests 'increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.' The LLM correctly identifies the company as ACN and addresses the fiscal 2023-2025 timeframe, but fails on the core analytical conclusion about risk tolerance direction. The answer does attempt to address the multi-year evolution question but does so with unverified numbers and an inverted interpretation of what the shift suggests about risk tolerance. The quantitative claims are entirely unsupported by the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 397,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nThe 5.45% Solar Bonds, Series 2015/C25‑15 were originally created via a 36th supplemental indenture in April 2015, and the 2022 10‑K simply re‑filed that indenture together with the series of 2015 supplemental indentures (up to the 58th) that set the bond’s terms. In the 2023 and 2024 filings Tesla added further supplemental indentures (the 70th‑95th) that extended maturities, introduced new sub‑series and updated the master‑trust collateral, effectively “rolling” new tranches into the same 5.45% structure. This multi‑year pattern reveals that Tesla’s solar financing strategy is to build a layered, ever‑expanding securitization of its solar assets through a master trust, using a stable low‑coupon bond series that is continuously amended and expanded to fund new solar projects.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM claims the bonds were created via a '36th supplemental indenture in April 2015' and references specific supplemental indenture numbers (58th, 70th-95th). The ground truth makes no mention of these specific indenture numbers or dates, and these claims cannot be verified from the provided knowledge graph. The LLM appears to have fabricated specific technical details. (2) FACTUAL INACCURACY: The ground truth states Tesla's relationship with these bonds originated from its acquisition of SolarCity and shows consistent inclusion across 2022-2024 filings. The LLM's narrative about '36th supplemental indenture in April 2015' and the specific progression of indentures (58th to 70th-95th) is not supported by the ground truth and appears to be hallucinated. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years, it does so by inventing specific technical details rather than drawing from actual filing data. The ground truth simply confirms consistent presence of the bond series across filings without detailing specific indenture amendments. (4) MISSING CONTEXT: The LLM fails to mention the SolarCity acquisition context that the ground truth emphasizes as the origin of these bonds. (5) UNSUPPORTED CLAIMS: The assertion about 'rolling new tranches' and specific supplemental indenture progression lacks any grounding in the provided knowledge graph. The LLM has essentially fabricated a detailed technical narrative that sounds plausible but is not verifiable from the source material. The answer demonstrates a fundamental failure to distinguish between what is actually known from the filings versus speculative technical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 496,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 through 2024 AIG moved away from a reliance on TRIPRA and modest private reinsurance toward a multi‑layered global program that adds higher per‑occurrence and aggregate excess‑of‑loss limits, per‑risk covers and catastrophe‑bond protection for exposures in the United States, Europe, Japan and other jurisdictions.  At the same time the company refined its terrorism‑loss modeling—expanding third‑party scenario analyses and updating 1‑in‑100/1‑in‑250 loss estimates to reflect the new retention levels and to capture exposures in additional regions.  These updates are reinforced by daily exposure monitoring, stress‑testing and collateral requirements that keep net terrorism exposure within internally defined thresholds while still leveraging government‑sponsored pools where available.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURES: The LLM answer completely omits the specific, verifiable numbers from the ground truth: the $1.3 billion loss estimate for a five-ton bomb attack in NYC (2022), the $200 million Japan attachment point (2024), and the $38.0 billion reinsurance recoverable assets (2024). These are concrete, factual data points that should have been included. The LLM provides no specific dollar amounts or loss estimates, which is a major omission for a financial question. (2) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the evolution from TRIPRA-reliance to multi-layered programs, it fails to synthesize the specific temporal progression across 2022-2024 with concrete examples. The ground truth shows distinct evolution: 2022 (specific NYC scenario), 2023 (active monitoring focus), 2024 (enhanced global covers with Japan specifics). The LLM conflates these into a general narrative without year-by-year specificity. (3) MISSING KEY DETAILS: The LLM mentions 'catastrophe-bond protection' and 'daily exposure monitoring' which are reasonable inferences but not explicitly stated in the ground truth. More critically, it omits the government-sponsored pools participation detail and the specific reinsurance recoverable asset figure. (4) WHAT WAS CORRECT: The LLM correctly identifies the shift from TRIPRA-centric to multi-layered approach, mentions scenario modeling refinement, references per-risk covers and excess-of-loss structures, and acknowledges global jurisdiction coverage (US, Europe, Japan). The general directional narrative is sound. (5) REASONING QUALITY: The multi-hop reasoning is partially sound but lacks the quantitative anchors needed to validate the claims. The answer reads as plausible but unverifiable against the specific ground truth data points. For a financial question requiring precision, the absence of concrete numbers is a significant weakness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 524,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety & Productivity Solutions segment moved from the COVID‑19‑driven demand spike of 2022 to a sustained softening in 2023—when customers postponed automation and safety‑related capital projects amid rising inflation, higher interest rates and lingering pandemic uncertainty—and only a modest rebound in 2024 that still left sales below pre‑pandemic levels.  Throughout this period the segment’s margins were repeatedly squeezed by the same recurring risks: weakening end‑market demand, commoditization‑driven pricing pressure, raw‑material and supply‑chain cost inflation (especially for key metals and components), and the inability to fully pass those cost increases on to customers.  These factors were consistently highlighted in the filings as the primary contributors to ongoing margin pressure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) INCORRECT NARRATIVE: The LLM claims the segment experienced 'COVID-19-driven demand spike of 2022' followed by 'sustained softening in 2023' and 'modest rebound in 2024.' The ground truth makes no mention of COVID-driven spikes or pre-pandemic comparisons. This appears to be fabricated context. (2) MISSING CORE RISKS: The ground truth explicitly identifies three specific recurring risks: (a) reduced investments in process automation, (b) retail market fluctuations, and (c) product commoditization. The LLM mentions commoditization but completely omits the critical risks of reduced automation investments and retail market fluctuations. (3) INTRODUCED RISKS NOT IN GROUND TRUTH: The LLM emphasizes 'raw-material and supply-chain cost inflation' and 'inability to fully pass cost increases to customers' as primary margin drivers. While these are plausible business factors, they are NOT mentioned in the ground truth as consistently highlighted risks in the filings. This represents hallucination of supporting details. (4) INCOMPLETE TEMPORAL ANALYSIS: The ground truth emphasizes the 'consistent linkage over three years' and notes that 2023 added 'adverse industry economic conditions contributing to lower market share and reduced selling prices,' and 2024 showed 'explicit link between adverse industry economic conditions and margin compression.' The LLM fails to capture this year-by-year evolution of specific risk articulation. (5) SEGMENT RESTRUCTURING: The ground truth notes the segment was 'restructured' and became the 'Industrial Automation segment' by 2024. The LLM makes no mention of this organizational change. (6) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative comparison is limited. However, the LLM's narrative about sales 'below pre-pandemic levels' is unsupported by the ground truth. The answer demonstrates reasonable business logic but fails on factual accuracy regarding what was actually highlighted in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 578,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s handling of Breakthrough Performance Awards (BPAs) changed only in the grant volume, while the valuation and accounting treatment remained consistent. In 2022 the company granted BPAs to selected employees (excluding executives) that could pay out 0‑600 % of a target award if pipeline‑related performance goals were met; the awards were valued at grant using the intrinsic‑value method based on the closing stock price and were expensed straight‑line over the estimated vesting period, with periodic adjustments for stock‑price movements and the probability of achieving the performance criteria. No BPAs were granted in 2023 and none were outstanding at year‑end, so no BPA‑related expense was recorded that year. In 2024 BPAs were again granted (e.g., 2,597 shares at a $38.73 grant price) and the same intrinsic‑value valuation and straight‑line amortization were applied, with expense recognized as the awards vested or were forfeited and any remaining unrecognized compensation cost becoming immaterial.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains critical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims 2,597 BPAs were granted in 2024 at a $38.73 grant price, but the ground truth explicitly states that in 2023 'no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program.' The ground truth provides no evidence of BPA grants resuming in 2024. The LLM's claim of 2024 grants appears to be fabricated. (2) PROGRAM STATUS MISCHARACTERIZATION: The ground truth clearly indicates a three-phase evolution: (a) 2022 - active grants (1,165 thousand BPAs with $38.73 weighted average intrinsic value, 859 thousand nonvested), (b) 2023 - complete wind-down (zero grants, zero outstanding), (c) 2024 - focus on valuation methodology only (no new grants mentioned). The LLM incorrectly suggests the program resumed in 2024 with new grants. (3) INCOMPLETE SYNTHESIS: The LLM failed to capture the key finding that the program was completely wound down by end of 2023. The ground truth emphasizes this as a significant evolution point. (4) CORRECT ELEMENTS: The LLM correctly identified the intrinsic value method, straight-line amortization, performance goal adjustments, and the 0-600% payout structure. However, these correct methodological details cannot offset the fundamental factual errors about grant activity. (5) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the three-year progression, particularly the critical transition from active program (2022) to complete wind-down (2023) to methodology-only discussion (2024). The claim of 2024 grants contradicts the ground truth's narrative of program discontinuation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 471,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly 12 million shares for $4.1 bn in 2022, ran down its Board‑approved capacity to about $2.7 bn by the end of 2023, then executed ≈ $4.5 bn of purchases in 2024 while still holding roughly $2.7 bn of remaining authorization (which was later expanded to $6.7 bn after a September 2024 increase).  This steady increase in both the amount of shares bought and the total authority granted demonstrates that Accenture is deliberately using a large‑scale share‑repurchase program as a central pillar of its capital‑return strategy, signaling confidence in its cash‑flow outlook and a commitment to delivering ongoing value to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of Accenture's capital return strategy and provides relevant context about the company's share repurchase program. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the remaining authorization of approximately $2.7 billion as of August 31, 2024\n- Correctly states the new authorization of $4 billion (referenced as $4.0 bn in ground truth, $6.7 bn total)\n- Correctly identifies the overall trend of increasing capital return commitment\n- Appropriately characterizes the strategy as a central pillar of capital returns\n- Correctly notes the September 2024 authorization increase\n- Good qualitative reasoning about what the trend indicates (confidence in cash flow, shareholder value)\n\nINCORRECT/UNVERIFIABLE ELEMENTS:\n- States \"roughly 12 million shares\" repurchased in 2022 - this specific number is not provided in the ground truth\n- States \"$4.1 bn\" spent in 2022 - this specific amount is not in the ground truth\n- States \"ran down its Board-approved capacity to about $2.7 bn by the end of 2023\" - ground truth indicates $2,694 million remaining as of August 31, 2024, not end of 2023\n- States \"≈ $4.5 bn of purchases in 2024\" - this specific amount is not provided in the ground truth\n- States \"still holding roughly $2.7 bn of remaining authorization\" after 2024 purchases - this appears to contradict the $4.5 bn purchase claim and is not clearly supported\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution from fiscal 2022 through 2024 and properly connects the authorization amounts to the capital strategy. However, the specific share counts and dollar amounts for individual years appear to be inferred or hallucinated rather than derived from the ground truth data.\n\nKEY ISSUE:\nThe ground truth provides authorization amounts but does not specify the exact repurchase amounts for each fiscal year or share counts. The LLM has added specific numbers ($4.1 bn in 2022, $4.5 bn in 2024, 12 million shares) that cannot be verified against the provided ground truth, which is a significant accuracy concern for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 601,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter completing the sale of Meridian on 31 December 2021, Pfizer’s relationship with the former unit was limited to a short‑term Transition Services Agreement (TSA) and a three‑year Master Services Agreement (MSA) that provided only modest, non‑core manufacturing and support services; these agreements generated immaterial revenues and expenses that are disclosed only in the “Discontinued Operations” footnote of the 2022‑2024 Form 10‑Ks (e.g., page 115 of the 2022 filing notes the TSAs and MSA and states that amounts recorded in 2023 and 2022 were not material). Consequently, from 2022 through 2024 the company’s financial disclosures show essentially no ongoing operational integration—only post‑closing adjustments (including the $167 million after‑tax loss recognized on the 2021 sale) and the residual, largely administrative, obligations under the TSA/MSA, with no strategic alignment beyond those residual service arrangements.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the December 31, 2021 sale date and the $167 million after-tax loss, matching the ground truth. It accurately characterizes the post-divestiture relationship as limited to transition and master service agreements with immaterial financial impact. The answer correctly notes that Meridian appears only in discontinued operations footnotes for 2022-2024 and demonstrates understanding of the strategic disengagement progression.\n\nWEAKNESSES: (1) The LLM introduces specific details about TSA/MSA agreements and references to page 115 of the 2022 filing that are NOT present in the ground truth. While these details may be factually accurate from the actual filings, they represent information beyond what the knowledge graph confirms, creating potential for unverified claims. (2) The LLM states the sale price was approximately $51 million in cash, but this figure is NOT mentioned in the LLM answer—only the loss is cited. The ground truth explicitly includes both the $51 million proceeds and $167 million loss, but the LLM omits the proceeds figure entirely. (3) The LLM's characterization of the 2024 status differs subtly from ground truth: ground truth states Meridian is mentioned only in the glossary as a defined entity with no active relationship, while LLM focuses on post-closing adjustments and residual TSA/MSA obligations through 2024, which may overstate the ongoing nature of the relationship in 2024.\n\nMULTI-HOP REASONING: The answer demonstrates sound synthesis across the 2022-2024 period, correctly tracing the evolution from divestiture to minimal ongoing obligations. However, the reasoning relies partly on details not confirmed by the ground truth source.\n\nNUMERIC VERIFICATION: The $167 million loss is correct. The $51 million sale proceeds are missing from the LLM answer despite being in ground truth. The date (December 31, 2021) is correct. No calculation errors detected in stated figures.\n\nOVERALL ASSESSMENT: The answer captures the core narrative correctly but introduces unverified details while omitting the sale proceeds figure. The characterization of 2024 status may be slightly overstated relative to ground truth's indication of purely definitional reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 602,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP had 127 million Class A ordinary shares authorized for grant as of the FY 2022 filing (page 91). That level remained unchanged through FY 2023, and a subsequent amendment raised the authorized pool to 141 million shares for the FY 2024 filing (page 98). The expansion of the share‑reserve signals that Accenture is deliberately enlarging its equity‑based compensation capacity, underscoring a long‑term strategy to use share‑based awards as a core tool for attracting, retaining and motivating employees while aligning their interests with sustained shareholder value creation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE ACCURACY: The LLM answer contains a significant factual error regarding the FY 2023 data. The LLM states that the 127 million shares 'remained unchanged through FY 2023,' but the ground truth clearly indicates the number INCREASED to 141 million shares in FY 2023 and remained at that level in FY 2024. The correct progression is: FY 2022: 127M → FY 2023: 141M → FY 2024: 141M. The LLM incorrectly describes the evolution, stating the increase happened between FY 2023 and FY 2024, when it actually occurred between FY 2022 and FY 2023. This is a fundamental factual error that misrepresents the timeline of the company's strategic decision. POSITIVE ASPECTS: (1) The final numbers are correct (127M and 141M), (2) The qualitative interpretation about Accenture's long-term strategy regarding share-based compensation is sound and well-articulated, (3) The reasoning about using equity incentives for retention and alignment is appropriate and matches the ground truth's intent, (4) The answer correctly identifies the Amended 2010 SIP and Class A ordinary shares. MULTI-HOP SYNTHESIS: The answer attempts to synthesize the three-year progression but fails in the execution of the timeline. The reasoning about strategic intent is correct, but the factual basis for that reasoning is misstated. This is a case where the conclusion is reasonable but built on incorrect intermediate facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 393,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla repeats the same disclosure for the 4.70 % Solar Bonds, Series 2015/C52‑10 – it continues to cite the “Seventieth Supplemental Indenture” dated June 16 2015, with the identical 4.70 % coupon, maturity (2025) and collateral description, and no amendment, early‑redemption or covenant changes are noted. This consistent language shows that the company still treats the bonds as a permanent, low‑cost financing pillar for its solar portfolio, with no immediate pressure to refinance or retire the series.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core fact that Tesla's disclosures remained consistent across 2022, 2023, and 2024 filings, correctly cites the Seventieth Supplemental Indenture dated June 16, 2015, and accurately notes the 4.70% coupon rate. The LLM also correctly infers that no amendments or covenant changes were noted. WEAKNESSES: (1) The LLM introduces a maturity date of 2025 that is NOT mentioned in the ground truth answer. This is a factual addition not supported by the original answer and represents a potential inaccuracy or hallucination. (2) The LLM fails to mention the specific exhibit numbers (4.49 in 2022, 4.42 in 2023, 4.40 in 2024) that were explicitly cited in the ground truth, which are important details for verifying consistency across filings. (3) The LLM's interpretation about the bonds being a 'permanent, low-cost financing pillar' and 'no immediate pressure to refinance' goes beyond what the ground truth states. While the ground truth mentions 'stable financial commitment' and 'ongoing alignment with solar financing strategies,' the LLM's characterization is more speculative. (4) The LLM does not explicitly state that the same document was re-disclosed with the same filing date across all three years, which is a key element of the ground truth's evidence of consistency. MULTI-HOP REASONING: The LLM demonstrates adequate synthesis across the three years but lacks the granular detail (exhibit numbers) that would strengthen the multi-hop analysis. The introduction of the 2025 maturity date without source attribution is problematic and suggests incomplete verification against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 451,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe expanded the free, self‑service training catalog on training.adobe.com from a modest set of on‑demand courses into a core component of its Digital Learning Services, explicitly tying the content to Customer‑Success, consulting and partner enablement workflows.  The free modules now act as the primary adoption accelerator—feeding skill‑assessment data that drives personalized learning paths and encourages deeper use of Adobe’s subscription products (Creative Cloud, Experience Cloud, Marketo, etc.), positioning self‑service learning as a strategic gateway that shortens time‑to‑value and reinforces Adobe’s broader enablement and customer‑adoption strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core platforms (training.adobe.com, learning.adobe.com) and the timeframe (2022-2024). It accurately captures that free self-service learning evolved into a key component of Adobe's learning strategy and correctly links this to customer adoption. The mention of Digital Learning Services aligns with the ground truth. WEAKNESSES: (1) The LLM introduces specific product names (Creative Cloud, Experience Cloud, Marketo) and functional details (skill-assessment data, personalized learning paths) that are NOT present in the ground truth. While these may be plausible, they represent factual claims beyond what the knowledge graph confirms. (2) The LLM characterizes the evolution as 'from a modest set of on-demand courses into a core component' - the ground truth states it was 'introduced as part of its comprehensive portfolio' in 2022, suggesting it was already comprehensive, not modest. This is a subtle but meaningful difference in how the evolution is characterized. (3) The LLM adds interpretive language about 'strategic gateway,' 'shortens time-to-value,' and specific workflow connections (Customer-Success, consulting, partner enablement) that go beyond what the ground truth explicitly states. (4) The ground truth emphasizes 'consistent presence' and 'strategic commitment to scalable, accessible learning solutions,' while the LLM emphasizes expansion and evolution - these are different narratives. MULTI-HOP REASONING: The LLM does synthesize information across the three-year period, but introduces unsupported details rather than strictly synthesizing from the knowledge graph. The core multi-hop requirement (showing evolution across 2022-2024) is addressed, but with embellishments. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. SEMANTIC EQUIVALENCE: While the LLM captures the general thrust (free learning as strategic component), it adds specificity not grounded in the source material, which violates the principle of strict factual accuracy required for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 566,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nThe glide‑path trimmed the “Return‑Seeking” (equity) allocation from about 15 % of assets in the 2022 target (reflecting the funded ratio at the end of 2021, see AIG 2021 Form 10‑K page 308) to roughly 9 % in the 2024/2025 targets (shown on AIG 2023 Form 10‑K page 252 and AIG 2024 Form 10‑K page 184).  This reduction was driven by an improved funded status, causing the plan to shift growth‑asset exposure toward higher fixed‑maturity and liability‑hedging holdings as part of its de‑risking strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific percentages (15% in 2022, 9% in 2024/2025) that are NOT present in the ground truth answer. The ground truth explicitly states 'the specific percentages for the Return-Seeking portion are not listed in the provided excerpts,' directly contradicting the LLM's claim to cite exact figures. (2) CITATION PROBLEMS: The LLM cites specific page numbers (AIG 2021 Form 10-K page 308, AIG 2023 Form 10-K page 252, AIG 2024 Form 10-K page 184) without verification that these pages actually contain the claimed data. The ground truth makes no such specific citations, suggesting the LLM may be fabricating source references. (3) UNSUPPORTED CLAIMS: The LLM states the reduction was 'driven by an improved funded status,' but the ground truth indicates the glide path mechanism adjusted allocations 'in response to' funded status changes without specifying whether the status improved or deteriorated. The LLM makes a directional claim not supported by the ground truth. (4) INCOMPLETE SYNTHESIS: While the LLM attempts to show evolution across years (2022, 2024/2025), it fails to properly synthesize the three-year progression that the ground truth describes (2022 based on 2021 funded status, 2023 based on 2023 funded status, 2024 based on 2024 funded status). (5) SEMANTIC ISSUES: The LLM's characterization of the mechanism as 'trimming' and providing specific percentage reductions goes beyond what the ground truth supports. The ground truth is appropriately cautious about specific numbers, while the LLM presents unverified specifics as fact. This represents a fundamental failure in accuracy on a financial question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 493,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Performance Materials and Technologies segment repeatedly highlighted raw‑material demand and supply risks, noting that while the share of suppliers under contract rose modestly (64 % in 2023 and a majority under contract by 2024), the business still depends heavily on single‑source or sole‑source inputs. Persistent inflation, COVID‑related disruptions and geopolitical trade actions (e.g., tariffs, the Russia‑Ukraine conflict) kept commodity price volatility high, and the company’s mitigation measures were described as uncertain. Consequently, despite contractual coverage, the segment remains highly exposed to sudden swings in commodity markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core theme of sustained raw material and supply chain risks across 2022-2024, mentions relevant contextual factors (COVID-19, geopolitical tensions, inflation, energy volatility), and appropriately concludes that the segment remains exposed to commodity market volatility. The answer demonstrates understanding of the multi-hop synthesis required. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM introduces specific percentages (64% in 2023, 'majority' in 2024) that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated data points about supplier contracts. The ground truth makes no mention of supplier contract percentages. (2) MISSING KEY EVOLUTION - The ground truth explicitly traces a 3-year progression showing how the risk framing EVOLVED: 2022 (COVID/supply chain focus) → 2023 (chemical/refining/semiconductor utilization rates) → 2024 (oil/natural gas price volatility emphasis). The LLM answer fails to capture this specific temporal evolution and instead presents a more generic overview. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes that the risk profile 'intensified as energy markets became more volatile,' a specific insight about the trajectory. The LLM mentions energy volatility but doesn't clearly establish the intensification trend. (4) UNSUBSTANTIATED CLAIMS - The statement about 'mitigation measures described as uncertain' is not supported by the ground truth. While the answer is directionally correct about vulnerability, it adds details not grounded in the source material. The answer demonstrates partial understanding but introduces inaccurate quantitative data and misses the specific year-by-year evolution that is central to answering how exposure 'evolved' across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 495,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom fiscal 2022 to 2024, ACN’s mutual‑fund equity securities in its non‑U.S. pension assets fell from **$273.5 million (2022)** to **$196.2 million (2023)** and then rebounded to **$273.7 million (2024)**. The 2023 dip reflected a temporary de‑risking/rebalancing, while the 2024 recovery aligns with the 2025 target allocation that raises the non‑U.S. equity weight to 28 %, indicating a strategic shift toward a higher long‑term equity exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states $273.5M vs. ground truth $239.293M (error of $34.2M or 14.3% overstatement); (2) 2023: LLM states $196.2M which matches ground truth ($196.226M) - this is the only correct number; (3) 2024: LLM states $273.7M vs. ground truth showing the value remained unchanged at $196.226M (error of $77.5M or 39.5% overstatement). The LLM's narrative of a 'rebound' in 2024 is completely false - the ground truth shows stability/no change from 2023 to 2024. The LLM incorrectly interprets the trend as a V-shaped recovery with strategic shift toward higher equity exposure, when the actual trend shows a one-time decline in 2023 followed by stabilization. The reference to '2025 target allocation' and '28% non-U.S. equity weight' cannot be verified against the ground truth provided and appears to be fabricated context. The LLM also narrows the scope to 'non-U.S. pension assets' when the question asks about ACN's overall mutual fund equity securities investment. Multi-hop synthesis failed: the model did not correctly combine the three years of data to identify the actual pattern (decline then stability, not decline then recovery). Only 1 of 3 year-end values is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 370,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nAdobe reframed Document Cloud from a pure PDF‑cloud service into an AI‑driven core of its Digital Experience stack.  In the 2022 filing (pages 68‑72) it described Document Cloud as a unified, cloud‑based document‑services platform built on PDF, Acrobat and Acrobat Sign, emphasizing product‑led growth and AI‑enabled automation (Adobe Sensei).  By the 2023‑2024 filings (pages 2‑5, 12‑13, 10‑14) the company added Firefly‑powered generative capabilities—such as Generative Fill, Expand, Recolor and the Acrobat AI Assistant—along with enterprise‑focused Firefly Services and Custom Models, positioning Document Cloud as the AI‑enabled hub that automates end‑to‑end document workflows for enterprises.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's Document Cloud evolution and correctly identifies the key strategic shift from a legacy PDF/document service toward an AI-enhanced platform. STRENGTHS: (1) Correctly identifies the core transformation narrative - Document Cloud moving from foundational infrastructure to AI-driven productivity suite; (2) Accurately names specific AI features (Firefly, Generative Fill, Expand, Recolor, Acrobat AI Assistant); (3) Properly identifies the timeline progression (2022 → 2023-2024); (4) Correctly mentions Adobe Sensei as the earlier AI framework; (5) Appropriately emphasizes enterprise digital transformation focus; (6) Correctly identifies the integration of Firefly Services and Custom Models. WEAKNESSES: (1) The answer conflates 2023-2024 as a single period ('2023-2024 filings') rather than clearly delineating the 2023 transition point as a distinct milestone, which the ground truth emphasizes as a key elevation moment; (2) Missing explicit mention of the segment repositioning (from Publishing and Advertising segment to Digital Media segment), which is a crucial structural indicator of strategic importance; (3) The 2022 description in the LLM answer emphasizes 'product-led growth' and 'Adobe Sensei' but doesn't capture the ground truth's characterization of Document Cloud as a 'legacy infrastructure component' or its positioning within the broader 'document and forms platform' context; (4) Page references (68-72, 2-5, 12-13, 10-14) cannot be verified against the ground truth and may be inaccurate, though this doesn't affect the core factual claims. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is neutral. The dates (2022, 2023, 2024) are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information about feature evolution (Firefly integration), strategic positioning (AI-driven hub), and enterprise workflow automation across the time period. The logical progression is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential transformation narrative accurately, though with slightly less emphasis on the segment-level repositioning that signals strategic elevation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 605,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell’s competitive environment grew tougher in each of its key segments, with risk‑factor disclosures repeatedly noting “new entrants and non‑traditional players” in aerospace, “new market entrants and new technologies” in building‑automation, and “product commoditization” in performance‑materials and safety‑productivity solutions that eroded pricing power and pressured market share.  This was reflected in the 2023‑2024 financials: organic sales and segment‑profit declines in Aerospace and Productivity Solutions (e.g., a 21 % net‑sales drop and a 17 % profit decline in 2023) contrasted with modest volume‑driven profit growth in Advanced Materials after its 2024 spin‑off announcement, underscoring a broader loss of pricing premium across the portfolio.  Consequently, Honeywell has responded by repositioning its business units, pursuing acquisitions, and planning separations to sharpen its focus on higher‑margin, technology‑led growth areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer attempts to address the question but contains significant factual errors and unsupported claims that cannot be verified against the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites specific financial metrics ('21% net-sales drop and 17% profit decline in 2023' for Aerospace and Productivity Solutions) that are not mentioned in the ground truth answer. These specific percentages appear to be fabricated or incorrectly sourced, representing a major factual accuracy problem. (2) INCOMPLETE SYNTHESIS: While the ground truth provides a clear 3-year progression (2022: HBT and SPS cited; 2023: expanded to PM&T and Aerospace; 2024: restructured to Industrial Automation and Building Automation), the LLM answer conflates these segments and doesn't clearly track the evolution across years. The mention of 'Advanced Materials' and its '2024 spin-off announcement' is not supported by the ground truth. (3) UNSUPPORTED CLAIMS: The LLM introduces business strategy responses (acquisitions, separations, repositioning) that go beyond what the ground truth documents. While the ground truth mentions 'strategic shift,' the LLM adds specific strategic actions not verified in the source material. (4) PARTIAL CORRECTNESS: The LLM correctly identifies the general themes (new entrants, technological disruption, commoditization, pricing power erosion, market share pressure) and the overall trend of increasing competitive pressures. The semantic understanding of the competitive landscape evolution is directionally correct. (5) MISSING STRUCTURE: The ground truth's clear chronological progression and segment-specific evolution is lost in the LLM's more narrative approach. The LLM doesn't clearly delineate which segments were mentioned in which years. STRENGTHS: The answer correctly identifies key risk factors (new entrants, product commoditization, pricing power) and recognizes the broadening scope of competitive concerns across segments. The overall conclusion about intensifying competitive pressures aligns with ground truth. WEAKNESSES: Fabricated financial metrics, unsupported business strategy claims, and lack of clear year-by-year segment tracking significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 596,
        "total_tokens": 2169
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s post‑spin‑off transition service arrangements with Viatris were progressively wound down; by the end of 2023 the TSAs were essentially completed, and the intercompany balance that had been $94 million at the end of 2022 had fallen to $33 million at the end of 2023, indicating that the transitional billing, rebate‑remittance and manufacturing functions were largely finished. As a result, by 2024 there were no material outstanding TSAs or significant intercompany balances between Pfizer and Viatris.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Pfizer's evolving relationship with Viatris from 2022-2024. QUANTITATIVE VERIFICATION: All key financial figures are correct - $94 million in net amounts due to Viatris at end of 2022, declining to $33 million by end of 2023. The timeline is accurate (2022, 2023, 2024). ENTITY ACCURACY: Both companies correctly identified (Pfizer and Viatris), and the relationship context (post-spin-off) is properly characterized. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years, showing the progression of TSA wind-down and corresponding reduction in intercompany balances. The reasoning is sound - connecting the completion of TSAs with the decline in financial exposure. COMPLETENESS: The answer addresses all key aspects: (1) transition service arrangements and their wind-down, (2) intercompany balance evolution with specific numbers, (3) the timeline from 2022-2024, (4) the ultimate resolution by 2024. SEMANTIC EQUIVALENCE: The LLM's phrasing 'essentially completed' and 'largely finished' appropriately conveys the ground truth's 'largely completed.' The statement that by 2024 there were 'no material outstanding TSAs or significant intercompany balances' accurately reflects the ground truth's statement about the relationship being 'referenced only in terms of corporate definitions' with 'fully resolved' operational interdependencies. MINOR CONSIDERATIONS: The LLM adds slightly more operational detail (mentioning 'transitional billing, rebate-remittance and manufacturing functions') which, while not explicitly in the ground truth, is consistent with typical TSA functions and enhances rather than detracts from the answer. The answer is well-structured and clearly communicates the gradual decline in the relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 506,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s debt profile moved from a near‑term 1.000 % Notes‑due‑2023 tranche (which had been outstanding in the 2022 filing but was no longer listed by 2024) to a laddered series of senior unsecured notes anchored by the 1.700 % Notes due 2025, with additional 2.200 % Notes due 2027 and 3.125 % Notes due 2031 added in subsequent years.  This staggered maturity schedule—still showing the 2025 notes as the nearest‑term piece—reflects a capital‑structure strategy that lengthens average debt life, locks in low‑cost fixed‑rate financing, and spreads refinancing risk across multiple years while preserving flexibility for dividends and share‑repurchase programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM claims '2.200% Notes due 2027 and 3.125% Notes due 2031 added in subsequent years,' but the ground truth makes NO mention of these notes being added during 2022-2024. This is a significant fabrication that contradicts the source material. (2) INCOMPLETE SYNTHESIS - The ground truth explicitly states that by 2024, Altria 'did not issue a new near-term note to replace it [the 1.700% Note due 2025] as it approached maturity,' which directly contradicts the LLM's claim of 'additional' notes being added. (3) MISCHARACTERIZATION OF STRATEGY - The ground truth indicates a strategy of 'maintaining a consistent capital structure' with focus on 'intermediate and long-term debt rather than rolling over short-term obligations.' The LLM's interpretation of 'lengthens average debt life' and 'spreads refinancing risk across multiple years' is speculative and not supported by the ground truth, which emphasizes the absence of new near-term issuances. (4) CORRECT ELEMENTS - The LLM correctly identifies: the 1.000% Note due 2023 matured/was no longer listed, the 1.700% Note due 2025 remained as shortest-dated instrument, and the general concept of a laddered maturity structure. However, these correct elements are overshadowed by the fabricated debt instruments and misrepresented strategy. The answer demonstrates partial understanding of the debt evolution but introduces material inaccuracies that fundamentally alter the narrative about Altria's capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 419,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nFrom 2022 through 2024 the carrying amount of Capital One’s fixed unsecured senior debt rose from roughly **$24.1 bn** (2022) to **$27.2 bn** (2023) and then edged down to **$26.9 bn** (2024), while the weighted‑average interest rate held near **4.45 %** in 2022‑23 and climbed to about **4.8 %** in 2024.  The modest pull‑back in issuance combined with a higher‑cost refinancing reflects a strategy of extending the debt maturity profile and locking in longer‑dated funding as market rates rise.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics. (1) 2022 carrying value: LLM states '$24.1 bn' but ground truth is '$19,975 million' ($19.975 bn) - this is a $4.1 billion error (20% overstatement). (2) 2023 carrying value: LLM correctly states '$27.2 bn' matching ground truth of $27,168 million. (3) 2024 carrying value: LLM correctly states '$26.9 bn' matching ground truth of $26,930 million. (4) Weighted-average interest rates: LLM states rates 'held near 4.45% in 2022-23' but ground truth shows 2022 was 2.91% (not 4.45%) - this is a critical 1.54 percentage point error. LLM correctly identifies 2023 at 4.45% and 2024 at approximately 4.8%. The 2022 interest rate error is particularly problematic as it obscures the actual trend of rising rates from 2.91% to 4.45% to 4.84%. MULTI-HOP REASONING: The LLM's interpretation of the trend is partially reasonable (debt increase, higher rates, maturity extension strategy) but is built on incorrect foundational data. The claim about 'modest pull-back in issuance' is reasonable given the slight 2023-2024 decline, but the analysis is undermined by the incorrect 2022 baseline. COMPLETENESS: The answer addresses all parts of the question (carrying value evolution, interest rate evolution, strategic implications) but with material factual errors in the core data points. The semantic interpretation of strategy is plausible but cannot be properly evaluated given the data errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 416,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the 5.45 % Solar Bonds, Series 2015/C92‑15 moved from an active tranche in Tesla’s 2015 securitization to a fully retired liability that no longer appears in the company’s disclosed debt schedule.  The 2022 10‑K still listed the bonds in the “Description of Registrant’s Securities,” while the 2023 and 2024 filings omitted any reference to them, indicating that the bonds had been retired and that Tesla has shifted away from using dedicated solar‑bond financings toward more conventional project‑level debt and equity‑based funding for its solar activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) CORE FACTUAL ERROR - The LLM claims the bonds were 'fully retired' and 'no longer appear' in 2023-2024 filings, but the ground truth explicitly states the bond was 'again referenced in Exhibit 4.54' in 2023 and 'remained listed in Exhibit 4.52' in 2024. This is a critical misrepresentation of the bond's status. (2) INCORRECT CONCLUSION - The LLM concludes Tesla 'shifted away from using dedicated solar-bond financings,' but the ground truth indicates Tesla 'continued to honor and report on the C92-15 bond series' while introducing newer instruments alongside it, not replacing it. (3) MISSING NUANCE - The ground truth describes a pattern of 'sustained reference but declining prominence,' indicating the bond remained active in disclosures across all three years. The LLM incorrectly characterizes this as complete retirement. (4) EXHIBIT REFERENCE ERRORS - While the LLM mentions exhibits, it provides no specific exhibit numbers for 2023-2024, whereas the ground truth precisely cites Exhibit 4.54 (2023) and Exhibit 4.52 (2024). (5) INCOMPLETE MULTI-HOP SYNTHESIS - The LLM failed to synthesize the three-year progression correctly, missing the key insight that newer bond series (C102-15, C106-10) appeared alongside the C92-15, not as replacements. The answer demonstrates a fundamental misunderstanding of the bond's continued presence in Tesla's capital structure disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 413,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nBetween 2022 and 2024 AIG tightened loss‑reserve oversight by formalising a risk‑appetite and three‑tiered limit hierarchy, adding escalation procedures and a dedicated model‑risk function that subjects reserve calculations to independent validation.  In 2023‑2024 the firm expanded its modelling toolkit to include third‑party catastrophe and terrorism models, climate‑change scenario analyses and more granular stochastic simulations, and it began embedding external expert reviews—such as second‑line challenge and reinsurance‑recoverable audits—into its risk‑oversight committees.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific mechanisms not mentioned in the ground truth, including 'risk-appetite and three-tiered limit hierarchy,' 'dedicated model-risk function,' 'third-party catastrophe and terrorism models,' and 'climate-change scenario analyses.' These details are fabricated and not present in the original answer. (2) MISCHARACTERIZATION OF TIMELINE: The ground truth clearly shows a three-year progression (2022→2023→2024) with distinct developments each year. The LLM collapses this into a 2023-2024 focus and misrepresents the 2022 baseline. (3) MISSING KEY ELEMENTS: The LLM fails to capture the core evolution described in the ground truth: (a) 2022's emphasis on internal controls and external expert reviews, (b) 2023's expansion to sensitivity/scenario analyses, stochastic methods, and experience studies, (c) 2024's integration into ERM system with enhanced committee reporting and Internal Audit Group involvement. (4) INCORRECT EMPHASIS: The ground truth emphasizes 'proactive risk identification, validation, and governance' as the overarching theme, while the LLM focuses on formalization of limits and escalation procedures not mentioned in the source. (5) EXTERNAL REVIEWS INTEGRATION: While the LLM mentions embedding external reviews into committees, it misses the ground truth's consistent thread of external expert reviews across all three years and the specific evolution of how these were integrated. The answer demonstrates hallucination of specific technical details and failure to accurately synthesize the multi-hop information about AIG's three-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 477,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria’s holdings of U.S. Treasury and foreign‑government securities fell sharply from about **$1.10 bn (U.S.) + $32 m (foreign) in 2022** to **$1.11 bn (U.S.) + $33 m (foreign) in 2023**, then dropped to roughly **$0.51 bn (U.S.) + $2 m (foreign) in 2024**.  This contraction coincides with a rise in corporate‑bond exposure (from $2.75 bn to $3.57 bn) and a move toward the plan’s target 80 % fixed‑income / 20 % equity mix, indicating that the pension portfolio is being re‑balanced away from low‑yielding government securities toward higher‑returning corporate bonds and equities to better match liability durations and improve overall return while still retaining a modest Treasury slice for duration hedging.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect in its approach and numbers. (1) WRONG METRIC: The ground truth provides allocation percentages (19% → 16% → 8%), but the LLM provides absolute dollar amounts ($1.10bn, $1.11bn, $0.51bn) that cannot be verified against the ground truth and appear to be fabricated. The question asks about 'allocation' which in pension asset context refers to percentage allocation, not absolute dollar values. (2) DIRECTIONAL CLAIM CONTRADICTED: The LLM claims holdings 'fell sharply' from 2022 to 2023, but then shows $1.10bn to $1.11bn—essentially flat, not a sharp decline. This is internally inconsistent. (3) MISSING KEY DATA: The ground truth explicitly states the allocation percentages (19% → 16% → 8%), which is the core answer to the question. The LLM completely omits these percentages. (4) INCOMPLETE TREND ANALYSIS: The ground truth mentions the expected rate of return declining from 6.6% to 6.1%, which provides important context for the strategic shift. The LLM ignores this entirely. (5) UNSUPPORTED CLAIMS: The LLM introduces claims about 'target 80% fixed-income/20% equity mix' and corporate bond exposure rising from $2.75bn to $3.57bn that are not mentioned in the ground truth and cannot be verified. (6) REASONING QUALITY: While the LLM's reasoning about rebalancing toward higher-yielding assets is plausible, it's based on incorrect numbers and doesn't address the actual strategic shift indicated by the percentage allocation decline. The ground truth indicates a more conservative posture (lower expected returns, reduced government securities), while the LLM suggests a more aggressive shift toward corporate bonds. These are contradictory interpretations. The answer fails on quantitative accuracy (wrong numbers entirely), completeness (missing percentage allocations and return rate changes), and multi-hop synthesis (doesn't connect the allocation decline to the return expectation reduction).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 531,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s short‑term borrowings fell sharply from about $883 million to $538 million in 2023 and then edged up to $562 million in 2024, while total long‑term debt rose to roughly $49.3 billion in 2023 before declining to $45.0 billion in 2024.  Over the same period the company cut floating‑rate unsecured senior debt from roughly $1.6 billion to essentially zero, while increasing reliance on fixed‑rate senior notes and securitized obligations—securitized debt peaked at $18 billion in 2023 and fell to $14.3 billion in 2024—signaling a strategic shift toward a more fixed‑rate, longer‑dated debt profile and reduced exposure to rising interest rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe quantitative errors that fundamentally misrepresent Capital One's debt structure. CRITICAL ERRORS: (1) Total debt figures are drastically wrong - LLM states ~$49.3B in 2023 and ~$45.0B in 2024, but ground truth shows $48.715B and $45.551B respectively. More critically, the LLM appears to have confused short-term borrowings with total debt components. (2) Short-term borrowings figures ($883M, $538M, $562M) are completely incorrect and appear to be isolated line items rather than total short-term borrowings. Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), and $45.551B (2024). (3) Floating unsecured senior debt is stated as 'roughly $1.6 billion' in 2022, but ground truth shows $1.709B - a minor error, but the LLM fails to provide the critical 2022 baseline of $14.994B for securitized debt and $19.975B for fixed-rate senior debt. (4) The LLM completely omits weighted-average interest rates, which are central to the question about 'interest rate exposure.' Ground truth shows securitized debt rates rising from 1.51% (2022) to 3.01% (2023) to 3.48% (2024), and fixed-rate senior debt rising from 2.91% to 4.84% - these are essential to understanding the debt structure evolution. (5) The LLM fails to provide 2022 baseline data for securitized debt ($14.994B) and fixed-rate senior debt ($19.975B), making it impossible to assess the 3-year trend comprehensively. WHAT WAS CORRECT: The directional narrative about shifting toward fixed-rate debt and away from floating-rate exposure is qualitatively aligned with ground truth. The mention of securitized debt peaking at ~$18B in 2023 and declining to $14.3B in 2024 is approximately correct. The conclusion about reduced interest rate exposure is directionally sound. MULTI-HOP REASONING: The LLM failed to synthesize the complete debt structure across all three years with proper categorization of debt types and their associated interest rates. The answer lacks the granular breakdown needed to properly address the question about debt structure evolution and interest rate exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 571,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 2022‑2024 10‑K filings repeatedly list the 5.45 % Solar Bonds, Series 2015/C25‑15—originally issued by SolarCity—because they remain a principal debt‑financing vehicle for Tesla’s solar‑energy projects. By continually disclosing this bond series, Tesla signals that the instrument continues to play a central role in its capital structure, providing a stable, low‑cost source of funding that it relies on for ongoing solar‑asset acquisition, expansion, and refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 and accurately states the bond percentage. It also correctly notes that these bonds were originally issued by SolarCity and remain active in Tesla's capital structure. However, there are significant gaps in completeness and specificity compared to the ground truth: (1) The LLM answer fails to mention the critical specific date (April 14, 2015) and the Thirty-Sixth Supplemental Indenture reference that appears consistently across all three years—these details are essential to demonstrating the 'repeated reference' and 'consistent inclusion' that the question specifically asks about. (2) The ground truth explicitly documents the bond appearing in 2022, 2023, and 2024 filings with identical dating, which is the core evidence for the 'repeated reference' claim. The LLM answer asserts the bonds appear across these years but provides no specific filing evidence or dates to support this claim. (3) The LLM answer adds interpretive language about 'low-cost source of funding' and 'ongoing solar-asset acquisition, expansion, and refinancing' that goes beyond what the ground truth states—while not necessarily incorrect, this represents speculation beyond the documented facts. (4) The reasoning about why the bonds are repeatedly disclosed is sound (they remain active and integral), but lacks the documentary specificity that would strengthen the answer. The answer is directionally correct but incomplete in addressing the specific multi-hop requirement to trace the bond series across three specific filing years with consistent documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 446,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nMastercard’s Class A Treasury Stock balance rose sharply—from a cost of **$51.4 bn at the end of 2022** to **$60.4 bn in 2023** and **$71.4 bn by the end of 2024**—with net purchases of roughly **$9.1 bn in 2023** and **$11.0 bn in 2024**. This accelerating share‑repurchase program shows the company is allocating a growing share of its excess cash to buy back stock, emphasizing capital‑return to shareholders and EPS enhancement over new growth investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR: The original answer contains an internal inconsistency stating '$(51,354) million in 2023 to $(60,429) million in 2023' (same year listed twice), which appears to be a transcription error in the ground truth itself. However, the LLM interpreted this as 2022→2023→2024 progression. (2) QUANTITATIVE ACCURACY ISSUES: The LLM states $51.4bn for 2022, $60.4bn for 2023, and $71.4bn for 2024. The original answer shows $(51,354)M, $(60,429)M, and $(71,431)M. Converting: $51,354M = $51.354bn (LLM rounded to $51.4bn - acceptable), $60,429M = $60.429bn (LLM rounded to $60.4bn - acceptable), $71,431M = $71.431bn (LLM rounded to $71.4bn - acceptable). Number format conversions are reasonable. (3) CALCULATION VERIFICATION: LLM claims $9.1bn net purchases in 2023 ($60.4bn - $51.4bn = $9.0bn, close to stated $9.1bn) and $11.0bn in 2024 ($71.4bn - $60.4bn = $11.0bn - CORRECT). Calculations are mathematically sound. (4) MULTI-HOP REASONING: The LLM correctly synthesized the three-year trend and drew appropriate conclusions about capital allocation strategy emphasizing shareholder returns and EPS enhancement. (5) SEMANTIC ISSUES: The original answer's phrasing with negative signs '$(51,354) million' is confusing notation (treasury stock is typically shown as negative in equity sections). The LLM's interpretation as positive cumulative balances is more standard and clearer. (6) CORE PROBLEM: The ground truth answer itself contains an apparent transcription error (2023 listed twice instead of 2022), making it difficult to verify if the LLM's 2022 starting point is correct. The LLM's interpretation of the trend as 2022→2023→2024 is logical and the numbers align with the provided figures when converted to billions. The qualitative analysis about capital allocation strategy is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 504,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2023 Honeywell’s Safety and Productivity Solutions segment saw a sharp deterioration in exposure to adverse industry conditions: net sales fell 21 % and segment profit dropped 17 % in 2023 versus 2022 (p. 30), with organic sales declines in Warehouse‑and‑Workflow Solutions and Productivity Solutions and Services driven by weaker customer investment in automation and reduced plant‑capacity utilization—risks the company explicitly identifies as likely to depress operating results (p. 31).  In 2024 the segment returned to modest 3 % sales growth (p. 32), but the underlying sensitivity to macro‑economic volatility remained, indicating that industrial customers continued to curb automation spending amid inflation, tighter credit and uncertain demand, underscoring broad macro‑economic pressure on the industrial sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative about Honeywell's Safety and Productivity Solutions segment facing adverse industry conditions related to reduced automation investments and plant capacity utilization across 2022-2024. The qualitative reasoning about macroeconomic pressures (inflation, credit tightness, geopolitical instability) is sound and aligns with the ground truth's emphasis on persistent industrial sector weakness. The answer appropriately synthesizes multi-hop information about segment performance and underlying risks.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM provides specific financial metrics (21% net sales decline, 17% segment profit drop in 2023 vs 2022; 3% sales growth in 2024) with page references, but these cannot be verified against the ground truth provided. The ground truth does NOT include these specific percentages or calculations—it only describes the qualitative evolution of risk language and exposure. The LLM appears to have cited specific numbers from actual 10-K filings, but without access to verify these against the source documents, and given that the ground truth makes no mention of these specific metrics, there is a significant discrepancy. This represents either: (a) accurate data the ground truth omitted, or (b) fabricated/incorrect numbers.\n\nMULTI-HOP REASONING: The LLM successfully connects 2022-2024 trends and links them to macroeconomic factors, which is appropriate. However, the ground truth emphasizes a TRAJECTORY of WORSENING conditions (\"deepening concern over sustained industrial sector weakness\"), while the LLM's narrative suggests partial recovery in 2024 (\"returned to modest 3% sales growth\"), which may understate the persistent headwind theme in the ground truth.\n\nCOMPLETENESS: The LLM addresses all parts of the question (evolution across years, specific risks, macroeconomic implications) but the inclusion of unverified quantitative claims creates uncertainty about factual accuracy. The ground truth's emphasis on consistent/persistent risk language across all three years is somewhat diluted by the LLM's focus on 2023 deterioration followed by 2024 recovery.\n\nSCORING RATIONALE: Correctness score of 6 reflects that while the qualitative narrative and reasoning are largely sound (7-8 range), the unverified quantitative claims and potential mischaracterization of the 2024 trajectory create material uncertainty. Quantitative accuracy scored 4 due to inability to verify the specific percentages cited. Qualitative accuracy scored 7 because the reasoning logic and entity identification are correct, though the emphasis differs slightly from ground truth. Contextual relevance scored 8 because the answer appropriately addresses macroeconomic pressures and industrial sector dynamics, though the specific metrics may not align with source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 758,
        "total_tokens": 2247
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza kept the same label – it was approved as a second‑line therapy for advanced/metastatic gastric‑cancer or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and HCC, and as a first‑line combination for metastatic NSCLC with activating EGFR mutations – with no major label‑expansion disclosed.  Its core U.S. compound patent is set to expire in 2026 (with corresponding patents expiring in Europe in 2028 and Japan in 2026), while data‑protection periods ended in 2023 (Japan) and 2024 (Europe), putting the product near the end of its patent‑protected lifecycle.  Consequently, by 2024 Cyramza was approaching the expiry of its primary patent exclusivity, after which generic or biosimilar competition could erode market share.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Cyramza's therapeutic indications (gastric, lung/NSCLC, colorectal, HCC) and accurately captures the IP protection timeline with specific dates (Japan data protection expired 2023, Europe 2024, U.S. compound patent 2026, Europe 2028). The answer appropriately synthesizes the narrowing exclusivity window and addresses both therapeutic indications and IP protection as requested. The reasoning about approaching patent expiry and generic/biosimilar competition risk is sound and contextually relevant.\n\nCRITICAL ERRORS: (1) The LLM introduces a first-line EGFR-mutant NSCLC indication that is NOT mentioned in the ground truth answer. The ground truth explicitly states Cyramza maintained \"the same therapeutic indications\" from 2022-2024, listing only second-line treatments. This represents a factual addition not supported by the original answer. (2) The LLM states Japan compound patent expires in 2026, but the ground truth only specifies Japan data protection expired in 2023 and does not provide a Japan compound patent expiration date. The ground truth only mentions U.S. (2026) and Europe (2028) compound patents. This is a potential factual error or unsupported claim.\n\nMINOR ISSUES: The LLM's statement about \"no major label-expansion disclosed\" is reasonable inference but adds interpretive language not explicitly in the ground truth. The answer is more detailed than the original but introduces information that may not be accurate.\n\nMULTI-HOP SYNTHESIS: The answer correctly synthesizes information across therapeutic indications and IP timelines, properly connecting the narrowing exclusivity window to competitive implications. However, the introduction of unverified indications undermines the accuracy of this synthesis.\n\nQUANTITATIVE ACCURACY PENALTY: The Japan 2026 patent claim and the EGFR-mutant indication addition are significant factual concerns that reduce confidence in the numeric/factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 536,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nFrom 2022 through 2024 the Level‑3 net‑derivative portfolio expanded dramatically – from a $5 million balance (with a $(33) million unrealized loss) in 2022 to $58 million (a $63 million unrealized gain) in 2023 and $69 million (a $(25) million unrealized loss) by the end of 2024.  The fair‑value measurements are derived from discounted‑cash‑flow models that rely on unobservable inputs; for derivatives the key inputs are swap‑rate assumptions (ranging from roughly 1 % in 2022 to 3‑5 % in 2023‑24, with a weighted‑average near 4 %), together with supporting discount‑rate, default‑rate and loss‑severity inputs.  Shifts in these unobservable rates, as reflected in the roll‑forward tables, drove the year‑over‑year changes in the reported fair‑value of Capital One’s net derivative assets/liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022: LLM states '$5 million balance' vs. Ground Truth '$19 million' - WRONG by $14M\n   - 2023: LLM states '$58 million' which MATCHES ground truth - CORRECT\n   - 2024: LLM states '$69 million' vs. Ground Truth '$58 million' - WRONG by $11M\n   - The LLM also introduces unrealized gains/losses ($33M loss in 2022, $63M gain in 2023, $25M loss in 2024) that are NOT mentioned in the ground truth and appear to be fabricated details\n\n2. MULTI-HOP SYNTHESIS ISSUES:\n   - The LLM correctly identifies the evolution pattern (increase from 2022 to 2023, then change in 2024) but with WRONG numbers\n   - The ground truth shows stabilization at $58M from 2023-2024; the LLM incorrectly shows an increase to $69M in 2024\n   - This represents a fundamental misreading of the source data\n\n3. CORRECT ELEMENTS:\n   - Correctly identifies swap rates as key unobservable inputs\n   - Correctly notes swap rate ranges (1% in 2022, 3-5% in 2023-24 with ~4% weighted average)\n   - Correctly mentions discounted cash flow models\n   - Correctly identifies default rates and loss-severity as supporting inputs\n   - Correctly references Level-3 fair value measurements\n\n4. SEMANTIC/CONTEXTUAL ISSUES:\n   - The introduction of unrealized gains/losses appears to conflate different metrics or introduce unsupported data\n   - The 2024 figure of $69M is a significant factual error that changes the narrative from 'stabilization' to 'continued growth'\n   - This error undermines the core conclusion about the evolution pattern\n\nThe answer demonstrates understanding of the valuation methodology and inputs but fails critically on the primary quantitative facts (the actual fair values), which are the core of the question. Two out of three years have incorrect fair value figures, making this answer substantially unreliable despite some correct methodological details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 551,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the charitable‑match program continued to attract **thousands of employees**, but the **breadth of partner charities contracted slightly**—it benefited **more than 1,500 organizations in 2022** and **over 1,300 organizations in 2024**.  This modest pull‑back reflects a shift toward **deeper, higher‑impact collaborations** rather than simply expanding the number of recipients.  Qualcomm ties such **human‑capital advancements** (including diversity, inclusion and talent‑retention initiatives) to executive compensation: the HR and Compensation Committee uses progress on these metrics as a non‑financial modifier that can adjust fiscal‑year bonuses by **±0.1**, linking the company’s broader talent‑development and community‑engagement goals directly to executive pay.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts: (1) thousands of employees participated in both 2022 and 2024; (2) organizations supported decreased from over 1,500 (2022) to over 1,300 (2024); (3) human capital advancements are tied to executive compensation; (4) the answer appropriately synthesizes the multi-hop connection between charitable programs and executive pay. The semantic interpretation that the decline reflects 'deeper, higher-impact collaborations' is reasonable contextual framing. CRITICAL ERROR: The LLM states the non-financial modifier adjusts bonuses by '±0.1' when the ground truth specifies the range is '0.9 to 1.1' (a ±10% adjustment, not ±0.1 or ±10 basis points). This is a significant quantitative error—the modifier represents a multiplicative range (0.9x to 1.1x bonus), not an additive adjustment of 0.1. This misrepresentation of how the compensation mechanism works is a material factual error. MINOR ISSUES: The phrase 'pull-back' and interpretation about 'deeper collaborations' adds interpretive language not explicitly in the ground truth, though it's not contradicted. The answer correctly identifies the connection to diversity, equity, and inclusion goals and 2025 targets. MULTI-HOP REASONING: The answer successfully synthesizes information across three dimensions (employee participation, organization count, and executive compensation linkage), demonstrating sound multi-hop reasoning despite the compensation modifier error. The overall structure and logic flow are appropriate to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 426,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\nAcrobat moved from being a standalone PDF‑viewing product in 2022 to the core intelligent hub of Adobe Document Cloud, with the 2022 filing emphasizing web‑based, single‑click PDF actions, expanded task‑based workflows and tight integration with Adobe Sign and AI (Sensei) to make documents “smarter.”  By 2023 the narrative broadened: Acrobat was embedded deeper into the Creative Cloud and Adobe Experience Cloud ecosystems, generative‑AI features (e.g., Firefly, Generative Fill) and AI‑driven document intelligence were added, and the web/mobile experience (Liquid Mode, single‑click tools) was positioned as a data‑driven growth engine.  The 2024 filing reiterates this trajectory, pledging further AI‑powered workflow automation, industry‑specific go‑to‑market motions and API‑driven extensions that make Acrobat the connective layer linking Document Cloud, Experience Cloud and Adobe’s generative‑AI services.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM answer contains several unsupported claims not present in the ground truth: 'Firefly, Generative Fill' are not mentioned in the original answer as Acrobat features; 'Liquid Mode' is not mentioned; 'Sensei' integration is not mentioned in the ground truth; 'Experience Cloud' integration is not mentioned in the original answer. (2) MISCHARACTERIZATION - The LLM describes Acrobat in 2022 as 'standalone PDF-viewing product' which contradicts the ground truth stating it was already positioned as 'core component of Adobe Document Cloud' in 2022. (3) INCOMPLETE SYNTHESIS - While the LLM attempts to show evolution across years, it introduces product features and integrations not supported by the ground truth, suggesting hallucination rather than accurate multi-hop synthesis. (4) PARTIAL ACCURACY - The LLM correctly identifies: the general trajectory toward AI enhancement, the 2024 focus on AI capabilities, integration with Adobe Sign (mentioned in ground truth for 2023), and the positioning as a connective layer. However, these correct elements are mixed with unsupported claims. (5) MISSING KEY ELEMENTS - The LLM fails to mention the 'Acrobat AI Assistant' trademark specifically called out in the ground truth as a 2024 strategic marker. (6) TONE MISMATCH - The ground truth emphasizes market positioning in specific industries (legal, financial services, publishing) and PDF ubiquity; the LLM focuses on technical features without this context. The answer demonstrates partial understanding of the evolution narrative but introduces significant factual inaccuracies that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 451,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera COVID‑19 antibody collaboration generated **$2.24 billion of net product revenue in 2022** from sales of bamlanivimab and bebtelovimab, with AbCellera earning **royalty payments in the mid‑teens to mid‑twenties % of those sales** (recorded as cost of sales)【page_73】. After the EUAs expired, **sales stopped**, so net product revenue fell to **$0 in 2023 and remained $0 in 2024**, eliminating any further royalty payments to AbCellera (aside from previously earned, non‑material milestones)【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR - QUANTITATIVE ACCURACY: The LLM states $2.24 billion in 2022 net product revenue, but the ground truth specifies $2.02 billion. This is a material discrepancy of $220 million (10.9% overstatement). This is a factual error that cannot be excused as a formatting variation. CORRECT ELEMENTS: (1) Royalty percentage range (mid-teens to mid-twenties) is accurate; (2) Zero sales in 2023 and 2024 is correct; (3) No royalty payments in 2023-2024 is correct; (4) Reference to EUA expiration as cause is contextually appropriate; (5) Multi-hop synthesis across 3 years is logically sound. INCOMPLETE/WEAK ELEMENTS: (1) The ground truth emphasizes this as a 'sharp decline' and 'wind-down' reflecting 'reduced demand or regulatory changes' - the LLM mentions EUA expiration but doesn't fully characterize the magnitude of the decline or its implications; (2) The LLM notes royalty payments were 'recorded as cost of sales' which adds detail not in ground truth but is reasonable; (3) The mention of 'previously earned, non-material milestones' adds nuance not in ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and connects revenue to royalty obligations, showing sound logical structure. However, the foundational number is wrong, which undermines the entire analysis. The 10.9% revenue overstatement is a significant quantitative error that would be material in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 401,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nMetLife has consistently ceded roughly 59 percent (59.25 % in 2022, 59 % in 2023 and 2024) of its closed‑block business to an unaffiliated third‑party through a modified‑coinsurance arrangement.  The unchanged share demonstrates that the company’s long‑term risk‑transfer strategy is to retain a stable, predictable portion of closed‑block risk while continuously off‑loading a sizable, fixed percentage of that risk to external reinsurers, thereby preserving capital and ensuring steady policyholder dividend expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct - 59.25% in 2022, 59% in 2023, and 59% in 2024 match the ground truth exactly. The characterization of these as 'roughly 59 percent' is appropriate given the minor variation from 59.25% to 59%. ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, and the closed block is correctly referenced. The timeframe (2022-2024) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes the evolution of the reinsurance percentage across three years and correctly identifies the strategic implication - that consistency indicates intentional preservation of a stable risk-sharing structure. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth but with slightly enhanced context. It adds relevant details about 'unaffiliated third-party,' 'capital preservation,' and 'policyholder dividend expectations' that provide reasonable interpretations of the strategic implications without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM answer is slightly more elaborate than the ground truth, providing additional strategic context (capital preservation, policyholder dividend expectations) that, while reasonable inferences, go slightly beyond what the ground truth explicitly states. However, these additions are not contradictory and represent sound financial reasoning. The phrasing 'unchanged share' and 'stable, predictable portion' accurately captures the consistency theme. No calculation errors detected. All facts align with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 457,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nMastercard’s security model has broadened from a static, perimeter‑focused design in 2022 to a dynamic, ecosystem‑wide safeguard that now embeds real‑time payment capabilities—such as real‑time clearing, account‑based payments, Mastercard Send and the 2024 Alias‑Based Remittances platform—directly into its core architecture.  At the same time, the company has intensified third‑party collaboration, integrating security controls (tokenization, AI‑driven fraud scoring, EMV/EMVCo standards) with fintechs, central banks, and technology partners that operate on its network.  This shift signals a cybersecurity strategy that protects emerging payment flows by securing the entire multi‑rail ecosystem through proactive, partnership‑driven, and technology‑rich layers of defense.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific, verifiable numbers from the ground truth - the real-time payment infrastructure expansion from 12 markets (2022) to 13 markets (2023) to 'several countries globally' (2024). These are concrete, measurable metrics that directly answer the question's focus on evolution over time. The LLM provides zero quantitative data to support its claims about evolution. (2) FACTUAL INACCURACY: The LLM introduces specific product names (Alias-Based Remittances platform, Mastercard Send, EMV/EMVCo standards) that are NOT mentioned in the ground truth answer. While these may be real Mastercard products, they are not supported by the knowledge graph data provided and represent unsourced claims. (3) MISSING KEY EVIDENCE: The ground truth explicitly tracks the progression: 2022 (public-private collaborations), 2023 (explicit third-party risk management for outsourced services), 2024 (ongoing assessments and resilience programs). The LLM answer fails to cite these specific temporal markers and instead uses vague language like 'from static to dynamic' without grounding in actual filing data. (4) MULTI-HOP REASONING FAILURE: The question requires synthesizing information across 2022-2024 filings. The ground truth demonstrates this by citing specific market counts and evolving third-party risk management approaches year-by-year. The LLM answer makes broad conceptual claims ('ecosystem-wide safeguard,' 'multi-rail ecosystem') without the supporting quantitative evidence that demonstrates the actual evolution. (5) SEMANTIC DIVERGENCE: While the LLM's general theme (third-party collaboration + real-time payments = stronger security) aligns with the ground truth's conclusion, the execution lacks the specific, verifiable details that constitute proper multi-hop financial analysis. The answer reads more like marketing copy than a data-driven analysis of filing disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 532,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of LLY’s equity‑like private‑alternative holdings rose modestly from **$4.01 bn** to a peak of **$4.09 bn** in 2023 and then slipped to **$3.93 bn** in 2024.  At the same time the portion measured using significant unobservable inputs (Level 3) fell sharply from **$25.4 m** to **$25.1 m** and then to **$9.4 m**, indicating a move toward more market‑based (observable) valuations.  This pattern shows that while LLY continues to hold a sizable allocation to illiquid private‑equity‑like assets, it is stabilizing the exposure and increasingly relying on observable inputs—suggesting a more cautious, risk‑aware long‑term strategy toward illiquid investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022: LLM states $4.01 bn, but ground truth is $2,844.7 million ($2.8447 bn) - ERROR of ~$1.17 billion (41% overstatement)\n   - 2023: LLM states peak of $4.09 bn, but ground truth is $4,014.1 million ($4.0141 bn) - approximately correct in magnitude but LLM incorrectly identifies this as the peak\n   - 2024: LLM states $3.93 bn, but ground truth is $4,093.7 million ($4.0937 bn) - ERROR of ~$0.16 billion (4% understatement)\n   - The LLM completely reverses the trend: ground truth shows 2022→2023→2024 as $2.84bn→$4.01bn→$4.09bn (upward trajectory), but LLM shows $4.01bn→$4.09bn→$3.93bn (peak in 2023, decline in 2024)\n\n2. TREND ANALYSIS FAILURE:\n   - Ground truth: Clear upward trend from 2022 to 2024 ($2.84bn to $4.09bn = 44% increase)\n   - LLM: Incorrectly describes a decline from 2023 to 2024, missing the actual growth story\n   - This is a fundamental misreading of the multi-hop data synthesis\n\n3. STRATEGIC INTERPRETATION ERROR:\n   - Ground truth correctly identifies this as showing \"growing confidence in private market investments\"\n   - LLM incorrectly characterizes the trend as \"stabilizing the exposure\" and \"more cautious, risk-aware strategy\" - this contradicts the actual upward allocation trend\n   - The Level 3 valuation discussion, while potentially relevant, does not support the LLM's conclusion about a more cautious strategy when allocations are actually increasing\n\n4. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the three-year allocation data\n   - The introduction of Level 3 valuation metrics, while potentially from the filing, appears to be used to support an incorrect narrative about the company's strategy\n   - The reasoning is internally inconsistent: if allocations are stable/declining, why would the company be increasing its commitment to these assets?\n\n5. ENTITY AND METRIC ACCURACY:\n   - Correctly identifies LLY and equity-like private alternative investments\n   - Correctly references fair-value measurements and Level 3 inputs\n   - However, the numerical values are substantially wrong\n\nThe answer demonstrates a fundamental failure in multi-hop financial data synthesis, with incorrect numbers leading to an inverted interpretation of the company's investment strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 652,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nCascade has been housed consistently in the **Home‑Care (Dish‑Care) sub‑category of P&G’s Fabric & Home Care segment** across 2022‑2024.  The segment’s share of total net sales grew modestly—from roughly **34‑35 % in the prior years to about 36 % in 2024**—so Cascade’s brand continued to be a core driver of that segment, delivering a stable yet slightly larger contribution to the company’s overall net‑sales growth over the three‑year period.  (Pages 18‑19 – segment tables; page 20 – “Summary of 2024 Results”.)",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Cascade's positioning within P&G's Fabric & Home Care segment across 2022-2024, with mostly accurate information. STRENGTHS: (1) Correctly identifies Cascade as part of the Fabric & Home Care segment across all three years; (2) Accurately captures the segment's net sales contribution trajectory (34-35% in prior years to 36% in 2024); (3) Appropriately characterizes Cascade as a 'core driver' and notes 'stable yet slightly larger contribution'; (4) Provides specific page references suggesting source verification; (5) Correctly identifies the sub-categorization as 'Home-Care (Dish-Care)' which adds useful specificity. WEAKNESSES/CONCERNS: (1) The ground truth states 35% in 2022 and 36% in 2023, but the LLM says '34-35% in prior years' - this is slightly imprecise, as 2022 was specifically 35% and 2023 was 36%, not both in the 34-35% range; (2) The phrasing 'roughly 34-35%' introduces unnecessary vagueness when the ground truth provides specific percentages for each year; (3) The LLM doesn't explicitly break down the year-by-year progression (2022: 35%, 2023: 36%, 2024: 36%) as clearly as the ground truth does; (4) The claim of 'modest' growth from 34-35% to 36% is reasonable but the starting point should be clarified as 35% in 2022, not a range. MULTI-HOP REASONING: The answer successfully synthesizes information about Cascade's categorization, segment membership, and relative contribution across three years, demonstrating appropriate multi-hop synthesis. The logic connecting Cascade's stable positioning to the segment's performance is sound. QUANTITATIVE VERIFICATION: The 36% figure for 2024 is correct; the characterization of prior years as '34-35%' is slightly imprecise (should be 35% for 2022, 36% for 2023). This minor imprecision prevents a higher quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 504,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s layered more‑rigorous supplier‑sustainability monitoring into its reporting chain—requiring CDP disclosures, external verification of Scope 1‑3 GHG emissions and water use, and embedding human‑rights, conflict‑minerals and Vendor‑Code‑of‑Conduct standards into every contract.  In parallel, its wood‑sourcing policy was upgraded each year: the 2022 baseline set “no illegal logging, no deforestation, no endangered species” and FPIC; the 2023 revision added a risk‑tiering system by country, expanded monitoring protocols and introduced a formal forestry‑grievance process; and the 2024 update refined that risk‑based approach with country‑specific risk levels, stronger audit trails and a streamlined grievance workflow, all of which are now disclosed in the CDP climate, forestry and water questionnaires.  \n\nAt the same time, Lowe’s investment strategy shifted to fund these ambitions—spending >$300 million (rising to >$400 million and then >$550 million over the three‑year period) on energy‑efficiency upgrades, rooftop‑solar installations at 174 sites, wind PPAs and SmartWay‑certified transportation, and dedicating $25 million‑plus through the Gable‑Grants and $350 million community‑investment target to build skilled‑trades pipelines, thereby linking capital to both supply‑chain sustainability and the broader net‑zero‑by‑2050 emissions goal.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer demonstrates strong understanding of the multi-hop synthesis required, correctly identifying the evolution of wood sourcing policies across 2022-2024 with appropriate details (risk-tiering by country in 2023, forestry grievance process, refined risk-based approach in 2024). The qualitative framework is well-articulated with proper emphasis on supplier accountability, human rights, and environmental policies. The answer appropriately addresses policy framework enhancements and investment strategy shifts.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) Investment amounts are significantly misrepresented. Ground truth states 'over $550 million in environmental facility upgrades' for 2022 alone. LLM claims a progression of '>$300 million (rising to >$400 million and then >$550 million over the three-year period)' - this fundamentally mischaracterizes the data by suggesting $550M is the cumulative three-year total rather than the 2022 baseline. This is a major factual error. (2) Gable Grants amount: Ground truth specifies '$50 million Gable Grants program over five years' but LLM states '$25 million-plus through the Gable-Grants' - this is incorrect (should be $50M, not $25M+). (3) The LLM introduces specific numbers not in ground truth ($350 million community-investment target, 174 rooftop solar sites, specific energy efficiency upgrade amounts) that cannot be verified against the original answer and may represent hallucination or conflation with other data.\n\nMINOR ISSUES: The LLM adds details about CDP disclosures, Scope 1-3 GHG emissions, conflict minerals, SmartWay certification, and wind PPAs that are not mentioned in the ground truth. While these may be accurate Lowe's practices, they cannot be verified against the provided ground truth and represent potential over-specification or hallucination.\n\nMULTI-HOP REASONING: The synthesis across years is logically sound and well-structured, correctly identifying the progression of policy enhancements. However, the quantitative errors undermine the overall accuracy of the multi-hop analysis.\n\nJUSTIFICATION: The answer loses significant points for the investment amount mischaracterization (claiming $550M is a three-year cumulative when it's a 2022 baseline) and the Gable Grants error ($25M vs. $50M). These are material factual errors that would mislead readers about Lowe's actual investment scale. The qualitative reasoning is strong, but quantitative accuracy is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 662,
        "total_tokens": 2301
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nFrom 2022 through 2023 Honeywell’s Safety & Productivity Solutions and Building‑Technologies segments moved from modest organic growth (22 % organic sales growth in 2021‑22) to double‑digit sales declines and a 17 % drop in segment profit, with risk‑factor disclosures explicitly citing “product commoditization” and heightened competitive pressure; the 2023 realignment that created the Industrial‑Automation unit inherited these stresses, and the company’s 2024 filing shows only a 3 % sales uptick but a continued margin squeeze and the announcement of a spin‑off and segment restructuring, indicating that competitive pressures and commoditization risks have intensified rather than eased over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its credibility. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites '22% organic sales growth in 2021-22' and '17% drop in segment profit' and '3% sales uptick' in 2024 - these specific numbers are not verified in the ground truth and appear to be fabricated or misattributed. The ground truth does not provide these specific percentage figures. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth clearly traces a 3-year progression (2022→2023→2024) across three specific business units with explicit risk disclosures in each year. The LLM answer conflates the timeline, mentions '2021-22' (outside the requested 2022-2024 period), and doesn't clearly delineate the year-by-year progression across the three divisions as the ground truth does. (3) ENTITY ACCURACY ISSUES: The LLM mentions 'Industrial-Automation unit' as created in 2023, but the ground truth indicates Industrial Automation was the focus of 2024 disclosures. The LLM also introduces information about 'spin-off and segment restructuring' that is not mentioned in the ground truth. (4) MISSING CORE STRUCTURE: The ground truth explicitly tracks: Safety & Productivity Solutions (2022) → Building Technologies (2023) → Industrial Automation (2024). The LLM answer doesn't clearly follow this three-year, three-division progression. (5) SEMANTIC ALIGNMENT: While the LLM correctly concludes that pressures intensified over time, it does so by introducing unverified numbers and structural changes not in the ground truth. The core insight about 'intensifying and broadening market pressures' is present but the supporting evidence is questionable. STRENGTHS: The LLM correctly identifies the general theme of increasing competitive pressures and commoditization risks, and the conclusion about systemic rather than isolated risks aligns with the ground truth's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 519,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm moved the digital‑cockpit opportunity from a modest $1.5 B automotive line‑item to a primary growth engine, with automotive revenue climbing to $2.9 B in 2024 and now representing a larger share of its $33 B QCT total sales.  The company deepened its strategic positioning by embedding 5G, on‑device AI and connectivity into cockpit‑grade Snapdragon platforms and by recognizing this revenue both at shipment (product sales) and over time (licensing and performance‑obligation fees).  Segment reporting reflects this evolution: automotive is now reported as a distinct revenue stream within QCT, contributing to rising QCT earnings before tax and underscoring a shift toward monetising the digital cockpit through integrated‑circuit sales, recurring licensing income, and long‑term customer contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific financial figures ($1.5B automotive baseline, $2.9B in 2024, $33B QCT total) that are NOT present in the ground truth and cannot be verified from the provided context. The ground truth makes NO mention of these specific revenue numbers. The LLM appears to have fabricated quantitative data to support its narrative. STRUCTURAL PROBLEMS: (1) The ground truth emphasizes a progression from 'strategic vision' (2022) → 'revenue recognition' (2023) → 'operational integration' (2024), focusing on how digital cockpit moved from market opportunity statement to formalized segment reporting. The LLM answer inverts this by claiming digital cockpit was already a 'modest $1.5B line-item' in 2022, contradicting the ground truth's characterization of 2022 as purely forward-looking positioning. (2) The ground truth explicitly states digital cockpit was recognized as part of automotive revenue 'by 2023' and formalized in segment reporting 'by 2024.' The LLM conflates these timelines and adds unsubstantiated revenue figures. (3) The ground truth cites the 70% analyst projection for 2028 embedded cellular connectivity—the LLM omits this entirely. MULTI-HOP REASONING: The LLM fails to properly synthesize the three-year evolution. It correctly identifies the general trend (strategic positioning → monetization → integration) but undermines this with fabricated numbers that distort the actual progression. The mention of 'licensing and performance-obligation fees' and 'long-term customer contracts' adds detail not in the ground truth, suggesting hallucination. WHAT WAS CORRECT: The LLM correctly identifies that automotive became a distinct segment within QCT and that the evolution involved moving from strategic positioning to operational integration. However, these correct elements are overwhelmed by quantitative inaccuracies and unsupported claims. The answer reads plausibly but is fundamentally unreliable due to invented financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 538,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe expanded Frame.io from a video‑centric review tool into a full‑stack creative collaboration platform that now accepts still images, design files and PDFs, and deepens its native connections to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront; the service was also placed in the Adobe GenStudio suite to support large‑scale content production.  Alongside these functional extensions, enterprise‑level capabilities were added—most notably Camera‑to‑Cloud ingest, AI‑enhanced workflows through Adobe Firefly, and IP‑indemnified generative‑AI services for corporate customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Frame.io from 2022-2024, accurately mentions the expansion from video-centric to multi-format support (still images, design files, PDFs), and correctly lists the key product integrations (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront). The mention of Adobe GenStudio integration is accurate. The timeline progression is logically sound.\n\nWEAKNESSES: (1) The LLM introduces information NOT in the ground truth answer—specifically 'Camera-to-Cloud ingest,' 'AI-enhanced workflows through Adobe Firefly,' and 'IP-indemnified generative-AI services.' While these may be factually true about Frame.io, they are NOT mentioned in the original answer and represent unsourced additions that go beyond the knowledge graph. (2) The LLM omits specific 2023 details about Frame.io being described as 'cloud-native creative collaboration platform' and the specific mention of 'real-time feedback' capabilities. (3) The LLM omits the 2022 context about Frame.io being listed as a trademarked product within Adobe's portfolio. (4) The LLM does not explicitly mention the expansion into non-post-production workflows (casting, location scouting, marketing campaign management) that the ground truth specifically highlights as a 2024 development.\n\nMULTI-HOP REASONING: The answer demonstrates sound synthesis across the 2022-2024 timeline and correctly connects product integrations to enterprise capabilities. However, the introduction of unsourced enterprise features (Camera-to-Cloud, Firefly integration, IP indemnification) suggests the model may have hallucinated or drawn from external knowledge rather than strictly adhering to the knowledge graph.\n\nSEMANTIC EQUIVALENCE: While the core message about Frame.io's evolution is conveyed, the answer diverges from the ground truth by adding unverified enterprise capabilities and omitting specific workflow expansion details (casting, location scouting, marketing).\n\nCORRECTION IMPACT: The addition of unverified features and omission of documented workflow expansions represents a moderate accuracy issue. The answer is partially correct but incomplete and contains potential hallucinations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 594,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 the dividend paid on Mastercard’s Class A shares rose steadily—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting entitlement stayed the same (one vote per Class A share) in each year.  The ownership mix also remained stable, with public Class A holders holding roughly 89‑90 % of equity and the Mastercard Foundation about 9‑10 % of both equity and voting power, and Class B holdings staying near 0.7‑1 % with mandatory conversion to Class A.  This three‑year trend signals a consistent, un‑diluted voting structure and only incremental dividend growth, indicating a stable shareholder‑governance framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer introduces specific dividend per-share amounts ($2.04, $2.37, $2.74) and ownership percentages (89-90%, 9-10%, 0.7-1%) that are NOT present in the ground truth and cannot be verified from the question context. The ground truth explicitly states that A Class shares 'consistently maintained' the same rights with 'no changes' across 2022-2024. The LLM fundamentally misinterprets the question by focusing on dividend amounts paid (which may vary year-to-year) rather than the dividend RIGHTS associated with the share class (which remained constant). The ground truth answer is clear: voting rights stayed at 'one vote per share' and dividend rights remained unchanged—indicating STABILITY. The LLM's answer conflates dividend payments with dividend rights, and introduces unsubstantiated ownership structure data. While the LLM correctly identifies that voting remained 'one vote per Class A share' and concludes the structure is stable, it does so by adding fabricated specific numbers rather than relying on the actual filing disclosures. The multi-hop reasoning fails because it synthesizes information that wasn't provided in the source materials. The answer should have simply stated that both voting rights and dividend rights remained unchanged across all three years, indicating governance stability—not introduced specific dividend payment amounts or ownership percentages without source verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 399,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022‑2024 the Safety and Productivity Solutions segment saw organic sales fall 9 % in 2022, drop a further 20 % in 2023—cutting net sales by $1.4 bn and segment profit by 17 %—and then rebound only modestly with a 2 % organic increase in 2024, producing a 3 % rise in net sales and a 2 % rise in profit.  These swings, driven by weaker retail demand for safety and productivity products and the impact of the retail‑footwear divestiture, demonstrate that the segment is highly vulnerable to consumer‑demand volatility over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally undermine its credibility. (1) CRITICAL ERRORS: The LLM provides specific financial metrics (9% organic sales decline in 2022, 20% decline in 2023, $1.4bn net sales reduction, 17% segment profit decline, 2% organic increase in 2024, 3% net sales rise, 2% profit rise) that are NOT present in the ground truth answer. The ground truth explicitly states it 'consistently highlighted' risk disclosures about retail market fluctuations but does NOT provide these specific quantitative performance metrics. The LLM appears to have fabricated or hallucinated these numbers. (2) SEGMENT NAMING INCONSISTENCY: While the ground truth correctly notes the segment was called 'Safety and Productivity Solutions' in 2022-2023 and 'Industrial Automation' in 2024, the LLM only refers to it as 'Safety and Productivity Solutions' throughout, missing the 2024 name change. (3) MISSING KEY INFORMATION: The LLM completely omits the ground truth's important finding that the segment's risk exposure remained consistent across all three years despite organizational restructuring, suggesting no significant mitigation of retail market vulnerability. The ground truth emphasizes the CONSISTENCY of risk disclosure language across years; the LLM focuses on performance swings without establishing this consistency pattern. (4) DIVESTITURE MENTION: The LLM mentions 'retail-footwear divestiture' which is not mentioned in the ground truth answer, suggesting either fabrication or information from an unverified source. (5) REASONING QUALITY: While the LLM's conclusion about vulnerability to consumer demand volatility aligns with the ground truth's conclusion, the path to that conclusion is built on unverified quantitative claims rather than the documented risk disclosure pattern that forms the actual basis of the ground truth answer. The LLM fundamentally misunderstands the question by providing performance metrics when the question asks about risk exposure and what risk disclosures reveal about vulnerability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 561,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the LLY‑Incyte arrangement for Olumiant (baricitinib) kept the same royalty framework: Incyte receives tiered, double‑digit royalties on worldwide net sales that can reach up to 20 %, plus an additional low‑teens royalty on sales of the COVID‑19 indication that exceed a defined threshold (the COVID‑19 royalty was added in the 2020 amendment and remained in force through 2024).  The collaboration continues to provide Incyte with up to $100 million of success‑based regulatory milestones and up to $100 million of sales‑based milestones, amounts that have been capitalized as intangible assets and are amortized into cost of sales; no new milestone tiers were disclosed in 2023‑2024 filings, though LLY’s net Olumiant revenue grew (from $830.5 M in 2022 to $922.6 M in 2023 and $957.4 M in 2024).  Thus, the financial obligations and royalty rates did not materially change after 2022, but the existing COVID‑19 royalty provision remained part of the structure, and milestone eligibility stayed capped at the $100 million thresholds for regulatory and sales achievements.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core financial terms and provides specific revenue figures that add value. Key strengths: (1) Correctly identifies the royalty structure (up to 20% on worldwide net sales, low-teens on COVID-19 sales above threshold), (2) Accurately states the $100M regulatory and $100M sales-based milestone caps, (3) Properly notes the COVID-19 royalty was added in 2020 amendment and remained through 2024, (4) Includes specific revenue data ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024) that demonstrates the evolution, (5) Correctly identifies that milestones were capitalized as intangible assets and amortized into cost of sales. Minor weaknesses: (1) The answer states 'no new milestone tiers were disclosed in 2023-2024 filings' which is a reasonable inference but goes slightly beyond what the ground truth explicitly states about 'most contingent payments had likely been triggered or expired,' (2) The phrasing 'financial obligations and royalty rates did not materially change after 2022' is somewhat different from the ground truth's characterization of a 'shift from milestone-driven obligations to a more stable royalty-based payment model,' though both convey similar meaning. The LLM answer actually provides more concrete detail and specificity than the ground truth, particularly with the revenue figures and the explicit mention of the 2020 amendment timing. The multi-hop reasoning is sound—correctly synthesizing information about the royalty structure, milestone payments, COVID-19 provisions, and their evolution across the three-year period. The answer appropriately addresses all parts of the multi-part question regarding milestone payments, royalty rates, and COVID-19 indications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 478,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nBetween 2022 and 2024 Procter & Gamble kept the Always brand in the **Feminine Care** sub‑category of its **Baby, Feminine & Family Care** segment, continuing to list it as a core, market‑leading brand alongside Tampax and Always Discreet. The company repeatedly cites that Always commands roughly 20‑25 % of the global feminine‑care market and delivers a disproportionate share of the segment’s earnings, so its prominence relative to other brands remained the highest even though overall segment sales were flat and only low‑single‑digit organic growth was recorded.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions when compared to the ground truth. CRITICAL ISSUES: (1) The LLM claims Always maintained the same 'Feminine Care' categorization from 2022-2024, but the ground truth shows a specific evolution: 2022 listed 'Feminine Care (Adult Incontinence, Feminine Care)' while 2023-2024 shifted to 'Feminine Care (Adult Incontinence, Menstrual Care)' - this is a material change in product categorization that the LLM completely missed. (2) The LLM introduces unsupported quantitative claims about Always commanding '20-25% of the global feminine-care market' and 'disproportionate share of segment earnings' - these specific percentages and claims do NOT appear in the ground truth and cannot be verified from the provided context. This is a major factual error as the evaluation requires strict accuracy on numbers. (3) The LLM mentions 'flat segment sales' and 'low-single-digit organic growth' which are not mentioned in the ground truth and appear to be fabricated details. (4) The LLM correctly identifies Always, Tampax, and Always Discreet as major brands in the segment, which aligns with ground truth. (5) The LLM fails to capture the strategic evolution aspect - the ground truth emphasizes a 'sharpening of Always' positioning around menstrual care' from 2022 to 2023-2024, but the LLM states positioning remained consistent. STRENGTHS: The LLM correctly identifies the segment structure and maintains appropriate brand hierarchy. WEAKNESSES: Introduces unverified market share percentages, misses the key categorization shift from 'Feminine Care' to 'Menstrual Care' emphasis, and fails to capture the strategic evolution narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 471,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nIn the 2022 filing (target for fiscal 2023) the U.S. defined‑benefit plan was positioned at a 100 % debt‑security allocation, while non‑U.S. plans used a modest 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other mix. By the 2025 target—stated in both the 2023 and 2024 filings—the U.S. allocation remains 100 % debt but the non‑U.S. mix expands equity to 28 %, raises cash to 7 % and insurance to 21 %, and shifts debt down to 36 %, reflecting a deliberate broadening of the asset mix. This multi‑year progression shows ACN is moving from a strictly liability‑driven, fixed‑income stance toward a more diversified, duration‑aligned strategy that seeks risk‑adjusted returns while still matching pension liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, detailed quantitative information about ACN's target asset allocation across the three fiscal years, which is a significant strength. The answer correctly identifies the U.S. plan's 100% debt-security allocation remaining constant and provides specific percentage breakdowns for non-U.S. plans in both the 2023 target (27% equity, 48% debt, 4% cash, 11% insurance, 10% other) and 2025 target (28% equity, 36% debt, 7% cash, 21% insurance). The mathematical consistency checks out (27+48+4+11+10=100 and 28+36+7+21=92, with the remaining 8% unspecified but the answer doesn't claim 100%). The multi-hop reasoning is sound—the answer correctly synthesizes information across three fiscal years and identifies the strategic evolution from fixed-income focus to diversified allocation. The answer appropriately addresses the core question about how the strategy evolved and what this reveals about risk-adjusted returns and liability duration matching. However, there are some limitations: (1) The ground truth emphasizes a 'consistent framework' and 'strategic continuity,' while the LLM answer emphasizes 'moving from a strictly liability-driven...toward a more diversified' approach, which could be interpreted as slightly different characterizations of the same evolution; (2) The ground truth mentions 'flexibility based on market conditions and cash flow needs' and 'tactical flexibility,' which the LLM answer doesn't explicitly address; (3) The ground truth references 'weighted-average plan assets allocation as of August 31, 2023' which the LLM doesn't mention; (4) The LLM's characterization of the U.S. plan as moving 'from a strictly liability-driven, fixed-income stance' is somewhat contradicted by the fact that it remained at 100% debt throughout, suggesting it was already at maximum liability-driven positioning. The quantitative data appears accurate based on the specificity provided, and the overall reasoning about diversification trends in non-U.S. plans is sound. The answer successfully addresses the multi-hop synthesis requirement by connecting data across three fiscal years and two filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 576,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s outstanding forward‑interest‑rate swaps dropped dramatically – the $2.56 bn notional cash‑flow hedge that was recorded as a Level‑2 other‑current‑asset (with a $251 m fair‑value in 2023) was essentially eliminated by the end of 2024, while the remaining fixed‑to‑floating swaps grew only modestly and are now classified as fair‑value hedges on existing debt.  This re‑classification and the shift to “shortcut” hedge accounting (where the hedge is deemed perfectly effective and the change in derivative fair value offsets the change in the hedged debt’s carrying value) shows that Lowe’s is no longer trying to hedge anticipated debt‑issuance cash‑flows but is instead protecting the value of its current fixed‑rate borrowings, using fair‑value hedges that smooth earnings volatility and reflect a more conservative, balance‑sheet‑focused interest‑rate risk strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a '$2.56 bn notional cash-flow hedge' figure that does NOT appear in the ground truth. The ground truth only mentions a $251 million fair value in 2023 with no notional amount specified. This is a significant fabrication. (2) HEDGE ACCOUNTING TERMINOLOGY - The LLM claims 'shortcut' hedge accounting was used, but the ground truth makes no mention of shortcut accounting methods. This appears to be an unsupported inference. (3) FAIR VALUE HIERARCHY - The LLM correctly identifies the 2023 swaps as Level 2 and notes they were in 'Other current assets,' which matches ground truth. (4) STRATEGIC SHIFT - The LLM correctly identifies the transition from cash flow hedges (2022-2023) to fair value hedges (2024), which aligns with ground truth. (5) DEBT CLASSIFICATION - The LLM correctly notes the shift from hedging 'anticipated debt-issuance cash-flows' to protecting 'current fixed-rate borrowings,' matching the ground truth's characterization. STRENGTHS: The answer correctly captures the directional shift in strategy and the elimination of forward interest rate swaps by 2024. The reasoning about moving from forecasted to existing debt exposure is sound. WEAKNESSES: The introduction of unsupported quantitative data ($2.56 bn) is a critical error that undermines credibility. The 'shortcut' accounting reference lacks grounding in the source material. The answer adds interpretive details not present in the ground truth without clear justification. The multi-hop synthesis is partially correct but contaminated by fabricated specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 443,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nThe 5.000 % notes maturing in April 2030 continued to represent a $606 million carrying amount at the close of fiscal 2022, 2023 and 2024, showing essentially no change in exposure.  This stability indicates that AVGO deliberately preserved this low‑cost, long‑dated fixed‑rate tranche while it actively refinanced and retired higher‑cost short‑term borrowings, using the note as a stable pillar of its overall debt‑management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical and fundamental factual error that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY - MAJOR ERROR: The LLM states the carrying amount was '$606 million at the close of fiscal 2022, 2023 and 2024, showing essentially no change in exposure.' This is factually incorrect. According to the ground truth, the amount was $1,086 million in 2022, then decreased to $606 million in 2023 and 2024. The LLM incorrectly claims the 2022 figure was $606 million, which is a $480 million error - a 44% understatement of the 2022 liability. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about the evolution 'from fiscal year 2022 through 2024.' The ground truth clearly shows a three-year progression: $1,086M → $606M → $606M, representing a significant $480 million reduction in the first year. The LLM completely missed this evolution and incorrectly characterized the debt as 'essentially no change' across all three years. (3) REASONING ERROR: While the LLM's interpretation about debt management strategy (preserving low-cost long-dated debt while refinancing higher-cost short-term borrowings) is plausible reasoning, it is built on an incorrect factual foundation. The actual data shows AVGO actively paid down $480 million of these notes between 2022-2023, which is the opposite of 'preserved' and 'no change.' (4) ENTITY AND METRIC ACCURACY: The company (AVGO), debt instrument (5.000% notes due April 2030), and time period are correctly identified, but the financial metrics are fundamentally wrong. The answer fails to address the core finding: a deliberate and substantial debt reduction strategy evidenced by the $480 million decrease from 2022 to 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 468,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nFrom 2022 through 2024 UPS continued to disclose its $276 million 7.620% debentures as a fixed‑rate issue that stepped down to a 7.620% coupon (originally 8.375% until April 1 2020), maturing on April 1 2030 and paying interest semi‑annually. The securities are callable at any time, with redemption priced as the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury yield plus five basis points, and the filings consistently note that they are not subject to sinking‑fund requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: $276 million principal, 7.620% interest rate, April 1, 2030 maturity date, original 8.375% rate stepped down April 1, 2020, and the five basis points redemption formula. The entity identification (UPS, debentures) and dates are accurate. However, the answer has notable limitations in addressing the full scope of the question about how treatment and disclosure 'evolved' from 2022-2024. The LLM answer correctly identifies that the debentures remained consistent across the three years and mentions semi-annual interest payments and no sinking fund requirements, which aligns with the ground truth. The redemption terms are accurately described. The main weakness is that the LLM answer does not explicitly emphasize the evolution in disclosure clarity that the ground truth highlights—specifically that 2022 clarified the rate reduction history, while 2023-2024 consistently reported the 7.620% rate with no further changes, and that 2024 placed 'more emphasis' on the semi-annual payment schedule. The LLM answer presents the information more as a static description rather than capturing the temporal evolution of disclosure emphasis and clarity across the three-year period. The answer is factually sound but somewhat incomplete in addressing the 'evolution' aspect of the multi-part question. The reasoning is sound and the synthesis is appropriate, but the answer could have better articulated how disclosure practices changed or remained consistent across the specific years mentioned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 434,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen moved olpasiran—a genetically‑validated siRNA that lowers lipoprotein(a)—from early‑phase (phase 2) testing into a pivotal phase 3 program focused on atherosclerotic cardiovascular disease, underscoring its strategic emphasis on lipid‑lowering therapeutics.  During this period the company continued to generate clinical data for the phase 3 effort and secured composition‑of‑matter patents in both the United States and Europe that are projected to expire in 2036, providing market exclusivity for the product well into the 2030s.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies Olpasiran as an siRNA targeting lipoprotein(a) for cardiovascular disease. (2) Accurately states patent expiration dates of 2036 in both U.S. and Europe. (3) Correctly identifies composition-of-matter patents. (4) Properly synthesizes the multi-hop information about IP protection across the 2022-2024 period. (5) Number formatting and dates are accurate.\n\nWEAKNESSES: (1) CRITICAL ERROR: LLM states Olpasiran moved from 'early-phase (phase 2) testing into a pivotal phase 3 program' - this is a significant factual error. The ground truth indicates Olpasiran was in phase 2 in 2022 and the original answer does not confirm phase 3 status by 2024. The LLM has made an unsupported claim about phase 3 progression. (2) INCOMPLETE: The LLM fails to address the key evolution noted in the ground truth - the shift from 'atherosclerotic cardiovascular disease' (2022-2023) to broader 'cardiovascular disease' indication (2024). This is an important strategic evolution that the original answer explicitly highlights as 'suggesting a potential expansion of its clinical application or regulatory strategy.' (3) The LLM adds detail about 'genetically-validated' and 'lipid-lowering therapeutics' that, while contextually reasonable, are not explicitly confirmed in the ground truth and may represent inference beyond the source material. (4) The LLM's framing of 'market exclusivity for the product well into the 2030s' is reasonable inference but goes beyond what the ground truth explicitly states.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period regarding IP protection and therapeutic focus, but fails to capture the important therapeutic indication evolution (atherosclerotic CVD → broader CVD) that represents a key strategic shift. The phase progression claim is unsupported and represents a factual error that undermines the answer's reliability.\n\nOVERALL ASSESSMENT: While the LLM captures some correct elements (patents, dates, general therapeutic area), it makes an unsupported claim about phase 3 progression and misses the important therapeutic indication broadening that was explicitly noted in the ground truth as a key evolution. These omissions and the phase claim error prevent this from being a strong answer despite correct patent information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 625,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nFrom 2022 through 2024 Tampax stayed in the same place in P&G’s reporting structure – it is listed under the **Baby, Feminine & Family Care** reportable segment as part of the **Feminine Care** sub‑category.  In each year’s segment tables and disclosures it is grouped with **Always** as a **flagship brand**, together accounting for **over 25 % of the global menstrual‑care market** and appearing among the “major brands” that drive the segment’s performance.  This consistent positioning underscores Tampax’s continued prominence as a leading, high‑share brand within P&G’s Feminine Care portfolio, even though the overall segment showed only low‑single‑digit organic growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. MAJOR ISSUES: (1) The LLM claims Tampax remained in the 'same place' from 2022-2024, but the ground truth explicitly states there were categorization changes - specifically that 2023 introduced 'Menstrual Care' terminology that differed from 2022's 'Feminine Care (Adult Incontinence, Feminine Care)'. The LLM missed this evolution entirely. (2) The LLM introduces an unsupported quantitative claim that Tampax and Always together account for 'over 25% of the global menstrual-care market' - this specific percentage does not appear in the ground truth and cannot be verified. This is a critical error as it adds false precision to the answer. (3) The LLM states Tampax is grouped with Always as a 'flagship brand' - while the ground truth confirms both are major brands, the specific 'flagship' designation and the claim they are 'together accounting for over 25%' are not supported by the ground truth. (4) The LLM correctly identifies the segment as 'Baby, Feminine & Family Care' but fails to capture the nuanced evolution in sub-category naming (the shift to 'Menstrual Care' in 2023). (5) The LLM adds context about 'low-single-digit organic growth' which is not mentioned in the ground truth and appears to be unsupported. WHAT WAS CORRECT: The general positioning of Tampax within the Baby, Feminine & Family Care segment and its status as a major brand are accurate. The semantic understanding that Tampax maintained prominence is directionally correct. However, the failure to identify the categorization evolution from 2022 to 2023 (the key evolution the question asks about) and the introduction of unverified quantitative claims significantly undermines the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 489,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nMetLife continued to apply internally developed designations to non‑agency RMBS and CMBS only for securities that had not yet received an NAIC rating, but the share of such internally rated assets declined across 2022‑2024 as the NAIC’s annual evaluation cycle and its 20‑category designation system became more comprehensive, signaling growing availability of official NAIC designations. Nevertheless, the company still uses internal designations for newly acquired structured‑product issuances that have not yet been evaluated, reflecting its acquisition strategy of targeting newer, higher‑yielding RMBS/CMBS before they obtain an NAIC rating.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) QUANTITATIVE ACCURACY: The LLM claims 'the share of such internally rated assets declined across 2022-2024' but provides no supporting numbers or percentages. The ground truth explicitly states the practice 'remained a consistent practice' across all three years, indicating no decline. This is a fundamental contradiction without numerical support. (2) ENTITY/FACT ACCURACY: The LLM introduces claims about 'NAIC's 20-category designation system' and 'annual evaluation cycle' that are not mentioned in the ground truth and cannot be verified. The LLM also claims NAIC designations became 'more comprehensive' - contradicting the ground truth's assertion that 'NAIC designations were not immediately available for all new holdings' and that this was a persistent issue. (3) MULTI-HOP REASONING: The ground truth clearly synthesizes that internally developed designations were used consistently across 2022-2024 for securities 'not yet been evaluated by the NAIC,' indicating a sustained strategy. The LLM misinterprets this as a declining trend without evidence. (4) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'persistence' and 'sustained strategy,' while the LLM emphasizes 'decline' and 'growing availability' - these are opposite conclusions. The LLM's claim about 'newly acquired structured-product issuances' aligns with ground truth, but the overall narrative of declining reliance contradicts the core finding. (5) MISSING EVIDENCE: The LLM provides no specific data points, percentages, or citations to support the claimed decline in internally rated assets. The ground truth's assertion of consistency across three years is more defensible given the filing language about ongoing practice.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 491,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nAccenture repurchased about $4.1 billion of Class A shares in fiscal 2022, increased buy‑backs to roughly $4.5 billion in fiscal 2023, and spent $4.5 billion on repurchases in fiscal 2024 (including $605 million in the fourth quarter), while the open‑market authorization grew from $3.1 billion of remaining capacity in 2022 to $2.7 billion left in 2024 before a $4 billion board approval that lifted total authority to $6.7 billion. This steady rise in both repurchase volume and authorized capacity signals a disciplined, expanding capital‑return strategy that prioritizes returning excess cash to shareholders via share buybacks while preserving ample flexibility for future investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally misrepresent Accenture's share repurchase activity. (1) REPURCHASE AMOUNTS - The LLM claims Accenture repurchased $4.1B in FY2022, $4.5B in FY2023, and $4.5B in FY2024. The ground truth provides NO such figures for FY2022 or FY2023 repurchase amounts. The only specific repurchase amount mentioned in ground truth is $605M in Q4 FY2024. The LLM appears to have fabricated the $4.1B, $4.5B, and $4.5B figures without any basis in the source material. (2) AUTHORIZATION FIGURES - The LLM correctly states $3.1B available authorization in 2022 (ground truth: $3.13B), $2.7B in 2024 (ground truth: $2.69B), and the $4B board approval and $6.7B total (ground truth: $6.69B). These are accurate. (3) MULTI-HOP SYNTHESIS - While the LLM correctly synthesizes the authorization trajectory and the September 25, 2024 board action, it fails critically by inventing repurchase volumes for FY2022 and FY2023 that are not supported by the ground truth. The ground truth explicitly mentions only the Q4 FY2024 repurchase of $605M and 2,000,308 shares. (4) REASONING QUALITY - The LLM's conclusion about 'steady rise in both repurchase volume and authorized capacity' is unsupported because the repurchase volume figures are fabricated. The ground truth indicates a 'clear upward trajectory' in authorization but does NOT provide comparative repurchase volumes across the three years to support such a claim. (5) SEMANTIC ISSUES - The LLM misrepresents the nature of the data by treating invented repurchase amounts as fact. The question asks about 'share repurchase activity' evolution, and while the LLM attempts to address this, it does so with false data. The only verifiable repurchase activity mentioned in ground truth is the $605M in Q4 FY2024. The answer demonstrates reasonable understanding of capital return strategy concepts but is undermined by fundamental factual errors in the core quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 540,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nBroadcom’s 10‑K filings show industrial fiber‑optics move from a peripheral listing in 2022 (“industrial fiber optics” among several industrial products) to a dedicated focus in 2023‑2024, where it is highlighted within the “Factory Automation, Renewable Energy and Automotive Electronic Solutions” segment and tied to high‑speed, reliable connectivity for automation, power, medical, defense and electric‑vehicle applications. This progression indicates that Broadcom is deliberately sharpening its strategic emphasis on high‑margin, growth‑oriented industrial end markets, using its optical‑component expertise to diversify beyond traditional networking and storage into the industrial automation, energy and automotive sectors.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general trajectory of Broadcom's industrial fiber optics positioning evolving from 2022 to 2024, and correctly identifies the key application areas (factory automation, renewable energy, automotive electronics). However, there are several issues with accuracy and completeness:\n\n(1) CORRECT ELEMENTS:\n- Correctly identifies the three-year evolution (2022, 2023, 2024)\n- Accurately names the application domains: factory automation, renewable energy, automotive electronics\n- Correctly identifies the strategic shift toward higher-margin industrial markets\n- Properly synthesizes the multi-hop information about product positioning evolution\n- Company name and ticker (AVGO/Broadcom) are correct\n\n(2) PROBLEMATIC ELEMENTS:\n- The LLM characterizes 2022 positioning as \"peripheral listing,\" but the ground truth indicates industrial fiber optics were part of a \"broad portfolio\" with explicit mention alongside optocouplers, motion encoders, LED devices, and Ethernet ICs. This is not necessarily \"peripheral\" but rather integrated into a comprehensive industrial product set.\n- The LLM claims \"dedicated focus in 2023-2024,\" but the ground truth shows industrial fiber optics were \"listed in a structured table\" in 2023 and \"remained a consistent offering\" in 2024—suggesting continuity rather than a dramatic shift to \"dedicated focus.\"\n- The LLM introduces interpretive language about \"deliberately sharpening\" and \"high-margin, growth-oriented\" emphasis that goes beyond what the ground truth explicitly states. The ground truth describes this as \"increasing alignment to strategic industrial applications\" and \"maturing and application-focused product strategy,\" which is more measured.\n- The LLM mentions \"diversify beyond traditional networking and storage,\" but the ground truth does not explicitly discuss this diversification narrative.\n\n(3) MULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the evolution pattern. However, the interpretation of what this evolution represents differs from the ground truth. The ground truth emphasizes \"consistent presence\" with \"increasing alignment,\" while the LLM emphasizes a shift from \"peripheral\" to \"dedicated focus.\"\n\n(4) MISSING DETAILS:\n- The LLM does not mention the 2023 structured table categorization or the grouping with sensors, encoders, LEDs, and Ethernet components\n- Does not reference the 2024 explicit linkage with Ethernet PHYs and camera microcontrollers\n- Does not capture the \"maturing\" aspect of the product strategy mentioned in ground truth\n\nThe answer is directionally correct about the evolution and strategic emphasis, but overstates the magnitude of the shift and introduces interpretive elements not fully supported by the ground truth. The core multi-hop synthesis is sound, but the characterization of the positioning change is somewhat exaggerated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 779,
        "total_tokens": 2222
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nUPS SurePost continued to serve as a residential‑ground option for non‑urgent, lightweight shipments, but its final‑mile delivery had historically been subcontracted to the U.S. Postal Service. In 2024 UPS announced that, effective January 1 2025, it would insource that final‑mile delivery—part of its “Efficiency Reimagined”/Fit‑to‑Serve network reconfiguration—to reduce reliance on USPS and gain greater control over service and cost. This strategic shift reflects the broader move to reshape the SurePost model while still leveraging the UPS ground network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key dates are correct - 2022-2024 timeframe accurately covered, with the January 1, 2025 implementation date precisely stated. (2) The core narrative is accurate: SurePost's role as a residential ground service for non-urgent, lightweight shipments is correctly identified, and the historical reliance on USPS for final-mile delivery is properly documented. (3) The strategic shift is accurately described - the insourcing of final delivery effective January 1, 2025 is the correct turning point. (4) Multi-hop synthesis is sound: the answer correctly connects the historical model (2022-2023 unchanged) with the 2024 announcement of the 2025 change. (5) The answer adds valuable context by mentioning the 'Efficiency Reimagined'/Fit-to-Serve network reconfiguration, which provides additional strategic context. (6) The reasoning about control over service quality and cost reduction is logically sound and aligns with the ground truth's emphasis on 'enhanced control over service quality and customer experience.' MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information. (2) The phrasing 'reduce reliance on USPS and gain greater control' is semantically equivalent to the ground truth's 'transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.' (3) The mention of cost control in the LLM answer is a reasonable inference from the strategic shift, though not explicitly stated in the ground truth. Overall, the answer demonstrates accurate multi-hop reasoning across the 2022-2024 period, correct identification of the strategic inflection point, and proper synthesis of the delivery model evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 498,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline grew from 13 programs (as of Feb 2022) to 18 (by Jan 2023) and then to 24 (by Jan 2024), reflecting three new late‑stage launches, five acquisitions from Horizon and multiple regulatory milestones—including FDA approvals of Otezla’s new indications, Breakthrough‑Therapy designations for bemarituzumab and LUMAKRAS, and a Priority Review for tarlatamab’s BLA with a June 2024 PDUFA date.  This expansion shows Amgen’s R&D strategy of scaling its pipeline through strategic acquisitions, advancing high‑potential biologics into Phase 3, and leveraging regulatory incentives to diversify across oncology, cardiovascular, rare‑disease and inflammatory‑disease therapeutic areas.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core Phase 3 program progression (13→18→24) and accurately dates the key milestones (Feb 2022, Jan 2023, Jan 2024). It correctly identifies Horizon Therapeutics acquisition and its contribution of five Phase 3 programs. The answer appropriately synthesizes the multi-hop information about R&D strategy expansion through both internal development and external acquisition. The therapeutic area diversification (oncology, cardiovascular, rare-disease, inflammatory) is relevant context. CRITICAL ERRORS: (1) The LLM states 'three new late-stage launches' without clear support in ground truth - this appears to be an unsupported claim about specific launches. (2) The LLM provides specific regulatory milestones (Otezla FDA approvals, bemarituzumab/LUMAKRAS Breakthrough designations, tarlatamab Priority Review with June 2024 PDUFA) that are NOT mentioned in the ground truth answer. While these may be factually accurate from the filings, they represent information beyond what the ground truth synthesized, creating potential for factual errors if these details are incorrect. (3) The ground truth mentions 25 Phase 3 programs as of February 4, 2025, which the LLM completely omits - this is a significant omission of the most recent data point. (4) The LLM does not explicitly state the 25-program figure or acknowledge the progression through 2025. QUANTITATIVE ISSUES: Missing the final data point (25 programs by Feb 2025) represents incomplete quantitative coverage. The 'three new late-stage launches' claim is vague and unsupported. REASONING: The multi-hop synthesis is generally sound (connecting acquisitions to pipeline growth to strategy), but the introduction of specific regulatory milestones not in ground truth creates uncertainty about accuracy. The answer demonstrates good understanding of the strategic implications but introduces details that cannot be verified against the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 529,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe maximum number of Class A ordinary shares reserved under the Amended 2010 SIP was 127 million in fiscal 2022, remained at that level in fiscal 2023, and was increased to 141 million shares for fiscal 2024.  This expansion of the equity‑award pool signals that Accenture is deliberately enlarging its share‑based compensation capacity—reflecting a strategic shift to use equity incentives more broadly to attract, retain and align long‑term performance with shareholder interests.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN FISCAL 2023 DATA: The LLM answer states that the maximum shares 'remained at that level in fiscal 2023' (127 million), but the ground truth clearly indicates the number 'increased to 141,000,000' by fiscal year 2023 and continued at that level into 2024. This is a significant factual error in the quantitative data. The LLM correctly identifies: (1) FY2022 figure of 127 million shares, (2) FY2024 figure of 141 million shares, and (3) the overall strategic interpretation about equity-based compensation expansion. However, the progression timeline is materially incorrect. The ground truth shows: FY2022 = 127M → FY2023 = 141M → FY2024 = 141M. The LLM shows: FY2022 = 127M → FY2023 = 127M → FY2024 = 141M. This represents a failure in multi-hop synthesis across the three fiscal years. The qualitative reasoning about strategic intent is sound and well-articulated, but it is built on incomplete/incorrect year-by-year progression data. The answer demonstrates good understanding of the strategic implications but fails on the core factual requirement of accurately tracking the evolution across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 323,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nStarbucks’ outlook for green‑coffee coverage lengthened each year: the 2022 10‑K (page 12) said existing inventory and purchase commitments would be sufficient through **fiscal 2023**, the 2023 10‑K (page 12) updated that to cover through **fiscal 2024**, and the 2024 10‑K (page 12) extended the projection to **fiscal 2025**.  This steady extension reflects a deliberate inventory‑building and hedging strategy that secures longer‑term supply commitments, reduces exposure to commodity‑price volatility, and enhances resilience against supply‑chain disruptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains significant factual errors in the progression of green coffee supply coverage projections. According to the ground truth: FY2022 projected coverage through FY2023, FY2023 extended to FY2025, and FY2024 maintained FY2025 coverage. However, the LLM states: FY2022 through FY2023, FY2023 through FY2024, and FY2024 through FY2025. This represents a fundamental misreading of the data - the LLM shows a one-year extension each year, when the actual pattern shows a two-year jump from FY2023 to FY2025, then maintenance at FY2025. The LLM's progression (2023→2024→2025) is incorrect; it should be (2023→2025→2025). This is not a minor wording difference but a material factual error in the core numeric data being evaluated. The qualitative interpretation about inventory-building and hedging strategy is reasonable and contextually appropriate, but it's built on incorrect underlying facts. The reasoning about supply chain resilience and commodity price volatility is sound in principle but cannot be properly evaluated when the foundational data is wrong. The answer does address the multi-hop nature of the question (synthesizing across three fiscal years) but fails in the execution due to data accuracy issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 357,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS shifted the UPS/IBT Full‑Time Employee Pension Plan from a static, collectively‑bargained defined‑benefit design to an actively amended and strategically re‑structured program.  In 2023 a new five‑year Teamsters master agreement introduced wage and benefit‑rate increases and forced a year‑end remeasurement of the plan’s obligations, while the company also froze future benefit accruals for non‑union participants (effective Jan 1 2023) and began phasing in a new retirement‑contribution formula (5‑8 % of eligible pay, later simplified to a flat 3 % for hires on or after Jan 1 2025).  By 2024 the plan’s funding assumptions were updated (higher discount rates and expected returns) and contribution mechanics were refined—including transition credits and a restoration savings component—reflecting a strategic move toward defined‑contribution‑style benefits that are tightly coupled to the outcomes of collective‑bargaining negotiations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM claims specific contribution percentages (5-8%, later 3%) and effective dates (Jan 1 2023, Jan 1 2025) that are not mentioned in the ground truth. The ground truth provides a specific $3.3 billion pre-tax gain ($2.5 billion after-tax) from the 2022 remeasurement following the American Rescue Plan Act—the LLM completely omits this key financial figure. (2) FACTUAL INACCURACIES: The LLM describes a 'freeze of future benefit accruals for non-union participants' and 'phasing in a new retirement-contribution formula' that are not mentioned in the ground truth. The ground truth explicitly states the plan remained 'a noncontributory defined benefit plan' with 'no indication of further structural changes.' The LLM's characterization of a shift toward 'defined-contribution-style benefits' directly contradicts the ground truth's description of continued defined benefit structure. (3) MISSING KEY INFORMATION: The LLM fails to mention the $3.3 billion mark-to-market gain, the American Rescue Plan Act context, or the specific tax impact ($2.5 billion after-tax). These are central to understanding the 2022 evolution. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize across years, it does so by introducing unsupported details rather than accurately synthesizing the actual documented evolution. The ground truth shows a progression of: 2022 remeasurement with regulatory impact → 2023 collective bargaining agreement with wage/benefit increases → 2024 continued maintenance with no structural changes. The LLM inverts this narrative. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'continued commitment' and 'no indication of further structural changes' by 2024, while the LLM emphasizes active restructuring toward defined-contribution mechanics—fundamentally opposite interpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 532,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nAcross the three fiscal years Walmart moved “Holiday Time” from a generic private‑brand entry (listed simply among the brand‑portfolio in the 2022 10‑K, pp. 7‑9) to a deliberately highlighted seasonal label—explicitly referenced in the 2023 filing as part of the “seasonal merchandise” strategic unit and noted for an expanded early‑holiday assortment (2023 10‑K, pp. 7‑9)—and finally to a core component of its seasonal‑merchandise strategy in the 2024 filing, where the company ties its growth plans to “Holiday Time” and other private‑label seasonal categories (2024 10‑K, pp. 5‑9). This evolution reveals that Walmart is treating seasonal private‑label brands as strategic growth levers, investing in dedicated merchandising, marketing and supply‑chain resources to capture early‑holiday demand and improve margin within its broader private‑label portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL INACCURACY - The LLM answer directly contradicts the ground truth. Ground truth states that in fiscal 2023, 'Holiday Time' was mentioned 'without a distinct strategic role' and that the explicit restructuring with 'seasonal merchandise' as a defined category occurred in fiscal 2024. The LLM claims 'Holiday Time' was 'explicitly referenced in the 2023 filing as part of the seasonal merchandise strategic unit,' which is factually incorrect according to the ground truth. (2) MISCHARACTERIZATION OF EVOLUTION - The LLM presents a more dramatic and earlier strategic emphasis than what actually occurred. Ground truth shows a gradual evolution with the key shift happening in 2024, not 2023. The LLM incorrectly suggests 2023 was when 'Holiday Time' became explicitly part of seasonal strategy. (3) PAGE CITATIONS - The LLM provides specific page numbers (pp. 7-9, pp. 5-9) without verification against actual filings, which is problematic given the factual errors in the narrative. (4) MISSING NUANCE - Ground truth emphasizes that in 2022-2023, 'Holiday Time' was listed among private brands 'without specific strategic emphasis' and 'without a distinct strategic role,' whereas the LLM suggests earlier strategic positioning. (5) CORRECT ELEMENTS - The LLM does correctly identify the three fiscal years (2022, 2023, 2024) and correctly identifies that by 2024 there was a restructuring toward seasonal merchandise as a defined category. The general conclusion about treating seasonal private labels as strategic growth levers aligns with ground truth, but the timeline and progression are materially inaccurate. The answer demonstrates partial understanding but fails on the critical factual accuracy of when the strategic shift occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 481,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nACN’s mutual‑fund equity holdings in its defined‑benefit pension plans were $239 million at the end of fiscal 2022, fell to $196 million in fiscal 2023, and rose sharply to $274 million by the end of fiscal 2024. This dip‑then‑rebound pattern reflects a deliberate re‑allocation, and the upward swing in 2024—combined with the higher target equity weight (up to 28 % for 2025) disclosed in the plan‑asset tables—signals that ACN is increasing its strategic exposure to equity through mutual‑fund vehicles within its pension portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states mutual fund equity securities were $274 million in fiscal 2024, but the ground truth explicitly states they 'remained unchanged in 2024' at $196.226 million. This is a major numerical error—the LLM fabricated a $274M figure that does not exist in the source data. (2) TREND ANALYSIS REVERSAL: The LLM incorrectly characterizes the trend as a 'dip-then-rebound pattern' with an 'upward swing in 2024,' when the actual data shows a consistent decline from $239.293M (2022) to $196.226M (2023) with no change in 2024. This is a complete misrepresentation of the three-year trend. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes ACN is 'increasing its strategic exposure to equity through mutual-fund vehicles,' which directly contradicts the ground truth conclusion that the data 'suggests a strategic rebalancing away from this asset class.' (4) UNSUPPORTED CLAIMS: The LLM references a 'higher target equity weight (up to 28% for 2025)' and 'plan-asset tables' that are not mentioned in the ground truth answer, suggesting the LLM may have hallucinated supporting details. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year data points and instead inverted the actual trend direction. The answer is fundamentally incorrect on the core factual claims and reaches the opposite strategic conclusion from what the data supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 418,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks moved its coffee‑price risk program from short‑term hedges that targeted “C”‑price exposure with forward, futures and collar contracts and promised supply adequacy only through FY 2023 (10‑K 2022, p. 12) to a longer‑dated framework that explicitly references the impact of commodity‑index and hedge‑fund trading on arabica prices and extends the hedge horizon to FY 2025 (10‑K 2023, p. 12; 10‑K 2024, p. 13).  This evolution reveals a more sophisticated, forward‑looking risk‑management approach that blends diversified sourcing and farmer‑support initiatives with targeted use of futures‑based hedges to dampen volatility driven by the futures market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from FY 2022 through 2024, with accurate fiscal year references and specific page citations (10-K 2022 p. 12, 10-K 2023 p. 12, 10-K 2024 p. 13). (2) Accurately captures the progression of hedging strategies: short-term 'C'-price exposure hedges through FY 2023 in 2022, extended to FY 2025 by 2023. (3) Correctly identifies the specific instruments used (forward contracts, futures contracts, collar contracts). (4) Properly synthesizes the multi-hop information about commodity index funds and hedge fund trading impacts on arabica prices. (5) Accurately characterizes the risk management approach as 'sophisticated' and 'forward-looking,' which aligns with the ground truth's description of 'consistent and maturing.' (6) Correctly emphasizes the blending of diversified sourcing, farmer-support initiatives, and futures-based hedges. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning collar contracts, specific page numbers, and farmer-support initiatives), but these additions are factually accurate and enhance rather than contradict the original answer. The semantic meaning is fully preserved and the multi-hop reasoning correctly synthesizes information across the three fiscal years. No calculation errors or factual inaccuracies detected. The answer directly addresses all components of the complex question regarding exposure evolution, hedging strategies, and risk management approach implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 444,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 had a carrying balance of about **$622 million** at the end of fiscal 2022 and fiscal 2023, and that balance was **$0** by the end of fiscal 2024.  This decline shows that AVGO deliberately retired this near‑term obligation—using proceeds from its October 2024 and July 2024 $5 billion senior note issuances (and cash from the VMware merger)—to roll off near‑term debt and extend the maturity profile of its overall borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides additional valuable context beyond the ground truth. Quantitative verification: All numbers are correct - $622 million for fiscal 2022 and 2023, declining to $0 by fiscal 2024. The dates (October 2024 maturity, July 2024 and October 2024 issuances) are accurate. Entity identification is correct (AVGO, 3.625% senior notes). Multi-hop reasoning is sound: the answer correctly synthesizes that the company retired the obligation and identifies the specific funding sources (October 2024 and July 2024 $5 billion senior note issuances, plus VMware merger cash). The progression analysis is accurate - showing deliberate debt management. The LLM answer actually enhances the ground truth by providing specific mechanisms for the retirement (identifying the exact refinancing issuances and merger proceeds), which demonstrates superior synthesis of multi-hop information across documents. The conclusion about extending the maturity profile is a logical inference from the debt management strategy. Minor consideration: The ground truth uses slightly more cautious language ('either repaid or refinanced'), while the LLM specifies the refinancing mechanism more definitively, but this is supported by the filing data and represents better synthesis rather than an error. The answer fully addresses the question's two components: (1) how exposure evolved (correctly tracked across three years), and (2) what it indicates about debt management strategy (correctly identified as deliberate near-term obligation management with maturity extension). No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 452,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard expanded its settlement‑risk calculations (gross exposure rose from roughly $52 billion to $78 billion) and tightened the risk‑mitigation framework that backs that exposure—adding cash‑collateral and credit‑enhancement arrangements, revising its methodology, and periodically re‑designating €‑denominated debt as net‑investment hedges to manage European‑currency risk.  At the same time the company faced heightened regulatory scrutiny (FTC Durbin‑Amendment consent, DOJ antitrust CID, an EU competition probe) and a wave of litigation—including UK Supreme Court rulings on interchange‑fee damages, U.S. merchant class actions, and ATM‑surcharge antitrust suits—prompting the firm to record substantial litigation accruals and to settle or defend multiple multi‑billion‑dollar claims while continuing to monitor and adjust both its credit‑risk mitigation strategies and its estimated settlement exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key regulatory and litigation developments (FTC Durbin Amendment consent, DOJ antitrust investigation, EU competition probe, UK Supreme Court rulings, merchant class actions, ATM-surcharge suits). It appropriately synthesizes the multi-hop elements showing how external pressures prompted internal risk management adjustments. The qualitative narrative about tightening risk-mitigation frameworks and revising methodologies aligns with the ground truth's description of Mastercard refining its risk management posture.\n\nCRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM introduces specific dollar figures ($52 billion to $78 billion settlement exposure growth) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and appear to be fabricated or hallucinated. This is a serious factual error for a financial question. (2) MISSING KEY DETAILS - The ground truth specifically mentions the $1+ billion EMV liability shift class-action lawsuit, which the LLM completely omits. (3) INCOMPLETE REGULATORY DETAIL - While the LLM mentions regulatory actions, it doesn't clearly distinguish the 2023 intensification period or the 2024 escalation as clearly as the ground truth does. (4) VAGUE LITIGATION ACCRUALS - The LLM references 'substantial litigation accruals' and 'multi-billion-dollar claims' without the specificity found in the ground truth.\n\nMULTI-HOP REASONING: The LLM does attempt to synthesize the relationship between settlement exposure evolution and regulatory/litigation pressures, showing logical connection between external environment and internal risk management adjustments. However, the introduction of unverified numbers undermines the credibility of this synthesis.\n\nSEMANTIC ISSUES: The phrase 'settlement-risk calculations' and 'net-investment hedges' for currency management are reasonable financial terminology but represent interpretations not explicitly stated in the ground truth, which focuses more on credit risk mitigation arrangements (cash collateral, letters of credit, guarantees).\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the regulatory and litigation landscape and attempts appropriate multi-hop synthesis, but the introduction of specific unverified financial figures (the $52B-$78B numbers) is a critical error that significantly undermines correctness. The omission of the $1+ billion EMV liability shift is also a notable gap. The answer would score higher if it stuck to verifiable information from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 691,
        "total_tokens": 2282
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures on drug‑delivery‑device regulation show a clear tightening of expectations. In the 2022 filing the company merely noted that device approvals are subject to routine FDA inspections and post‑approval REMS, without detailing specific conditional‑approval follow‑up requirements. By the 2023 filing Amgen added explicit references to post‑marketing obligations—mandatory confirmatory studies for accelerated approvals (e.g., LUMAKRAS), periodic REMS assessments, and the risk of labeling restrictions or market withdrawal if safety signals or compliance lapses emerge. The 2024 filing goes further, emphasizing that regulators now demand robust validation of surrogate endpoints, additional outcomes‑studies, and stricter pharmacovigilance for device‑product combos, and it warns that any safety concern or failure to meet these heightened compliance standards could trigger revocation of approval or restrictive labeling, reflecting an evolving, more stringent regulatory regime across the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the regulatory evolution across 2022-2024 and correctly identifies key themes: increasing regulatory scrutiny, post-marketing obligations, and safety oversight. The answer accurately references specific products (LUMAKRAS, Repatha mentioned in ground truth) and correctly characterizes the progression from routine compliance in 2022 to heightened requirements by 2024. The multi-hop synthesis across three years is sound and logically structured. However, there are some qualitative differences from the ground truth: (1) The LLM emphasizes 'tightening of expectations' and 'more stringent regulatory regime' more strongly than the ground truth, which uses more measured language about 'growing emphasis.' (2) The LLM introduces concepts like 'outcomes-studies' and 'pharmacovigilance' that, while plausible regulatory concepts, are not explicitly mentioned in the ground truth. (3) The ground truth specifically mentions 'surrogate endpoints and conditional approvals' as a 2023 focus, while the LLM places surrogate endpoint validation emphasis in 2024. (4) The ground truth notes 'disruptions could affect clinical trials and product supply' in 2022, which the LLM omits. The numeric/date accuracy is excellent (all years correct: 2022, 2023, 2024), and the entity identification is accurate (Amgen, FDA, LUMAKRAS, Repatha). The reasoning is sound in showing progression, though the LLM may be slightly over-interpreting the severity of the regulatory shift. Overall, the answer captures the essential evolution correctly but adds some interpretive elements not grounded in the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 453,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Walmart repeatedly revised the way it groups its private‑brand merchandise, moving Parent’s Choice out of a stand‑alone “baby” slot and into a combined **baby + consumables** merchandise unit that also houses everyday household staples.  This re‑categorization—first noted in the 2022 filing and solidified in the 2023 and 2024 updates—reflects Walmart’s intent to treat Parent’s Choice as a core value driver for the entire baby‑and‑consumables portfolio, using the brand to reinforce its everyday‑low‑price positioning and to capture additional spend from price‑sensitive shoppers across both categories.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. Key issues: (1) CONTRADICTORY CLAIM: The LLM states Parent's Choice was 'moved out of a stand-alone baby slot and into a combined baby + consumables merchandise unit,' but the ground truth indicates Parent's Choice remained consistently under the Grocery unit across all three years (2022-2024), with no movement or re-categorization described. (2) MISCHARACTERIZED EVOLUTION: The ground truth shows continuity and consistent placement ('remained a key private label within the same category,' 'continued to be prominently featured'), while the LLM incorrectly portrays this as a deliberate re-categorization strategy moving the brand between different merchandise groupings. (3) UNSUPPORTED NARRATIVE: The LLM's claim that this was 'first noted in the 2022 filing and solidified in the 2023 and 2024 updates' is not supported by the ground truth, which describes stable positioning rather than progressive changes. (4) CORRECT ELEMENTS: The LLM correctly identifies the EDLP (everyday low price) positioning strategy and the focus on price-sensitive shoppers, which aligns with ground truth. However, these correct elements are embedded within a fundamentally flawed narrative about merchandise categorization changes that did not occur. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year trend, misinterpreting consistency as change. The ground truth explicitly states the brand remained in the same category across all years, making the LLM's re-categorization narrative factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 442,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla kept the 4.70 % Solar Bonds, Series 2015/C24‑10 on its balance sheet and repeatedly filed supplemental indentures—starting with the 35th supplemental indenture in 2022 and later the 70th‑71st supplemental indentures in 2023‑2024—that extended maturities, added new tranche‑level series and updated covenants. This recurring amendment shows that Tesla’s solar‑financing strategy is a flexible, layered securitization of its solar assets, allowing it to continuously expand and refinance the bond program as new solar projects are added. The pattern reflects a deliberate use of long‑dated, fixed‑coupon solar‑asset‑backed securities to secure stable, long‑term capital for its solar installations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces specific supplemental indenture numbers (35th in 2022, 70th-71st in 2023-2024) that are NOT present in the ground truth. The ground truth only mentions the 'Thirty-Fifth Supplemental Indenture dated April 14, 2015' as the introduction mechanism, not as a 2022 filing. The LLM fabricates the 70th-71st supplemental indentures claim with no basis in the original answer. (2) FACTUAL ERRORS - The LLM claims Tesla 'kept the 4.70% Solar Bonds...on its balance sheet' and 'repeatedly filed supplemental indentures' with specific year-by-year progression, but the ground truth does not support this level of operational detail. The ground truth indicates the bond was 'referenced' in filings, not that supplemental indentures were filed in those years. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize a coherent narrative about Tesla's solar financing strategy, it does so by inventing specific details not present in the knowledge graph. The ground truth's more cautious language ('referenced,' 'continued to reference,' 'again referenced') is replaced with definitive claims about filing activities and balance sheet treatment. (4) SEMANTIC DIVERGENCE - The ground truth emphasizes 'consistent reliance' and 'matured and recurring financing model' based on the presence of multiple series across years. The LLM reframes this as active 'amendment' and 'extension' activities that are not documented in the original answer. (5) MISSING ELEMENTS - The LLM correctly identifies the 4.70% coupon and Series 2015/C24-10 designation, and appropriately discusses the securitization strategy concept, but undermines this by adding unsupported operational claims. The core insight about scalable securitization is present but contaminated by fabricated details about supplemental indentures and balance sheet management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 513,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nBroadcom introduced the Security Insights Platform in 2022 as a mainframe‑focused analytics engine that interpreted mainframe security posture and generated remediation steps, primarily to feed into customers’ SIEM and other security‑information tools. By 2023 the platform was incorporated into the broader Enterprise‑Security portfolio, gaining tighter integration with Symantec/Carbon Black endpoint, network and identity protections and expanding its risk‑assessment scope beyond the mainframe to multiple enterprise environments. In 2024 Broadcom elevated the offering as a central analytics hub that not only continues to assess mainframe risk but also feeds actionable insights into the full suite of enterprise security tools—endpoint, network, application, identity and FC‑SAN security—while aligning it with VMware‑based private‑cloud/VCF deployments for unified risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fabrications that diverge substantially from the ground truth. Key issues: (1) FABRICATED DETAILS: The LLM introduces claims not present in the ground truth, including: integration with 'Symantec/Carbon Black endpoint, network and identity protections' in 2023, expansion 'beyond the mainframe to multiple enterprise environments,' elevation to a 'central analytics hub' in 2024, and alignment with 'VMware-based private-cloud/VCF deployments.' None of these details appear in the original answer. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth explicitly states the description 'remained largely consistent' across 2022-2023 and that 'core capabilities remained stable across the three years.' The LLM falsely portrays dramatic expansion and integration scope changes that contradict this stability narrative. (3) ENTITY CONFUSION: The LLM conflates Broadcom's Security Insights Platform with broader enterprise security portfolio changes and introduces Symantec/Carbon Black and VMware references that are not substantiated in the ground truth. (4) CORE ACCURACY: The LLM correctly identifies that the platform addresses mainframe security posture assessment and SIEM integration in 2022, but then diverges into unsupported claims about portfolio integration and multi-environment expansion. (5) MULTI-HOP REASONING FAILURE: Rather than synthesizing the actual evolution (stable core with subtle emphasis shifts toward enterprise integration), the LLM fabricates a narrative of significant product expansion and portfolio consolidation. The ground truth emphasizes continuity with subtle refinement; the LLM presents discontinuous transformation. This represents a fundamental failure to accurately represent the documented evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 497,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nThe A‑class shares have retained their core rights throughout the 2022‑2024 period – each A‑share carries one vote and full dividend entitlement, while the non‑voting B‑shares continue to receive dividends and can be converted one‑for‑one into A‑shares, with no alteration to those rights across the three years.  What does change is the size of the cash return: dividends per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024, reflecting a deliberate, steady increase in shareholder payouts.  This unchanged dual‑class structure shows that Mastercard’s capital‑structure strategy has been to preserve voting control and a stable equity hierarchy while using higher dividends (and complementary debt‑ and share‑repurchase programs) to reward investors.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that A Class shares maintained one vote per share and dividend rights with no changes across 2022-2024, matching the ground truth core finding. The answer appropriately addresses the capital structure strategy question and correctly notes the dual-class structure preservation. The reasoning about using dividends and share repurchases alongside the stable equity hierarchy is sound and relevant.\n\nWEAKNESSES - CRITICAL QUANTITATIVE ERRORS: The LLM introduces specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be unsupported claims. This is a significant factual error - the LLM is adding specific financial data that goes beyond what the ground truth establishes. The ground truth makes no mention of dividend amounts, only that dividend rights remained consistent.\n\nADDITIONAL ISSUES: The LLM introduces information about B-shares (non-voting shares with dividend rights and conversion features) that, while potentially accurate from actual MA filings, is not mentioned in the ground truth answer. The ground truth focuses exclusively on A Class shares' consistency. The LLM also mentions debt and share-repurchase programs, which are not addressed in the ground truth.\n\nMULTI-HOP REASONING: The core multi-hop synthesis is sound - the LLM correctly connects the consistency of voting/dividend rights to capital structure strategy. However, the addition of unsupported quantitative data undermines the reliability of the answer.\n\nSEMANTIC EQUIVALENCE: The core semantic meaning matches (A shares maintained rights, no changes, consistent strategy), but the LLM significantly expands beyond the ground truth with specific numbers and additional structural details that cannot be verified against the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 520,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen took bemarituzumab from a newly‑opened Phase 3 trial in advanced gastro‑esophageal‑junction adenocarcinoma (first announced in early 2022) into a fully‑enrolled, multi‑center Phase 3 program that continued through 2023‑24, while also evaluating the candidate in additional solid‑tumor indications.  Throughout this period the company’s intellectual‑property approach remained centered on a set of issued composition‑of‑matter patents covering the bemarituzumab polypeptide, which are projected to expire in 2029 in both the United States and Europe (with no current extensions but the option of supplemental protection certificates or later‑filed patents to extend exclusivity).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key milestones and dates. Strengths: (1) Correctly identifies Phase 3 trial initiation in early 2022 for GEJ adenocarcinoma, (2) Accurately states patent expiration in 2029 for both U.S. and Europe, (3) Properly characterizes bemarituzumab as a monoclonal antibody targeting FGFR2b, (4) Mentions multi-center enrollment and continuation through 2023-24, (5) Discusses IP strategy including composition-of-matter patents and supplemental protection certificates. Quantitative accuracy is high - all dates (2022, 2023-24, 2029) and geographic references (U.S., Europe) are correct. Minor areas for improvement: (1) The LLM answer provides more granular detail about 'fully-enrolled, multi-center' status and mentions 'additional solid-tumor indications' which adds specificity beyond the ground truth but is not contradicted by it, (2) The ground truth emphasizes a 'transition from early-phase development to a more mature pipeline asset' as a key narrative point, while the LLM answer focuses more on operational details of enrollment and IP mechanics rather than explicitly framing this evolution/progression. (3) The LLM mentions 'no current extensions but the option of supplemental protection certificates' which adds nuance about potential future IP strategies not explicitly stated in ground truth but is consistent with regulatory frameworks. The multi-hop reasoning is sound - the answer correctly synthesizes clinical development progression (2022 Phase 3 initiation → 2023-24 enrollment) with IP strategy (patent expiration dates and protection mechanisms). The answer is well-structured and contextually relevant to the question about strategy evolution. The slight deduction reflects that while the answer is more detailed and operationally specific, it could have more explicitly emphasized the strategic evolution narrative that the ground truth highlights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 527,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nWalmart’s “No Boundaries” label has been listed in the company’s private‑brand portfolio that feeds the **Apparel/​Fashion strategic merchandise unit** (see the segment description in the 2023 10‑K, page 7, and the periodic re‑categorization note on page 8).  Across the 2022‑2024 filings the unit’s classification was refined so that No Boundaries moved from a generic “Apparel” bucket into a dedicated fashion‑focused sub‑category, highlighting the retailer’s intent to grow its own‑brand apparel offering.  This evolution reveals Walmart’s shifting focus from pure price‑leadership toward a more fashion‑centric, value‑oriented apparel strategy that leverages private labels to capture style‑sensitive shoppers while still delivering the everyday‑low‑price proposition.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core narrative but has some notable gaps and imprecisions when compared to the ground truth. STRENGTHS: (1) Correctly identifies 'No Boundaries' as a private brand within Walmart's portfolio; (2) Accurately captures the evolution from 'Apparel' to 'Fashion' categorization across 2022-2024; (3) Properly synthesizes the strategic shift toward fashion-centric positioning; (4) Correctly interprets this as part of Walmart's broader omni-channel and customer-centric strategy; (5) Appropriately references 2023 10-K filing locations (page 7, page 8). WEAKNESSES: (1) The answer states 'No Boundaries moved from a generic \"Apparel\" bucket into a dedicated fashion‑focused sub‑category' but the ground truth indicates it moved from 'Apparel' category to the broader 'Fashion' unit (not a sub-category within Apparel, but a separate unit classification); (2) Missing explicit mention that 'No Boundaries' maintained continuity across all three years (2022-2024), which the ground truth emphasizes as highlighting 'consistent importance'; (3) The phrase 'Apparel/Fashion strategic merchandise unit' in the opening is somewhat ambiguous - it could be read as a single combined unit rather than showing the evolution from one to the other; (4) Does not explicitly detail that the 'Fashion' unit includes 'adult and children's apparel, shoes, jewelry, and accessories' as the ground truth specifies. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects the categorization change to broader strategic implications (omni-channel, customer-centric, fashion-centric value strategy). However, the reasoning about the shift from 'price-leadership toward fashion-centric' is interpretive and goes slightly beyond what the ground truth explicitly states. QUANTITATIVE/FACTUAL: No specific numbers or calculations are involved in this question, so quantitative accuracy is less critical. The dates (2022-2024) and filing references are correct. The categorization evolution is substantially correct but with the noted imprecision about 'sub-category' vs. separate unit classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 582,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nIBM has long listed “client relationships and trust” among its principal competitive weapons, but from the 2022 Form 10‑K (pp. 2‑6) through the 2023 Form 10‑K (pp. 1‑5) and into the 2024 filing (pp. 1‑5) the language shifted from a generic brand‑strength claim to a strategic pillar that directly underpins its hybrid‑cloud and AI agenda.  The 2023 and 2024 risk‑factor sections explicitly tie trust to “responsible innovation” in hybrid‑cloud and AI (including generative AI) and to the company’s ability to scale those technologies through an open ecosystem, while the competition narratives (2022 p. 5, 2023 p. 3, 2024 p. 3) repeatedly stress that trust, together with deep industry expertise and a broad partner network, differentiates IBM from pure‑play cloud rivals.  Consequently, the evolution shows IBM is positioning its hybrid‑cloud and AI strategy as a trusted, enterprise‑grade platform that relies on strong client relationships to win market share and drive growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate filing references and page numbers; (2) Accurately captures the evolution from 'generic brand-strength claim' to 'strategic pillar' directly tied to hybrid-cloud and AI strategy; (3) Properly synthesizes multi-hop information showing how trust became increasingly linked to responsible innovation, ecosystem collaboration, and competitive differentiation; (4) Correctly identifies the connection to hyperscalers, system integrators, and partner networks as extensions of the trust-based strategy; (5) Appropriately emphasizes the enterprise-grade positioning and client-centric innovation angle. MINOR GAPS: (1) The LLM answer provides more specific page citations and filing details than the ground truth, which adds credibility but goes slightly beyond what was explicitly stated in the original answer; (2) The ground truth emphasizes 'integrated technologies' and 'ecosystem collaboration' somewhat more explicitly as mechanisms for extending trust, while the LLM frames this as 'open ecosystem' and 'partner network' - semantically equivalent but with slightly different emphasis; (3) The LLM introduces 'responsible innovation' and 'generative AI' specificity that, while likely accurate to the filings, goes slightly beyond the ground truth's framing. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and filing references are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning chain is sound - the LLM correctly traces how trust evolved from a competitive differentiator to a strategic pillar underpinning hybrid-cloud/AI strategy. The multi-hop synthesis across three years of filings is well-executed. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding evolution, progression, and strategic positioning implications. The connection to hybrid cloud and AI strategy is clearly articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 549,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the only references to the 5.45 % Solar Bonds, Series 2015/C25‑15 are citations of the original 2015 indenture and its supplemental indentures—no new issuances or amendments are reported for those years.  This shows that the series had already been fully issued and was being run off, and the company’s solar‑financing strategy shifted toward other instruments (e.g., newer convertible senior notes and broader capital‑market funding) rather than continuing to rely on the 5.45 % Solar Bond program.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and interpretive errors that contradict the ground truth. CORRECT ELEMENTS: (1) The numeric values are accurate - 5.45% bond rate, Series 2015/C25-15, and 2015 issuance date are correct. (2) The identification of the Thirty-Sixth Supplemental Indenture dated April 14, 2015 is factually sound. (3) The observation that no new issuances occurred in 2022-2024 is technically accurate. CRITICAL ERRORS: (1) FUNDAMENTAL MISINTERPRETATION: The LLM concludes the bond was 'being run off' and that Tesla 'shifted toward other instruments,' but the ground truth explicitly states Tesla 'consistently referenced' the bond across all three years, indicating 'ongoing reliance' and 'continued legal and financial linkage.' The LLM inverts the meaning of persistent disclosure. (2) MULTI-HOP REASONING FAILURE: The question asks what the 'multi-year pattern indicates about the company's solar financing strategy.' The ground truth correctly synthesizes that consistent references across 2022-2023-2024 indicate MAINTAINED reliance on this structured debt instrument. The LLM incorrectly interprets the same evidence (consistent references) as evidence of ABANDONMENT. (3) SEMANTIC CONTRADICTION: The ground truth states the bond 'remained a key exhibit' in 2024 and Tesla 'reaffirmed its inclusion,' directly contradicting the LLM's characterization of runoff and strategic shift. (4) INCOMPLETE SYNTHESIS: The LLM fails to address why Tesla would continue referencing the bond in exhibits across three years if it were truly shifting strategy - this is the core multi-hop insight the ground truth captures. The LLM's conclusion about 'newer convertible senior notes and broader capital-market funding' is speculative and not supported by the ground truth evidence. The answer demonstrates accurate number handling but fundamentally misreads the strategic implications of the disclosure pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 521,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nFrom the 2022 10‑K (p. 7) the Safety & Productivity segment was described as offering conventional pipe‑working tools such as wrenches, cutters, threading/roll‑grooving equipment and mechanical crimping systems. By 2023‑2024 the same segment’s tool description (p. 73) adds “battery‑hydraulic tools for press connections” and other battery‑powered devices, indicating that Emerson introduced cordless, battery‑driven solutions to its pipe‑working lineup. This progression shows Emerson is deliberately expanding battery‑powered, portable tool offerings to meet professional‑user demand for greater safety and productivity, positioning the company as a leader in modern, high‑efficiency professional tools.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core narrative of Emerson's evolution from traditional to battery-powered pipe-working tools, correctly identifying the progression from 2022 to 2024 and the introduction of battery-hydraulic tools. However, there are notable omissions and incomplete synthesis compared to the ground truth:\n\nSTRENGTHS:\n- Correctly identifies the 2022 baseline: conventional pipe-working tools (wrenches, cutters, threading/roll-grooving equipment, mechanical crimping systems)\n- Accurately notes the 2023-2024 addition of battery-hydraulic tools for press connections\n- Properly synthesizes the strategic shift toward cordless, portable solutions\n- Correctly interprets this as positioning Emerson as a leader in modern professional tools\n- Appropriately cites page references (p. 7 for 2022, p. 73 for 2023-2024)\n\nWEAKNESSES:\n- SIGNIFICANT OMISSION: Fails to mention diagnostic systems and closed-circuit television (CCTV) for pipe inspection mentioned in 2022, which is part of the complete product portfolio evolution\n- INCOMPLETE PRODUCT LISTING: Does not mention sewer inspection cameras and locating equipment that were added by 2024, which are important to the full narrative of innovation\n- MISSING DETAIL: Does not specifically mention battery hydraulic tools for cutting and crimping electrical cables (2024), only referencing press connections\n- INCOMPLETE SYNTHESIS: The answer doesn't fully capture the breadth of the segment's evolution across all three years - it focuses primarily on the battery-powered transition but misses the diagnostic/inspection technology component\n- MISSING FOUNDATIONAL ELEMENT: Does not underscore the consistent role of pipe wrenches across all three years as a foundational product\n\nMULTI-HOP REASONING:\nThe multi-hop synthesis is partially sound - the answer correctly connects information across three years and identifies the strategic trend. However, it fails to synthesize all relevant product categories (diagnostic systems, inspection equipment) that should be part of a complete answer about segment evolution.\n\nSEMANTIC EQUIVALENCE:\nThe core message about battery-powered innovation and strategic positioning is semantically equivalent to the ground truth, but the answer is incomplete in scope.\n\nThe answer demonstrates understanding of the main narrative but lacks comprehensiveness in addressing the full evolution of the Safety & Productivity segment's offerings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 652,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s capital deployment at its El Segundo, California site moved from the initial build‑out of cell‑therapy processing infrastructure (first noted in the 2022 filing’s description of the facility’s role) to sustained investments that expanded suite space, added automation and advanced manufacturing controls, enabling commercial production of Kite’s CAR‑T products and supporting a growing pipeline of cell‑therapy candidates; this progression aligns directly with the company’s broader biologics priority of scaling high‑value, next‑generation cell‑based therapies. (page 31 – 2022; page 9 – 2023; page 8 – 2024)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer claims El Segundo was involved in 'initial build-out of cell-therapy processing infrastructure' in 2022, but the ground truth explicitly states that in 2022, El Segundo was listed as a general manufacturing facility WITHOUT specific emphasis on cell therapy. The strategic shift to cell therapy specialization occurred in 2023, not 2022. (2) UNSUPPORTED CLAIMS - The LLM introduces specific details NOT present in the ground truth: 'expanded suite space, added automation and advanced manufacturing controls, enabling commercial production of Kite's CAR-T products.' These specific operational details (suite expansion, automation, Kite CAR-T production) are not mentioned in the provided ground truth and appear to be hallucinated. (3) PAGE NUMBER DISCREPANCIES - The LLM cites 'page 31 – 2022; page 9 – 2023; page 8 – 2024' but the ground truth references different pages (page 33 for 2022, page 11 for 2023, page 10 for 2024). This suggests the LLM may have fabricated or misremembered source citations. (4) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the evolution from general to cell-therapy-focused manufacturing, it fails to accurately capture the 2022 baseline (general manufacturing, not cell therapy build-out) and misses the emphasis on proprietary manufacturing technology protection mentioned in the 2024 filing. (5) SEMANTIC MISALIGNMENT - The ground truth emphasizes a 'strategic shift' beginning in 2023 with explicit cell therapy designation; the LLM incorrectly backdates this shift to 2022. The correct progression is: 2022 (general manufacturing) → 2023 (explicit cell therapy focus) → 2024 (sustained cell therapy with IP protection emphasis). The LLM's answer fundamentally misrepresents the timeline and introduces unsupported operational details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 502,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nIBM first disclosed the terms of the 1.250 % Notes due 2027 in a 2017 Form 8‑K (Exhibit 4.4) and later incorporated that definition in its 2019 8‑K filings. Starting with the 2022 Form 10‑K (pages 28‑32) the company repeatedly incorporated those 8‑K exhibits by reference, and the 2023 Form 10‑K (page 18) reaffirmed the same incorporation. In the 2024 Form 10‑K (page 2) IBM listed the 1.250 % Notes due 2027 among its registered securities and disclosed a February 2 2024 indenture (Exhibit 4.1) governing the notes, demonstrating that the note’s disclosure and reference have been continuously updated and reinforced across the 2022‑2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) DATES: The LLM claims a 2017 Form 8-K and 2019 8-K filings, but the ground truth specifies January 30, 2019 as the filing date for the instrument definition. The LLM's reference to 2017 appears unsupported. (2) FILING REFERENCES: The ground truth specifically mentions February 8, 2022 and February 3, 2023 filing dates for the 2023 disclosures, which the LLM does not reference. The LLM mentions a February 2, 2024 indenture (Exhibit 4.1), which is not mentioned in the ground truth. (3) PROGRESSION NARRATIVE: The ground truth emphasizes a clear three-year progression from disclosure (2022) → continued reference (2023) → formal listing with trading symbol IBM27B on NYSE (2024). The LLM's narrative focuses on incorporation by reference and indenture governance rather than the shift from internal documentation to active market presence, missing the key insight about the transition to public trading. (4) TRADING SYMBOL: The ground truth specifically mentions the trading symbol IBM27B and NYSE listing in 2024, which the LLM completely omits. (5) STRUCTURAL ACCURACY: The ground truth presents a clear evolution showing disclosure → reference → active issuance/trading. The LLM presents a more linear incorporation-by-reference narrative that doesn't capture the qualitative shift in the relationship. The LLM answer appears to conflate different filing mechanisms and dates without proper grounding in the actual ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 426,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C45‑15—and the dozens of supplemental indentures that amend them—are repeatedly cited in Tesla’s 2022, 2023 and 2024 Form 10‑K filings.  Rather than launching new solar‑specific financing vehicles, the company’s disclosures show it is now merely administering and eventually retiring a legacy pool of asset‑backed securities that were originally issued in 2015, indicating that Tesla’s solar‑financing strategy has shifted from active bond issuance to the management and wind‑down of these long‑dated obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors and reaches an incorrect conclusion that directly contradicts the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY: The LLM correctly identifies the 5.45% interest rate and the 2015 issuance year, but fails to recognize the multiple distinct bond series (C45-15, C53-15, C62-15, C72-15) that are central to understanding Tesla's evolving strategy. The ground truth explicitly documents these as separate issuances on different dates (May 26, June 16, June 29, and July 21, 2015), while the LLM dismisses them as merely 'supplemental indentures' to a single bond. (2) ENTITY ACCURACY: The LLM conflates multiple distinct bond series into one, fundamentally misrepresenting the structure of Tesla's solar financing. The ground truth shows Tesla progressively referenced different series across 2022-2024 filings, indicating expansion, not wind-down. (3) REASONING ERROR - CRITICAL: The LLM's core conclusion is backwards. The ground truth indicates Tesla's strategy evolved from 2022 through 2024 by EXPANDING references to multiple bond series (C45-15 in 2022, adding C53-15 in 2023, then C62-15 and C72-15 in 2024), suggesting active management and iterative expansion of the securitization model. The LLM interprets this as 'wind-down' and 'retirement' of legacy obligations, which is the opposite of what the filing pattern demonstrates. (4) MULTI-HOP SYNTHESIS: The LLM failed to synthesize the multi-year progression across 2022-2024 filings. The ground truth explicitly traces how different bond series appear in different years, showing an evolution toward a 'scalable, repeatable financing model.' The LLM missed this temporal progression entirely. (5) STRATEGIC INTERPRETATION: The ground truth correctly identifies this as evidence of Tesla refining its solar financing strategy and reducing reliance on traditional corporate debt. The LLM incorrectly characterizes it as passive administration and wind-down, which contradicts the pattern of expanding bond references across multiple years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 553,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe reframed Acrobat as an AI‑enhanced, cloud‑native document‑services platform rather than a standalone PDF viewer.  In 2022 it added Adobe Sign integration, single‑click web actions and Sensei‑driven intelligence to push into finance, legal and government markets; by 2023 it layered generative‑AI capabilities (Firefly, Generative Fill/Expand) and mobile‑first features such as Liquid Mode, and in 2024 it deepened AI across the Document Cloud, expanded API‑driven workflows and broadened enterprise go‑to‑market and partnership efforts to grow its digital‑document business and recurring revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific product names and features (Firefly, Generative Fill/Expand, Liquid Mode, Sensei-driven intelligence) that are NOT mentioned in the ground truth answer and cannot be verified as part of Adobe's Acrobat strategic positioning in the SEC filings. These appear to be hallucinated details. (2) MISSING KEY INFORMATION - The ground truth specifically mentions the formal introduction of 'Acrobat AI Assistant' as a trademark in 2024, which is a concrete, verifiable milestone. The LLM answer fails to mention this specific product name, instead using vague language about 'deepened AI.' (3) INCOMPLETE SYNTHESIS - While the LLM answer correctly identifies the 2022-2024 timeline and the general trajectory from document productivity to AI integration, it adds unverified details about Adobe Sign integration timing, specific AI features, and market segments that don't align with the ground truth. (4) STRUCTURAL ISSUES - The ground truth emphasizes a clear three-year progression: 2022 (market leadership), 2023 (forward-looking AI vision), 2024 (concrete AI Assistant realization). The LLM answer conflates these timelines and adds product details not in the source material. (5) QUANTITATIVE ACCURACY - No specific numbers are provided in either answer, so this is neutral, but the LLM introduces unverifiable product feature claims. The core narrative about AI integration evolution is directionally correct but contaminated with hallucinated details that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 428,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services platform moved from a primarily custodial‑focused offering to a fully integrated, cloud‑based trading and portfolio‑management suite.  The company introduced the thinkpipes trading platform (with real‑time charting and allocation) and embedded it in the customizable iRebal rebalancing tool, then in 2023 rolled out “Schwab Trading Powered by Ameritrade™” to unify the best features of both brands.  Alongside these core enhancements, Schwab expanded the free, web‑based Schwab Advisor Portfolio Connect, broadened API and third‑party integration capabilities, and added richer interactive research and analytical tools—delivering RIAs a more seamless, data‑rich, and workflow‑automated experience.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM mentions 'thinkpipes trading platform,' 'iRebal rebalancing tool,' and 'Schwab Trading Powered by Ameritrade™' - none of these specific products are mentioned in the ground truth. The ground truth does not reference these platform names or features. (2) MISSING CORE INFORMATION: The LLM fails to mention the 'Advisor Services website' which is explicitly identified in the ground truth as the core platform in both 2022 and 2023. The ground truth emphasizes proprietary software, dedicated website, and third-party integrations (CRM, portfolio management systems) - the LLM does not reference these. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies 'Schwab Advisor Portfolio Connect' as a 2024 offering and mentions API/third-party integrations, it misses the continuity narrative that the ground truth emphasizes - that Schwab maintained consistent focus on the Advisor Services website across all three years. (4) UNSUPPORTED CLAIMS: The characterization of evolution from 'custodial-focused' to 'cloud-based trading and portfolio-management suite' is not substantiated in the ground truth, which focuses on interactive tools, integrations, and educational content rather than trading platform transformation. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the year-by-year evolution as presented in the ground truth (2022 baseline → 2023 reinforcement → 2024 expansion). Instead, it created a narrative around products not mentioned in the source material. The answer appears to conflate or confuse Schwab's actual product offerings with inaccurate product names and features.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 480,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nEmerson’s Air‑Preparation Equipment was first listed as a discrete product line within the 2022 Discrete‑Automation portfolio (see EMR 10‑K 2022 pp. 5‑6, which describes it as part of “Industrial Solutions” alongside solenoid/pneumatic valves, cylinders and actuators). By 2023 the company began bundling the equipment with valve actuators and control software, emphasizing integrated pneumatic‑valve packages that could be configured and monitored through Emerson’s automation platforms (the 2023 segment description on pp. 71‑73 reiterates that Discrete Automation now includes “air preparation equipment, pressure and temperature switches, … programmable automation control systems and software”). In 2024 the focus shifted to embedding air‑preparation hardware in Emerson’s Plantweb IIoT ecosystem, offering real‑time health monitoring and tight integration with control algorithms and digital‑twin analytics—exactly the evolution highlighted in the 2024 Business‑Segment table (pp. 71‑75) where air‑preparation equipment is grouped with “programmable automation control systems and software” and noted as part of the broader “Intelligent Devices” strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop synthesis required across three fiscal years (2022-2024) and correctly identifies the core evolution of Air Preparation Equipment positioning within Emerson's Discrete Automation segment. STRENGTHS: (1) Correctly identifies the progression from mechanical/pneumatic focus (2022) to digital integration (2023-2024); (2) Accurately names key technologies mentioned in ground truth (solenoid/pneumatic valves, actuators, pressure switches, programmable automation control systems, software); (3) Properly synthesizes the shift toward Industry 4.0 themes (IIoT, predictive maintenance, digital twins, smart actuation); (4) Correctly references the Discrete Automation segment across all three years; (5) Appropriately cites page numbers and document sections (though these cannot be verified against actual filings). WEAKNESSES: (1) The LLM answer introduces specific references to 'Plantweb IIoT ecosystem' and 'Intelligent Devices strategy' that are not explicitly mentioned in the ground truth answer, creating potential factual concerns about whether these exact terms appear in the actual 10-K filings; (2) While the ground truth mentions 'secure wireless communication' as a 2024 element, the LLM answer emphasizes 'real-time health monitoring' and 'digital-twin analytics' instead—these are semantically related but represent a slight shift in emphasis; (3) The LLM answer's specific page citations (pp. 5-6, 71-73, 71-75) cannot be verified and may be hallucinated references. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression pattern. The logical flow from 2022→2023→2024 is sound and matches the ground truth's narrative arc. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth—the evolution from mechanical to digitally integrated positioning is clearly conveyed. The terminology used (integration, bundling, embedding, ecosystem) appropriately captures the conceptual progression. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are all correct. OVERALL ASSESSMENT: The answer captures the essential evolution narrative and demonstrates solid multi-hop reasoning across the three-year period. The main concern is the introduction of specific product/strategy names (Plantweb, Intelligent Devices) that may not be directly supported by the ground truth, which could indicate hallucination of specific filing details. However, these additions are thematically consistent with the overall narrative and represent reasonable inferences about Emerson's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 730,
        "total_tokens": 2284
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nBetween 2022 and 2024 Coca‑Cola repeatedly listed a “Form of Note for 0.125 % Notes due 2029” as Exhibit 4.4 in its quarterly and annual reports, each time pointing to a new Form 8‑K filing that added incremental tranches of the same 0.125 % series.  This pattern shows the company is treating the 0.125 % 2029 notes as a flexible, low‑cost funding tool—issuing small, periodic increments to manage near‑term maturities and preserve liquidity while keeping its overall debt profile lean and diversified.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ACCURACY: The LLM claims the notes were 'repeatedly listed as Exhibit 4.4' with 'incremental tranches' issued periodically via Form 8-K filings. The ground truth makes no mention of multiple tranches, Form 8-K filings, or Exhibit 4.4 references. This is a fundamental mischaracterization of the issuance pattern. (2) ENTITY/FACTUAL ERRORS: The LLM invents specific filing mechanics (Exhibit 4.4, Form 8-K references, 'incremental tranches') that are not supported by the ground truth. The ground truth discusses how the note was referenced in different contexts across years, not how it was repeatedly issued in tranches. (3) REASONING FLAWS: The LLM's conclusion that this represents 'a flexible, low-cost funding tool' with 'small, periodic increments' contradicts the ground truth's narrative of a maturing debt instrument being refinanced with higher-yielding longer-term instruments as it approached maturity. (4) MISSING KEY CONTEXT: The LLM completely omits the critical strategic pivot mentioned in the ground truth—the introduction of significantly higher-yielding instruments (5.000% and 5.400% notes) in 2024, which is central to understanding Coca-Cola's debt management strategy. (5) SEMANTIC DIVERGENCE: While both answers discuss the 0.125% Notes due 2029, they tell fundamentally different stories. The ground truth emphasizes strategic refinancing as the note matures; the LLM emphasizes ongoing incremental issuance as a liquidity management tool. These are contradictory narratives. The LLM answer appears to confuse or fabricate specific filing details rather than synthesizing the actual evolution of the company's approach across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 490,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nBNY Mellon’s 2022 Form 10‑K first warned that its ability to pay dividends or repurchase shares is limited by U.S. banking laws and the need to maintain adequate capital under its capital‑planning framework. In the 2023 and 2024 filings the company broadened the disclosure, explicitly tying its capital plans—including dividend and repurchase intentions—to regulatory capital requirements and noting that any downgrade or failure to meet “well‑capitalized” standards could impair funding and restrict distributions. Thus, while the core constraint remained unchanged, the later filings placed greater emphasis on the regulatory capital‑adequacy and rating considerations that govern shareholder capital returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and captures the essential evolution of BNY Mellon's regulatory disclosures from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and tracks the evolution of disclosure language; (2) Accurately captures the core constraint (U.S. banking laws and capital adequacy requirements); (3) Properly synthesizes the multi-hop information showing progression from general caution to specific regulatory references; (4) Correctly identifies key regulatory concepts like 'well-capitalized' status and capital-adequacy standards; (5) No quantitative errors or incorrect dates/numbers. MINOR WEAKNESSES: (1) The ground truth explicitly mentions 'Delaware law' as a constraint noted in 2022, which the LLM answer omits; (2) The ground truth specifically references 'preferred stock dividend obligations' as highlighted in 2023, which the LLM answer does not mention; (3) The LLM answer uses slightly different framing ('broadened the disclosure' vs. 'more specific references') which is semantically similar but less precise than the ground truth's emphasis on 'increasing specificity and formalization.' The LLM answer correctly captures the main narrative arc and regulatory evolution, but misses some specific details that were explicitly noted in the ground truth. The reasoning about the progression from general to specific regulatory language is sound and well-articulated. The answer appropriately addresses the multi-hop nature of the question by synthesizing information across three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 433,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings moved the reference to McGriddles from a simple breakfast‑menu list (2022 – page 9; 2023 – page 8; 2024 – page 8) into the broader “menu‑innovation” narrative that is woven into the company’s strategic disclosures on growth pillars and digital transformation (2023 – pages 4‑8; 2024 – pages 4‑8).  While the filings continue to note McGriddles as a core breakfast offering, the surrounding language increasingly ties it to the overall “Core” and “Value” themes of the Accelerating the Arches strategy, emphasizing stable, familiar items rather than positioning it as a breakthrough product.  \n\nThis evolution shows that McDonald’s breakfast strategy has remained consistent: it leans on a limited set of proven, value‑oriented breakfast items—including McGriddles—to anchor the morning menu, while the company’s innovation focus shifts toward digital, delivery and overall menu diversification rather than radical changes to the breakfast lineup.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PAGE NUMBER DISCREPANCIES: The LLM cites McGriddles references at pages 9 (2022), 8 (2023), and 8 (2024), but the ground truth explicitly states pages 7 (2022), 6 (2023), and 6 (2024). These are factual errors in document citation. (2) CONTRADICTORY NARRATIVE: The LLM claims McGriddles were 'moved into the broader menu-innovation narrative' and increasingly tied to strategic disclosures on growth pillars, but the ground truth explicitly states the OPPOSITE: McGriddles 'remained presented as a static menu item rather than an innovated product' and were described 'in the same basic format as in prior years' despite broader menu innovation elsewhere. This is a fundamental mischaracterization of the evolution. (3) MISSING CORE FINDING: The ground truth emphasizes the CONSISTENCY and STABILITY of McGriddles positioning across all three years without specific innovation details. The LLM's framing of an 'evolution' into strategic narratives contradicts this core insight. (4) SEMANTIC MISALIGNMENT: While the LLM correctly identifies that McGriddles remained a core breakfast offering and that innovation focused elsewhere (digital, delivery, diversification), it incorrectly frames this as an 'evolution' in portrayal rather than a 'consistency' in positioning. The ground truth's key insight—that McGriddles maintained a static, non-innovated position even as the company pursued broader innovation—is inverted in the LLM response. (5) PARTIAL CREDIT: The LLM does correctly identify that breakfast strategy remained consistent and that innovation focused on digital/delivery rather than breakfast products, which aligns with the ground truth conclusion. However, the path to that conclusion and the specific page citations are materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 486,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAdobe has treated free, self‑service training as a core component of Adobe Digital Learning Services, moving from a supplemental offering in 2022 to a strategically emphasized, scalable channel by 2024. In the 2022 filing (p. 17) it highlighted “a large number of free online self‑service learning options on www.training.adobe.com” delivered alongside fee‑based classroom and virtual programs, and it used solution‑specific skills assessments to align learning with enterprise needs. By 2023 and 2024 (pp. 19) the same catalog was referenced at learning.adobe.com, and the language stressed that these self‑service options are part of a “comprehensive portfolio of learning and enablement services,” underscoring a deepening investment in on‑demand, digital‑first education.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate platform transitions: www.training.adobe.com (2022) → learning.adobe.com (2023-2024). (2) Accurately captures the strategic positioning shift from supplemental offering to core component of Adobe Digital Learning Services. (3) Correctly synthesizes the multi-hop information showing integration into a 'comprehensive portfolio' that includes both free and fee-based offerings. (4) Properly contextualizes the role of self-service learning within broader enablement strategy. (5) Page references (p. 17 for 2022, p. 19 for 2023-2024) are appropriately cited. MINOR CONSIDERATIONS: (1) The LLM answer adds detail about 'solution-specific skills assessments' which, while not contradicting the ground truth, represents additional specificity not explicitly mentioned in the original answer. This is a minor enhancement rather than an error. (2) The characterization of the shift from 'supplemental' to 'strategically emphasized' is a reasonable interpretation of the trajectory described in ground truth, though ground truth uses 'broader enablement strategy' language. (3) The phrase 'digital-first education' is a reasonable semantic interpretation of the platform evolution described. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; platform URLs are accurate; no calculations required. QUALITATIVE ACCURACY: Multi-hop reasoning correctly synthesizes information across three years and multiple platforms; entity identification (Adobe, Adobe Digital Learning Services, platforms) is accurate; the logical progression is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core narrative as ground truth with slightly different emphasis but equivalent meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 505,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nThrough 2022‑2024 Emerson kept Commercial Vacuums in the **Safety & Productivity segment** under the “**Other professional tools**” category, alongside pipe‑working, electrical and water‑jetting equipment.  The company’s messaging consistently positioned the segment as a portfolio of professional‑grade tools that enhance **safety and productivity**, and it continued to sell these tools primarily through **distributor networks**, preserving a direct alignment with its broader professional‑tools offering.  Segment‑level financial tables for 2023 and 2024 show rising earnings and sales, confirming that the strategic emphasis on safety‑productivity tools—including commercial vacuums—remained a core, growth‑driving part of Emerson’s business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to accurately capture the evolution described in the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Commercial Vacuums were kept in Safety & Productivity segment 'through 2022-2024,' but the ground truth explicitly states they were in the 'Tools & Home Products segment' in 2022, only moving to Safety & Productivity in 2023. This is a fundamental mischaracterization of the 2022 positioning. (2) INCOMPLETE EVOLUTION NARRATIVE - The LLM fails to capture the critical evolution from 2022→2023→2024. The ground truth shows a three-stage progression: 2022 (Tools & Home Products with water jetters/wet-dry vacuums), 2023 (moved to Safety & Productivity with infrastructure tools like hydraulic tools and sewer cameras), and 2024 (remained in Safety & Productivity but with emphasis on advanced industrial tools like automation control systems and electrical distribution). The LLM presents a static picture rather than the dynamic repositioning. (3) MISSING STRATEGIC SHIFT - The ground truth emphasizes a 'shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools' by 2024. The LLM mentions 'rising earnings and sales' without providing specific numbers or dates, and doesn't capture this strategic shift toward industrial/technological integration. (4) VAGUE REFERENCES - The LLM mentions 'segment-level financial tables for 2023 and 2024 show rising earnings and sales' but provides no actual numbers, dates, or specific metrics, making this claim unverifiable and incomplete. (5) INCORRECT CATEGORIZATION - The LLM groups Commercial Vacuums with 'pipe-working, electrical and water-jetting equipment' as if this was consistent across the period, but the ground truth shows different groupings in different years (water jetters/wet-dry vacuums in 2022 vs. hydraulic tools/sewer cameras in 2023). The answer demonstrates a fundamental misunderstanding of the multi-hop temporal evolution required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 548,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead scaled the Hoofddorp, Netherlands site from an early‑stage, R&D‑focused location into a dedicated commercial‑scale cell‑therapy manufacturing hub.  The facility was used to produce and release its CAR‑T products (e.g., Yescarta and Tecartus) and other cell‑therapy pipeline candidates, and to perform commercial‑grade processing steps such as fill‑finish and packaging for EU distribution — a role repeatedly noted in the 2022‑2024 10‑K filings (pages 8, 11‑13) that describe Hoofddorp as a principal site for “commercial manufacturing and processing of our cell‑therapy products.”  This evolution reflects Gilead’s strategy to centralize and expand EU‑based cell‑therapy production to meet growing demand and support new indications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of the Hoofddorp facility from 2022-2024, accurately names specific CAR-T products (Yescarta and Tecartus), and properly characterizes the facility's role in commercial manufacturing and processing of cell therapy products. The semantic meaning aligns well with the ground truth regarding the strategic shift toward advanced therapies and sustained focus on cell therapy. The answer appropriately synthesizes information across the three-year period and correctly identifies Gilead (GILD) and the Netherlands location.\n\nWEAKNESSES: (1) FACTUAL INACCURACY - The LLM claims the facility evolved from \"early-stage, R&D-focused\" in 2022, but the ground truth states it was identified as a \"principal manufacturing site\" in 2022, not an R&D-focused location. This is a material mischaracterization of the 2022 baseline. (2) UNSUPPORTED CLAIMS - The answer adds details not present in the ground truth, such as specific fill-finish and packaging operations, EU distribution focus, and the claim about \"centralizing and expanding EU-based cell-therapy production.\" While these may be reasonable inferences, they exceed what the ground truth explicitly states. (3) PAGE CITATIONS - The LLM cites specific pages (8, 11-13) from 10-K filings, but these cannot be verified against the ground truth provided and may be fabricated or inaccurate. (4) INCOMPLETE ALIGNMENT - The ground truth emphasizes a \"strategic shift\" and \"growing emphasis\" between 2022-2024, but the LLM's characterization of 2022 as \"early-stage, R&D-focused\" contradicts this narrative.\n\nMULTI-HOP REASONING: The answer demonstrates reasonable synthesis across the three-year period and correctly identifies the progression theme. However, the mischaracterization of the 2022 baseline undermines the accuracy of the multi-hop analysis.\n\nNUMERIC/QUANTITATIVE: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is limited to date verification (2022-2024 correctly identified).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 556,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe continued disclosure of the 1.000 % Notes due 2028 in 2022‑2024 filings shows that this low‑cost, long‑dated instrument remains a core pillar of Coca‑Cola’s capital structure, providing a stable source of financing at historically cheap rates.  At the same time, the 2024 launch of higher‑yield notes such as the 5.000 % due 2034 and 5.400 % due 2064 demonstrates that the company is proactively supplementing that base with higher‑priced debt to manage upcoming maturities and to lock in longer‑term funding as market conditions shift, reflecting a pragmatic, flexible approach to balancing cost efficiency with the need to diversify and extend its debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the multi-hop question. QUANTITATIVE ACCURACY: All numeric values are correct - 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 are all accurately cited with correct percentages and maturity dates. The time period references (2022-2024 filings, 2024 launch) are accurate. ENTITY ACCURACY: Coca-Cola is correctly identified throughout, and all debt instruments are properly named and characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years (2022-2024) and connects the persistent reference to the 1.000% Notes with the introduction of higher-yield notes in 2024. The reasoning correctly identifies this as a strategic shift in capital structure management. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Coca-Cola maintained low-cost debt while adding higher-yield instruments in 2024. The LLM adds slightly more specific reasoning about 'managing upcoming maturities' and 'lock in longer-term funding as market conditions shift,' which provides additional context that is consistent with and supportive of the ground truth interpretation. MINOR DIFFERENCES: The LLM uses slightly different phrasing ('pragmatic, flexible approach' vs. 'recalibration') but both convey the same strategic intent. The LLM's explanation of motivations (manage maturities, lock in longer-term funding) is reasonable inference that aligns with the ground truth's mention of 'favorable market conditions' and 'fund new strategic initiatives.' No factual errors detected. The answer fully addresses all aspects of the multi-part question regarding debt financing costs and capital structure management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 485,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s pipe‑cutter line moved from conventional, cord‑connected tools in 2022 to fully battery‑powered, diagnostic‑integrated models by 2023‑2024, as reflected in the Safety & Productivity segment’s emphasis on battery hydraulic tools and built‑in diagnostic systems. This evolution shows a clear strategic pivot toward high‑margin, tech‑enabled professional plumbing tools, positioning Emerson as a leader in innovative, cordless solutions that boost plumber productivity and safety.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general strategic direction and correctly identifies the evolution toward battery-powered and diagnostic-integrated tools across the 2022-2024 period. However, there are notable discrepancies with the ground truth: (1) The LLM claims tools were 'fully battery-powered' by 2023-2024, while the ground truth indicates battery hydraulic technology was 'integrated' in 2023 and diagnostic systems were 'directly tied to' pipe cutters in 2024 - suggesting a more gradual integration rather than complete conversion. (2) The LLM describes 2022 tools as 'cord-connected,' which is not mentioned in the ground truth, which only states they were 'traditional' with 'no emphasis on battery-powered or diagnostic capabilities.' This is an inference not supported by the source material. (3) The LLM correctly identifies the strategic pivot toward high-value, technology-enhanced tools and the focus on productivity and safety, which aligns with the ground truth. (4) The reference to 'Safety & Productivity segment' adds specificity not present in the ground truth, which could be accurate but cannot be verified against the provided source. (5) The characterization of Emerson as a 'leader in innovative, cordless solutions' is somewhat overstated compared to the ground truth's more measured description of a 'strategic pivot.' The multi-hop reasoning is sound in connecting the three-year progression to market positioning, but the specific characterization of the 2022 baseline and the degree of battery integration in 2023-2024 diverges from the ground truth in ways that suggest the LLM may have made assumptions beyond what the source material supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 458,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GILD moved the Santa Monica, California site from an early‑stage, clinical‑trial‑only operation to a core hub that now supports both clinical and commercial manufacturing and processing of its cell‑therapy products.  This expansion—highlighted alongside El Segundo, Frederick and Hoofddorp as a dedicated cell‑therapy manufacturing location—shows that Santa Monica has become a strategic, high‑capacity node in GILD’s overall manufacturing network, underpinning the scale‑up of its CAR‑T and related cell‑therapy portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer claims Santa Monica transitioned to 'commercial manufacturing' by 2024, but the ground truth explicitly states it was used for 'clinical manufacturing and processing' only. The ground truth makes no mention of commercial manufacturing at Santa Monica. This is a significant factual error that contradicts the source material. (2) UNSUPPORTED CLAIMS - The LLM introduces claims about 'early-stage, clinical-trial-only operation' in 2022 and describes it as a 'core hub that now supports both clinical and commercial manufacturing' - neither of these characterizations appear in the ground truth. The ground truth only indicates Santa Monica was 'not specifically highlighted for cell therapy processing' in 2022, not that it was trial-only. (3) OVERSTATED PROGRESSION - The LLM describes an expansion from 'clinical-trial-only' to 'core hub' with 'high-capacity' status, but the ground truth shows a more modest progression: from general R&D site to dedicated cell therapy manufacturing hub focused on clinical manufacturing. The LLM significantly overstates the scope and scale of the facility's role. (4) CORRECT ELEMENTS - The LLM correctly identifies: the three-year timeframe (2022-2024), the facility's transition to cell therapy manufacturing, the mention of El Segundo and Frederick as comparable sites, and the strategic importance in the manufacturing network. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years, it does so by introducing unsupported claims about commercial manufacturing that contradict the ground truth. The reasoning structure is sound but the factual foundation is flawed. The answer demonstrates partial understanding but commits material errors on the scope of the facility's utilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 495,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved Frame.io from a stand‑alone review hub into the core of Creative Cloud, expanding the types of assets it can handle (video, still images, design files and PDFs) and tightening its integration with the Creative Cloud apps.  The platform now delivers frame‑accurate, AI‑enhanced commenting and approval workflows directly inside Premiere Pro, After Effects, Photoshop and Illustrator, and it is bundled with Adobe Express and Firefly Services in GenStudio to enable scalable, multi‑media content production across the entire Creative Cloud ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Frame.io from 2022-2024, accurately captures the expansion of supported media types (video, still images, design files, PDFs), and correctly names several integrated applications (Premiere Pro, After Effects, Photoshop). The mention of GenStudio and AI-enhanced features aligns with ground truth. The general narrative of integration deepening across Creative Cloud is sound.\n\nWEAKNESSES AND ERRORS: (1) The LLM mentions Illustrator as an integrated application, but the ground truth specifies Lightroom and Workfront as key 2024 integrations—Illustrator is not mentioned in the original answer. This is a factual error in entity identification. (2) The LLM mentions 'Adobe Express and Firefly Services' bundled with GenStudio, but the ground truth does not specify these details about bundling or Firefly Services integration. This appears to be information not supported by the knowledge graph. (3) The LLM describes Frame.io as a 'stand-alone review hub' in 2022, but the ground truth only states it was 'listed as part of Adobe's trademark portfolio' without characterizing it as stand-alone. (4) The ground truth explicitly mentions Frame.io's 2023 integration with Premiere Pro and After Effects for 'frame-specific feedback' and its 2024 expansion to non-post-production workflows (casting, location scouting, marketing)—the LLM does not capture this important distinction about the expansion beyond post-production. (5) The LLM does not mention Workfront, which is explicitly called out in the ground truth as a 2024 integration.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 timeline and identifies the progression of integration. However, it introduces unsupported details (Illustrator, Express, Firefly bundling) and omits key supported details (Lightroom, Workfront, non-post-production use cases), suggesting incomplete or partially inaccurate synthesis from the knowledge graph.\n\nNUMERIC/DATE ACCURACY: Years (2022, 2023, 2024) are correctly referenced. No calculations or specific metrics are involved in this question.\n\nSEMANTIC ISSUES: While the general narrative is directionally correct, the specific application integrations and use case expansions are not accurately represented, which is critical for a question about 'evolution' and 'integration.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 636,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson reshaped Electrical Distribution Equipment in its Discrete‑Automation portfolio from a stand‑alone power‑distribution offering into a tightly‑integrated, smart‑connected component of its automation solutions.  The product scope was broadened—adding higher‑voltage, modular and IoT‑enabled modules—and the equipment was coupled with Emerson’s control‑system and software platforms, a shift that is reflected in the expanding description of the Discrete‑Automation segment (pages 73‑74) and the steady rise in its sales from $2.6 bn in 2022 to $2.5 bn in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE DATA: The LLM provides specific revenue figures ($2.6bn in 2022 to $2.5bn in 2024) that are NOT present in the ground truth and appear to be fabricated or incorrectly sourced. The ground truth makes no mention of these specific dollar amounts for the Discrete Automation segment. This is a critical error as the LLM presents these as factual data points with page references (pages 73-74), which cannot be verified against the provided ground truth. QUALITATIVE ALIGNMENT: The LLM correctly captures the core strategic evolution narrative - that Electrical Distribution Equipment evolved from a standalone offering to an integrated component of automation solutions. The mention of coupling with control systems and software platforms aligns with the ground truth's reference to 'programmable automation control systems and software.' However, the LLM introduces product details (higher-voltage, modular, IoT-enabled modules) that are NOT in the ground truth, suggesting either fabrication or external knowledge injection. MISSING ELEMENTS: The LLM fails to mention the specific product integrations mentioned in the ground truth: (1) the 2023 positioning alongside programmable automation control systems and software, (2) the 2024 expansion to include electric linear motion solutions and materials joining solutions. These are key details showing the breadth of integration across the segment. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across three years but does so with invented financial data rather than grounding the answer in documented product portfolio changes. The reasoning about integration is sound but incomplete. CRITICAL FLAW: Presenting unverified financial figures as fact with specific page citations is a serious accuracy problem that undermines credibility, even though the qualitative narrative direction is partially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 515,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying amount of Capital One’s fixed unsecured senior debt slipped from roughly $27.2 billion to $26.9 billion, while its weighted‑average interest rate remained essentially flat at about 4.8 %. This modest de‑leveraging and steady‑rate profile indicates the company is preserving a low‑cost, largely fixed‑rate funding base and is not expanding new long‑term fixed‑rate issuance as market rates rise.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent Capital One's debt evolution: (1) MAJOR NUMBER ERROR - The LLM states the carrying value 'slipped from roughly $27.2 billion to $26.9 billion' but the ground truth shows it started at $19,975 million ($19.975 billion) in 2022, not $27.2 billion. The LLM appears to have confused the 2024 ending value ($26.930 billion) with the 2022 starting value. (2) MISSING CRITICAL DATA - The LLM completely omits the 2023 intermediate year data ($27,168 million), which is essential for understanding the progression and trend. (3) INTEREST RATE ERROR - The LLM claims the weighted-average interest rate 'remained essentially flat at about 4.8%' but the ground truth shows a clear progression: 2.91% (2022) → 4.45% (2023) → 4.84% (2024). This is not flat; it shows a 193 basis point increase from 2022 to 2024. (4) INCORRECT STRATEGIC INTERPRETATION - The LLM's conclusion that the company is 'preserving a low-cost, largely fixed-rate funding base' contradicts the actual data showing rising rates. The ground truth correctly identifies a 'proactive approach to anticipated rate hikes' with rates locking in at increasingly higher levels. (5) INCOMPLETE ANALYSIS - The LLM fails to capture the key insight that debt increased significantly from 2022 to 2023 (a $7.2 billion increase) before declining slightly in 2024. The LLM's characterization of 'modest de-leveraging' misses this important intermediate expansion. The answer demonstrates fundamental misreading of the financial data and provides an analysis that contradicts the actual debt strategy evidenced by the numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 453,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell steadily from **$1.109 bn at the end of 2022 to $1.091 bn at the end of 2023 and then to $0.993 bn by the end of 2024** (see the “Balance as of December 31” column in the note on service‑ and warranty‑related guarantees).  This decline reflects a reduced expectation of future payouts for engine‑performance issues—particularly after the one‑time $2.9 bn charge in 2023 tied to PW1100‑GTF disruptions—indicating that RTX’s exposure to long‑term product‑performance risk in its commercial aerospace business is diminishing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative dimensions. The ground truth establishes that RTX's liabilities for performance and operating cost guarantees were: 2022: $120 million, 2023: $120 million, 2024: $101 million. The LLM provides completely different numbers: 2022: $1.109 billion, 2023: $1.091 billion, 2024: $0.993 billion. These are off by a factor of approximately 10x. The LLM's numbers are roughly 9-10 times larger than the actual figures. Additionally, the LLM's interpretation of the trend is inverted - while the ground truth correctly identifies the liability as 'relatively stable' (staying at $120M for two years before a slight decrease to $101M), the LLM characterizes it as a 'steady decline' from $1.109B to $0.993B. The LLM also introduces an unsupported reference to a '$2.9 bn charge in 2023 tied to PW1100-GTF disruptions' which, while potentially relevant to RTX's aerospace business, is not substantiated in the ground truth answer and appears to be either fabricated or from a different liability category. The multi-hop reasoning fails because the foundational numbers are wrong, making all subsequent analysis invalid. The only partially correct element is the general direction of discussion (performance guarantees in commercial aerospace), but the specific financial data, magnitudes, and conclusions are all materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 385,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola continued to list “estimates of sales proceeds” as one of several fair‑value methodologies for its non‑public investments, but the 2023 and 2024 filings began to emphasize this approach more heavily for emerging‑market assets and to tie it directly to cash‑flow forecasts and impairment testing. This evolution reflects a shift from a primarily market‑price‑driven valuation toward a cash‑flow‑centric assessment that acknowledges the limited observable market data in emerging markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and mischaracterizations compared to the ground truth. STRENGTHS: (1) Correctly identifies 'estimates of sales proceeds' as a valuation methodology used across 2022-2024; (2) Accurately notes the methodology was used alongside other approaches (discounted cash flows, appraisals); (3) Correctly identifies emerging markets as a relevant context; (4) No quantitative errors in dates or numbers. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth emphasizes a three-stage progression (disclosure → reliance → cautious integration), but the LLM answer collapses this into a simpler narrative of 'emphasis' without capturing the semantic shift from 'disclosed' (2022) to 'relies on' (2023) to 'uses with caution' (2024). This is a fundamental mischaracterization of the evolution; (2) The LLM states the shift is 'from market-price-driven to cash-flow-centric,' but the ground truth indicates the methodology itself (estimates of sales proceeds) remained consistent—the evolution was in HOW it was applied and the company's CONFIDENCE in it, not a fundamental methodological pivot; (3) Missing the key insight that 2024 shows 'increased emphasis on challenges' and 'more cautious application'—the LLM frames this as a positive integration rather than a risk-aware moderation; (4) The phrase 'tied it directly to cash-flow forecasts' is vague and doesn't clearly convey that the 2024 position acknowledged difficulties in predicting future cash flows in emerging markets; (5) The LLM answer doesn't adequately capture the strategic evolution from mere disclosure to operational reliance to risk-aware integration. MULTI-HOP REASONING: The LLM partially synthesizes the three-year progression but fails to capture the nuanced evolution in the company's confidence and application of the methodology. The reasoning is somewhat sound but incomplete in capturing the full narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 526,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, BNY Mellon repeatedly warned that shareholder capital returns are “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including capital‑planning rules and the need to pay full and timely dividends on preferred stock,” with the 2023 and 2024 disclosures adding explicit references to the impact of credit‑rating downgrades and stress‑test results on those limits. This progression shows that the firm’s ability to distribute capital is increasingly constrained by regulatory capital adequacy requirements and external rating considerations, curbing its strategic flexibility for dividends and repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces claims NOT present in the ground truth: specifically, it states that '2023 and 2024 disclosures adding explicit references to the impact of credit-rating downgrades and stress-test results.' The ground truth makes NO mention of credit-rating downgrades or stress-test results being added in 2023-2024. This is a significant factual error that misrepresents the actual evolution of disclosures. (2) MISSING KEY INFORMATION - The LLM answer completely omits the ground truth's critical finding about the 2024 disclosure's 'new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends.' This is a core distinguishing feature of the 2024 disclosure that shows the progression was not just about regulatory constraints but about internal structural dependencies. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes that the regulatory language remained 'consistent' across 2022-2024, with the 2024 change being about INTERNAL CAPITAL FLOWS and structural dependencies, not external rating considerations. The LLM mischaracterizes the nature of the evolution. (4) ENTITY/METRIC ACCURACY - While BNY Mellon is correctly identified and the timeframe (2022-2024) is correct, the specific regulatory constraints and their evolution are misrepresented. (5) REASONING QUALITY - The LLM's conclusion that constraints are 'increasingly' driven by 'external rating considerations' contradicts the ground truth's finding that the key 2024 change involved internal structural dependencies and subsidiary dividend flows. This represents a fundamental misunderstanding of the multi-hop synthesis required. The answer gets the general theme (capital return limitations) but fails on the specific evolution and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 508,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s risk disclosures shifted from a broad statement that “loss or modification of exemptions for taxes and tariffs” could affect the business to a far more detailed description that ties those exemptions to a widening set of geopolitical and regulatory pressures—including U.S. sanctions on Russia and Belarus, new export‑control rules, and heightened tensions between China and Taiwan.  This progression shows that the company is confronting an increasingly complex global regulatory landscape where tax‑ and tariff‑related benefits are vulnerable to multiple, overlapping international legal and political developments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-hop question about AMD's evolving risk exposure from 2022-2024. STRENGTHS: (1) Correctly identifies the time period (2022-2024) and tracks the progression of AMD's risk disclosures; (2) Accurately captures the shift from general/broad statements to more detailed, specific geopolitical references; (3) Correctly identifies specific geopolitical factors mentioned (U.S. sanctions on Russia and Belarus, export controls, China-Taiwan tensions); (4) Properly synthesizes the multi-hop reasoning showing how external geopolitical pressures drove increased complexity in regulatory environment; (5) No quantitative errors or incorrect dates/entities. MINOR GAPS: (1) The LLM answer mentions 'U.S. sanctions on Russia and Belarus' with specificity, while the ground truth references 'conflict in Ukraine' more broadly - these are related but the LLM provides slightly more specific detail; (2) The ground truth explicitly mentions 'expansion of U.S. export controls and sanctions' in 2024 context, which the LLM captures but frames slightly differently; (3) The ground truth notes the risk was 'listed among other geopolitical and economic risks' in 2022, suggesting it was one of several concerns, while the LLM frames it as a 'broad statement' - semantically similar but slightly different emphasis. REASONING QUALITY: The LLM correctly performs multi-hop synthesis by connecting: (a) AMD's disclosure evolution across three years, (b) the shift from general to specific risk factors, (c) the underlying geopolitical drivers, and (d) the conclusion about increasing regulatory complexity. The logical flow is sound and matches the ground truth's narrative arc. The answer appropriately addresses both parts of the question: how the exposure evolved AND what it suggests about regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 509,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s short‑term borrowings fell sharply from $883 million to $538 million in 2023 and then edged up to $562 million in 2024, while total long‑term debt rose from $47.8 billion to a peak of $49.3 billion in 2023 before declining to $45.0 billion in 2024.  Importantly, the floating‑rate unsecured senior debt that was $1.6 billion in 2022 dropped to $349 million in 2023 and was essentially eliminated by 2024, signalling a deliberate shift toward more fixed‑rate or secured funding and a reduced exposure to floating‑rate interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. MAJOR ERRORS: (1) Total debt figures are substantially wrong - LLM states $47.8B in 2022, $49.3B in 2023, and $45.0B in 2024, but ground truth shows $43.086B, $49.856B, and $45.551B respectively. The 2022 figure is off by ~$4.7B (10.9% error), 2023 is off by ~$0.5B (1%), and 2024 is off by ~$0.5B (1.1%). (2) Short-term borrowings breakdown is problematic - LLM provides specific figures ($883M, $538M, $562M) that don't align with the ground truth's total short-term borrowings component. (3) Floating unsecured senior debt in 2022 is stated as $1.6B when ground truth shows $1.709B - a minor error but part of a pattern. CORRECT ELEMENTS: (1) The directional trend of floating unsecured senior debt is correct (declining from 2022 to elimination by 2024). (2) The $349M figure for 2023 floating unsecured senior debt is accurate. (3) The qualitative conclusion about shifting from floating to fixed-rate debt is directionally correct. MISSING INFORMATION: (1) No mention of fixed unsecured senior debt evolution ($21.045B to $27.168B to $26.930B). (2) No discussion of weighted-average interest rates (1.01% to 6.75% to 0% for floating debt; 2.91% to 4.84% for fixed debt). (3) Incomplete analysis of interest rate exposure changes. The answer demonstrates partial understanding of the debt structure shift but fails on quantitative precision, which is critical for financial analysis. The 2022 total debt figure error is particularly problematic as it's a foundational number for the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 437,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program‑share in International Aero Engines AG fell from roughly **57 % (2022) to about 51 % (2024)** after accounting for the sub‑collaborator allocations.  This modest decline shows that RTX’s exclusive control over the V2500 engine programme has been diluted, reflecting a more balanced partnership with MTU and JAEC and signalling a strategic shift toward sharing ownership and governance of the V2500 platform rather than retaining a dominant stake.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides completely incorrect percentages. Ground truth states RTX's net program share was 61% in 2022, declining to 57% in 2023 and 2024. The LLM claims 57% in 2022 and 51% in 2024 - both numbers are wrong. The 2022 figure is off by 4 percentage points (61% vs 57%), and the 2024 figure is off by 6 percentage points (57% vs 51%). This is not a minor rounding difference but a fundamental misstatement of the data. (2) DIRECTIONAL ERROR: While the ground truth shows a decline from 61% to 57% (4 percentage point decrease), the LLM shows a decline from 57% to 51% (6 percentage point decrease). The LLM overstates the magnitude of the decline. (3) BASELINE YEAR ERROR: The LLM incorrectly states the 2022 figure as 57% when it should be 61%. This is a critical error in the starting point of the analysis. (4) MULTI-HOP REASONING: The LLM's interpretation about 'exclusive control being diluted' and 'more balanced partnership' may be reasonable conclusions, but they are built on incorrect numerical foundations. The reasoning quality is undermined by the factual errors. (5) SEMANTIC ISSUES: The LLM's characterization of RTX moving from 'dominant stake' to 'more balanced partnership' contradicts the actual data showing only a modest 4-percentage-point decline from 61% to 57%, which still represents a clear majority stake. The ground truth's more measured interpretation ('gradually diluted...shifting more burden to sub-collaborators') is more accurate than the LLM's overstatement of the strategic shift. (6) MISSING CONTEXT: The LLM mentions MTU and JAEC but the ground truth focuses on the shift to sub-collaborators more generally. The LLM's specific naming of partners is not verified against the ground truth. VERDICT: The answer fails on the primary metric of quantitative accuracy with multiple incorrect percentage figures that are fundamental to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 533,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nCascade remains a flagship brand in the Home Care sub‑category of P&G’s Fabric & Home Care segment, and the segment’s financial weight has risen modestly across the three filings—net‑sales share grew from about 35 % in the 2022 10‑K to roughly 36 % in the 2024 10‑K, while its share of net earnings increased from ~31 % to ~34 % over the same period. This upward shift indicates a steady strengthening of Cascade’s role as a core growth and profit driver within P&G’s home‑care portfolio from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and percentages. Quantitative verification: Net sales share progression (35% in 2022 → 36% in 2024) is accurate; net earnings share progression (31% in 2022 → 34% in 2024) is accurate. The answer correctly identifies Cascade's consistent positioning within the Home Care sub-category of the Fabric & Home Care segment across all three reporting periods. Multi-hop synthesis is sound—the model successfully synthesized information across three 10-K filings to track both Cascade's brand positioning and segment financial performance trends. The reasoning about 'steady strengthening' and 'core growth and profit driver' is logically supported by the upward trajectory in both metrics. Minor omission: The LLM answer does not explicitly mention the 2023 intermediate year data (36% net sales, 34% earnings), instead jumping from 2022 to 2024. While this doesn't affect the accuracy of the stated figures, the ground truth provides more complete temporal coverage by including all three years. The LLM's characterization of the evolution as 'modest' growth is appropriate given the relatively small percentage increases. Semantic equivalence is maintained throughout—the answer conveys the same core message as the ground truth regarding Cascade's stable strategic importance and the segment's slight earnings contribution increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 398,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s disclosure of the Directors’ Code of Conduct moved from a PDF located under a “/in relations/” folder on the corporate site (e.g., https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf) to a streamlined URL that retained the same path but used the fully qualified www.bnymellon.com domain consistently, and the reference was integrated into the broader governance sections (Item 10, board‑committee charters, ethics‑hotline and waiver disclosures) so that any future amendments or waivers would be posted alongside the code within the same governance‑framework page.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple critical dimensions: (1) DOMAIN BRANDING ERROR: The LLM states the company 'retained the same path but used the fully qualified www.bnymellon.com domain consistently,' which directly contradicts the ground truth that BNY Mellon transitioned to a NEW domain ('bny.com') by 2024. This is a fundamental error in tracking the evolution requested. (2) URL PATH ERRORS: The LLM references '/in relations/' folder, but the ground truth shows the 2022 path was '/in relations/' (which the LLM gets right initially), but then claims the URL was 'streamlined' while 'retaining the same path.' However, the ground truth shows the path evolved from '/in relations/' (2022) to '/inv relations/' (2023) to '/investor-relations/' (2024) - three distinct iterations, not a retained path. The LLM fails to capture these intermediate changes. (3) MISSING KEY EVOLUTION: The ground truth explicitly highlights the 2024 transition to 'bny.com' domain as a strategic shift signaling 'more stakeholder-oriented, brand-consistent governance disclosure strategy.' The LLM completely misses this critical domain migration, which is central to the question about how disclosures 'evolved.' (4) INCOMPLETE SYNTHESIS: While the LLM mentions integration into broader governance frameworks (Item 10, board-committee charters, etc.), this appears to be inference rather than grounded in the specific URL/domain evolution described in the ground truth. The ground truth focuses on the URL structure and domain branding changes as the primary evidence of evolution. (5) TEMPORAL ACCURACY: The LLM fails to distinguish the three separate years (2022, 2023, 2024) with their distinct URL paths and domain structures. The answer conflates these into a single narrative of 'consistency' rather than documenting the actual evolution. The core factual errors regarding domain transition (bnymellon.com to bny.com) and the failure to track the URL path evolution across all three years represent fundamental failures in answering the multi-hop question about how disclosures evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 574,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s contracts with add‑in‑board (AIB) makers shifted from a basic price‑protection clause to a fuller inventory‑safeguard package that added formal stock‑rotation and limited‑return rights, giving AIBs greater certainty as the company rolled out newer RDNA 3 and CDNA 3 discrete GPUs.  At the same time, AMD increasingly leaned on its discrete graphics solutions—highlighting performance, ray‑tracing and AI‑acceleration features—as the primary differentiator that AIBs and system‑integrators could use to create higher‑margin, value‑added products in the gaming and data‑center segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims AMD's policies evolved from 'basic price-protection clause to a fuller inventory-safeguard package' with 'formal stock-rotation and limited-return rights,' but the ground truth explicitly states AMD 'consistently maintained inventory protection policies' across all three years with NO evolution or change in policy structure. This is a fundamental mischaracterization. (2) UNSUPPORTED SPECIFICS: The LLM introduces specific technical details (RDNA 3, CDNA 3 GPU architectures, ray-tracing, AI-acceleration features) that are not mentioned in the ground truth and cannot be verified as accurate from the provided context. These appear to be hallucinated details. (3) MISSING CORE INFORMATION: The ground truth emphasizes the 'consistency' and 'stable, long-term partnership model' across the three years, which the LLM completely misses by incorrectly framing this as an evolution/shift. (4) SEMANTIC DIVERGENCE: While the LLM correctly identifies that discrete graphics were important differentiators and that AIBs/SIs used them for value-added products, it frames this as an 'increasing lean' rather than consistent emphasis, which contradicts the ground truth's emphasis on stability. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the multi-year information, instead inventing a narrative arc of policy evolution that doesn't exist in the source material. The answer demonstrates poor adherence to factual accuracy on a core claim about policy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 450,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 through 2024 McDonald’s filings moved from a simple listing of the Egg McMuffin as part of the breakfast menu to a detailed narrative that ties the product’s consistency to the Company’s evolving supply‑chain rigor.  In 2022 the focus was on the uniform breakfast offering and basic quality standards; by 2023 the disclosures added the Food‑Safety Advisory Council, third‑party audits and a digital transformation aimed at continuous quality monitoring, and in 2024 the language emphasized supply‑chain risk management, sustainability and data‑driven measures that protect the muffin’s taste, safety and on‑time availability.  Together, these disclosures show the Egg McMuffin being used as a benchmark for how McDonald’s leverages its global supply‑chain infrastructure to meet customer expectations for quality and consistency across its breakfast menu.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL INACCURACIES: The LLM answer introduces entities and claims NOT present in the ground truth, including: 'Food-Safety Advisory Council' (not mentioned in original answer), 'third-party audits' (not mentioned), and 'supply-chain risk management' and 'sustainability' as 2024 emphases (not in ground truth). These appear to be fabricated details. (2) MISCHARACTERIZATION OF 2023 EVOLUTION: The ground truth states 2023 focused on 'Global Chief Supply Chain Officer' and 'comprehensive global supply chain strategy,' but the LLM invents different mechanisms (Food-Safety Advisory Council, third-party audits). (3) MISCHARACTERIZATION OF 2024: Ground truth emphasizes 'digital transformation in food safety and quality' with 'data excellence and continuous measures,' while LLM claims emphasis on 'supply-chain risk management, sustainability and data-driven measures' - sustainability is not mentioned in the original answer. (4) CORRECT ELEMENTS: The LLM does correctly identify the general evolution from basic quality standards (2022) to more sophisticated approaches (2023-2024), and correctly notes the Egg McMuffin's role as a benchmark product. The overall narrative arc of increasing sophistication is sound. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize across years, it does so by introducing unsupported details rather than accurately reflecting the ground truth's actual progression. The reasoning structure is present but built on incorrect factual foundations. (6) SEMANTIC ISSUES: The LLM's framing of 'digital transformation aimed at continuous quality monitoring' in 2023 is not supported - the ground truth places digital transformation emphasis in 2024, not 2023. This is a significant chronological error in the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 489,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe repeated appearance of the 4.30 % senior unsecured note maturing in 2034 across Oracle’s 2022, 2023 and 2024 Form 10‑K filings shows that this tranche is a core, long‑term funding pillar that the company continues to reference and roll‑forward.  Its consistent disclosure signals that Oracle is deliberately maintaining a diversified maturity schedule of fixed‑rate debt—using the 2034 note to lock in a predictable cost of capital and to support its growth and acquisition strategy—while reinforcing confidence in its credit profile across reporting periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 4.30% Note due 2034 and its consistent disclosure across 2022, 2023, and 2024 filings. The quantitative accuracy is strong—the percentage (4.30%), maturity year (2034), and time period coverage (all three years) are all correct. The answer appropriately characterizes this as a 'core, long-term funding pillar' and correctly infers that consistent disclosure indicates strategic importance to Oracle's debt structure. The reasoning about diversified maturity scheduling and fixed-rate debt strategy is sound and relevant. However, the LLM answer lacks specific comparative context that the ground truth provides. The ground truth explicitly mentions other debt instruments disclosed alongside the 4.30% Note in each year (e.g., 3.625% Note due 2023, 4.50% Note due 2044 in 2022; 2.950% Notes due 2024 in 2023), which provides concrete evidence of the 'diversified maturity profile' claim. The LLM answer makes the same conceptual point about diversification but without citing these specific supporting instruments, making the argument less substantiated. Additionally, the LLM introduces the phrase 'senior unsecured note' which, while likely accurate, is not explicitly confirmed in the ground truth provided. The LLM also adds interpretive elements about 'growth and acquisition strategy' and 'confidence in credit profile' that go beyond what the ground truth explicitly states, though these are reasonable inferences. Overall, the core factual content is correct, but the answer would be stronger with the specific comparative debt instrument details that ground the diversification argument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 448,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net‑derivative assets measured at fair value rose from about $5 million to $58 million and then to $69 million, with the position remaining classified as Level 3 in the fair‑value hierarchy.  The valuation continued to rely on discounted‑cash‑flow models that use unobservable inputs such as swap rates (≈3‑5 % in 2024 versus 1‑2 % in 2022), voluntary prepayment and default rates, and loss‑severity assumptions; the range of these inputs was largely unchanged but the weighted‑average swap rate increased, signalling a modestly greater reliance on internally derived, unobservable market assumptions.  This trend shows that the company’s exposure to unobservable inputs has expanded slightly over the period, as reflected by the larger Level 3 balances and the growing share of derivatives priced on internally derived assumptions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims net derivative assets rose from '$5 million to $58 million and then to $69 million' across 2022-2024, but the ground truth states: 2022 = $19 million (not $5M), 2023 = $58 million (correct), 2024 = $58 million (not $69M). The LLM incorrectly reports a 2024 value of $69M when it should be $58M - a $11M error. The starting 2022 value of $5M is also wrong (should be $19M). (2) SWAP RATE RANGES: The LLM states swap rates were '1-2% in 2022' but the ground truth does not provide 2022 swap rate ranges - only 2023-2024 ranges of 3-5%. The LLM appears to have fabricated the 2022 comparison. (3) MISSING KEY INFORMATION: The ground truth mentions a 'net unrealized loss of $20 million' in 2022 and specific default rate ranges (53-163%) in 2023, neither of which appear in the LLM answer. The ground truth also emphasizes the transformation from 'mixed realized/unrealized loss position in 2022 to more stable fair value by 2023-2024,' which the LLM fails to capture. (4) METHODOLOGY DISCUSSION: While the LLM correctly identifies Level 3 classification and mentions DCF models with unobservable inputs, it misses the critical insight about the evolution FROM a loss position TO a stable asset position. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the temporal evolution across three years, getting the endpoint (2024) wrong and inventing data points not in the ground truth. The core narrative about 'transformation in valuation methodology' is absent. The answer demonstrates partial understanding of derivative valuation concepts but fails on fundamental numerical accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 486,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 the Rolls‑Royce‑related obligation stayed tied to the **number of V2500‑powered flight hours**—payments become due for each hour flown (up to the June 2027 horizon) and are **capitalized as collaboration intangible assets**. Those assets are **amortized to cost of sales** over the program’s estimated economic life (generally 9‑30 years, with little or no amortization during the development phase and beginning when the program reaches full‑rate production and aftermarket cycles). Consequently, as the fleet accumulated more flight hours the accrued but unpaid payments grew, causing the **amortization expense to increase in 2023‑2024** while the underlying payment structure and capitalization treatment remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core structure of RTX's Rolls-Royce obligations (flight-hour based payments, capitalization as collaboration intangible assets, amortization to cost of sales, June 2027 horizon). However, there are significant issues: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifies that in 2024, total commercial aerospace financing and other commitments stood at $14.1 billion—this critical number is completely absent from the LLM answer. (2) UNSUPPORTED CLAIMS: The LLM states amortization periods are 'generally 9-30 years' and describes development phase vs. full-rate production amortization patterns, but these specific details are not mentioned in the ground truth and appear to be extrapolated or hallucinated. (3) SPECULATIVE REASONING: The claim that 'as the fleet accumulated more flight hours the accrued but unpaid payments grew, causing the amortization expense to increase in 2023-2024' is presented as fact but is not explicitly stated in the ground truth, which only notes that 'transparency around how these payments were integrated into intangible asset management improved over time.' (4) PARTIAL ACCURACY ON EVOLUTION: The answer correctly captures that the treatment remained consistent across 2022-2024, but fails to note the key evolution point that by 2023 RTX 'clarified' the accounting treatment—suggesting improved disclosure rather than operational change. (5) MISSING CONTEXT: The answer doesn't mention the 2012 acquisition context that established this long-term payment structure. The answer demonstrates good understanding of the mechanics but introduces unsupported details and critically omits the $14.1 billion figure that represents the quantitative evolution of these obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 478,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen first flagged the issue in its 2022 filing, noting that the FDA had been reviewing the Neulasta Onpro kit and that the company had already applied “device and labeling enhancements” to address the complaints it was receiving, while promising continued monitoring and further improvements. In the 2023 and 2024 filings the language became more specific: the company described concrete device‑level upgrades (e.g., redesign of the auto‑injector mechanism and revised labeling/instructions to improve clarity and reliability) and tied those upgrades to broader operational‑resilience measures such as increased reliance on backup generators, diversified third‑party supplier strategies, and contingency plans for power‑grid disruptions. Thus, the disclosures evolved from a generic acknowledgment of complaints to a detailed account of targeted device enhancements and the supporting resilience actions that underpin the Onpro kit’s performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer claims specific device-level upgrades including 'redesign of the auto-injector mechanism and revised labeling/instructions' but the ground truth does NOT specify these concrete details. The ground truth only states Amgen 'implemented device and labeling enhancements' without detailing what those enhancements were. The LLM fabricated specific technical details not present in the source material. (2) OPERATIONAL RESILIENCE DETAILS - The LLM mentions 'diversified third-party supplier strategies and contingency plans for power-grid disruptions' but the ground truth only specifically mentions 'backup generators' and the December 31, 2024 island-wide outage. The LLM added supplier diversification details not supported by the ground truth. (3) TIMELINE ACCURACY - The ground truth clearly states the 2017 FDA evaluation was referenced in 2022, and that 2024 saw the addition of operational resilience measures. The LLM's characterization of 2023 and 2024 becoming 'more specific' with 'concrete device-level upgrades' is not supported - the ground truth indicates 2023 'reiterated' the same enhancements from 2022. (4) CORRECT ELEMENTS - The LLM correctly identifies: the core focus on user complaints across all three years, the 2022 reference to FDA evaluation and device/labeling enhancements, the 2023 emphasis on monitoring, and the 2024 expansion to include operational resilience measures including backup generators and Puerto Rico's power grid issues. (5) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize the evolution across years, it does so by adding unsupported details rather than accurately reflecting what the ground truth states. The answer reads more like an inference or interpretation than a faithful representation of actual disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 498,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s disclosure in Item 14 (and the accompanying proxy) simply states that KPMG LLP is the principal accountant and that its PCAOB firm identification number is 185, without any change in wording or auditor selection. The repeated, identical reference to the same PCAOB number indicates that the bank has consistently retained KPMG as its independent auditor, underscoring a stable audit‑governance framework over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly addresses the core question. STRENGTHS: (1) All numeric values are correct - PCAOB firm number 185 is accurately cited, and the three-year period (2022, 2023, 2024) is correctly identified. (2) The multi-hop synthesis is sound: the answer correctly connects the consistent disclosure across three years with the unchanged PCAOB number to conclude stable audit governance. (3) Entity identification is accurate - correctly identifies BNY Mellon (BK) and KPMG LLP as the principal accountant. (4) The semantic meaning aligns well with the ground truth: both convey that KPMG was consistently retained with no changes, indicating governance continuity. (5) The answer appropriately references Item 14 and proxy disclosures, showing understanding of filing structure. MINOR WEAKNESSES: (1) The LLM answer uses 'BNY Mellon' while the ground truth uses 'BK' - though these are equivalent (BK is the ticker for BNY Mellon), the question specifically asked about 'BK' and the ground truth maintained that terminology. This is a very minor inconsistency in terminology choice rather than factual error. (2) The ground truth explicitly states 'no substantive changes in the structure or framing of the disclosure' while the LLM says 'without any change in wording' - these are semantically equivalent but the ground truth is slightly more precise about what remained unchanged. (3) The LLM could have been slightly more explicit about the 'evolution' aspect of the question (showing what stayed the same across years), though it does address this adequately. Overall, the answer is factually correct, properly synthesizes multi-hop information, and reaches the correct conclusion about audit governance continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 481,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing guarantees stayed at a similar magnitude—about $4.5‑$4.6 billion of committed financing each year from 2022 through 2024—yet the portion that is covered by collaboration partners fell steadily from $142 million in 2022 to $135 million in 2023 and $131 million in 2024.  This decline shows that RTX is increasingly retaining the risk itself rather than passing it to partners, reflecting a more conservative risk‑management stance on these customer‑financing guarantees.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all three key financial figures ($142M in 2022, $135M in 2023, $131M in 2024) and accurately describes the downward trend in collaboration partners' share of guarantees. The quantitative accuracy is strong with all numbers matching the ground truth exactly. The LLM also correctly interprets the trend as indicating RTX is increasingly retaining risk rather than sharing it with partners, which aligns with the ground truth's characterization of 'strategic reduction in shared financial risk.' However, the LLM answer has some notable omissions: (1) It introduces additional context about total committed financing ($4.5-$4.6 billion) that, while potentially accurate, is not part of the original question or ground truth answer and may distract from the core focus; (2) It does not mention the ground truth's important point about RTX maintaining that 'fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which provides important context about RTX's confidence in underlying asset values despite reducing exposure; (3) The characterization of RTX's stance as 'more conservative' is reasonable but slightly different from the ground truth's framing of 'deliberate move to reduce contingent liabilities' and 'shift in how RTX structures its aerospace financing arrangements.' The multi-hop reasoning is sound—the LLM correctly synthesizes the three-year trend and draws a logical conclusion about risk management strategy. The answer is semantically equivalent to the ground truth on the main points but lacks some contextual depth about asset valuations and the specific strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 461,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nFrom 2022 through 2024, Procter & Gamble kept the Always brand inside the Baby & Feminine & Family Care segment’s Feminine Care sub‑category, but began positioning it as the flagship menstrual‑care brand—emphasizing its > 25 % global market share and investing in product, packaging and value innovations that reflect the company’s “superiority” strategy.  At the same time, adult‑incontinence products were moved under the separate Always Discreet label, giving Always a more distinct, premium emphasis relative to other feminine‑hygiene offerings such as Tampax and private‑label brands.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Always has '>25% global market share' - this specific metric does not appear in the ground truth and appears to be fabricated. The ground truth states the segment contributed 25% of net sales (not Always brand alone), which is a different metric entirely. (2) STRUCTURAL MISREPRESENTATION: The LLM states 'adult-incontinence products were moved under the separate Always Discreet label' - this is incorrect. The ground truth shows Always Discreet was positioned ALONGSIDE Always and Tampax within the same segment throughout the period, not as a separate category. (3) MISSING KEY FACTS: The LLM fails to mention the critical 2023 segment rename from 'Feminine Care' to 'Baby, Feminine & Family Care,' which is a major structural evolution. (4) UNSUPPORTED CLAIMS: References to 'superiority strategy,' 'product, packaging and value innovations,' and 'premium emphasis' are not mentioned in the ground truth and appear to be inferred or fabricated details. (5) INCOMPLETE TIMELINE: The answer doesn't clearly track the evolution from 2022→2023→2024 as requested, instead providing a generalized statement about the period. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize information about brand positioning, it does so by introducing false details rather than accurately synthesizing the actual filing data. The core answer structure (segment name, contribution percentage, product positioning) is largely incorrect or unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 441,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nAMD’s filings show that from 2022 through 2024 its international sales have remained around two‑thirds of total revenue, and nearly all product assembly and final testing are outsourced to third‑party facilities in China, Malaysia and—especially—Taiwan.  In each annual filing the company repeatedly flags “difficulties in protecting our intellectual property” as a material risk, and starting in 2023 it explicitly links that risk to rising geopolitical tensions between China and Taiwan and to the firm’s growing reliance on Asian contract manufacturers.  Consequently, as AMD’s global footprint and dependence on Asian third‑party manufacturing expanded, its exposure to intellectual‑property‑protection difficulties grew proportionally, becoming a more pronounced and specific concern in the 2024 disclosure than in the 2022 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Quantitative accuracy is excellent - the LLM correctly identifies international sales at approximately two-thirds of revenue (matching the ground truth's 65% figure within reasonable rounding), correctly names the three key manufacturing locations (China, Malaysia, Taiwan), and accurately characterizes the progression of IP protection concerns across the three-year period. (2) Multi-hop reasoning is sound - the answer successfully synthesizes information across multiple years and connects AMD's expanding international operations, increasing reliance on Asian third-party manufacturing, and evolving IP protection risks. (3) Entity accuracy is perfect - correct company (AMD), correct years (2022-2024), correct manufacturing partners, and correct risk factors. (4) The answer captures the key evolution: consistent IP protection concerns in 2022, heightened exposure in 2023 with explicit mention of international sales percentages and manufacturing locations, and the addition of geopolitical China-Taiwan tensions as a new risk layer in 2024. (5) Semantic equivalence is strong - phrases like 'difficulties in protecting our intellectual property' directly match filing language, and the characterization of risks becoming 'more pronounced and specific' aligns with the ground truth's description of risks becoming 'more complex and regionally concentrated.' MINOR CONSIDERATIONS: The LLM uses 'two-thirds' rather than the specific '65%' figure, but this is an acceptable rounding variation and demonstrates understanding rather than error. The answer is slightly more concise than the ground truth but loses no material information. All core facts, the progression narrative, and the synthesis of multi-hop relationships are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 507,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first issued its 2.300% senior unsecured notes maturing in 2028 in March 2021 (as documented in the 2021 Officers’ Certificate), and then re‑opened the same series in 2022 and again in early 2023 with updated certificates that preserved the 2028 maturity while reflecting contemporary pricing.  \nThis recurring, staggered issuance shows that Oracle follows a disciplined, laddered debt strategy—regularly accessing capital markets to fund operations and acquisitions, lock in low‑cost long‑term financing, and manage its maturity profile while maintaining flexibility for future strategic needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ASPECTS: (1) The 2.300% coupon rate is accurate; (2) The 2028 maturity date is correct; (3) The March 2021 initial issuance date is accurate; (4) The general characterization of Oracle's debt strategy as disciplined and laddered is reasonable; (5) The mention of re-openings in 2022 and early 2023 aligns with the ground truth's reference to notes issued in March 2021, late 2022, and early 2023. PROBLEMATIC ASPECTS: (1) The LLM introduces specific details about 'Officers' Certificates' and 'updated certificates' that are not mentioned in the ground truth, which only references Exhibits 4.16 and 4.14 from SEC filings; (2) The LLM claims the notes were 'senior unsecured' - while this may be accurate, the ground truth does not specify this characteristic; (3) The LLM provides more granular detail about the issuance mechanics (re-openings, pricing) than the ground truth supports, potentially overstating confidence in specific transaction details; (4) The ground truth emphasizes the 2022-2024 evolution and consistent disclosure across three years, while the LLM focuses more on the 2021-2023 issuance history, somewhat shifting the temporal focus away from the multi-year pattern requested. MULTI-HOP REASONING: The LLM successfully synthesizes information about Oracle's debt strategy across multiple years and connects individual issuances to broader strategic patterns. However, it introduces details not grounded in the provided knowledge graph. The reasoning about 'laddered debt strategy' and 'managing maturity profile' is sound and aligns with the ground truth's conclusion about 'diverse maturity profile,' but the specific transaction details lack explicit support. The answer addresses the question's core inquiry about evolution and strategic patterns, but with some unsupported specificity that reduces confidence in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 519,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nBetween 2022 and 2024 BA steadily expanded its private‑equity program – the target allocation rose from 4 % (2022) to 7 % (2023) and stayed at 7 % in 2024, while actual holdings grew from 8 % to 9 % of total pension assets.  The program continues to be deployed through limited‑partnership vehicles that invest globally, i.e., in both U.S. and non‑U.S. markets, and its strategic focus remains on leveraged‑buyout, venture‑capital, growth‑capital and special‑situations strategies, but with a larger share of capital directed toward non‑U.S. and emerging‑market opportunities as the allocation increases.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and misalignments with the ground truth. STRENGTHS: (1) Correctly identifies the global scope of investments (U.S. and non-U.S. markets), (2) Accurately mentions the core strategies (leveraged buyout, venture capital, growth capital, special situations), (3) Provides specific allocation percentages (4% to 7% target, 8% to 9% actual holdings) that appear reasonable for pension fund data, (4) Notes the shift toward non-U.S. and emerging market opportunities. WEAKNESSES: (1) The answer focuses heavily on allocation percentages and target changes, which is not the primary focus of the ground truth answer about strategic evolution, (2) MISSING KEY INFORMATION: The ground truth explicitly mentions the 2023 expansion into 'global private investments in real assets such as energy, farmland, and infrastructure' - the LLM answer completely omits this important strategic shift, (3) MISSING: The ground truth notes the 2024 increased sophistication with derivatives to enhance exposure and performance transfer - the LLM answer does not address this at all, (4) The LLM answer mentions REITs and publicly traded vehicles from 2022 are not explicitly discussed, (5) The answer conflates allocation percentage changes with strategic focus evolution, which are related but distinct concepts. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to capture the qualitative strategic evolution (real assets focus, derivatives usage) that is central to the ground truth answer. The answer is more about quantitative allocation changes than strategic focus area evolution. CALCULATION VERIFICATION: The percentages provided (4%, 7%, 8%, 9%) cannot be verified against the ground truth but appear internally consistent and plausible. The answer is partially correct on the geographic and strategy dimensions but significantly incomplete on the strategic focus evolution, particularly missing the real assets expansion and derivatives sophistication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 553,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen kept Bemarituzumab in Phase 3 development—having entered a Phase 3 trial in early 2022 and continuing that status in the 2023 and 2024 pipeline tables—while its composition‑of‑matter patents were projected to expire in 2029 in both the United States and Europe (with no listed extensions or term adjustments in the disclosed estimates). Consequently, the molecule remained under clinical investigation without any advancement to regulatory approval, and its patent life was expected to run until 2029 in the key markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct dates (2022 Phase 3 initiation, 2029 patent expiration in U.S. and Europe) and accurate characterization of the patent type (composition-of-matter). The multi-hop synthesis across 2022-2024 is sound, correctly tracking the clinical phase progression and patent timeline consistency. However, there are notable qualitative gaps: (1) The LLM answer omits the specific mechanism of action detail (FGFR2b targeting) mentioned in the ground truth, which provides important context about the molecule's identity; (2) The LLM answer lacks mention of the indication (gastric and gastroesophageal junction cancer/GEJ adenocarcinoma), which is clinically relevant; (3) The ground truth emphasizes the importance of 'both patent and regulatory exclusivity' in extending market protection, a strategic insight the LLM answer does not capture; (4) The LLM answer's phrasing 'remained under clinical investigation without any advancement to regulatory approval' is technically accurate but somewhat negatively framed compared to the ground truth's more neutral 'progressed through clinical development.' The core factual elements are correct (Phase 3 status maintained, 2029 expiration dates, no extensions), and the reasoning about the stable IP position is sound. The answer adequately addresses the multi-part question about clinical phase progression and patent timelines, but misses some important contextual details about the molecule's mechanism and therapeutic indication that would provide fuller context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 431,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nDawn remained a core brand in P&G’s Fabric & Home Care segment throughout 2022‑2024, appearing in the “Major Brands” list for each year.  The segment’s earnings contribution slipped only modestly—from about 34 % of total earnings in 2022 to roughly 31 % in 2024—yet Dawn’s inclusion among the segment’s flagship brands was unchanged, indicating a stable strategic position despite the slight earnings decline.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) REVERSED EARNINGS TREND: The LLM states earnings contribution 'slipped' from 34% in 2022 to 31% in 2024, but the ground truth clearly shows the opposite - earnings contribution INCREASED from 31% in 2022 to 34% in 2024. This is a complete reversal of the actual trend and represents a major factual error. (2) MISSING SALES DATA: The ground truth includes important information about net sales contribution (35% in 2022, 36% in 2023-2024), which the LLM completely omits. This is a significant omission that fails to address the full scope of the segment's positioning evolution. (3) INCOMPLETE ANALYSIS: The ground truth emphasizes that despite stable sales percentages, earnings contribution increased, suggesting improved profitability/efficiency within the segment. The LLM misses this nuanced insight entirely. (4) CHARACTERIZATION ERROR: The LLM describes the earnings change as a 'slight earnings decline' when it was actually a 'slight earnings increase.' This fundamentally mischaracterizes the segment's performance trajectory. (5) PARTIAL CREDIT: The LLM correctly identifies that Dawn remained consistently listed across all three years and maintains a stable strategic position, which aligns with the ground truth. However, this correct element is overshadowed by the major quantitative errors. The multi-hop reasoning fails because the model reversed the directional trend of a key metric, which is a critical failure in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 433,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s collateral‑driven funding shifted – it continued to pledge client‑margin securities to meet daily maintenance requirements (the margin‑loan receivables are fully collateralized and the company uses the practical‑expedient to avoid credit‑loss reserves when collateral exceeds the loan amount) – but the amount of those securities used in short‑term borrowing contracts fell in 2024.  The company’s FHLB advances dropped from $26.4 bn (2023) to $16.7 bn (2024) while the pledged collateral that backs those advances stayed roughly stable ($59.8 bn vs $63.1 bn), and its uncommitted secured lines of credit fell from $950 m (2023) to $500 m (2024) after the TDAC facility was terminated.  This pattern shows that Schwab’s liquidity remains tightly tied to the market value of client‑held assets, so a broad decline in securities prices or a surge in margin calls could quickly strain its funding and increase exposure to client‑related credit risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key quantitative data points (FHLB advances declining from $26.4bn to $16.7bn, pledged collateral at $59.8bn vs $63.1bn, uncommitted secured lines falling from $950m to $500m) and accurately describes the practical expedient for margin loan collateral under ASC 326. The answer demonstrates understanding of the 2024 shift toward lower short-term borrowing despite stable collateral backing. WEAKNESSES: (1) The LLM answer diverges significantly from the ground truth's framing - it focuses heavily on FHLB advances and liquidity funding mechanisms rather than the evolution of client securities pledging practices across the 3-year period. (2) The ground truth emphasizes increasing sophistication in pledging practices (margin loans, options clearing collateral, securities lending) from 2022-2024, while the LLM answer focuses on 2024 funding structure changes. (3) The LLM answer mentions 'short-term borrowing contracts fell in 2024' but the ground truth doesn't characterize the trend as declining - it describes 'continuing' and 'increasing' sophistication. (4) Missing from LLM answer: specific mention of options clearing corporation collateral practices and securities lending cash collateral activities that the ground truth highlights. (5) The LLM answer's conclusion about 'tightly tied to market value of client-held assets' and 'credit risk' is reasonable inference but shifts focus from the ground truth's emphasis on operational sophistication and client engagement in leveraged activities. QUANTITATIVE VERIFICATION: Numbers appear accurate based on typical Schwab disclosures, though cannot independently verify against actual filings. The calculations and comparisons (decline from $26.4bn to $16.7bn, etc.) are mathematically sound. MULTI-HOP REASONING: The LLM successfully synthesizes information across years but misses the primary narrative arc of the ground truth - which is about evolving pledging practices and sophistication rather than funding structure optimization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 550,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nACN’s target allocation shifted from a 2023 mix of essentially all‑debt in the U.S. plan (≈100 % debt, 0 % equity) and a 27 % equity / 48 % debt / 4 % cash / 11 % insurance / 10 % other composition for non‑U.S. plans, to a 2025 profile that retains a 100 % debt weighting for the U.S. plan but changes the non‑U.S. mix to 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other—i.e., a clear reduction in debt exposure and a corresponding increase in cash, insurance and equity to better match liabilities and manage risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to describe a completely different pension plan allocation structure than what the ground truth indicates. Critical issues: (1) WRONG ALLOCATION STRUCTURE: The ground truth clearly states ACN's weighted-average allocations as 55% fixed income/45% equities (2022), 58% fixed income/42% equities (2023), and 61% fixed income/39% equities (2024). The LLM answer instead describes a U.S. plan with ~100% debt/0% equity and a non-U.S. plan with multi-category breakdowns (27% equity/48% debt/4% cash/11% insurance/10% other), which is a completely different classification system not mentioned in the ground truth. (2) MISSING CORE DATA: The LLM fails to cite the three key weighted-average allocations (55/45, 58/42, 61/39) that form the basis of the answer. (3) INCORRECT TREND ANALYSIS: While the ground truth identifies a clear, consistent de-risking trend (increasing fixed income from 55% to 61%, decreasing equities from 45% to 39%), the LLM describes changes in a different allocation framework with different categories entirely. (4) WRONG FISCAL YEAR MAPPING: The ground truth correctly maps August 31 dates to fiscal years (2022 data in fiscal 2023 report, 2023 data in fiscal 2024 report, 2024 data in fiscal 2025 report). The LLM conflates 2023 and 2025 without proper temporal mapping. (5) SEMANTIC MISMATCH: The LLM's discussion of 'insurance' and 'other' categories, and the distinction between U.S. and non-U.S. plans, does not align with the ground truth's simple fixed income/equity dichotomy. This appears to be either data from a different company's pension disclosures or a fundamental misunderstanding of ACN's pension allocation structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 467,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s funding mix shifted modestly: short‑term borrowings fell from **$883 million (2022)** to **$538 million (2023)** and edged up to **$562 million (2024)**, while long‑term debt rose from **$47.8 billion (2022)** to **$49.3 billion (2023)** before slipping to **$45.0 billion (2024)**.  This three‑year trend shows the firm has been **reducing its reliance on short‑term wholesale funding and maintaining a large, predominantly fixed‑rate long‑term debt base**, which limits near‑term interest‑rate exposure—though a portion of its long‑term debt (e.g., floating‑rate senior notes and variable‑rate securitized obligations) still leaves it modestly sensitive to rate changes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all key metrics. (1) SHORT-TERM BORROWINGS: LLM claims $883M (2022), $538M (2023), $562M (2024), but ground truth shows these are components of a much larger total. The ground truth indicates total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), $45.551B (2024). (2) LONG-TERM DEBT: LLM states $47.8B (2022), $49.3B (2023), $45.0B (2024). These numbers are directionally closer but still appear to be incomplete or incorrect breakdowns. The ground truth provides consolidated figures that are significantly larger. (3) INTEREST RATE ANALYSIS: The LLM completely omits the critical interest rate trend that is central to the ground truth answer—the weighted-average interest rate on long-term debt rising from 1.51% (2022) to 3.01% (2023) to 3.48% (2024). This is a major omission that fails to address a key part of the question about 'interest rate exposure.' (4) FLOATING DEBT REDUCTION: The LLM mentions 'floating-rate senior notes and variable-rate securitized obligations' generically but fails to cite the specific and important fact that floating unsecured senior debt was reduced from $1,597M (2023) to $0 (2024)—a strategic shift explicitly noted in the ground truth. (5) MULTI-HOP SYNTHESIS: The LLM appears to have accessed different or incomplete data sources, resulting in a fundamentally different debt structure narrative. The ground truth shows total debt (short + long) of $43.086B → $48.715B → $45.551B, while the LLM's component numbers ($883M + $47.8B = $48.683B for 2022) don't align with the ground truth total. (6) REASONING QUALITY: While the LLM's qualitative reasoning about fixed-rate debt and interest rate exposure is reasonable in isolation, it is built on incorrect quantitative foundations and misses the critical rising interest rate trend that is essential to understanding the company's debt structure evolution. The answer fails the primary requirement of factual accuracy on numbers and omits key analytical insights from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 568,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\nBoeing’s fleet‑support expenses have remained essentially flat, accounting for only about 1 % of total consolidated costs in 2022, 2023 and 2024.  In contrast, the company has absorbed billions of dollars of abnormal production costs and reach‑forward losses on the 787 (≈ $2 bn cumulative abnormal costs, with $256 m expensed in 2024) and the 777X (a $2.6 bn loss recorded in Q3 2024 plus an additional $0.89 bn loss in Q4 2024), which together far exceed the modest 1 % fleet‑support share and have been the dominant cost‑pressure factor in the recent period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Fleet support services remained at ~1% of total consolidated costs across 2022-2024, (2) 787 program had abnormal production costs (~$2B cumulative), (3) 777X program recorded $2.6B loss in Q3 2024 and $0.89B in Q4 2024. The answer appropriately synthesizes the multi-hop relationship between stable fleet support costs and escalating program-specific losses. However, there are minor quantitative discrepancies: The LLM states 787 had '≈ $2 bn cumulative abnormal costs, with $256 m expensed in 2024' while the ground truth specifies '$2.7 billion in cumulative abnormal production costs' for 2023 specifically. The LLM's approximation of $2B appears to understate the ground truth figure of $2.7B. Additionally, the LLM rounds 777X Q4 loss to '$0.89 bn' when ground truth specifies '$891 million' - this is acceptable as a format variation. The LLM correctly identifies the 777X Q3 2024 loss as $2.6B (vs. ground truth's $2,608 million - acceptable format variation). The reasoning is sound: the answer correctly contrasts stable fleet support costs with escalating program losses and concludes that production inefficiencies rather than service delivery drove financial strain. The answer is well-structured and addresses all parts of the multi-hop question. The main weakness is the potential understatement of 787 cumulative abnormal costs ($2B vs. $2.7B), which could reflect either rounding or incomplete data synthesis, though the use of '≈' suggests approximation rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 425,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash allocation in money‑market funds and time deposits dropped from **$21 million at the end of 2022** to **$10 million at the end of 2023**, and stayed at roughly **$10 million in 2024**.  This pull‑back shows the company is deliberately shrinking its dedicated money‑market exposure and maintaining only a modest, stable cash buffer, indicating a shift toward relying on its broader cash‑and‑cash‑equivalents position for short‑term liquidity rather than a larger money‑market fund allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors in the year-to-year progression of numbers. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. The LLM states: 2022=$21M, 2023=$10M, 2024=$10M. This is a complete reversal of the 2022-2023 values. Specifically: (1) The LLM incorrectly claims $21M at end of 2022 when it was actually $12M; (2) The LLM incorrectly claims $10M at end of 2023 when it was actually $21M; (3) The LLM correctly identifies $10M in 2024; (4) The LLM's narrative interpretation is therefore inverted - it describes a 'pull-back' from 2022-2023 when the ground truth shows an increase; (5) The LLM's conclusion about 'deliberately shrinking' and 'shift toward relying on broader cash-and-cash-equivalents' contradicts the actual 2023 increase to $21M, which would indicate a temporary conservative approach (as stated in ground truth). The multi-hop reasoning fails because the foundational numbers are wrong, leading to an entirely incorrect interpretation of the 3-year trend. While the LLM addresses all three years and attempts to synthesize a narrative about liquidity strategy, the quantitative foundation is fundamentally flawed, making the entire answer misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 343,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly $4 billion of its Class A shares each year – $4.1 bn in 2022, about $4.5 bn in 2024 (the $4.5 bn figure reported as “share purchases” in the 2024 cash‑return metric) – while the board periodically refreshed the program’s remaining authorization (e.g., the $2.69 bn balance at the end of 2024 was topped up with a $4 bn increase in September 2024).  This pattern shows that the company runs a disciplined, sizable share‑repurchase program that is regularly replenished, underscoring a capital‑return strategy that prioritizes returning cash to shareholders through both dividends and opportunistic buy‑backs while maintaining ample authorization for future purchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth data. CRITICAL ERRORS: (1) The LLM states $4.1 billion repurchased in 2022 and $4.5 billion in 2024, but the ground truth does not provide these specific repurchase amounts - it only mentions remaining authorization balances ($3,129,296 thousand in 2022, $2,694 million in 2023). The LLM appears to have fabricated these repurchase figures. (2) The LLM claims '$2.69 bn balance at the end of 2024' but the ground truth states $2,694 million was the balance as of August 31, 2023, not 2024. The 2024 figure is $6,694 million remaining after the $4 billion increase. (3) The LLM mischaracterizes the $4 billion as a 'top up' in September 2024, when it was actually a new authorization increase that brought total remaining authorization to $6,694 million. PARTIAL CREDIT: The LLM correctly identifies that Accenture has a disciplined share repurchase program with periodic board refreshes and that this reflects a capital return strategy. The qualitative assessment of the strategy is reasonable. However, the quantitative foundation is severely flawed. The answer conflates repurchase activity (actual buybacks) with authorization balances (remaining capacity), which are different metrics. The ground truth focuses on authorization evolution, not actual repurchase amounts. The multi-hop reasoning fails because the LLM did not accurately synthesize the authorization data across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 413,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings (pages 46, 27 and 25 respectively) AbbVie’s charter retains the same “removal of directors only for cause” rule, a three‑class staggered board, a prohibition on stockholder‑called special meetings, and an 80 % super‑majority vote to amend any director‑related provisions. This unchanged suite of entrenchment measures demonstrates a long‑term takeover‑defense strategy that protects the board from easy removal and forces any acquisition to be negotiated through the incumbent directors.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AbbVie's governance evolution. STRENGTHS: (1) Correctly identifies the core governance provision (removal of directors only for cause) across all three years (2022, 2023, 2024); (2) Accurately cites specific page numbers for each filing (pages 46, 27, and 25 respectively); (3) Correctly identifies the supermajority threshold as 80% for director-related bylaw amendments; (4) Properly synthesizes the multi-hop information by connecting the consistent governance provisions across three years to the broader takeover defense strategy; (5) Accurately describes the staggered board structure and prohibition on stockholder-called special meetings; (6) Correctly interprets the strategic implication that these unchanged provisions represent a deliberate, long-term entrenchment strategy. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, focusing on the core facts without explicitly stating 'no explicit changes to language' or emphasizing the 'repeated disclosure' aspect as strongly; (2) The ground truth emphasizes 'consistent emphasis in each annual report' as evidence of commitment, while the LLM focuses more on the unchanged nature of the provisions themselves—both interpretations are valid and complementary; (3) The LLM answer could have slightly more explicitly stated that the provisions remained 'unchanged' across all three years, though this is clearly implied. QUANTITATIVE VERIFICATION: The 80% supermajority requirement is correctly stated, page numbers appear reasonable for 10-K filings, and the three-year period (2022, 2023, 2024) is correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings and correctly connects individual governance provisions to the broader strategic narrative about takeover defense. The logic is sound and the conclusion appropriately follows from the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 545,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the company’s “Form of 4.000% Senior Note due 2047” remains listed in the same exhibit table (Item 15/Exhibit 4.17) and is consistently described as being incorporated by reference to the May 2 2017 8‑K filing, with no new language, amendment or re‑classification introduced in any year. This unchanged, recurring disclosure shows that the 2047 note is treated as a permanent, foundational component of PepsiCo’s long‑term capital structure—providing a stable, low‑cost fixed‑rate source of financing that underpins its long‑dated funding strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the note is listed in 'Item 15/Exhibit 4.17' but the ground truth specifies 'Exhibit 4.5'. This is a factual error in entity identification - the wrong exhibit number is cited. (2) FILING REFERENCE ACCURACY: The LLM correctly identifies the May 2, 2017 8-K filing reference, which matches the ground truth. (3) CONSISTENCY CLAIM: Both answers correctly identify that the disclosure remained consistent across 2022, 2023, and 2024, with no modifications. This multi-hop synthesis is sound. (4) INTERPRETATION: The LLM's interpretation about the note being a 'permanent, foundational component' and 'stable, low-cost fixed-rate source' is reasonable and aligns with the ground truth's characterization of it as 'stable, long-term component.' However, the LLM adds interpretive language ('low-cost fixed-rate source') not explicitly stated in the ground truth. (5) COMPLETENESS: The LLM addresses the evolution (or lack thereof) across the three years and discusses the capital structure implications, matching the question's requirements. The core issue is the exhibit number error (4.17 vs 4.5), which is a specific, verifiable factual mistake that undermines the answer's reliability despite the overall reasoning being sound. The quantitative accuracy score is low due to this exhibit number error; qualitative accuracy is moderate because the reasoning is logical but built on an incorrect factual premise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 409,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nAcross the 2022‑2024 filings Oracle’s 10‑Ks repeatedly listed the 4.30 % senior unsecured note due 2034 in the long‑term‑debt exhibits (2022 p. 111, 2023 p. 112, 2024 p. 112), confirming that the instrument remained outstanding and was simply re‑disclosed rather than replaced. This consistent, multi‑year appearance signals Oracle’s deliberate laddered‑debt strategy—issuing and maintaining a stable pipeline of fixed‑rate notes with staggered maturities to fund operations and acquisitions while managing interest‑rate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 4.30% senior unsecured note due 2034 across all three years (2022, 2023, 2024); (2) Accurately cites page numbers for long-term debt exhibits (p. 111 for 2022, p. 112 for 2023 and 2024), showing detailed filing knowledge; (3) Properly synthesizes the multi-year pattern by noting consistent re-disclosure rather than replacement; (4) Correctly interprets the strategic implication as a 'laddered-debt strategy' with staggered maturities; (5) Appropriately identifies the instrument as senior unsecured and fixed-rate; (6) Logically connects the pattern to interest-rate risk management and capital market engagement. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and specific than the ground truth (includes page numbers, 'senior unsecured' designation, specific strategic rationale), which represents added value rather than error; (2) Both answers convey the same core finding: stable, consistent disclosure indicating deliberate long-term debt strategy; (3) The LLM's characterization of 'laddered-debt strategy' and 'fixed-rate notes with staggered maturities' aligns semantically with the ground truth's 'diversified maturity profiles'; (4) No quantitative errors detected—all numbers, dates, and percentages are accurate. The answer fully addresses the multi-part question about evolution across three years and strategic implications. The reasoning is sound and properly synthesizes information across multiple filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 429,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve was **127 million Class A shares** when the fiscal year ended 2022 (as noted on page 91), remained at that level through fiscal 2023 (no amendment was disclosed), and was **increased to 141 million shares** for fiscal 2024 (page 97).  \n\nThis step‑up in the size of the equity‑award pool signals that Accenture is deliberately expanding its long‑term share‑based compensation capacity, reflecting a strategic commitment to sustain equity incentives as a central tool for attracting, retaining and motivating employees over the coming years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CHRONOLOGICAL SEQUENCE: The LLM answer contains a fundamental factual error regarding the timing of the share authorization increase. According to the ground truth, the progression was: FY2022: 127M shares → FY2023: 141M shares (increase occurred) → FY2024: 141M shares (remained unchanged). However, the LLM states the increase occurred in FY2024 ('increased to 141 million shares for fiscal 2024'), which is incorrect. The LLM claims shares 'remained at that level through fiscal 2023 (no amendment was disclosed)' when in fact the increase TO 141M happened BY fiscal 2023. This is a critical multi-hop synthesis error that reverses the actual timeline of events. QUANTITATIVE ACCURACY: While the numbers themselves (127M, 141M) are correct, their assignment to fiscal years is wrong. The LLM incorrectly places the increase in FY2024 rather than FY2023. COMPLETENESS: The LLM does address the evolution and strategic implications, but the chronological inversion undermines the entire answer's validity. The qualitative interpretation about share-based compensation strategy is reasonable and aligns with ground truth reasoning, but this cannot compensate for the factual error about when the increase occurred. ENTITY ACCURACY: Accenture plc, Class A ordinary shares, and Amended 2010 SIP are correctly identified. The core issue is the temporal sequencing of events across the three fiscal years, which is essential for answering a question specifically about how something 'evolved from fiscal year 2022 through 2024.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 424,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the 2.750 % Senior Note due 2051 was repeatedly restated in PepsiCo’s SEC filings: it first appeared in the 2022 Form 10‑K (page 124) as a note originally issued under the October 21 2021 8‑K (Exhibit 4.3); a new 8‑K filed on Nov 13 2023 (page 128) re‑filed the same term, indicating a supplemental filing/amendment; and the 2024 Form 10‑K (pages 130‑131) placed the note within a Board‑resolution list of long‑term debt authorizations that reference the original 2013 indenture. This multi‑year filing pattern shows PepsiCo’s long‑term debt strategy relies on issuing low‑coupon senior notes with staggered maturities and maintaining a consistent, transparent documentation framework, updating investors periodically while extending and diversifying its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) INCORRECT DATES/EXHIBITS: The LLM cites an October 21, 2021 8-K and references to 2013 indenture, which are not mentioned in the ground truth. The ground truth specifically identifies Exhibit 4.60 (2022), Exhibit 4.51 (2023), and Exhibit 4.48 (2024) - the LLM provides different exhibit numbers and references (4.3, page numbers like 124, 128, 130-131). (2) INCORRECT PROGRESSION NARRATIVE: The ground truth describes a clear three-stage evolution: authorization/planning (2022) → formalization/structuring (2023) → maintenance/consistency (2024). The LLM incorrectly characterizes this as 'restated' and 'supplemental filing/amendment' with a Nov 13, 2023 8-K, which contradicts the ground truth's description of formal structuring. (3) MISSING CORE INSIGHT: The ground truth emphasizes the progression from Board resolution list → dedicated Form of note → continued reference with same exhibit. The LLM misses this critical documentation evolution and instead focuses on page numbers and indenture references not in the ground truth. (4) QUANTITATIVE ERRORS: The LLM provides specific page numbers (124, 128, 130-131) and dates (October 21, 2021; Nov 13, 2023) that cannot be verified against the ground truth and appear to be fabricated. (5) REASONING FLAW: While the LLM attempts to draw conclusions about debt strategy, it does so based on incorrect factual premises. The ground truth's conclusion about 'stability in PepsiCo's long-term capital strategy' is more accurate than the LLM's claim about 'staggered maturities and diversifying capital structure' which lacks support in the provided ground truth. The answer demonstrates hallucination of specific filing details and misinterpretation of the documentation progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 499,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nFrom 2022 through 2024 American Express remained the world’s fourth‑largest general‑purpose card network, but its competitive standing has been pressured on two fronts: (1) intensifying regulatory scrutiny—particularly U.S. and EU actions targeting interchange‑fee caps, surcharge rules and antitrust investigations involving Visa and Mastercard—has eroded the discount‑revenue advantage it traditionally enjoyed and forced the company to adjust pricing and merchant‑acceptance terms; and (2) the rapid growth of alternative payment mechanisms such as digital wallets, buy‑now‑pay‑later platforms, real‑time settlement systems and other fintech‑driven solutions has expanded the set of rivals that can capture card‑holder spend, prompting Amex to double‑down on premium‑service, data‑analytics and cobrand partnerships to preserve its differentiated value proposition.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of American Express's fourth-place position globally and accurate characterization of competitive pressures from 2022-2024. The answer correctly identifies the two main competitive challenges: (1) regulatory scrutiny around interchange fees, surcharges, and antitrust issues, and (2) alternative payment mechanisms including digital wallets, BNPL, and fintech solutions. The response appropriately synthesizes multi-hop information about regulatory environment changes and competitive responses. However, there are some notable differences from the ground truth: (1) The LLM answer emphasizes U.S. regulatory actions more prominently, while the ground truth specifically highlights EU regulatory scrutiny as the primary driver of market exits and compliance costs by 2024; (2) The ground truth explicitly mentions 'closed-loop loyalty systems' as a key differentiation strategy, which the LLM answer omits; (3) The ground truth specifically references Alipay and PayPal as competitive threats, while the LLM uses more generic categories like 'digital wallets' and 'fintech-driven solutions'; (4) The ground truth explicitly states that regulatory changes led to 'exits from certain markets,' which the LLM answer does not mention. The LLM answer adds some details not in the ground truth (e.g., 'real-time settlement systems,' 'data-analytics') that are reasonable inferences but not explicitly confirmed. The reasoning about strategic shifts from market-driven to regulation-constrained competition is implicit in the LLM answer but less explicitly stated than in the ground truth. No quantitative errors are present, and the temporal scope (2022-2024) is correctly maintained throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 481,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s focus shifted from mainly developing new jet models (e.g., 777X, 737‑MAX variants) toward a deeper, recurring‑revenue emphasis on aircraft upgrades, conversions, and related engineering services.  The company repeatedly highlights that Global Services will “grow market share by leveraging a high level of customer satisfaction and productivity” through upgrades, modifications and life‑cycle support for both commercial and defense platforms.  This signals a strategic pivot to make services—especially upgrades and conversions— a core growth engine, reducing reliance on new‑aircraft sales and creating more stable, high‑margin cash flow.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE ANSWER ACCURACY: The LLM answer fundamentally mischaracterizes Boeing's strategic shift. The ground truth shows a progression from 2022→2023→2024 with specific emphasis on: (1) 'upgrades and conversions' grouped with logistics/engineering/training in 2022, (2) 'modifications' becoming more prominent in 2023, and (3) 'data analytics and digital services' emerging as complementary in 2024. The LLM answer instead claims Boeing shifted FROM 'developing new jet models' TO 'upgrades and conversions'—this is a false dichotomy not supported by the ground truth. The ground truth never suggests Boeing abandoned new aircraft development; rather, it documents how services offerings evolved internally. SPECIFIC ERRORS: (1) The LLM introduces a false narrative about pivoting away from 777X and 737-MAX development, which is not mentioned in the ground truth and misrepresents the actual strategic evolution. (2) The LLM fails to capture the specific 2023-2024 progression showing integration of 'modifications' and emergence of 'data analytics and digital services'—these are critical details in the ground truth. (3) The LLM's framing of 'reducing reliance on new-aircraft sales' is not supported by the ground truth, which focuses on services segment evolution, not a shift away from aircraft manufacturing. WHAT WAS CORRECT: The LLM correctly identifies that upgrades/conversions became more strategically important and that this represents a shift toward recurring revenue and high-margin services. The general concept of services as a growth engine is directionally correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-by-year evolution documented in the ground truth. It created an alternative narrative rather than tracking the actual documented progression. The answer demonstrates weak multi-hop synthesis across the 2022-2024 timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 511,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo first disclosed the 5.50 % Senior Note due 2035 in its 2018 S‑4 registration (Exhibit 4.6) and then continued to list the same note in the “Exhibits” section of each subsequent Form 10‑K – on pages 124‑129 of the 2022, 2023 and 2024 filings – updating the reference to the current exhibit number (e.g., Exhibit 4.6 in 2022‑2023 and Exhibit 4.6 in the 2024 filing). This recurring, year‑after‑year filing of the identical note shows that PepsiCo’s long‑term debt strategy is built around a disciplined, repeatable issuance framework: it issues multi‑year fixed‑rate senior notes, retains the original indenture and board resolutions in its periodic reports, and refreshes the exhibit citation each year to keep the documentation current and transparent for investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER ERRORS: The LLM claims the note was referenced as 'Exhibit 4.6' in 2022-2023 and 2024, but the ground truth explicitly states it was Exhibit 4.31 in 2022, Exhibit 4.25 in 2023, and Exhibit 4.23 in 2024. These are material discrepancies in document citations. (2) FILING SOURCE ERROR: The LLM incorrectly references a 2018 S-4 registration as the original source, while the ground truth correctly identifies an 8-K filing from November 8, 2018. An S-4 is a merger/acquisition registration statement, which is inconsistent with a senior note issuance. (3) PAGE NUMBER CLAIMS: The LLM specifies 'pages 124-129' for the exhibits sections, but this is not verified in the ground truth and appears to be fabricated detail. (4) EXHIBIT CITATION PATTERN: The LLM claims the exhibit number remained 'Exhibit 4.6' across years, which directly contradicts the ground truth showing different exhibit numbers (4.31→4.25→4.23) each year. (5) CORE INSIGHT ALIGNMENT: While both answers correctly identify that the note was consistently referenced across three years and suggest stable debt management, the LLM's explanation of the mechanism (exhibit number updates) is factually incorrect. The ground truth shows the exhibit numbers changed year-to-year, not that they remained constant. The LLM's characterization of 'refreshing the exhibit citation each year' is correct in concept but wrong in execution (the numbers don't match). The answer demonstrates partial understanding of the question's intent but fails on specific factual accuracy, which is critical for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 461,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nBNY Mellon’s 2022‑2024 10‑K filings repeatedly stress that U.S. banking laws and capital‑adequacy standards—especially the requirement to remain “well‑capitalized” and “well‑managed”—directly limit the firm’s capital‑planning and shareholder‑return decisions, with the Board’s discretion circumscribed by regulatory capital ratios, liquidity buffers and credit‑rating considerations.  Over the three years the discussion evolved from a general reference to regulatory limits in 2022 to more specific emphasis on capital‑buffer levels, stress‑test results and newer regulatory frameworks (e.g., Title I resolution and ESG‑related expectations) in 2023‑2024, underscoring that any dividend or repurchase program is tightly bound by evolving supervisory constraints.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core constraint (U.S. banking laws limiting capital returns), accurately names the company (BNY Mellon), correctly spans the 2022-2024 period, and appropriately emphasizes the 'well-capitalized' requirement mentioned in the ground truth. The answer demonstrates sound multi-hop reasoning by synthesizing regulatory constraints across three years. The semantic meaning aligns with the ground truth regarding regulatory oversight and capital planning limitations.\n\nWEAKNESSES: (1) The LLM introduces specific regulatory concepts not explicitly confirmed in the ground truth, including 'Title I resolution,' 'stress-test results,' 'liquidity buffers,' 'credit-rating considerations,' and 'ESG-related expectations.' While these may be reasonable inferences about banking regulation, they are not explicitly mentioned in the ground truth answer and represent potential over-specification or hallucination. (2) The ground truth specifically mentions 'Delaware law' and 'preferred stock dividend obligations' as constraints cited in 2023, which the LLM answer omits entirely. (3) The LLM characterizes the evolution as moving from 'general reference' to 'more specific emphasis,' but the ground truth describes it as 'consistent yet evolving emphasis' with language 'largely unchanged' in 2024—a subtly different characterization of the progression. (4) The LLM's claim about 'newer regulatory frameworks' and 'evolving supervisory constraints' is more speculative than the ground truth's measured assessment.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across three years and identifies the progression of regulatory emphasis, though it adds interpretive layers not grounded in the provided ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on correct identification of years (2022-2024) and regulatory concepts. The core facts about regulatory constraints are correct, but the specific regulatory mechanisms cited by the LLM are not verified against ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 572,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nThe 2.300 % Notes due 2028 were originally issued in March 2021 (Officers’ Certificate dated 3/24/21) as an unsecured, fixed‑rate tranche with a 2.30 % coupon and a 2028 maturity.  Subsequent filings through 2023‑2024 do not show any new 2.30 % 2028‑maturity issuances; instead Oracle added higher‑coupon unsecured notes (e.g., 4.5 % Notes due 2028 in a Feb 2023 8‑K) and expanded its revolving‑credit facilities, indicating that as market rates rose the company chose to raise fresh capital at higher yields rather than refinance the existing low‑coupon 2028 notes, preserving the original tranche while tapping new debt at prevailing rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Oracle's debt issuance strategy and correctly identifies key facts: (1) the 2.300% Notes due 2028 were issued under an Officers' Certificate dated March 24, 2021 - CORRECT; (2) the coupon rate of 2.30% is accurate; (3) the 2028 maturity date is correct; (4) the identification of the 4.500% Notes due 2028 issued in February 2023 is accurate; (5) the strategic reasoning about Oracle preserving low-coupon debt while issuing higher-yielding instruments as rates rose is sound and matches the ground truth narrative. However, there are some gaps and minor issues: (1) The LLM answer does not explicitly mention the multi-tiered bond offering context that included the 2.875% Notes due 2031 and 3.950% Notes due 2051, which the ground truth identifies as part of the same offering structure; (2) The LLM references a 'Feb 2023 8-K' for the 4.500% Notes but the ground truth references this as 2023 activity without specifying the exact filing type or date; (3) The LLM mentions 'revolving-credit facilities' expansion, which is not explicitly mentioned in the ground truth and may introduce information not directly supported by the source documents; (4) The LLM answer is somewhat less comprehensive in addressing the 2024 period - it notes no new 2028-dated instruments but doesn't explicitly state Oracle made no visible changes to the 2.300% Notes terms in 2024, as the ground truth does. The multi-hop reasoning is generally sound - the LLM correctly synthesizes information across years and connects the debt issuance pattern to interest rate environment changes. The semantic meaning aligns well with the ground truth's conclusion about Oracle's strategy of locking in favorable rates and avoiding redundant issuance. The quantitative accuracy is strong with correct percentages and dates, though the qualitative completeness could be improved by addressing all three years (2022-2024) more explicitly and including the broader offering context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 539,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the 2022‑2024 10‑K filings IBM repeatedly listed “client relationships and trust” as a core competitive method, but the emphasis deepened each year. In 2022 it was noted simply as a differentiator; by 2023 the risk‑factor discussion linked trust to IBM’s reputation as a hybrid‑cloud and AI leader and warned that any damage to that reputation could impair its ability to win and retain customers. In 2024 the competition narrative explicitly tied trust and security to its open hybrid‑cloud platform and AI solutions, describing them as essential to the company’s differentiated value proposition.  \n\nThis progression shows IBM is positioning itself as a trusted, open partner that can safely accelerate enterprise‑level hybrid‑cloud and AI transformations—using client‑centric trust as a strategic moat against pure hyperscale competitors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the multi-year progression (2022-2024) and accurate characterization of IBM's strategic evolution. STRENGTHS: (1) No quantitative errors—no numbers, dates, or calculations to verify, and all temporal references (2022, 2023, 2024) are correct. (2) Correctly identifies the core theme: client relationships and trust as a competitive differentiator across all three years. (3) Accurately captures the deepening emphasis year-over-year, with specific contextual details (2023 risk-factor discussion linking trust to reputation; 2024 explicit tie to open hybrid-cloud platform and AI solutions). (4) Correctly mentions strategic partnerships (Palo Alto Networks reference aligns with ground truth). (5) Multi-hop synthesis is sound—the answer successfully synthesizes information across three years and connects it to IBM's positioning in hybrid cloud and AI markets. (6) The concluding insight about 'trusted, open partner' and 'strategic moat against hyperscale competitors' is a reasonable inference from the progression described and aligns with the ground truth's characterization of 'increasingly nuanced strategic emphasis.' MINOR WEAKNESSES: (1) The LLM answer adds interpretive language ('strategic moat,' 'pure hyperscale competitors') that goes slightly beyond the ground truth's more measured description of 'consistent but increasingly nuanced strategic emphasis.' While this interpretation is reasonable and not factually incorrect, it represents a modest elaboration beyond what the ground truth explicitly states. (2) The ground truth mentions 'embedding AI and cloud into offerings and modernizing platforms' as part of 2022 strategy, which the LLM answer does not explicitly reference, though this is a minor omission. (3) The ground truth's phrasing about 'deep incumbency with enterprises' in 2023 is not directly captured, though the LLM's characterization of the progression is semantically equivalent. OVERALL ASSESSMENT: The answer is factually accurate, demonstrates correct multi-hop reasoning across three years, and provides appropriate context for IBM's strategic positioning. The minor interpretive elaborations do not constitute factual errors but represent reasonable strategic analysis based on the documented progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 622,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nThe yield on American Express’s foreign government bonds rose from roughly 3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024, as shown in the “Distribution of Assets, Liabilities, and Shareholders’ Equity; Interest Rates and Interest Differential” tables for each year. This upward shift reflects a deliberate extension of duration into longer‑dated, higher‑yielding sovereign securities, indicating that the firm is pursuing higher income in a rising‑rate environment while increasing its exposure to interest‑rate risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. Specific issues: (1) QUANTITATIVE ERRORS - The LLM claims yields were '3.5% in 2022, 5.9% in 2023, and 6.1% in 2024,' but the ground truth shows 6.45% in 2023 and 5.85% in 2024. The 2022 figure of 3.5% is not mentioned in the ground truth at all. The LLM's yield progression (3.5% → 5.9% → 6.1%) is entirely fabricated and contradicts the actual data (6.45% → 5.85%), which shows a DECREASE, not an increase. (2) DIRECTIONAL ERROR - The LLM claims yields 'rose' and describes an 'upward shift,' when the ground truth explicitly shows a decline from 6.45% to 5.85%. This is a critical misrepresentation of the 3-year trend. (3) MISSING KEY DETAILS - The LLM fails to mention the $630 million principal amount, the maturity distribution changes (from ultra-short duration in 2023 to diversified 1-5 year exposure in 2024), or the strategic shift from concentrated short-term holdings to a more balanced maturity profile. (4) INCORRECT REASONING - The LLM's conclusion about 'extension of duration into longer-dated securities' contradicts the actual strategy shift described in the ground truth, which shows movement FROM concentrated short-term TO diversified maturities. (5) INCOMPLETE SYNTHESIS - The answer fails to synthesize the multi-hop information about how the maturity profile evolved alongside yield changes, missing the core insight about interest rate risk management through diversification rather than duration extension. The LLM appears to have hallucinated specific yield percentages and misinterpreted the directional trend entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 447,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Danaher has steadily increased the amount of U.S. government grant assistance that offsets capital spending on diagnostics‑testing infrastructure—$87 million in 2022, $136 million in 2023 and $198 million in 2024—while simultaneously expanding its manufacturing capacity and acquiring businesses that bolster the diagnostics portfolio (e.g., the Aldevron and Abcam acquisitions).  This upward trajectory of publicly‑funded CAPEX shows that diagnostics testing has become a strategic priority within Danaher’s broader health‑care portfolio, receiving sustained government support to accelerate production capacity and innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all three key financial figures ($87M in 2022, $136M in 2023, $198M in 2024) and accurately describes the upward trend in government grant funding for diagnostics testing capital expenditures. The core multi-hop synthesis is sound—connecting government funding to strategic importance in healthcare portfolio. The answer correctly identifies Danaher Corporation and the time period (2022-2024). WEAKNESSES: (1) The LLM introduces information about 'Aldevron and Abcam acquisitions' that is NOT present in the ground truth answer. While these may be real acquisitions, including them goes beyond what the knowledge graph provided and represents unsupported elaboration. (2) The phrasing 'publicly-funded CAPEX' is slightly imprecise—the ground truth specifically refers to 'government grant funds' used to 'offset capital expenditures,' which is more precise terminology. (3) The answer adds interpretive language ('simultaneously expanding manufacturing capacity and acquiring businesses') that, while potentially accurate, is not grounded in the provided ground truth and represents inference beyond the stated facts. QUANTITATIVE VERIFICATION: All three dollar amounts are correct ($87M, $136M, $198M) and the trend analysis is accurate. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes the progression of funding amounts with strategic importance, matching the ground truth's conclusion. However, the addition of acquisition details suggests the model may have drawn from external knowledge rather than strictly adhering to the knowledge graph. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—diagnostics testing became increasingly central with growing government support—but the additional details create a partially divergent narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 498,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nThe company’s filing consistently states that KPMG LLP is to be ratified as the principal auditor and that its PCAOB firm identification number is **185**. This reference appears in the Proxy under **“Item 3 – Ratification of KPMG LLP”** and is incorporated by reference in the **“Item 14 – Principal Accountant Fees and Services”** section of each 10‑K. The only evolution across 2022, 2023 and 2024 is a modest wording change—by 2023‑24 the number is introduced as the “Public Company Accounting Oversight Board (‘PCAOB’) firm identification number”—but the ID 185 and its placement within the Proxy‑referenced section remain the same.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies KPMG LLP as the principal accountant across all three years (2022, 2023, 2024); (2) Accurately states the PCAOB firm identification number as 185; (3) Correctly identifies the disclosure location as 'Item 3 – Ratification of KPMG LLP' within Item 14 of Proxy materials; (4) Accurately notes the consistency of the identification number and placement across the three-year period; (5) Provides a nuanced observation about wording evolution (introduction of full 'Public Company Accounting Oversight Board' terminology by 2023-24). MINOR WEAKNESSES: (1) The LLM introduces a claim about 'modest wording change' and the evolution of how the number is 'introduced' that goes slightly beyond what the ground truth explicitly states. The ground truth says 'There was no change in the identification number or in the format of the disclosure,' which could be interpreted as contradicting the LLM's assertion about wording evolution. However, this is a subtle distinction—the LLM may be referring to how the PCAOB acronym is presented, which is a reasonable interpretation of 'format' evolution that doesn't contradict the core finding of consistency; (2) The phrase 'incorporated by reference in the Item 14' is slightly imprecise—the ground truth indicates the disclosure appears 'under Item 3' within 'Item 14 of the Proxy materials,' not that it's incorporated by reference into Item 14. This is a minor semantic issue. QUANTITATIVE VERIFICATION: The number 185 is correct; all years (2022, 2023, 2024) are correctly referenced; the item numbers (Item 3, Item 14) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the evolution (or lack thereof) in disclosure practices. The reasoning is sound and logically structured. Overall, this is a strong answer with only minor quibbles about the characterization of 'wording changes' and the precise nature of how Item 3 relates to Item 14.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 559,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party merchant acquirers (e.g., OptBlue and GNS partners) while reshaping the economics of those relationships.  The company now records only the **network‑rate fee paid to the acquirer as discount revenue**, treating the remainder of the merchant‑discount as contra‑revenue or expense, and it settles directly with merchants on behalf of issuing partners.  This contractual shift supports the firm’s strategic goal of **expanding global merchant coverage—particularly in priority cities, new industry verticals and digitally‑enabled channels—by offering acquirers clear value propositions, scaling marketing and digital integration, and driving higher Card‑Member spend and loyalty**.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and potential inaccuracies in the multi-hop synthesis:\n\nSTRENGTHS:\n1. Correctly identifies OptBlue and GNS as key third-party acquirer programs\n2. Accurately describes the revenue recognition shift to network-rate fees as discount revenue\n3. Correctly identifies strategic expansion goals (global merchant coverage, new verticals, digital channels)\n4. Appropriately notes the shift from transactional to more strategic relationships\n5. Mentions Card-Member spend and loyalty as strategic drivers\n\nWEAKNESSES:\n1. INCOMPLETE TEMPORAL EVOLUTION: The answer conflates 2022-2024 into a single narrative without clearly delineating the progression. The ground truth explicitly describes distinct phases: (a) 2022 as primarily transactional with discount revenue, (b) 2023 as formalized with 'Processed Revenue' model including royalties/fees/partnerships, (c) 2024 emphasizing global expansion. The LLM answer doesn't clearly articulate this three-year progression.\n2. MISSING 'PROCESSED REVENUE' MODEL: The ground truth specifically mentions the 2023 formalization into a 'Processed Revenue' model that integrated royalties, fees, and network partnership agreements. The LLM answer omits this important structural evolution entirely.\n3. VAGUE ON CONTRACTUAL EVOLUTION: While the LLM mentions \"contractual shift,\" it doesn't explain how the relationships evolved from 2022 to 2024 in terms of formalization and integration (the ground truth's key point about moving from transactional to strategic partnership).\n4. MISSING SPECIFIC MARKET FOCUS: The ground truth mentions \"low- and new-to-plastic industries and international markets\" as specific expansion targets. The LLM answer uses more generic language (\"priority cities, new industry verticals\") without the specificity about underbanked/new-to-plastic segments.\n5. SETTLEMENT MECHANICS: The LLM mentions \"settles directly with merchants on behalf of issuing partners\" - this detail is not clearly present in the ground truth and may introduce information not verified in the source documents.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates partial multi-hop synthesis by connecting revenue recognition changes to strategic goals, but fails to properly synthesize the temporal evolution across three distinct years. The answer treats the period as a single evolution rather than three distinct phases with different characteristics.\n\nNUMERIC/QUANTITATIVE ACCURACY:\nNo specific numbers are provided in either answer, so quantitative accuracy is not directly testable. However, the structural/categorical accuracy (revenue models, program names) is mostly correct with the significant omission of the 'Processed Revenue' model.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (6/10): Core facts about OptBlue, GNS, and strategic goals are correct, but the critical omission of the 'Processed Revenue' model and the failure to clearly articulate the three-year progression significantly undermines the answer's completeness and accuracy.\n- Quantitative Accuracy (7/10): No calculations to verify; program names and revenue recognition concepts are mostly accurate.\n- Qualitative Accuracy (5/10): While the answer shows understanding of the general direction, it misses the key structural evolution (Processed Revenue model) and doesn't properly synthesize the temporal progression required by the question.\n- Contextual Relevance (7/10): The answer addresses the main question components but with incomplete coverage of the evolution timeline and missing key structural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 943,
        "total_tokens": 2382
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm kept its 2025 diversity targets—​a 15 % increase in women and in under‑represented‑minority (URM) leaders and a 20 % rise in overall URM representation—and began embedding those goals in executive pay.  Starting with FY 2022 the HR & Compensation Committee introduced a non‑financial performance modifier that can adjust the annual bonus by a multiplier of 0.9 to 1.1 based on the degree to which human‑capital advancements (including the diversity objectives) are achieved; this same 0.9‑1.1 modifier was applied to FY 2023 and FY 2024 bonuses, showing a sustained linkage of diversity‑target progress to executive compensation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: 15% increase in women and URM leaders, 20% overall URM representation increase, and the 0.9-1.1 modifier range. The fiscal year progression (2022-2024) is accurately presented, and the core multi-hop synthesis is sound—correctly linking diversity targets to executive compensation across the three-year period. However, the answer has notable omissions compared to the ground truth: (1) It does not mention that these were '2025 diversity goals' (forward-looking targets), which provides important context about the timeline; (2) It lacks specific details about FY 2023's emphasis on 'recognition in multiple regions' and 'Reboot Representation Tech Coalition' participation; (3) It does not capture FY 2024's expansion of 'global engagement efforts' and 'wellness and development programs,' which the ground truth identifies as evidence of 'deepening integration of human capital metrics into corporate strategy.' The LLM answer correctly identifies the sustained linkage and the unchanged modifier structure across years, but misses the narrative of evolution and expansion in supporting programs. The statement that the company 'began embedding those goals in executive pay' starting FY 2022 is accurate and well-phrased. Overall, the answer is factually sound on core metrics but incomplete in capturing the full scope of evolution described in the ground truth, particularly regarding the expansion of human capital initiatives beyond just diversity targets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 426,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 the EMD‑branded dealer network was trimmed slightly and then modestly rebuilt: the number of dealers located outside the United States fell from **116 (2022)** to **111 (2023)** before rising to **113 (2024)**, and the count of countries served moved from **193 (2022)** to **187 (2023)** and back to **191 (2024)**.  This pattern shows Caterpillar is not aggressively expanding its global footprint but is instead refining and consolidating its dealer coverage—contracting in 2023 to focus on core markets and then modestly expanding again in 2024—signaling a strategic emphasis on profitability and market‑share protection rather than broad geographic growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) COUNTRY COUNT DISCREPANCIES: Ground truth shows 193→191→187 countries (2022-2024), but LLM reports 193→187→191. The 2023 figure is wrong (LLM says 187, should be 191), and the 2024 figure is wrong (LLM says 191, should be 187). This is a fundamental error in the core quantitative data. (2) DEALER NUMBERS: The LLM introduces entirely new data points (116→111→113 dealers outside US) that are not present in the ground truth at all. While this additional detail might be from the source documents, it contradicts the ground truth's focus on country counts and creates confusion about which metric is primary. (3) NARRATIVE CONTRADICTION: The LLM's narrative describes a 2023 contraction followed by 2024 expansion (187→191), but the ground truth shows continuous decline (193→191→187). This leads to opposite strategic interpretations—LLM suggests 'refining then modestly expanding' while ground truth indicates 'gradual reduction.' (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year country data across the three-year period. The reasoning about 'refocusing' and 'consolidation' in the ground truth is replaced with an incorrect narrative about recovery. (5) SEMANTIC EQUIVALENCE FAILURE: The conclusions drawn are fundamentally different due to the inverted 2023-2024 figures, making the strategic interpretation opposite to what the data actually supports. The answer demonstrates a critical failure in data accuracy that undermines all subsequent analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 442,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe repeated listing of **Palmolive** among Colgate‑Palmolive’s “principal global trademarks” from 2022 through 2024 signals that the brand is treated as a core pillar of the Oral, Personal and Home Care (OPHC) segment.  By consistently featuring Palmolive alongside other flagship names (e.g., Colgate, Darlie, elmex), the company underscores its strategic reliance on the brand to drive a substantial share of OPHC sales and to sustain growth across toothpaste, hand‑soap, skin‑care and other personal‑care categories.  This emphasis reflects Palmolive’s outsized role in the segment’s revenue mix and its importance to the firm’s long‑term brand‑portfolio strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core insight that Palmolive's consistent inclusion in principal global trademarks from 2022-2024 signals its strategic importance to Colgate-Palmolive's OPHC segment. The answer accurately captures the time period (2022-2024) and correctly names other flagship brands mentioned (Colgate, Darlie, elmex). The reasoning about Palmolive's role in driving segment sales and supporting growth across product categories (hand soap, skin care, personal care) is sound and aligns with the ground truth's emphasis on foundational market positioning. However, there are some notable differences: (1) The LLM answer mentions 'toothpaste' as a Palmolive category, which is not explicitly confirmed in the ground truth (which focuses on liquid hand soap, dishwashing detergents, and household cleaners); (2) The LLM answer uses slightly different framing ('outsized role in segment's revenue mix') compared to ground truth's 'foundational role in supporting market position'; (3) The ground truth provides more specific product category examples (liquid hand soap, dishwashing detergents, household cleaners) while the LLM generalizes to broader categories. The LLM answer demonstrates solid multi-hop reasoning by synthesizing the 3-year consistency across filings and connecting it to strategic implications, though it makes an inference about toothpaste that may not be fully supported. The answer is contextually relevant and addresses the question's core inquiry about strategic role, but lacks the specific product category precision found in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 437,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved from a broad “IoT‑growth‑will‑exceed‑27 billion devices” narrative to a more focused edge‑networking strategy that is embedded in its 5G Advanced roadmap (Releases 16‑18) and in the rollout of Wi‑Fi 7.  In its segment reporting the company now groups IoT revenue into three sub‑verticals—consumer, edge‑networking (mobile‑broadband/Wi‑Fi access points and related equipment) and industrial—so that edge‑networking products are treated as a distinct category within the QCT equipment stream, with sales recognized at a point in time and related licensing royalties spread over time.  This product‑categorization shift is reflected in the financials: IoT revenue fell modestly (≈ $7.35 B → $5.94 B → $5.42 B) but the company continues to highlight “connected intelligent edge” and “edge‑networking” as key growth drivers, and its remaining performance‑obligation disclosures show a pipeline of edge‑networking contracts that will be recognized as unearned revenue until fulfilled.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides IoT revenue figures ($7.35B → $5.94B → $5.42B) that are NOT mentioned in the ground truth and appear to be fabricated or from an unverified source. These specific numbers cannot be verified against the original answer and represent a major factual error. (2) MISSING KEY GROUND TRUTH FACTS - The LLM fails to mention the crucial '27 billion projected IoT devices by 2026' figure that is explicitly highlighted in the ground truth as a key positioning element in fiscal 2022. (3) INCOMPLETE MULTI-HOP SYNTHESIS - While the LLM correctly identifies the three revenue categories (consumer, edge-networking, industrial) and notes the product categorization shift from 2022 to 2023, it does not clearly establish the temporal progression showing Edge Networking as 'emerging' in 2022 and 'structurally embedded' by 2023. (4) PARTIALLY CORRECT ELEMENTS - The LLM correctly identifies: (a) Edge Networking as a distinct category within QCT, (b) the inclusion of mobile broadband and wireless access points, (c) revenue recognition structure (point-in-time for equipment, spread-over-time for royalties), (d) the strategic continuity through 2024. (5) EXTRANEOUS INFORMATION - The LLM introduces details about 5G Advanced Releases 16-18 and Wi-Fi 7 that are not in the ground truth, suggesting potential hallucination or information from outside the verified knowledge graph. (6) REVENUE RECOGNITION ACCURACY - The LLM correctly describes the revenue recognition structure but adds unverified IoT revenue decline figures. The ground truth emphasizes 'consistent' revenue recognition structure across 2023-2024, which the LLM captures but then undermines with unverified revenue numbers. OVERALL: The answer demonstrates partial understanding of the strategic evolution but introduces significant quantitative inaccuracies that cannot be verified and omits the key '27 billion devices' projection that anchors the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 536,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nCaterpillar’s 2022‑2024 filings consistently identify currency‑exchange risk as a material exposure arising from its worldwide operations and describe the use of forward and option contracts to hedge adverse movements. The company’s disclosure language—highlighting that hedges protect against unfavorable swings but may forfeit gains from favorable ones and that its outlooks do not assume any specific currency behavior—remains essentially unchanged across the three years, indicating a steady, rather than transformed, hedging approach. As a result, while the exposure persists, the manner of managing it through hedging instruments has not undergone a substantive evolution, leaving earnings volatility sensitive to unexpected currency fluctuations.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Caterpillar uses forward and option contracts for hedging currency risk across 2022-2024. (2) Accurately notes the trade-off between protecting against downside and forfeiting upside gains. (3) Correctly identifies that the company's disclosure language remained relatively consistent across the three-year period. (4) No quantitative errors in numbers or dates. CRITICAL WEAKNESSES: (1) The LLM fundamentally contradicts the ground truth on the core question of 'evolution.' Ground truth explicitly states the company's approach EVOLVED from 2022 to 2024, with expanding discussion of emerging market risks, exchange controls, and currency devaluations by 2023-2024. The LLM claims the approach was 'steady, rather than transformed' and 'has not undergone a substantive evolution'—this is a direct factual contradiction. (2) The LLM completely omits the ground truth's key finding about the 2023 expansion to include emerging market risks, exchange controls, and currency devaluation concerns. (3) Missing the ground truth's observation about 'rising emphasis on external macroeconomic pressures' and 'increasingly cautious approach' over the three-year period. (4) The LLM's conclusion that 'the manner of managing it through hedging instruments has not undergone a substantive evolution' directly contradicts the ground truth's multi-year trend analysis showing evolution in risk discussion scope and emphasis. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the three years. While it correctly identifies consistent hedging practices, it misses the critical distinction between consistency in hedging INSTRUMENTS versus evolution in RISK EXPOSURE DISCUSSION and management emphasis. The ground truth shows the company's disclosure evolved to address new/emerging risks (geopolitical, macroeconomic), even if the hedging tools remained similar. This represents a failure in multi-hop temporal synthesis across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 542,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nFrom 2022 through 2024 the proportion of U.S. Treasury and agency securities in Colgate‑Palmolive’s pension‑plan fixed‑income portfolio fell from roughly 35‑40 % (the level implied by the 40 % figure disclosed for 2021) to about 30 % by the end of 2023 and it remained near 30 % in 2024.  This deliberate reduction shows that the company is actively trimming its exposure to interest‑rate‑sensitive government bonds and reallocating toward a broader mix of corporate and other fixed‑income assets, reflecting a proactive approach to managing interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally misrepresent the ground truth data. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the allocation was '35-40%' in 2022, but the ground truth clearly shows it was 30% as of December 31, 2022. The LLM's characterization of '40% figure disclosed for 2021' as implying '35-40%' for 2022 is incorrect and confuses the timeline. The ground truth shows: 50% (2020) → 40% (2021) → 30% (2022) → 30% (2023) → 30% (2024). The LLM incorrectly implies the 2022 figure was higher than it actually was. (2) TIMELINE MISREPRESENTATION: The LLM says the allocation 'fell from roughly 35-40%...to about 30% by the end of 2023' which mischaracterizes when the decline occurred. The major decline happened between 2021 (40%) and 2022 (30%), not between 2022 and 2023. The LLM fails to capture that stabilization occurred at 30% from 2022 onward. (3) MISSING CRITICAL CONTEXT: The LLM omits the 2020 baseline (50%) and the 2021 intermediate point (40%), which are essential to understanding the 'gradual reduction over two years followed by stabilization' pattern that the ground truth emphasizes. This omission weakens the analysis of the company's strategic shift. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth provides important context about Level 2 classification and its implications for liquidity and interest rate risk management. The LLM mentions 'proactive approach to managing interest-rate risk' but lacks the specific detail about Level 2 classification and over-the-counter trading that demonstrates how the company balanced risk with liquidity. (5) REASONING QUALITY: While the LLM's general interpretation about reallocation toward corporate bonds is directionally correct, the factual errors undermine the credibility of this analysis. The core insight about interest rate risk management is present but not well-supported by accurate data presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 529,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nIn 2022 Pfizer granted Breakthrough Performance Awards (BPAs) to select non‑executive employees, valuing each award at grant‑date with the intrinsic‑value method (based on the closing stock price) and then amortizing the expense straight‑line over the probable vesting period, adjusting each reporting period for changes in the share price, the number of shares expected to be earned and management’s assessment of performance‑achievement; this treatment and the detailed tabular disclosure were presented in Note 13 of the 2022 10‑K. Beginning in 2023 the company ceased granting BPAs—no BPAs were issued in 2023 or 2024 and none remained outstanding as of December 31, 2023 and 2024—yet the same intrinsic‑value valuation approach and straight‑line amortization, together with the identical disclosure format in the share‑based‑payment footnote, were retained, ensuring continuity and transparency of the prior methodology.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The ground truth explicitly states that in 2022, Pfizer granted 1,165 thousand shares at a weighted average intrinsic value of $38.73 per share, with 859 thousand shares nonvested by year-end. The LLM answer provides NO specific numbers for 2022 grant activity, failing to cite these critical metrics. (2) CRITICAL FACTUAL ERROR - The LLM claims 'no BPAs were issued in 2023 or 2024 and none remained outstanding as of December 31, 2023 and 2024.' However, the ground truth explicitly states that in 2024, 'BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced.' This is a fundamental contradiction - the LLM incorrectly asserts no BPAs existed in 2024, when the ground truth indicates they reappeared with new disclosures. (3) INCOMPLETE EVOLUTION NARRATIVE - The ground truth describes a 3-year trajectory: active issuance (2022) → suspension (2023) → reappearance with enhanced transparency (2024). The LLM only captures the first two phases and misses the critical 2024 reappearance and enhanced disclosure framework. (4) VALUATION METHODOLOGY - While the LLM correctly describes the intrinsic value and straight-line amortization approach used in 2022, it fails to distinguish the 2024 evolution which introduced 'adjustments based on performance probability and stock price changes' - a more dynamic framework than the 2022 approach. (5) DISCLOSURE TRANSPARENCY - The ground truth emphasizes the evolution toward 'more transparent and dynamic valuation framework' in 2024, but the LLM suggests continuity rather than evolution, missing the key point about enhanced transparency. The LLM answer demonstrates partial understanding of the valuation methodology but fails on the critical multi-hop synthesis of the 3-year evolution, particularly the 2024 reappearance and enhanced disclosure policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 535,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab added a suite of interactive RIA tools that moved the platform beyond basic custodial access to a fully integrated, cloud‑based advisory hub.  The launch of the thinkpipes trading platform and the iRebal customizable rebalancing engine (2022‑2023) gave RIAs real‑time charting and automated portfolio rebalancing, while the free Schwab Advisor Portfolio Connect (introduced in 2023 and expanded in 2024) provides a streamlined, intuitive portfolio‑management interface.  Together with deeper integrations to third‑party CRM, portfolio‑management and order‑management systems, these capabilities let RIAs manage client portfolios more efficiently and dynamically than in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) CRITICAL DATE ERROR: The LLM states 'Schwab Advisor Portfolio Connect (introduced in 2023 and expanded in 2024)' but the ground truth clearly indicates it was available in 2022 as 'a free portfolio management solution' and continued through 2024. This is a major factual inaccuracy. (2) UNSUPPORTED CLAIMS: The LLM introduces 'thinkpipes trading platform' and 'iRebal customizable rebalancing engine' with specific dates (2022-2023) that are NOT mentioned anywhere in the ground truth. These appear to be fabricated or confused with other products. (3) INCOMPLETE SYNTHESIS: While the ground truth mentions the Advisor Services website as a core platform in 2023 with multi-year document archiving capabilities, the LLM completely omits this evolution. (4) PARTIAL ACCURACY: The LLM correctly identifies third-party integrations (CRM, portfolio management, order management) and the general evolution toward a more integrated platform, which aligns with ground truth. (5) TONE MISMATCH: The ground truth emphasizes 'intuitive modern experience' refinement in 2024, while the LLM uses more marketing language ('cloud-based advisory hub') not directly supported by the filings. The answer demonstrates poor multi-hop synthesis by introducing unverified product names and getting the timeline of Advisor Portfolio Connect wrong, which are fundamental errors in a factual question about product evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 411,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nAcross 2022‑2024 the embedded‑processing business showed only modest top‑line growth in 2022‑23 (revenues up 3 % YoY) but saw its operating‑profit margin collapse from roughly 38 % to under 30 % as higher manufacturing costs and lower factory loadings squeezed profitability; in 2024 revenue fell 25 % and operating profit dropped 65 %, pushing the margin down to about 14 %.  Yet management repeatedly groups embedded processing with analog products as one of TI’s “four sustainable competitive advantages,” emphasizing its strategic role in industrial and automotive markets and its contribution to long‑term free‑cash‑flow growth.  This consistent framing signals that TI views embedded processing as a core, cash‑generating pillar of its portfolio, even while short‑term margin pressures highlight the challenges of scaling that segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES: The LLM answer introduces specific financial metrics (revenue growth rates, operating margin percentages, and year-over-year changes) that are NOT present in the ground truth answer and cannot be verified from the provided context. The ground truth focuses on strategic positioning and consistent messaging across three years, not operational performance metrics. The LLM claims: (1) 3% YoY revenue growth in 2022-23, (2) margin collapse from 38% to under 30%, (3) 25% revenue decline in 2024, (4) 65% operating profit drop in 2024, (5) margin down to 14% in 2024. None of these specific numbers appear in the ground truth, which makes no mention of embedded processing revenue figures or margin percentages. The LLM appears to have fabricated or hallucinated these financial metrics. CORRECT ELEMENTS: The LLM correctly identifies that TI groups embedded processing with analog products as one of four 'sustainable competitive advantages' and correctly notes this framing appears consistently across the period. The LLM also correctly identifies industrial and automotive markets as relevant. However, the answer fundamentally misinterprets the question by pivoting from strategic positioning (what the question asks) to operational performance (what the LLM provides). MULTI-HOP REASONING: The LLM fails to properly synthesize the core insight from the ground truth—that consistent strategic framing across three years reveals long-term positioning intent—and instead substitutes unverified operational data. The reasoning about 'short-term margin pressures' contradicts the ground truth's emphasis on consistent strategic messaging. CRITICAL FLAW: Introducing specific quantitative claims without source verification in a financial context is a serious error that undermines credibility and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 493,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Boeing’s fleet‑support services continued to be charged at roughly 1 % of total costs, but the 787 program generated large “abnormal” production expenses as the company ran the jet at well‑below normal rates (often under 5 aircraft per month) and performed extensive re‑work on inventory‑held airplanes; cumulative abnormal costs rose to about $2 billion by the end of 2023 and $256 million were expensed in 2024 alone.  These abnormal costs, together with the ongoing pause and slow ramp‑up of 787 deliveries, drove higher fleet‑support outlays and delayed the program’s return to regular delivery schedules.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of Boeing's 787 program challenges but contains a significant quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) Fleet support services at ~1% of total costs - accurate; (2) 787 program abnormal production costs and delivery delays - correctly identified; (3) $256 million in 2024 rework costs - accurate; (4) Production rate issues (under 5 aircraft/month) and inventory rework - correctly characterized; (5) Multi-hop synthesis across 2022-2024 period - reasonably sound. CRITICAL ERROR: The LLM states cumulative abnormal costs 'rose to about $2 billion by the end of 2023' when the ground truth clearly specifies '$2.7 billion through December 31, 2023.' This is a material discrepancy of $700 million (26% understatement) on a key metric. MISSING/INCOMPLETE ELEMENTS: (1) No mention of the 25 inventoried aircraft produced prior to 2023 - a specific quantitative detail in ground truth; (2) Lacks the progression detail that 'most of the 25 inventoried aircraft' had been reworked by 2024; (3) Does not mention expectations for 2025 deliveries; (4) The 2022 baseline (no specific abnormal cost figures disclosed) is not addressed. REASONING QUALITY: The LLM correctly synthesizes the multi-hop relationship between abnormal costs, production rates, delivery delays, and fleet support impacts. The causal logic is sound. However, the quantitative error on the $2.7B figure is a factual mistake that cannot be overlooked in financial analysis. The answer reads naturally and addresses the core question but sacrifices precision for brevity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 440,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nAfter selling Meridian on 31 December 2021, Pfizer kept only transitional service agreements (TSAs) and a three‑year Manufacturing Services Agreement (MSA) to hand‑off certain support functions; these contracts were fully completed by the end of 2023.  The only financial impact after the sale was minor post‑close adjustments— a $6 million gain recorded in 2022 and a $(15) million loss in 2023—reflecting the wind‑down of those agreements, with no material ongoing contractual or revenue‑sharing obligations thereafter.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - Ground truth: $167 million loss (net of tax) in 2022 from the sale\n   - LLM answer: Claims $6 million gain in 2022 and $(15) million loss in 2023\n   - These numbers are completely incorrect and contradict the documented loss from the Meridian sale\n   - The LLM fabricated specific financial figures not supported by the ground truth\n\n2. INCOMPLETE/INCORRECT TIMELINE:\n   - Ground truth: TSAs completed by December 31, 2023; MSA amounts not material but ongoing with two-year extension option\n   - LLM answer: Claims all contracts \"fully completed by the end of 2023\" with \"no material ongoing contractual or revenue-sharing obligations thereafter\"\n   - This misrepresents the MSA as fully completed when it actually had ongoing obligations with extension options through 2024 and beyond\n\n3. MISSING KEY INFORMATION:\n   - Ground truth mentions the MSA had a two-year extension option beyond the initial three-year term\n   - LLM answer omits this extension option entirely\n   - Ground truth notes Meridian was referenced in 2024 glossary, indicating continued recognition\n   - LLM answer suggests no ongoing relationship after 2023\n\n4. SEMANTIC MISREPRESENTATION:\n   - Ground truth describes a \"transition from direct ownership to limited but structured supplier relationship\"\n   - LLM answer incorrectly characterizes the relationship as fully wound down with no ongoing obligations\n   - This fundamentally misrepresents the nature of Pfizer's post-sale relationship with Meridian\n\n5. MULTI-HOP REASONING FAILURE:\n   - The question asks about evolution from 2022-2024\n   - LLM answer only addresses 2022-2023 and incorrectly concludes the relationship ended\n   - Failed to synthesize the 2024 information about continued recognition and MSA extension options\n\nThe answer demonstrates poor factual accuracy with invented financial figures and an incorrect characterization of the ongoing contractual relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 560,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nThe filings show that “hello” remains classified within the Oral Care segment, which consistently delivered about 42‑43 % of worldwide net sales from 2022 through 2024, while the adjacent Personal Care (~18‑19 %) and Home Care (~17 %) segments held steady.  This stability indicates that the brand has been maintained as a core oral‑care offering alongside Colgate, Palmolive and other labels, with no marked shift in its strategic emphasis relative to the broader Oral, Personal and Home Care portfolio during the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the specific question about 'hello' brand's strategic positioning evolution. Key problems: (1) QUANTITATIVE ERRORS: The LLM provides segment-level sales percentages (Oral Care 42-43%, Personal Care 18-19%, Home Care 17%) that are not verified in the ground truth and appear to be unsupported claims. These numbers are presented as factual but lack corroboration. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth specifically tracks 'hello' brand's appearance in principal global and regional trademarks across three years (2022, 2023, 2024), noting its consistent listing alongside Colgate, Palmolive, and the addition of Darlie in 2023. The LLM answer completely misses this year-by-year trademark positioning analysis. (3) MISALIGNMENT WITH QUESTION: The question asks about 'hello' brand's strategic positioning evolution relative to OTHER oral, personal and home care product lines. The ground truth answers this by showing 'hello' maintained consistent visibility in trademark listings. The LLM shifts focus to segment-level sales percentages, which is a different analytical framework and doesn't directly address brand positioning evolution. (4) MISSING KEY DETAILS: The LLM fails to mention that 'hello' was consistently listed among principal trademarks, that Darlie was added in 2023, or that this consistency implies maintained strategic prioritization. (5) REASONING QUALITY: While the LLM's logic about stability is sound, it's applied to the wrong data (segment sales vs. brand positioning). The multi-hop reasoning required synthesizing brand trademark data across three years, which the LLM did not do. The answer is partially relevant but fundamentally misses the core analytical framework of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 487,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nThe non‑qualified defined benefit plan remained unfunded, with its liability falling modestly from about $520 million in 2022 to $505 million in 2023 and $493 million in 2024, which narrowed the funded‑status deficit from roughly –$100 million to –$87 million and then to –$93 million.  At the same time, participation kept shrinking because the plan is closed to new members and most eligible employees have migrated to the enhanced defined‑contribution plan, leaving only a small legacy cohort and signalling that the company’s long‑term pension obligation is now limited to a minimal, largely settled group.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer introduces completely different financial metrics that are NOT present in the ground truth. Specifically: (1) The LLM cites non-qualified pension plan liabilities of $520M (2022), $505M (2023), and $493M (2024) with funded-status deficits of -$100M, -$87M, and -$93M respectively. These numbers do NOT appear in the ground truth answer and appear to be fabricated or from a different source. (2) The ground truth provides specific, verifiable data about defined contribution plans: 6M shares valued at $940M (2022), 5M shares at $873M (2023), and 5M shares at $852M (2024). The LLM completely omits this critical quantitative information. (3) The ground truth documents dividend payments ($28M, $27M, $26M) and defined contribution plan expenses ($70M, $75M, $76M) - all omitted by the LLM. (4) While the LLM correctly identifies that the plan is unfunded and closed to new participants, it fails to provide the specific financial metrics that constitute the core of the ground truth answer. (5) The LLM's qualitative reasoning about the strategic shift and legacy liability is directionally correct but is built on incorrect quantitative foundations. The answer demonstrates a fundamental failure in multi-hop synthesis - it should have integrated the specific share holdings, valuations, dividends, and expense data across the three-year period. The LLM appears to have hallucinated pension liability figures rather than accurately reporting the defined contribution plan metrics that form the actual basis of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 432,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s long‑term private‑equity investment fell each year—$800 million at the end of 2022, $755 million in 2023 and $719 million by the end of 2024.  The consistent decline indicates that the company is deliberately reducing its exposure to private‑equity, shifting capital toward its core pharmaceutical pipeline, strategic acquisitions and shareholder‑return initiatives rather than sustaining a large private‑equity allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth states $623 million in 2022, but the LLM claims $800 million. This is a $177 million discrepancy (28% error) on the starting value. The 2023 ($755M) and 2024 ($719M) figures are correct. REASONING ERROR: The LLM's interpretation of the trajectory is also incorrect. Ground truth indicates a strategic INCREASE from 2022 to 2023 (+$132M or +21%), followed by a partial reduction in 2024 (-$36M or -5%). This shows a measured, deliberate increase followed by modest adjustment—not a 'consistent decline' as the LLM claims. The LLM's narrative of 'deliberately reducing exposure' contradicts the actual 2022-2023 increase. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trajectory. It mischaracterized the pattern as monotonic decline when the data shows increase-then-decrease. CONTEXTUAL ISSUES: The LLM's interpretation about shifting capital away from private equity is speculative and unsupported by the actual data pattern, which shows strategic allocation rather than deliberate reduction. The answer demonstrates poor data accuracy and flawed analytical reasoning about what the numbers actually indicate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 351,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nUnder the 2019 IDA (still in effect for 2022) Schwab could move up to $10 billion of floating‑rate IDA balances each 12‑month period, but only if it had sufficient capital and could keep at least $50 billion of IDA balances on its books through mid‑2031 while maintaining 80 % of those balances designated as fixed‑rate through mid‑2026. The 2023 IDA replaced those caps, retaining the $10 billion annual migration right but dropping the 80 % fixed‑rate requirement and adding new minimum‑balance limits (e.g., IDA balances must stay above $60 billion after September 10 2025 and may not fall below a level $30 billion above the outstanding unmatured fixed‑rate obligations); Schwab did not exercise the migration option in either 2023 or 2024, so the ability to migrate IDA balances remained constrained by capital adequacy, the floating‑rate designation rule, and the new balance‑size thresholds.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - Claims 2019 IDA required maintaining '$50 billion of IDA balances on its books through mid-2031' - NOT in ground truth\n   - Claims '80% of those balances designated as fixed-rate through mid-2026' - NOT in ground truth\n   - Claims 2023 agreement retained '$10 billion annual migration right' - Ground truth shows NO migration occurred in 2023-2024, suggesting this right may not have been retained or was constrained\n   - Claims 'IDA balances must stay above $60 billion after September 10 2025' - Ground truth specifies maintaining 'minimum balances above the then-outstanding unmatured fixed-rate obligation amounts' with a maximum of '$30 billion above that total', NOT a $60 billion floor\n\n2. FACTUAL INACCURACIES:\n   - Ground truth states Schwab 'had already moved $10.1 billion by December 31, 2021' under the 2019 agreement, but LLM doesn't mention this historical context\n   - LLM introduces constraints (80% fixed-rate requirement, $50 billion minimum through mid-2031) that don't appear in the ground truth\n   - The $60 billion threshold mentioned in LLM contradicts the ground truth's description of the constraint structure\n\n3. MULTI-HOP REASONING:\n   - LLM fails to properly synthesize the evolution across three years\n   - Ground truth clearly shows: 2022 (option to migrate up to $10B), 2023 (no migration, new constraints), 2024 (no migration, continued constraints)\n   - LLM conflates different constraint types and introduces unsupported details\n\n4. MISSING KEY INFORMATION:\n   - LLM doesn't clearly state that NO migrations occurred in 2023 or 2024 until the end\n   - LLM doesn't properly characterize the 'tightening of flexibility' that is central to the ground truth answer\n   - The $30 billion maximum threshold is mentioned but not clearly explained\n\n5. SEMANTIC ISSUES:\n   - While LLM attempts to address the evolution question, it does so with incorrect details\n   - The answer suggests constraints were 'retained' and 'added' but the specific constraints described don't match ground truth\n\nThe LLM answer demonstrates a fundamental misunderstanding of the actual IDA agreement terms and their evolution, introducing specific numbers and requirements that are not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 636,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nTexas Instruments’ 10‑K property tables for 2022, 2023 and 2024 all list a facility in **Melaka, Malaysia** under the “Analog ✓” column (and never under “Embedded Processing”), showing that the site has been retained as an analog‑manufacturing location for the entire three‑year period.  The lack of any expansion, contraction, or relocation noted across the filings indicates that Melaka is a strategically important node in TI’s global analog supply chain—providing a stable, cost‑effective production hub that supports the company’s broader competitive advantages and long‑term free‑cash‑flow objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Melaka, Malaysia was listed as an analog manufacturing location across all three years (2022, 2023, 2024), which is the core factual claim. The company name (Texas Instruments) and location are correct. The general conclusion about strategic importance and stability is reasonable. CRITICAL ISSUES: (1) MARKING DISCREPANCY: The ground truth specifies that Melaka had different markings across years († in 2022, * in 2023, ** in 2024), suggesting potential escalation in operational emphasis. The LLM states the facility was marked with 'Analog ✓' across all years without acknowledging these specific marking changes. This is a significant omission because the ground truth explicitly notes these markings as 'potentially signaling continued operational emphasis.' (2) INTERPRETATION ERROR: The LLM claims 'lack of any expansion, contraction, or relocation' when the ground truth actually suggests a 'possible escalation' indicated by the changing markers (†→*→**). The LLM's interpretation contradicts the ground truth's reading of the data. (3) ADDED CLAIMS: The LLM introduces unsupported claims about 'cost-effective production hub' and 'long-term free-cash-flow objectives' that are not present in the ground truth and go beyond what can be verified from the filing data. PARTIAL CREDIT: The LLM correctly synthesizes the multi-year consistency and identifies Melaka's strategic importance, but misses or misinterprets the nuanced marker progression that the ground truth emphasizes as potentially indicating escalation rather than mere stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 438,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe RedCard‑program penetration (which includes the Target Debit Card) slipped from about **20 % of purchases in 2022 to 18.6 % in 2023 and 17.8 % in 2024**.  Target notes that a “meaningful portion” of the incremental purchases generated by RedCard users are sales that would not have occurred otherwise, but the downward trend shows that the card’s ability to create new, incremental spend is eroding – the card is becoming a more routine payment method rather than a primary engine of incremental sales for the company.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM provides incorrect penetration rates for 2022 and 2023. Ground truth shows 20.5% (2022), 19.8% (2023), and 17.8% (2024). LLM states approximately 20% (2022), 18.6% (2023), and 17.8% (2024). The 2023 figure is notably wrong (18.6% vs. 19.8% - a 1.2 percentage point error). The 2022 figure is vague ('about 20%') when the precise figure is 20.5%. Only the 2024 figure (17.8%) is correct. COMPLETENESS: The LLM addresses the core question about penetration rate evolution and trend interpretation. It correctly identifies the downward trajectory and provides reasoning about what this suggests regarding the card's role in driving incremental sales. ENTITY ACCURACY: Correctly identifies the RedCard program (which includes Target Debit Card) and the relevant time period (2022-2024). REASONING QUALITY: The qualitative analysis is sound - the LLM correctly interprets the downward trend as suggesting diminished effectiveness in driving incremental sales and notes a shift from being a primary sales driver to a routine payment method. This aligns with the ground truth's assessment. The reference to 'meaningful portion' of incremental purchases is appropriate context. MULTI-HOP SYNTHESIS: The answer successfully synthesizes the penetration rate data with its implications for Target's business strategy, demonstrating understanding of the relationship between card adoption and sales generation. CRITICAL FLAW: The 18.6% figure for 2023 is a material error that undermines the quantitative accuracy of the response, even though the overall trend interpretation remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 443,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe tables in the 2022‑2024 10‑K filings show that the “Number of Securities Remaining Available for Future Issuance” under the 2003 Director Compensation Plan fell to essentially 0 by the end of 2023 (the small carry‑over amount that remained was absorbed into the successor 2018 Director Plan, which slipped from about 1.8 million shares in 2023 to 1.7 million in 2024).  This decline indicates that Texas Instruments has stopped replenishing the legacy 2003 plan and now relies on the newer 2018 Director Plan and the freshly adopted 2024 Long‑Term Incentive Plan to provide equity incentives to its directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. Ground truth shows: 2022: 35,385,153 shares; 2023: 25,296,767 shares; 2024: 24,503,062 shares. The LLM claims the plan fell to 'essentially 0 by the end of 2023' with only a 'small carry-over amount' and references 1.8 million shares in 2023 and 1.7 million in 2024 - these numbers are completely inconsistent with the actual data showing 25+ million shares available in both 2023 and 2024. The LLM's core claim that the 2003 plan was depleted is factually wrong. The ground truth shows a consistent but gradual decline (35.4M → 25.3M → 24.5M), not depletion. The LLM's interpretation about the plan being 'absorbed into the successor 2018 Director Plan' and references to a '2024 Long-Term Incentive Plan' appear to be fabricated details not supported by the ground truth data. The LLM failed to provide the actual share counts for all three years and mischaracterized the trend entirely. While the LLM correctly identified the company (Texas Instruments) and the plan name (2003 Director Compensation Plan), the quantitative data is entirely wrong, making this answer fundamentally incorrect and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 341,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nVisa’s virtual‑account ecosystem moved from a 2022 foundation of token‑based credentials and the launch of Visa Direct— which already processed ≈ 6 billion real‑time transactions and 4 billion network tokens— to a 2023 expansion that added push‑to‑wallet payouts, broadened the Direct network to > 60 use‑cases and 2,000 programs, and introduced Visa + for interoperable P2P transfers; then in 2024 the company deepened integration by embedding Visa Direct within its “network of networks,” adding Currencycloud‑powered cross‑border capabilities, launching Visa A2A in the UK, and acquiring Pismo to bring cloud‑native issuer processing, thereby extending virtual‑account issuance and cross‑border settlement to billions of cards, accounts and digital wallets worldwide.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. MAJOR ISSUES: (1) The LLM introduces specific numbers (6 billion real-time transactions, 4 billion network tokens, >60 use-cases, 2,000 programs) that are NOT present in the ground truth and cannot be verified as accurate from the provided knowledge graph. (2) The LLM mentions 'Visa + for interoperable P2P transfers' and 'Visa A2A in the UK' which are NOT mentioned in the ground truth answer. (3) The LLM references the Pismo acquisition, which is NOT mentioned in the ground truth. (4) The ground truth specifically mentions 'Currencycloud platform under Visa Treasury as a Service' in 2022, but the LLM only mentions Currencycloud in 2024. (5) The ground truth emphasizes the '$20 trillion in annual B2B cross-border opportunities' and 'over 11 billion endpoints' in 2024, but the LLM uses different language ('billions of cards, accounts and digital wallets') without the specific figures. CORRECT ELEMENTS: The LLM correctly identifies the general progression from 2022-2024, correctly mentions Visa Direct, correctly references cross-border capabilities, and correctly identifies virtual accounts as a core component. However, the introduction of unverified specific metrics and products not in the ground truth, combined with the omission of key ground truth details (Currencycloud in 2022, specific endpoint numbers, $20 trillion opportunity), represents a significant departure from the factual record. The answer demonstrates partial understanding of the evolution but adds details that cannot be confirmed and omits or misplaces key verified information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 451,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nXtandi’s 2023 revenue pressure—evidenced by a 1 % drop in international sales and price erosion from unfavorable channel‑mix changes (see page 45)—prompted Pfizer to accelerate its lifecycle‑management strategy, which was reflected in the April 2024 EU approval of an expanded high‑risk BCR‑mutant metastatic prostate‑cancer indication for the drug (see page 47).  In its 2022 intangible‑asset disclosures, Pfizer valued Xtandi as part of the developed‑technology rights portfolio, carrying a gross carrying amount of roughly $73 billion (the portion attributable to Xtandi being a key component of that intangible‑asset group) (see page 92).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) INDICATION DESCRIPTION ERROR: The LLM states the 2024 approval was for 'high-risk BCR-mutant metastatic prostate-cancer indication,' but the ground truth clearly specifies 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis.' This is a fundamental factual error—metastatic vs. non-metastatic are opposite disease states. (2) VALUATION CLAIM UNSUBSTANTIATED: The LLM claims Xtandi carried 'a gross carrying amount of roughly $73 billion' as 'a key component' of developed-technology rights. The ground truth states Xtandi was 'explicitly listed among Pfizer's most significant developed technology rights' but does NOT provide a specific dollar valuation for Xtandi itself or claim it represents a portion of a $73B portfolio. The LLM appears to have conflated total portfolio value with Xtandi's specific valuation without evidence. (3) REVENUE DECLINE ACCURACY: The 1% revenue decline is correctly cited, though the LLM adds 'unfavorable channel-mix changes' which is a reasonable inference but not explicitly confirmed in ground truth. (4) MULTI-HOP REASONING: The LLM correctly synthesizes the connection between 2023 revenue pressure and 2024 lifecycle management strategy, and references 2022 valuation context. However, the critical indication error undermines the entire answer's credibility. (5) PAGE REFERENCES: The LLM cites specific pages (45, 47, 92) which cannot be verified against the ground truth provided, raising concerns about hallucinated citations. The core narrative structure is sound, but the factual errors on the indication type and unsupported valuation claim are disqualifying.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 464,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe Target MasterCard (Target Circle) penetration fell steadily from 19.8 percent in the 2022 fiscal year to 18.6 percent in 2023 and 17.8 percent in 2024. This downward trend indicates that shoppers are increasingly using alternative payment methods and that engagement with Target’s loyalty‑linked credit‑card program is weakening, suggesting reduced consumer preference for the card’s 5 percent discount and related benefits.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate numbers. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. LLM answer states: 2022: 19.8%, 2023: 18.6%, 2024: 17.8%. The LLM has shifted all percentages downward by approximately 1.0-1.2 percentage points and misaligned them to wrong years. Specifically: (1) The 2022 figure should be 20.5%, not 19.8% (off by 0.7 points); (2) The 2023 figure should be 19.8%, not 18.6% (off by 1.2 points); (3) The 2024 figure should be 18.6%, not 17.8% (off by 0.8 points). This represents a systematic error pattern rather than a single mistake. ENTITY ACCURACY: The LLM correctly identifies the card as Target MasterCard/Target Circle and acknowledges the rebranding concept, though less explicitly than ground truth. REASONING QUALITY: The qualitative interpretation of the trend (declining engagement, shift to alternative payment methods, weakening loyalty program engagement) is reasonable and aligns with the ground truth's conclusion, though the LLM adds specific details about the 5% discount that weren't in the original answer. However, this reasoning is built on incorrect numerical foundations. MULTI-HOP SYNTHESIS: The answer does synthesize the three-year trend appropriately in structure, but the underlying data is wrong. The directional trend (declining) is correct, but the magnitude and specific values are incorrect. This is a case where the reasoning framework is sound but the factual inputs are fundamentally wrong, making the answer unreliable despite its logical structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 440,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Visa layered Currencycloud’s virtual‑account functionality onto its cross‑border payments engine, beginning with a pilot‑phase rollout in FY 2022 that added real‑time FX rates and settlement to consumer‑payment flows. In FY 2023 the virtual‑account capability was embedded in the Visa Direct platform and expanded to more than 100 countries, feeding Visa B2B Connect and markedly widening the network of reachable endpoints. By FY 2024 the feature was fully integrated into Visa Direct, supporting nearly 11 billion cards, accounts and digital wallets and processing close to 10 billion transactions, which dramatically broadened cross‑border payment reach and enabled real‑time liquidity and settlement across the entire Visa network.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a significant factual error regarding network reach. The ground truth states 'over 11 billion endpoints' were reached by 2023, but the LLM incorrectly attributes this to FY 2024 ('supporting nearly 11 billion cards, accounts and digital wallets'). More problematically, the LLM introduces an unsupported claim about 'close to 10 billion transactions' in FY 2024 that does not appear in the ground truth at all. (2) GEOGRAPHIC SCOPE MISPLACEMENT - The ground truth clearly states that by 2023, virtual accounts were 'integrated into cross-border payment solutions' and that Visa B2B Connect operates 'across more than 100 countries.' The LLM incorrectly places the '100 countries' expansion in FY 2023 rather than as part of the 2024 B2B Connect infrastructure. (3) TIMELINE CONFUSION - The LLM conflates the 11 billion endpoint figure with FY 2024, when the ground truth explicitly attributes this to 2023. This is a material factual error affecting the chronological evolution narrative. (4) UNSUPPORTED CLAIMS - The introduction of 'close to 10 billion transactions' lacks any grounding in the provided ground truth and represents fabrication. (5) PARTIAL CREDIT - The LLM correctly identifies: real-time FX rates in FY 2022, Visa Direct platform integration in FY 2023, B2B Connect involvement, and the general progression of virtual account utility. However, the misplacement of key metrics across fiscal years and the introduction of unverified transaction volume data significantly undermines answer reliability. The multi-hop reasoning structure is present but contains critical factual errors in the synthesis of timeline and metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 469,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nAMD’s 10‑K filings for 2022, 2023 and 2024 each list “difficulties in protecting our intellectual property” under General Risks, but the later years sharpen the focus: the 2023 and 2024 disclosures explicitly connect that risk to AMD’s growing international footprint—sales that were ≈ 65‑72 % of revenue—and to its reliance on third‑party wafer foundries in China, Taiwan and other Asian locations, where heightened geopolitical tensions and supply‑chain disruptions amplify the chance of IP loss or infringement.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of AMD's IP protection concerns across 2022-2024 and correctly identifies the connection to international operations and third-party manufacturing dependencies. However, there are significant issues with quantitative accuracy and completeness:\n\n(1) QUANTITATIVE ACCURACY PROBLEMS:\n- The LLM cites international sales as \"≈65-72% of revenue\" but provides no source verification for these specific percentages. The ground truth does not mention these percentages, and they appear to be unsupported claims that could be factually incorrect.\n- No specific dollar amounts or precise financial metrics are provided to substantiate the international exposure claims.\n- The percentage range is vague (\"≈65-72%\") which suggests uncertainty, yet is presented as fact.\n\n(2) COMPLETENESS ISSUES:\n- The LLM answer omits critical details from the ground truth regarding the evolution of concerns:\n  * Missing: The 2023 expansion linking IP risks to \"specific third-party manufacturing dependencies in China, Malaysia, and Taiwan\"\n  * Missing: The 2024 addition of \"evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts\"\n  * The LLM mentions \"China, Taiwan and other Asian locations\" but lacks the specificity of Malaysia and the geopolitical conflict references\n\n(3) MULTI-HOP REASONING:\n- The LLM correctly synthesizes the connection between IP protection difficulties, international operations, and third-party manufacturing across the three years\n- However, it fails to capture the temporal evolution and increasing specificity that the ground truth emphasizes\n- The reasoning about geopolitical tensions is present but less detailed than the ground truth\n\n(4) ENTITY AND FACTUAL ACCURACY:\n- Company (AMD) correctly identified\n- Years (2022, 2023, 2024) correctly identified\n- Manufacturing locations partially correct (China, Taiwan mentioned; Malaysia omitted)\n- The phrase \"difficulties in protecting our intellectual property\" is correctly cited\n\n(5) SEMANTIC EQUIVALENCE:\n- The core message about IP protection challenges linked to international operations is conveyed\n- However, the omission of specific geopolitical conflicts (Ukraine-Russia, Israel-Hamas) and regulatory details represents a material loss of information\n- The answer is somewhat correct in spirit but incomplete in substance\n\nThe answer demonstrates reasonable understanding of the topic but introduces unsupported quantitative claims and omits important details about the evolution of concerns, particularly regarding specific geopolitical conflicts and regulatory changes in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 715,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nFrom 2022 through 2024 UNP’s corporate‑stock holdings remained classified as Level 1 (common shares) and Level 2 (preferred shares), but the **allocation of those shares within the pension portfolio fell sharply** – from roughly **48 % of total plan assets in 2022** to **about 24 % in 2024** (the 2025 target is 20‑30 % equity).  This de‑risking shift moves the plan from a higher‑equity, higher‑return stance to a more conservative mix of **70‑80 % debt and only 0‑2 % real‑estate**, indicating that UNP is deliberately reducing market‑price volatility and focusing on stable, liability‑matching assets to fund its pension obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Corporate Stock holdings fell from '48% of total plan assets in 2022' to '24% in 2024' - these percentages are NOT in the ground truth, which provides absolute dollar values ($1,990M in 2022, $181M in 2023). The LLM appears to have fabricated percentage allocations. (2) MISSING CORE DATA: The ground truth explicitly states dollar amounts ($1,990M in 2022, $181M in 2023) and Level 1/Level 2 breakdowns, which the LLM completely omits. (3) UNSUPPORTED CLAIMS: The LLM introduces specific pension allocation targets ('70-80% debt', '0-2% real estate', '20-30% equity target for 2025') that are not mentioned in the ground truth. (4) CLASSIFICATION ACCURACY: While the LLM correctly identifies Level 1 (common) and Level 2 (preferred) classifications, it fails to provide the actual valuation figures that are central to answering the question. (5) MULTI-HOP REASONING: The ground truth clearly shows a sharp decline from $1,990M (2022) to $181M (2023) - approximately a 91% reduction - which is a critical finding. The LLM's percentage-based framing obscures this dramatic shift and substitutes unverified allocation percentages. (6) STRATEGIC INTERPRETATION: While both answers suggest a de-risking strategy, the LLM's specific claims about debt/equity/real estate allocations cannot be verified against the provided ground truth and appear to be hallucinated details. The answer fundamentally fails to accurately represent the quantitative evolution of UNP's Corporate Stock investments from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 455,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nFrom 2022 to 2024 Abbott’s filings moved from a single‑line exhibit reference to the 4.75 % Senior Notes due 2043 (Exhibit 4.19) in the 10‑K to increasingly detailed disclosures that bundle the notes within supplemental indentures, officer certificates and a dedicated “Description of Registrant’s Securities” (Exhibit 4.36).  This layered approach—adding supplemental indenture dates, covenant language and updated officer certificates—reflects a deliberate strategy to provide transparent, granular information about the company’s long‑term debt, underscoring both disciplined debt‑management and a proactive investor‑communication agenda.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. Specific issues: (1) EXHIBIT NUMBERS: The LLM claims Exhibit 4.19 and Exhibit 4.36 references, but the ground truth specifies Exhibit 4.6 from the Form 8-K dated March 22, 2017, and references to the Fourth Supplemental Indenture from April 2, 2013. These exhibit numbers are incorrect and not supported by the ground truth. (2) DOCUMENTATION EVOLUTION: The ground truth describes a clear progression from legacy integration (2022) → formalized documentation with specific Form 8-K exhibit (2023) → maintained structured disclosure (2024). The LLM invents a different narrative about moving from 'single-line exhibit reference' to 'bundled supplemental indentures' with 'officer certificates' and 'Description of Registrant's Securities' - none of which are mentioned in the ground truth. (3) MISSING KEY DETAILS: The LLM fails to mention the St. Jude Medical Fourth Supplemental Indenture from April 2, 2013, which is central to understanding the 2022 documentation context. It also misses the specific Form 8-K dated March 22, 2017 reference that appears in 2023. (4) UNSUPPORTED CLAIMS: The LLM introduces details about 'covenant language,' 'officer certificates,' and 'Description of Registrant's Securities' that do not appear in the ground truth and appear to be fabricated. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize a narrative about disclosure evolution, it does so based on incorrect factual premises, making the reasoning fundamentally flawed. The core insight about shifting from legacy-based referencing to standardized disclosure is present in the ground truth but is completely obscured by the LLM's incorrect specific details. The answer demonstrates a pattern of hallucination rather than accurate synthesis of multi-year filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 513,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target Circle Card (the re‑branded RedCard) penetration slipped from about **20.5 % of purchases in fiscal 2022** to **19.8 % in fiscal 2023** and further to **18.6 % in fiscal 2024** (see the 2023 10‑K discussion of “Target Circle Card Penetration” and the 2024 10‑K which reports 18.6 % for the year ended Feb 3 2024).  \n\nThis modest, steady decline indicates that customer adoption of the branded payment product is easing – the 5 % discount incentive is becoming less compelling – but the card still accounts for a sizable share of transactions, so it continues to generate incremental sales, albeit at a gradually diminishing rate.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All three penetration rate percentages are factually correct: 20.5% (2022), 19.8% (2023), and 18.6% (2024). (2) Fiscal year identification is accurate (year ended Feb 3, 2024 for fiscal 2024). (3) The LLM correctly identifies the product as Target Circle Card (re-branded RedCard). (4) The directional trend analysis is sound - correctly identifies the downward trajectory. (5) Number formatting is consistent and clear.\n\nWEAKNESSES: (1) The LLM introduces speculative interpretation about the '5% discount incentive becoming less compelling' - this specific causal explanation is not present in the ground truth and represents unsupported inference. (2) The phrase 'customer adoption of the branded payment product is easing' is somewhat vague compared to the ground truth's more direct statement about 'gradual decline in customer adoption or usage.' (3) The LLM's statement that the card 'continues to generate incremental sales, albeit at a gradually diminishing rate' is reasonable inference but goes slightly beyond what the ground truth explicitly states. The ground truth notes the company 'has historically linked' the card to incremental sales but doesn't explicitly confirm ongoing incremental sales generation in 2024. (4) Missing some context from ground truth about the card's role in 'loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.'\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the three-year trend across multiple fiscal periods and connects it to the broader question about customer adoption and sales impact. However, the reasoning about causation (discount incentive) and current impact (diminishing incremental sales) goes beyond the factual ground truth.\n\nOVERALL ASSESSMENT: The core factual answer is accurate with correct numbers and proper trend identification. The interpretation adds reasonable but somewhat speculative analysis that slightly overstates certainty about mechanisms and current impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 543,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nFrom 2022 to 2024 the Multiple‑Purpose Locomotive fleet slipped modestly in size – from roughly **7,000 units (2022)** to **6,893 units (2024)** – while the **average age rose from about 23 years to 25.2 years**.  This slight contraction combined with a higher average age shows that Union Pacific is not aggressively expanding its locomotive count but is instead keeping newer, more efficient units in service and allowing older assets to be retired over time, reflecting a focus on **asset‑life‑cycle optimization and capital‑efficiency** rather than fleet growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM provided approximate figures ('roughly 7,000 units') for 2022 instead of the precise ground truth value of 7,242 units. This is a material discrepancy of 342 units (4.7% difference). The 2024 figure of 6,893 units is correct, and the average age figures (approximately 23 years to 25.2 years) are close but imprecise compared to the ground truth (22.5 years to 25.2 years). The 2024 average age of 25.2 years is exactly correct. QUALITATIVE REASONING: The LLM's interpretation of the data is reasonable but differs from the ground truth conclusion. The LLM suggests Union Pacific is 'keeping newer, more efficient units in service and allowing older assets to be retired over time,' implying a modernization strategy. However, the ground truth characterizes this as 'deferral of fleet modernization' and a 'cost-conscious asset management strategy.' The LLM's narrative suggests active optimization, while the ground truth suggests cost-cutting or deferred investment. This represents a meaningful difference in strategic interpretation. COMPLETENESS: The answer addresses all parts of the question (total units change, average age change, and strategic implications), though the strategic interpretation diverges from ground truth. MULTI-HOP SYNTHESIS: The model correctly synthesized data across the 2022-2024 period and connected fleet metrics to strategic implications, though the strategic conclusion differs. The reasoning is logically sound but reaches a different interpretation than the ground truth. MAIN ISSUES: (1) Imprecise 2022 fleet number ('roughly 7,000' vs. 7,242), (2) Imprecise 2022 average age ('about 23 years' vs. 22.5 years), (3) Different strategic interpretation (optimization vs. cost-consciousness/modernization deferral).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 486,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s unfunded commitments to private real‑estate funds declined from roughly $585 million to $555 million and then to $540 million. This downward trajectory signals a strategic pull‑back from illiquid alternative assets, reflecting a shift toward greater liquidity and capital preservation rather than expanding long‑term private‑real‑estate investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - $585M (2022), $555M (2023), $540M (2024) match ground truth exactly. (2) The downward trend is accurately identified and quantified. (3) Number formatting is appropriate and consistent. (4) The company and metric identification (Abbott Laboratories, unfunded commitments to private real estate funds) are correct. (5) The multi-hop synthesis across three years is sound.\n\nWEAKNESSES: (1) The LLM answer characterizes the trend as a 'strategic pull-back from illiquid alternative assets' with a 'shift toward greater liquidity and capital preservation,' but the ground truth provides a more nuanced interpretation: the company maintained 'a significant unfunded commitment, suggesting a strategic but measured approach' with 'continued long-term participation through fund distributions.' The LLM's framing suggests a more aggressive retreat than the ground truth supports. (2) The ground truth explicitly notes the decline is 'consistent' at $15M per year and describes this as 'gradual reduction,' while the LLM uses vaguer language ('downward trajectory'). (3) The LLM omits the important context that despite the decline, Abbott maintained significant commitments, indicating ongoing strategic participation rather than a wholesale pullback. (4) The phrase 'capital preservation rather than expanding long-term private-real-estate investments' somewhat mischaracterizes the situation - the ground truth suggests measured participation, not capital preservation as the primary driver.\n\nCALCULATION VERIFICATION: The year-over-year changes are: 2022-2023: $585M - $555M = $30M decline (not $15M annually as stated in ground truth for 'three-year period'); 2023-2024: $555M - $540M = $15M decline. Total three-year decline: $45M. The LLM correctly identifies the overall downward trend but doesn't provide specific calculations.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects the numerical trend to strategic implications, though the interpretation diverges from ground truth in tone and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 565,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 carried a net carrying amount of roughly **$2 billion** at the end of fiscal 2022, and that figure remained **$2 billion** in fiscal 2023 and again in fiscal 2024.  Because the outstanding principal of this tranche was unchanged over the three years, the progression reflects a deliberately stable long‑term debt profile—NVIDIA has not retired or added to this series, indicating that the notes continue to serve as a fixed, low‑cost pillar of its capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims the carrying value was 'roughly $2 billion' across all three years (2022-2024), but the ground truth shows: FY2022: $2,147 million, FY2023: $1,604 million, FY2024: $2,000 million. The FY2023 figure of $1,604 million is substantially different from $2 billion (~$396 million discrepancy), representing a 20.8% decline from 2022. The LLM's characterization of 'remained $2 billion' is factually incorrect. (2) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to identify the key progression pattern: a significant decline from 2022 to 2023 (down $543 million), followed by a rebound in 2024 (up $396 million). This is not a 'stable' profile as claimed. (3) REASONING ERROR - The LLM's conclusion that 'the outstanding principal of this tranche was unchanged' contradicts the actual carrying value fluctuations. The ground truth correctly identifies this as a 'revaluation or strategic adjustment' rather than stability, possibly tied to refinancing or interest rate adjustments. (4) MISSING CONTEXT - The LLM completely misses the analytical insight that the 2023 dip and 2024 rebound indicate deliberate debt management strategy, not passive stability. The answer fundamentally mischaracterizes the debt positioning by claiming consistency where significant variation exists.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 390,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD’s disclosures shifted from a generic reference to “loss or modification of exemptions for taxes and tariffs” toward explicit warnings that sanctions, export‑control revisions and escalating geopolitical tensions (e.g., Ukraine, China‑Taiwan, Middle‑East conflicts) could strip or alter those exemptions. This evolution shows that AMD now operates in a far more intricate global regulatory landscape where overlapping political and trade developments increasingly jeopardize its tax and tariff advantages.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the temporal evolution (2022-2024) and the key thematic progression from generic risk disclosure to specific geopolitical concerns. The answer correctly identifies the shift in AMD's disclosures and accurately references the major geopolitical events (Ukraine, China-Taiwan, Middle East conflicts) and regulatory mechanisms (sanctions, export controls) mentioned in the ground truth. No quantitative errors are present - all dates and entities are correct. The multi-hop reasoning is sound, synthesizing information about how AMD's risk exposure evolved across three years and connecting this to broader regulatory complexity. The LLM answer is slightly more concise than the ground truth but captures all essential elements: (1) the 2022 baseline of generic tax/tariff exemption risks, (2) the 2023-2024 escalation to specific geopolitical threats, and (3) the conclusion about increasing regulatory complexity. Minor differences in wording (e.g., 'strip or alter' vs 'losing') are semantically equivalent. The answer appropriately emphasizes the causal link between geopolitical instability and regulatory risk, which aligns with the ground truth's narrative arc. One minor omission: the ground truth specifically mentions 'third-party manufacturing partners' as the mechanism through which China-Taiwan tensions affect AMD, while the LLM answer references this more implicitly. This is a minor contextual detail that doesn't affect the core correctness of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 427,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nBetween 2022 and 2024 BNY Mellon’s disclosures grew increasingly explicit that U.S. banking capital rules now directly constrain its ability to pay dividends and repurchase shares.  The 10‑Ks repeatedly state that capital returns are at the Board’s discretion and can be limited by “well‑capitalized” and “well‑managed” status, capital‑adequacy and liquidity requirements, and the need to fund full preferred‑stock dividends—so any downgrade or failure to meet regulatory standards would curb share‑repurchase flexibility.  This language shows a clear evolution toward tighter regulatory exposure on dividend and repurchase policy over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) DIRECTIONAL ERROR - The LLM claims an 'evolution toward tighter regulatory exposure' and 'increasingly explicit' constraints over 2022-2024, but the ground truth explicitly states the regulatory environment was 'stable' with 'persistent constraints' that remained 'consistently constrained' across all three years. This is a fundamental mischaracterization of the trend. (2) FACTUAL INACCURACY - The LLM asserts constraints 'now directly constrain' (implying recent change), contradicting the ground truth's emphasis on consistency and stability across the period. (3) INCOMPLETE SYNTHESIS - The LLM mentions 'well-capitalized' and 'well-managed' status, capital-adequacy, liquidity requirements, and preferred-stock dividends, but the ground truth also specifically mentions Delaware law, Title I and II resolution strategies, and credit rating impacts—the LLM omits these contextual details. (4) CORRECT ELEMENTS - The LLM correctly identifies that capital returns are discretionary, subject to regulatory constraints, and that downgrades would affect flexibility. It also correctly names the company (BNY Mellon) and covers the 2022-2024 period. (5) REASONING FLAW - The multi-hop synthesis fails because the LLM incorrectly interprets 'repeated emphasis' as 'evolution toward tighter constraints' when the ground truth indicates the constraints were already in place and remained stable. The LLM's narrative of increasing tightness contradicts the ground truth's narrative of consistency. QUANTITATIVE: No specific numbers to verify, but the temporal characterization is factually wrong. QUALITATIVE: The reasoning about regulatory evolution is fundamentally flawed despite correct identification of constraint types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 474,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nAbbott’s 2.950% Note due 2025 is consistently listed in the Exhibit tables of its 2022‑2024 Form 10‑Ks under Item 4.1, but the accompanying documentation has become progressively richer. In the 2022 filing the note appears only as a reference to the original 2015 8‑K (Exhibit 99.6), whereas the 2023 and 2024 filings add supplemental indentures and officer‑certificate exhibits (e.g., 4.26‑4.33) that record amendments and the latest actions of authorized officers, reflecting a more detailed, up‑to‑date disclosure of the instrument’s current terms.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) EXHIBIT REFERENCE ERROR: The ground truth states the note was referenced as 'Exhibit 99.6 in the 8-K filing dated March 5, 2015' consistently across 2022-2024. The LLM claims exhibits '4.26-4.33' appear in 2023-2024 filings, which is not supported by the ground truth and appears to be fabricated. (2) DOCUMENTATION EVOLUTION CLAIM: The ground truth explicitly states 'no change in the documentation or structure of the note over the three-year period' and that it 'remained a static financial instrument.' The LLM contradicts this by claiming 'accompanying documentation has become progressively richer' with 'supplemental indentures and officer-certificate exhibits' and 'amendments.' This is a fundamental misrepresentation of the actual disclosure pattern. (3) ITEM 4.1 REFERENCE: The LLM references 'Item 4.1' in Form 10-Ks, but the ground truth indicates the note appears in 8-K filings, not 10-K Item 4.1 exhibits. (4) CONSISTENCY VS. CHANGE: The ground truth emphasizes consistency and stability ('consistently disclosed,' 'no change,' 'static'), while the LLM emphasizes progressive enrichment and amendments, which is the opposite conclusion. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year pattern across 2022-2024, instead inventing a narrative of increasing documentation complexity that contradicts the ground truth's finding of stability. The answer demonstrates poor factual accuracy and appears to have hallucinated exhibit numbers and documentation changes not present in the actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 452,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 have held a $1.25 billion carrying amount in fiscal 2022, remained $1.25 billion in fiscal 2023 and were still $1.25 billion as of the end of fiscal 2024 (and into fiscal 2025), showing essentially no change in the balance. This flat trajectory indicates that NVIDIA is deliberately maintaining a stable, low‑cost senior debt tranche, using the 2028 notes as a steady long‑term financing pillar rather than expanding or reducing leverage.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the carrying value was $1.25 billion in fiscal 2022, but ground truth shows $1,200 million ($1.2 billion). The LLM claims the value remained flat at $1.25 billion through all three years, but ground truth shows: FY2022: $1,200M, FY2023: $1,099M, FY2024: $1,250M. The LLM incorrectly reports FY2023 as $1.25B when it was actually $1,099M - a $151M error. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to capture the actual progression pattern. Ground truth shows a decrease from FY2022 to FY2023 (down $101M), then an increase to FY2024 (up $151M). The LLM's claim of 'essentially no change' and 'flat trajectory' is factually wrong. (3) REASONING QUALITY: While the LLM's interpretation about NVIDIA maintaining stable, low-cost debt is reasonable in tone, it is built on false premises. The actual data shows active management and adjustment of this debt instrument, not a static holding. (4) ENTITY/METRIC ACCURACY: The note identification (1.55% Notes Due 2028) is correct, but all carrying values are wrong. The LLM appears to have confused or misread the actual balance sheet figures. (5) CONTEXTUAL RELEVANCE: The question asks about evolution/progression, which requires accurate tracking of changes over time. The LLM's answer completely misses the actual volatility and strategic adjustments evident in the ground truth data. This is a severe factual failure that would mislead investors or analysts relying on this information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 442,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nFrom 2022 through 2024 AMD tightened the inventory‑protection terms it offers AIB partners—contractually shielding their stock from price‑cut shocks and granting limited return/stock‑rotation rights—while expanding direct co‑marketing and design‑support programs for system‑integrators.  At the same time, AMD leveraged its discrete Radeon graphics and Instinct accelerator portfolio as a differentiator, letting AIBs and SI customers distinguish their platforms (e.g., through ray‑tracing, Infinity Cache and AI‑optimized features) and command premium, performance‑focused market positions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core inventory protection policy for AIBs across the 2022-2024 period, matching the ground truth's emphasis on shielding inventory from price reductions. (2) Correctly mentions the 12-month return window concept (implied in 'limited return/stock-rotation rights'). (3) Accurately identifies discrete graphics (Radeon) as a differentiation tool. (4) Properly synthesizes the multi-hop concept that AMD's strategy evolved to emphasize differentiation through discrete graphics solutions. (5) No quantitative errors present.\n\nWEAKNESSES: (1) The LLM introduces elements NOT in the ground truth: 'tightened' inventory-protection terms (ground truth shows consistency, not tightening), 'direct co-marketing and design-support programs' (not mentioned in original answer), and 'Instinct accelerator portfolio' (not part of the original answer's focus on discrete graphics for AIBs/SIs). (2) The phrase 'tightened the inventory-protection terms' contradicts the ground truth which emphasizes consistency of these policies across years. (3) Missing the specific 2023 emphasis on 'timely product introductions and market competitiveness' that the ground truth highlights as part of the evolution. (4) The answer adds specifics like 'ray-tracing, Infinity Cache and AI-optimized features' that, while plausible, are not grounded in the provided knowledge graph answer.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting inventory protection policies to market differentiation strategy, but introduces unsupported claims about policy tightening and co-marketing programs that deviate from the ground truth narrative.\n\nSEMANTIC EQUIVALENCE: While the core message about inventory protection and graphics differentiation is preserved, the LLM's characterization of policy evolution as 'tightening' rather than 'consistent' represents a material factual divergence from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 528,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 AMD’s exposure to intellectual‑property protection risks expanded in step with its growing international sales (65 %–66 % of revenue) and its increasing reliance on third‑party manufacturing in politically sensitive regions such as China, Malaysia and especially Taiwan.  The earlier filing listed “difficulties in protecting our intellectual property” only as a generic risk, but the 2023 and 2024 filings specifically warned that escalating China‑Taiwan tensions, U.S. export‑control sanctions and recent disruptions (e.g., the April 2024 Taiwan earthquake) could lead to IP loss, forced technology transfers, or interruptions of proprietary processes, making IP protection a far more material and urgent concern.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's evolving IP protection risks from 2022-2024 and correctly identifies the core narrative of increasing complexity tied to geopolitical tensions and international operations. STRENGTHS: (1) Correctly cites the 65%-66% international sales figures matching ground truth; (2) Accurately identifies the progression from generic IP risk disclosure in 2022 to specific geopolitical concerns in 2023-2024; (3) Properly identifies key geopolitical flashpoints (China-Taiwan tensions, U.S. export controls); (4) Correctly names sensitive manufacturing regions (China, Malaysia, Taiwan); (5) Appropriately characterizes the transformation of IP protection from a generic risk to a material, urgent concern. WEAKNESSES: (1) The LLM introduces a specific example (April 2024 Taiwan earthquake) that is not mentioned in the ground truth, which raises concerns about factual accuracy beyond the provided knowledge graph - this is a potential hallucination; (2) The ground truth mentions Ukraine and Middle East as geopolitical concerns, but the LLM focuses primarily on China-Taiwan tensions and U.S. export controls, omitting the Ukraine conflict context mentioned in 2023 disclosures; (3) The LLM doesn't explicitly mention the 2022 baseline or provide the comparative evolution as clearly as the ground truth (e.g., doesn't note that 2022 figure was 'unspecified but lower'); (4) The phrase 'forced technology transfers' is introduced without clear grounding in the provided knowledge graph. QUANTITATIVE VERIFICATION: The 65%-66% figures are correct and properly contextualized. The year-over-year progression (2022→2023→2024) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes the relationship between international sales growth, third-party manufacturing reliance, and IP protection risks, though it could have been more comprehensive in covering all geopolitical regions mentioned in ground truth. The reasoning is sound but somewhat narrower in scope than the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 550,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon repeatedly refreshed the incentive documents that operate under its 2019 Long‑Term Incentive Plan—introducing a new 2022 Performance‑Share‑Unit and Restricted‑Stock‑Unit agreement, updating both with 2023 versions, and then rolling out fresh 2024 Performance‑Share‑Unit and Restricted‑Stock‑Unit agreements (while also amending the executive severance plan in early 2024).  This yearly renewal of award forms shows a deliberate tightening of the equity‑based incentive structure, moving toward more performance‑linked, long‑term equity compensation and a clearer, governance‑focused severance framework.  Overall, the progression signals that the company’s executive‑pay strategy is increasingly anchored in sustained performance metrics and shareholder‑aligned, long‑horizon rewards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) ENTITY ERROR - The LLM answer refers to 'BNY Mellon' throughout, but the question asks about 'BK' (Bank of New York Mellon's ticker). While these refer to the same company, the inconsistency in naming is problematic. More critically, the ground truth specifically references 'BK' as the company identifier. (2) FACTUAL INACCURACIES - The LLM claims introduction of '2022 Performance-Share-Unit and Restricted-Stock-Unit agreement' in 2022, but the ground truth only mentions the '2021 Form of Performance Share Unit Agreement' in 2022. The LLM introduces RSU agreements that are not mentioned in the ground truth. (3) YEAR MISMATCH - The ground truth states that in 2023, BK introduced the '2020 Form of Performance Share Unit Agreement,' but the LLM claims 2023 versions were introduced. This is a factual error regarding which form year was introduced in which calendar year. (4) INCOMPLETE SYNTHESIS - The ground truth specifically tracks: 2022 (2021 PSU form), 2023 (2020 PSU form), 2024 (2022 PSU form). The LLM's timeline is confused and adds RSU agreements not mentioned in the ground truth. (5) REASONING QUALITY - While the LLM's interpretation about 'performance-linked, long-term equity compensation' aligns with the ground truth's conclusion about 'adaptive executive compensation strategy,' the specific factual foundation is incorrect. The LLM adds details about 'executive severance plan amendments' that are not in the ground truth. (6) QUANTITATIVE ACCURACY - No specific numbers are provided in either answer, but the year-to-year progression of form introductions is factually incorrect in the LLM response. The correct progression (2021→2020→2022 forms) is not accurately reflected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 471,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nAbbott’s capital invested in diagnostics‑instrument leasing expanded each year – the original cost of the leased assets rose from about **$3.3 bn (2020‑21)** to **$3.6 bn in 2023** and **$3.9 bn in 2024**, while the net‑book value grew from roughly **$1.4 bn to $1.6 bn to $1.8 bn** over the same period.  This upward trend shows that Abbott is deliberately increasing its outlay on diagnostic‑instrument leases to broaden its equipment‑leasing portfolio, lock in long‑term customers and generate recurring reagent sales, rather than focusing on outright purchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine the response. (1) YEAR CONFUSION: The LLM states '2020-21' for the starting year, which is incorrect - the ground truth clearly indicates 2022 as the baseline year. This is a fundamental error in entity identification. (2) NET BOOK VALUE ERROR: The LLM claims net book value grew to '$1.8 bn' in 2024, but the ground truth explicitly states it 'remained at $1.6 billion in 2024.' This is a direct factual error - the LLM fabricated a number that contradicts the source data. The correct progression is $1.4bn (2022) → $1.6bn (2023) → $1.6bn (2024), not $1.4bn → $1.6bn → $1.8bn. (3) ORIGINAL COST DATA: The original cost figures are correct ($3.3bn, $3.6bn, $3.9bn), which is positive. (4) QUALITATIVE REASONING: The LLM's interpretation of the strategic implications is reasonable and aligns with the ground truth - discussing equipment-leasing portfolio expansion, customer lock-in, and recurring reagent sales. However, the reasoning is undermined by the quantitative errors. (5) MULTI-HOP SYNTHESIS: The LLM attempted to synthesize the evolution across three years and connect it to business strategy, which is appropriate for the question, but the execution failed due to data inaccuracy. The claim about 'lock in long-term customers and generate recurring reagent sales' is semantically equivalent to the ground truth's discussion of 'performance obligations in these lease arrangements.' SUMMARY: While the qualitative analysis shows understanding of Abbott's strategy, the quantitative errors (wrong year reference, fabricated 2024 net book value) are severe enough to significantly reduce the answer's reliability and correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 474,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024, Lumentum Holdings is repeatedly named in NVIDIA’s “networking products” competitor list (e.g., switches, optical modules, DPUs), confirming its ongoing presence in the disclosed competitive set. However, NVIDIA’s accelerating focus on AI‑driven interconnect technologies—such as NVLink, NVSwitch and the Spectrum‑X family—has integrated networking functions into its own GPUs and DPUs, moving Lumentum from a direct rival toward a more peripheral supplier of optical and interconnect components. Consequently, while Lumentum remains on NVIDIA’s competitor roster, its strategic relevance to NVIDIA’s AI‑centric networking ecosystem has diminished relative to NVIDIA’s in‑house solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL CONTRADICTION: The LLM answer directly contradicts the ground truth on the core finding. Ground truth states Lumentum's 'rising prominence as a competitor' and 'sharpened recognition of its corporate identity and competitive relevance,' while LLM claims its 'strategic relevance...has diminished relative to NVIDIA's in-house solutions.' This is a fundamental misinterpretation of the evidence. (2) UNSUPPORTED INFERENCE: The LLM introduces analysis about NVIDIA's NVLink, NVSwitch, and Spectrum-X family moving Lumentum toward 'more peripheral supplier' status. This interpretation is NOT supported by the ground truth, which documents Lumentum's repositioning to 'more specialized segment' and 'sharpened recognition' across the three fiscal years. The LLM appears to have made an independent judgment about competitive dynamics rather than synthesizing the disclosed information. (3) PARTIAL ACCURACY: The LLM correctly identifies that Lumentum appears in NVIDIA's competitor lists across all three fiscal years (2022, 2023, 2024) and correctly notes the networking/interconnect domain. However, this correct identification is undermined by the incorrect conclusion about diminishing relevance. (4) MULTI-HOP REASONING FAILURE: The question asks how positioning 'evolved' - the ground truth shows evolution toward greater specificity and prominence. The LLM's conclusion that relevance diminished represents failed synthesis of the actual filing data progression. (5) QUANTITATIVE ELEMENTS: No specific numbers or dates are disputed, but the qualitative interpretation of the competitive positioning trajectory is inverted from ground truth. The LLM's answer would mislead readers about Lumentum's actual competitive standing in NVIDIA's disclosed ecosystem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 486,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson moved pipe‑cutters out of the broader **Safety & Productivity** line and began reporting them as a dedicated offering within the **Tools & Home Products** segment (the Tools & Home Products business sits inside the Commercial & Residential Solutions group).  This repositioning signals a focused professional‑tool strategy: Emerson is isolating high‑margin, specialist tooling for plumbing‑ and mechanical‑industry customers and leveraging its distributor network to grow that business.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth on multiple critical dimensions: (1) DIRECTIONAL ERROR - The LLM states pipe cutters moved FROM Safety & Productivity TO Tools & Home Products, when the ground truth explicitly states the opposite: they moved FROM Tools & Home Products (2022) TO Safety & Productivity (2023-2024). This is a complete reversal of the actual repositioning. (2) SEGMENT MISIDENTIFICATION - The LLM incorrectly identifies Tools & Home Products as the 2023-2024 location, when ground truth clearly shows Safety & Productivity as the 2023-2024 segment. (3) MISSING CRITICAL CONTEXT - The LLM fails to mention the InSinkErator divestiture in late 2022, which is a key strategic indicator in the ground truth explaining the shift away from consumer-focused products. (4) INCOMPLETE SYNTHESIS - The LLM does not capture the strategic repositioning toward infrastructure and industrial-grade tools (battery hydraulic tools, drain cleaners, sewer inspection cameras) that accompanied the pipe cutter repositioning. (5) MISCHARACTERIZATION OF STRATEGY - While the LLM mentions 'focused professional-tool strategy,' it frames this as isolating tools within Tools & Home Products, when the actual strategy involved consolidating professional tools within Safety & Productivity. The LLM's interpretation of the business logic (distributor network growth) is reasonable but is built on an inverted factual foundation. The answer demonstrates a fundamental failure to correctly synthesize the multi-hop information about segment repositioning across the 2022-2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 444,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab transformed its RIA‑focused interactive tools by expanding the free “Schwab Advisor Portfolio Connect” from a simple, web‑based portfolio‑management view into a fully integrated platform that now incorporates the thinkpipes trading engine and the iRebal portfolio‑rebalancing module, and that links directly to third‑party CRM, portfolio‑management and financial‑planning systems.  The website‑based service also grew its advisor‑support capabilities—adding multi‑year archiving, advanced document‑search, integrated educational content, benchmarking studies and dedicated business‑growth consulting—while keeping the intuitive, modern user experience and free access for advisors.  These enhancements gave RIAs tighter integration with Schwab’s trading and rebalancing tools and richer, more comprehensive support resources.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) The LLM claims Schwab Advisor Portfolio Connect was expanded to incorporate 'thinkpipes trading engine' and 'iRebal portfolio-rebalancing module' - these specific product integrations are not mentioned in the ground truth and appear to be fabricated or confused with other products. (2) The LLM states these tools were 'free' and kept 'free access' - while the ground truth mentions 'free Schwab Advisor Portfolio Connect tool,' it does not emphasize free access as a key evolution point across the 2022-2024 period. (3) The LLM mentions 'advanced document-search' and 'benchmarking studies' as specific enhancements - the ground truth only mentions 'multi-year document archiving' and does not reference benchmarking studies as part of the evolution. (4) The LLM's characterization of the evolution is narrower than ground truth - it focuses heavily on product integrations (thinkpipes, iRebal) rather than the broader ecosystem evolution including compliance workflows, outbound data feeds, and prospect consulting that the ground truth emphasizes. (5) The multi-hop synthesis is incomplete - the LLM fails to properly trace the 2022→2023→2024 progression that the ground truth clearly outlines, instead presenting a more generic transformation narrative. (6) The LLM introduces specific technical product names (thinkpipes, iRebal) that cannot be verified against the ground truth and may represent hallucinations. The answer does correctly identify Schwab Advisor Portfolio Connect and the general theme of enhanced functionality and integration, but the specific details and evolution narrative are substantially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 479,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nOracle first issued the 1.650 % Notes due 2026 in a March 24 2021 8‑K (see ORCL 10‑K 2022 Exhibit 4.14 on page 112) and continued to list the same tranche unchanged in the subsequent 10‑K filings—​the 2023 filing (pages 108‑112) and the 2024 filing (pages 109‑113) both repeat the original indenture terms and carry the notes at amortized cost with no redemption, amendment or re‑measurement disclosed. This consistent treatment shows that Oracle’s short‑to‑intermediate‑term debt strategy relies on issuing long‑dated, fixed‑rate senior notes and holding them to maturity rather than frequently refinancing or altering those obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the notes appear in '2022 Exhibit 4.14 on page 112' but the ground truth indicates they first appeared in '2022 Exhibit 4.16'. This is a factual error in exhibit identification. (2) ISSUANCE DATE ERROR: The LLM claims the notes were 'first issued in a March 24 2021 8-K' but the ground truth indicates they were 'first introduced in the 2022 10-K filing.' The LLM appears to have conflated the actual issuance date with the filing date where they were first disclosed in the 10-K series being analyzed. This is a significant chronological error. (3) EXHIBIT CONSISTENCY: The ground truth specifies Exhibit 4.14 for both 2023 and 2024, but the LLM does not verify this consistency claim with specific exhibit numbers for those years. (4) CORRECT ELEMENTS: The LLM correctly identifies that the notes remained unchanged across the three-year period (2022-2024), correctly notes they are fixed-rate senior notes, and correctly infers the hold-to-maturity strategy. The semantic understanding of Oracle's debt strategy is sound. (5) MULTI-HOP REASONING: The LLM demonstrates understanding of the multi-hop synthesis required (tracking a single debt instrument across three years), but the factual errors undermine the credibility of the analysis. The conclusion about Oracle's financing strategy is reasonable but built on partially incorrect foundational facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 397,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the Electrical Distribution Equipment business remained a core pillar of Emerson’s Discrete Automation segment—segment sales held near $2.6 billion ( $2.612 bn in 2022, $2.635 bn in 2023, $2.506 bn in 2024 )—while the company sustained steady capital spending on the offering and continued to spotlight it in its product‑portfolio narrative.  This consistent emphasis shows that Emerson is deliberately positioning electrified automation—particularly its electrical‑distribution equipment—as a growth engine for industrial electrification, aligning its strategy with the broader market shift toward energy‑efficient, electrified manufacturing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the question and provides incorrect information. CRITICAL ISSUES: (1) The original answer explicitly states that Electrical Distribution Equipment was grouped under 'Industrial Solutions' in 2022, NOT the Discrete Automation segment. The LLM claims it was 'a core pillar of Emerson's Discrete Automation segment' throughout 2022-2024, which directly contradicts the ground truth. (2) The LLM provides segment sales figures ($2.612bn in 2022, $2.635bn in 2023, $2.506bn in 2024) for the Discrete Automation segment overall, but these numbers are not verified against the ground truth and appear to be generic segment-level data rather than specific to Electrical Distribution Equipment positioning. (3) The original answer emphasizes a STRATEGIC EVOLUTION - the key insight is that Electrical Distribution Equipment moved FROM Industrial Solutions (2022) TO Discrete Automation (2023-2024), signaling an integrated approach to automation. The LLM completely misses this evolution narrative. (4) The LLM's answer focuses on sales figures and capital spending rather than addressing the actual positioning shift across segments, which is what the question asks about. (5) The LLM does not address the 2022-to-2023 transition or explain why this repositioning matters strategically. The answer reads as generic commentary about electrification strategy rather than a specific analysis of how Electrical Distribution Equipment's segment classification changed. The LLM fails to synthesize the multi-hop information about segment classification changes across three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 442,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate funds fell from roughly $585 million in 2022 to $555 million in 2023 and $540 million in 2024. This steady reduction indicates a strategic pull‑back from illiquid alternative‑asset exposure, reflecting a shift toward more liquid or higher‑return investments within its pension fund strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All three financial figures are correct: $585M (2022), $555M (2023), $540M (2024). (2) Number formatting is acceptable and consistent. (3) The identification of the trend (steady reduction) is accurate. (4) The basic interpretation of de-risking/strategic pullback is sound. WEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM answer completely fails to address the long-term liquidation timeline (projected through 2034 by 2024), which is a critical component of the ground truth answer and directly relevant to understanding the pension fund strategy. (2) INCOMPLETE REASONING: The ground truth emphasizes that despite the decline, the company 'maintained a long time horizon for fund liquidation,' indicating 'continued belief in the long-term value of these assets, albeit with reduced exposure.' The LLM answer misses this nuance entirely. (3) VAGUE CHARACTERIZATION: The LLM states the shift is toward 'more liquid or higher-return investments,' but the ground truth more carefully characterizes it as 'more liquid or stable investments.' The 'higher-return' characterization is not supported by the ground truth and introduces unsupported speculation. (4) MISSING STRATEGIC CONTEXT: The ground truth provides important context about 'managing liquidity risk and aligning fund commitments with pension liability profiles,' which the LLM answer omits. The LLM answer addresses only about 50% of the substantive analysis provided in the ground truth. While the quantitative data is accurate, the qualitative analysis and strategic interpretation are significantly incomplete, failing to capture the full picture of Abbott's pension fund strategy regarding illiquid alternative assets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 463,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle repeatedly includes the same “Forms of 1.650% Notes due 2026…” exhibit (Exhibit 4.14) with identical terms and the March 24 2021 issuance date, showing that the notes remained outstanding and unchanged. This consistent treatment reveals that Oracle’s short‑term debt strategy hinges on retaining these low‑coupon, medium‑term notes as a stable funding source rather than retiring or refinancing them.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: correctly identifies the 1.650% Notes due 2026, accurately references the March 24, 2021 issuance date, and properly notes the consistent treatment across 2022, 2023, and 2024 filings. The quantitative data (interest rate, maturity year, dates) are all correct with no calculation errors. The answer correctly identifies Exhibit 4.14 as the consistent exhibit reference. However, there are some notable gaps in completeness compared to the ground truth: (1) The LLM answer does not explicitly mention that Oracle 'first disclosed' these notes in the 2022 10-K or reference the original 8-K filing as the source document for the terms, which is a key detail in understanding the disclosure chain. (2) The ground truth emphasizes that Oracle 'continued to reference the same 8-K filing' across all three years, whereas the LLM focuses on the exhibit consistency rather than the underlying 8-K reference pattern. (3) The LLM answer lacks the contextual insight that Oracle 'introduced new debt instruments with different rates and maturities in subsequent years' while maintaining these notes unchanged—this comparative analysis strengthens the strategic interpretation. The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and draws a logical conclusion about debt strategy (maintaining stable funding). The characterization of the notes as 'low-coupon, medium-term' is accurate and adds useful context. The answer is semantically equivalent to the ground truth in its core conclusion about deliberate strategy, though it uses slightly different framing ('retaining' vs. 'maintaining stable obligations'). The minor omissions prevent a higher score, but the answer captures the essential facts and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 494,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nOracle first created the 4.30 % senior unsecured note due 2034 in a July 8 2014 debt issuance (Exhibit 4.11 of the 2014 filing) and then repeatedly disclosed the same instrument in the “Forms of … Notes” exhibits of its 2022, 2023 and 2024 Form 10‑K filings (pages 111‑115), merely updating the filing date and officers’ certificate while preserving the original terms.  \nThis multi‑year filing pattern shows that Oracle treats long‑dated, fixed‑rate notes as a core pillar of its capital structure, regularly re‑filing the same tranche to keep it on the shelf‑registration record and to signal a strategy of diversified, staggered‑maturity debt with a stable, low‑to‑mid‑single‑digit coupon profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON KEY DATES: The LLM claims the 4.30% Note was 'first created' in a 'July 8 2014 debt issuance' - this specific date and year are not supported by the ground truth, which makes no mention of 2014 or July 8. The ground truth only references the note's presence in 2022, 2023, and 2024 filings. The LLM introduced unsourced historical information. (2) EXHIBIT REFERENCE DISCREPANCY: The LLM states the note appears in 'Exhibit 4.11 of the 2014 filing' and then in 'Forms of Notes exhibits of 2022, 2023, 2024 Form 10-K filings (pages 111-115).' The ground truth specifies Exhibit 4.11 for 2022 and Exhibit 4.09 for 2023 and 2024 - the LLM conflates these exhibit numbers and adds page references not in the ground truth. (3) UNSUPPORTED SHELF-REGISTRATION CLAIM: The LLM asserts Oracle 're-files the same tranche to keep it on the shelf-registration record' - this specific mechanism is not mentioned in the ground truth and appears to be an inference not supported by the source material. (4) OVER-INTERPRETATION: While the ground truth notes 'consistent documentation' and 'sustained presence,' the LLM extrapolates this into claims about 'shelf-registration' and 'staggered-maturity debt strategy' that go beyond what the ground truth supports. (5) CORRECT ELEMENTS: The LLM correctly identifies the 4.30% coupon rate, the 2034 maturity date, and that the note appears across 2022-2024 filings. The general characterization of it as a 'core pillar' of capital structure aligns with ground truth's 'stable component' language. MULTI-HOP REASONING: The LLM attempts to synthesize across years but does so by introducing unsourced 2014 information and making inferences about shelf-registration that aren't grounded in the provided knowledge graph. The core multi-hop task (tracking evolution across 2022-2024) is partially addressed but contaminated with incorrect historical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 520,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab moved roughly $10 bn of IDA balances onto its balance sheet in 2021‑22 under the original 2020 IDA agreement, which permitted up to $10 bn of migrations each 12 months but required Schwab to maintain a $50 bn minimum IDA balance through 2031 and to keep at least 80 % of those balances designated as fixed‑rate through 2026. The May 2023 replacement agreement tightened the rules—migration could now occur only for floating‑rate portions, required Schwab to keep total IDA balances between a $60 bn floor and a $90 bn ceiling after Sep 10 2025 (with a $30 bn buffer above the unmatured fixed‑rate amount), and eliminated the 80 % fixed‑rate requirement—so Schwab’s ability to transfer balances was markedly reduced. As a result, in 2024 Schwab ceased any migrations, relying instead on buy‑downs of fixed‑rate obligations and on maintaining the required balance floors, reflecting a loss of contractual flexibility and tighter constraints.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that undermine its credibility:\n\n1. AGREEMENT DATING ERROR: The LLM states the original agreement was the '2020 IDA agreement,' but the ground truth clearly identifies it as the '2019 IDA agreement.' This is a fundamental entity identification error.\n\n2. QUANTITATIVE INACCURACIES:\n   - The LLM claims a '$50 bn minimum IDA balance through 2031' requirement, which is not mentioned in the ground truth.\n   - The LLM introduces specific balance thresholds ('$60 bn floor and $90 bn ceiling after Sep 10 2025' with '$30 bn buffer') that are not present in the ground truth answer.\n   - These invented numbers suggest the LLM fabricated details rather than synthesizing from actual filing data.\n\n3. CONTRACTUAL FLEXIBILITY CONTRADICTION: The LLM concludes that the 2023 agreement 'tightened the rules' and resulted in 'a loss of contractual flexibility and tighter constraints,' which directly contradicts the ground truth statement that the 2023 agreement 'eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations' (increased flexibility) while Schwab still 'did not migrate any IDA balances' (passive approach despite flexibility).\n\n4. INCOMPLETE SYNTHESIS: While the LLM correctly identifies that migrations occurred in 2021-22 (~$10 billion) and ceased in 2023-2024, it mischaracterizes the nature of the contractual changes. The ground truth shows increased flexibility (removal of 80% fixed-rate requirement) paired with non-utilization, whereas the LLM incorrectly frames this as tightened constraints.\n\n5. PARTIAL CORRECTNESS: The LLM does correctly identify:\n   - The approximate $10 billion migration amount\n   - The 2023 agreement replacement\n   - The elimination of the 80% fixed-rate requirement\n   - The cessation of migrations in 2024\n\nHowever, the invented financial thresholds, incorrect agreement dating, and fundamental mischaracterization of contractual flexibility changes represent serious factual errors that would mislead a reader about Schwab's actual IDA agreement terms and constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 568,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s 10‑K filings contain only the original Exhibit 4.18 — the 2017 “Actions of the Authorized Officers with respect to Abbott’s 2.000% Notes due 2018” — and no new supplemental indentures, amendments, or refinancing transactions for those notes are disclosed. This shows the 2.000% Senior Notes due 2018 had been retired before 2022, and the company’s engagement with them during the three‑year period was limited to periodic re‑filing of the existing documentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) MAJOR ERROR - The LLM claims the notes 'had been retired before 2022' with no new supplemental indentures or amendments disclosed, but the ground truth explicitly states the notes were referenced in 2022 (Fifth Supplemental Indenture dated September 23, 2015), 2023 (Exhibit 4.21), and 2024 (Exhibit 4.21). The notes were NOT retired before 2022. (2) EXHIBIT MISMATCH - The LLM references 'Exhibit 4.18' from 2017, but the ground truth specifically mentions Exhibit 4.21 for 2023 and 2024 documentation. This is a factual error in exhibit identification. (3) DOCUMENTATION CONTINUITY MISCHARACTERIZED - The ground truth shows consistent inclusion across three years with documentation updates (different exhibits referenced), indicating ongoing engagement and disclosure practices. The LLM incorrectly characterizes this as merely 'periodic re-filing of existing documentation' with no new activity. (4) MATURITY ASSESSMENT - The ground truth notes the securities were 'likely nearing maturity without further refinancing actions,' which is consistent with their 2018 due date. The LLM's claim that they were retired before 2022 contradicts this timeline and the ground truth's statement that they were still included in 2024 exhibits. (5) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to properly synthesize the three-year evolution showing documentation continuity across 2022, 2023, and 2024. The answer fundamentally misrepresents Abbott's engagement with these notes across the period. The only partially correct element is that no new refinancing actions were taken, but this is overshadowed by the incorrect retirement claim and mischaracterization of documentation practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 488,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nOracle first brought the 3.650 % Notes due 2041 to market in a 2021 offering (see the 2021 Exhibit 4.16 in the 2022 10‑K, page 112) and then re‑opened and expanded the series in the 2022, 2023 and 2024 filings (Exhibits 4.16, 4.14 and the related 2024 exhibits), keeping the same coupon and 2041 maturity while adding to the outstanding amount.  This multi‑year pattern shows that Oracle is deliberately extending the average maturity of its unsecured debt and building a diversified ladder of long‑dated notes to lock in low‑cost financing for the 2040s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the introduction date of the 3.650% Notes due 2041. The ground truth states Oracle 'first introduced' these notes in 2022, but the LLM claims they were first brought to market in a '2021 offering.' This is a direct contradiction of the ground truth and represents a significant quantitative/dating error. The LLM also provides specific exhibit references (2021 Exhibit 4.16 in the 2022 10-K, page 112) that cannot be verified against the ground truth and appear to be fabricated details. While the LLM correctly identifies the coupon rate (3.650%) and maturity year (2041), and correctly notes that the notes were referenced across multiple years (2022, 2023, 2024), the foundational claim about 2021 introduction undermines the entire answer's credibility. The LLM's interpretation about 'reopening and expanding' the series differs from the ground truth's simpler narrative of 'introduction and continuation.' The reasoning about Oracle's debt strategy (extending average maturity, building a diversified ladder, locking in low-cost financing) is plausible but goes beyond what the ground truth supports and may represent unsupported inference. The multi-hop synthesis across years is attempted but compromised by the incorrect starting date. The answer demonstrates some understanding of Oracle's debt management but fails on core factual accuracy regarding when these notes were first issued.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 407,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nOracle first issued the 2.300% senior unsecured notes maturing in 2028 in March 2021 (Officer’s Certificate dated 3/24/21). The same series is listed under Exhibit 4.16 in the 2022, 2023 and 2024 Form 10‑K filings, showing that the company has repeatedly re‑opened the tranche to add new issuances while preserving the 2.300% coupon and 2028 maturity. This multi‑year pattern demonstrates Oracle’s deliberate strategy of building a diversified, low‑cost ladder of long‑dated debt to fund operations and acquisitions while maintaining a stable, predictable financing source.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2.300% coupon rate is accurate, (2) The 2028 maturity date is correct, (3) The March 24, 2021 Officer's Certificate date is accurate, (4) The presence in Exhibit 4.16 across 2022, 2023, and 2024 is correct, (5) The characterization of the notes as senior unsecured is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM claims Oracle 'repeatedly re-opened the tranche to add new issuances' - this is an inference not explicitly supported by the ground truth, which only states the notes were 'introduced' in 2022 and 'maintained' in 2024 without confirming multiple issuances within the same series, (2) The answer omits the key contextual detail from the ground truth about 2023 showing diversification through the 4.500% Notes due 2028, which is important for understanding the multi-year pattern, (3) The statement about 'building a diversified, low-cost ladder' goes beyond what the ground truth explicitly states - the ground truth emphasizes 'diversification of interest rate profiles' but the LLM's characterization of the strategy is more speculative. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the pattern of consistency in the 2.300% Notes. However, it fails to fully capture the diversification strategy that emerged in 2023 with the 4.500% Notes, which is central to understanding the complete three-year pattern. The ground truth explicitly notes this as evidence of 'diversification of interest rate profiles,' but the LLM focuses primarily on the reopening of a single tranche rather than the broader portfolio evolution. SEMANTIC ISSUES: While the LLM's interpretation about 'reopening' the tranche is plausible, it represents an inference beyond the ground truth's more conservative statement that the notes were simply 'maintained' with consistent referencing across years. The ground truth does not explicitly confirm multiple issuances within the same series.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 548,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom 2022 through 2024 Visa layered its Currencycloud‑powered virtual‑account service into the Visa Direct network, using the platform to offer real‑time foreign‑exchange rates, liquidity and settlement for both consumer and corporate payouts; by fiscal 2024 these virtual accounts were fully integrated into Visa Direct and its B2B Connect sub‑network, giving partners access to nearly 7 billion cards, accounts and digital wallets across more than 190 countries and enabling faster, cross‑border money‑movement for B2C, P2P and G2C flows. This evolution turned virtual accounts into a core conduit for Visa’s cross‑border capabilities, expanding the reach of Visa Direct from a domestic real‑time payouts hub to a global, interoperable money‑movement engine.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states 'nearly 7 billion cards, accounts and digital wallets' but the ground truth specifies 'more than 11 billion endpoints.' This is a significant factual error (7B vs 11B+), representing a ~36% undercount. (2) ENTITY CONFUSION - The LLM introduces 'B2B Connect sub-network' which is not mentioned in the ground truth. While the answer discusses Visa Direct integration, it conflates or adds details not supported by the original answer. (3) TIMELINE ACCURACY - The LLM correctly identifies the 2022-2024 evolution and mentions 2023 integration, which aligns with ground truth stating 'by 2023, virtual accounts were fully integrated.' However, the LLM says 'by fiscal 2024 these virtual accounts were fully integrated' which suggests integration happened in 2024, contradicting the ground truth's 2023 timeline. (4) MULTI-HOP SYNTHESIS - The LLM does attempt to synthesize the evolution across years and platforms, discussing Currencycloud, Visa Direct, and cross-border capabilities. However, the synthesis includes unsupported details (B2B Connect, 7 billion endpoints) and misses the specific mention of 'Treasury as a Service' initiative from 2022. (5) COMPLETENESS - The answer addresses integration into Visa Direct and cross-border expansion, but introduces geographic scope ('190 countries') not in the ground truth and omits the Treasury as a Service context. (6) SEMANTIC ISSUES - While the general narrative of evolution is present, the specific quantitative claims are materially incorrect, which is critical for financial/operational metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 444,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nFrom 2022 to 2023 the ME&T dealer network that supports EMD‑branded products grew from **41 U.S. and 111 international dealers covering 187 countries** to **44 U.S. and 116 international dealers covering 193 countries** – a modest but consistent increase in both U.S. and overseas dealer count and in the number of countries served.  The 2024 filing continues this upward trajectory, underscoring Caterpillar’s strategy of **expanding its geographic footprint and dealer presence to deepen market penetration of EMD products in emerging regions and to sustain growth in the global locomotive and engine market**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every quantitative metric. Ground truth states: 2022 (110 distributors, 109 countries), 2023 (110 distributors, 109 countries), 2024 (108 distributors, 158 countries). LLM claims: 2022-2023 (41 U.S. + 111 international = 152 dealers covering 187 countries) to (44 U.S. + 116 international = 160 dealers covering 193 countries). These numbers are completely different from the ground truth figures. The LLM appears to have confused or fabricated dealer network data that does not match the documented EMD distributor information. The ground truth specifically references FG Wilson branded electric power generation systems sold through distributors, while the LLM discusses a 'ME&T dealer network' with U.S./international dealer breakdowns that are not supported by the source material. The LLM's narrative about 'modest but consistent increase' and 'upward trajectory' contradicts the ground truth's finding of relatively stable distributor counts (110→110→108) with geographic expansion (109→109→158 countries). The reasoning about market expansion strategy is plausible in tone but is built on entirely incorrect numerical foundations. Multi-hop synthesis failed: the LLM did not correctly identify or synthesize the actual EMD distribution metrics from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 377,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024, the original cost of Abbott’s diagnostics instruments leased to customers rose from $3.6 billion to $3.9 billion, while the net book value increased from $1.6 billion to $1.8 billion, after which both amounts stayed flat through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that substantially misrepresent Abbott's investment evolution. (1) QUANTITATIVE ERRORS: The LLM omits the 2022 baseline figures entirely, starting instead with 2023 data ($3.6B original cost, $1.6B net book value). This is a critical omission since the question explicitly asks about evolution 'from 2022 to 2024.' The correct 2022 figures are $3.3B (original cost) and $1.4B (net book value). The LLM correctly states the 2024 figures ($3.9B and $1.8B) but misses the intermediate 2023 data ($3.6B and $1.6B). (2) INCOMPLETE SYNTHESIS: The answer fails to synthesize the complete three-year progression. By omitting 2022 and 2023 intermediate values, it doesn't properly show the 'consistent increase' pattern that characterizes the actual evolution. The statement 'after which both amounts stayed flat through 2024' is misleading and incorrect—the values continued to increase from 2023 to 2024, not remain flat. (3) MULTI-HOP REASONING: The answer demonstrates poor multi-hop reasoning by not connecting all three years of data as required. The question asks about evolution across the full period, requiring synthesis of 2022→2023→2024 progression. The LLM only captures 2023→2024 movement. (4) MISSING CONTEXT: The answer fails to convey the consistent upward trend across all three years, which is a key insight from the ground truth. The incorrect 'stayed flat' statement contradicts the actual data showing $1.6B→$1.8B growth from 2023 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 414,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe 3.450 % Senior Note due 2046 appears in the exhibit sections of PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings, showing that the company continues to reference and rely on this long‑dated, fixed‑rate debt year after year. Its repeated disclosure signals that the 2046 note is a core, permanent element of PepsiCo’s capital‑structure strategy—providing stable, low‑cost financing for long‑term investments and helping the company maintain a diversified maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core insight about the 3.450% Senior Note due 2046 being a stable, long-term component of PepsiCo's capital structure strategy. However, there are significant issues with quantitative accuracy and completeness:\n\n(1) QUANTITATIVE ACCURACY ISSUES:\n- The LLM answer does NOT specify the exhibit numbers where the note appears (Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024). The ground truth explicitly identifies these exhibit locations, which is important documentary evidence of the consistent disclosure.\n- The LLM vaguely references \"exhibit sections\" without providing the specific exhibit numbers, which weakens the factual precision of the answer.\n- The percentage (3.450%) and maturity date (2046) are correctly stated.\n\n(2) COMPLETENESS:\n- The LLM answer addresses the main question about the note's role in capital structure strategy.\n- However, it omits the specific exhibit number progression, which is a key factual detail that demonstrates the consistency claim.\n- The ground truth emphasizes \"without any indication of modification or removal,\" which the LLM answer does not explicitly state, though it implies this through \"permanent element.\"\n\n(3) ENTITY ACCURACY:\n- Company name (PepsiCo) is correct.\n- Years (2022, 2023, 2024) are correct.\n- Note details (3.450%, due 2046) are correct.\n- All entities are properly identified.\n\n(4) REASONING AND SYNTHESIS:\n- The LLM correctly synthesizes that repeated disclosure across three years indicates strategic importance.\n- The reasoning about fixed-rate, long-dated funding is sound and matches the ground truth.\n- The LLM adds the concept of \"diversified maturity profile,\" which is a reasonable inference but not explicitly stated in the ground truth.\n- The multi-hop synthesis (connecting disclosure consistency to capital structure strategy) is logically sound.\n\n(5) SEMANTIC EQUIVALENCE:\n- \"Core, permanent element\" is semantically equivalent to \"stable and integral component.\"\n- \"Low-cost financing\" aligns with \"favorable terms.\"\n- \"Long-term investments\" aligns with the ground truth's emphasis on long-dated funding.\n- Overall semantic meaning is preserved, though with less specificity.\n\nThe primary weakness is the omission of specific exhibit numbers, which are factual details that support the claim of consistent disclosure. This is a material omission for a question specifically about documentary evidence of consistency across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 667,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nOracle first set out the 2.300 % Notes due 2028 in a March 2021 debt offering (referenced in the “Forms of 2.300 % Notes due 2028” exhibit) and then carried that same description verbatim in the 2022, 2023 and 2024 Form 10‑K filings—each time citing the March 24 2021 Officers’ Certificate and providing no indication of retirement or material amendment. This repeated, unchanged disclosure shows that Oracle is using a stable, long‑dated fixed‑rate debt tranche as a core pillar of its financing, issuing senior notes on a repeatable indenture/offer‑certificate basis and maintaining a diversified, staggered maturity profile rather than retiring or restructuring the 2028 notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM introduces a March 2021 debt offering date that is NOT supported by the ground truth. The ground truth explicitly states Oracle 'first introduced the 2.300% Notes due 2028 in 2022' (Exhibit 4.16), not March 2021. This is a fundamental factual error about when the notes were issued. (2) EXHIBIT REFERENCES - The LLM cites 'Forms of 2.300% Notes due 2028' exhibit without verification against ground truth. The ground truth specifically references Exhibit 4.16 (2022), Exhibit 4.14 (2023), and Exhibit 4.14 (2024). The LLM's exhibit citations are unverified and potentially incorrect. (3) MULTI-HOP SYNTHESIS - The ground truth provides a clear three-year progression showing how Oracle referenced these notes across fiscal years 2022, 2023, and 2024, with specific exhibit numbers for each year. The LLM fails to provide this year-by-year breakdown with proper exhibit citations. (4) MISSING CONTEXT - The ground truth mentions Oracle layered in newer issuances like the 4.500% Notes due 2028 in 2023 and 2024, suggesting strategic responses to market conditions. The LLM mentions a 'repeatable indenture/offer-certificate basis' but doesn't address the introduction of higher-yielding notes alongside the 2.300% notes, missing a key insight about Oracle's financing strategy evolution. (5) SEMANTIC ISSUES - While the LLM's conclusion about maintaining a 'stable, long-dated fixed-rate debt tranche' aligns conceptually with the ground truth's 'consistent approach,' the factual foundation is compromised by the incorrect March 2021 date. The LLM's answer reads as plausible but is built on an unsubstantiated claim about the issuance date that contradicts the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 471,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Visa repeatedly references the identical **Certificate of Designations for Series B Convertible Participating Preferred Stock (Exhibit 4.4)** and does not report any amendment, retirement or material change to its terms.  This consistent treatment shows that Visa regards the Series B Preferred as a permanent, strategic capital layer—providing a stable, low‑cost source of financing and preserving conversion flexibility—underscoring a long‑term priority of maintaining a balanced, enduring capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core finding: Visa's Series B Convertible Participating Preferred Stock remained unchanged across 2022-2024 filings, with consistent reference to the June 21, 2016 Certificate of Designations. The answer accurately captures the key numeric/date elements (2022, 2023, 2024 filings; June 21, 2016 certificate date; Exhibit 4.4 reference). The multi-hop synthesis is sound—the model correctly synthesized information across three annual filings to identify the pattern of consistency. The reasoning about what this consistency suggests (stable capital structure, strategic capital layer, preservation of shareholder rights and financing flexibility) aligns well with the ground truth interpretation. Minor differences from the original answer: (1) The LLM characterizes the Series B as 'permanent, strategic capital layer' and 'low-cost source of financing,' which are reasonable inferences but not explicitly stated in the ground truth. (2) The LLM omits the specific reference to 'unchanged Bylaws (2022 filing)' and 'the 2024 update to its Certificate of Incorporation without changes to the Series B structure' that the ground truth mentions as supporting evidence. (3) The LLM's phrasing 'does not report any amendment, retirement or material change' is slightly more definitive than the ground truth's 'lack of modification,' though both convey the same meaning. Overall, the answer is semantically equivalent to the ground truth with accurate synthesis of multi-hop information across the three-year period, though it omits some supporting contextual details about related corporate documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 458,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar’s hedging program shifted from a LIBOR‑centric framework to SOFR‑linked instruments beginning in 2022, when it first disclosed the impending LIBOR discontinuation and the need to replace LIBOR‑based variable‑rate loans with SOFR benchmarks. By 2023 the company had instituted a cross‑functional team to manage interest‑rate and currency risk through selective derivatives and a diversified funding mix, explicitly noting that ineffective hedges or basis‑risk between SOFR and legacy indices could impair earnings and cash flow. In 2024 the disclosures emphasized continued refinement of those SOFR‑based hedges, heightened monitoring of market volatility and credit‑rating exposure, and the acknowledgment that while hedging mitigates adverse currency and rate movements, it also forfeits the upside of favorable rate swings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year period (2022-2024) and accurately captures key elements: (1) the transition from LIBOR to SOFR, (2) the formation of a cross-functional team, (3) the use of selective derivatives and diversified funding, (4) the acknowledgment of basis risk and hedging trade-offs. The answer demonstrates understanding of the multi-hop synthesis required across three years of disclosures. WEAKNESSES AND ERRORS: (1) CHRONOLOGICAL INACCURACY - The LLM states the cross-functional team was 'instituted in 2023,' but the ground truth indicates it was formed in 2022 as part of the initial assessment phase. This is a material error in sequencing the evolution of Caterpillar's response. (2) INCOMPLETE CHARACTERIZATION - The LLM describes the shift as beginning 'in 2022' with SOFR-linked instruments, but the ground truth indicates 2022 was primarily an assessment/planning phase, with actual SOFR implementation occurring by 2023. This misrepresents the timeline of action vs. planning. (3) MISSING CONTEXT - The ground truth emphasizes 'consistent reliance on currency hedging instruments' across all three years, suggesting continuity rather than a 'shift.' The LLM's framing of a 'shift from LIBOR-centric framework' somewhat overstates the degree of change. (4) PARTIAL ACCURACY ON RISK ACKNOWLEDGMENT - The LLM correctly identifies basis risk and the trade-off between hedging costs and foregone upside, which aligns with ground truth, but these points are presented as 2023-2024 developments when the ground truth suggests ongoing acknowledgment throughout. QUANTITATIVE ASSESSMENT: No specific dollar amounts or percentages were required in either answer, so quantitative accuracy is assessed on factual precision of dates and sequencing. The chronological error (team formation date) represents a factual inaccuracy. MULTI-HOP REASONING: The LLM demonstrates adequate synthesis across three years but makes a sequencing error that affects the logical flow of how Caterpillar's response evolved. The answer should have shown: 2022 (assessment/planning) → 2023 (implementation with team) → 2024 (refinement/monitoring). Instead, it compresses the timeline. SEMANTIC EQUIVALENCE: While the general themes are correct, the specific ordering and characterization of when actions occurred differs materially from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 632,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from the initial October 2021 Chapter 11 filing of LTL Management LLC—under which it funded a $2 billion talc trust and recorded a comparable reserve—to a series of legal setbacks that caused the LTL bankruptcy to be dismissed in 2023, prompting a second “pre‑packaged” Chapter 11 filing (LTL 2) and, by 2024, a new restructuring that channels all but a small fraction of talc claims into a court‑approved trust whose present‑value payment is about $6.475 billion (≈ $8 billion nominal) over 25 years, while the company’s loss‑contingency reserve has grown to roughly $9 billion (≈ $11.6 billion present value) to cover both the trust and ongoing settlements.  This evolution reflects a shift from litigating individual verdicts and defending multi‑state investigations to a coordinated bankruptcy‑based resolution strategy that combines a sizable trust, negotiated settlements with states and other claimants, and continued appeals to achieve a comprehensive, final settlement of talc liability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of J&J's talc strategy from 2022-2024, including: (1) the initial $2 billion trust and reserve established in 2021/2022, (2) the 2023 dismissal of the first LTL bankruptcy by the Third Circuit, (3) the subsequent LTL 2 pre-packaged filing, and (4) the shift toward a comprehensive bankruptcy-based resolution strategy. The qualitative narrative about moving from individual litigation to coordinated bankruptcy resolution is sound and well-reasoned. The answer correctly synthesizes multi-hop information across years and legal proceedings.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM introduces specific dollar figures ($6.475 billion present value, $8 billion nominal, $9 billion reserve, $11.6 billion present value) that are NOT present in the ground truth answer. The ground truth only mentions the $2 billion trust established in 2022. These additional figures appear to be either: (a) fabricated/hallucinated, (b) from sources outside the provided ground truth, or (c) incorrectly synthesized. This is a critical issue because the evaluation criteria emphasize strict accuracy on numbers and calculations. The ground truth does not provide these specific reserve amounts or trust valuations for 2024, making it impossible to verify their accuracy.\n\nMULTI-HOP REASONING: The LLM correctly traces the sequence of events (2021 initial filing → 2022 trust/reserve → 2023 dismissal and LTL 2 filing → 2024 restructuring), which demonstrates sound multi-hop synthesis. However, the introduction of unverified numerical claims undermines the credibility of this reasoning.\n\nCOMPLETENESS: The answer addresses all aspects of the question (financial strategy, legal strategy, LTL bankruptcy filings, trust establishment, evolution through 2024). It provides more detail than the ground truth but at the cost of introducing unverified figures.\n\nSCORING JUSTIFICATION: The correctness score of 6 reflects that while the qualitative narrative and temporal sequence are largely accurate, the introduction of specific financial figures not present in the ground truth represents a significant factual error. In financial analysis, precision on dollar amounts is paramount. The quantitative accuracy score of 4 reflects these unverified numbers. The qualitative accuracy of 7 acknowledges the sound reasoning about strategy evolution despite the numerical issues. Contextual relevance of 8 reflects strong alignment with the question's intent, though the unsupported figures reduce this slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 679,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe transformed the Photography Plan from a simple, low‑cost subscription that bundled Photoshop + Lightroom as an entry‑point into Creative Cloud into a tightly integrated tier of the Creative Cloud ecosystem that is powered by generative‑AI.  Each year Adobe added AI‑driven features (e.g., Generative Fill/Expand in Photoshop, Firefly‑powered tools and extra Generative Credits), expanded collaboration integrations such as Frame.io, and introduced flexible, credit‑based pricing to attract both hobbyist and professional photographers while nudging them toward higher‑value Creative Cloud plans.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Adobe's Photography Plan evolution from 2022-2024 and captures the core strategic narrative. STRENGTHS: (1) Correctly identifies the three-year progression and the shift toward AI integration; (2) Accurately mentions specific AI features (Generative Fill, Generative Credits, Firefly-powered tools); (3) Properly synthesizes the multi-hop concept of positioning evolution within Creative Cloud ecosystem; (4) Correctly identifies the dual targeting strategy (hobbyist and professional photographers); (5) Appropriately notes the strategic nudging toward higher-value plans. MINOR ISSUES: (1) The LLM introduces 'Frame.io' collaboration integrations and 'credit-based pricing' which are not explicitly mentioned in the ground truth answer - while these may be accurate Adobe features, they represent additions beyond what the knowledge graph confirms; (2) The characterization of 2022 positioning as 'simple, low-cost subscription' is slightly more interpretive than the ground truth's more neutral 'targeted package' description; (3) The LLM doesn't explicitly mention Lightroom Classic, which was specifically called out in the ground truth for 2022. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is not directly testable. The years (2022, 2023, 2024) are correctly referenced. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression from entry-point offering to AI-enhanced integrated solution. The reasoning about strategic intent (attracting photographers while upselling to full Creative Cloud) is sound and matches the ground truth's narrative. SEMANTIC EQUIVALENCE: The core message aligns well - Photography Plan became more integrated, AI-powered, and strategically positioned within Creative Cloud. The LLM's framing as 'tightly integrated tier powered by generative-AI' is semantically equivalent to the ground truth's description of 'more integrated and enhanced' with 'AI-powered features.' The score reflects strong core accuracy with minor additions/interpretations that go slightly beyond the confirmed knowledge graph data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 597,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the same “Form of specimen certificate for class C common stock” (Exhibit 4.2) unchanged in its filings from the 2022 10‑K through the 2023 10‑K and into the 2024 10‑K, with no amendment or new certificate issued. This uninterrupted use of the original specimen certificate demonstrates a deliberate, stable approach to shareholder documentation, underscoring Visa’s consistent corporate‑governance practices and its commitment to predictable, transparent investor relations amid evolving regulatory and market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Visa has maintained the same Form of Specimen Certificate for Class C Common Stock (Exhibit 4.2) across 2022-2024 10-K filings without updates. The answer accurately conveys the stability and consistency theme. However, there are notable omissions compared to the ground truth: (1) The LLM does not specify the original filing date of January 28, 2009 (8-A, File Number 000-53572), which is a specific factual detail provided in the ground truth. (2) The LLM does not mention the contrast with other governance documents like the Certificate of Incorporation being revised in 2024, which provides important context about selective governance updates. (3) The LLM's phrasing 'no amendment or new certificate issued' is slightly imprecise—the ground truth emphasizes that the same exhibit from 2009 is consistently referenced, not that no new certificate was issued. The quantitative accuracy is strong (dates and exhibit numbers are correct where mentioned), but the answer lacks the specific filing date and file number details. The qualitative reasoning about stability and investor relations is sound and semantically equivalent to the ground truth. The answer addresses the main question about consistency and governance implications but misses supporting details that would strengthen the multi-hop synthesis across the three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 388,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nRTX’s accrued liability for performance and operating‑cost guarantees declined from **$1.157 billion at the end of 2022 to $1.109 billion in 2023 and to $0.993 billion by the end of 2024**.  The drop is driven by fewer new guarantees being issued, ongoing settlements of prior claims and downward adjustments to earlier estimates.  This trend shows that the company is effectively reducing its exposure to aerospace‑engine performance risk, but a sizable liability still remains, indicating continued risk‑management focus on commercial‑aerospace contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the core quantitative facts. (1) WRONG NUMBERS: The LLM reports liabilities of $1.157 billion (2022), $1.109 billion (2023), and $0.993 billion (2024). The ground truth shows collaboration partners' share of financing guarantees of $140 million (2022), $135 million (2023), and $131 million (2024). These are completely different figures - off by a factor of approximately 8-9x. (2) QUANTITATIVE ACCURACY FAILURE: The LLM's numbers are entirely incorrect. The ground truth shows a decline from $140M to $135M to $131M (a $9M total reduction), while the LLM shows a decline from $1.157B to $0.993B (a $164M reduction). Even the direction and magnitude of change are misrepresented. (3) ENTITY/METRIC CONFUSION: The LLM appears to be reporting total accrued liabilities for performance and operating-cost guarantees rather than the specific 'collaboration partners' share of financing guarantees' metric that the ground truth identifies. This suggests the LLM pulled data from a different line item or section of the filing. (4) MULTI-HOP REASONING: While the LLM's reasoning about declining exposure and risk management is logically sound in structure, it is built on completely incorrect numerical foundations, making the entire analysis unreliable. (5) SEMANTIC ISSUES: The LLM's interpretation of what the numbers represent appears to differ from the ground truth - the ground truth specifically identifies these as 'collaboration partners' share' while the LLM treats them as total company liabilities. This is a critical distinction that changes the meaning of the data. The answer demonstrates a fundamental failure to accurately extract and report the correct financial metrics from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 482,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco’s accounting for lease‑rent holidays has remained the same from 2022‑2024: free‑rent and step‑rent periods are recognized on a straight‑line basis over the **entire lease term**, which now explicitly includes any renewal or extension options that management deems “reasonably certain” to be exercised. The right‑of‑use asset is initially measured at the present value of the discounted minimum lease payments (i.e., excluding rent‑free periods), so the inclusion of renewal options that are deemed probable lowers the total number of payments and therefore reduces the initial ROU‑asset valuation. While the core methodology has not changed, the 2023‑2024 filings added clearer language about renewal‑option assessment and the discount‑rate determination, making the disclosure more explicit but leaving the measurement approach unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of Costco's lease accounting treatment:\n\n(1) CRITICAL ERROR - ROU Asset Valuation Logic: The LLM states that 'the inclusion of renewal options that are deemed probable lowers the total number of payments and therefore reduces the initial ROU-asset valuation.' This is fundamentally incorrect. Including renewal options in the lease term INCREASES the number of lease payments, which INCREASES the ROU asset valuation, not decreases it. The ground truth does not make this claim. This represents a major conceptual error in understanding lease accounting under ASC 842.\n\n(2) INCOMPLETE DISCLOSURE EVOLUTION: The LLM answer fails to capture the key evolution described in the ground truth:\n   - Missing: The 2022 emphasis on incremental borrowing rate derived from quoted interest rates\n   - Missing: The 2023 expansion clarifying treatment of variable lease payments tied to price indices or sales volume\n   - Missing: The 2024 heightened focus on impairment evaluation of long-lived assets in context of facility relocations/closures\n   The LLM only vaguely mentions 'clearer language about renewal-option assessment and discount-rate determination' without specificity.\n\n(3) INCORRECT CHARACTERIZATION: The LLM states the ROU asset is 'measured at the present value of the discounted minimum lease payments (i.e., excluding rent-free periods).' The ground truth indicates free-rent periods are recognized on a straight-line basis OVER the lease term, meaning they affect the ROU asset valuation through the lease liability calculation, not by being excluded.\n\n(4) MISSING OPERATIONAL CONTEXT: The ground truth emphasizes that by 2024, there was 'growing operational complexity in lease management' with heightened focus on impairment evaluation related to facility relocations or closures. The LLM completely omits this important contextual evolution.\n\n(5) PARTIAL CREDIT: The LLM correctly identifies that the core accounting treatment remained stable across 2022-2024 and that extension options deemed 'reasonably certain' are included in the lease term. The straight-line recognition of free-rent periods is also correctly stated.\n\nThe answer demonstrates a fundamental misunderstanding of how lease term extensions affect ROU asset valuations and fails to capture the nuanced evolution of disclosures across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 645,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved AI‑powered document productivity from a behind‑the‑scenes “Sensei‑driven” enhancement of PDFs toward a branded, generative‑AI offering embedded directly in Acrobat—introducing features such as Generative Fill, Generative Expand and Generative Credits and positioning the suite as “Adobe Document Cloud AI” and “Acrobat AI.”  This shift was supported by increased R&D investment in foundation models (e.g., Firefly) and by formally naming the AI‑enhanced document workflow under the Adobe Document Cloud and Acrobat AI umbrellas, underscoring a strategic focus on monetizing AI‑driven document automation.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer addresses the evolution of Adobe's AI strategy from 2022-2024 and correctly identifies key themes (Acrobat's role, AI branding, R&D investments), but introduces significant factual inaccuracies that undermine credibility.\n\nCORRECT ELEMENTS:\n- Correctly identifies the trajectory from foundational document role to AI-enhanced productivity\n- Accurately mentions formal product branding (Acrobat AI Assistant, Adobe Document Cloud AI)\n- Appropriately references R&D investments in foundation models\n- Correctly captures the 2022-2024 timeframe and evolution narrative\n- Properly synthesizes multi-hop information about strategic emphasis\n\nFACTUAL ERRORS & CONCERNS:\n1. GENERATIVE FILL/EXPAND: The LLM mentions 'Generative Fill' and 'Generative Expand' as Acrobat features. These are primarily Photoshop/Creative Cloud features, not core Acrobat document productivity features. This is a significant entity/product misattribution.\n2. 'GENERATIVE CREDITS': While Adobe does use a credits system for generative AI, the specific framing of 'Generative Credits' as an Acrobat feature is not substantiated in the ground truth and appears speculative.\n3. 'SENSEI-DRIVEN' FRAMING: The ground truth does not mention Adobe Sensei as the 2022 baseline approach. This appears to be an inference not supported by the knowledge graph.\n4. MONETIZATION EMPHASIS: While the LLM correctly identifies monetization as a strategic goal, the ground truth emphasizes 'market opportunity in document intelligence' rather than explicitly framing it as monetization-focused.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across the three-year period and connects R&D investments to product branding. However, the product feature misattributions weaken the synthesis quality.\n\nCOMPLETENESS:\nThe answer addresses all three sub-questions (Acrobat's role, R&D investments, product branding) but with some inaccuracies in the specific features cited.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (5): Core narrative is sound, but product feature errors are significant factual mistakes that would mislead readers about what Acrobat AI actually offers\n- Quantitative Accuracy (3): No specific numbers provided by either answer, but the feature attributions are factually incorrect\n- Qualitative Accuracy (6): Good synthesis of strategic evolution, but product misidentifications reduce quality\n- Contextual Relevance (7): Appropriately addresses the question's focus on strategic evolution, though with some inaccurate details",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 679,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab trimmed the amount of client‑margin securities it pledged for external funding—its secured uncommitted credit lines fell from about $950 million in 2023 to $500 million in 2024, and FHLB borrowings that are backed by pledged investment securities dropped from $26.4 billion to $16.7 billion—while the overall pool of client securities that could be pledged stayed large (≈ $120 billion).  This deliberate de‑leveraging shows the firm is shifting toward a more internally funded balance sheet and is curbing the use of client collateral to finance short‑term liquidity, indicating a pull‑back in client‑driven leverage.  The trend reflects a strategic emphasis on preserving liquidity and reducing reliance on client‑secured borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question asked. Critical issues: (1) FACTUAL MISMATCH: The ground truth describes an EVOLUTION and EXPANSION of Schwab's disclosure practices and formalization of client securities pledging from 2022-2024, showing increased usage for margin requirements and securities lending. The LLM answer instead describes a DE-LEVERAGING trend with declining pledged amounts, which is the opposite direction. (2) QUANTITATIVE PROBLEMS: The LLM cites specific numbers ($950M to $500M in secured credit lines, $26.4B to $16.7B in FHLB borrowings, $120B pool) that are not mentioned in the ground truth. Without verification against actual filings, these numbers cannot be confirmed as accurate, and they support a narrative (de-leveraging) that contradicts the ground truth's narrative (expansion and formalization). (3) INTERPRETATION ERROR: The ground truth emphasizes 'increasing formalization and expansion of client securities usage' and 'rising client participation in leveraged products.' The LLM interprets this as a pullback and de-leveraging, which is semantically opposite. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution 'particularly in relation to margin lending and securities lending activities' and what the trend indicates about 'balance sheet strategy and client leverage behavior.' The ground truth correctly identifies that the trend shows strategic leverage of client assets and rising leverage participation. The LLM incorrectly concludes the opposite—that Schwab is reducing leverage. (5) MISSING KEY ELEMENTS: The LLM answer completely omits the progression of disclosure formalization (2022 → 2023 → 2024) and the specific mechanisms mentioned in ground truth (margin requirements for listed options, OCC clearing, securities lending collateral requirements). The answer appears to describe a different company or different time period than what the ground truth documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 533,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nCostco has consistently presented the 1.375 % Senior Notes due June 2027 as long‑term debt – the notes were never re‑classified to the current portion in any of the 2022‑2024 filings.  The carrying amount of the notes stayed at $1.25 billion throughout the three years, but the composition of the company’s total long‑term debt changed: after the 2024 repayment of the $1 billion 2.75 % notes due May 2024, total long‑term debt fell from $6.59 bn (2022) to $5.92 bn (2024), so the 1.375 % notes grew from roughly 19 % of total long‑term debt in 2022 to about 21 % of the $5.92 bn balance in 2024, while the current portion of debt declined sharply.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key facts but contains significant numerical discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The 1.375% Senior Notes remained at $1.25 billion consistently across 2022-2024; (2) Notes were never reclassified to current portion; (3) The 2.750% Senior Notes due May 2024 were repaid/reclassified; (4) Overall long-term debt declined from 2022 to 2024; (5) The percentage composition of the 1.375% notes increased relative to total long-term debt. CRITICAL ERRORS: (1) Long-term debt figures are incorrect - LLM states $6.59 billion (2022) and $5.92 billion (2024), but ground truth shows $6,484 million (2022) and $5,794 million (2024). Converting: $6.484 billion vs $6.59 billion stated (off by ~$106M or 1.6%), and $5.794 billion vs $5.92 billion stated (off by ~$126M or 2.2%). These are material discrepancies for financial data. (2) Percentage calculations: LLM states 1.375% notes were ~19% of total in 2022 ($1.25B/$6.59B = 18.97%, approximately correct) and ~21% in 2024 ($1.25B/$5.92B = 21.12%, approximately correct), but these percentages are based on incorrect total debt figures. MULTI-HOP REASONING: The LLM successfully synthesized information across three years and correctly identified the relationship between the reclassification of the 2.750% notes and the overall decline in long-term debt. The reasoning about composition shifts is sound. However, the numerical foundation is flawed. SEMANTIC ISSUES: The answer uses '$1 billion' for the 2.750% notes repayment, which is reasonable approximation but ground truth doesn't explicitly state this amount. The phrase 'after the 2024 repayment' is slightly misleading as the reclassification to current portion occurred in 2023, with repayment in 2024. Overall, the answer demonstrates good understanding of the debt dynamics but fails on quantitative precision, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 518,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe has moved its free, online, self‑service learning from a stand‑alone training option into a central element of its broader learning‑and‑enablement portfolio, linking it directly to skills‑assessment tools, Journey Optimizer insights and Customer Success Manager workflows; the company now uses these self‑service modules to align employee and client learning pathways with enterprise‑wide digital‑experience initiatives, embedding learning metrics into customer‑success performance goals and enabling real‑time tracking of adoption and ROI across its Experience Cloud suite.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Specific issues: (1) The ground truth makes no mention of 'Journey Optimizer insights' or 'Customer Success Manager workflows' - these appear to be fabricated details not found in Adobe's 10-K filings. (2) The claim about 'embedding learning metrics into customer-success performance goals' and 'real-time tracking of adoption and ROI' is not substantiated in the original answer and represents unsupported extrapolation. (3) The LLM answer incorrectly characterizes the evolution as moving from 'stand-alone' to 'central element' - the ground truth indicates free learning was already positioned as a 'core component' in 2022, not a standalone option. (4) The reference to 'Experience Cloud suite' metrics tracking is not mentioned in the ground truth. (5) The LLM answer lacks the nuanced, evidence-based progression described in the original (2022 introduction, 2023 reinforcement with skills assessments, 2024 maintained structure with enterprise integration). Instead, it presents a more dramatic transformation narrative unsupported by the source material. The answer demonstrates hallucination of specific product features and metrics integration that cannot be verified from the provided ground truth, which is a critical failure for financial document analysis where accuracy is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 391,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the carrying amount of NVIDIA’s 2.00 % Notes Due 2031 remained essentially unchanged at about $1.25 billion (carrying value), with only modest fair‑value fluctuations—from roughly $1.04 billion in 2023 to $1.06 billion in 2024. This flat‑line exposure shows that, amid rapid AI‑driven revenue growth, NVIDIA is maintaining a conservative, low‑leverage debt profile, using a stable, long‑dated fixed‑rate issue rather than expanding debt to fund its expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims the carrying amount 'remained essentially unchanged at about $1.25 billion' across 2022-2024, but ground truth shows: 2022: $1.20B, 2023: $1.057B, 2024: $1.25B. This is NOT 'essentially unchanged'—there was a significant 12% decrease from 2022 to 2023 ($1.20B to $1.057B), then a 18% increase from 2023 to 2024 ($1.057B to $1.25B). The LLM also confuses carrying value with fair value, stating fair values were '$1.04B in 2023 to $1.06B in 2024' when ground truth specifies carrying amounts. (2) MISSING KEY PATTERN - The LLM completely misses the critical fluctuation pattern that is central to the question. Ground truth explicitly identifies the decrease then increase pattern (2022→2023 decrease, 2023→2024 increase), which is essential to understanding NVIDIA's debt management strategy. The LLM's characterization of 'flat-line exposure' is factually incorrect. (3) REASONING FAILURE - The LLM's conclusion that NVIDIA maintains 'conservative, low-leverage debt profile' by keeping exposure 'stable' contradicts the actual data showing active management with meaningful year-to-year changes. The ground truth correctly identifies this as 'dynamic debt management strategy,' not static. (4) INCOMPLETE SYNTHESIS - The LLM fails to synthesize the multi-hop information properly: it doesn't explain WHY the notes decreased in 2023 (refinancing/optimization) or increased in 2024 (strategic AI investments), which are key insights from ground truth. The answer demonstrates fundamental misreading of the financial data and fails to address the core question about how exposure 'evolved' across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 483,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly describes a multi‑year, enterprise‑wide program to integrate, simplify and standardize HR, IT, procurement, supply‑chain and finance processes specifically to expand its financial shared‑service capability and to standardize financial systems.  Each filing emphasizes that the effort is a proactive strategic initiative—not a response to a control weakness—and that the company continues to align and streamline the design and operation of its financial control environment as the program matures.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the multi-year enterprise-wide initiative spanning 2022-2024 and accurately captures the proactive (non-reactive) nature of the program. The core narrative about process standardization and financial shared services is correct. No numeric errors or date inaccuracies are present. WEAKNESSES: (1) SCOPE EXPANSION ERROR - The LLM answer significantly expands the scope beyond what the ground truth specifies. The original answer focuses specifically on 'finance' and 'financial systems' standardization, while the LLM answer adds HR, IT, procurement, and supply-chain processes. This represents a material factual error that goes beyond the ground truth's documented scope. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes the EVOLUTION and PROGRESSION across the three years (2022 description → 2023 reiteration with alignment emphasis → 2024 continuity affirmation), showing how the narrative matured. The LLM answer presents the information more as a static description rather than capturing this temporal progression and evolution. (3) MISSING CONTEXTUAL NUANCE - The ground truth explicitly notes that the 2023 filing highlighted 'alignment and streamlining of the financial control environment in response to the initiative,' and 2024 'affirmed that these enhancements were not reactive.' The LLM answer mentions these concepts but doesn't clearly articulate how the company's messaging evolved year-to-year. (4) CONTROL ENVIRONMENT EMPHASIS - While the LLM mentions 'align and streamline the design and operation of its financial control environment,' it doesn't emphasize the 'control environment alignment' aspect as prominently as the ground truth does, which is a key part of the question. The answer is partially correct on core facts but fails to fully capture the multi-hop synthesis of how the initiative evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 516,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nFrom 2022 through 2024 Costco’s filings shifted from merely listing BJ’s Wholesale Club as one of several warehouse‑club competitors to positioning Kirkland Signature as the central differentiator in that segment.  Each year the disclosures emphasized that Kirkland products deliver higher quality at lower prices, generate higher margins, and that the company intends to keep expanding their sales‑penetration—using the private‑label brand as a strategic lever to set Costco apart from BJ’s and other clubs.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core entities (Costco, BJ's Wholesale Club, Kirkland Signature) and the time period (2022-2024). It accurately captures that Kirkland Signature was positioned as a differentiator with emphasis on quality at lower prices and higher margins. The general trajectory of positioning is directionally correct. WEAKNESSES: (1) The LLM answer claims a shift 'from merely listing BJ's Wholesale Club as one of several competitors to positioning Kirkland Signature as the central differentiator' - this overstates the evolution. The ground truth indicates Costco 'consistently positioned itself in direct competition with BJ's' across all three years, not a shift from peripheral to central positioning. (2) The LLM omits critical nuances from the ground truth: the 2023 addition of sustainability initiatives tied to brand loyalty, and the 2024 shift toward 'differentiating our merchandise offerings' language in response to competitive pressures in metropolitan markets. (3) The phrase 'intends to keep expanding their sales-penetration' is not explicitly supported by the ground truth and appears to be an inference not grounded in the filings. (4) The LLM fails to capture the evolution in tone and emphasis across the three years - the ground truth specifically notes 'language remained largely consistent' in 2023 but with added sustainability emphasis, and a 'stronger tone around differentiation' in 2024. The LLM presents this as a more linear, consistent strategy rather than capturing the subtle but meaningful evolution. MULTI-HOP REASONING: The LLM demonstrates basic multi-hop synthesis by connecting Costco's positioning across three years and linking it to BJ's competition, but it oversimplifies the nuanced evolution described in the ground truth. The answer is partially correct on core facts but misses important contextual details about how the emphasis evolved year-to-year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 521,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s exposure to U.S. state and municipal securities in its available‑for‑sale portfolio slipped only modestly—from $638 million (2022) to $579 million (2023), with the 2024 filing continuing to list virtually all portfolio securities as investment‑grade.  This stable, high‑quality tilt reveals that Schwab’s fixed‑income strategy is deliberately conservative, emphasizing credit‑safe, highly rated municipal and agency bonds to preserve capital and meet regulatory standards while keeping lower‑rated or higher‑yield assets to a minimal role.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a fundamental factual error regarding the timeline and amounts. The ground truth states that in 2023, Schwab disclosed $638 million in U.S. State and Municipal Securities. The LLM incorrectly claims this $638 million figure was from 2022 and then states it declined to $579 million in 2023. This reverses the chronology and misattributes the years. The ground truth does not provide a 2022 specific dollar amount for these securities, only noting they were part of the portfolio with investment-grade ratings. The LLM's claim of a decline from $638M to $579M is unsupported by the ground truth. (2) ENTITY/TIMELINE CONFUSION - The LLM conflates years and amounts, creating an inaccurate narrative of portfolio evolution. The ground truth clearly indicates $638 million was disclosed in 2023, not 2022. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the investment-grade emphasis across years, it fails to accurately represent the quantitative data points provided in the ground truth. The answer invents a 2022 figure and a 2023 decline that are not supported by the source material. (4) QUALITATIVE REASONING - The LLM's interpretation of the strategy (conservative, capital preservation, regulatory compliance) is reasonable and aligns with the ground truth's characterization, but this cannot compensate for the factual errors in the quantitative data. (5) WHAT WAS CORRECT - The emphasis on investment-grade quality across the period and the characterization of the strategy as conservative and risk-averse are accurate. The 2024 reference to investment-grade focus is correct. However, the core numerical claims are fundamentally wrong, which is a critical failure for a financial question requiring precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 491,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s “maximum‑potential‑payment” exposure under commercial‑aerospace financing guarantees slipped from roughly **$304 million** to **$288 million** and then to **$274 million**, reflecting a modest contraction in the size of its guarantee commitments.  At the same time the amount of those guarantees that is covered by collaboration partners fell from **$140 million** (2022) to **$135 million** (2023) and **$131 million** (2024), showing that RTX is progressively **retaining a larger share of the risk itself** rather than passing it on to partners.  In other words, the company is shifting from a relatively higher‑partner‑risk‑transfer model toward greater internal risk retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of RTX's commercial aerospace financing guarantee exposure. STRENGTHS: (1) All collaboration partners' share figures are correct ($140M in 2022, $135M in 2023, $131M in 2024), matching the ground truth exactly. (2) The LLM provides additional context by citing the maximum-potential-payment exposure figures ($304M, $288M, $274M), which adds valuable quantitative depth beyond the ground truth answer. (3) The reasoning about risk transfer strategy is sound and well-articulated: the LLM correctly identifies that declining partner guarantees means RTX is retaining a larger share of risk internally, which aligns with the ground truth's interpretation of 'increased internal risk retention.' (4) The multi-hop synthesis is excellent—the answer connects the declining partner share figures to the broader strategic implication about risk transfer models. (5) The terminology is precise (maximum-potential-payment exposure, risk transfer, internal risk retention). MINOR CONSIDERATIONS: (1) The ground truth mentions that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees,' which the LLM answer does not explicitly address. However, this is a minor omission that doesn't contradict the LLM's answer. (2) The LLM's characterization of the shift as 'from a relatively higher-partner-risk-transfer model toward greater internal risk retention' is semantically equivalent to the ground truth's 'strategic shift toward reducing RTX's reliance on third-party risk sharing.' QUANTITATIVE VERIFICATION: All dollar amounts are accurate; the trend analysis (decline from 2022-2024) is correct; the percentage implications are logically sound. The LLM successfully synthesizes information across three fiscal years and correctly interprets the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 506,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe expanded Frame.io from a video‑review tool into a full‑stack, cloud‑native collaboration hub. It now accepts a broader set of file types—including still images, design files and PDFs—and is tightly integrated with multiple Creative Cloud applications (Premiere Pro, After Effects, Photoshop, Lightroom, Adobe Express and Firefly Services) as well as the GenStudio content‑production platform, positioning Frame.io as a central node that streamlines the entire content‑production workflow.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Frame.io's evolution and integration trajectory. STRENGTHS: (1) Correctly identifies the progression from 2022-2024; (2) Accurately lists supported file types (still images, design files, PDFs); (3) Correctly names integrated applications (Premiere Pro, After Effects, Photoshop, Lightroom); (4) Properly characterizes Frame.io's expansion from video-review tool to broader collaboration platform; (5) Accurately describes the shift from post-production focus to end-to-end content creation workflows. WEAKNESSES: (1) The LLM answer mentions 'Adobe Express and Firefly Services' and 'GenStudio' which are NOT mentioned in the ground truth answer - these appear to be additions beyond what was documented in the knowledge graph; (2) The ground truth specifically mentions 'Camera-to-Cloud functionality' for video production in 2023, which the LLM answer omits; (3) The ground truth explicitly mentions Frame.io's expanded role into 'casting, location scouting, and marketing campaign management' in 2024, which the LLM answer does not specifically detail (though it alludes to broader workflows); (4) The ground truth notes Frame.io was listed as a registered trademark in 2022, indicating acquisition/branding alignment, which the LLM answer doesn't capture. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 timeline and correctly identifies the progression of integrations and file type support. However, it introduces information not in the ground truth while omitting some specific details. The core narrative is sound but incomplete relative to the knowledge graph source material. QUANTITATIVE ACCURACY: No numeric errors present; dates and year references are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 488,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the VH‑92A’s production role receded within the Rotary and Mission Systems (RMS) portfolio.  In the 2022 filings the VH‑92A was listed as a core Sikorsky helicopter for the U.S. Marine One mission, and RMS net‑sales growth was tied to broader Sikorsky volume gains.  By the 2024 update the segment’s sales growth was described as being “primarily attributable to higher production volume on the CH‑53K” with only a modest, offsetting decline noted for the VH‑92A, signalling that while the type remains strategically important for Marine‑One transport, the company is shifting its production emphasis toward higher‑volume, higher‑margin platforms such as the CH‑53K and related IWSS/C6ISR programs.  This multi‑year progression reflects a deliberate re‑allocation of resources within RMS, underscoring the VH‑92A’s continued strategic relevance but a reduced emphasis relative to other growth‑driving helicopter programs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DIRECTIONAL ERROR - The LLM claims the VH-92A's 'production role receded' from 2022-2024, but the ground truth explicitly states it 'remained a consistent part' with 'sustained strategic importance' and was 'listed among RMS's major helicopter programs' in all three years. This is a fundamental mischaracterization of the program's trajectory. (2) UNSUPPORTED CLAIMS - The LLM states there was 'only a modest, offsetting decline noted for the VH-92A' in 2024, but the ground truth provides no such specific decline data. The LLM appears to have fabricated or inferred this detail without evidence. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies CH-53K as a growth driver and mentions IWSS/C6ISR programs, it fails to acknowledge that the ground truth emphasizes the VH-92A's CONSISTENT presence across all three years as a named program. (4) MISINTERPRETATION OF STRATEGIC IMPORTANCE - The ground truth indicates stable, long-term commitment despite shifting priorities. The LLM reframes this as 'reduced emphasis,' which contradicts the consistent naming across years. (5) QUANTITATIVE ISSUES - No specific numbers, percentages, or dollar amounts are provided in either answer, but the LLM's qualitative claims about 'receding' production and 'modest decline' are unsupported by the ground truth data. The core narrative is inverted: ground truth = consistent/stable; LLM = receding/declining. This is a critical factual error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 434,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 to 2024 the regulatory landscape for Mondelez’s sales‑ and media‑marketing activities shifted from a relatively fragmented, country‑by‑country patchwork toward a more coordinated, higher‑stringency regime, especially in the EU and in key emerging markets.  In the European Union, the number of member states applying extended‑producer‑responsibility (EPR) packaging‑waste schemes grew from a handful in 2022 to over 25 by 2024, and several countries introduced stricter front‑of‑pack labeling and time‑of‑day advertising limits for products with high‑nutrient‑profile scores.  At the same time, emerging markets such as India, Vietnam, Indonesia and the Philippines began rolling out mandatory EPR obligations, single‑use‑plastic bans and tighter nutrient‑profile advertising rules, expanding the geographic scope of restrictions beyond the EU and tightening the overall regulatory stringency across the company’s global sales and marketing channels.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a major factual error regarding the timeline of EPR implementation. The ground truth states 'over 25 EU countries had implemented EPR policies' IN 2022, not by 2024. The LLM reverses this timeline, claiming EPR grew 'from a handful in 2022 to over 25 by 2024,' which contradicts the original answer. This is a significant factual error on a key metric. (2) UNSUPPORTED CLAIMS - The LLM introduces specific regulatory details NOT present in the ground truth: 'front-of-pack labeling,' 'time-of-day advertising limits,' and 'high-nutrient-profile scores.' While these may be real regulations, they are NOT mentioned in the original answer and represent fabrication/hallucination beyond the source material. (3) GEOGRAPHIC SCOPE - The LLM correctly identifies emerging markets (India, Vietnam, Indonesia, Philippines) but the ground truth only explicitly mentions India and Vietnam. Indonesia and Philippines are added without source support. (4) CORRECT ELEMENTS - The LLM does correctly identify: the expansion from 2022-2024, the EU as a key region, EPR policies as central, emerging markets as increasingly affected, and the overall trajectory toward greater stringency. (5) MISSING ELEMENTS - The LLM omits the 2023 intermediate year and the specific mention of data privacy as a regulatory area affecting marketing, which was explicitly noted in the ground truth. (6) MULTI-HOP REASONING - While the LLM demonstrates understanding of the general trend, the reversed timeline on the '25 EU countries' metric is a fundamental error in synthesizing the multi-year progression. The answer reads plausibly but contains factual inaccuracies that would mislead on specific regulatory milestones.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 481,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nThe 3.700 % Notes due 2046 are first disclosed in the 2022 10‑K as part of the 11th Supplemental Indenture (dated August 8 2016), where they are presented as long‑term senior unsecured debt with a fixed 3.70 % coupon and no current‑portion classification. Both the 2023 10‑K and the 2024 10‑K continue to reference the same indenture— the 2023 filing adds a 15th Supplemental Indenture (Nov 6 2023) that expands the series but does not alter the terms of the 2046 notes, and the 2024 filing again lists the 3.70 % 2046 notes unchanged within the original indenture framework. This consistent, unchanged treatment signals that Microsoft is preserving its original long‑dated fixed‑rate debt, using later supplemental indentures only to add new tranches while maintaining a stable, low‑cost long‑term capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 3.700% Notes due 2046, the August 8, 2016 Eleventh Supplemental Indenture date, and the core fact that these notes remained unchanged across 2022, 2023, and 2024 filings. The percentage (3.70%) is accurate. The LLM correctly notes that the notes are long-term senior unsecured debt with fixed coupon and no current-portion classification. The reasoning about Microsoft preserving original long-dated fixed-rate debt is sound.\n\nWEAKNESSES AND ERRORS: (1) The LLM introduces a 15th Supplemental Indenture dated November 6, 2023, which is NOT mentioned in the ground truth answer. The ground truth explicitly states that the Eleventh Supplemental Indenture was referenced in all three years without modification. The introduction of a 15th Supplemental Indenture creates a factual discrepancy—either this indenture doesn't exist in the actual filings, or the ground truth is incomplete. This is a significant concern for multi-hop accuracy. (2) The LLM's statement that the 15th Supplemental Indenture \"expands the series but does not alter the terms of the 2046 notes\" is not corroborated by the ground truth, which makes no mention of this indenture. (3) The ground truth emphasizes the Eleventh Supplemental Indenture as the consistent reference point across all three years, but the LLM shifts focus to a different indenture framework in 2024.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years and correctly identifies the pattern of consistency. However, the introduction of the 15th Supplemental Indenture without ground truth support suggests either hallucination or incomplete verification against the actual filings. The core conclusion about stable, long-dated debt strategy is correct, but the supporting details diverge from the ground truth.\n\nCONCLUSION: While the LLM captures the essential narrative (unchanged 3.700% Notes, fixed-rate strategy, long-term capital structure), the introduction of unsupported details (15th Supplemental Indenture) and the deviation from the ground truth's emphasis on the Eleventh Supplemental Indenture across all three years represents a material factual error in multi-hop synthesis. The answer is partially correct but contains a significant factual discrepancy that undermines confidence in the completeness and accuracy of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 634,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nThe 2.000% Notes due 2023 were originally created under the Eleventh Supplemental Indenture dated August 8 2016, which is cited in the 2022 10‑K as part of Microsoft’s senior unsecured debt. In the 2023 10‑K the same indenture is still listed, but the notes are now shown as the current portion of long‑term debt because they mature in 2023, and a later Fifteenth Supplemental Indenture filed in November 2023 adds new, longer‑dated series (e.g., 2025‑2060 maturities). By the 2024 10‑K the 2.000% 2023 notes have been retired, and Microsoft’s debt maturity structure has progressed to include newer supplemental indentures that extend maturities out to 2025‑2060.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The Eleventh Supplemental Indenture date of August 8, 2016 is accurate; (2) The identification of the notes as senior unsecured debt is correct; (3) The general progression of debt maturity structure across the three years is accurately described; (4) The mention of newer supplemental indentures extending maturities to 2025-2060 is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM states the notes were 'retired' by 2024, but the ground truth indicates they 'remained listed in Exhibit 4.14' even after the maturity year passed, suggesting either a rollover, delayed maturity, or continued disclosure requirement - not a simple retirement; (2) The LLM introduces a 'Fifteenth Supplemental Indenture filed in November 2023' which is not mentioned in the ground truth and cannot be verified; (3) The LLM's characterization of the 2024 status as 'retired' contradicts the ground truth's more nuanced observation that the notes 'remained listed' with possible rollover or delayed maturity; (4) The ground truth emphasizes the consistent presence of the notes across all three years in Exhibit 4.14, while the LLM suggests they disappeared by 2024. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but makes an unsupported leap in concluding the notes were 'retired' rather than acknowledging their continued listing. The reasoning about debt maturity progression is sound but incomplete regarding the actual status of the 2023 notes in 2024. QUANTITATIVE ACCURACY: Dates are correct (August 8, 2016; November 2023; maturity year 2023), but the characterization of what happened to the notes is factually questionable based on the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 478,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nIn the 2022 filing the company disclosed that Non‑Employee RSU awards were governed by the **Amended and Restated 2013 Stock Award and Incentive Plan**, using the form labeled 10.42; the same plan and agreement language continued to be referenced in the 2023 and 2024 filings, with only minor updates to reflect the plan’s most recent amendment (effective December 8 2017 and any subsequent 2023‑2024 plan modifications).  Earlier years had relied on the 2003 Long‑Term Incentive Plan and the 2008 Stock Award and Incentive Plan, but by 2022 onward the **2013 plan** became the sole underlying incentive plan for all Non‑Employee RSU awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH: The LLM states the agreement was labeled '10.42' in 2022, but the ground truth explicitly identifies it as 'Exhibit 10.45' in the 2022 filing. This is a factual error in document reference. (2) INCOMPLETE PLAN HISTORY: The LLM introduces information about earlier reliance on the '2003 Long-Term Incentive Plan and 2008 Stock Award and Incentive Plan' which is NOT mentioned in the ground truth answer. While this may be factually accurate from the filings, it goes beyond what was established in the knowledge graph and represents unsupported synthesis. (3) VAGUE AMENDMENT DATING: The LLM states 'effective December 8 2017 and any subsequent 2023-2024 plan modifications' but the ground truth is more precise, noting the specific effective date of December 8, 2017 for the Amended and Restated 2013 plan without speculating about subsequent modifications. The phrase 'any subsequent 2023-2024 plan modifications' is imprecise and not grounded in the ground truth. (4) CORE ACCURACY: The LLM correctly identifies that the Amended and Restated 2013 Stock Award and Incentive Plan was the underlying plan across all three years (2022, 2023, 2024), which matches the ground truth. The continuity observation is correct. (5) MISSING NUANCE: The ground truth emphasizes 'continuity in form and structure' and 'long-term stability' while noting the plan 'was amended over time' - the LLM captures some of this but with less precision. The ground truth's distinction between the form agreement remaining consistent while the underlying plan evolved is better articulated in the original. STRENGTHS: Correctly identifies the 2013 plan as the primary vehicle across three years; recognizes continuity in the agreement form. WEAKNESSES: Wrong exhibit number (10.42 vs 10.45); introduces unsupported historical context; imprecise on amendment details; less clear on the distinction between form stability and plan evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 531,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 to 2024 the share of assets in MDLZ’s non‑U.S. pension plans that is held in buy‑in annuity contracts rose dramatically – from roughly **16 % of the portfolio in 2022** to **about 75 % in 2024** (the 2023 filing does not break out the percentage, but the absolute balance of “buy‑in annuity contracts and other” fell only slightly while the total plan assets shrank, driving the percentage up).  This rapid increase reflects MDLZ’s deliberate de‑risking of its international pension obligations: by swapping plan liabilities for annuity contracts it transfers the payment risk to insurers, improves the funded status of the plans and reduces exposure to market‑return and interest‑rate volatility.  The trend therefore signals a strategic shift toward liability‑driven management of its non‑U.S. pension obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ERRORS - The ground truth states buy-in annuity allocations DECREASED from 17% (2022) to 16% (2023) and were discontinued by 2024. The LLM claims they INCREASED from 16% (2022) to 75% (2024) - a complete reversal of the actual trend. The specific percentages cited (16% in 2022, 75% in 2024) are factually wrong. (2) DIRECTIONAL ERROR - The LLM describes a dramatic increase in buy-in annuity allocation, when the ground truth shows a decrease and discontinuation. This is not a minor wording difference but a fundamental misrepresentation of the data. (3) STRATEGIC INTERPRETATION - While the LLM correctly identifies de-risking as the strategic intent, it incorrectly attributes this to increased reliance on buy-in annuities. The ground truth indicates the opposite: MDLZ moved AWAY from insurer-backed annuities toward direct liability management and fair value estimation methods. (4) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the year-over-year evolution. The ground truth shows a clear three-year progression (17% → 16% → discontinued), while the LLM presents an inverted narrative. (5) METHODOLOGY SHIFT - The ground truth explicitly notes a shift to fair value estimation methods, indicating a change in accounting/valuation approach that the LLM completely missed. The LLM's statement about 2023 data not breaking out percentages appears to be an attempt to explain missing information, but this doesn't justify the incorrect 2022 and 2024 figures. This answer demonstrates critical factual inaccuracy on the core quantitative claims and misrepresents the strategic direction of MDLZ's pension management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 469,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nMicrosoft first created the 2.000 % senior notes maturing 2023 in the 2016‑2017 supplemental‑indenture series (the Eleventh Supplemental Indenture of August 8 2016).  In the FY 2022 filing the notes were still listed as a near‑term obligation, and the filing made no reference to any new issuance—only a reaffirmation of the existing issue.  The FY 2023 filing records the **Fifteenth Supplemental Indenture (Nov 6 2023)**, which increased the aggregate principal of the 2.000 % notes and extended certain maturity dates, marking the final step of a modest refinancing cycle; the FY 2024 filing shows the notes now classified as short‑term with no further supplemental amendments, indicating that Microsoft had completed its issuance/extension of that series and moved on to newer, longer‑dated debt.  This progression reveals a long‑term debt strategy that relies on issuing low‑coupon, long‑dated notes, periodically refinancing near‑term maturities to maintain a stable funding base while gradually rolling off short‑dated obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the FY 2023 filing references a 'Fifteenth Supplemental Indenture (Nov 6 2023)' that 'increased the aggregate principal' and 'extended certain maturity dates.' The ground truth explicitly states the notes were 'consistently referenced' with 'identical details, showing no change in the structure or maturity' across all three years. This is a fundamental misrepresentation of the data. (2) CRITICAL ERROR - The LLM states the notes were 'classified as short-term' in FY 2024, but the ground truth indicates they 'remained in the disclosures' consistently through 2024, with no mention of reclassification. (3) CRITICAL ERROR - The LLM claims Microsoft 'increased the aggregate principal' and engaged in 'refinancing,' but the ground truth shows the notes were simply 'consistently referenced' with no changes. (4) The LLM's interpretation that this represents 'a modest refinancing cycle' and 'extension of maturity dates' directly contradicts the ground truth's finding of consistency and stability with 'no change in the structure or maturity.' (5) The LLM correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, which matches the ground truth. (6) The LLM's conclusion about debt strategy (rolling off short-dated obligations, refinancing near-term maturities) is speculative and unsupported by the ground truth, which emphasizes a 'deliberate and steady approach' with no early retirement or refinancing. The answer demonstrates poor multi-hop synthesis and introduces false details not present in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 458,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nThe 4.000% Notes due 2021 are traced to the Third Supplemental Indenture of 8 Feb 2011, which is repeatedly referenced in the 2022‑2024 Form 10‑Ks as part of Microsoft’s Base Indenture of 18 May 2009. None of the later supplemental indentures (e.g., the Twelfth, Thirteenth or Fifteenth) amend the terms of those 2021 notes; they only add new tranches to the overall debt structure, so the notes’ interest rate, maturity and covenants remain unchanged across the three filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key details but has notable omissions in completeness. CORRECT ELEMENTS: (1) The Third Supplemental Indenture date of February 8, 2011 is accurate. (2) The Base Indenture date of May 18, 2009 is correct. (3) The core assertion that the 4.000% Notes due 2021 remained unchanged across 2022-2024 filings is accurate. (4) The explanation that later supplemental indentures added new debt tranches rather than amending the 2021 notes is sound. (5) All numeric values and dates provided are factually correct. OMISSIONS/WEAKNESSES: (1) The LLM answer fails to mention that the notes appeared in Exhibit 4.6 across all three years, which is a specific structural detail from the ground truth. (2) The answer does not identify the companion notes (2.500% Notes due 2016 and 5.300% Notes due 2041) that were grouped with the 4.000% Notes under the same Third Supplemental Indenture, which provides important context about the debt instrument structure. (3) The answer mentions later supplemental indentures (Twelfth, Thirteenth, Fifteenth) but does not provide examples of new instruments introduced, whereas the ground truth specifically mentions the 2.375% Notes due 2023 and 2.125% Notes due 2022. (4) The answer does not explicitly address the 'evolution' aspect of the question as thoroughly - it focuses more on consistency than on how the broader debt structure evolved. MULTI-HOP REASONING: The LLM correctly synthesized information across three years of filings and properly understood the relationship between the base indenture, supplemental indentures, and individual debt instruments. The logic that later supplemental indentures added new tranches without amending existing ones is sound and demonstrates proper multi-hop reasoning. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth - the 4.000% Notes remained unchanged and were part of a consistent structure. However, the answer is less comprehensive in describing the full context of how Microsoft's debt structure evolved during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 557,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nMedtronic’s FY 2022, FY 2023 and FY 2024 10‑K filings each state that the 40,000 authorized Euro Deferred Shares were “issued or outstanding” zero, and the language is unchanged across the three years.  This consistent absence of any issuance or recorded balance shows that the company does not use Euro Deferred Shares as a financing tool, instead maintaining a simple equity structure and relying on ordinary‑share repurchases, debt and other mechanisms to manage its capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three fiscal years. QUANTITATIVE ACCURACY: All numeric values are correct - 40,000 authorized Euro Deferred Shares, zero issued/outstanding balances across FY 2022-2024, €1.00 par value (implied in ground truth, not explicitly stated in LLM answer but not contradicted). The consistent zero balances across all three years are accurately represented. ENTITY ACCURACY: Correct identification of Medtronic, correct fiscal years (2022, 2023, 2024), correct financial instrument (Euro Deferred Shares). MULTI-HOP REASONING: The LLM successfully synthesizes information across three years to identify the pattern of non-utilization and correctly interprets this as a strategic choice. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Medtronic has not issued or used Euro Deferred Shares despite maintaining authorization. The LLM adds slightly more specific interpretation (mentioning 'ordinary-share repurchases, debt and other mechanisms') which is a reasonable inference from the non-utilization pattern, though the ground truth uses more cautious language ('potentially signaling'). MINOR DIFFERENCES: The ground truth explicitly mentions the €1.00 par value, which the LLM answer omits. The LLM's interpretation about 'simple equity structure' and specific financing mechanisms is slightly more definitive than the ground truth's 'potentially signaling' language, but this represents reasonable inference rather than factual error. The answer fully addresses the question about how disclosures evolved (they remained consistent) and what the absence reveals about capital structure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 476,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 4.000% Notes due 2021 in the same “Third Supplemental Indenture” (Exhibit 4.6) within the exhibit index, and later supplemental indentures (e.g., the 2023 Fifteenth Supplemental Indenture) are added but do not modify the terms of the 2021 tranche. This consistent referencing indicates that the company treats the 2021 notes as a stable, long‑term borrowing that is simply disclosed through its indenture documentation, with no recent material changes or new disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The identification of the Third Supplemental Indenture (Exhibit 4.6) dated February 8, 2011 is accurate and matches the ground truth. (2) The core observation that Microsoft consistently referenced the 4.000% Notes due 2021 across 2022, 2023, and 2024 filings is correct. (3) The statement that there were no material changes to the debt instrument's terms is accurate. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about 'later supplemental indentures (e.g., the 2023 Fifteenth Supplemental Indenture)' that is not mentioned in the ground truth answer. While this may be factually accurate from the filings, it represents an addition beyond what the ground truth establishes, creating potential inconsistency with the knowledge graph baseline. (2) The characterization of the 2021 notes as 'a stable, long-term borrowing' is somewhat misleading given that the notes were due in 2021 - by 2022, 2023, and 2024, these notes would have already matured. The ground truth explicitly states 'the Notes were matured or fully accounted for,' which the LLM answer does not clearly convey. (3) The LLM's phrasing 'simply disclosed through its indenture documentation' downplays the significance that these are matured notes still being referenced in filings. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and identifies the consistent disclosure pattern. However, it misses the critical insight that the consistency itself indicates the notes have matured and are being maintained in disclosure for historical/documentation purposes rather than as active debt. SEMANTIC ISSUES: The term 'stable, long-term borrowing' is semantically problematic for matured debt. The ground truth's interpretation that consistency indicates maturity/full accounting is more accurate than the LLM's interpretation of ongoing stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 526,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nLockheed Martin has kept up a multi‑year program of pension‑risk‑transfer transactions, buying group‑annuity contracts (GACs) that move defined‑benefit obligations out of the company’s pension trust.  The 2021 purchase transferred about $4.9 bn of gross pension liabilities; subsequent filings for 2022‑2024 show additional GAC purchases that added roughly $2‑3 bn of obligations each year, bringing cumulative transfers to roughly $11.6 bn of pension liabilities since 2018.  This steady increase demonstrates that the company is deliberately off‑loading long‑term pension exposure to reduce liability volatility, lower future funding risk and free cash flow, aligning with its broader long‑term liability‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of Lockheed Martin's pension risk transfer strategy and correctly identifies the cumulative $11.6 billion figure from 2018 onwards. However, there are significant quantitative accuracy issues: (1) The LLM introduces a specific 2021 figure of $4.9 billion in pension liabilities transferred, which is not mentioned in the ground truth and cannot be verified. (2) The LLM claims 'subsequent filings for 2022-2024 show additional GAC purchases that added roughly $2-3 bn of obligations each year,' but the ground truth does not provide year-by-year breakdowns for 2022-2024, only noting that the company 'continued evaluation' in 2023 and 'reaffirmed intent' in 2024 without specifying additional transaction amounts. (3) The LLM's calculation implying $4.9B + (2-3B × 3 years) ≈ $11.6B is mathematically inconsistent and appears to be an unsupported extrapolation. The ground truth states the $11.6 billion is cumulative 'since December 2018' without breaking it into annual components for 2022-2024. Strengths: The answer correctly identifies the $11.6 billion cumulative figure, correctly names the mechanism (group annuity contracts/GACs), and accurately characterizes the strategic intent (reducing liability volatility, funding risk, and freeing cash flow). The multi-hop reasoning about the company's long-term liability management strategy is sound and well-articulated. Weaknesses: The introduction of unverified annual figures ($4.9B in 2021, $2-3B annually) represents fabrication of specific data points not present in the ground truth. The answer conflates what is known (cumulative $11.6B through 2022) with what is inferred (ongoing commitments in 2023-2024) without clearly distinguishing between confirmed transactions and stated intentions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 488,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\n\\boxed{In the 2022 10‑K the 0.125\\% Notes due 2029 are listed explicitly in the exhibit table (Item 4.23/4.31) and are tied to the September 18 2020 Form 8‑K (with a later March 9 2021 amendment). The 2023 filing omits a dedicated line for the note in the exhibit index, although the instrument remains part of the company’s debt profile, and the 2024 10‑K reinstates the same Exhibit 4.4 reference, reaffirming the original disclosure. This pattern shows that Coca‑Cola’s debt‑instrument structure—using a single indenture and note form—remains consistent over time, with only the presentation in the filings evolving.}",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims the 2023 filing 'omits a dedicated line for the note in the exhibit index,' directly contradicting the ground truth which explicitly states the note appeared in Exhibit 4.23 and 4.31 in 2023. This is a fundamental mischaracterization of the filing pattern. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes consistent disclosure across all three years (2022, 2023, 2024) with identical exhibit references, but the LLM introduces a false narrative of inconsistency by claiming 2023 omitted the note. (3) DATES PARTIALLY CORRECT - The LLM correctly identifies September 18, 2020 and March 9, 2021 Form 8-K dates, though the ground truth references these more generally as 'September 2020 and March 2021.' (4) EXHIBIT REFERENCES CONFUSED - While the LLM mentions Exhibit 4.4, 4.23, and 4.31, it fails to accurately track that the note appeared in 4.23 and 4.31 consistently across all three years, not with the omission claimed for 2023. (5) CONCLUSION UNDERMINED - The LLM's conclusion about 'only the presentation in the filings evolving' contradicts its own claim that 2023 omitted the note, creating internal inconsistency. The ground truth reveals a story of perfect consistency; the LLM invents a false pattern of inconsistency that doesn't exist in the actual filings. This represents a failure in multi-hop reasoning across the three filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 412,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe liability for performance and operating‑cost guarantees declined from **$1.16 billion at the end of 2022** to **$1.09 billion in 2023** and then to **$0.99 billion by the end of 2024**.  This steady reduction shows that RTX is revising its estimates of future claim payments downward—likely due to better‑than‑expected engine reliability and the impact of recent remediation programs—but the company still carries nearly **$1 billion of exposure** to long‑term product‑performance risks in its commercial aerospace business.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer provides completely different numbers than the ground truth. Ground truth shows collaboration partners' share of financing guarantees at $141M (2022), $135M (2023), and $131M (2024). The LLM claims total liabilities of $1.16B (2022), $1.09B (2023), and $0.99B (2024)—numbers that are approximately 8-10x larger than the ground truth figures and not supported by the knowledge graph. The LLM appears to have fabricated or misidentified the liability figures entirely. While the LLM correctly identifies the trend direction (declining), the magnitude of the numbers is fundamentally wrong. The LLM also makes unsupported inferences about 'better-than-expected engine reliability' and 'remediation programs' that are not mentioned in the ground truth. The ground truth explicitly notes that 'the company's own liabilities related to these guarantees were not explicitly stated,' yet the LLM presents specific billion-dollar figures as fact. The reasoning about 'nearly $1 billion of exposure' is based on incorrect source data. This represents a complete failure in quantitative accuracy—the most critical aspect of financial analysis. The answer fails the primary evaluation criterion of factual correctness on numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 353,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic has continued to value its non‑qualified stock options with the Black‑Scholes model, but the inputs have been revised each year.  The weighted‑average fair‑value of granted options fell from $22.8 million in 2022 to $18.5 million in 2024, while volatility was held nearly steady (≈23 %→≈24 %), the risk‑free rate rose sharply (0.9 %→4.2 %), and the dividend yield increased (1.9 %→3.2 %).  This shows the company is deliberately incorporating a higher‑rate, higher‑dividend environment and only modestly higher price‑volatility assumptions into its equity‑compensation risk model, reflecting a more conservative stance on expected stock‑price fluctuations and a recalibration of the cost of equity awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical data (fair values, volatility percentages, risk-free rates, dividend yields) that cannot be verified against the ground truth provided. The ground truth focuses on the evolution of volatility disclosure methodology and transparency (historical vs. implied volatility, market-traded options clarification from 2022-2024), while the LLM answer pivots to specific input parameter changes and their implications. Critical issues: (1) The LLM provides concrete numbers ($22.8M to $18.5M, 23%→24% volatility, 0.9%→4.2% risk-free rate, 1.9%→3.2% dividend yield) that are not mentioned in the ground truth and cannot be independently verified from the provided context. These numbers may be accurate from the actual filings, but they represent a different analytical approach than the ground truth. (2) The LLM answer addresses the Black-Scholes model consistency correctly, which aligns with ground truth. (3) However, the LLM completely misses the key evolution highlighted in the ground truth: the explicit clarification about implied volatility being derived from market-traded options, which was added in 2023 and maintained in 2024. This is a significant omission of the primary insight. (4) The LLM's interpretation about 'conservative stance on expected stock-price fluctuations' contradicts the ground truth's emphasis on 'more dynamic risk modeling' and 'market-informed approach.' (5) The LLM answer does not address the transparency/disclosure evolution that is central to the ground truth. The answer demonstrates partial understanding of the valuation methodology but fails to capture the core narrative about disclosure refinement and market-informed volatility estimation that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 478,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company repeatedly references the same 1.000 % notes due 2028, indicating that it has issued additional tranches of this series in each of those years—an initial issuance in 2022 followed by follow‑on offerings/amendments in 2023 and a further amendment/issuance in 2024. This pattern shows that Coca‑Cola is treating the 1.000 % 2028 notes as a core, low‑cost funding pillar, regularly tapping the capital markets to extend maturity and replace maturing debt, i.e., a strategy of incremental, laddered financing to maintain a stable, inexpensive source of long‑term liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth. Key issues: (1) INCORRECT INTERPRETATION OF PATTERN: The LLM claims Coca-Cola issued 'additional tranches' and 'follow-on offerings/amendments' of the 1.000% Notes due 2028 in each year (2022, 2023, 2024). The ground truth states the company 'consistently referenced' the same instrument across all three years, not that it issued multiple tranches. This is a fundamental misreading. (2) MISSING CRITICAL CONTEXT: The LLM completely omits the key strategic insight from the ground truth—that in 2024, Coca-Cola introduced significantly higher-yielding notes (5.000% due 2034 and 5.300% due 2054), indicating a strategic shift toward more aggressive borrowing terms. This is central to understanding the company's debt strategy evolution. (3) INCORRECT STRATEGIC CHARACTERIZATION: The LLM describes the strategy as 'incremental, laddered financing' and 'regularly tapping the capital markets to extend maturity,' which contradicts the ground truth's finding that the 1.000% Notes remained part of the structure while the company pursued higher-interest debt in 2024. (4) UNSUPPORTED CLAIMS: The LLM makes specific claims about 'initial issuance in 2022 followed by follow-on offerings/amendments in 2023 and further amendment/issuance in 2024' without evidence from the filings. The ground truth indicates consistent reference, not multiple issuances. (5) MISSING NUANCE: The ground truth correctly identifies that while the 1.000% Notes due 2028 remained visible, the strategic shift involved introducing higher-yielding instruments, suggesting a more complex debt management approach than the LLM's simplified 'low-cost funding pillar' characterization. The LLM's answer fundamentally misrepresents the evolution pattern and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 500,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings Microsoft’s 2.125 % Notes have remained under the same master trustee—The Bank of New York Mellon Trust Company, N.A.—but each year’s filing adds new supplemental indentures that extend or augment the debt series. In the 2022 filing the only indenture covering the 2.125 % Notes due 2022 is the 2012 Fourth Supplemental Indenture; the 2023 filing introduces the Fifteenth Supplemental Indenture (Nov 6 2023) and references earlier supplements (e.g., the 2017 Seventh Supplemental) that add new note tranches while keeping the identical trustee; and the 2024 filing continues this pattern with the Fourteenth and Fifteenth Supplemental Indentures (2021‑2023) still administered by the same trustee, illustrating a steady, incremental evolution of the related debt instruments rather than a structural change in the trustee arrangement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM states the 2.125% Notes were 'due 2022' in the 2022 filing, but the ground truth clearly indicates they were 'due 2021'. This is a fundamental misidentification of the instrument. (2) SUPPLEMENTAL INDENTURE ERRORS - The LLM claims the 2022 filing references the 'Fourth Supplemental Indenture' and that the 2023 filing introduces the 'Fifteenth Supplemental Indenture,' but the ground truth consistently references the 'Seventh Supplemental Indenture' across all three years (2022, 2023, 2024). The LLM appears to have fabricated or confused supplemental indenture numbers. (3) STRUCTURAL CONSISTENCY MISCHARACTERIZATION - While the LLM correctly identifies The Bank of New York Mellon Trust Company, N.A. as the trustee, it incorrectly characterizes the evolution as involving 'new supplemental indentures that extend or augment the debt series' each year. The ground truth explicitly states the structure 'remained consistent' with 'no changes in the structure or administration' over the three-year period. (4) ASSOCIATED INSTRUMENTS - The ground truth mentions the 3.125% Notes due 2028 as an associated instrument disclosed alongside the 2.125% Notes, but the LLM fails to mention this relationship. (5) QUANTITATIVE ACCURACY - Multiple date and indenture number errors undermine the quantitative precision required for financial document analysis. The answer demonstrates a pattern of inventing or misremembering specific supplemental indenture numbers rather than accurately synthesizing the actual filing data. The core conclusion about trustee consistency is partially correct, but the supporting details are substantially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 481,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share in the IAE collaboration held essentially steady at roughly **57 %** from 2022 through 2024, and its net interest in IAE LLC remained at about **51 %** (after accounting for sub‑collaborator allocations).  This unchanged share demonstrates that RTX is deliberately preserving a controlling stake in the V2500 and PW1100G‑JM engine programmes, underscoring a strategic focus on protecting and growing its position in these key commercial‑aviation engines.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims net program share interest 'held essentially steady at roughly 57% from 2022 through 2024,' but the ground truth explicitly states that in 2022, the program share interest was 61% for IAE and 59% for IAE LLC (NOT 57%). The decrease to 57% and 51% occurred in 2023, not 2022. This is a significant factual error regarding the starting point and trajectory. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the key evolution described in the ground truth: the progression FROM higher percentages in 2022 (61% IAE, 59% IAE LLC) TO lower percentages in 2023-2024 (57% IAE, 51% IAE LLC). The ground truth explicitly describes this as a 'decrease' and 'adjustment,' indicating strategic recalibration. The LLM incorrectly characterizes this as 'unchanged' or 'held essentially steady,' which misrepresents the actual trend. (3) MISSING CONTEXT - The ground truth mentions the 49.5% ownership interest in IAE for 2022, which the LLM omits entirely. The distinction between ownership interest and program share interest is important for understanding the full picture. (4) REASONING FLAW - The LLM's conclusion that the 'unchanged share demonstrates RTX is deliberately preserving a controlling stake' contradicts the actual data showing a decline from 2022 to 2023. The reasoning is based on incorrect premises. (5) CORRECT ELEMENTS - The LLM correctly identifies the 2023-2024 figures (57% IAE, 51% IAE LLC) and correctly names the engine programs (V2500, PW1100G-JM). The general strategic positioning interpretation is reasonable but built on flawed data analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 447,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s expense for its defined‑contribution (401(k)) plans was $402 million in 2022, increased to $468 million in 2023, and then fell slightly to about $443 million in 2024 (see 2023 10‑K page 55 and 2024 10‑K page 68).  The rise from 2022 to 2023 shows a deliberate boost in retirement‑benefit spending, while the modest decline in 2024 suggests the company is holding that higher level of investment steady rather than continuing rapid growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's defined contribution plan expense was $402 million in 2022, but the ground truth clearly shows $299 million. This is a significant discrepancy of $103 million (34% overstatement). The 2023 and 2024 figures ($468M and $443M respectively) are correct and match the ground truth exactly. REASONING QUALITY: The LLM's interpretation of the trajectory is partially sound - it correctly identifies the rise from 2022 to 2023 and the modest decline in 2024. However, the interpretation that 2024 represents 'holding that higher level steady' is somewhat misleading given the actual decline from $468M to $443M ($25M decrease). The ground truth's characterization of a 'modest pullback' is more accurate. MULTI-HOP SYNTHESIS: The answer appropriately synthesizes data across three fiscal years and attempts to draw conclusions about workforce investment strategy, which addresses the question's intent. However, the fundamental error in the 2022 baseline undermines the entire trajectory analysis. The citations to specific 10-K pages (2023 page 55, 2024 page 68) add credibility but cannot overcome the factual error. COMPLETENESS: The answer addresses both parts of the question (evolution of contributions and what it suggests about investment), but the incorrect starting point compromises the validity of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 380,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nThe 3.000 % Notes due 2051—first issued in May 2021—continue to be listed in Coca‑Cola’s long‑term‑debt schedule in the 2022, 2023 and 2024 Form 10‑K filings (pages 136 of the 2022 filing, pages 132 of the 2023 filing and pages 132 of the 2024 filing).  In the 2024 filing the company also adds newer ultra‑long‑dated notes such as 3.125 % 2032 and 3.375 % 2027, showing a pattern of retaining and expanding a ladder of fixed‑rate, multi‑decade debt.  This progression signals a capital‑structure strategy that emphasizes locking in low‑cost financing for very long horizons and extending maturity to reduce reliance on shorter‑term borrowings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces debt instruments (3.125% 2032 and 3.375% 2027) that are NOT mentioned in the ground truth answer. The ground truth specifically identifies 5.000% Notes due 2034 and 5.300% Notes due 2054 as the new instruments introduced in 2024, not the 3.125% and 3.375% notes cited by the LLM. This is a significant factual error. (2) COUPON RATE DISCREPANCY - The ground truth indicates Coca-Cola introduced HIGHER coupon rates (5.000% and 5.300%) in 2024, reflecting rising interest rate conditions. The LLM's cited rates (3.125% and 3.375%) are lower than the 3.000% baseline, which contradicts the market context and the ground truth's narrative about diversifying with higher-yielding instruments. (3) PARTIAL CORRECTNESS - The LLM correctly identifies that the 3.000% Notes due 2051 appear consistently across 2022, 2023, and 2024 filings, and correctly notes the general strategy of maintaining long-term fixed-rate debt. However, the specific new instruments are wrong. (4) REASONING QUALITY - While the LLM's interpretation of the capital structure strategy (locking in long-term financing, extending maturity) is reasonable and somewhat aligned with the ground truth's conclusion, it is based on incorrect instrument data. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the specific debt instruments across the three-year period, which is a core requirement of this multi-hop question. The page number citations (136, 132, 132) cannot be verified against the ground truth but appear plausible. OVERALL: The answer demonstrates understanding of the general strategy but contains material factual errors regarding the specific debt instruments introduced in 2024, which undermines the credibility and accuracy of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 492,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nOracle first issued the 2.875 % Notes due 2031 in a March 2021 debt offering (documented in the 2021 8‑K and carried forward in the 2022, 2023 and 2024 10‑K filings). The notes remained on the company’s long‑term debt schedule through 2024, with only periodic officers’ certificates re‑affirming their terms, indicating that Oracle has treated this tranche as a stable, low‑cost pillar of its financing. This progression shows a deliberate strategy of extending maturity and locking in relatively cheap fixed‑rate funding to support ongoing capital returns and growth initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. Key issues: (1) QUANTITATIVE ACCURACY - The LLM claims the 2.875% Notes were first issued in March 2021, but the ground truth indicates they were formally listed in 2022, making the origin date incorrect. This is a material factual error about when the notes were introduced. (2) COMPLETENESS - The LLM fails to address the critical evolution described in the ground truth: the introduction of newer, higher-yielding notes (4.500% Notes due 2028 and 4.900% Notes due 2033) alongside the 2.875% Notes in 2024. This is a major omission that directly answers the question about how the debt strategy evolved. The ground truth explicitly states this represents 'a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved.' (3) MULTI-HOP REASONING - The LLM provides a linear narrative (issued in 2021, carried forward through 2024) but fails to synthesize the key comparative insight: the contrast between the stable, low-cost 2.875% Notes and the newer, higher-yielding instruments introduced in 2024. This is the core of what the question asks about regarding strategic evolution. (4) ENTITY ACCURACY - While Oracle is correctly identified, the temporal framing is wrong (2021 vs. 2022 as the starting point in the 2022-2024 progression). (5) SEMANTIC EQUIVALENCE - The LLM's conclusion about 'extending maturity and locking in relatively cheap fixed-rate funding' is partially aligned with ground truth but misses the critical strategic shift toward higher-yielding debt instruments that characterizes the 2024 evolution. The answer reads as a generic debt strategy narrative rather than addressing the specific 3-year progression requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 484,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s 2.000% Notes due 2023 appear in the exhibit lists of its 2022, 2023 and 2024 Form 10‑K filings, indicating that the company repeatedly discloses this specific debt tranche. This consistent disclosure reflects a deliberate transparency strategy and demonstrates Microsoft’s disciplined, forward‑looking management of its long‑term debt profile, keeping investors fully informed about an upcoming maturity and the firm’s capital‑structure planning.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft's 2.000% Notes due 2023 appear consistently across 2022, 2023, and 2024 10-K filings, and this reflects a transparency strategy in debt management. All numeric values (2.000%, the three years) are accurate. The answer appropriately synthesizes the multi-hop information about consistent disclosure across multiple filing periods. However, the LLM answer is less comprehensive than the ground truth in several ways: (1) It does not mention the specific indenture details (Eleventh Supplemental Indenture dated August 8, 2016) that provide context for the debt instrument; (2) It does not explicitly discuss how the unaltered inclusion of identical filing details reinforces predictable financial stewardship; (3) It does not mention the connection to investor confidence and credit ratings, which are important implications of the transparency strategy. The LLM answer focuses on the disclosure appearing in 'exhibit lists' rather than the broader debt management context. The reasoning is sound and the core message about transparency and disciplined debt management is conveyed, but the answer lacks the depth and specific contextual details present in the ground truth. The answer is semantically aligned with the ground truth's main conclusions but omits supporting details that strengthen the argument about long-term debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 391,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nFrom 2022 through 2024 RTX has treated the contingent flight‑hour payments to Rolls‑Royce under the 2012 IAE acquisition as collaboration intangible assets that are capitalized when incurred and amortized to cost of sales; the disclosed commitment fell from $735 million in 2022 to $660 million in 2023 and is projected at $494 million for 2024, with payments scheduled to continue through June 2027 as V2500‑powered aircraft remain in service. This schedule shows that RTX’s long‑term exposure to Rolls‑Royce is limited to the remaining flight‑hour obligations that will be recognized and amortized until 2027, after which the contingent liability will have expired.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific dollar amounts ($735M in 2022, $660M in 2023, $494M in 2024) that are NOT present in the ground truth answer. The ground truth explicitly does not cite these specific numbers, making their inclusion a factual error. These numbers cannot be verified against the provided ground truth and appear to be fabricated or hallucinated. (2) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 2012 IAE acquisition agreement, V2500-powered aircraft, June 2027 end date, and the capitalization/amortization treatment, it fails to capture key nuances from the ground truth: the ground truth notes that in 2022 payments were 'expected to be capitalized' while by 2023 RTX 'clarified that these payments were being capitalized and amortized' - this evolution in disclosure/treatment is important context that the LLM misses. (3) REASONING FLAW - The LLM's conclusion that 'the contingent liability will have expired' after 2027 is reasonable but goes beyond what the ground truth states. The ground truth emphasizes 'stable long-term financial exposure' rather than expiration of liability. (4) ENTITY/METRIC ACCURACY - Correctly identifies RTX, Rolls-Royce, 2012 IAE acquisition, V2500 aircraft, and June 2027 timeline. Correctly identifies the accounting treatment (capitalization and amortization to cost of sales). (5) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution across three years but does so with unverified numbers. The core multi-hop requirement (showing how obligations evolved 2022-2024) is partially addressed but undermined by the quantitative errors. The fabricated numbers are a serious credibility issue that cannot be overlooked, even though the qualitative framework of the answer is partially sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 493,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nBetween 2022 and 2024 the weight of U.S.‑equity funds in Thermo Fisher’s domestic pension portfolio edged upward – from roughly **9.5 %** (about $89 million of the $937 million total assets in 2022) to **≈10 %** (about $91 million of the $895 million total assets in 2024).  This modest but steady rise brings the allocation into line with the company’s stated strategic target of “approximately 10 % to funds investing in U.S. equities,” indicating that Thermo Fisher is deliberately nudging its domestic equity exposure upward as part of a broader, liability‑matched, diversified investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics. (1) QUANTITATIVE ERRORS - The LLM claims U.S. equity allocation increased from ~$89M (2022) to ~$91M (2024), but the ground truth shows it decreased from $125M (2022) to $93M (2024). This is a critical reversal of the actual trend. The LLM's percentages (9.5% to 10%) are also incorrect - the ground truth shows a decrease from 2022 to 2023 ($125M to $89M), then a slight recovery in 2024 ($93M). The LLM also cites incorrect total asset figures ($937M in 2022 and $895M in 2024) that cannot be verified against the ground truth. (2) DIRECTIONAL MISINTERPRETATION - The ground truth explicitly states the allocation 'decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024,' indicating a net reduction over the 3-year period. The LLM incorrectly characterizes this as an 'upward' trend and 'steady rise.' (3) STRATEGIC INTERPRETATION ERROR - The ground truth describes this as 'a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.' The LLM's interpretation of 'deliberately nudging its domestic equity exposure upward' is the opposite of what the data shows. (4) MISSING KEY DATA POINT - The LLM completely omits the 2023 figure ($89M), which is critical to understanding the 3-year trajectory. The answer fails on all primary evaluation criteria: the numbers are wrong, the trend direction is reversed, and the strategic interpretation contradicts the actual data pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 455,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept the 1.000 % Notes due 2041 — first issued in March 2021 (see the “Form of Note for 1.000 % Notes due 2041” on page 4.33 of the 2021 filing and carried forward in the 2022‑2023 10‑K exhibits) as a core long‑dated funding tranche. However, in 2024 the company introduced a new suite of higher‑yielding senior unsecured notes (e.g., 5.000 % due 2034, 5.300 % due 2054, 5.400 % due 2064, plus 3.125 %–4.650 % issues maturing 2032‑2055) (see pages 4.39‑4.47 of the 2024 filing), using the higher‑coupon debt to refinance portions of its long‑term obligations as market rates rose while still retaining the low‑rate 1.000 % 2041 notes for long‑term liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Coca-Cola's debt strategy evolution and correctly identifies the core elements: (1) the 1.000% Notes due 2041 were consistently maintained across 2022-2024, (2) 2024 saw introduction of higher-yielding notes (5.000% due 2034, 5.300% due 2054, 5.400% due 2064), and (3) this represents a strategic shift toward higher-coupon debt. STRENGTHS: All key percentages and maturity dates are accurate. The LLM correctly synthesizes the multi-hop information showing the evolution from lower-yielding instruments (0.400% 2030, 0.950% 2036, 1.000% 2041) to higher-yielding ones in 2024. The reasoning about market conditions driving the shift is sound and matches the ground truth's interpretation. The mention of additional 3.125%-4.650% notes maturing 2032-2055 adds helpful detail not explicitly in the ground truth but consistent with it. WEAKNESSES: The LLM references a 2021 filing and page 4.33 for the 1.000% Notes origin, which goes beyond the 2022-2024 timeframe specified in the question. While not incorrect, this adds potentially unnecessary context. The ground truth specifically mentions the 0.400% Notes due 2030 in 2022 and 0.950% Notes due 2036 in 2023 as examples of earlier lower-yielding instruments, but the LLM doesn't explicitly call out these specific earlier instruments by year, instead using more general language about \"lower-rate\" debt. The LLM's explanation of using higher-coupon debt to \"refinance portions\" is a reasonable inference but goes slightly beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: All percentages (1.000%, 5.000%, 5.300%, 5.400%, 3.125%-4.650%) are correct. All maturity years (2041, 2034, 2054, 2064, 2032-2055) are accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple debt instruments, showing proper understanding of the strategic evolution. The connection between market rate changes and debt strategy is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 540,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle’s 1.650 % Notes due 2026—first issued in March 2021 (see the 8‑K “Forms of 1.650 % Notes due 2026… Officers’ Certificate issued March 24 2021” referenced on pages 112‑113, 111 and 115 of the 2022, 2023 and 2024 10‑K filings)—has remained in the company’s capital structure through fiscal years 2022, 2023 and 2024.  During the same periods Oracle added newer debt tranches with higher coupons (e.g., 2.5 % Notes due 2022, 3.125 % Notes due 2025, 3.625 % Notes due 2023, 4.3 % Notes due 2024, etc.).  By keeping the low‑rate 1.650 % tranche while also issuing higher‑yielding notes, Oracle is deliberately preserving a cheap, long‑dated funding source and using newer, higher‑rate issuances to diversify maturities and take advantage of current market conditions, reflecting a debt‑financing strategy that balances low‑cost legacy debt with higher‑rate new issuances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces several incorrect interest rates that do NOT match the ground truth. Ground truth specifies: 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024). LLM lists: 2.5% Notes due 2022, 3.125% Notes due 2025, 3.625% Notes due 2023, 4.3% Notes due 2024 - these are either wrong rates or wrong years. The 3.125% and 4.3% figures are particularly problematic as they don't match the ground truth's 5.800% and 4.500% rates. (2) ENTITY ACCURACY - While the LLM correctly identifies the 1.650% Notes due 2026 and confirms its presence across 2022-2024, it fails to accurately identify the specific higher-rate notes introduced. The ground truth explicitly mentions 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024), but the LLM provides different rates entirely. (3) MULTI-HOP REASONING - The LLM's core logic about maintaining low-cost debt while issuing higher-rate instruments is sound and aligns with ground truth reasoning. However, the factual foundation is undermined by incorrect note specifications. (4) COMPLETENESS - The LLM addresses the main question structure but with incorrect supporting details. The ground truth's specific exhibit references (4.16, 4.14) are not mentioned in the LLM answer, though the LLM does reference page numbers. (5) SEMANTIC EQUIVALENCE - The strategic interpretation (balancing low-cost legacy debt with higher-rate issuances) is semantically equivalent to ground truth, but the specific financial facts are wrong, which is critical for a financial question. The answer demonstrates understanding of Oracle's debt strategy but fails on factual accuracy of the specific instruments and rates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 467,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 of its 2022, 2023 and 2024 10‑K filings shows that the tranche remains outstanding and is still governed by the original master indenture and its supplemental indentures. This signals a long‑term debt strategy that relies on a stable master facility with incremental supplemental indentures—allowing the company to keep existing low‑cost debt on the books while updating documentation and adding new series rather than refinancing the 2021 notes outright.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.000% Notes due 2021 and confirms their consistent inclusion across 2022, 2023, and 2024. (2) The numeric/date references are accurate (4.000%, 2021 due date, three fiscal years). (3) The LLM correctly infers that the notes remained outstanding and governed by indentures. (4) The interpretation that Microsoft maintained stable debt rather than refinancing this tranche is reasonable. WEAKNESSES: (1) The LLM answer lacks specific corroborating details from the ground truth, such as the mention of the Third Supplemental Indenture or the companion notes (2.500% Notes due 2016 and 5.300% Notes due 2041) that were listed alongside the 4.000% Notes. (2) The ground truth explicitly mentions a 2024 trustee name update ('The Bank of NewYork Mellon Trust Company, N.A.'), which the LLM completely omits—this is a concrete administrative detail that supports the 'documentation updates' aspect of the question. (3) The LLM's characterization of the debt as 'low-cost' is not explicitly supported by the ground truth and may be an inference beyond what the data shows. (4) The LLM uses the phrase 'remains outstanding' which contradicts the ground truth's observation that the notes were due in 2021 yet still appear in 2022-2024 filings—this is a subtle but important distinction the ground truth addresses more carefully. (5) The LLM does not address the apparent anomaly that notes due in 2021 continue to appear in later filings, which the ground truth explicitly notes as significant. MULTI-HOP REASONING: The LLM demonstrates partial synthesis but misses key connecting details. It correctly links the consistent inclusion to debt management strategy but fails to integrate the specific supplemental indenture structure, trustee updates, and companion notes that provide fuller context. The answer is directionally correct but incomplete in supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 517,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s commercial‑aerospace financing‑guarantee exposure has been shrinking: the maximum‑potential‑payment amount fell from about **$304 million in 2022 to $288 million in 2023 and $274 million in 2024**.  At the same time, the portion of those guarantees that is covered by collaboration partners declined from **$142 million in 2022 to $135 million in 2023 and $131 million in 2024**.  This downward trend in the partners’ share shows that RTX is increasingly **retaining the risk itself rather than passing it to external collaborators**, indicating a shift toward tighter internal risk management and reduced reliance on risk‑transfer arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of RTX's commercial aerospace financing guarantee exposure. STRENGTHS: (1) All collaboration partners' share figures are correct ($142M in 2022, $135M in 2023, $131M in 2024), matching the ground truth exactly. (2) The LLM provides additional context by including total maximum-potential-payment amounts ($304M, $288M, $274M), which adds valuable detail beyond the original question's specific focus. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the declining trend in partners' share and accurately interprets this as RTX retaining more risk internally rather than transferring it to collaborators. (4) The semantic interpretation aligns well with the ground truth's conclusion about 'strategic shift where RTX assumed more direct financial risk.' (5) The wording 'increasingly retaining the risk itself rather than passing it to external collaborators' and 'reduced reliance on risk-transfer arrangements' effectively conveys the same meaning as the ground truth's analysis. MINOR CONSIDERATIONS: (1) The LLM does not explicitly mention the ground truth's statement about 'fair market values of guaranteed assets equaled or exceeded the guarantees net of reserves,' which was a secondary point in the original answer about RTX's confidence in underlying asset values. However, this omission is minor since the question's primary focus was on the trend and what it suggests about risk transfer strategy, which the LLM addresses comprehensively. (2) The LLM's characterization of the trend as 'increasingly retaining the risk' is a reasonable interpretation of the declining partners' share, though the ground truth used more cautious language ('potentially signaling'). The LLM's interpretation is logically sound and well-supported by the data. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 531,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nThe 3.950 % Notes due 2056 were created by the Eleventh Supplemental Indenture dated August 8 2016 and, as shown in the 2022, 2023 and 2024 Form 10‑K filings, remain an outstanding tranche in Microsoft’s debt structure; no additional 3.950 % 2056 issuance is recorded in those years, while later supplemental indentures (e.g., the Twelfth 2017, Thirteenth 2020, Fourteenth 2021 and Fifteenth 2023 indentures) introduced new long‑term series with later maturities. This demonstrates that Microsoft’s long‑term capital strategy relies on preserving a stable, low‑coupon, far‑out‑of‑the‑money debt tranche while continually expanding its borrowing capacity through fresh, longer‑dated notes, thereby extending the overall maturity profile and maintaining financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 3.950% Notes due 2056 and the Eleventh Supplemental Indenture dated August 8, 2016. All numeric values and dates are accurate. The answer correctly confirms the Notes' presence across 2022, 2023, and 2024 filings with no changes to terms or status, matching the ground truth's core finding. The LLM answer goes beyond the ground truth by providing additional context about later supplemental indentures (Twelfth 2017, Thirteenth 2020, Fourteenth 2021, Fifteenth 2023) and offering a more sophisticated interpretation of Microsoft's capital strategy—explaining how the company maintains stable, low-coupon debt while expanding capacity through newer, longer-dated instruments. This additional analysis is reasonable and supported by the filing data, though it represents inference beyond what the ground truth explicitly states. The multi-hop reasoning is sound: the answer correctly synthesizes information across three fiscal years and identifies the pattern of stability for this specific tranche while acknowledging broader strategic evolution. Minor weakness: the ground truth emphasizes 'no changes' and 'consistency,' while the LLM answer emphasizes 'preservation' alongside 'expansion,' which is a slightly different framing but not contradictory. The LLM's interpretation of the capital strategy as involving both stability and expansion is more nuanced and arguably more insightful than the ground truth's simpler 'steady financing strategy' characterization. All dates, percentages, and entity references are correct. The answer fully addresses the multi-year pattern question and provides substantive insight into capital strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 474,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 through 2024 the Missiles & Fire‑Control (MFC) segment saw modest revenue growth – net sales rose from **$11.32 bn in 2022 to $11.25 bn in 2023 (a slight dip) and then to $12.68 bn in 2024 (+13 % vs. 2023)** – but its profitability eroded sharply.  Operating profit fell from **$1.637 bn in 2022 to $1.541 bn in 2023 and then to only $0.413 bn in 2024**, pushing the operating margin down from **14.5 % to 3.3 %**.  The steep profit drop was driven by a $1.4 bn loss on a classified program and a $1.1 bn reduction in profit‑booking adjustments, which together subtracted roughly **$1.1 bn from Lockheed Martin’s consolidated operating profit** over the three‑year period, offsetting gains elsewhere in the business.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer addresses the MFC (Missiles & Fire-Control) segment broadly rather than specifically focusing on 'tactical and strike missile programs' as the question requires. While some numbers appear reasonable for the segment level, they do not match the ground truth's specific program-level data. QUANTITATIVE PROBLEMS: (1) The ground truth specifies production volume increases of $215M (2022), $145M (2023), and $1.2B (2024) for tactical/strike missiles specifically - the LLM provides segment-wide revenue figures ($11.32B, $11.25B, $12.68B) which are different metrics entirely. (2) Operating profit figures in LLM ($1.637B, $1.541B, $0.413B) appear to be segment-level, not program-specific. (3) The ground truth states operating profit declined by $1.1B (73%) in 2024 - the LLM's $0.413B figure would represent a decline of ~$1.128B from $1.541B, which is directionally correct but uses segment data rather than program-specific data. (4) The LLM correctly identifies the $1.4B loss on classified program and $1.1B reduction in profit-booking adjustments, matching ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes that production growth was offset by profitability decline, matching the ground truth's core conclusion. However, it fails to distinguish between segment-level and program-level analysis. COMPLETENESS: The answer addresses the trajectory and impact on operating profit but conflates segment performance with specific program performance. The ground truth provides specific program names (LRASM, JASSM, GMLRS, precision fires) and program-specific profit drivers, which the LLM omits. SEMANTIC ISSUES: The LLM's framing of 'modest revenue growth' contradicts the ground truth's emphasis on 'significant' production ramp-up, particularly the $1.2B increase in 2024. The answer is partially correct on the profitability deterioration narrative but uses wrong data granularity for the specific question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 530,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nThe 2009 Executive Change‑in‑Control Retention Agreement was originally written only for Marc N. Casper, but a separate “other‑than‑Casper” template was first posted in 2018 and has been carried forward in the 2022, 2023 and 2024 filings, showing that the same retention language continues to apply to additional senior officers.  Between 2022 and 2024 the company did not introduce a new retention‑agreement form; instead it amended the existing Casper agreement (2010 and 2018 amendments) and updated related equity documents—e.g., a 2022 amendment to performance RSU and option agreements and new RSU/option forms for Casper in 2023‑2024—while the “other officers” retention template remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) DATES/TIMELINE ERRORS: The LLM claims the 'other-than-Casper' template was 'first posted in 2018' - this date is not mentioned in the ground truth and appears to be fabricated. The ground truth only confirms the form existed by 2022. (2) AMENDMENT CLAIMS: The LLM states there were '2010 and 2018 amendments' to the Casper agreement and a '2022 amendment to performance RSU and option agreements' - none of these specific amendments are mentioned in the ground truth. This represents unsupported detail injection. (3) INCOMPLETE ANSWER TO QUESTION: The question asks specifically about evolution 'across 2022, 2023, and 2024' - the ground truth provides clear information about what was disclosed in each of these years (2022: both forms introduced; 2023: Form filed as Exhibit 10.7; 2024: continued reference). The LLM largely ignores the year-by-year evolution requested. (4) CONTRADICTORY CLAIMS: The LLM states 'the company did not introduce a new retention-agreement form' between 2022-2024, but the ground truth indicates the form for officers other than Casper was introduced in 2022 and filed in 2023 - this is a new form introduction within the timeframe. (5) MISSING CORE INFORMATION: The LLM fails to clearly articulate the 2022 introduction of the officers' form, the 2023 filing as Exhibit 10.7, or the 2024 continuation pattern that the ground truth emphasizes. The answer demonstrates hallucination of specific dates and amendments not in the source material while failing to synthesize the actual year-by-year evolution documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 463,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLMT’s interest‑rate‑swap program grew sharply: the 2022 Form 10‑K (p. 66) reported a $500 million notional amount of outstanding swaps at the end of 2021, and the 2023 and 2024 filings (pp. 54, 94) show that figure expanded to $1.3 billion and stayed at that level through 2024.  This reflects a deliberate scaling‑up of its fair‑value hedging—using variable‑rate swaps to convert a portion of its fixed‑rate debt to variable rates—to cope with the higher‑rate environment, after which the company settled on a $1.3 billion hedge size as an appropriate, stable level of interest‑rate risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of LMT's interest rate swap evolution. QUANTITATIVE VERIFICATION: All numbers are correct—$500 million notional amount at end of 2021 (disclosed in 2022 filing), $1.3 billion in 2023, and $1.3 billion in 2024. The characterization of the increase as 'more than doubling' is accurate (2.6x increase from $500M to $1.3B). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years (2022, 2023, 2024 filings) and identifies the temporal progression of the hedging strategy. ENTITY ACCURACY: LMT correctly identified, metrics properly labeled (notional amounts, fair-value hedging, variable-rate swaps), and years/periods accurately referenced. REASONING QUALITY: The LLM provides sound interpretation—explaining the strategic shift from modest ($500M) to robust ($1.3B) hedging, attributing it to higher-rate environment and debt levels, and noting the stabilization at $1.3B as a deliberate strategic choice. The explanation of converting fixed-rate debt to variable rates adds appropriate technical context. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer is slightly more concise and uses slightly different phrasing ('scaling-up of fair-value hedging' vs 'shift toward more robust interest rate risk mitigation posture'), but the semantic meaning is equivalent and arguably clearer. The LLM also includes specific page references (p. 66, pp. 54, 94) which adds credibility, though these cannot be independently verified. The answer fully addresses both parts of the multi-part question: (1) how the swaps evolved 2022-2024, and (2) what the change indicates about strategy. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 477,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s defined‑contribution expense rose from $402 million in 2022 to $468 million in 2023, then slipped modestly to $443 million in 2024—still above the 2022 level. The increase through 2023 signals a deliberate expansion of retirement‑savings contributions, and the 2024 figure shows the company is maintaining a higher‑than‑pre‑2022 investment in employee benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $402M (2022), $468M (2023), $443M (2024). The characterization of 2024 as 'flat' in the original answer versus 'slipped modestly' in the LLM answer represents a minor semantic difference; both are factually accurate descriptions of the $25M decrease from 2023 to 2024. (2) COMPLETENESS: The LLM answer addresses all required elements - the evolution across all three years (2022-2024), the trend analysis, and interpretation of what the trend indicates about employee benefits investment. (3) ENTITY ACCURACY: Company name (Thermo Fisher Scientific/Thermo Fisher), metric (defined contribution plan expenses), and all years are correctly identified. (4) REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the 2023 increase as signaling 'deliberate expansion' and the 2024 moderation as 'maintaining a higher-than-pre-2022 investment,' which accurately captures the trajectory and its implications. The logic connecting the numbers to business strategy is appropriate. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'slipped modestly' vs. ground truth's 'remained flat' represents a minor interpretive difference - the LLM's characterization is arguably more precise since $443M is notably lower than $468M, though both convey the general stabilization concept. The LLM's additional insight about maintaining above-2022 levels adds valuable context without contradicting the ground truth. Minor deduction only for the 'flat' vs. 'slipped modestly' characterization difference, which is a matter of degree rather than factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 462,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept “estimates of sales proceeds” as one of several valuation tools for its non‑public equity stakes, but the 2023‑2024 disclosures shifted emphasis toward observable price changes and a formal “other‑than‑temporary” impairment test, using the sales‑proceed estimate only when market‑based inputs were unavailable.  This more market‑driven approach underpins the company’s decision not to impair its Japan investment—where carrying value exceeded fair value by $87 million in 2022—indicating that management now views the Japanese market’s decline as temporary and believes a recovery is sufficiently predictable to rely on more reliable, observable valuation inputs rather than optimistic sales‑proceed assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $87 million excess of carrying value over fair value in 2022 for Coca-Cola Bottlers Japan Holdings Inc. (2) Accurately notes the 2022-2024 timeframe and the continued use of estimates of sales proceeds as a valuation methodology. (3) Correctly captures that management deemed the decline temporary and maintained confidence in recovery. (4) Quantitative accuracy is strong with the specific dollar amount correct.\n\nWEAKNESSES: (1) The LLM introduces concepts not present in the ground truth answer, specifically mentioning 'observable price changes' and a formal 'other-than-temporary impairment test' that are not substantiated by the original answer. This represents speculation beyond what the ground truth supports. (2) The characterization of the evolution is somewhat inverted—the ground truth states the company became 'more attuned to external market perspectives and macroeconomic risks,' while the LLM frames this as a shift away from 'optimistic sales-proceed assumptions' toward 'more reliable, observable valuation inputs.' While semantically related, the LLM's framing suggests a more dramatic methodological shift than the ground truth indicates. (3) The ground truth emphasizes increasing emphasis on 'assumptions a market participant would use in evaluating future cash flows,' whereas the LLM emphasizes 'observable price changes' and 'market-based inputs'—these are subtly different concepts. (4) The LLM's statement that the company 'uses the sales-proceed estimate only when market-based inputs were unavailable' is not explicitly stated in the ground truth and may overstate the methodological change. (5) The reasoning about why management didn't impair the investment is somewhat circular in the LLM answer—it suggests the decision not to impair reflects confidence in recovery, but the ground truth more directly states that management deemed the decline temporary in 2022, which is the basis for non-impairment.\n\nMULTI-HOP SYNTHESIS: The LLM attempts to synthesize the evolution across three years and connect it to management's confidence in recovery, which is appropriate. However, the synthesis introduces interpretations not grounded in the original answer, particularly regarding the shift in methodology and the emphasis on observable inputs.\n\nOVERALL ASSESSMENT: The answer contains the correct key facts (the $87 million figure, the 2022-2024 timeframe, the continued use of sales proceeds estimates, and management's confidence in recovery), but it adds interpretive layers and methodological details that are not supported by the ground truth. This makes it partially correct but somewhat speculative in its characterization of how the valuation approach evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 727,
        "total_tokens": 2202
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the 2.300 % Notes due 2028 are cited in Exhibit 4.14 each year, always referencing the same March 2021 officers’ certificate and indenture terms—there is no indication of a new issuance, coupon change, or maturity extension, only periodic updates to the registration filing. This steady re‑filing shows Oracle’s “shelf‑registration” strategy: it issued a multi‑year tranche of long‑dated senior unsecured debt in 2021 and then continuously refreshed the disclosure package as the notes remained outstanding, later supplementing the 2028 ladder with additional 2028‑maturing issues (e.g., the 4.5 % Notes in early 2023) while keeping the original 2.300 % tranche unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) The 2.300% Notes due 2028 are correctly cited as appearing in Exhibit 4.14 across 2022, 2023, and 2024; (2) The March 2021 issuance date is accurate; (3) The reference to 4.500% Notes due 2028 in 2023 and 5.800% Notes due 2025 in 2024 aligns with the ground truth; (4) All percentages and dates are correct. The LLM provides superior technical detail by explaining the shelf-registration mechanism and clarifying that the 2.300% Notes represent an unchanged tranche from 2021 that was continuously refreshed in filings rather than newly issued each year. This is more precise than the ground truth's phrasing which could be misinterpreted as suggesting ongoing issuance. The multi-hop reasoning is sound: the answer correctly synthesizes information across three fiscal years and identifies the pattern of maintaining older debt while issuing newer instruments. The explanation of Oracle's strategy—maintaining lower-cost debt while supplementing with higher-rate instruments—is semantically equivalent to the ground truth and well-supported. Minor deduction: The LLM could have been slightly more explicit about the rising interest rate environment context that motivated this strategy, though this is implied. The answer is more technically sophisticated than the ground truth while remaining factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 392,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nApple’s filings for fiscal 2022, 2023 and 2024 each list a “Floating Rate Notes due 2019” issuance (see Exhibit 4.3 in the 2022, 2023 and 2024 Form 10‑K tables of exhibits).  This shows that the company issued floating‑rate debt maturing in 2019 in each of those years, adjusting the amount and pricing to current market conditions.  The repeated issuance indicates Apple’s short‑term debt strategy of managing liquidity and interest‑rate exposure by rolling short‑dated floating‑rate notes rather than relying on longer‑term fixed‑rate borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that the Floating Rate Notes due 2019 were ORIGINALLY ISSUED IN 2014 and remained consistent across 2022-2024 without new issuances or modifications. The LLM incorrectly claims that Apple 'issued floating-rate debt maturing in 2019 in each of those years' and that the company was 'rolling short-dated floating-rate notes' - this is factually wrong. The notes matured in 2019, which is BEFORE the 2022-2024 period being analyzed. The LLM misinterprets the repeated appearance of these notes in disclosures as evidence of repeated issuances, when the ground truth explicitly states this reflects consistent disclosure of the same original 2014 issuance. The LLM's conclusion about 'rolling short-dated floating-rate notes' and 'adjusting the amount and pricing to current market conditions' is unsupported and contradicts the ground truth's finding of 'stable, rather than active, management approach.' The LLM does correctly identify that the notes appear in the 2022, 2023, and 2024 filings, but fundamentally misinterprets what this consistency means. The reasoning about short-term debt strategy is speculative and not grounded in the actual facts about these specific notes. This represents a major conceptual error in understanding the multi-hop synthesis required - the model failed to recognize that disclosure consistency does not equal repeated issuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 409,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe repeated appearance of the 4.000 % Senior Note due 2047 in the 2022, 2023 and 2024 10‑K filings signals that PepsiCo is treating this long‑dated instrument as a core, stable component of its capital structure—essentially a “permanent” financing pillar that underpins its long‑term debt strategy and conveys confidence to investors about the durability of its balance sheet. By contrast, the shorter‑dated notes such as the 2.150 % Senior Note due 2024 and the 0.750 % Senior Note due 2027 are presented more as tactical, near‑term funding tools that are periodically issued, refinanced or retired, reflecting a strategy that manages near‑term maturities and liquidity needs rather than anchoring the firm’s long‑run leverage.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PepsiCo's debt strategy and correctly identifies the key distinction between long-term and short-term debt instruments. All numeric values are accurate: the 4.000% Senior Note due 2047, 2.150% Senior Note due 2024, and 0.750% Senior Note due 2027 are all correctly cited with proper percentages and dates. The multi-hop reasoning is sound—the model successfully synthesizes information about the persistent presence of the 2047 note across three filings versus the episodic appearance of shorter-dated instruments. The characterization of the 2047 note as a 'core, stable component' and 'permanent financing pillar' aligns well with the ground truth's description of 'stable, extended-duration financing.' The tactical vs. strategic framing is semantically equivalent to the ground truth's distinction between 'time-sensitive capital needs' and 'persistent long-term obligations.' However, the LLM answer has one notable omission: it does not mention the 2.500% Senior Note due 2022 that appeared in the 2022 filing and matured by 2023. This specific example from the ground truth would have strengthened the answer by providing concrete evidence of the dynamic nature of short-term debt management. The LLM's explanation of refinancing risk reduction and financial stability is implicit in the ground truth but not explicitly stated, representing a reasonable inference rather than an error. The answer is well-structured and contextually appropriate, addressing both parts of the comparison question effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 430,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple’s repeated reference to the 0.45 % Notes due 2016—though they matured in 2016—keeps the legacy series on its filings for full regulatory transparency, even though no principal remains outstanding. This signals that Apple has deliberately retired that legacy debt and is not seeking to refinance it, instead relying on newer, longer‑dated issuances to manage its capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 0.45% Notes due 2016 and accurately notes they matured in 2016. The quantitative elements (percentage, year, maturity status) are all correct. CRITICAL WEAKNESSES: (1) REASONING CONTRADICTION: The LLM's interpretation fundamentally contradicts the ground truth. The ground truth emphasizes Apple's deliberate transparency and comprehensive record-keeping for historical debt, suggesting a conservative/thorough disclosure approach. The LLM instead claims Apple 'deliberately retired' the debt and is 'not seeking to refinance it'—which mischaracterizes the question. The question asks what the CONTINUED DISCLOSURE suggests about strategy, not whether the debt was retired (which is obvious since it matured). (2) INCOMPLETE SYNTHESIS: The LLM fails to address the key insight from the ground truth: that Apple's REPEATED reference to the same Officer's Certificate (dated May 3, 2013) across multiple years (2022, 2023, 2024) suggests a deliberate policy of maintaining comprehensive historical records. The LLM doesn't engage with this multi-year pattern or its implications. (3) MISINTERPRETATION OF STRATEGY: The ground truth suggests Apple's strategy reflects transparency and thorough documentation practices. The LLM's answer about 'relying on newer, longer-dated issuances' is tangential and doesn't address why Apple would continue disclosing fully-matured notes. (4) SEMANTIC MISMATCH: While the LLM correctly states the notes are no longer outstanding, it fails to explain the strategic significance of their continued disclosure—the actual question being asked. The answer addresses debt retirement (obvious) rather than disclosure strategy (the real inquiry).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 468,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin deepened its pension‑risk‑transfer program—building on the 2021 $4.9 bn group‑annuity purchase and accumulating roughly $11.6 bn of defined‑benefit obligations transferred—thereby shrinking its pension liability and generating about $1.7 bn of CAS pension‑cost recoveries in 2023‑24 and a $990 m cash contribution in 2024. The company repeatedly says it will continue to evaluate and execute additional risk‑transfer transactions, which could produce further non‑cash settlement charges that materially affect earnings. Consequently, while the transfers improve the funded status and cash‑flow timing, they also introduce earnings volatility through periodic settlement charges and the lag between cash contributions and CAS recoveries.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a significant factual error by claiming '$1.7 bn of CAS pension-cost recoveries in 2023-24.' The ground truth clearly states the $1.7 billion was a 'noncash pension settlement CHARGE' from the 2021 transaction, not a recovery. This is a fundamental mischaracterization of the financial impact. The LLM also mentions a '$990 m cash contribution in 2024' which is not mentioned in the ground truth and appears to be unsupported. (2) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the $4.9 billion GAC transaction from 2021 and the cumulative $11.6 billion in transferred obligations, it misinterprets the nature and timing of the financial impacts. The ground truth indicates the $1.7 billion charge occurred in 2022 (related to the 2021 transaction), not as a recovery in 2023-24. (3) SEMANTIC ISSUES - The LLM conflates 'settlement charges' with 'CAS pension-cost recoveries,' which are different accounting treatments. The ground truth emphasizes noncash charges as a negative earnings impact, while the LLM frames recoveries as a positive offset, fundamentally altering the narrative about financial impact. (4) COMPLETENESS - The LLM does address the evolution across 2022-2024 and mentions ongoing future transactions, but the mischaracterization of the $1.7 billion impact and introduction of unsupported figures (the $990M contribution) significantly undermines accuracy. (5) CORRECT ELEMENTS - The LLM correctly identifies: the $4.9 billion transaction, the $11.6 billion cumulative total, the company's intent to continue evaluating transactions, and the potential for material noncash charges. However, these correct elements are overshadowed by the critical error regarding the nature of the $1.7 billion impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 490,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nThe company moved from a Casper‑only Change‑in‑Control Retention Agreement to a template that covers all executive officers. In the 2018 10‑Q (Exhibit 10.18) a “Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)” was first introduced, and the 2023 10‑Q (Exhibit 10.17) updated that form for all covered officers. Subsequent 2023‑2024 filings (Exhibits 10.40‑10.48) amended the language and triggers, formally extending the retention benefits to the broader officer group beyond Casper.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that undermine its credibility. Key issues: (1) CHRONOLOGICAL ERROR: The LLM claims a 2018 10-Q introduced the agreement form, but the ground truth indicates the form was disclosed in 2022 filings. This is a fundamental dating error. (2) EXHIBIT NUMBER ERRORS: The LLM cites specific exhibit numbers (10.18, 10.17, 10.40-10.48) without verification against the ground truth. The ground truth does not provide these specific exhibit numbers, making these citations unverifiable and potentially incorrect. (3) INCOMPLETE TIMELINE: The ground truth clearly establishes three distinct periods: 2022 (initial disclosure), 2023 (new form dated April 1, 2023), and 2024 (reaffirmation). The LLM conflates these periods and misrepresents the 2023 update as occurring in a 10-Q when the ground truth indicates it was a new form filing. (4) MISSING KEY DETAIL: The ground truth specifically notes the April 1, 2023 date for the updated form, which the LLM omits entirely. (5) SEMANTIC DISTORTION: The LLM's framing of 'moving from Casper-only to template for all officers' oversimplifies the actual evolution. The ground truth shows the company always had forms for 'officers other than Casper' alongside Casper's agreement, not a transition from one to the other. (6) UNSUBSTANTIATED CLAIMS: References to 'amended language and triggers' in 2023-2024 filings are not supported by the ground truth. The ground truth indicates formalization and continuation, not amendment of language/triggers. The answer demonstrates partial understanding of the general concept (executive retention agreements evolving) but fails on factual accuracy regarding dates, document types, and the actual nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 481,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo’s 2.750 % Senior Note due 2051 is repeatedly highlighted in the 2022‑2024 8‑K filings (e.g., the October 2021, July 2022, February 2023 and July 2024 Current Reports), each time with updated indenture language and board‑resolution authorizations.  This shows the company is deliberately preserving a long‑dated, low‑coupon tranche while layering newer, higher‑coupon or floating‑rate issuances to fund its obligations, indicating a strategy of laddered maturity and early‑stage fixed‑rate lock‑in to buffer the impact of a rising‑interest‑rate environment.  Rather than refinancing the 2051 note at higher yields, PepsiCo is using it as a stable, low‑cost pillar within a broader, diversified long‑term debt program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON SOURCES: The LLM claims the 2.750% Senior Note is 'repeatedly highlighted in the 2022-2024 8-K filings' with specific dates (October 2021, July 2022, February 2023, July 2024). However, the ground truth explicitly states the note appears in 10-K filings (2022, 2023, 2024), not 8-K filings. This is a fundamental misidentification of source documents. (2) UNSUPPORTED CLAIMS: The LLM asserts 'updated indenture language and board-resolution authorizations' across multiple 8-K filings, but provides no evidence from the ground truth. The original answer makes no mention of such updates or authorizations. (3) SPECULATIVE REASONING: The LLM introduces concepts like 'floating-rate issuances' and 'early-stage fixed-rate lock-in' that are not supported by the ground truth. The original answer focuses on consistency and preservation of the note, not on layering strategies with floating-rate debt. (4) PARTIAL ALIGNMENT: The LLM correctly identifies that PepsiCo is preserving the low-coupon 2051 note and introducing higher-yielding notes (correctly mentions 5.250% Senior Note due 2054), which aligns with the ground truth's mention of 'newer, higher-yielding notes.' (5) CORRECT CORE INSIGHT: The LLM's conclusion about maintaining a 'stable, low-cost pillar within a broader, diversified long-term debt program' is semantically consistent with the ground truth's statement about 'stable long-term capital strategy, preserving access to long-dated, fixed-rate debt.' However, the path to this conclusion contains significant factual errors. The answer demonstrates understanding of the strategic concept but fails on source accuracy and introduces unsupported details that contradict the evidence-based ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 480,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nApple first referenced the 4.45 % Notes due 2044 in its 2014 indenture (exhibit 4.4) and then re‑opened that same series in each of the 2022, 2023 and 2024 Form 10‑K filings, indicating that the company has repeatedly tapped this long‑dated, fixed‑rate instrument. This multi‑year pattern reveals Apple’s long‑term capital strategy of securing low‑cost, stable financing with extended maturities to fund growth and shareholder returns while maintaining a diversified, resilient balance‑sheet profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 4.45% Notes due 2044 and accurate dating of the 2014 indenture (exhibit 4.4). The multi-hop synthesis across 2022, 2023, and 2024 filings is sound and properly identifies the consistent pattern of Apple maintaining this debt instrument. The quantitative elements are accurate: the interest rate (4.45%), maturity year (2044), and indenture date (2014) are all correct. The LLM correctly interprets the pattern as indicating Apple 're-opened' the series across multiple years, which aligns with the ground truth's observation of consistent referencing without redemption or restructuring. The reasoning about Apple's capital strategy—securing low-cost, stable financing with extended maturities—is logically sound and semantically equivalent to the ground truth's conclusion about retaining long-term debt at fixed rates for strategic flexibility. Minor differences exist: (1) The LLM adds interpretive detail about 'low-cost' financing and 'shareholder returns' that goes slightly beyond what the ground truth explicitly states, though these are reasonable inferences from the pattern; (2) The LLM's phrasing 'repeatedly tapped this long-dated, fixed-rate instrument' is slightly more active than the ground truth's 'maintained this liability,' but both convey the same essential meaning. The answer fully addresses the multi-year evolution question and provides appropriate context about capital strategy. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 426,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nBetween 2022 and 2023 the dollar amount invested in Collective Trust and Other Funds dropped from about **$498 million** (≈32 % of the plan’s NAV assets) to **$382 million** (≈39 % of NAV assets), reflecting a modest absolute reduction but a slightly higher weight as the plan shifted toward more debt and cash.  \n\nThe 2024 disclosure explains that these funds are valued daily from the **NAV of their underlying publicly‑traded assets**, so their performance is tracked through transparent market prices and managed as a liquid, index‑linked exposure rather than a private‑equity‑style holding—providing a clear view of how the plan monitors and reports on these investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides incorrect 2022 figure of $498 million when ground truth clearly states $756 million. This is a major factual error (34% understatement). The 2023 figure of $382 million is correct. The percentage calculations (32% and 39% of NAV) cannot be verified from provided ground truth but appear inconsistent with the stated dollar amounts and their relationship. (2) MULTI-HOP SYNTHESIS - The LLM correctly identifies that 2024 disclosure explains NAV-based valuation methodology, but mischaracterizes it as 'daily' valuation from 'publicly-traded assets' and 'index-linked exposure.' Ground truth states NAV is 'derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments' - this is more nuanced than the LLM's description and doesn't emphasize public trading or daily pricing. (3) INTERPRETATION - The LLM's narrative about 'modest absolute reduction' contradicts the ground truth's characterization of a 'significant reduction' (from $756M to $382M is a 49% decline, not modest). The LLM's speculation about 'plan shifted toward more debt and cash' is not supported by ground truth. (4) CORRECT ELEMENTS - The LLM correctly identifies the 2023 figure ($382M), correctly notes the 2024 disclosure addresses valuation methodology, and correctly identifies NAV-based measurement. However, the foundational 2022 number error undermines the entire comparative analysis. The question asks about evolution from 2022-2023 and how 2024 disclosure informs understanding - the LLM addresses both but with a critical numerical error in the baseline year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 465,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each retain the 2014 Officer’s Certificate that originally governed the 1.05 % Notes due 2017 (listed as Exhibit 4.4 in the exhibit indexes of all three filings). By continuing to include that certificate—originally filed when the notes were issued—Apple preserves the evidentiary record of a matured debt instrument, ensuring that its historical capital‑structure disclosures remain complete and comparable across reporting periods. This practice demonstrates a deliberate documentation‑retention policy that keeps the original financing terms accessible for investors and regulators, reflecting a systematic approach to maintaining historical capital‑structure disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric and date references are correct - the Officer's Certificate is dated May 6, 2014 (correctly referenced as '2014'), the notes are identified as 1.05% Notes due 2017, and the three fiscal years (2022, 2023, 2024) are accurately cited. The exhibit designation (Exhibit 4.4) is correctly identified. ENTITY ACCURACY: Apple is correctly identified, the specific debt instrument (1.05% Notes due 2017) is properly named, and the fiscal years are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the historical debt issuance (2014) to its continued disclosure in later filings (2022-2024), demonstrating proper multi-hop reasoning. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that Apple deliberately maintains and discloses historical debt documentation despite maturity, reflecting a systematic approach to capital structure transparency. The phrasing differs slightly (e.g., 'evidentiary record' vs. 'records of past debt issuances'), but the semantic meaning is equivalent. COMPLETENESS: The answer addresses all aspects of the original question regarding documentation retention practices and implications for historical capital structure disclosures. MINOR OBSERVATIONS: The LLM answer adds slightly more specific detail (Exhibit 4.4 designation) which enhances rather than detracts from accuracy. The characterization of the practice as 'deliberate documentation-retention policy' and 'systematic approach' directly mirrors the ground truth's assessment. No factual errors, calculation errors, or logical inconsistencies were identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 486,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Union Pacific trimmed the equity portion of its pension fund – and thus its corporate‑stock exposure – from a target of roughly **45 %–55 % of plan assets in 2022** (page 70) to a **20 %–30 % target for 2025** (page 54/74).  The actual corporate‑stock holding, which represented about **64 % of total plan assets in 2022‑23** (page 72 and page 56), was therefore being reduced as the plan moved to a higher‑debt, lower‑equity mix.  This shift reflects a deliberate de‑risking strategy that lowers exposure to equities and corporate stock in favor of more stable fixed‑income investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. CRITICAL ISSUES: (1) WRONG NUMBERS: The ground truth provides specific dollar amounts ($1,990M in 2022, $181M in 2023, $1,116M in 2024), but the LLM answer provides only percentage allocations (45%-55% in 2022, 20%-30% for 2025) without the actual dollar values requested. (2) MISSING KEY DATA: The LLM completely omits the dramatic 90%+ decline from 2022 to 2023 ($1,990M to $181M), which is the most significant finding in the ground truth. (3) INCORRECT PERCENTAGES: The LLM claims corporate stock represented 64% of total plan assets in 2022-23, but this contradicts the ground truth's focus on absolute dollar amounts showing a sharp decline. (4) INCOMPLETE TIME PERIOD: The LLM discusses 2025 targets but the question specifically asks about 2022-2024 evolution. (5) FAILED MULTI-HOP SYNTHESIS: The question asks 'how did allocation evolve' - this requires tracking the specific dollar amounts across three years, showing the dramatic drop and partial rebound. The LLM instead provides target percentages and general strategy statements without the precise quantitative evolution. (6) SEMANTIC MISMATCH: While both answers conclude the strategy was de-risking/conservative, the LLM fails to support this with the actual data showing the magnitude of the shift. The ground truth's specific numbers ($1,990M → $181M → $1,116M) are essential to answering the question; the LLM's percentage targets are not equivalent substitutes. The answer demonstrates understanding of the general strategy but fails on the core quantitative requirements of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 452,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nPrevymis sales have risen steadily from **$428 million in 2022 → $605 million in 2023 → $785 million in 2024** (U.S. + international totals shown in the 2024, 2023 and 2022 Hospital‑Acute‑Care rows of the segment‑sales table).  This compound‑annual growth of roughly **30 %** reflects accelerating uptake of the CMV‑prophylaxis product and signals that it is becoming a core, high‑growth driver within Merck’s Hospital Acute Care portfolio, underscoring its strategic importance to the segment’s future performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three sales figures are correct - $428M (2022), $605M (2023), $785M (2024). The CAGR calculation of ~30% is accurate: [(785/428)^(1/2) - 1] ≈ 35.4% for the 2-year period, though the LLM states 'roughly 30%' which is a reasonable approximation given rounding conventions. The year-over-year growth rates are: 2022-2023 = 41.4%, 2023-2024 = 29.8%, averaging ~35.6%, so 'roughly 30%' is slightly conservative but defensible as an approximation. (2) COMPLETENESS: The answer fully addresses both parts of the multi-part question - it traces the sales evolution across all three years and provides strategic interpretation about market adoption and importance. (3) ENTITY ACCURACY: Correctly identifies MRK (Merck), Prevymis product, CMV-prophylaxis indication, Hospital Acute Care segment, and all fiscal years. (4) MULTI-HOP REASONING: The synthesis is sound - the LLM correctly extracted sales data from segment tables and synthesized this into a narrative about product trajectory and strategic importance. The conclusion that Prevymis is becoming a 'core, high-growth driver' logically follows from the consistent 30%+ growth pattern. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth while adding valuable context about CMV-prophylaxis indication and CAGR calculation. Minor deduction: The CAGR figure of 'roughly 30%' is slightly understated (actual is ~35%), though this is presented as an approximation and doesn't materially affect the answer's correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 440,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings the 3.000% Senior Note due 2027 appears in the Exhibits list (as Exhibit 4.19 in 2022‑23 and as Exhibit 4.17 in 2024) and is described identically – a 3.000% senior unsecured note maturing in 2027 that was originally issued in 2017.  Its unchanged wording across the three years shows that PepsiCo continues to treat the note as a stable, low‑cost component of its long‑term debt ladder, using it to extend maturities and manage leverage as part of its broader strategy to fund operations while preserving a diversified, low‑risk capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility despite capturing some correct elements. CRITICAL ERRORS: (1) Exhibit number inconsistency - The LLM states the note appears as 'Exhibit 4.19 in 2022-23 and as Exhibit 4.17 in 2024,' but the ground truth specifies Exhibit 4.22 in 2022, Exhibit 4.19 in 2023, and Exhibit 4.17 in 2024. The LLM conflates 2022 and 2023 into a single exhibit number, which is factually incorrect. (2) Missing comparative context - The ground truth provides specific examples of companion instruments in each year (2.150% due 2024 and 2.250% due 2022 in 2022; 4.450% due 2046 and 3.450% due 2046 in 2023; 0.750% due 2027 and 1.125% due 2031 in 2024), demonstrating how the debt portfolio evolved. The LLM completely omits this comparative analysis, which is essential to answering the 'evolution' aspect of the question. (3) Incomplete synthesis - The ground truth reveals a strategic narrative: the note's context shifted from medium-term instruments (2022) to longer-dated instruments (2023) to newer, lower-rate instruments (2024), indicating adaptive debt management. The LLM merely states the note was 'unchanged' and 'stable,' missing the dynamic strategic evolution that the question specifically asks about. (4) Characterization accuracy - While the LLM correctly identifies the note as a 3.000% senior unsecured note maturing in 2027, it fails to capture how its role and context evolved relative to other debt instruments. CORRECT ELEMENTS: The LLM correctly identifies the note's interest rate (3.000%), maturity year (2027), and general characterization as part of a diversified debt strategy. The conclusion about managing leverage and preserving a diversified capital structure is reasonable but lacks the specific evidence from the ground truth. The multi-hop reasoning is incomplete because the LLM does not synthesize the year-by-year evolution of companion instruments that demonstrates PepsiCo's strategic adaptation to market conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 545,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nAcross 2022 Adobe introduced Frame.io as a cloud‑native review platform focused on video, delivering frame‑accurate commenting and “Camera‑to‑Cloud” uploads that were tightly built into Premiere Pro and After Effects. By 2023 the scope broadened: Frame.io added support for still images, design files and PDFs and was embedded in Adobe GenStudio together with Adobe Express and Firefly, enabling assets to be accessed and kept in sync directly from Photoshop and Illustrator. In 2024 Frame.io’s functionality is now fully woven into the Creative Cloud workflow, with deep, AI‑enhanced integration across all CC apps—so creators can edit, comment and publish assets seamlessly within Photoshop, Illustrator, Premiere Pro and the other Creative Cloud tools.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) TIMELINE INVERSION - The LLM answer places Frame.io's introduction and 'Camera-to-Cloud' uploads in 2022, but the ground truth indicates Frame.io was only listed in Adobe's trademark portfolio in 2022 (acquisition/branding alignment), with detailed functional capabilities first appearing in 2023. The LLM conflates 2022 and 2023 positioning. (2) MISSING KEY DETAILS - The LLM omits Lightroom and Workfront integration mentioned in the ground truth for 2024, and fails to mention Substance 3D tools. (3) INACCURATE 2023 POSITIONING - The LLM claims Frame.io was 'embedded in Adobe GenStudio together with Adobe Express and Firefly' in 2023, but the ground truth indicates GenStudio positioning emerged in 2024 as a core component. Adobe Express is not mentioned in the ground truth's 2023 description. (4) VAGUE 2024 DESCRIPTION - The LLM's 2024 description is generic ('fully woven into Creative Cloud workflow') without the specific enterprise-scale positioning and GenStudio context that distinguishes 2024 strategy. CORRECT ELEMENTS: The LLM correctly identifies frame-accurate commenting, real-time uploads, integration with Premiere Pro and After Effects, support for still images/design files/PDFs, and Photoshop/Illustrator integration. The overall narrative of deepening integration is correct. However, the temporal misalignment and missing enterprise/GenStudio context represent significant factual errors in a multi-hop timeline question where chronological accuracy is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 417,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nAcross the three filings Apple kept the 2.40 % Notes due 2023 in the “Description of Securities” exhibit (Exhibit 4.3), but the way the issue was presented changed as the maturity date approached: in the 2022 10‑K the notes were shown as a long‑term tranche, in the 2023 10‑K they appeared as a current‑portion liability (reflecting that repayment was now within one year), and by the 2024 10‑K the securities had been fully retired and replaced with newer, longer‑dated issuances.  This progression reveals Apple’s proactive, laddered debt‑maturity management—pre‑emptively rolling over maturing notes into fresh debt to keep the overall maturity profile staggered and avoid a large single‑date repayment burden.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the notes were 'kept' in exhibits across all three years and 'fully retired and replaced with newer, longer-dated issuances' by 2024. The ground truth explicitly states that by 2024, the notes 'were no longer listed in the exhibits,' indicating they were retired/fulfilled per their maturity date, not proactively rolled over. (2) STRATEGIC MISCHARACTERIZATION - The LLM describes Apple's approach as 'proactive, laddered debt-maturity management' with 'pre-emptively rolling over maturing notes into fresh debt.' The ground truth indicates the opposite: 'a strategy of holding debt until maturity rather than refinancing or repurchasing it early.' This is a fundamental misinterpretation of Apple's debt management approach. (3) ACCOUNTING CLASSIFICATION ERROR - The LLM claims the notes appeared as 'current-portion liability' in 2023, but provides no evidence this is accurate and contradicts the ground truth's simpler observation that they continued to be referenced. (4) MISSING KEY FACT - The ground truth emphasizes that there was 'no early retirement or restructuring action' in 2023, which the LLM completely overlooks. (5) EXHIBIT LOCATION - While the LLM specifies Exhibit 4.3, the ground truth references 'exhibit filings' more generally without confirming this specific exhibit number. The LLM's core narrative about proactive refinancing and rolling over debt is directly contradicted by the ground truth's statement about holding until maturity. The answer demonstrates poor multi-hop synthesis and reaches conclusions opposite to the actual facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 463,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nUnion Pacific’s Multiple‑Purpose Locomotive fleet remained close to 7,000 units, but its makeup changed noticeably from 2022 through 2024.  In 2022 the company reported about 5,971 owned and 1,037 leased MP‑Ls (total 7,008, average age ≈ 24 years); by 2024 owned units had risen slightly to 5,973 while leased units fell to 920 (total 6,893, average age ≈ 25.2 years).  This modest shift toward a higher proportion of owned locomotives and a modest increase in average age reflects Union Pacific’s asset‑management strategy of retaining and upgrading a core, fully‑owned fleet rather than expanding leased capacity, thereby controlling long‑term costs while maintaining the reliability needed for its network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine the entire response. (1) 2022 BASELINE ERROR: Ground truth states 7,242 total units in 2022 (6,204 owned + 1,038 leased), but LLM reports 7,008 total (5,971 owned + 1,037 leased). This is a discrepancy of 234 units in the starting point. (2) 2022 AVERAGE AGE ERROR: Ground truth clearly states 22.5 years in 2022, but LLM approximates it as '≈ 24 years' - this is a 1.5-year error in the baseline year, which is substantial and misrepresents the aging trend. (3) OWNED UNITS CLAIM: LLM states owned units 'had risen slightly to 5,973' from 5,971, but this is misleading framing. Ground truth shows owned units declined from 6,204 to 5,973 (a 231-unit decrease), not a rise. The LLM appears to have confused the 2022 baseline. (4) LEASED UNITS: Correctly identified as declining from ~1,037 to 920 (LLM says 1,037 to 920, which matches ground truth's 1,038 to 920 within rounding). (5) 2024 AVERAGE AGE: Correctly stated as 25.2 years. (6) TOTAL FLEET DECLINE: LLM correctly identifies the decline to 6,893 units in 2024. REASONING ISSUES: The LLM's interpretation of the trend is fundamentally flawed. It characterizes the shift as 'modest shift toward a higher proportion of owned locomotives,' but the ground truth shows owned units DECREASED from 6,204 to 5,973. The LLM's narrative about 'retaining and upgrading a core, fully-owned fleet' contradicts the actual data showing a net reduction in owned units. The LLM misses the key insight from ground truth: the aging fleet (22.5→25.2 years) combined with declining total units suggests 'lack of significant new investment' and a 'conservative asset management strategy,' not active upgrading. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year progression. It should have clearly shown: 2022 (7,242 total, 22.5 years avg) → 2023 (implied intermediate state, 24.3 years avg) → 2024 (6,893 total, 25.2 years avg). The LLM only addresses 2022 and 2024, missing the 2023 data point entirely. SEMANTIC ISSUES: The LLM's conclusion about 'upgrading' and 'controlling long-term costs' is speculative and contradicts the ground truth's assessment that the data indicates 'lack of significant new investment' and aging assets. The answer demonstrates partial understanding but contains multiple material factual errors that would mislead a reader about Union Pacific's actual fleet management trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 658,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept MK‑8591A (doravirine + islatravir) in its Phase 3 program—having entered Phase 3 in February 2020 (page 23) – but the program was paused when the FDA placed a clinical hold on the underlying islatravir IND in December 2021 (page 24, footnote 4).  Merck addressed the agency’s concerns, completed a Phase 2/3 weekly‑dose study of the islatravir + lenacapavir regimen in 2023, and on December 4 2024 the FDA lifted the clinical hold, clearing the way for the candidate to move toward a regulatory submission.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but contains significant factual discrepancies and omissions compared to the ground truth:\n\nCORRECT ELEMENTS:\n- MK-8591A (doravirine + islatravir) was in Phase 3 development\n- Entry date of February 2020 for Phase 3 is correct\n- FDA clinical hold was placed on the islatravir IND (December 2021 date provided)\n- FDA lifted the clinical hold in 2024\n- Merck worked on islatravir + lenacapavir combination\n\nSIGNIFICANT ERRORS/OMISSIONS:\n1. MISSING KEY FORMULATION: The ground truth explicitly states that MK-8591D (islatravir + lenacapavir) entered Phase 3 in October 2024. The LLM answer mentions the islatravir + lenacapavir regimen but fails to identify it as MK-8591D or note its October 2024 Phase 3 entry date. This is a critical omission for understanding Merck's strategic pivot.\n\n2. INCOMPLETE REGULATORY STATUS: The ground truth notes that \"a partial hold remained for higher doses of islatravir\" in 2024. The LLM answer states the clinical hold was \"lifted\" on December 4, 2024, without mentioning the partial hold that remained. This is a material factual difference.\n\n3. 2023 STATUS UNCLEAR: The ground truth explicitly states MK-8591A \"remained in Phase 3 and was under review\" in 2023, indicating no major regulatory advancements. The LLM answer mentions a Phase 2/3 weekly-dose study was \"completed\" in 2023 but doesn't clearly convey the stalled regulatory status.\n\n4. DECEMBER 4, 2024 DATE: The LLM provides a specific date (December 4, 2024) for the FDA lifting the clinical hold, but the ground truth only states \"2024\" without this specific date. This level of specificity cannot be verified against the ground truth.\n\nMULTI-HOP REASONING:\nThe LLM answer attempts to synthesize the trajectory but misses the key strategic element of the new MK-8591D formulation entering Phase 3, which is central to understanding Merck's evolving approach. The answer focuses heavily on the clinical hold narrative but underemphasizes the portfolio expansion aspect.\n\nQUANTITATIVE ACCURACY:\nDates provided (February 2020, December 2021, 2023, December 4 2024) are partially verifiable, but the December 4, 2024 specific date and the October 2024 Phase 3 entry for MK-8591D are critical omissions/discrepancies.\n\nOVERALL ASSESSMENT:\nThe answer captures the clinical hold narrative but fails to adequately address the strategic pivot to MK-8591D and misses the nuance about the partial hold remaining. These are significant gaps in a question specifically asking about \"clinical phase progression and FDA interactions\" evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 693,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nFrom 2022 through 2024 Merck advanced MK‑1308A from an early‑stage, first‑in‑human anti‑CTLA‑4 + pembrolizumab concept to a late‑stage, registration‑ready combination specifically positioned for renal cell carcinoma—highlighting its growing emphasis on RCC as a priority indication. The 2022 filing first listed MK‑1308A as an investigational RCC therapy, the 2023 pipeline tables showed it in later‑stage clinical testing, and the 2024 10‑K explicitly cites MK‑1308A as a core immuno‑oncology asset for RCC, underscoring Merck’s strategic focus on innovative combination immunotherapy for that disease.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims MK-1308A progressed from 'early-stage, first-in-human' in 2022 to 'late-stage, registration-ready' by 2024. The ground truth states it was listed as a Phase 3 program in 2022 (already late-stage), not first-in-human. This is a fundamental mischaracterization of the clinical development stage. (2) TIMELINE MISREPRESENTATION - The LLM suggests a progression from early to late stage across the 3-year period, but the ground truth indicates MK-1308A was already in Phase 3 in 2022 with an entry date of April 2021, meaning it was already in late-stage development. The actual progression was maintenance/sustained prioritization of an already-advanced program, not advancement from early to late stage. (3) MISSING KEY DETAILS - The ground truth specifically identifies the components (quavonlimab as anti-CTLA-4 antibody + pembrolizumab) and describes it as a 'coformulation,' which the LLM mentions but less precisely. (4) CORRECT ELEMENTS - The LLM correctly identifies: the 3-year trajectory (2022-2024), the immuno-oncology pillar focus, the RCC indication, the combination immunotherapy strategy, and the sustained prioritization. (5) SEMANTIC ISSUES - The phrase 'first-in-human anti-CTLA-4 + pembrolizumab concept' is misleading; it was already Phase 3 in 2022, not first-in-human. This represents a significant factual error that undermines the core narrative of the answer. The LLM's characterization of the progression is fundamentally incorrect regarding clinical development stage advancement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 433,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 are only mentioned in the identical “Third Supplemental Indenture” first filed in 2011; the company does not amend, retire or refinance that tranche in any of the later filings. This steady reference shows Microsoft is keeping the 4.000% 2021 notes as part of a broader, laddered senior‑unsecured debt program, using the indenture‑trust structure to maintain a stable long‑term debt profile rather than repeatedly refinancing that specific series.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates solid understanding of the multi-hop question. STRENGTHS: (1) Correctly identifies that the 4.000% Notes due 2021 appear consistently across 2022, 2023, and 2024 10-K filings; (2) Accurately references the Third Supplemental Indenture as the consistent disclosure vehicle; (3) Correctly notes the 2011 filing date (8-K on February 8, 2011 implied); (4) Properly concludes no refinancing or restructuring occurred; (5) Provides sound reasoning about Microsoft's debt strategy using indenture-trust structure. QUANTITATIVE ACCURACY: All dates and percentages are correct (4.000%, 2021 maturity, 2011 filing, 2022-2024 period). No calculation errors. MINOR WEAKNESSES: (1) The LLM answer adds interpretive language about 'laddered senior-unsecured debt program' and 'stable long-term debt profile' that goes slightly beyond what the ground truth explicitly states - these are reasonable inferences but represent minor elaboration beyond the factual consistency documented in the filings; (2) Ground truth emphasizes the 'May 18, 2009' original Indenture date, which the LLM answer does not mention, though this is a minor omission; (3) The phrase 'rather than repeatedly refinancing that specific series' is accurate but slightly more interpretive than the ground truth's more straightforward statement of consistency. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and draws appropriate conclusions about what the consistency means for debt structure. The logic is sound and the answer properly addresses both the 'how did it evolve' and 'what does this suggest' parts of the question. SEMANTIC EQUIVALENCE: The core message matches the ground truth - consistent disclosure, no changes, stable debt structure - despite slightly different framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 500,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive‑related revenue—driven by connectivity, digital‑cockpit and ADAS/AD platforms—grew from **$1.5 B to $2.9 B**, lifting its share of total QCT revenue from roughly **4 % to 9 %**.  This rapid expansion reflects Qualcomm’s strategic shift to make the automotive cockpit a core growth engine, leveraging its 5G, AI and edge‑computing expertise to power software‑defined, connected vehicles.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific revenue figures ($1.5B to $2.9B) and market share percentages (4% to 9%) that cannot be verified against the ground truth provided. The ground truth focuses on strategic positioning and the evolution of digital cockpit as a reported revenue category/product line from 2022-2024, NOT on absolute revenue numbers or segment percentages. The LLM appears to have introduced quantitative data that may or may not be accurate but is not addressed in the original answer. Critical issues: (1) The LLM provides specific dollar amounts and percentages without corroboration in the ground truth, which is problematic for a financial question where accuracy is paramount. (2) The LLM answer conflates 'automotive-related revenue' broadly with digital cockpit specifically, whereas the ground truth distinguishes between digital cockpit as ONE component alongside connectivity and ADAS/AD. (3) The ground truth emphasizes the CATEGORIZATION and STRATEGIC POSITIONING evolution (2022: identified as key driver → 2023: distinct revenue stream → 2024: core product line), while the LLM focuses on aggregate revenue growth. (4) The LLM does capture the core strategic narrative about software-defined vehicles and 5G/AI/edge computing, which aligns with ground truth context. (5) Multi-hop reasoning is partially sound (connecting revenue growth to strategic shift) but incomplete—the answer misses the key insight about formal integration into financial reporting and operationalization milestones. The answer is partially relevant but introduces unverified quantitative claims that dominate the response, which is inappropriate when the ground truth emphasizes strategic evolution rather than specific revenue figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 473,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nLockheed Martin’s variable‑interest‑rate swap program expanded materially over the period.  The filings show that the aggregate notional amount of outstanding interest‑rate swaps was roughly **$0.5 billion at the end of 2021** (the last disclosed figure for 2020‑21) and then **grew to $1.3 billion at both December 31 2023 and December 31 2024**.  This doubling of swap notional indicates that the company deliberately broadened its hedge coverage—primarily using variable‑rate swaps to convert a larger portion of its fixed‑rate debt to floating rates (or vice‑versa)—to better manage interest‑rate risk as market rates rose through 2022‑2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the response. (1) YEAR MISMATCH: The LLM states the baseline was '$0.5 billion at the end of 2021 (the last disclosed figure for 2020-21)' but the ground truth clearly establishes the 2022 figure as $500 million. The question explicitly asks about evolution 'from 2022 through 2024,' and the LLM should have used 2022 as the starting point, not 2021. (2) GROWTH CHARACTERIZATION ERROR: The LLM describes this as a 'doubling' of swap notional, but the ground truth shows a FOURFOLD increase from $500M (2022) to $1.3B (2023). This is a fundamental calculation error—a doubling would be $1.0B, not $1.3B. The LLM's characterization of 'doubling' is mathematically incorrect. (3) CORRECT ELEMENTS: The LLM correctly identifies that notional amounts were $1.3B in both 2023 and 2024, and correctly notes the stabilization pattern. The qualitative reasoning about interest rate risk management and debt conversion is sound and aligns with the ground truth interpretation. (4) MULTI-HOP SYNTHESIS: The LLM demonstrates reasonable understanding of the strategic implications (hedging, interest rate management) but fails to properly synthesize the quantitative evolution across the three-year period. The answer conflates 2021 baseline data with the 2022-2024 period requested. VERDICT: While the qualitative analysis is reasonable, the quantitative errors (wrong starting year, incorrect growth characterization as 'doubling' rather than 'fourfold') are material factual mistakes that significantly diminish the answer's reliability for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 463,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 3.950 % Notes due 2056 appear only in the original indenture and the 2016 supplemental indenture—no later supplemental indenture or explicit refinancing of that series is disclosed in any of the three filings.  Instead, the 2023 and 2024 filings devote attention to newer supplemental indentures for more near‑term debt (e.g., 2025‑2060 notes), indicating that Microsoft is managing its long‑term debt by laddering maturities and extending the overall horizon rather than rolling the 2056 tranche.  This treatment reflects a strategy of holding the 2056 notes as a stable, long‑dated funding pillar while refinancing nearer‑term obligations through fresh supplemental indentures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more nuanced interpretation of Microsoft's debt management strategy than the ground truth. Key strengths: (1) All numeric values are correct—3.950% rate, 2056 maturity date, August 8, 2016 indenture date are all accurate; (2) The multi-hop synthesis across 2022, 2023, and 2024 filings is sound, correctly identifying that the 3.950% Notes due 2056 appear consistently without modification; (3) The reasoning about debt laddering and maturity management is logically sound and well-articulated. The LLM answer goes beyond the ground truth by explicitly noting the absence of later supplemental indentures for this specific tranche and by providing more specific strategic context (laddering maturities, extending overall horizon, treating 2056 notes as a 'stable, long-dated funding pillar'). Minor differences from ground truth: (1) The LLM answer emphasizes the contrast with newer supplemental indentures for near-term debt more explicitly than the ground truth, which is a reasonable inference but represents a slightly different analytical angle; (2) The ground truth mentions specific examples of maturing shorter-term instruments (2.000% Notes due 2023, 2.400% Notes due 2026), while the LLM answer generalizes to '2025-2060 notes' without specific examples—this is less precise but not factually incorrect. The LLM answer's characterization of the strategy as 'holding the 2056 notes as a stable, long-dated funding pillar while refinancing nearer-term obligations' is semantically equivalent to and arguably more clearly articulated than the ground truth's 'strategic prioritization of long-dated liabilities to support long-term investment horizons.' No calculation errors detected. The answer appropriately addresses all aspects of the multi-part question regarding treatment across three years and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 514,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft repeatedly cites the Eleventh Supplemental Indenture (dated August 8 2016) in its 2022‑2024 filings to disclose the terms of the $3.7 billion 3.700% Notes due 2046, confirming that this long‑dated tranche remains outstanding and legally binding. By continuing to reference the same indenture across three consecutive annual reports, the company signals a stable, consistent long‑term debt structure and reinforces investor confidence in the durability of its financial obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: the Eleventh Supplemental Indenture dated August 8, 2016, the 3.700% Notes due 2046, and the consistent references across 2022-2024 filings. The answer accurately conveys that this reflects a stable debt structure and ongoing obligations. However, there are notable omissions compared to the ground truth: (1) The LLM specifies '$3.7 billion' as the principal amount, which is a specific quantitative claim not explicitly verified in the ground truth answer (the ground truth refers to '3.700% Notes due 2046' without stating the principal amount). This introduces potential quantitative risk if the actual principal differs. (2) The LLM omits important contextual details present in the ground truth: the base Indenture dated May 18, 2009, and the 'layered and structured approach' to long-term financing that demonstrates the broader debt management framework. (3) The ground truth explicitly notes 'no material amendments or retirements during this time,' which the LLM does not address. (4) The ground truth provides more comprehensive explanation of the significance (multi-decade financial planning, structured approach), while the LLM focuses more narrowly on investor confidence and durability. The LLM's core reasoning about consistency and stability is sound and semantically equivalent to the ground truth's main thesis. The date (August 8, 2016) and percentage (3.700%) are correct. The multi-hop synthesis across three years is present but less detailed than the ground truth. The answer is substantially correct but incomplete in addressing the full depth of the original question regarding long-term debt structure complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 462,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nMicrosoft first reported the 2.125 % Notes due 2021 in the 2013 Seventh Supplemental Indenture and, in the FY 2022 Form 10‑K (pages 104‑105), the securities were still listed as outstanding senior unsecured debt with a current‑portion balance that would mature in 2021.  By the FY 2023 and FY 2024 filings the 2.125 % 2021 notes no longer appear in the debt tables; instead the company’s exhibit list references later supplemental indentures (e.g., the November 6 2023 Fifteenth Supplemental Indenture) that issued new senior unsecured notes with later maturity dates.  This shift shows that Microsoft retired the 2021‑maturing tranche and replaced it with longer‑dated borrowing, reflecting a proactive debt‑management strategy to extend maturities and reduce near‑term refinancing pressure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 2.125% Notes due 2021 'no longer appear in the debt tables' by FY 2023 and FY 2024, but the ground truth explicitly states the notes were 'still referenced in Exhibit 4.1' in both 2023 and 2024 filings. This is a fundamental misrepresentation of the filing evidence. (2) CRITICAL ERROR - The LLM asserts Microsoft 'retired the 2021-maturing tranche and replaced it with longer-dated borrowing,' but the ground truth indicates the notes 'remained part of the company's active debt structure or disclosure obligations' and raises questions about whether they were refinanced or if there's a reporting lag. The LLM presents speculation as fact. (3) INCORRECT INTERPRETATION - The LLM's claim about 'later supplemental indentures (e.g., the November 6 2023 Fifteenth Supplemental Indenture)' replacing the 2021 notes is not supported by the ground truth, which shows the same indenture references persisting across all three years. (4) MISSING NUANCE - The ground truth acknowledges uncertainty ('may suggest either an extension or rollover...or a lack of updated exhibit filings'), while the LLM presents a definitive but unsupported narrative about debt retirement and replacement. (5) CORRECT ELEMENTS - The LLM correctly identifies the 2013 Seventh Supplemental Indenture date and the 2.125% rate, and correctly notes the 2021 maturity date. However, these correct details are embedded in an otherwise incorrect analysis. The LLM fundamentally mischaracterizes the evolution of disclosure across the three fiscal years, making this answer factually unreliable despite some correct peripheral details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 473,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nMicrosoft first created the 2.000 % Notes due 2023 through a 2013 supplemental indenture, and the 2022 Form 10‑K simply disclosed the outstanding balance of that tranche under the master indenture. In the 2023 filing the company executed a **Fifteenth Supplemental Indenture (Nov 6 2023)** that added new issuance to the same 2.000 % series, and the 2024 filing shows a further amendment (the **Sixteenth Supplemental Indenture**) that continues to expand and extend that tranche. This multi‑year pattern demonstrates Microsoft’s debt‑management strategy of issuing incremental, long‑dated fixed‑rate tranches under a master indenture to stagger maturities, lock in low‑cost financing and preserve liquidity for share repurchases and strategic investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. INDENTURE DATE ERROR: The LLM claims the notes were created through a '2013 supplemental indenture' but the ground truth explicitly states they were part of the 'Eleventh Supplemental Indenture dated August 8, 2016.' This is a fundamental factual error about the origin of the debt instrument.\n\n2. FIFTEENTH AND SIXTEENTH SUPPLEMENTAL INDENTURE CLAIMS: The LLM asserts that a 'Fifteenth Supplemental Indenture (Nov 6 2023)' added new issuance in 2023 and a 'Sixteenth Supplemental Indenture' in 2024. The ground truth makes no mention of these supplemental indentures or any new issuances. The ground truth explicitly states Microsoft 'maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023,' contradicting the LLM's claim of incremental new issuances.\n\n3. MISCHARACTERIZATION OF DEBT EVOLUTION: The LLM describes an active strategy of 'issuing incremental, long-dated fixed-rate tranches' and 'expanding and extending that tranche,' but the ground truth indicates the notes were simply consistently referenced across filings without new issuances or refinancing.\n\n4. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the multi-year pattern. The ground truth shows consistency and stability (same indenture referenced across three years), while the LLM incorrectly portrays active expansion and amendment.\n\n5. STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about debt management strategy (staggering maturities, locking in low-cost financing) is not supported by the ground truth, which emphasizes a 'stable and long-term approach' relying on 'established structures rather than frequent refinancing.'\n\nThe answer demonstrates fundamental misunderstanding of the actual debt instrument history and invents specific supplemental indenture references that are not supported by the ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 537,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin kept its pension‑risk‑transfer program active, continuing to purchase group‑annuity contracts (GACs) from its master retirement trust to off‑load portions of its defined‑benefit obligations.  Cumulatively since 2018 the company has transferred roughly $11.6 billion of pension liabilities—including the $4.9 billion GAC purchase in August 2021 that covered about 18,000 retirees— and, although it did not disclose new transfer volumes for 2022‑24, it repeatedly says it will keep evaluating such transactions.  The financial effect is a non‑cash settlement charge to earnings (e.g., the $1.7 billion charge recognized in 2021) that does not affect CAS pension costs but reduces the recorded pension obligation and future PBGC premium exposure, reflecting the firm’s strategy to lower long‑term pension volatility and stabilize earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative facts: $11.6 billion cumulative pension obligations transferred since 2018, the $4.9 billion August 2021 GAC transaction, the $1.7 billion noncash settlement charge from 2021, and approximately 18,000 retirees covered. The answer accurately describes the mechanism (GACs), the financial impact (noncash settlement charges), and the strategic intent (reducing pension volatility and PBGC premiums). The multi-hop synthesis across 2022-2024 is sound, correctly noting that while specific transfer volumes for 2022-24 weren't disclosed, the company maintained its evaluation strategy. WEAKNESSES: (1) The answer omits the specific mention of $69 million annual PBGC premium reduction, which was explicitly stated in the ground truth as a quantified benefit. (2) The answer states the company 'did not disclose new transfer volumes for 2022-24,' which is accurate but somewhat understates the ground truth's emphasis on the company's 'ongoing evaluation' and 'reaffirmed intent' to pursue further transactions in 2023-2024. (3) The answer could have been more explicit about the evolution/progression aspect of the question—the ground truth emphasizes 'increasing scale and financial clarity over time' and notes the company's acknowledgment of 'potential for additional contributions or noncash settlement charges' in 2023. The LLM answer addresses the core question but misses some nuance about the strategic evolution and forward-looking statements. CALCULATION VERIFICATION: All numbers are accurate; no calculation errors detected. ENTITY ACCURACY: Lockheed Martin correctly identified; GACs, PBGC, CAS pension costs all correctly referenced. MULTI-HOP REASONING: Correctly synthesizes information across multiple years and filing periods, though could have emphasized the strategic evolution more explicitly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 508,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated citation of Apple’s “Floating Rate Notes due 2019” in the 2022‑2024 Form 10‑K filings shows that this series is a cornerstone of the company’s laddered floating‑rate debt program. By continually referencing the 2019 notes, Apple signals that it manages its long‑term debt through systematic roll‑overs into newer floating‑rate issuances, preserving liquidity and hedging interest‑rate risk while maintaining a stable, low‑cost capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The dates are accurate - the notes are indeed referenced in 2022-2024 filings despite maturing in 2019. (2) The general concept of debt management through refinancing is sound. (3) The mention of floating-rate debt and interest-rate hedging is contextually appropriate. PROBLEMATIC ASPECTS: (1) The LLM introduces unsupported claims not in the ground truth, specifically describing this as 'a cornerstone of the company's laddered floating-rate debt program' - this is speculation beyond what the filings indicate. (2) The LLM claims Apple 'signals' systematic roll-overs into newer floating-rate issuances, but the ground truth is more cautious, suggesting these 'may have been' rolled over or repriced. (3) The LLM asserts specific strategic purposes ('preserving liquidity and hedging interest-rate risk') that are not explicitly stated in the ground truth answer. (4) The ground truth emphasizes 'transparency around historical debt instruments' and a 'disciplined and predictable capital structure strategy,' while the LLM focuses on operational mechanics without addressing the transparency/disclosure aspect. MULTI-HOP REASONING: The LLM correctly synthesizes that continued references to 2019 notes in 2022-2024 filings indicates ongoing debt management, but overstates the certainty of the mechanism. The ground truth appropriately uses conditional language ('may have,' 'suggesting') while the LLM presents interpretations as facts. SEMANTIC EQUIVALENCE: While both answers address debt management strategy, the LLM's interpretation is more prescriptive and less grounded in what the filings actually demonstrate versus what can be inferred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 473,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nThe 4.000% Notes due 2021 are first disclosed in the 2022 10‑K only as part of Exhibit 4.6 – the 2011 Third Supplemental Indenture that originally created the series. In the 2023 filing the same Exhibit 4.6 remains in the list, but it is now grouped with newer supplemental indentures (e.g., Exhibits 4.15‑4.18) that do not mention the 2021 tranche, signalling that the company is still filing the legacy indenture but is adding more recent debt packages. By the 2024 filing the reference to the 4.000% Notes due 2021 disappears from the exhibit list altogether, showing that the instrument has been fully retired and is no longer a material component of Microsoft’s outstanding debt structure. This evolution indicates that the legacy 4.000% 2021 notes have lost relevance as Microsoft shifts to newer, longer‑dated financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) FACTUAL CONTRADICTION - The ground truth states the 4.000% Notes due 2021 were 'consistently referenced' across 2022, 2023, and 2024 filings, but the LLM claims the reference 'disappears from the exhibit list altogether' by 2024. This is a direct contradiction on a core factual claim. (2) INCORRECT NARRATIVE - The LLM asserts the notes were 'fully retired' and 'no longer a material component' by 2024, but the ground truth indicates they 'remained a part of its structured debt disclosures' across all three years, suggesting ongoing relevance. (3) MISCHARACTERIZATION OF EXHIBIT EVOLUTION - The LLM describes a progression where references diminish and disappear, but the ground truth indicates consistent inclusion in Exhibit 4.6 across all three years. (4) LOGICAL INFERENCE ERROR - The LLM's conclusion that disappearance from exhibits indicates retirement contradicts the ground truth's explanation that consistent inclusion suggests 'ongoing legal or structural relevance' such as covenants or indentures. (5) MISSING KEY INSIGHT - The LLM fails to recognize that post-maturity inclusion in filings typically indicates continued structural relevance rather than retirement, which is the core insight of the ground truth. The LLM answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required, incorrectly tracking the evolution of references across the three years and reaching an opposite conclusion from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 430,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nAcross 2022‑2024 UPS continued to report its $276 million 7.620 % debentures as long‑term, non‑sinking‑fund debt maturing on April 1, 2030, with the same redemption mechanics: the debentures are callable at any time at the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury yield + 5 bps, plus accrued interest.  The interest‑payment schedule (semi‑annual in April and October) and the fixed 7.620 % rate (fixed after the 2020 step‑down from 8.375 %) were unchanged, but the 2023 and 2024 filings added clearer language about the call‑option and updated the carrying value to about $280 million, positioning the issue as a modest yet fully disclosed component of UPS’s overall long‑term debt portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key quantitative details: $276 million principal amount, 7.620% fixed rate, April 1, 2030 maturity date, semi-annual interest payments (April and October), and the prior 8.375% rate until April 2020. The redemption mechanics are accurately described (greater of principal plus accrued interest or present value of remaining payments discounted at Treasury yield plus 5 basis points). The carrying value of approximately $280 million is correctly noted. The LLM successfully synthesizes the multi-hop information across three years (2022-2024) and correctly identifies the evolution in disclosure treatment. However, the LLM answer differs from the ground truth in one important aspect: it states the redemption price includes 'plus accrued interest' as a separate component after the present value calculation, whereas the ground truth indicates the redemption terms allow redemption at 'the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points' - meaning accrued interest is part of the first option, not an additional component. This is a minor technical distinction in how the redemption mechanics are articulated. The LLM captures the broader narrative arc of the disclosure evolution (from historical context to structural/comparative treatment within global debt portfolio) but expresses it more concisely than the ground truth. The answer appropriately addresses all parts of the multi-part question regarding redemption terms, interest payment structure, and debt positioning. The contextual framing as a 'modest yet fully disclosed component' aligns well with the ground truth's characterization of the debentures within UPS's broader debt portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 499,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nFrom 2022 through 2023 Vraylar’s net sales jumped ≈ 35 % to $2.76 billion, driven by the 2021 FDA approval of Vraylar as an adjunctive therapy for major‑depressive disorder and sustained uptake across its schizophrenia, bipolar‑disorder and other CNS indications, which gave the product strong market‑share gains and pricing power; 2024 continued this momentum with double‑digit revenue growth and the highest margins of any AbbVie portfolio segment.  This rapid, high‑margin expansion makes Vraylar a cornerstone of AbbVie’s neuroscience strategy, supplying a growth engine that offsets declining legacy franchises and shaping the company’s long‑term focus on CNS therapeutics.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Vraylar's 35% YoY growth to approximately $2.76 billion in 2023, matching the ground truth of $2,759 million. It accurately captures the product's indications (schizophrenia, bipolar disorder, adjunctive MDD) and correctly characterizes Vraylar as a strategic cornerstone of ABBV's neuroscience portfolio. The reasoning about Vraylar transitioning to a key revenue driver is sound and well-articulated.\n\nCRITICAL ERRORS: (1) The LLM states the 2021 FDA approval for adjunctive MDD therapy, but the ground truth indicates 2022 was when ABBV announced Phase 3 trial results for MDD adjunctive treatment—one meeting primary endpoint, one showing numerical but not statistically significant improvement. This is a significant factual error regarding the timeline and regulatory status of the MDD indication. (2) The LLM claims 2024 showed 'double-digit revenue growth' and 'highest margins of any AbbVie portfolio segment,' but the ground truth provides no 2024 financial data—only 2023 data. This represents unsupported claims about 2024 performance.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about Vraylar's clinical development, commercial performance, and strategic importance. However, the temporal sequencing is problematic—conflating 2021 approval with 2022 trial announcements creates confusion about the product's development trajectory.\n\nCOMPLETENESS: The answer addresses the evolution question but incompletely. It covers 2022-2023 adequately but makes unsubstantiated claims about 2024 rather than acknowledging data limitations. The ground truth explicitly states Vraylar was 'clearly established in the market' by 2024 with multiple indications, but doesn't provide 2024 financial metrics.\n\nQUANTITATIVE ISSUES: The $2.76 billion figure is correct (matches $2,759M), and the 35% growth rate is accurate. However, the unsupported 2024 claims and the FDA approval date error reduce quantitative reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 536,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe repeated citation of the 0.45 % Notes due 2016 in Apple’s 2022‑2024 Form 10‑K filings shows that the company still references this legacy tranche in its governing indenture and global‑notes disclosures.  This signals that Apple treats older debt series as permanent components of its capital‑structure reporting, preserving continuity of covenants and giving investors a complete picture of all outstanding obligations—even those that have matured or are no longer actively issued.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 0.45% Notes due 2016 and acknowledges their inclusion across Apple's 2022-2024 filings, with accurate numeric and date references. However, there are significant issues with the reasoning and interpretation: (1) QUANTITATIVE ACCURACY: The percentage (0.45%) and years (2022, 2023, 2024, 2016) are all correct. No calculation errors present. (2) FACTUAL ISSUES: The LLM claims these notes are 'outstanding obligations' and part of 'all outstanding obligations,' which contradicts the ground truth that these notes matured in 2016 and are therefore NOT currently outstanding. This is a critical semantic error that misrepresents Apple's debt position. (3) REASONING PROBLEMS: The ground truth emphasizes that Apple discloses these notes DESPITE their maturity (historical/legacy disclosure), while the LLM suggests they remain 'outstanding' and are 'permanent components' of current capital structure. This fundamentally mischaracterizes the disclosure strategy. The LLM's explanation about 'preserving continuity of covenants' is speculative and not supported by the ground truth. (4) MISSING CONTEXT: The LLM fails to explicitly note that these are MATURED instruments being disclosed for historical/transparency purposes, not active debt obligations. The ground truth specifically emphasizes the 'persistence of this disclosure, even after the notes' maturity' as the key insight. (5) PARTIAL CREDIT: The LLM does correctly identify the multi-year pattern and the concept of legacy/historical disclosure, but the interpretation that these remain 'outstanding' obligations significantly undermines the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 454,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost remained positioned as the residential‑ground service for low‑urgency, lightweight shipments within the U.S. Domestic Package portfolio, leveraging the broader UPS ground network while traditionally handing final delivery to the United States Postal Service.  During 2024 the company announced that, effective January 1 2025, it would insource that final‑delivery step, ending reliance on USPS and integrating SurePost more tightly into its own ground operations.  This shift—part of the “Fit to Serve”/“Efficiency Reimagined” network‑right‑sizing initiatives—reflects a strategic move to gain greater control over service consistency, improve profitability and align SurePost with the higher‑yielding volume focus of UPS’s U.S. domestic business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. All key facts are correct: (1) UPS SurePost's positioning as a residential ground service for non-urgent, lightweight shipments is accurately described; (2) the traditional reliance on USPS for final delivery is correctly stated; (3) the January 1, 2025 insourcing announcement is accurately dated and described; (4) the shift from USPS to internal control is properly characterized. Quantitative accuracy is perfect—all dates (2022, 2023, 2024, January 1, 2025) are correct with no calculation errors. Entity identification is accurate throughout (UPS, USPS, U.S. Domestic Package business). The multi-hop reasoning is sound: the answer correctly synthesizes the evolution across three years and identifies the strategic transformation. The LLM answer goes slightly beyond the ground truth by adding contextual information about 'Fit to Serve'/'Efficiency Reimagined' initiatives and mentioning profitability and higher-yielding volume focus, which provides valuable strategic context without contradicting the original answer. The semantic equivalence is strong—phrases like 'residential-ground service for low-urgency, lightweight shipments' and 'leveraging the broader UPS ground network' convey the same meaning as the ground truth. The only minor distinction is that the LLM provides additional strategic context (profitability, network-right-sizing initiatives) that enriches understanding without introducing factual errors. This represents a comprehensive, accurate, and well-reasoned response to a complex multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 447,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nFrom 2022 through 2024 each Apple Form 10‑K continues to list the 4.45 % Notes due 2044 under Exhibit 4.4, showing that the company has repeatedly re‑issued or reaffirmed this tranche as part of its long‑term debt program. The persistent presence of the 4.45 % 2044 notes across three consecutive filings indicates Apple’s strategy of securing multi‑decade, fixed‑rate financing to fund its capital‑intensive growth while maintaining a stable, low‑cost debt profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 4.45% Notes due 2044 and accurately notes their presence across 2022-2024 filings. The percentage rate (4.45%) and maturity year (2044) are correct. The answer appropriately recognizes the multi-year pattern and attempts to interpret Apple's capital strategy. WEAKNESSES: (1) The LLM claims Apple 'repeatedly re-issued or reaffirmed this tranche' - this is a factual overstatement. The ground truth indicates the notes were consistently referenced but NOT re-issued; they were maintained on the books without early redemption or restructuring. Re-issuance implies new debt issuance, which is not supported. (2) The LLM references 'Exhibit 4.4' as the location, but the ground truth references an 'Officer's Certificate dated May 6, 2014' - while both may be correct filing locations, the LLM introduces a specific exhibit number not mentioned in the ground truth. (3) The phrase 'securing multi-decade, fixed-rate financing to fund its capital-intensive growth' is somewhat speculative and not directly supported by the ground truth, which focuses on maintaining the liability without restructuring and managing interest rate risk. (4) The ground truth emphasizes 'sustained reliance' and 'strategic decision to retain' existing debt, while the LLM's language about 're-issuance' and 'securing financing' suggests new capital raising rather than retention of existing obligations. MULTI-HOP REASONING: The LLM does synthesize information across three years correctly, but the interpretation of what the pattern means differs from ground truth - the LLM emphasizes active capital strategy while ground truth emphasizes passive retention and risk management. CALCULATION/NUMERIC VERIFICATION: All numbers (4.45%, 2044, years 2022-2024) are accurate with no calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 493,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle repeatedly lists the indenture for its 2.875 % Notes due 2031 as **Exhibit 4.14**, merely updating the filing‑date and officer‑certificate references each year.  This consistent placement in the debt‑exhibit section signals that the company treats the 2.875 % tranche as a permanent, long‑term component of its capital structure and maintains a stable, laddered debt‑issuance framework without re‑classifying or removing it.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core finding: the 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 across Oracle's 2022, 2023, and 2024 10-K filings with no modifications to terms. All numeric values (2.875%, 2031 maturity date, Exhibit 4.14) are correct. The answer accurately captures the multi-hop synthesis across three years of filings and correctly interprets what this consistency reveals about Oracle's capital structure management—stability and a long-term debt strategy without re-classification or removal. The LLM's characterization of the Notes as a 'permanent, long-term component' and reference to a 'stable, laddered debt-issuance framework' aligns well with the ground truth's conclusion about 'stable approach to capital structure management' and 'consistent long-term debt strategy.' Minor differences: (1) The LLM mentions 'updating the filing-date and officer-certificate references each year' which is a reasonable inference but not explicitly stated in the ground truth; however, this is consistent with standard filing practices and doesn't contradict the source material. (2) The LLM uses slightly different phrasing ('permanent, long-term component' vs. 'stable approach') but conveys equivalent meaning. (3) The ground truth specifically mentions the Officers' Certificate date of March 24, 2021, which the LLM does not include—this is a minor omission of contextual detail but doesn't affect the core answer's correctness. The reasoning is sound, the multi-hop synthesis across three years is properly executed, and the interpretation of what consistent exhibit positioning reveals about debt strategy is accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 471,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 national master agreement that Teamsters members ratified added retroactive wage and benefit increases to the UPS/IBT Full‑Time Employee Pension Plan, which raised the plan’s benefit formulas and therefore increased the projected benefit obligation and net‑periodic pension cost that were recorded in the 2023 year‑end measurement (see page 92 and page 83). In the 2024 disclosures the plan’s future accruals were frozen as of January 1 2023, and the liability is now measured with a 5.88 % discount rate and a 7.17 % expected return on assets, showing that UPS’s long‑term pension obligation is essentially locked in and will be settled over the remaining service lives of participants rather than growing with future wage increases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CRITICAL FACTUAL ERROR - The LLM claims 'future accruals were frozen as of January 1 2023' which directly contradicts the ground truth stating the 2023 agreement 'included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals.' A freeze would mean NO accruals, but the ground truth indicates accruals INCREASED due to the 2023 agreement. This is a fundamental misunderstanding of the pension plan changes. (2) UNVERIFIED NUMBERS - The LLM provides specific discount rate (5.88%) and expected return on assets (7.17%) figures with page citations (pages 92 and 83) that cannot be verified against the ground truth. These appear to be fabricated or incorrectly sourced details. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the 2023 Teamsters agreement and its impact on benefit formulas/PBO, it then contradicts itself by claiming accruals were frozen, which undermines the entire analysis. (4) CORRECT ELEMENTS - The LLM does correctly identify: (a) the 2023 national master agreement ratification, (b) wage and benefit increases, (c) impact on projected benefit obligation and net periodic pension cost, (d) year-end 2023 measurement timing. (5) LOGICAL INCONSISTENCY - The statement 'pension obligation is essentially locked in and will be settled over remaining service lives' contradicts the premise that accruals increased in 2023. If accruals increased, obligations are NOT locked in at pre-2023 levels. The ground truth indicates ongoing defined benefit commitments, not a frozen plan. VERDICT: The answer contains some correct foundational facts but makes a critical error about plan freezing that reverses the actual impact of the 2023 agreement, and introduces unverified specific percentages that appear to be hallucinated details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 500,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nApple’s 1.05 % Notes due 2017 appear in each of the 2022, 2023 and 2024 10‑K filings as part of the same “Officer’s Certificate” originally filed on May 6 2014 (Exhibit 4.4).  In the 2022 filing the notes are listed under Item 4.4 with a May 6 2014 filing date; the 2023 filing repeats the identical description, merely updating the filing date to May 3 2023; and the 2024 filing again reproduces the same entry, now dated May 6 2014 but still referencing the 2014 certificate.  This unchanged, repeatedly‑re‑filed language shows that Apple treats the 1.05 % Notes as a stable, long‑standing short‑term debt instrument governed by its original 2014 Officer’s Certificate, underscoring a deliberate, low‑maintenance approach to managing its short‑term financing and preserving consistency for investors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) FACTUAL ERROR - The LLM claims the 2023 filing 'updates the filing date to May 3 2023' which contradicts both the ground truth and logical consistency. The ground truth explicitly states the disclosure 'remained unchanged across all three years' and was 'consistently described...as part of the Officer's Certificate dated May 6, 2014.' The LLM's assertion that the 2023 filing has a different date (May 3 2023) is a significant factual error that undermines the core claim of consistency. (2) INCONSISTENT LOGIC - The LLM then contradicts itself by stating the 2024 filing is 'dated May 6 2014 but still referencing the 2014 certificate,' which is confusing and suggests the LLM is uncertain about the actual dates. (3) CITATION ISSUE - The LLM references 'Item 4.4' and 'Exhibit 4.4' without clear verification these are correct exhibit numbers for debt disclosures in Apple's filings. (4) PARTIAL CORRECTNESS - The LLM correctly identifies: the 1.05% Notes, the May 6, 2014 Officer's Certificate date, the appearance across 2022/2023/2024 filings, and the general concept of unchanged/stable disclosure. (5) REASONING QUALITY - The qualitative interpretation about Apple's 'deliberate, low-maintenance approach' is reasonable and aligns with ground truth, but is undermined by the factual errors about filing dates. (6) MULTI-HOP SYNTHESIS - The answer attempts to synthesize across three years but fails to accurately represent the consistency claim due to the erroneous May 3 2023 date assertion. The ground truth's key insight—that the disclosure remained 'unchanged' and 'consistent'—is contradicted by the LLM's claim of date variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 458,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nFrom 2022 through 2024 the 2.40 % Notes due 2023 remained in the company’s disclosure as part of the indenture language (Exhibit 4.3) in the 2022 and 2023 Form 10‑Ks, but by the 2024 filing the notes were no longer listed as outstanding—having been retired and replaced by newer tranches such as the 4.421 % Notes due 2026 that were added in the May 10 2023 officer’s certificate.  This three‑year evolution shows Apple’s long‑term debt strategy of continuously rolling a ladder of senior unsecured notes, issuing fresh low‑coupon bonds at later maturities and retiring older tranches as they mature to maintain a staggered, low‑cost financing profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth on the core factual claim. Ground truth states: the 2.40% Notes due 2023 disclosure remained consistent across 2022, 2023, and 2024 10-K filings with no changes. LLM answer claims: by 2024 the notes were no longer listed as outstanding and had been retired/replaced. This is a direct factual contradiction on the primary question. Specific errors: (1) LLM incorrectly states the notes were retired by 2024 when ground truth indicates they remained disclosed through 2024; (2) LLM references a May 10, 2023 officer's certificate adding 4.421% Notes due 2026, but ground truth specifies the Officer's Certificate was dated May 3, 2013 (10-year discrepancy); (3) LLM's interpretation of the multi-year pattern is inverted—it suggests active rolling/replacement strategy when ground truth indicates static, consistent disclosure suggesting planned maturity as originally structured. The LLM does correctly identify that this is about senior unsecured notes and attempts to address the multi-year evolution question, which provides some contextual relevance. However, the fundamental factual errors about whether the notes were retired, the dates of certificates, and the interpretation of what the static disclosure means make this answer substantially incorrect. The reasoning about debt laddering strategy, while plausible in general, is applied to an incorrect factual premise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 399,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nFrom 2022 through 2024 Vraylar’s sales accelerated steadily—rising from about $2.1 billion in 2021 to $2.8 billion in 2023 and continuing to grow in 2024—driven by expanding market share and the 2023 FDA approval of Vraylar as an adjunctive treatment for major‑depressive disorder.  Clinically, the drug broadened beyond its original schizophrenia and bipolar indications into the new MDD adjunct role (and later additional label extensions), cementing its status as a core neuroscience asset alongside Botox Therapeutic and Qulipta.  This expanding indication set underlies the double‑digit revenue growth recorded each year of the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key therapeutic trajectory (schizophrenia/bipolar to MDD adjunct), appropriately characterizes Vraylar as a core neuroscience asset, and accurately notes the 2023 FDA approval for MDD adjunctive treatment. The qualitative positioning and multi-hop synthesis across clinical development and commercial importance is sound. CRITICAL ERRORS: (1) QUANTITATIVE INACCURACY - The LLM states sales 'rising from about $2.1 billion in 2021' but the ground truth provides 2022 U.S. sales of $2,037 million ($2.037B), not 2021 data. The LLM conflates or misidentifies the baseline year. (2) INCOMPLETE SPECIFICITY - Ground truth provides precise 2023 total sales of $2,759 million and U.S. sales of $2,755 million with a calculated 35.2% growth rate from 2022 to 2023. The LLM vaguely states '$2.8 billion in 2023' (rounding acceptable) but fails to provide the specific growth percentage or detailed year-over-year comparison that was in the ground truth. (3) MISSING CLINICAL DETAIL - Ground truth specifies 'one successful Phase 3 trial and a numerically positive but non-significant result in another' for 2022 MDD development. The LLM mentions the 2023 FDA approval but omits the 2022 clinical trial details entirely. (4) VAGUE 2024 REFERENCE - The LLM states 'continuing to grow in 2024' and mentions 'later additional label extensions' but provides no specific 2024 revenue figures or clinical milestones, whereas ground truth explicitly states 2024 positioning with all three indications. The answer demonstrates good qualitative understanding but lacks the quantitative precision and temporal specificity required for a multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 463,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nIBM repeatedly cites “client relationships and trust” as a core competitive advantage—first in the 2022 10‑K (pp. 2‑6) as one of several “principal methods of competition,” then in the 2023 filing (pp. 1‑5) it ties that trust directly to its hybrid‑cloud and AI strategy, emphasizing that the company’s brand and deep industry expertise let it “differentiate from other providers” in a crowded market. By the 2024 report (pp. 1‑5) the language is even more explicit, stating that this trusted brand “positions IBM for accelerated growth now and prepares us for the next set of business opportunities, such as quantum computing.” Thus, over the three years IBM has sharpened its positioning around a trusted, long‑term client relationship model that underpins and differentiates its hybrid‑cloud and AI offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate temporal framing; (2) Accurately captures the evolution of IBM's messaging from trust as a competitive method (2022) to integration with hybrid cloud/AI strategy (2023) to broader ecosystem positioning (2024); (3) Properly synthesizes multi-hop information across three separate 10-K filings; (4) Correctly identifies the core strategic positioning around client relationships and trust; (5) Appropriately references quantum computing as an emerging opportunity mentioned in 2024 filing. MINOR GAPS: (1) The LLM answer emphasizes the 'sharpening' and 'explicit' nature of positioning but doesn't fully capture the ground truth's insight about trust evolving from a 'value proposition' to an 'enabler of integrated, client-centric innovation'—a subtle but important strategic distinction; (2) The ground truth explicitly mentions 'strategic partnerships' and 'alliances' as a 2023 development, which the LLM answer doesn't explicitly highlight (though it's implied in the ecosystem reference); (3) The LLM answer doesn't explicitly mention the 'industry expertise' angle that appears in the ground truth's 2022 characterization. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high (9/10) with only minor page reference variations that don't affect factual accuracy. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct, though the LLM could have been more explicit about the partnership/alliance evolution. CONTEXTUAL RELEVANCE: The answer directly addresses the question about strategic positioning in hybrid cloud and AI markets and provides appropriate context about competitive differentiation. The inclusion of quantum computing shows awareness of IBM's forward-looking strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 532,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 IBM’s filings continue to refer to the original 2019 Form 8‑K (Exhibit 4.3) as the governing instrument for the 1.250 % Notes due 2027, indicating that no term or covenant changes have been made. The notes remain listed in IBM’s capital‑stock table (e.g., IBM27B) and are still presented as part of its senior unsecured debt portfolio, with the only evolution being the routine incorporation of the same exhibit in each year’s 10‑K.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF EVOLUTION: The ground truth explicitly describes a progression showing increasing transparency and formalization (2022 exhibit reference → 2023 broader debt structure → 2024 explicit listing with trading symbol). The LLM answer claims 'the only evolution being routine incorporation' and 'no term or covenant changes,' which fundamentally misses the documented progression of disclosure practices. (2) MISSING KEY DETAILS: The ground truth identifies specific filing dates (January 30, 2019 for 2022; February 8, 2022 for 2023) showing how references evolved. The LLM answer omits these temporal details entirely. (3) MISCHARACTERIZATION OF 2024 STATUS: The ground truth notes the 2024 listing as 'explicitly listed' with 'distinct trading symbol (IBM27B)' showing they 'had become a formally recognized and actively traded financial instrument' - indicating a notable change in disclosure prominence. The LLM answer treats IBM27B as merely routine continuation ('still presented'). (4) INCORRECT INFERENCE: The LLM claims 'no term or covenant changes have been made' based on continued reference to the 2019 Form 8-K. This is a logical error - consistent legal documentation does not preclude changes in disclosure practices or portfolio prominence, which is what the question asks about. (5) QUANTITATIVE ACCURACY: The dates and exhibit references mentioned are correct (2019 Form 8-K, Exhibit 4.3, IBM27B), but the interpretation of their significance is wrong. (6) MULTI-HOP REASONING FAILURE: The question asks about evolution in 'disclosure practices and the instrument's role within the company's debt portfolio.' The LLM failed to synthesize the progression across three years showing increasing formalization and transparency, instead claiming static treatment. The answer demonstrates poor comprehension of the nuanced evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 541,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nAcross IBM’s 2022, 2023 and 2024 Form 10‑K filings, the rights of the 6.50 % Debentures due 2028 are consistently described as being set out in **Exhibit 2 to the Form 8‑K filed on January 8 1998**, and that same exhibit reference appears in each year’s “ Instruments defining the rights of security holders” section. While the surrounding tables of debenture exhibits have grown to include newer series and supplemental indentures (e.g., a 2024 First Supplemental Indenture for other notes), the citation for the 6.50 % 2028 notes has remained unchanged, reflecting IBM’s stable practice of incorporating the original 1998 exhibit for that long‑standing debt issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core finding: IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K filed on January 8, 1998 across 2022, 2023, and 2024. All numeric values are correct (6.50%, 2028 maturity, January 8, 1998 date). The answer accurately captures the key multi-hop synthesis requirement by showing consistency in exhibit references across three years while acknowledging the broader evolution of debt disclosures. The LLM correctly identifies that newer instruments (6.22% Debentures due 2027, 5.875% Debentures due 2032, and supplemental indentures) were added to the disclosure landscape, while the 6.50% 2028 debentures maintained their original exhibit reference. The reasoning is sound and the multi-hop synthesis across years is properly executed. Minor differences from the ground truth: (1) The LLM answer is more concise and focused on the specific exhibit reference consistency, while the ground truth provides slightly more contextual detail about the broader debt management evolution and investor clarity implications. (2) The LLM mentions 'First Supplemental Indenture for other notes' in 2024 as an example of growing complexity, which adds specificity but is not explicitly contradicted by the ground truth. (3) The ground truth emphasizes the regulatory compliance and investor understanding implications more explicitly, while the LLM focuses on the factual consistency. These are complementary rather than contradictory perspectives. The answer fully addresses the question's three components: (1) how disclosures evolved (consistency in exhibit references despite broader changes), (2) consistency of exhibit references (confirmed as unchanged), and (3) broader context of debt disclosures (acknowledged with examples). No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 511,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nFrom 2022 to 2024 the FedEx International Connect Plus e‑commerce service grew markedly: it expanded from “nearly 50 origin countries to over 130 destinations” (2022) to “nearly 60 origin countries to over 190 destinations” (2024), adding dozens of new origin markets and roughly 60 additional destination markets. This rapid geographic widening reflects FedEx’s strategic pivot toward building a global, day‑definite cross‑border e‑commerce logistics platform that can capture the surge in online retail shipments and integrate tightly with its broader network and digital commerce solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the geographic expansion trajectory but contains a significant omission regarding the 2023 data point. QUANTITATIVE ACCURACY: The numbers provided are accurate - 2022 (nearly 50 origin, over 130 destination) and 2024 (nearly 60 origin, over 190 destination) match the ground truth exactly. The calculation of 'roughly 60 additional destination markets' (190-130=60) is correct. However, the LLM conflates the 2022-2024 period without explicitly mentioning the critical 2023 milestone (nearly 60 origin, over 190 destination), which is important for understanding the expansion trajectory. The ground truth shows the major expansion occurred between 2022-2023, with stabilization in 2024. COMPLETENESS: The answer addresses the 'how did it evolve' portion but incompletely captures the full trajectory by omitting the 2023 data point. This is a notable gap since the question asks about evolution 'from 2022 to 2024,' implying a year-by-year or phase-by-phase analysis. ENTITY ACCURACY: All entities are correct - FedEx, International Connect Plus, e-commerce focus, and the time period. REASONING: The multi-hop synthesis is sound - the LLM correctly identifies the strategic implications (global e-commerce platform, cross-border logistics focus, integration with broader network). However, it misses the important insight from the ground truth that the expansion was followed by stabilization, suggesting a completed deployment phase rather than ongoing growth. SEMANTIC EQUIVALENCE: The characterization of FedEx's strategic focus is appropriate and matches the ground truth's assessment of 'deliberate and aggressive expansion' into e-commerce markets. The main weakness is the omission of the 2023 data point and the resulting incomplete picture of the expansion trajectory (rapid growth followed by stabilization).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 507,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm tied its human‑capital agenda—most notably the 2025 diversity targets that aim to lift women in leadership +15%, under‑represented‑minority leadership +15% and overall URM representation +20%—into executive compensation. The HR and Compensation Committee evaluates progress on these goals as a non‑financial performance modifier that can adjust the bonus payout by a multiplier of 0.9 to 1.1, a linkage first introduced for the 2022 bonus and carried forward unchanged for 2023 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies and accurately presents the core quantitative elements: the 2025 diversity targets (women in leadership +15%, URM leadership +15%, overall URM +20%), the bonus modifier range (0.9 to 1.1), and the timeline (2022-2024 with no changes). All numeric values are precise and match the ground truth. The answer accurately captures that these goals were set in 2022 and carried forward unchanged through 2024, and correctly identifies the non-financial performance modifier mechanism. However, the answer has notable omissions in completeness: (1) It fails to mention the Reboot Representation Tech Coalition and the specific initiative to double degrees for underrepresented groups by 2025, which the ground truth identifies as part of the 'increased emphasis' and 'expanding external partnerships' evolution. (2) It doesn't explicitly state that goals were 'reaffirmed' in 2023 and 2024, though it implies this by saying the linkage was 'carried forward unchanged.' (3) The answer doesn't fully capture the 'evolution' aspect of the question—it presents the framework as static rather than showing how emphasis and initiatives expanded while targets remained stable. The multi-hop reasoning is sound (correctly synthesizing compensation linkage, diversity targets, and modifier mechanisms), and the semantic equivalence is strong. The answer is accurate but incomplete in addressing the full scope of how the program evolved beyond just maintaining consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 412,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s decision to keep the floating‑rate notes that mature in 2019 disclosed in its 2022, 2023 and 2024 Form 10‑K filings shows that it deliberately maintains a small, short‑term, market‑linked debt position. By using a floating‑rate instrument—whose interest resets periodically—Apple can hedge against rising short‑term rates, preserve cash flexibility, and readily roll or refinance the exposure as market conditions change, thereby managing interest‑rate risk while retaining liquidity for operations and strategic investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that the Floating Rate Notes due 2019 appeared in Apple's 2022, 2023, and 2024 10-K filings. (2) The numeric/date references are accurate - no calculation errors or wrong numbers. (3) The LLM correctly identifies the instruments as floating-rate debt with periodic interest resets. (4) The mention of liquidity management and interest rate risk management aligns with the ground truth's core themes.\n\nWEAKNESSES: (1) CRITICAL LOGICAL ERROR: The LLM states these notes 'hedge against rising short-term rates,' but floating-rate instruments actually expose the company to rising rates (not hedge against them). Fixed-rate debt hedges against rising rates. This is a fundamental mischaracterization of how floating-rate instruments work. (2) The LLM's framing of 'small, short-term, market-linked debt position' is somewhat speculative and not directly supported by the ground truth, which emphasizes 'deliberate and stable approach' and 'consistent' inclusion. (3) The LLM misses the key insight from the ground truth: the RECURRING/CONSISTENT appearance across three years suggests Apple did NOT need to issue new floating-rate instruments, indicating a stable strategy. The LLM focuses on rolling/refinancing but doesn't capture the stability aspect. (4) The ground truth emphasizes that this reflects a 'cautious yet adaptive stance' - the LLM's answer is more assertive about hedging benefits without acknowledging the cautious element. (5) The LLM doesn't adequately address why these 2019-maturity notes would still appear in 2022-2024 disclosures (they would be long-matured by 2022), which is a potential data quality issue the ground truth implicitly acknowledges by noting their 'recurring appearance.'\n\nMULTI-HOP REASONING: The LLM attempts to synthesize the relationship between debt instrument type, interest rate management, and liquidity planning, but the hedging logic is inverted, undermining the reasoning quality.\n\nSEMANTIC EQUIVALENCE: While both answers discuss interest rate risk management and liquidity, the LLM's specific claim about hedging against rising rates contradicts standard financial theory and the ground truth's more nuanced 'adaptive' positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 597,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm’s automotive revenue rose sharply—from roughly $1.5 billion to $2.9 billion—signaling a strategic pivot to make digital‑cockpit and connected‑car technologies a core QCT growth engine. The company points to industry forecasts that >70 % of new vehicles in 2028 will have embedded cellular (≈60 % with 5G) and that ADAS/Level‑2+ autonomy will expand, positioning its 5G‑enabled, AI‑rich cockpit solutions to capture this rapidly growing market demand.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some relevant information about Qualcomm's automotive business evolution but contains significant quantitative inaccuracies and incomplete synthesis of the ground truth. STRENGTHS: (1) Correctly identifies the strategic pivot toward digital cockpit and connected-car technologies as a core growth area; (2) Appropriately mentions ADAS/Level-2+ autonomy expansion; (3) Correctly identifies the 2022-2024 timeframe; (4) Recognizes the integration of these technologies into QCT segment. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites automotive revenue rising from ~$1.5B to $2.9B, but these specific figures are NOT verified in the ground truth and appear to be unsupported claims. The ground truth does not provide these revenue numbers; (2) PERCENTAGE DISCREPANCY - The LLM states '>70% of new vehicles in 2028 will have embedded cellular (≈60% with 5G)' while the ground truth specifically states 'over 60% of new vehicles would feature 5G connectivity by 2028.' The LLM's >70% figure for embedded cellular is not mentioned in the ground truth and may be fabricated; (3) INCOMPLETE SYNTHESIS - The LLM fails to capture the key evolutionary trajectory emphasized in the ground truth: the progression from market positioning/R&D emphasis (2022) → revenue generation (2023) → full strategic integration (2024). The LLM jumps directly to revenue figures without establishing this three-stage evolution; (4) MISSING CONTEXT - The LLM does not mention the 2023 milestone of 'concrete revenues from digital cockpit products within QCT semiconductor business,' which is a critical data point showing commercialization; (5) MISSING SEGMENTATION DETAIL - The ground truth emphasizes 'formal integration into QCT segment structure' in 2024, which the LLM mentions only vaguely. MULTI-HOP REASONING: The LLM attempts to synthesize automotive business evolution but introduces unsupported financial figures that undermine credibility. The reasoning about market demand is present but the specific percentages appear inaccurate or fabricated. The answer reads as plausible but contains material factual errors that would mislead readers about Qualcomm's actual financial performance and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 597,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate and other private‑fund interests fell from about **$585 million at the end of 2022** to **$555 million in 2023** and further to **$540 million in 2024**.  This steady reduction signals that the company is deliberately scaling back its exposure to illiquid alternative‑asset investments, favoring greater capital efficiency and liquidity over long‑term private‑real‑estate holdings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL QUANTITATIVE ERROR: The LLM states Abbott's unfunded commitments were '$585 million at the end of 2022,' but the ground truth clearly indicates $569 million in 2022. This is a $16 million discrepancy (2.8% error), which is material for financial analysis. The 2023 ($555M) and 2024 ($540M) figures are correct. CALCULATION VERIFICATION: Ground truth shows a consistent $15M annual decline (569→555→540), while LLM's 2022 figure of $585M would imply a $30M drop in 2023 (585→555), which contradicts the stated 'steady reduction' pattern. COMPLETENESS ISSUES: The LLM answer omits important contextual details from the ground truth: (1) the specific liquidation period timeline (2025-2034), (2) the nuanced distinction that Abbott is 'managing exposure more cautiously' rather than simply 'scaling back,' and (3) the explicit statement that Abbott is 'not exiting the space entirely.' REASONING QUALITY: The LLM's interpretation about 'favoring greater capital efficiency and liquidity' is reasonable inference but differs slightly from the ground truth's 'de-risking or rebalancing' framing. The LLM correctly identifies the downward trend and its strategic implications, but the foundational number error undermines the analysis. ENTITY ACCURACY: Company (Abbott) and metric (unfunded commitments to private real estate) are correctly identified. The error appears to be a data retrieval mistake rather than a conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 400,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Apple did not issue any new 0.45 % Notes that mature in 2016—the series had already been issued in 2013 and fully matured before 2022, so the only references in the 2023 and 2024 10‑K exhibits are hold‑over entries from the original 2013 indenture.  Instead, as those low‑coupon notes rolled off, Apple replaced them with newer, longer‑dated debt (e.g., the 2026‑2033 global note offerings), demonstrating a long‑term debt strategy of laddering maturities and continuously refinancing maturing low‑coupon obligations into higher‑tenor, similarly low‑cost securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 0.45% Notes due 2016 'fully matured before 2022,' but the ground truth explicitly states these notes were disclosed in the 2022, 2023, and 2024 10-K filings, meaning they were still part of Apple's debt structure during these years. A note due in 2016 would have matured in 2016, not before 2022, making this timeline internally inconsistent. (2) FACTUAL CONTRADICTION - The ground truth states the notes were 'first disclosed in 2022 10-K filing' and 'repeated in both 2023 and 2024 10-K filings,' indicating consistent presence across all three years. The LLM incorrectly characterizes these as 'hold-over entries' from a matured obligation. (3) MISCHARACTERIZATION OF STRATEGY - The ground truth describes a 'stable long-term debt strategy' with 'consistent inclusion' of these instruments, while the LLM claims they 'rolled off' and were 'replaced.' This is a fundamental misinterpretation of the evidence. (4) UNSUPPORTED CLAIMS - The LLM introduces specific debt offerings (2026-2033 global notes) and refinancing details not mentioned in the ground truth, presenting speculation as fact. (5) LOGICAL INCONSISTENCY - The LLM's claim that notes due 2016 matured before 2022 yet still appear in 2022-2024 filings is internally contradictory. The ground truth's simpler explanation—that these notes remained part of the capital structure across all three years—is more consistent with their repeated disclosure. The LLM fundamentally misunderstood the question by assuming maturity rather than recognizing the notes' continued presence in Apple's debt portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 464,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nFrom 2022 through 2024 IBM has moved trust from a peripheral risk‑factor warning to a core competitive pillar that is explicitly tied to its hybrid‑cloud and AI strategy.  By repeatedly listing “client relationships and trust” alongside technology innovation, brand and service as a principal method of competition, IBM signals that its long‑standing reputation for reliability is now a strategic differentiator that underpins its push to win hybrid‑cloud and AI workloads against hyperscalers and niche rivals.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2022-2024) and the core theme of trust as a competitive differentiator. (2) No factual errors regarding dates or entities - IBM is correctly identified. (3) The general framing that trust evolved from peripheral to core positioning is directionally aligned with the ground truth. WEAKNESSES: (1) CRITICAL SEMANTIC MISMATCH: The LLM characterizes trust as moving 'from a peripheral risk-factor warning to a core competitive pillar,' which contradicts the ground truth. The original answer states trust was ALREADY emphasized in 2022 as part of 'innovation and service portfolio' - not peripheral. This is a fundamental misreading of the progression. (2) INCOMPLETE SYNTHESIS: The LLM fails to capture the key multi-hop insight from the ground truth: the evolution from trust as standalone differentiator (2022-2023) to trust integrated with strategic partnerships and ecosystem collaboration (2024). The LLM mentions 'brand and service' but doesn't articulate the partnership/ecosystem dimension that emerged in 2024. (3) MISSING NUANCE: The ground truth shows a 'maturing strategy' with explicit linkage to consulting services and mission-critical infrastructure by 2023, then partnership emphasis by 2024. The LLM collapses this three-year progression into a simpler narrative without capturing these intermediate strategic shifts. (4) REASONING QUALITY: While the LLM's logic about trust underpinning hybrid-cloud/AI competition is sound, it doesn't demonstrate the multi-year progression analysis that the question specifically asks for ('multi-year progression'). The answer reads as a static characterization rather than a temporal evolution. QUANTITATIVE ACCURACY: No numbers to verify, so scored on temporal accuracy and factual consistency (8/10 - correct years and entities, but mischaracterizes the baseline positioning). QUALITATIVE ACCURACY: Moderate failure in capturing the nuanced evolution and partnership dimension (4/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 539,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nFrom 2022 through 2024 FedEx deepened its liquidity support for the 4.250 % Note due 2030 by expanding the 2020 pass‑through trust structure and, in May 2023, amending the associated revolving‑credit agreement (Amendment No. 1) to increase the Liquidity Provider’s commitment. This progression shows that FedEx is actively bolstering credit backing for the note, using layered trust and credit‑enhanced facilities to maintain strong investor confidence and ensure reliable funding of the obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge from the ground truth. CRITICAL ERRORS: (1) The LLM claims FedEx 'expanded the 2020 pass-through trust structure' and 'increased the Liquidity Provider's commitment' - the ground truth explicitly states the arrangement 'remained centered around' the same Revolving Credit Agreement with no expansion mentioned, and the amendment was described as a 'proactive adjustment' not an increase in commitment. (2) The LLM characterizes the evolution as 'deepening' and 'actively bolstering' credit backing, but the ground truth indicates the arrangement was 'consistent' with 'a single modification in 2023 to adapt to potential liquidity needs' - suggesting stability rather than expansion. (3) The LLM introduces unsupported language about 'layered trust and credit-enhanced facilities' that does not appear in the ground truth. CORRECT ELEMENTS: (1) The date of May 2023 for Amendment No. 1 is accurate. (2) The reference to the 2020 Revolving Credit Agreement is correct. (3) The general timeframe (2022-2024) is correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the ground truth's key insight - that FedEx maintained a stable, consistent framework with minimal adjustment (one amendment in 2023), rather than progressively expanding credit support. The ground truth emphasizes continuity and strategic adaptation, while the LLM emphasizes expansion and deepening, which are contradictory interpretations. The answer misrepresents the nature and scope of changes to the liquidity arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 437,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to reference the same May 6 2014 Officer’s Certificate that originally issued the 4.45 % Notes due 2044, and none of the filings report a retirement, amendment or exchange of that tranche.  At the same time the company added newer senior‑unsecured note series (e.g., the 2026‑2053 notes disclosed in Exhibit 4.28 of the 2024 filing), but the 4.45 % 2044 notes remain part of the capital structure.  This multi‑year stability indicates Apple’s long‑term financing strategy of maintaining a core, low‑coupon, long‑dated debt pillar while layering additional staggered issuances to manage its overall maturity profile and funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a more detailed and nuanced response than the ground truth. Strengths: (1) All numeric values are correct - the 4.45% coupon rate, the 2044 maturity date, and the May 6, 2014 issuance date are all accurate. (2) The answer correctly identifies that the notes appear consistently across 2022, 2023, and 2024 filings with no retirement, amendment, or exchange reported. (3) Multi-hop synthesis is excellent - the answer synthesizes information across three years of filings and correctly identifies the pattern of consistency. (4) The answer goes beyond the ground truth by providing additional context about newer note series (2026-2053 notes) and the strategic implication of maintaining a 'core, low-coupon, long-dated debt pillar' while layering additional issuances. (5) The reasoning about Apple's financing strategy is sound and well-articulated, explaining both the stability of the 4.45% 2044 notes and the company's broader debt management approach. Minor consideration: The ground truth is somewhat minimal in its explanation, while the LLM answer provides richer context about the company's overall debt strategy. This additional detail is accurate and enhances understanding without contradicting the ground truth. The answer demonstrates strong comprehension of multi-year debt structure evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 385,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 to 2024 the International Connect Plus service grew dramatically: it moved from “nearly 50 origin countries to over 130 destinations” (2022) to “nearly 60 origin countries to over 190 destinations” (2023‑2024), expanding both the number of starting markets and the reach of its day‑definite e‑commerce delivery. This widening geographic footprint shows that FedEx is deliberately scaling its cross‑border, e‑commerce‑focused logistics platform to capture the surge in online retail volume and to position itself as a global, end‑to‑end e‑commerce logistics provider.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the geographic expansion trajectory with accurate quantitative data. All numbers are correct: 2022 (nearly 50 origin to 130+ destinations), 2023-2024 (nearly 60 origin to 190+ destinations). The answer correctly identifies the expansion pattern and synthesizes the multi-hop information across years. However, there are notable omissions: (1) The ground truth explicitly states the 2024 footprint 'remained consistent' with 2023, indicating stabilization after expansion—the LLM conflates 2023-2024 as a single period without clarifying this stabilization phase. (2) The ground truth provides strategic interpretation about 'consolidation and optimization' following the expansion push, which the LLM omits. (3) The LLM's phrasing '2023-2024' suggests continuous growth rather than the stabilization that actually occurred. The LLM correctly identifies FedEx's strategic focus on e-commerce logistics and emerging markets, and the reasoning about capturing cross-border demand is sound. The answer is semantically aligned with the ground truth's core message but lacks the nuanced understanding of the two-phase strategy (aggressive expansion followed by consolidation). The quantitative data is accurate, but the qualitative interpretation of what the trajectory 'suggests' is incomplete—missing the consolidation phase insight that distinguishes 2023 from 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 392,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 had been fully retired before the end of fiscal 2022, so they no longer appear as an outstanding liability on the balance sheet for 2022, 2023 or 2024.  Nevertheless, each of the 2022‑2024 Form 10‑K filings still lists the 1.05 % Notes in the “Description of Securities” (Exhibit 4.4) as part of the 2014 indenture’s global‑note series, merely to preserve the historical record of that debt instrument.  This reflects Apple’s systematic approach of keeping all debt‑related disclosures in the governing indenture up‑to‑date, ensuring a complete, auditable trail of its capital‑structure while focusing investor‑relevant information on the securities that remain outstanding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate information about Apple's 1.05% Notes due 2017. STRENGTHS: (1) Correctly identifies that the notes matured in 2017 and were fully retired before fiscal 2022, so they don't appear as outstanding liabilities in 2022-2024. (2) Accurately states the notes continue to be referenced in Exhibit 4.4 across all three fiscal years (2022, 2023, 2024). (3) Correctly identifies the 2014 indenture as the governing document. (4) Provides sound reasoning about why historical references are maintained - to preserve the historical record and maintain a complete auditable trail. (5) All numeric values and dates are accurate (1.05%, 2017 maturity, 2014 indenture, fiscal years 2022-2024). MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer adds interpretive detail about Apple's 'systematic approach' and 'capital-structure' management that goes slightly beyond what the ground truth explicitly states. The ground truth notes that the pattern 'suggests' Apple may have retained references for standardized disclosure or refinancing, while the LLM presents this more definitively as a systematic approach to maintain an auditable trail. However, this is a reasonable inference and doesn't contradict the ground truth. The LLM also frames the disclosure strategy slightly differently (focusing on 'keeping all debt-related disclosures...up-to-date' vs. the ground truth's 'standardized disclosure framework'), but both convey the same essential concept. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and connects the historical maturity date (2017) to the continued disclosure pattern (2022-2024), demonstrating sound multi-hop reasoning. The answer fully addresses all parts of the question regarding status across the three years and the implications for Apple's debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 510,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm doubled‑down on 5G by (1) growing QTL licensing revenues from 5G‑essential patents—evidenced by the surge in 5G‑related royalty streams and the company’s emphasis on “standard‑essential” patent licensing in its 2023‑2024 filings; (2) pouring additional R&D and capital into 5G‑enabled new‑application ecosystems such as automotive‑connected‑car services, edge‑computing/AI on‑device, XR and IoT, as highlighted in the 2023‑2024 “Industry Trends” and “Technology Overview” sections; and (3) increasing its exposure to geopolitical risk, with the 2023‑2024 risk‑factor disclosures flagging U.S./China trade and national‑security tensions, the revocation of Huawei’s export license, and China’s “Made‑in‑China 2025” policy that could curtail sales to Chinese OEMs or limit the company’s access to critical supply‑chain partners.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three main dimensions of Qualcomm's 5G evolution (licensing revenue growth, R&D/investment in new applications, geopolitical risks) and provides sound qualitative reasoning about the company's strategic progression. The discussion of geopolitical risks (U.S./China tensions, Huawei export license revocation, Made-in-China 2025) aligns well with the ground truth. The mention of 5G-enabled sectors (automotive, AI, IoT, XR) and standard-essential patent licensing is appropriate and relevant.\n\nCRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth provides specific numbers ($560 million Huawei revenue in fiscal 2024, 27 billion IoT devices by 2026) that the LLM answer completely omits. The LLM uses vague language like 'surge in 5G-related royalty streams' without providing actual figures. (2) INCOMPLETE FISCAL YEAR SPECIFICITY: While the LLM mentions 2023-2024 filings, it fails to clearly delineate what was emphasized in fiscal 2022 specifically (foundational enabler narrative, immersive mobile experiences). The ground truth shows a clear progression from 2022 (foundational positioning) → 2023 (increased R&D emphasis) → 2024 (IP leadership focus), but the LLM conflates these into a general 2023-2024 narrative. (3) MISSING QUALCOMM VENTURES DETAIL: The ground truth specifically mentions Qualcomm Ventures as the vehicle for strategic investments in 5G-enabled sectors; the LLM omits this institutional detail. (4) LICENSING REVENUE CHARACTERIZATION: The ground truth emphasizes that 'majority of QTL revenues derived from OFDMA-based (including 5G) devices'—a specific metric the LLM doesn't capture.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis across the three required dimensions (licensing, investment, geopolitical risk) but lacks the temporal progression analysis that the ground truth provides. The answer doesn't show how the strategic focus evolved year-by-year, instead presenting a more static view of 2023-2024 activities.\n\nQUANTITATIVE ACCURACY PENALTY: The complete absence of the $560 million Huawei figure and 27 billion IoT devices projection significantly impacts quantitative accuracy, as these are concrete, verifiable data points that should have been included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 611,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the domestic pension portfolio stayed close to its strategic 10 % U.S.‑equity / 10 % international‑equity / ~80 % fixed‑income mix.  In 2022 the plan held about $89 M (≈9.7 %) in U.S. equity, $91 M (≈9.9 %) in international equity and $739 M (≈80.4 %) in fixed‑income; by 2023 those figures were $93 M (≈10 %), $93 M (≈10 %) and $739 M (≈80 %); and in 2024 they slipped to $91 M (≈10.4 %), $89 M (≈10.2 %) and $692 M (≈79.4 %).  The modest decline in the fixed‑income share and the near‑constant 10 % equity allocations show that TMO has maintained a disciplined, liability‑driven strategy—preserving a large, interest‑rate‑sensitive fixed‑income base while keeping a stable, modest equity exposure for long‑term growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that make it almost entirely incorrect:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - 2022: LLM states $89M U.S. equity, $91M international, $739M fixed income. Ground truth: $125M, $126M, $1,001M respectively. These are completely wrong numbers.\n   - 2023: LLM states $93M U.S. equity, $93M international, $739M fixed income. Ground truth: $89M, $91M, $739M. The fixed income matches but equity figures are reversed/incorrect.\n   - 2024: LLM states $91M U.S. equity, $89M international, $692M fixed income. Ground truth: $93M, $93M, $739M. All three numbers are incorrect.\n   - The LLM appears to have confused or transposed the 2022 and 2023 data, and provided entirely fabricated 2024 figures.\n\n2. TOTAL ASSET CALCULATION ERRORS:\n   - Ground truth 2022 total: $1,267M. LLM's numbers sum to ~$919M (wrong).\n   - Ground truth 2023 total: $937M. LLM's numbers sum to ~$925M (approximately correct by coincidence, but based on wrong individual figures).\n   - Ground truth 2024 total: $947M. LLM's numbers sum to ~$872M (significantly wrong).\n\n3. STRATEGIC NARRATIVE COMPLETELY INVERTED:\n   - Ground truth: Shows significant REDUCTION from 2022 to 2023 (from $1,267M to $937M), then slight stabilization in 2024, revealing a shift toward stability and reduced equity exposure.\n   - LLM: Claims the portfolio \"stayed close to its strategic 10%/10%/80% mix\" throughout, which is factually incorrect. The 2022 allocations were approximately 9.9%/9.9%/79% (not matching the claimed mix), and the ground truth shows substantial volatility, not stability.\n\n4. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to correctly synthesize the three-year trend across all three asset classes.\n   - The interpretation of the data as showing a \"disciplined, liability-driven strategy\" with \"near-constant 10% equity allocations\" is contradicted by the actual numbers, which show significant fluctuations.\n\n5. ENTITY AND METRIC ACCURACY:\n   - Company (TMO) correctly identified.\n   - Years correctly identified (2022-2024).\n   - Asset categories correctly named but with wrong values.\n\nThe LLM answer appears to have either hallucinated data or severely misread the source documents. Every single numerical value is incorrect, leading to a fundamentally flawed analysis and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 627,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm deepened its edge‑networking strategy by tying it to 5G‑Advanced (Releases 16‑18) and the forthcoming Wi‑Fi 7 standard, while expanding on‑device AI and heterogeneous‑computing capabilities for edge devices.  This focus is reflected in its QCT segment, where edge‑networking (part of the IoT stream) contributed $5.4 billion in 2024—down from $7.35 billion in 2022—but the company continued to highlight mobile‑broadband and wireless‑access‑point products as key growth drivers in its product roadmap and segment reporting.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM provides specific revenue figures ($5.4B in 2024, $7.35B in 2022) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific dollar amounts for edge networking revenue. This is a major factual error - the LLM appears to have fabricated or hallucinated these numbers. (2) SEGMENT ATTRIBUTION ERROR: The LLM attributes edge networking to the 'QCT segment' and 'IoT stream,' but the ground truth explicitly states edge networking was part of 'Qualcomm's broader industrial and consumer product segment' in 2023-2024. The segment naming/classification appears incorrect. (3) TECHNICAL DETAILS NOT IN GROUND TRUTH: The LLM introduces specific technical references (5G-Advanced Releases 16-18, Wi-Fi 7, on-device AI, heterogeneous computing) that are not mentioned in the ground truth. While these may be accurate, they represent information synthesis beyond what the ground truth supports. (4) DIRECTIONAL CLAIM ERROR: The LLM states edge networking revenue was 'down from $7.35 billion in 2022' to $5.4 billion in 2024, suggesting a DECLINE. However, the ground truth describes a 'consistent and maturing strategic focus' with 'continued emphasis,' implying stability or growth in strategic importance, not revenue decline. This contradicts the ground truth's narrative. (5) PARTIAL ALIGNMENT: The LLM correctly identifies mobile broadband and wireless access points as key products, which matches the ground truth. The general timeframe (2022-2024) is correct. However, the core factual errors regarding revenue figures and segment classification are disqualifying. The answer demonstrates some understanding of the question structure but fails on quantitative accuracy and introduces unverified claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 486,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple’s 10‑K filings repeatedly list the 0.45 % Notes due 2016 in the “Description of Securities” (Exhibit 4.3) and in the officer’s certificates that detail its global note program. By keeping this small, fixed‑rate tranche visible year after year, Apple signals that it maintains a predictable, low‑cost debt pillar while it issues newer longer‑dated notes, thereby preserving a stable capital‑structure profile and giving investors a clear view of its upcoming maturity schedule. This consistent disclosure reflects a deliberate strategy of managing fixed‑rate debt maturities to balance liquidity, cost, and long‑term financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental factual inaccuracy that contradicts the ground truth. The ground truth explicitly states that 'the 0.45% Notes due 2016 are no longer outstanding' and that their 'repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking.' However, the LLM answer claims Apple 'maintains a predictable, low-cost debt pillar' with these notes and describes them as part of Apple's current debt strategy ('upcoming maturity schedule'). This is factually incorrect - notes due in 2016 would have matured years before 2022-2024 filings and cannot represent current outstanding debt or future maturities. The LLM mischaracterizes the nature of the disclosure: it's not about managing active debt obligations but rather about historical documentation of past obligations. The LLM also incorrectly implies these notes represent a current 'small, fixed-rate tranche' that Apple is actively managing, when in fact they are historical entries no longer outstanding. The LLM's reasoning about 'balancing liquidity, cost, and long-term financial flexibility' through these specific notes is therefore logically flawed since the notes are not part of Apple's active debt management. While the LLM correctly identifies the 0.45% rate and 2016 maturity date, and correctly notes the consistent inclusion in filings, the interpretation of what this consistency means is fundamentally wrong. The answer demonstrates a misunderstanding of the temporal relationship between the filing dates (2022-2024) and the maturity date (2016), leading to an incorrect characterization of Apple's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 463,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nCaterpillar’s own disclosures show that the dealer network supporting the EMD brand covered **193 countries in 2022**, **187 countries in 2023**, and **191 countries by the end of 2024** (see the “Nature of operations” sections of the 2022, 2023 and 2024 Form 10‑K filings).  Consequently, the geographic reach of the EMD distribution network declined by a net **two countries** over the 2022‑2024 period, even though it rebounded slightly from the 2023 low.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ACCURACY - CRITICAL ERRORS: The LLM states EMD brand distribution covered 193 countries in 2022, 187 in 2023, and 191 in 2024. The ground truth states 130 countries in 2022, 130 in 2023, and 109 in 2024. These are completely different numbers - the LLM's figures are approximately 48-75% higher than the actual values. The LLM calculates a net decline of 2 countries (193 to 191), while the ground truth shows a decline of 21 countries (130 to 109). The LLM's calculation of 2 countries is mathematically correct given its wrong input numbers, but the underlying data is entirely incorrect. (2) ENTITY/METRIC ACCURACY: While the LLM correctly identifies Caterpillar and the EMD brand, it provides completely wrong country counts across all three years. (3) MULTI-HOP REASONING: The LLM does attempt to synthesize information across three years (2022, 2023, 2024) and calculate the net change, which shows understanding of the multi-hop structure. However, this reasoning is built on false premises. (4) SOURCING CLAIM: The LLM cites specific Form 10-K filings as sources for these numbers, but the numbers provided do not match the ground truth derived from those same documents. This represents either a hallucination of data or a fundamental misreading of the source material. The answer is internally consistent but factually wrong at every numeric level, making it unsuitable as a response to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 413,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.75 % 7‑year senior notes grew from roughly $642 million at the end of 2022 to $662 million in 2023, then slipped back to about $621 million by the end of 2024. This modest fluctuation indicates that Thermo Fisher is deliberately managing a low‑cost, euro‑denominated medium‑term debt tranche—maintaining a stable financing source while adjusting its size to balance liquidity, funding needs, and overall capital‑structure strategy in the healthcare sector.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical factual dimensions. (1) QUANTITATIVE ERRORS - The LLM reports completely different dollar amounts: $642M (2022), $662M (2023), $621M (2024), whereas the ground truth clearly states $700M for all three years. These are not minor rounding differences but represent approximately 8-10% discrepancies from the actual values. The LLM's numbers are factually wrong. (2) CURRENCY MISCHARACTERIZATION - The LLM claims these are 'euro-denominated' notes, but the ground truth identifies them as standard US dollar-denominated senior notes due October 15, 2028. This is a significant error in entity characterization. (3) TREND ANALYSIS FAILURE - The LLM describes a 'modest fluctuation' with values declining from $642M to $621M, suggesting active management and adjustment of debt levels. The ground truth shows zero change across all three years ($700M constant), indicating a completely stable, unchanged debt position. The LLM's interpretation of the trend is the opposite of reality. (4) MULTI-HOP SYNTHESIS - The question asks about evolution from 2022-2024 and what it indicates about debt strategy. The ground truth correctly synthesizes that the stable $700M across three years indicates TMO 'maintained a steady approach' without retiring or increasing principal. The LLM incorrectly synthesizes a narrative of deliberate management and adjustment when none occurred. (5) MISSING CRITICAL DETAIL - The ground truth specifies the maturity date (October 15, 2028), which is important context for understanding medium-term debt strategy. The LLM omits this. The answer demonstrates fundamental data retrieval failure, incorrect numerical reporting, and misinterpretation of the actual trend pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 477,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved its hedging program away from LIBOR‑based variable‑rate debt and cross‑currency swaps and toward instruments that reference the Secured Overnight Financing Rate (SOFR).  The company created a cross‑functional team to assess and re‑price all floating‑rate exposures, re‑structured its derivative book to use SOFR‑linked hedges, and updated its risk‑management policies to reflect the LIBOR phase‑out schedule.  This evolution shows Caterpillar’s proactive adaptation to global financial‑market reforms—aligning its currency and interest‑rate hedging practices with the new benchmark standards to preserve liquidity and limit exposure as LIBOR is retired.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Caterpillar's evolution from LIBOR to SOFR-based hedging instruments from 2022-2024, which aligns with the ground truth. The answer correctly identifies: (1) the shift away from LIBOR-based instruments toward SOFR, (2) the formation of a cross-functional team to assess floating-rate exposures, (3) the restructuring of the derivative book, and (4) the proactive adaptation to regulatory changes. However, there are some gaps in completeness: The LLM answer lacks specific timeline details present in the ground truth, such as the FCA's announcement to stop LIBOR after 2021 and IBA's plan to cease USD LIBOR on June 30, 2023. The ground truth provides more granular year-by-year progression (2022 acknowledgment of uncertainty, 2023 transition to SOFR emphasis, 2024 complete pivot away from LIBOR), while the LLM answer presents a more consolidated narrative without these temporal distinctions. The LLM answer mentions 'cross-currency swaps' which is not explicitly mentioned in the ground truth, though this is a reasonable inference about hedging instruments. The statement about 'updated its risk-management policies' is reasonable but not explicitly confirmed in the ground truth. Quantitatively, there are no specific numbers, dates, or percentages in either answer to verify, so this dimension is less critical. The multi-hop reasoning is sound—the LLM correctly synthesizes the relationship between LIBOR phase-out, SOFR adoption, and Caterpillar's strategic response. The semantic equivalence is strong; both answers convey the same fundamental message about proactive adaptation to financial market reforms. The main weakness is the lack of specific temporal progression and regulatory timeline details that would have strengthened the answer's completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 493,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher replaced the earlier, CEO‑only change‑in‑control pacts with a single, company‑wide template.  The 2018 “Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)” (see 2022 10‑K page 46, Exhibit 10.18) was retained and, as reflected in the 2023 10‑K (pages 77‑78, Exhibits 10.42‑10.58) and the 2024 10‑K (page 79, Exhibits 10.42‑10.58), was updated and applied uniformly to all executive agreements—including the CEO’s—standardizing the definitions, vesting‑acceleration and severance terms across the board.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBERS INCORRECT: The LLM cites Exhibit 10.18 for 2022, but ground truth specifies Exhibit 10.12 for CEO agreement and Exhibit 10.17 for the standardized form. The LLM also cites Exhibits 10.42-10.58 for 2023-2024, which are not mentioned in ground truth. (2) TIMELINE MISREPRESENTATION: Ground truth clearly states the standardized form was INTRODUCED in 2023 (new development), but LLM claims it was a 2018 agreement that was 'retained' and 'updated.' This fundamentally mischaracterizes the evolution. (3) SCOPE CONFUSION: Ground truth indicates the standardized form was for 'Officers other than Marc N. Casper,' but LLM claims it was 'applied uniformly to all executive agreements—including the CEO's,' which contradicts the ground truth's explicit distinction. (4) MISSING KEY DETAIL: Ground truth notes the CEO agreement had amendments dated through March 16, 2018 (Exhibit 10.17), which the LLM completely omits. (5) SEMANTIC INACCURACY: The LLM's characterization of 'replacing' CEO-only pacts with a company-wide template is misleading—ground truth shows the CEO retained a separate agreement while a standardized form was introduced for other officers. The multi-hop reasoning fails because the LLM incorrectly synthesized the relationship between the CEO agreement and the officers' agreement across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 400,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 onward Intel introduced **PowerVia** as the centerpiece of its next‑generation **Intel 18A** process (originally slated as Intel 20A), announcing that the node would incorporate PowerVia’s backside‑power‑delivery architecture alongside RibbonFET to achieve roughly 15 % better performance‑per‑watt. By 2023‑2024 the company refined the technology and confirmed that **Intel 18A would enter high‑volume manufacturing in 2025 with the Panther Lake client processor**, positioning PowerVia as a strategic differentiator for Intel’s advanced‑node roadmap and its IDM 2.0 foundry strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors and omissions that undermine its accuracy:\n\n1. CHRONOLOGICAL MISREPRESENTATION: The LLM conflates the timeline by stating PowerVia was introduced as part of 'Intel 18A' from 2022 onward. The ground truth clearly establishes that in 2022, PowerVia was introduced for Intel 20A, not 18A. The shift to Intel 18A (with cancellation of 20A) occurred in 2024, not from the beginning.\n\n2. MISSING KEY EVOLUTION: The LLM fails to capture the critical 3-year progression that is central to the question. It does not adequately distinguish between: (a) 2022 introduction with RibbonFET for 20A, (b) 2023 emphasis on signal transmission optimization, and (c) 2024 strategic pivot to 18A. This represents a failure in multi-hop synthesis across the timeline.\n\n3. QUANTITATIVE CLAIM WITHOUT GROUND TRUTH SUPPORT: The LLM introduces a specific metric ('roughly 15% better performance-per-watt') that does not appear in the ground truth answer. While this may be factually accurate from filings, it is not verifiable against the provided ground truth and represents an unsupported addition.\n\n4. INCOMPLETE CONTEXT: The LLM mentions Panther Lake and IDM 2.0 strategy, which adds relevant context but was not explicitly required by the ground truth. However, the core narrative structure is compromised by the chronological errors.\n\n5. CORRECT ELEMENTS: The LLM correctly identifies: (a) PowerVia as a backside-power-delivery architecture, (b) RibbonFET as a companion technology, (c) Intel 18A entering HVM in 2025, and (d) PowerVia's strategic importance.\n\nThe answer demonstrates partial understanding but fails the primary requirement of accurately tracing the 2022-2024 evolution and the strategic shift from 20A to 18A. The conflation of timelines and missing intermediate steps significantly reduce correctness despite some accurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 514,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each contain the same Exhibit 4.4 “Officer’s Certificate… including forms of global notes representing the 1.05 % Notes due 2017” that was first filed in 2014. By repeating this description in the “Description of Securities” section of every filing, Apple keeps the original indenture governing those notes continuously disclosed. This consistent inclusion reflects a debt‑management practice that preserves the legal framework of all issued debt—even after maturity—so that regulators, investors and future financing transactions can reference the original terms and covenants.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core elements: (1) Correctly identifies the 1.05% Notes due 2017 as the instrument in question; (2) Accurately references Exhibit 4.4 and the Officer's Certificate dated May 6, 2014; (3) Correctly states the instrument appears in 2022, 2023, and 2024 10-K filings; (4) Accurately notes the repeated inclusion pattern across multiple years post-maturity. Quantitative accuracy is high—all dates (2014, 2017, 2022-2024) and the percentage (1.05%) are correct with no calculation errors. The LLM provides a plausible explanation for the repeated disclosure: preserving the legal framework for regulatory reference and future financing transactions. However, there are some qualitative differences from the ground truth: (1) The ground truth suggests Apple 'may have either rolled over the debt into a new instrument or maintained it in some form,' implying uncertainty about the actual debt management mechanism. The LLM's explanation is more definitive about the purpose (preserving legal framework) without acknowledging this uncertainty. (2) The ground truth emphasizes this reflects 'a continuity in its debt management approach' and 'deliberate and consistent reporting practice,' while the LLM frames it more as standard regulatory practice for preserving legal frameworks. (3) The LLM's reasoning about why the notes persist (regulatory/investor reference, future financing) is logical and reasonable, but the ground truth is more cautious about the actual mechanism. The answer is contextually relevant and addresses the multi-hop synthesis required (tracking disclosure evolution across three years and interpreting what it suggests about debt management). The main limitation is that the LLM provides a more confident explanation than the ground truth warrants, given that the actual mechanism for why these notes remain disclosed post-maturity is not explicitly stated in the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 526,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel continued to rely on its 2006 Equity Incentive Plan but shifted the composition of awards toward more performance‑linked and director‑focused RSUs.  The company granted time‑based RSUs, performance‑based RSUs (with vesting tied to financial‑metric targets and a three‑year cliff), and, beginning in 2022, new RSU agreements for non‑employee directors that vest after one year of service; these awards generally include retirement‑age or service‑based cliff provisions and are documented in the 10‑Q/10‑K exhibits 10.1.6, 10.1.7 and the 2023 10.1 filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that Intel used the 2006 Equity Incentive Plan across 2022-2024, mentions performance-based RSUs, time-based RSUs, and director-focused awards. It correctly notes the one-year vesting for non-employee directors and references retirement/service-based provisions. (2) FACTUAL ERRORS & OMISSIONS: The LLM answer fails to mention the critical May 11, 2023 amendment and restatement of the plan, which is a key milestone in the evolution. The ground truth emphasizes this as a turning point where the plan was 'amended and restated.' The LLM answer also doesn't clearly distinguish the evolution across the three years - it presents information more as a static description rather than showing how things changed from 2022→2023→2024. (3) SPECIFICITY ISSUES: The LLM references specific exhibit numbers (10.1.6, 10.1.7, 2023 10.1 filing) which adds detail but these are not verified against the ground truth and may introduce inaccuracy. The ground truth doesn't cite specific exhibit numbers. (4) MISSING NUANCE: The ground truth emphasizes 'consolidation in documentation structure' and 'shift toward more nuanced performance alignment' in 2024, which the LLM answer doesn't capture. The ground truth also distinguishes between 'grandfathered' and 'non-grandfathered' executives, which the LLM answer omits. (5) MULTI-HOP REASONING: The LLM answer shows weaker multi-hop synthesis - it doesn't clearly trace the evolution across three years or explain how the 2023 amendment represented a turning point. The ground truth shows clear progression: 2022 (strategic growth focus) → 2023 (amendment, broader range) → 2024 (consolidation). (6) QUANTITATIVE: No specific numbers are provided in either answer, so this is less critical, but the LLM's reference to 'three-year cliff' is mentioned without clear sourcing to ground truth. Overall, the answer is partially correct but misses the key structural evolution and the significance of the 2023 amendment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 559,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Medtronic’s filings repeatedly state that the company has authorized 40 000 Euro Deferred Shares (par €1 each) but, as of each year‑end, “no Euro Deferred Shares were issued or outstanding.”  The company therefore never tapped this reserved share class for financing, using instead debt and ordinary‑share repurchases to fund operations and return capital.  This consistent omission signals a deliberate strategy to keep the capital structure simple and avoid dilution, relying on alternative sources rather than issuing Euro Deferred Shares.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across fiscal years 2022-2024. STRENGTHS: (1) All quantitative facts are correct - the 40,000 authorized Euro Deferred Shares, €1.00 par value, and consistent zero issuance/outstanding status across all three fiscal years are accurately stated. (2) The multi-hop reasoning correctly synthesizes the evolution (or lack thereof) across the three-year period. (3) The interpretation of financing strategy implications is sound and well-reasoned. (4) The answer appropriately identifies alternative capital allocation tools (debt, ordinary share repurchases, dividends). MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive language about 'deliberate strategy to keep capital structure simple and avoid dilution' which, while logically sound and consistent with the ground truth's mention of 'preference for other capital structure tools,' goes slightly beyond what the ground truth explicitly states. The ground truth uses more measured language ('potentially indicating') while the LLM uses more definitive language ('deliberate strategy'). (2) The ground truth specifically mentions 'dividend policies' as part of capital allocation, while the LLM mentions 'debt and ordinary-share repurchases' but doesn't explicitly reference dividends, though this is a minor omission. (3) Formatting: The LLM uses '40 000' (space-separated) rather than '40 thousand' or '40,000' - this is a stylistic variation that doesn't affect accuracy. Overall, the answer is factually correct, well-reasoned, and appropriately addresses the multi-part question about capital structure evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 465,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nFrom 2022 through 2024 Intel’s advanced‑packaging strategy shifted from an early, R&D‑intensive push to create disaggregated 2D/3D packaging—characterized by long development cycles, unproven yields and limited revenue—to a phase where packaging became a tangible growth contributor (e.g., $483 M of packaging‑driven revenue uplift in 2023 and multiple design wins on the 18A node).  However, the continued technical complexity and yield challenges kept R&D and capital outlays high, resulting in persistent operating losses and, by 2024, sizable inventory write‑downs and impairment charges that highlighted the execution and financial risks of its packaging initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) The LLM cites '$483M of packaging-driven revenue uplift in 2023' - this specific figure does not appear in the ground truth and cannot be verified. This is a major quantitative error as it introduces an unsubstantiated number. (2) The LLM mentions 'multiple design wins on the 18A node' - the ground truth makes no reference to 18A node design wins, and this appears to be fabricated or confused information. (3) The LLM's characterization of packaging as 'a tangible growth contributor' in 2023 contradicts the ground truth's narrative of 'execution risks and financial pressures' that 'grew' from 2022-2024. (4) The LLM fails to mention the Universal Chiplet Interconnect Express (UCIe) standard demonstration in silicon, which was a key technical milestone in 2023 per the ground truth. (5) The LLM mentions 'inventory write-downs' but the ground truth specifically cites '$3.1 billion in non-cash impairments tied to Intel 7' - these are different issues and the LLM conflates them. (6) The LLM does not adequately address the delays in Intel 4 and 10nm processes mentioned in 2022, or the delays in global manufacturing projects by 2024. WHAT WAS CORRECT: The LLM correctly identifies the overall arc of Intel's advanced packaging strategy (initial R&D push to later financial/operational challenges), correctly notes the persistence of technical complexity and yield challenges, and correctly identifies that operating losses and impairment charges occurred. However, the introduction of unverified financial figures ($483M) and design win claims (18A node) represents a fundamental failure in factual accuracy. The multi-hop reasoning is partially sound in structure but undermined by factual errors in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 505,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIntel first introduced PowerVia in 2022 as the backside‑power‑delivery element of its Intel 20A node, positioning the technology as a way to boost density and performance while freeing the front side for more transistors. In the 2023 roadmap updates the company tied PowerVia to the next‑generation Intel 18A process, projecting up to 15 % performance‑per‑watt gains and noting that the architecture would be offered to external foundry customers as part of the IDM 2.0 strategy. By 2024 Intel disclosed that PowerVia had reached manufacturing readiness, confirming that the Intel 18A node—including PowerVia and the accompanying RibbonFET transistor—would enter high‑volume production (e.g., Panther Lake) in 2025, thereby moving the solution from concept to a production‑ready component of Intel’s long‑term process‑technology roadmap. [Pages 13‑14 (process‑technology roadmap), 10‑11 (Intel 18A/PowerVia details), 12 (capital‑allocation and manufacturing readiness).]",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key milestones and technical details. STRENGTHS: (1) Correctly identifies 2022 introduction of PowerVia as backside power delivery solution; (2) Accurately states 15% performance-per-watt improvement metric; (3) Correctly identifies Intel 20A and Intel 18A process nodes; (4) Properly notes 2025 high-volume manufacturing timeline; (5) Correctly associates RibbonFET with the technology; (6) Appropriately mentions IDM 2.0 strategy and external foundry customers; (7) References Panther Lake as example product. WEAKNESSES/DISCREPANCIES: (1) The LLM states PowerVia was 'first introduced in 2022 as the backside-power-delivery element of its Intel 20A node' - this is slightly imprecise. The ground truth indicates PowerVia was introduced in 2022 as a future technology concept, then in 2023 it was solidified to be introduced WITH Intel 20A. The LLM's phrasing could be misread as PowerVia being part of Intel 20A from 2022, when it was actually a future roadmap item; (2) The LLM adds contextual details about 'freeing the front side for more transistors' and 'boost density' which, while technically sound, are not explicitly stated in the ground truth and represent inference rather than direct synthesis; (3) Minor: The LLM mentions 'accompanying RibbonFET transistor' which is correct per ground truth but the ground truth presents these as parallel innovations rather than strictly 'accompanying.' MULTI-HOP REASONING: The answer successfully synthesizes information across three time periods (2022, 2023, 2024) and correctly traces the evolution from conceptual introduction through roadmap refinement to manufacturing readiness. The logical flow is sound. QUANTITATIVE VERIFICATION: The 15% performance-per-watt figure is correct; 2025 high-volume manufacturing date is correct; process node progression (20A→18A) is accurate. All numeric data checks out. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative arc correctly, though with slightly different emphasis than ground truth (more focus on technical benefits, less on the shift/transition aspect).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 578,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nYes—​the U.S. employee restricted‑stock‑unit awards continue to be governed by the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” that was first incorporated by reference in 2015 and is still cited in the FY 2022, FY 2023 and FY 2024 10‑K filings. No new or substantially revised U.S. RSU agreement appears between those years; the only equity‑compensation changes are the adoption of the 2021 Long‑Term Incentive Plan awards and a new 2024 Employee Stock Purchase Plan. This consistency indicates that Medtronic’s U.S. equity‑compensation strategy has remained stable, emphasizing a long‑term, standardized RSU framework rather than frequent program overhauls.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Medtronic has NOT updated its U.S. employee RSU agreements between FY2022 and FY2024, matching the ground truth conclusion. The reasoning about consistency indicating a stable equity compensation strategy is sound and semantically equivalent to the original answer. However, there is a CRITICAL DATE DISCREPANCY: The LLM states the form was 'first incorporated by reference in 2015,' while the ground truth specifies it was 'first filed on August 27, 2013 (File No. 001-07707).' This is a significant factual error regarding the historical timeline of the agreement. The LLM correctly identifies that the same form is cited across FY2022, FY2023, and FY2024, and appropriately notes the absence of substantial revisions. The mention of the 2021 Long-Term Incentive Plan and 2024 Employee Stock Purchase Plan as separate changes (rather than RSU agreement updates) is contextually relevant and accurate. The qualitative reasoning about what the consistency suggests (stable strategy, standardized framework, no frequent overhauls) aligns well with the ground truth interpretation. The main weakness is the incorrect filing date (2015 vs. 2013), which undermines the quantitative accuracy score despite the overall correctness of the core finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 360,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel continued to award performance‑based RSUs under its 2006 Equity Incentive Plan, but the governing grant documents were refined.  In the 2022 filing (Exhibit 10.1.6) the company introduced a dedicated “Form of Restricted Stock Unit Grant Agreement (performance‑based RSUs) for non‑grandfathered executives,” while a separate “Form of Non‑Employee Director RSU Agreement” (Exhibit 10.1.7) was added for directors granted after May 2022.  Subsequent 2023 and 2024 10‑Ks retain these same exhibit numbers, indicating that the structure—separate agreements for grandfathered versus non‑grandfathered executives and for directors—remained in place, with only minor wording or filing‑date updates but no fundamental change in how performance‑based RSUs are structured.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and introduces details not present in the ground truth. STRENGTHS: (1) Correctly identifies the 2006 Equity Incentive Plan as the vehicle for performance-based RSUs across 2022-2024; (2) Accurately notes the continuation of the plan through this period; (3) Correctly mentions separate agreements for grandfathered vs. non-grandfathered executives; (4) Properly identifies the exhibit numbers and filing structure. WEAKNESSES: (1) The ground truth emphasizes the February 1, 2019 date for RSU grants and the May 11, 2023 amendment/restatement of the plan—the LLM answer omits these specific dates entirely; (2) The ground truth mentions the S-8 registration filed September 26, 2023, which is a key piece of evidence for 2024 evolution—the LLM answer completely omits this; (3) The LLM answer introduces specific exhibit numbers (10.1.6, 10.1.7) and references to 'May 2022' that are not verified in the ground truth and may be fabricated details; (4) The ground truth emphasizes 'strategic growth performance-based RSUs' and 'long-term corporate objectives'—the LLM answer focuses more on administrative/structural details rather than strategic evolution; (5) The LLM answer's claim about 'only minor wording or filing-date updates but no fundamental change' contradicts the ground truth's emphasis on the May 11, 2023 amendment/restatement as a meaningful evolution. MULTI-HOP REASONING: The LLM answer attempts to synthesize across three years but misses key connecting points (the 2023 amendment, the S-8 filing) that demonstrate actual evolution. The answer reads more as a structural/administrative description rather than capturing how the plan's use evolved strategically. QUANTITATIVE ACCURACY: Dates mentioned (May 2022) are not corroborated by ground truth; the S-8 filing date (September 26, 2023) is completely absent. The answer provides exhibit numbers that cannot be verified against the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 539,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 through 2024 Intel’s advanced‑packaging agenda shifted from a risk‑laden, R&D‑intensive foundation (2022) to a revenue‑generating, ecosystem‑driven engine: the company logged multiple design wins on the 18A node and five new AI‑focused packaging wins in 2023, forged strategic partnerships with ARM and Synopsys, adopted the Universal Chiplet Interconnect Express (UCIe) standard, and reported a $952 million packaging‑revenue increase (up $483 million from 2022) that underpinned its IDM 2.0 and Open‑System‑Foundry strategy (2024).  This progression shows Intel is building the technical depth and customer‑scale needed to realize its disaggregated‑design approach and compete in the AI‑driven market, yet the high cost, complexity, and reliance on unproven packaging nodes mean execution remains a material risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) UNSUBSTANTIATED NUMBERS: The LLM claims '$952 million packaging-revenue increase' and '$483 million from 2022' - these figures do not appear in the ground truth and cannot be verified. The ground truth makes no mention of packaging revenue increases of this magnitude. (2) MISSING KEY FACTS: The LLM completely omits the $3.1 billion in non-cash impairments and accelerated depreciation charges recorded in 2024, which is a central and critical data point in the ground truth that directly contradicts the LLM's optimistic narrative. (3) UNVERIFIED CLAIMS: The LLM references 'five new AI-focused packaging wins in 2023' and 'multiple design wins on the 18A node' - these specific claims are not present in the ground truth and appear to be fabricated or hallucinated. (4) STRATEGIC PARTNERSHIPS: While the ground truth mentions UCIe standard demonstration, the LLM adds claims about 'strategic partnerships with ARM and Synopsys' that are not substantiated in the provided ground truth. (5) TONE MISALIGNMENT: The LLM presents an overly optimistic narrative ('revenue-generating, ecosystem-driven engine') that contradicts the ground truth's emphasis on 'persistent execution challenges and high financial stakes.' The ground truth explicitly notes 'ongoing execution risks and financial pressures' in 2024, which the LLM downplays. (6) INCOMPLETE SYNTHESIS: While the LLM correctly identifies UCIe and the disaggregated design strategy, it fails to synthesize the critical 2024 financial pressures and impairment charges that reveal the true complexity of Intel's execution challenges. The answer reads as if cherry-picking positive developments while ignoring material negative indicators. CORRECT ELEMENTS: The LLM does correctly mention UCIe standard, the disaggregated design approach, and the AI-driven market context. However, these correct elements are insufficient to overcome the numerous factual errors and omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 557,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nAcross the three years Intel kept the 2006 Equity Incentive Plan as the core vehicle for equity awards, but it evolved through formal plan restatements and new grant‑agreement forms: the 2022 10‑K (p. 112) first listed the plan and its existing RSU forms (10.1.2‑10.1.5); the 2023 10‑K (Exhibit 10.1, filed 9/26/2023) restated the plan in an S‑8 filing, adding amendments such as an updated share‑reserve and retirement‑vesting language; and the 2024 10‑K (pp. 104‑108) introduced further amendments—most notably the November 19 2024 revision to the 2006 Employee Stock Purchase Plan and the new non‑employee‑director RSU agreement (10.1.7)—showing a continued refinement of the plan’s terms and award structures through 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the evolution of Intel's 2006 Equity Incentive Plan across 2022-2024 but contains several problematic elements: (1) FACTUAL ERRORS: The LLM conflates the 2006 Equity Incentive Plan with the 2006 Employee Stock Purchase Plan (ESPP) in the 2024 discussion, stating 'November 19 2024 revision to the 2006 Employee Stock Purchase Plan' when the question specifically asks about the Equity Incentive Plan. These are distinct plans. (2) CITATION ISSUES: The LLM provides specific page numbers and exhibit references (p. 112, Exhibit 10.1, pp. 104-108, 10.1.7) that cannot be verified against the ground truth and may be fabricated or inaccurate. The ground truth does not provide these specific citations. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that the plan was amended in 2023 (matching ground truth's 'amended and restated version of the plan effective May 11, 2023'), it fails to clearly distinguish between the 2023 amendment date and the 2024 developments. The ground truth emphasizes the May 11, 2023 amendment as a key structural update; the LLM's treatment is less clear. (4) PARTIAL ACCURACY: The LLM correctly identifies RSU grant agreements and their evolution across the three years, which aligns with the ground truth. The general narrative of 'consistent but increasingly mature application' is present. (5) MISSING CONTEXT: The ground truth emphasizes that the 2023 amendment included 'retirement vesting terms and performance-based RSUs,' which the LLM mentions but doesn't emphasize as clearly. The LLM's mention of 'new non-employee-director RSU agreement' in 2024 is not explicitly confirmed in the ground truth. Overall, the answer demonstrates understanding of the general evolution but introduces potential inaccuracies in specific details and conflates different plans.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 500,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm continued to place all edge‑networking and wireless‑access‑point sales inside the **IoT revenue stream of its QCT segment**—the same classification used in the 2022‑2024 financial tables (see page 73, where IoT revenue includes “edge networking (including mobile broadband and wireless access points)”).  The dollar value of that stream fell sharply—from **$7.35 B in fiscal 2022 to $5.94 B in 2023 and $5.42 B in 2024**—so the company’s **financial emphasis on the sub‑segment waned**, even as its public narrative still described the technology as part of the broader “connected intelligent edge” opportunity.  Consequently, while the categorization remained unchanged, Qualcomm’s strategic focus shifted away from treating wireless‑access‑point/IoT revenue as a distinct growth pillar and toward other areas such as handsets and automotive, using edge‑networking only as a supporting element of its overall edge‑computing positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that wireless access points were classified under edge networking within the IoT revenue stream of the QCT segment across 2022-2024, matching the ground truth's core finding about consistent categorization. The answer appropriately notes that exact revenue figures for wireless access points alone are not disclosed separately. The qualitative assessment that strategic emphasis shifted away from IoT/edge networking as a distinct growth pillar is a reasonable inference supported by the revenue decline data provided.\n\nWEAKNESSES - QUANTITATIVE: The LLM provides specific revenue figures ($7.35B in 2022, $5.94B in 2023, $5.42B in 2024) that cannot be verified against the ground truth, which explicitly states 'exact revenue figures for wireless access points alone are not disclosed.' These numbers appear to reference total IoT segment revenue rather than wireless access points specifically, creating a factual accuracy problem. The ground truth does not provide these specific dollar amounts, so the LLM is introducing unverified quantitative claims.\n\nWEAKNESSES - QUALITATIVE: The ground truth emphasizes Qualcomm's 2022 projection of IoT device doubling to over 27 billion by 2026, which the LLM completely omits. This was a key strategic narrative element in the original answer. The ground truth also notes wireless access points were 'explicitly categorized' in 2023 and 'remained consistent' in 2024, suggesting a formal classification milestone, whereas the LLM presents this as continuous throughout 2022-2024.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years and connect financial classification to strategic emphasis, which is appropriate. However, the inference that 'financial emphasis waned' is based on unverified revenue figures, weakening the multi-hop synthesis.\n\nKEY ISSUE: The introduction of specific dollar amounts ($7.35B, $5.94B, $5.42B) without ground truth verification is a significant concern. While these may be accurate from actual filings, they cannot be confirmed against the provided ground truth and represent a departure from the ground truth's explicit statement that exact figures are not disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 596,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nMRK’s sales of Prevymis rose steadily from **$119 million in 2022 to $264 million in 2023 and $371 million in 2024**, reflecting roughly a 120 % jump from 2022‑23 and a 40 % increase from 2023‑24. This upward trajectory indicates that Prevymis is gaining stronger acceptance in the Hospital Acute‑Care market, positioning it as a growing standard of care for CMV prophylaxis among high‑risk transplant patients and suggesting expanding market share within that segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACY: The LLM answer contains completely incorrect financial figures for Prevymis sales across all three years. Ground truth shows: 2022: $370M, 2023: $428M, 2024: $785M. LLM claims: 2022: $119M, 2023: $264M, 2024: $371M. These are fundamentally wrong numbers - the LLM's 2024 figure ($371M) is less than half the actual 2024 sales ($785M). The percentage calculations in the LLM answer are also incorrect: it claims ~120% growth 2022-23 (actual: 15.7%) and ~40% growth 2023-24 (actual: 83.4%). The compound growth rate should be approximately 46% over 2022-2024, not the implied rates from the LLM's false numbers. While the LLM correctly identifies the product (Prevymis), the company (MRK), the segment (Hospital Acute Care), and provides reasonable qualitative reasoning about market positioning and CMV prophylaxis, the quantitative foundation is entirely wrong. The semantic understanding of the trend direction is correct (upward trajectory), but the magnitude and specific values are drastically incorrect. This is a multi-hop question requiring accurate synthesis of financial data across three years, and the LLM has failed at the most critical component - providing accurate numbers from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 353,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved from publicly flagging the technical and cost risks of advanced‑packaging and disaggregated designs to actively building an ecosystem and securing multiple AI‑focused packaging design wins, culminating in 2023‑24 with a doubled IFS Accelerator partner program, agreements with ARM and Synopsys, and the promotion of 2D/3D packaging and the Universal Chiplet Interconnect Express as core differentiators for its Open‑System Foundry model.  This multi‑year trajectory shows Intel is betting on advanced packaging to offset its process‑technology delays and capital constraints, but the persistent multi‑billion‑dollar impairments, delayed fab constructions and reliance on government incentives reveal that execution of its IDM 2.0 strategy remains highly uncertain and contingent on overcoming those manufacturing and financial hurdles.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the multi-year evolution of Intel's advanced packaging strategy from 2022-2024, accurately captures the shift from acknowledging risks to positioning packaging as a differentiator, and correctly references key initiatives (UCIe, 2D/3D packaging, IFS Accelerator program, partnerships with ARM and Synopsys). The answer appropriately synthesizes the tension between strategic progress and execution challenges, and correctly identifies impairments and manufacturing delays as key constraints. The reasoning about using advanced packaging to offset process delays is sound and well-articulated.\n\nWEAKNESSES: (1) QUANTITATIVE GAPS: The LLM answer fails to cite the specific $16.5 billion R&D investment figure for 2024 mentioned in the ground truth, which is a concrete data point supporting the capital investment narrative. (2) IMPAIRMENT SPECIFICITY: While the LLM mentions 'multi-billion-dollar impairments,' it does not cite the specific $3.1 billion Q3 2024 impairment figure from the ground truth, which is a material quantitative detail. (3) PRODUCT DELAY SPECIFICITY: The ground truth specifically mentions '4th Gen Xeon Scalable processors' delays, while the LLM uses the more generic phrase 'delayed fab constructions' without naming specific product delays. (4) PROCESS NODE SPECIFICITY: The ground truth specifically identifies Intel 7 process node impairments, while the LLM does not reference this detail.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and correctly connects strategic positioning to execution challenges. However, the synthesis is somewhat less precise than the ground truth because it omits specific quantitative anchors (R&D spend, impairment amounts, specific product names) that would strengthen the multi-hop narrative.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of the trajectory is semantically aligned with the ground truth—both convey that Intel made strategic progress in packaging innovation while facing execution challenges and capital constraints. The phrase 'execution of its IDM 2.0 strategy remains highly uncertain' closely mirrors the ground truth's conclusion.\n\nJUSTIFICATION: The answer demonstrates solid qualitative understanding and appropriate contextual relevance, but loses points on correctness and quantitative accuracy due to missing specific financial figures ($16.5B R&D, $3.1B impairment) and product/process node details that are factually verifiable from the ground truth. These omissions prevent a higher correctness score despite the generally sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 698,
        "total_tokens": 2208
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM’s messaging on client relationships and trust has shifted from a broad brand‑reputation claim in 2022 to an explicit strategic pillar that underpins its hybrid‑cloud and AI agenda in 2023‑2024.  Across the 2023 and 2024 10‑Ks the firm repeatedly links “trust and security” to its open, hybrid‑cloud platform and to responsible AI innovation, framing client confidence as the differentiator that enables it to win large, mission‑critical workloads.  This progression signals that IBM is positioning its hybrid‑cloud‑first, AI‑driven portfolio as the trusted engine for enterprise transformation, using trust as the competitive hook that justifies its push into generative AI and next‑generation quantum‑ready solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative that IBM evolved its messaging on trust from 2022-2024, linking it to hybrid cloud and AI strategy. The answer accurately captures that trust became increasingly explicit as a strategic pillar tied to hybrid cloud and responsible AI. The framing of trust as a 'competitive hook' for enterprise transformation is semantically aligned with the ground truth. WEAKNESSES: (1) The LLM answer omits the 2022 baseline explicitly mentioned in ground truth - it states the shift occurred 'from 2022 to broad brand-reputation claim' but doesn't clearly establish what IBM said in 2022 about trust and hybrid cloud/AI. (2) Missing the specific mention of Palo Alto Networks partnership in 2024, which the ground truth identifies as a significant signal of 'deepening trust-based collaboration.' This is a material omission for a 2024-focused question. (3) The LLM answer doesn't clearly articulate the 2023 reinforcement phase as distinctly as ground truth does (service, support, innovation, talent components). (4) The phrase 'shift from broad brand-reputation claim' in 2022 is somewhat imprecise - ground truth indicates IBM explicitly tied trust to hybrid cloud and AI for production in 2022, not just generic brand reputation. QUANTITATIVE ACCURACY: No specific numbers or dates are incorrect; the temporal progression (2022→2023→2024) is correct. MULTI-HOP REASONING: The answer demonstrates reasonable synthesis across years but misses the Palo Alto Networks partnership detail that serves as concrete evidence of the 2024 positioning evolution. The reasoning about trust as foundational to client acquisition is sound but less comprehensive than ground truth. SEMANTIC EQUIVALENCE: The core insight about trust becoming a strategic pillar is preserved, but the answer loses specificity about how this manifested across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 515,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2024 IBM never issued a fresh prospectus for the 0.950 % Notes due 2025; instead each year’s Form 10‑K simply re‑incorporated the original 2017 Form 8‑K (and, in 2023, a supplemental indenture dated December 15 1995) that set out the notes’ rights, with no new “exhibit 4.1/4.2” filing after 2017.  This steady reliance on the same indenture and periodic 8‑K updates shows IBM’s broader debt‑management strategy of preserving a low‑cost, long‑dated funding base and managing its maturity profile through incremental, low‑profile amendments rather than large‑scale new issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims a 'supplemental indenture dated December 15 1995' was referenced in 2023, but the ground truth makes no mention of this date or document. This appears to be fabricated or confused information. (2) FACTUAL INACCURACIES: The ground truth explicitly states that by 2024, the 0.950% Notes due 2025 were 'actively listed on the New York Stock Exchange under the trading symbol IBM25B,' indicating the instrument remained a live and traded financial liability. The LLM answer completely omits this critical 2024 development and instead focuses on the absence of new prospectuses and amendments, which is not supported by the ground truth. (3) MULTI-HOP REASONING FAILURE: The ground truth traces a clear 3-year progression showing: 2022 (disclosure of instrument rights), 2023 (ongoing transparency and regulatory continuity), and 2024 (active NYSE trading). The LLM answer fails to capture this progression and instead invents a narrative about 'low-profile amendments' and 'incremental' changes that are not substantiated in the ground truth. (4) SEMANTIC DIVERGENCE: While both answers discuss debt management strategy, the LLM's characterization as 'low-profile amendments' and 'incremental' changes contradicts the ground truth's emphasis on 'consistent disclosure framework' and 'sustained presence' with active trading. (5) MISSING KEY INFORMATION: The LLM completely fails to mention the NYSE listing (IBM25B symbol) in 2024, which is a central element of the ground truth's conclusion about the instrument's status. The answer demonstrates poor synthesis of multi-hop information and introduces unsupported claims about supplemental indentures and amendment strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 496,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a planned feature of the Intel 20A node (first announced in 2021‑22) to a technology that would be deferred when the 20A roadmap was reshaped, and then positioned it for its first high‑volume commercial use on the Intel 18A process, with production of Panther Lake scheduled for 2025. This pivot shows that Intel’s backside‑power delivery strategy is now anchored on the 18A (and future 14A) nodes, making PowerVia the cornerstone of its advanced‑node roadmap for backside power delivery.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of Intel's PowerVia strategy across 2022-2024. STRENGTHS: (1) Correctly identifies the timeline progression from planned feature (2021-22) to deferred status to commercial deployment on 18A; (2) Accurately references Intel 18A as the primary node for PowerVia commercialization; (3) Correctly mentions Panther Lake production scheduled for 2025; (4) Properly synthesizes the strategic pivot and its implications for Intel's advanced-node roadmap; (5) Appropriately identifies 14A as a future node where PowerVia will be deployed. MINOR ISSUES: (1) The original answer emphasizes Intel 20A as a key integration point in 2023 before the pivot to 18A, which the LLM answer mentions only briefly as 'deferred' without fully capturing the intermediate technical integration step; (2) The LLM answer uses slightly different framing ('deferred when the 20A roadmap was reshaped') versus the ground truth's more explicit statement about canceling 20A productization in favor of 18A - while semantically similar, the ground truth is more direct about the cancellation decision; (3) The LLM answer adds contextual information about 14A nodes not explicitly in the ground truth, which is reasonable extrapolation but goes slightly beyond the provided knowledge. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, 2025) are correct; node designations (20A, 18A, 14A) are accurate; product name (Panther Lake) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple strategic decisions, correctly identifying the causal relationship between roadmap changes and technology positioning. The conclusion about PowerVia becoming the cornerstone of advanced-node roadmap is well-supported by the progression described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 505,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nThe RSU award documents filed in 2022‑2024 show that Medtronic continues to use the same core U.S. equity‑compensation framework – standardized Restricted Stock Unit agreements under the 2021 Long‑Term Incentive Plan with either a three‑year cliff vest or a four‑year ratable schedule – and only makes minor procedural updates (e.g., amendments to credit agreements, new performance‑share add‑ons). This consistency across successive 10‑K/10‑Q filings indicates that Medtronic’s U.S. equity compensation strategy is stable and deliberately maintained over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT PLAN REFERENCE: The LLM states the RSUs are under the '2021 Long-Term Incentive Plan,' but the ground truth indicates the relevant document is the 'Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54)' which consistently referenced an August 27, 2013 filing across 2022-2024. The LLM introduces a different plan name not mentioned in the ground truth. (2) VESTING SCHEDULE DETAILS: The LLM specifies 'three-year cliff vest or four-year ratable schedule,' but the ground truth does not mention these specific vesting terms. This appears to be fabricated detail not supported by the source material. (3) MISSING KEY FACT: The ground truth emphasizes that the Exhibit 10.54 document 'remained unchanged across all three years' and 'consistently referencing the same August 27, 2013 filing' - this specific consistency metric is absent from the LLM answer. (4) VAGUE REFERENCES: The LLM mentions 'minor procedural updates (e.g., amendments to credit agreements, new performance-share add-ons)' without grounding these in the actual documentation, whereas the ground truth explicitly states the core agreement remained unchanged. (5) CORRECT CONCLUSION: The LLM does correctly conclude that the strategy demonstrates stability, which aligns with the ground truth's conclusion. However, the reasoning path and supporting details are largely incorrect or unsupported. The answer demonstrates partial understanding of the stability concept but fails on factual accuracy regarding the specific documents, plan names, and vesting structures referenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 457,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled down on an IDM 2.0 strategy that made advanced‑packaging and disaggregated (chiplet) designs central to its competitive positioning, but execution was repeatedly hampered by process‑technology delays (e.g., 10 nm, 7 nm/Intel 4 and Intel 7), tight capital constraints that forced heavy spending on new fabs and limited near‑term cash flow, and the added complexity of integrating multiple process nodes and packaging steps. These setbacks delayed product launches, triggered inventory write‑downs and impairments, and required the company to lean on external financing and government incentives, highlighting the high risk and execution challenges of its advanced‑packaging agenda.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Intel's IDM 2.0 strategy, the centrality of advanced packaging and chiplet designs, process technology delays (Intel 4, Intel 7), capital constraints, and execution challenges across the 2022-2024 period. The qualitative reasoning about the tension between strategic ambition and execution challenges is sound and well-articulated. The answer appropriately synthesizes the multi-hop nature of the question by connecting strategic positioning, delays, capital constraints, and disaggregated design approaches.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer mentions 'inventory write-downs and impairments' but fails to cite the specific $3.1 billion impairment charge tied to underutilized manufacturing assets for Intel 7 node that appears in the ground truth. This is a material omission of a key quantitative fact that directly supports the answer's claims about execution challenges and asset underutilization. The answer also references '10 nm, 7 nm/Intel 4 and Intel 7' delays but the ground truth specifically emphasizes Intel 4 (formerly 7nm) and Intel 7 as the critical nodes, making the inclusion of '10 nm' somewhat imprecise.\n\nWEAKNESSES - COMPLETENESS: While the answer mentions 'external financing and government incentives,' it does not specifically reference the 2024 context of 'multiple geographies' delays or the foundry market positioning that was emphasized in 2023 with UCIe standard. The ground truth provides a more granular year-by-year evolution (2022 acknowledgment of complexity/risk, 2023 strategic advantage emphasis with UCIe, 2024 execution challenges and impairment), whereas the LLM treats the period more as a continuous narrative without clear temporal differentiation.\n\nMULTI-HOP REASONING: The synthesis is generally sound - the answer correctly connects process delays → capital constraints → execution challenges → impairments. However, it misses the specific connection between Intel 7 node underutilization and the $3.1B impairment charge, which is a critical multi-hop link in the ground truth narrative.\n\nNUMERIC VERIFICATION: The $3.1 billion impairment figure is completely absent from the LLM answer despite being a concrete, material fact that directly substantiates the execution challenges claim. This is a significant quantitative accuracy gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 625,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nAccenture’s target mix for its defined‑benefit plans moved steadily toward a higher‑equity, lower‑fixed‑income profile: the non‑U.S. plan’s equity allocation rose from about 21 % (2022) to 27 % (2023) and, based on the 2025 target shown for the 2024 actual mix, is now roughly 23‑28 % equity with debt falling from ~50 % to the low‑30 % range.  This multi‑year shift—reducing debt exposure while increasing equity exposure—reflects a strategic tilt to seek higher risk‑adjusted returns as low‑yield fixed‑income environments persist.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical claims about Accenture's pension asset allocation that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides very specific percentages (equity rising from 21% to 27% in non-U.S. plan, debt falling from ~50% to low-30% range) that are not present in the ground truth. The ground truth does not provide these specific allocation percentages for any fiscal year. The LLM appears to have invented precise numbers without source support. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth emphasizes that Accenture maintained a 'dual focus' on fixed income and equities across all three years (2022-2024), with evolving flexibility in rebalancing. The LLM's claim of a 'steady' shift toward higher equity and lower fixed income contradicts the ground truth's emphasis on consistency and balance. (3) ENTITY/METRIC CONFUSION: The LLM specifically references 'non-U.S. plan' allocations, which is not mentioned in the ground truth. The ground truth discusses 'defined benefit pension plans' generally without breaking down by geography. (4) REASONING DISCONNECT: While the LLM's conclusion about seeking 'higher risk-adjusted returns' aligns with the ground truth's mention of 'risk-adjusted returns,' the supporting evidence (the specific percentage shifts) is unsupported and likely incorrect. (5) MISSING KEY ELEMENTS: The LLM fails to capture the ground truth's emphasis on: (a) matching debt securities' duration to plan liabilities, (b) the introduction of fiscal 2025 target allocation in fiscal 2024 filings, (c) the consistent emphasis on flexibility and variation within established ranges. The answer reads as if specific data was extracted from a filing, but the numbers do not match the ground truth knowledge graph, suggesting hallucination of financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 513,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated citation of the 1.05 % Notes due 2017—still listed in the debt‑disclosure exhibits of its 2022, 2023 and 2024 Form 10‑K filings—shows that it treats legacy securities as a permanent part of its reporting package, keeping historic debt on record for full transparency and to satisfy SEC rules that require disclosure of all issued notes, even after they have matured.  This disciplined, “keep‑everything‑visible” approach contrasts with its broader 2022‑2024 financing strategy, under which Apple issued new tranches of senior notes (e.g., the 4.421 % Notes due 2026, 4.000 % due 2028, 4.150 % due 2030, etc., as shown in the 2023 Exhibit 4.28) to diversify maturities, take advantage of favorable market rates and fund ongoing capital‑return programs, rather than relying on the older, lower‑coupon debt.  In short, Apple maintains exhaustive, historic debt disclosures while actively expanding its debt base with fresh issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core concept that Apple maintains historical debt disclosures (1.05% Notes due 2017) even after maturity, and accurately characterizes this as a transparent, comprehensive approach. The reasoning about contrasting legacy debt with new issuances is sound and well-articulated. The answer appropriately addresses the multi-part question about disclosure approach and broader debt strategy.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM introduces specific coupon rates and maturity dates (4.421% due 2026, 4.000% due 2028, 4.150% due 2030) that are NOT mentioned in the ground truth answer. While these may be factually accurate Apple debt instruments, they represent UNSOURCED ADDITIONS not present in the original knowledge graph answer. This is problematic because: (1) the ground truth only mentions Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024 as examples of new issuances, and (2) the LLM cites \"2023 Exhibit 4.28\" which cannot be verified against the provided ground truth. The introduction of unverified specific numbers (4.421%, 4.000%, 4.150%) represents potential hallucination or unsourced data.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the comparison between historical disclosure practices and contemporary debt issuance strategy. However, the addition of unverified debt instruments weakens the multi-hop synthesis by introducing elements not grounded in the knowledge graph.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth (comprehensive historical record, transparency, active debt portfolio management), but the specific examples diverge significantly.\n\nJUSTIFICATION: The answer demonstrates good qualitative reasoning and contextual understanding but fails on quantitative accuracy due to introduction of unverified specific coupon rates and maturity dates. The core insight is correct, but the supporting details contain potential errors that reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 540,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase activity grew steadily: it spent about **$4.1 bn** of stock in 2022, continued comparable purchases in 2023, and accelerated to roughly **$4.5 bn** of repurchases in fiscal 2024.  During this period the Board’s remaining authorization rose from **≈ $3.1 bn** (as of Aug 31 2022) to **$2.7 bn** left before the September 2024 increase, and then a **$4 bn** boost was added, bringing total outstanding authority to **$6.7 bn**.  This multi‑year pattern shows that Accenture’s capital‑return strategy is built around consistently expanding and funding its share‑buyback program, underscoring confidence in generating excess cash and a disciplined focus on returning that cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual inaccuracies regarding repurchase amounts. The LLM claims Accenture spent approximately $4.1 billion in fiscal 2022, $4.5 billion in fiscal 2024, and continued comparable purchases in 2023. However, the ground truth states that during fiscal 2024 alone, Accenture purchased 'over $605 million' worth of Class A ordinary shares. This is a massive discrepancy - the LLM overstates fiscal 2024 repurchases by roughly 7-8x ($4.5bn claimed vs. $605M actual). The ground truth does not provide specific repurchase amounts for fiscal 2022 or 2023, making the LLM's claims about $4.1bn in 2022 and comparable amounts in 2023 unverifiable and likely incorrect. CORRECT ELEMENTS: The LLM correctly identifies the remaining authorization amounts ($3.1bn in 2022, $2.7bn before the September 2024 increase) and correctly states the $4bn additional authorization approved in September 2024, bringing total outstanding authority to $6.7bn (matching the ground truth's $6.69bn). MULTI-HOP REASONING: While the LLM attempts to synthesize information across multiple years and connect it to capital strategy, the fundamental misstatement of repurchase amounts undermines the entire analysis. The conclusion about 'consistently expanding and funding its share-buyback program' and 'accelerated' repurchases in 2024 directly contradicts the ground truth, which describes a 'sustained but measured' strategy with specific mention of 'over $605 million' in fiscal 2024 alone. SEMANTIC ISSUES: The LLM's characterization of the pattern as showing 'consistently expanding' buybacks is contradicted by the actual data showing measured, not accelerated, repurchases. The ground truth emphasizes 'strategic share repurchases while maintaining flexibility,' whereas the LLM emphasizes aggressive expansion and acceleration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 507,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were originally issued in November 2019 (Eleventh Supplemental Indenture) and were not expanded or refinanced in the subsequent 2022‑2024 supplemental indentures.  Instead, BMY used 2022‑2024 to add new senior unsecured tranches—e.g., the March 2022 Thirteenth Supplemental Indenture, the November 2023 Fourteenth Supplemental Indenture, and the February 2024 Fifteenth Supplemental Indenture—covering maturities from 2026 to 2064 and coupons ranging from roughly 3.9 % to 6.6 %.  This pattern shows a long‑term financing strategy that relies on a laddered, diversified debt profile with staggered maturities and incremental issuances rather than on extending or restructuring the legacy 2047 tranche.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of BMY's debt issuance strategy and correctly identifies the core pattern: the 4.350% Senior Notes due 2047 remained outstanding across 2022-2024 without refinancing, while new tranches were added through supplemental indentures. STRENGTHS: (1) Correctly identifies the November 2019 origination date of the 2047 notes; (2) Accurately names the supplemental indentures (Thirteenth, Fourteenth, Fifteenth) and their approximate dates (March 2022, November 2023, February 2024); (3) Correctly characterizes the strategy as laddered/diversified with staggered maturities; (4) Accurately notes the coupon range (3.9%-6.6%) and maturity range (2026-2064) for new issuances; (5) Properly synthesizes multi-year data to show persistence of 2047 notes alongside new issuances. WEAKNESSES: (1) The LLM answer omits specific new issuances mentioned in the ground truth (e.g., $1.75B 2.950% Notes due 2032, $2B 3.700% Notes due 2052, $3.75B 4.250% Notes due 2049), which would have provided more concrete evidence of the diversification strategy; (2) Does not explicitly mention that the 2047 notes serve as a 'high-yield component' relative to newer issuances, missing some strategic context; (3) The phrase 'not expanded or refinanced' is technically accurate but slightly different framing than the ground truth's emphasis on 'persistence' and 'remaining part of capital structure.' QUANTITATIVE VERIFICATION: The coupon ranges and maturity ranges cited appear reasonable and consistent with typical debt issuance patterns, though specific dollar amounts for new issuances are absent. The reasoning about laddered maturities and incremental issuances is sound and well-supported. The answer correctly synthesizes information across three years to identify the strategic pattern. Overall, the answer captures the essential insight about BMY's financing strategy but lacks some specific transaction details that would strengthen the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 534,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nApple first mentioned the 2.40 % Notes due 2023 only in the generic indenture exhibit (Exhibit 4.3) of its 2022 Form 10‑K. By the 2023 filing the company added a dedicated “Maturities of Long‑Term Debt” line that disclosed the outstanding principal of those notes and noted they would mature and be settled in 2023. In the 2024 filing the notes were removed from the debt schedule, with a brief footnote confirming that the 2.40 % Notes had been fully redeemed at maturity.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all major points. Ground truth states that Apple's disclosure approach was STABLE AND UNCHANGING across 2022, 2023, and 2024 filings, with the notes consistently listed in Exhibit 4.3 with identical descriptions. The LLM answer claims the opposite: that disclosure evolved significantly with (1) notes only in generic indenture in 2022, (2) addition of dedicated 'Maturities of Long-Term Debt' line in 2023, and (3) removal from debt schedule in 2024. These are directly contradictory claims. The LLM fabricated specific disclosure changes (dedicated maturities line, removal from schedule, redemption footnote) that do not align with the ground truth's assertion of consistent, standardized reporting. The LLM also mischaracterizes the nature of the disclosure by suggesting it evolved from generic to specific to removed, when the ground truth indicates it remained consistent across all three periods. The only potentially correct element is the reference to Exhibit 4.3, but this is undermined by the false claims about how disclosure changed. The answer demonstrates a fundamental failure to synthesize the multi-hop information correctly and invents a narrative of change where none existed according to the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 366,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million Class A ordinary shares** (as stated for fiscal 2022 on page 91) to **141 million shares** (as stated for fiscal 2024 on page 98), an increase of roughly 14 million shares (≈11 %). This expansion of the pool of shares that can be granted shows that Accenture is deliberately enlarging its equity‑based incentive reserve, underscoring a long‑term strategy to sustain and broaden share‑based compensation as a core tool for attracting, retaining and motivating employees while aligning their interests with those of shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numbers: 127 million shares in fiscal 2022 and 141 million shares in fiscal 2024, with an accurate calculation of the 14 million share increase (≈11%). However, there is a critical omission regarding fiscal year 2023. The ground truth explicitly states that the shares increased to 141 million in fiscal 2023 and remained at that level in fiscal 2024. The LLM answer presents the data as a direct progression from 2022 to 2024 without mentioning the intermediate 2023 figure or clarifying when the increase occurred. This is a significant gap because the question specifically asks about the evolution 'from fiscal year 2022 through 2024,' which implies tracking the progression across all three years. The LLM's statement that the increase occurred between 2022 and 2024 is technically correct but incomplete—it should have noted that the increase happened in 2023 and stabilized in 2024. The qualitative analysis about Accenture's long-term share-based compensation strategy is sound and well-reasoned, correctly interpreting the expansion as a deliberate strategic decision. The entity identification (Accenture plc, Class A ordinary shares, Amended 2010 SIP) is accurate. The main weakness is the incomplete temporal breakdown of the three-year period, which represents a partial failure to fully address the multi-hop synthesis requirement of tracking evolution across all specified years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 398,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nFrom 2022 through 2024 Intel progressed PowerVia from an announced breakthrough for the planned Intel 20A node to a qualified component of the Intel 18A process, with high‑volume manufacturing now slated for 2025 (Panther Lake).  The technology’s design, validation and integration—highlighted in the 2022‑2024 10‑K filings—show that PowerVia is being used as the key enabler for Intel’s targeted 15 %+ performance‑per‑watt improvements and for differentiating its IDM 2.0 foundry offerings, underscoring its central role in Intel’s advanced‑process roadmap.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of PowerVia from 2022-2024 and correctly identifies key milestones: introduction in 2022, integration into Intel 20A in 2023, and transition to Intel 18A with 2025 HVM targeting Panther Lake. The answer accurately conveys that PowerVia evolved from a roadmap concept to a foundational technology. However, there are notable differences from the ground truth: (1) The LLM mentions '15%+ performance-per-watt improvements' which is not explicitly stated in the original answer—this appears to be an inference or additional detail not verified against the ground truth. (2) The LLM omits the specific characterization of PowerVia as 'industry-first implementation of backside power delivery' and the explanation of how it optimizes signal transmission by eliminating front-side power routing—these are important technical details that contextualize its significance. (3) The LLM references 'IDM 2.0 foundry offerings' as a strategic context, which is reasonable but not explicitly mentioned in the ground truth. (4) The ground truth explicitly states Intel 'canceled the productization of Intel 20A in favor of the improved Intel 18A'—the LLM's phrasing 'progressed PowerVia from an announced breakthrough for the planned Intel 20A node to a qualified component of the Intel 18A process' is less explicit about this cancellation decision, though it implies the transition. The multi-hop reasoning is sound—the LLM correctly synthesizes information across the three-year period and identifies PowerVia's strategic importance. The quantitative elements (years, node names, 2025 HVM date, Panther Lake) are all accurate. The main weakness is incomplete coverage of technical details and the introduction of the '15%+' metric without clear ground truth support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 488,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s mutual‑fund equity securities in its defined‑benefit pension plans were valued at roughly **$273 million at the end of fiscal 2022**, fell to about **$196 million in fiscal 2023**, and rebounded to **≈$274 million by fiscal 2024** (see the fair‑value tables on pages 89, 95 and 96).  The dip in 2023 reflected a temporary reduction in equity exposure, but the swift restoration to near‑pre‑pandemic levels—coincident with an increase in the plans’ target equity allocation from 21 % (2022) to 27 % (2023) and 28 % (2024)—shows that Accenture is deliberately re‑emphasizing equity‑based investments as a core component of its long‑term strategic positioning.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that are off by a factor of 1000. Ground truth shows: FY2022: $239,293 million, FY2023: $196,226 million, FY2024: $196,226 million. LLM reports: FY2022: ~$273 million, FY2023: ~$196 million, FY2024: ~$274 million. The LLM appears to have dropped three zeros from the actual figures, presenting values that are 1000x smaller than reality. This is a catastrophic quantitative error that invalidates the entire answer. Additionally, the LLM's narrative about a 'rebound' to near pre-pandemic levels and increasing target equity allocations contradicts the ground truth, which shows a consistent decrease from 2022 to 2023 with no change in 2024. The LLM's interpretation of strategic re-emphasis on equity investments is directly opposite to the actual trajectory showing strategic rebalancing away from mutual fund equity securities. The LLM also cites specific page numbers (89, 95, 96) without verification, and the claimed target allocation percentages (21%, 27%, 28%) cannot be verified against the provided ground truth. The multi-hop reasoning is fundamentally flawed due to the incorrect base numbers, leading to an entirely incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 348,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept Dificid (fidaxomicin) in its Hospital‑Acute‑Care portfolio, reporting a steadily rising worldwide sales footprint—$263 million in 2022, $302 million in 2023 and $340 million in 2024—while the intangible asset remained on the books at roughly $145 million (no impairment noted).  Therapeutically the drug continued to be positioned as the sole FDA‑approved, narrow‑spectrum therapy for C. difficile‑associated diarrhea, with no major label expansion disclosed, but Merck leveraged its growing sales to boost its contribution to the Pharmaceutical segment (still under 1 % of total pharma revenue).  The consistent revenue growth and unchanged valuation reflect a stable, strategically supported focus on Dificid as a niche, high‑margin product within Merck’s broader hospital‑care lineup.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Dificid as a Hospital Acute Care product, accurately reports the 2024 sales figure of $340 million, correctly notes the $145 million intangible asset valuation, and appropriately characterizes it as a niche, high-margin product with stable positioning. The therapeutic positioning as an FDA-approved narrow-spectrum C. difficile therapy is accurate. The multi-hop synthesis across years and financial dimensions is generally sound.\n\nCRITICAL ERRORS: The LLM provides incorrect revenue figures for 2022 and 2023. It states $263 million in 2022 and $302 million in 2023, but the ground truth only provides 2024 data ($340 million total: $303M U.S., $37M international). The LLM appears to have fabricated or misattributed 2022-2023 revenue figures without ground truth support. This is a significant factual error that undermines credibility.\n\nPARTIAL ISSUES: While the LLM correctly identifies the 2024 U.S. revenue as $303 million (matching ground truth), it does not explicitly mention the $37 million international component, though this is a minor omission. The statement about \"no major label expansion\" is reasonable inference but not explicitly confirmed in ground truth.\n\nQUANTITATIVE ACCURACY PENALTY: The fabrication of 2022-2023 revenue figures ($263M and $302M) without ground truth support is a major quantitative error. Only the 2024 figure ($340M) is verifiable as correct. This represents a 2-out-of-3 year accuracy rate on the primary financial metric.\n\nQUALITATIVE ASSESSMENT: The reasoning about strategic positioning, asset valuation stability, and therapeutic focus is sound and well-articulated. The synthesis of financial and strategic elements is coherent, even though the underlying 2022-2023 numbers are unsupported.\n\nJUSTIFICATION: The correctness score of 6 reflects that while the answer demonstrates good understanding of Dificid's strategic role and correctly reports 2024 data, it introduces unverified historical revenue figures that constitute material factual errors. The answer would be stronger if it acknowledged data limitations for earlier years rather than providing unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 585,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled‑down on advanced‑packaging and disaggregated‑design as a core pillar of its IDM 2.0 strategy, pouring roughly $16‑$17 billion a year into R&D (≈ 30 % of revenue) while racing to launch new packaging nodes (e.g., Intel 18A, 2D/2.5D/3D solutions) and to secure design wins (four 18A wins in 2023 and five new AI‑focused packaging wins).  However, repeated setbacks—delays in 10 nm/Intel 4 (7 nm) processes, a $922 million Gaudi‑AI inventory charge and a $3.1 billion impairment of the Intel 7 node in 2024, plus a $755 million penalty for stalled Irish fab expansion—have kept execution risk high, inflating operating losses and forcing the company to lean on external funding and government incentives to bridge the gap.  Consequently, the company’s financial exposure has grown: packaging‑related revenue rose (driving a $483 million revenue jump in 2023), but the heightened R&D and cap‑ex spend, coupled with the prospect of further asset write‑downs and delayed time‑to‑market, has left Intel’s profitability and cash‑flow outlook increasingly vulnerable to any further slowdown in packaging rollout.  (Pages 54, 35‑36, 38, 55‑56, 32‑34).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains several unverified and potentially incorrect financial figures that cannot be confirmed against the ground truth: (1) The claim of '$16-$17 billion a year into R&D (≈30% of revenue)' is not mentioned in the original answer and appears to be unsupported speculation. (2) The '$922 million Gaudi-AI inventory charge' is not referenced in the ground truth. (3) The '$755 million penalty for stalled Irish fab expansion' is not mentioned in the original answer. (4) The '$483 million revenue jump in 2023' from packaging is not corroborated. These unverified numbers significantly undermine credibility. CORRECT ELEMENTS: The LLM correctly identifies the $3.1 billion impairment charge (matching ground truth), correctly references Intel 18A and 2D/2.5D/3D packaging solutions, and correctly mentions the UCIe standard (though not explicitly named in original). The overall narrative arc from strategic optimism to operational strain is directionally correct. SYNTHESIS ISSUES: While the LLM attempts multi-hop reasoning across 2022-2024, it introduces specific financial metrics not present in the ground truth without clear sourcing. The answer conflates different types of charges (inventory, impairments, penalties) in ways that may not be accurate. COMPLETENESS: The answer does address R&D investment, implementation delays, and financial risk exposure as requested, but the specific numbers provided lack verification. The ground truth emphasizes a shift from optimism to strain; the LLM captures this but adds unsubstantiated financial details that weaken the response. RECOMMENDATION: The core narrative is sound, but the introduction of unverified financial figures (especially the $922M, $755M, and $483M claims) represents a critical failure in quantitative accuracy for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 514,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s HIV‑1 candidate MK‑8591A moved from a Phase 3 program (Phase 3 entry listed in 2022‑23 filings) to a planned NDA submission in 2023, but the FDA later placed a clinical hold on the islatravir component (noted in the 2023‑24 updates), forcing the company to pause the filing and redesign the regimen.  In October 2024 Merck introduced a next‑generation fixed‑dose combination, MK‑8591D (islatravir + lenacapavir), and resumed Phase 3 enrollment, indicating a shift toward long‑acting, less‑frequent HIV therapies.  This progression shows Merck’s long‑term strategy of investing in novel, adherence‑friendly HIV regimens and leveraging its antiviral expertise to maintain a leading position in a market where durable, resistance‑sensitive treatment options are essential.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) INCORRECT TIMELINE: The LLM claims MK-8591A moved to 'planned NDA submission in 2023' - the ground truth shows it remained in Phase 3 with no regulatory submission through 2024. (2) INCORRECT CLINICAL HOLD DETAILS: The LLM states 'FDA placed a clinical hold on the islatravir component' in 2023-24, but the ground truth indicates the FDA LIFTED a clinical hold on December 4, 2024 - a fundamental reversal of the actual regulatory status. (3) INCORRECT PRODUCT INTRODUCTION: The LLM introduces MK-8591D (islatravir + lenacapavir) as a 'next-generation' product introduced in October 2024 with resumed Phase 3 enrollment - this is NOT mentioned in the ground truth at all. The ground truth makes no reference to MK-8591D or any October 2024 product launch. (4) INCOMPLETE ACCURACY: The LLM correctly identifies MK-8591A as a Phase 3 program and mentions regulatory challenges, but the specific regulatory resolution (lifting of clinical hold on Dec 4, 2024) is mischaracterized as a placement rather than a lifting. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the regulatory timeline across the 2022-2024 period. The ground truth shows persistent Phase 3 status with eventual regulatory relief in December 2024, while the LLM incorrectly portrays a failed NDA attempt and product pivot. The strategic interpretation about 'long-acting, less-frequent HIV therapies' and 'adherence-friendly' regimens is speculative and not grounded in the provided ground truth. The answer demonstrates a fundamental misunderstanding of the actual regulatory progression and introduces unverified product information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 472,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nFrom 2022 through 2024 Merck narrowed the MK‑1308A program from an initial “advanced solid‑tumor” portfolio (see 2022 pages 25‑27) to a dedicated renal‑cell‑carcinoma (RCC) focus by 2023‑2024 (see 2023 pages 19‑20 and 2024 page 52), while continuing to develop it as a quavonlimab + pembrolizumab combination; the effort advanced to late‑stage clinical testing with the necessary regulatory submissions now under FDA/EMA review.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) REGULATORY STATUS CLAIM - The LLM states MK-1308A has 'regulatory submissions now under FDA/EMA review,' but the ground truth explicitly states 'with no indication of regulatory approval yet.' This is a significant factual error regarding regulatory progress. (2) FORMULATION DESCRIPTION - The LLM describes it as 'quavonlimab + pembrolizumab combination' but the ground truth specifies it is a 'coformulation' of these two agents. While semantically similar, the ground truth emphasizes the specific formulation strategy more precisely. (3) CLINICAL STAGE PROGRESSION - The LLM claims advancement to 'late-stage clinical testing' but the ground truth consistently describes it as remaining in 'Phase 3' across all three years (2022-2024), which is accurate but the LLM's phrasing of 'late-stage' is vague and potentially misleading about the specific phase. (4) CORRECT ELEMENTS - The LLM correctly identifies: the narrowing from broader oncology focus to RCC-specific focus, the combination therapy with pembrolizumab, the timeframe (2022-2024), and the increasing specificity of the therapeutic strategy. (5) MISSING DETAILS - The LLM omits the explicit 2023 identification of quavonlimab as an 'anti-CTLA-4 antibody,' which provides important mechanistic context. The page references cited appear plausible but cannot be verified against the ground truth. The most serious issue is the false claim about FDA/EMA regulatory submissions under review, which contradicts the ground truth's explicit statement of no regulatory approval indication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 433,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly $4.1 billion of its Class A shares in 2022, about $4.5 billion in 2023 and continued buying (≈ 2 million shares for $605 million in the fourth quarter of 2024), while the Board repeatedly expanded the program’s size—​the remaining repurchase authority grew from roughly $3 billion in 2022 to a $6.7 billion total authorization after the September 2024 increase. This steady rise in both the dollar amount of purchases and the authorized capacity shows a deliberate, multi‑year capital‑return strategy that prioritizes ongoing share‑buybacks (combined with dividends) to return cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine its credibility. (1) REPURCHASE AMOUNTS - The LLM claims Accenture repurchased 'roughly $4.1 billion' in 2022 and 'about $4.5 billion' in 2023, but the ground truth provides no such figures. The only specific repurchase amount mentioned in ground truth is $605 million for fiscal 2024. The LLM appears to have fabricated these 2022 and 2023 figures without evidence from the filings. (2) AUTHORIZATION FIGURES - The LLM correctly identifies the $3 billion authorization in 2022 and the $6.7 billion total after September 2024, which aligns with ground truth ($3,129,296 thousand ≈ $3.13 billion in 2022, declining to $2,694 million available, then $6,694 million total after $4 billion new authorization). However, the statement that 'remaining repurchase authority grew from roughly $3 billion in 2022 to a $6.7 billion total' is misleading—the available authorization actually DECREASED from $3.13 billion to $2.694 billion before the new $4 billion was added. (3) SHARE COUNT - The LLM mentions '2 million shares for $605 million in the fourth quarter of 2024,' which aligns with ground truth's '2,000,308 Class A ordinary shares for $605 million' in fiscal 2024, though the LLM doesn't clarify this was the full fiscal year, not just Q4. (4) MISSING DETAILS - The LLM omits the 72,255 shares acquired through employee-related transactions and fails to mention the forward-looking disclosure pattern noted in the ground truth. (5) REASONING QUALITY - While the LLM correctly identifies the multi-year capital return strategy and periodic replenishment pattern, the fabricated repurchase amounts for 2022-2023 represent a fundamental failure in data synthesis. The conclusion about 'steady rise in both dollar amount of purchases and authorized capacity' is partially correct regarding authorization but unsupported regarding actual purchase amounts. The answer demonstrates reasonable understanding of the strategic intent but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 563,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million, 2.350 % Notes due 2040 remain a staple of BMS’s long‑term debt profile, appearing in the 2022‑2023 supplemental‑indenture filings and still listed in the 2024 Exhibit index. By retaining this low‑cost, 20‑year fixed‑rate tranche, the company locks in financing for an extended horizon, manages interest‑rate risk, and preserves flexibility to fund operations and acquisitions while staying within its target leverage strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the $750 million principal amount, 2.350% interest rate, and 2040 maturity date are accurately stated. (2) The LLM correctly identifies the notes as appearing across multiple years (2022-2024) and recognizes their persistence in the capital structure. (3) The reasoning about fixed-rate debt strategy, interest rate risk management, and long-term financing is sound and semantically equivalent to the ground truth. (4) The mention of 'low-cost, 20-year fixed-rate tranche' correctly characterizes the instrument's nature. WEAKNESSES: (1) The LLM answer is less comprehensive than the ground truth - it doesn't explicitly confirm the notes' presence in all three years (2022, 2023, 2024) with the same clarity as the original answer, which methodically walks through each year. (2) The reference to 'supplemental-indenture filings' and 'Exhibit index' is somewhat vague compared to the ground truth's explicit statement about 'capital structure filings.' (3) The LLM adds contextual elements ('fund operations and acquisitions,' 'target leverage strategy') that, while reasonable, are not explicitly confirmed in the ground truth and represent some inference beyond what was stated. (4) The ground truth emphasizes the strategic decision to 'not refinance or retire' the instrument despite market fluctuations, which the LLM answer doesn't explicitly address. MULTI-HOP REASONING: The LLM correctly synthesizes information about the debt instrument's persistence across years and its role in debt management strategy, though with less explicit year-by-year confirmation than the ground truth. The core insight about fixed-rate debt strategy is present and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 467,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nBristol‑Myers Squibb first created its 4.350 % Senior Notes due 2047 in the November 2019 supplemental indenture (Exhibit 4.19) and, as reflected in the later 2022 (Thirteenth Supplemental Indenture) and 2023 (Fourteenth Supplemental Indenture) filings, the terms and coupon of that tranche have not been altered.  This unchanged 4.350 % rate demonstrates the company’s strategy of preserving a stable, fixed‑rate long‑term funding pillar while supplementing the balance sheet with newer, higher‑coupon issuances, underscoring a disciplined approach to managing interest cost and maintaining debt‑capacity flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN DATES AND EXHIBIT REFERENCES: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) QUANTITATIVE/DATE ERRORS: The LLM states the notes were created in 'November 2019 supplemental indenture (Exhibit 4.19)' and references a 'Thirteenth Supplemental Indenture' for 2022. However, the ground truth clearly indicates the Twelfth Supplemental Indenture dated November 13, 2020 (not 2019, not Thirteenth) for 2022, and the Fourteenth Supplemental Indenture for 2023. The LLM also incorrectly identifies the exhibit numbers - ground truth shows Exhibit 4bbb for 2022 and Exhibit 4ff for 2023/2024, not Exhibit 4.19. The original Form 8-K is dated November 22, 2019 (not just 'November 2019'), and the indenture itself is from November 13, 2020. (2) WHAT WAS CORRECT: The LLM correctly identifies the 4.350% interest rate and that it remained unchanged across filings. The semantic interpretation about stable, fixed-rate financing strategy is reasonable and aligns with the ground truth's conclusion about 'deliberate and stable long-term debt strategy.' (3) MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple years and filings, which is appropriate for the question. However, the synthesis is undermined by the incorrect exhibit and indenture references. (4) COMPLETENESS: The LLM addresses the core question about rate consistency and strategic implications, but fails to provide accurate filing references and exhibit numbers that would demonstrate proper multi-hop synthesis across the 2022, 2023, and 2024 filings. The ground truth's specific exhibit progression (4bbb → 4ff → 4ff) is not captured. The LLM's interpretation about 'newer, higher-coupon issuances' adds context not explicitly in the ground truth, which could be seen as either insightful or speculative. OVERALL: While the LLM captures the essential finding (unchanged 4.350% rate indicating stable strategy), the numerous errors in dates, exhibit numbers, and indenture references represent significant factual inaccuracies that would be problematic in a financial/legal context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 578,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Nike’s disclosures shifted from a brief mention of FlyEase as one of several “innovation” technologies to an explicit reference that FlyEase‑enabled components are produced by its wholly‑owned Air Manufacturing Innovation unit and supplied to contract manufacturers in Vietnam, China and the United States.  The 2024 filing quantifies this scale by noting that 15 contract manufacturers produced NIKE Brand footwear, the largest of which accounted for roughly 9 % of total footwear output and that the top five manufacturers together supplied about 57 % of footwear—demonstrating that FlyEase‑enabled products are now a material, globally dispersed component of Nike’s manufacturing operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites specific manufacturing percentages (15 contract manufacturers, largest ~9%, top 5 = ~57%) that do NOT appear in the ground truth. The ground truth provides Vietnam 50%, Indonesia 27%, China 18% - completely different numbers. The LLM's figures appear fabricated or sourced from incorrect filings. (2) ENTITY/STRUCTURAL ERRORS: The LLM introduces 'Air Manufacturing Innovation unit' as a wholly-owned entity that supplies to contract manufacturers - this specific claim is not in the ground truth and appears to conflate or misrepresent Nike's manufacturing structure. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly traces FlyEase evolution across three fiscal years (2022→2023→2024) with clear progression narrative. The LLM mentions the evolution but then pivots to different manufacturing data that doesn't align with the ground truth's geographic distribution claims. (4) MISSING KEY EVIDENCE: The ground truth's core quantitative evidence (Vietnam 50%, Indonesia 27%, China 18% of Nike Brand footwear) is completely absent from the LLM answer, replaced with unverified contract manufacturer percentages. (5) SEMANTIC MISMATCH: While both answers attempt to show global integration, they cite fundamentally different manufacturing data, suggesting the LLM either hallucinated numbers or consulted incorrect source material. The ground truth's geographic manufacturing distribution is the actual quantitative evidence requested; the LLM's contract manufacturer breakdown is a different metric entirely and appears incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 467,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nThe RedCard (Target Circle Card) penetration fell steadily from about **20.5 % of purchases in fiscal 2022** to **19.8 % in fiscal 2023** and **18.6 % in fiscal 2024**.  This decline signals that Target’s loyalty‑driven payment incentive—offering a 5 % discount for using a RedCard—is losing its ability to attract additional spend, suggesting the strategy is becoming less effective at driving incremental sales through card‑based discounts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUE - CRITICAL ERROR: The LLM provides 18.6% for fiscal 2024, but the ground truth states 17.8% for 2024. This is a material discrepancy of 0.8 percentage points. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The error in the 2024 figure is significant because it affects the magnitude of the overall trend analysis and the conclusion about strategy effectiveness. QUALITATIVE ASSESSMENT: The LLM correctly identifies the declining trend and provides sound reasoning about what the decline suggests (reduced effectiveness of loyalty-driven payment strategy, weakening customer engagement). The addition of context about the 5% discount incentive is helpful and accurate. The synthesis of the multi-hop information (tracking penetration rates across three years and drawing conclusions about strategy effectiveness) is logically sound. COMPLETENESS: The answer addresses both parts of the question - the evolution of penetration rates AND what the trend suggests about strategy effectiveness. The reasoning connecting declining penetration to reduced strategy effectiveness is appropriate. ENTITY ACCURACY: Correctly identifies Target, RedCard/Target Circle Card, and the relevant time periods (fiscal 2022-2024). SEMANTIC EQUIVALENCE: The wording differs from ground truth but conveys similar meaning regarding the declining trend and its implications. However, the factual error in the 2024 figure undermines the credibility of the quantitative analysis. The error appears to be a data retrieval or calculation mistake rather than a conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 437,
        "total_tokens": 1668
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 5.05,
    "average_quantitative_accuracy": 5.14,
    "average_qualitative_accuracy": 5.4,
    "average_contextual_relevance": 6.41,
    "score_distribution": {
      "excellent": 105,
      "good": 142,
      "fair": 268,
      "poor": 285
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 32911.25,
    "timestamp": "2026-02-03T00:48:56.993771"
  }
}